1	Biochemical	JJ	O	biochemical	amod	2	SENT_1	[p1l810t81r963b103],
2	Pharmacology	NN	O	pharmacology	_	0	SENT_1	[p1l974t81r1153b108],
3	83	CD	NUMBER	83	number	4	SENT_1	[p1l1164t82r1193b103],
4	(	CD	NUMBER	(	dep	2	SENT_1	[p1l1205t81r1288b108],
5	2012	CD	DATE	2012	dep	4	SENT_1	[p1l1205t81r1288b108],
6	)	CD	NUMBER	)	num	7	SENT_1	[p1l1205t81r1288b108],
7	903-908	CD	NUMBER	903-908	dep	2	SENT_1	[p1l1299t82r1409b103],

1	Contents	NNS	O	contents	_	0	SENT_2	[p1l706t188r842b213],
2	lists	NNS	O	list	dep	1	SENT_2	[p1l856t188r915b213],
3	available	JJ	O	available	amod	2	SENT_2	[p1l928t188r1064b213],
4	at	IN	O	at	_	0	SENT_2	[p1l1078t191r1105b213],
5	SciVerse	NNP	O	SciVerse	nn	6	SENT_2	[p1l1118t188r1250b213],
6	ScienceDirect	NNP	O	ScienceDirect	prep_at	3	SENT_2	[p1l1264t188r1473b213],

1	‘	NN	O	‘	_	0	SENT_3	[p1l43t282r50b290],
2	’	CD	NUMBER	’	number	3	SENT_3	[p1l70t290r75b291],
3	,3	CD	NUMBER	,3	dep	1	SENT_3	[p1l117t325r162b389],
4	Biochemical	JJ	O	biochemical	amod	6	SENT_3	[p1l732t286r1050b332],
5	Pharmacology	NN	O	pharmacology	nn	6	SENT_3	[p1l1074t286r1447b344],
6	Es	NNS	O	e	dep	3	SENT_3	[p1l15t385r97b453],

1	»	NN	O	»	_	0	SENT_4	[p1l119t383r161b389],
2	_	SYM	O	_	dep	4	SENT_4	[p1l119t383r161b389],
3	@c	FW	O	@c	nn	4	SENT_4	[p1l200t372r252b396],
4	*	FW	O	*	rcmod	1	SENT_4	[p1l200t372r252b396],
5	E	NN	O	e	dep	1	SENT_4	[p1l101t417r249b451],
6	\	CD	NUMBER	\	num	5	SENT_4	[p1l101t417r249b451],
7	/	:	O	/	punct	11	SENT_4	[p1l101t417r249b451],
8	[	CD	NUMBER	[	num	11	SENT_4	[p1l101t417r249b451],
9	ER	NN	O	er	nn	11	SENT_4	[p1l101t417r249b451],
10	journal	NN	O	journal	nn	11	SENT_4	[p1l511t418r643b448],
11	homepage	NN	O	homepage	dep	5	SENT_4	[p1l664t418r867b449],
12	:	:	O	:	_	0	SENT_4	[p1l664t418r867b449],
13	www.elsevier.com/locate/biochempharm	NN	O	www.elsevier.com/locate/biochempharm	dep	11	SENT_4	[p1l885t418r1663b448],

1	The	DT	O	the	det	2	SENT_5	[p1l6t565r103b610],
2	impact	NN	O	impact	_	0	SENT_5	[p1l127t566r310b621],
3	of	IN	O	of	_	0	SENT_5	[p1l332t565r387b610],
4	genetic	JJ	O	genetic	amod	5	SENT_5	[p1l403t566r595b621],
5	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_5	[p1l618t565r1035b621],
6	of	IN	O	of	_	0	SENT_5	[p1l1059t565r1114b610],
7	P2Y12	NN	O	p2y12	prep_of	2	SENT_5	[p1l1129t567r1301b617],
8	,	,	O	,	_	0	SENT_5	[p1l1129t567r1301b617],
9	CYP3A5	NN	O	cyp3a5	prep_of	2	SENT_5	[p1l1326t567r1519b610],
10	and	CC	O	and	_	0	SENT_5	[p1l1543t565r1639b610],
11	CYP2C19	NN	O	cyp2c19	prep_of	2	SENT_5	[p1l1663t567r1887b610],
12	on	IN	O	on	dep	2	SENT_5	[p1l1910t578r1975b610],
13	clopidogrel	NN	O	clopidogrel	nn	15	SENT_5	[p1l8t636r305b692],
14	response	NN	O	response	nn	15	SENT_5	[p1l329t649r564b692],
15	variability	NN	O	variability	pobj	12	SENT_5	[p1l586t636r860b692],
16	in	IN	O	in	dep	2	SENT_5	[p1l882t637r931b680],
17	Iranian	JJ	MISC	iranian	amod	18	SENT_5	[p1l954t637r1141b681],
18	patients	NNS	O	patient	pobj	16	SENT_5	[p1l1165t637r1377b692],

1	Soha	NNP	PERSON	Soha	nn	2	SENT_6	[p1l6t742r104b777],
2	Namazi	NNP	PERSON	Namazi	_	0	SENT_6	[p1l122t742r279b777],
3	3	CD	NUMBER	3	num	2	SENT_6	[p1l290t735r343b783],
4	'	''	O	'	_	0	SENT_6	[p1l290t735r343b783],
5	1	CD	NUMBER	1	dep	2	SENT_6	[p1l290t735r343b783],
6	,	,	O	,	_	0	SENT_6	[p1l290t735r343b783],
7	Javad	NNP	PERSON	Javad	appos	5	SENT_6	[p1l356t742r472b786],
8	I	PRP	O	I	nsubj	9	SENT_6	[p1l491t734r682b786],
9	(	VBP	O	(	rcmod	7	SENT_6	[p1l491t734r682b786],
10	ojuri	NNS	O	ojurus	poss	12	SENT_6	[p1l491t734r682b786],
11	'	POS	O	'	_	0	SENT_6	[p1l491t734r682b786],
12	°	NN	O	°	dobj	9	SENT_6	[p1l491t734r682b786],
13	'	''	O	'	_	0	SENT_6	[p1l491t734r682b786],
14	1	CD	NUMBER	1	tmod	9	SENT_6	[p1l491t734r682b786],
15	,	,	O	,	_	0	SENT_6	[p1l491t734r682b786],
16	Andia	NNP	PERSON	Andia	appos	2	SENT_6	[p1l699t742r820b777],
17	I	PRP	PERSON	I	nsubj	18	SENT_6	[p1l839t735r1035b782],
18	(	VBP	O	(	rcmod	16	SENT_6	[p1l839t735r1035b782],
19	halili	NNS	O	halilus	nsubj	30	SENT_6	[p1l839t735r1035b782],
20	"	``	O	"	punct	19	SENT_6	[p1l839t735r1035b782],
21	"	``	O	"	punct	22	SENT_6	[p1l839t735r1035b782],
22	1	CD	NUMBER	1	dep	19	SENT_6	[p1l839t735r1035b782],
23	,	,	O	,	_	0	SENT_6	[p1l839t735r1035b782],
24	Negar	NNP	PERSON	Negar	nn	26	SENT_6	[p1l1054t744r1177b786],
25	Azarpira	NNP	PERSON	Azarpira	nn	26	SENT_6	[p1l1192t742r1369b786],
26	°	NN	O	°	appos	22	SENT_6	[p1l1379t740r1419b761],
27	'	''	O	'	_	0	SENT_6	[p1l1379t740r1419b761],
28	*	CD	NUMBER	*	num	30	SENT_6	[p1l1379t740r1419b761],
29	“	NNP	O	“	nn	30	SENT_6	[p1l6t817r167b845],
30	Department	NNP	ORGANIZATION	Department	xcomp	18	SENT_6	[p1l6t817r167b845],
31	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l177t818r203b845],
32	Pharmacotherapy	NNP	ORGANIZATION	Pharmacotherapy	prep_of	30	SENT_6	[p1l208t818r427b845],
33	.	.	O	.	_	0	SENT_6	[p1l208t818r427b845],

1	Faculty	NN	O	faculty	_	0	SENT_7	[p1l439t818r526b845],
2	of	IN	O	of	_	0	SENT_7	[p1l537t818r563b845],
3	Pharmacy	NN	O	pharmacy	prep_of	1	SENT_7	[p1l569t818r694b845],
4	,	,	O	,	_	0	SENT_7	[p1l569t818r694b845],
5	Shiraz	NNP	ORGANIZATION	Shiraz	nn	6	SENT_7	[p1l705t818r780b840],
6	University	NNP	ORGANIZATION	University	appos	3	SENT_7	[p1l791t818r913b845],
7	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l924t818r950b845],
8	Medical	NNP	ORGANIZATION	Medical	nn	9	SENT_7	[p1l955t818r1050b840],
9	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	6	SENT_7	[p1l1059t818r1163b843],
10	,	,	O	,	_	0	SENT_7	[p1l1059t818r1163b843],
11	Shiraz	NNP	O	Shiraz	appos	9	SENT_7	[p1l1174t818r1253b843],
12	,	,	O	,	_	0	SENT_7	[p1l1174t818r1253b843],
13	Iran	NNP	LOCATION	Iran	nn	17	SENT_7	[p1l1265t819r1313b840],
14	"	``	O	"	punct	17	SENT_7	[p1l6t848r168b880],
15	Department	NNP	ORGANIZATION	Department	nn	17	SENT_7	[p1l6t848r168b880],
16	of	IN	ORGANIZATION	of	amod	17	SENT_7	[p1l178t853r204b880],
17	Cardiology	NNP	ORGANIZATION	Cardiology	appos	9	SENT_7	[p1l210t853r343b880],
18	,	,	O	,	_	0	SENT_7	[p1l210t853r343b880],
19	Faculty	NNP	ORGANIZATION	Faculty	appos	9	SENT_7	[p1l355t853r442b880],
20	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l453t853r479b880],
21	Medicine	NNP	ORGANIZATION	Medicine	prep_of	19	SENT_7	[p1l484t853r598b878],
22	,	,	O	,	_	0	SENT_7	[p1l484t853r598b878],
23	Shiraz	NNP	ORGANIZATION	Shiraz	nn	24	SENT_7	[p1l609t853r684b875],
24	University	NNP	ORGANIZATION	University	appos	9	SENT_7	[p1l695t853r817b880],
25	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l828t853r854b880],
26	Medical	NNP	ORGANIZATION	Medical	nn	27	SENT_7	[p1l859t853r954b875],
27	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	24	SENT_7	[p1l963t853r1067b878],
28	,	,	O	,	_	0	SENT_7	[p1l963t853r1067b878],
29	Shiraz	NNP	O	Shiraz	dep	1	SENT_7	[p1l1078t853r1157b878],
30	,	,	O	,	_	0	SENT_7	[p1l1078t853r1157b878],
31	Iran	NNP	LOCATION	Iran	nn	35	SENT_7	[p1l1169t854r1217b875],
32	“	CD	NUMBER	“	num	35	SENT_7	[p1l6t888r150b916],
33	Transplant	NNP	ORGANIZATION	Transplant	nn	35	SENT_7	[p1l6t888r150b916],
34	Research	NNP	ORGANIZATION	Research	nn	35	SENT_7	[p1l159t889r265b911],
35	Center	NNP	ORGANIZATION	Center	appos	29	SENT_7	[p1l277t890r358b914],
36	,	,	O	,	_	0	SENT_7	[p1l277t890r358b914],
37	Shiraz	NNP	ORGANIZATION	Shiraz	nn	38	SENT_7	[p1l370t889r445b911],
38	University	NNP	ORGANIZATION	University	appos	29	SENT_7	[p1l456t889r577b916],
39	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l588t889r614b916],
40	Medical	NNP	ORGANIZATION	Medical	nn	41	SENT_7	[p1l619t889r714b911],
41	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	38	SENT_7	[p1l724t889r828b914],
42	,	,	O	,	_	0	SENT_7	[p1l724t889r828b914],
43	Shiraz	NNP	O	Shiraz	nn	45	SENT_7	[p1l839t889r918b914],
44	,	,	O	,	_	0	SENT_7	[p1l839t889r918b914],
45	Iran	NNP	LOCATION	Iran	appos	29	SENT_7	[p1l929t890r978b911],

1	ARTICLEINFO	NNP	O	ARTICLEINFO	_	0	SENT_8	[p1l6t1028r308b1048],
2	ABSTRACT	NN	O	abstract	dep	1	SENT_8	[p1l698t1028r915b1048],

1	Article	NNP	O	Article	nn	2	SENT_9	[p1l6t1097r82b1119],
2	history	NN	O	history	_	0	SENT_9	[p1l96t1097r183b1124],
3	-	:	O	-	_	0	SENT_9	[p1l96t1097r183b1124],
4	‘	CD	NUMBER	‘	dep	2	SENT_9	[p1l96t1097r183b1124],
5	Clopidogrel	NNP	O	Clopidogrel	nsubj	8	SENT_9	[p1l708t1098r870b1129],
6	is	VBZ	O	be	cop	8	SENT_9	[p1l887t1099r908b1123],
7	an	DT	O	a	det	8	SENT_9	[p1l924t1105r957b1123],
8	inhibitor	NN	O	inhibitor	rcmod	4	SENT_9	[p1l973t1098r1098b1123],
9	of	IN	O	of	_	0	SENT_9	[p1l1113t1098r1142b1123],
10	platelet	NN	O	platelet	nn	13	SENT_9	[p1l1154t1098r1262b1129],
11	ADP	NN	O	adp	nn	13	SENT_9	[p1l1276t1100r1337b1123],
12	P2Yl2	NN	O	p2yl2	nn	13	SENT_9	[p1l1352t1100r1440b1123],
13	receptors	NNS	O	receptor	prep_of	8	SENT_9	[p1l1457t1102r1588b1129],
14	and	CC	O	and	_	0	SENT_9	[p1l1605t1098r1656b1123],
15	currently	RB	DATE	currently	advmod	16	SENT_9	[p1l1672t1098r1803b1129],
16	used	VBN	O	use	rcmod	4	SENT_9	[p1l1818t1098r1883b1123],
17	for	IN	O	for	_	0	SENT_9	[p1l1900t1098r1939b1123],
18	prevention	NN	O	prevention	prep_for	16	SENT_9	[p1l1954t1099r2109b1129],
19	of	IN	O	of	_	0	SENT_9	[p1l2125t1098r2154b1123],
20	stent	NN	O	stent	prep_of	18	SENT_9	[p1l6t1142r76b1163],
21	Received	VBN	O	receive	partmod	20	SENT_9	[p1l8t1167r118b1189],
22	6	CD	DATE	6	num	23	SENT_9	[p1l130t1168r144b1189],
23	November	NNP	DATE	November	dobj	21	SENT_9	[p1l155t1167r286b1189],
24	2011	CD	DATE	2011	num	23	SENT_9	[p1l296t1168r355b1189],
25	Accepted	JJ	O	accepted	amod	26	SENT_9	[p1l6t1203r122b1230],
26	3	CD	DATE	3	dep	23	SENT_9	[p1l132t1204r146b1225],
27	January	NNP	DATE	January	tmod	23	SENT_9	[p1l155t1204r254b1230],
28	2012	CD	DATE	2012	num	27	SENT_9	[p1l264t1204r326b1225],
29	Available	JJ	O	available	amod	23	SENT_9	[p1l6t1239r118b1260],
30	online	NN	O	online	prep	23	SENT_9	[p1l129t1239r204b1260],
31	12	CD	DATE	12	dep	30	SENT_9	[p1l216t1240r243b1260],
32	January	NNP	DATE	January	tmod	21	SENT_9	[p1l252t1240r347b1266],
33	2012	CD	DATE	2012	num	32	SENT_9	[p1l357t1240r416b1260],

1	thrombosis	NN	O	thrombosis	_	0	SENT_10	[p1l6t1352r174b1376],
2	.	.	O	.	_	0	SENT_10	[p1l6t1352r174b1376],

1	Despite	IN	O	despite	_	0	SENT_11	[p1l194t1352r300b1382],
2	certain	JJ	O	certain	amod	4	SENT_11	[p1l320t1352r417b1376],
3	clinical	JJ	O	clinical	amod	4	SENT_11	[p1l437t1352r537b1376],
4	beneﬁt	NN	O	beneﬁt	prep_despite	22	SENT_11	[p1l556t1352r656b1376],
5	using	VBG	O	use	partmod	4	SENT_11	[p1l675t1352r751b1382],
6	this	DT	O	this	det	7	SENT_11	[p1l769t1352r821b1376],
7	drug	NN	O	drug	dobj	5	SENT_11	[p1l841t1352r907b1382],
8	in	IN	O	in	_	0	SENT_11	[p1l925t1352r952b1376],
9	patients	NNS	O	patient	prep_in	5	SENT_11	[p1l971t1352r1085b1382],
10	undergoing	VBG	O	undergo	partmod	9	SENT_11	[p1l1105t1352r1268b1382],
11	percutaneous	JJ	O	percutaneous	amod	16	SENT_11	[p1l1287t1355r1478b1382],
12	coronary	JJ	O	coronary	amod	16	SENT_11	[p1l6t1399r132b1422],
13	intervention	NN	O	intervention	nn	16	SENT_11	[p1l143t1392r318b1416],
14	(	CD	NUMBER	(	num	16	SENT_11	[p1l329t1392r403b1422],
15	PCI	NN	O	pcus	nn	16	SENT_11	[p1l329t1392r403b1422],
16	)	NN	O	)	dobj	10	SENT_11	[p1l329t1392r403b1422],
17	,	,	O	,	_	0	SENT_11	[p1l329t1392r403b1422],
18	some	DT	O	some	det	19	SENT_11	[p1l414t1399r489b1416],
19	patients	NNS	O	patient	nsubj	22	SENT_11	[p1l499t1392r613b1422],
20	do	VBP	O	do	aux	22	SENT_11	[p1l624t1392r658b1416],
21	not	RB	O	not	neg	22	SENT_11	[p1l669t1395r715b1416],
22	attain	VB	O	attain	_	0	SENT_11	[p1l725t1392r807b1416],
23	adequate	JJ	O	adequate	amod	25	SENT_11	[p1l818t1392r948b1422],
24	antiplatelet	JJ	O	antiplatelet	amod	25	SENT_11	[p1l959t1392r1123b1422],
25	effects	NNS	O	effect	dobj	22	SENT_11	[p1l1133t1392r1232b1416],
26	.	.	O	.	_	0	SENT_11	[p1l1133t1392r1232b1416],

1	In	IN	O	in	_	0	SENT_12	[p1l1243t1393r1269b1416],
2	this	DT	O	this	det	3	SENT_12	[p1l1279t1392r1331b1416],
3	study	NN	O	study	prep_in	6	SENT_12	[p1l1343t1392r1427b1422],
4	,	,	O	,	_	0	SENT_12	[p1l1343t1392r1427b1422],
5	we	PRP	O	we	nsubj	6	SENT_12	[p1l1438t1399r1479b1416],
6	investigated	VBD	O	investigate	_	0	SENT_12	[p1l7t1432r180b1462],
7	the	DT	O	the	det	8	SENT_12	[p1l188t1432r233b1456],
8	role	NN	O	role	nsubj	13	SENT_12	[p1l242t1432r295b1456],
9	of	IN	O	of	_	0	SENT_12	[p1l304t1432r333b1456],
10	three	CD	NUMBER	three	num	12	SENT_12	[p1l337t1432r411b1456],
11	genetic	JJ	O	genetic	amod	12	SENT_12	[p1l419t1432r522b1462],
12	factors	NNS	O	factor	prep_of	8	SENT_12	[p1l530t1432r625b1456],
13	(	VBP	O	(	ccomp	6	SENT_12	[p1l634t1432r737b1462],
14	P2Y12	NN	O	p2y12	dobj	13	SENT_12	[p1l634t1432r737b1462],
15	,	,	O	,	_	0	SENT_12	[p1l634t1432r737b1462],
16	CYP3A5	NN	O	cyp3a5	conj_and	14	SENT_12	[p1l746t1433r856b1460],
17	,	,	O	,	_	0	SENT_12	[p1l746t1433r856b1460],
18	CYP2C19	NN	O	cyp2c19	nn	19	SENT_12	[p1l865t1432r1003b1462],
19	)	NN	O	)	conj_and	14	SENT_12	[p1l865t1432r1003b1462],
20	,	,	O	,	_	0	SENT_12	[p1l865t1432r1003b1462],
21	demographic	JJ	O	demographic	amod	22	SENT_12	[p1l1012t1432r1198b1462],
22	characteristics	NNS	O	characteristic	conj_and	14	SENT_12	[p1l1206t1432r1419b1460],
23	,	,	O	,	_	0	SENT_12	[p1l1206t1432r1419b1460],
24	and	CC	O	and	_	0	SENT_12	[p1l1427t1432r1479b1456],
25	Keywords	NNPS	O	Keywords	conj_and	14	SENT_12	[p1l6t1487r132b1514],
26	:	:	O	:	_	0	SENT_12	[p1l6t1487r132b1514],
27	Clopidogrel	NNP	O	Clopidogrel	nn	28	SENT_12	[p1l7t1523r151b1549],
28	P2YI2	NNP	O	P2YI2	dobj	13	SENT_12	[p1l6t1560r82b1580],
29	polymorphism	NN	O	polymorphism	nn	38	SENT_12	[p1l93t1558r279b1585],
30	CYP3A5	NN	O	cyp3a5	nn	38	SENT_12	[p1l7t1595r99b1616],
31	polymorphism	NN	O	polymorphism	nn	38	SENT_12	[p1l110t1594r296b1621],
32	CYP2C19	NN	O	cyp2c19	nn	38	SENT_12	[p1l7t1631r114b1651],
33	polymorphism	NN	O	polymorphism	nn	38	SENT_12	[p1l125t1630r310b1657],
34	Post	NN	O	post	nn	38	SENT_12	[p1l7t1667r60b1687],
35	stent	NN	O	stent	nn	38	SENT_12	[p1l70t1669r133b1687],
36	thrombosis	NN	O	thrombosis	nn	38	SENT_12	[p1l143t1665r285b1687],
37	pathologic	JJ	O	pathologic	amod	38	SENT_12	[p1l6t1762r155b1792],
38	condition	NN	O	condition	dep	28	SENT_12	[p1l167t1762r302b1786],
39	on	IN	O	on	_	0	SENT_12	[p1l314t1769r349b1786],
40	clopidogrel	NN	O	clopidogrel	nn	42	SENT_12	[p1l361t1762r519b1792],
41	response	NN	O	response	nn	42	SENT_12	[p1l532t1769r658b1792],
42	variability	NN	O	variability	prep_on	13	SENT_12	[p1l670t1762r816b1792],
43	in	IN	O	in	_	0	SENT_12	[p1l828t1762r854b1786],
44	Iranian	JJ	MISC	iranian	amod	45	SENT_12	[p1l867t1762r966b1786],
45	patients	NNS	O	patient	prep_in	42	SENT_12	[p1l979t1762r1093b1792],
46	after	IN	O	after	_	0	SENT_12	[p1l1106t1762r1172b1786],
47	PCI	NN	O	pcus	prep_after	45	SENT_12	[p1l1184t1763r1234b1786],
48	.	.	O	.	_	0	SENT_12	[p1l1184t1763r1234b1786],

1	Patients	NNS	O	patient	nsubjpass	9	SENT_13	[p1l50t1802r162b1826],
2	who	WP	O	who	nsubj	4	SENT_13	[p1l174t1802r236b1826],
3	were	VBD	O	be	cop	4	SENT_13	[p1l247t1809r318b1826],
4	candidate	NN	O	candidate	rcmod	1	SENT_13	[p1l330t1802r468b1826],
5	for	IN	O	for	_	0	SENT_13	[p1l481t1802r520b1826],
6	elective	JJ	O	elective	amod	7	SENT_13	[p1l532t1802r640b1826],
7	PCI	NN	O	pcus	prep_for	4	SENT_13	[p1l653t1803r696b1826],
8	were	VBD	O	be	auxpass	9	SENT_13	[p1l708t1809r779b1826],
9	enrolled	VBN	O	enrol	_	0	SENT_13	[p1l791t1802r908b1826],
10	in	IN	O	in	_	0	SENT_13	[p1l920t1802r946b1826],
11	this	DT	O	this	det	12	SENT_13	[p1l958t1802r1010b1826],
12	study	NN	O	study	prep_in	9	SENT_13	[p1l1023t1802r1107b1832],
13	.	.	O	.	_	0	SENT_13	[p1l1023t1802r1107b1832],

1	All	DT	O	all	det	2	SENT_14	[p1l1119t1802r1157b1826],
2	patients	NNS	O	patient	nsubj	4	SENT_14	[p1l1170t1802r1283b1832],
3	had	VBD	O	have	aux	4	SENT_14	[p1l1296t1802r1348b1826],
4	received	VBN	O	receive	_	0	SENT_14	[p1l1360t1802r1479b1826],
5	aspirin	NN	O	aspirin	nn	7	SENT_14	[p1l6t1842r103b1872],
6	80-325	CD	NUMBER	80-325	num	7	SENT_14	[p1l111t1843r217b1866],
7	mg	NN	O	mg	dobj	4	SENT_14	[p1l228t1849r272b1872],
8	daily	RB	SET	daily	advmod	4	SENT_14	[p1l280t1842r349b1872],
9	for	IN	O	for	_	0	SENT_14	[p1l357t1842r397b1866],
10	2	CD	NUMBER	2	num	12	SENT_14	[p1l406t1843r440b1870],
11	]	CD	NUMBER	]	num	12	SENT_14	[p1l406t1843r440b1870],
12	week	NN	NUMBER	week	prep_for	4	SENT_14	[p1l452t1842r528b1866],
13	before	IN	O	before	_	0	SENT_14	[p1l536t1842r625b1866],
14	PCI	NNP	O	PCI	prep_before	12	SENT_14	[p1l634t1843r684b1866],
15	.	.	O	.	_	0	SENT_14	[p1l634t1843r684b1866],

1	Blood	NN	O	blood	nn	2	SENT_15	[p1l694t1842r773b1866],
2	samples	NNS	O	sample	nsubjpass	4	SENT_15	[p1l782t1842r897b1872],
3	were	VBD	O	be	auxpass	4	SENT_15	[p1l905t1849r975b1866],
4	taken	VBN	O	take	_	0	SENT_15	[p1l984t1842r1062b1866],
5	from	IN	O	from	_	0	SENT_15	[p1l1071t1842r1138b1866],
6	patients	NNS	O	patient	prep_from	4	SENT_15	[p1l1147t1842r1261b1872],
7	at	IN	O	at	_	0	SENT_15	[p1l1270t1845r1297b1866],
8	baseline	NN	O	baseline	prep_at	6	SENT_15	[p1l1304t1842r1428b1870],
9	,	,	O	,	_	0	SENT_15	[p1l1304t1842r1428b1870],
10	2	CD	NUMBER	2	num	11	SENT_15	[p1l1437t1843r1452b1866],
11	h	NN	O	h	appos	8	SENT_15	[p1l1462t1842r1479b1866],
12	after	IN	O	after	_	0	SENT_15	[p1l6t1881r72b1906],
13	taking	VBG	O	take	prepc_after	4	SENT_15	[p1l82t1881r171b1912],
14	a	DT	O	a	det	19	SENT_15	[p1l182t1888r196b1906],
15	600	CD	NUMBER	600	number	16	SENT_15	[p1l207t1883r318b1912],
16	—	CD	NUMBER	—	num	19	SENT_15	[p1l207t1883r318b1912],
17	mg	NN	O	mg	nn	19	SENT_15	[p1l207t1883r318b1912],
18	loading	NN	O	loading	nn	19	SENT_15	[p1l329t1881r434b1912],
19	dose	NN	O	dose	dobj	13	SENT_15	[p1l444t1881r508b1906],
20	of	IN	O	of	_	0	SENT_15	[p1l520t1881r549b1906],
21	clopidogrel	NN	O	clopidogrel	prep_of	19	SENT_15	[p1l557t1881r722b1912],
22	,	,	O	,	_	0	SENT_15	[p1l557t1881r722b1912],
23	24	CD	NUMBER	24	num	24	SENT_15	[p1l734t1883r769b1905],
24	h	NN	O	h	prep_of	19	SENT_15	[p1l778t1881r795b1905],
25	and	CC	O	and	_	0	SENT_15	[p1l806t1881r857b1906],
26	30	CD	DURATION	30	num	27	SENT_15	[p1l868t1883r903b1906],
27	days	NNS	NUMBER	day	prep_of	19	SENT_15	[p1l914t1881r977b1912],
28	after	IN	O	after	_	0	SENT_15	[p1l989t1881r1055b1906],
29	PCI	NN	O	pcus	prep_after	13	SENT_15	[p1l1066t1883r1116b1906],
30	.	.	O	.	_	0	SENT_15	[p1l1066t1883r1116b1906],

1	Platelet	NN	O	platelet	nn	2	SENT_16	[p1l1128t1881r1235b1906],
2	aggregation	NN	O	aggregation	nsubjpass	4	SENT_16	[p1l1246t1882r1413b1912],
3	was	VBD	O	be	auxpass	4	SENT_16	[p1l1424t1888r1478b1906],
4	measured	VBN	O	measure	_	0	SENT_16	[p1l6t1921r145b1945],
5	by	IN	O	by	_	0	SENT_16	[p1l156t1921r190b1951],
6	turbidimetric	JJ	O	turbidimetric	amod	8	SENT_16	[p1l199t1921r391b1945],
7	aggregation	NN	O	aggregation	nn	8	SENT_16	[p1l401t1922r568b1951],
8	assay	NN	O	assay	agent	4	SENT_16	[p1l579t1928r655b1951],
9	with	IN	O	with	_	0	SENT_16	[p1l664t1921r730b1945],
10	two	CD	NUMBER	two	num	12	SENT_16	[p1l740t1925r794b1945],
11	different	JJ	O	different	amod	12	SENT_16	[p1l804t1921r927b1945],
12	concentrations	NNS	O	concentration	prep_with	4	SENT_16	[p1l937t1922r1148b1945],
13	of	IN	O	of	_	0	SENT_16	[p1l1159t1921r1188b1945],
14	ADP	NN	O	adp	prep_of	12	SENT_16	[p1l1194t1922r1254b1945],
15	(	CD	NUMBER	(	number	16	SENT_16	[p1l1264t1921r1291b1951],
16	5	CD	NUMBER	5	dep	14	SENT_16	[p1l1264t1921r1291b1951],
17	and	CC	O	and	_	0	SENT_16	[p1l1303t1921r1354b1945],
18	20	CD	NUMBER	20	num	21	SENT_16	[p1l1364t1923r1398b1945],
19	p.	NN	O	p.	nn	21	SENT_16	[p1l1410t1922r1478b1953],
20	M	NN	O	m	nn	21	SENT_16	[p1l1410t1922r1478b1953],
21	)	NN	O	)	prep_of	12	SENT_16	[p1l1410t1922r1478b1953],
22	.	.	O	.	_	0	SENT_16	[p1l1410t1922r1478b1953],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_17	[p1l6t1961r331b1991],
2	*	NN	O	*	nsubjpass	27	SENT_17	[p1l6t1961r331b1991],
3	2	CD	NUMBER	2	number	4	SENT_17	[p1l6t1961r331b1991],
4	(	CD	NUMBER	(	num	6	SENT_17	[p1l6t1961r331b1991],
5	rs4244285	NN	O	rs4244285	nn	6	SENT_17	[p1l6t1961r331b1991],
6	)	NN	O	)	dep	2	SENT_17	[p1l6t1961r331b1991],
7	,	,	O	,	_	0	SENT_17	[p1l6t1961r331b1991],
8	CYP2C19	NN	O	cyp2c19	conj_and	2	SENT_17	[p1l344t1961r668b1991],
9	*	CD	NUMBER	*	num	8	SENT_17	[p1l344t1961r668b1991],
10	3	CD	NUMBER	3	num	13	SENT_17	[p1l344t1961r668b1991],
11	(	NN	O	(	nn	13	SENT_17	[p1l344t1961r668b1991],
12	rs4986893	NN	O	rs4986893	nn	13	SENT_17	[p1l344t1961r668b1991],
13	)	NN	O	)	dep	8	SENT_17	[p1l344t1961r668b1991],
14	,	,	O	,	_	0	SENT_17	[p1l344t1961r668b1991],
15	CYP3A5	NN	O	cyp3a5	nn	18	SENT_17	[p1l681t1962r785b1985],
16	(	CD	NUMBER	(	num	18	SENT_17	[p1l796t1961r933b1991],
17	A6986G	NN	O	a6986g	nn	18	SENT_17	[p1l796t1961r933b1991],
18	)	NN	O	)	appos	13	SENT_17	[p1l796t1961r933b1991],
19	,	,	O	,	_	0	SENT_17	[p1l796t1961r933b1991],
20	and	CC	O	and	_	0	SENT_17	[p1l945t1961r996b1985],
21	P2Y12	NN	O	p2y12	conj_and	2	SENT_17	[p1l1007t1962r1093b1985],
22	(	CD	NUMBER	(	num	25	SENT_17	[p1l1104t1961r1212b1991],
23	T744C	NN	O	t744c	nn	25	SENT_17	[p1l1104t1961r1212b1991],
24	)	NN	O	)	nn	25	SENT_17	[p1l1104t1961r1212b1991],
25	genotypings	NNS	O	genotyping	dep	21	SENT_17	[p1l1223t1962r1397b1991],
26	were	VBD	O	be	auxpass	27	SENT_17	[p1l1409t1968r1479b1985],
27	performed	VBN	O	perform	_	0	SENT_17	[p1l6t2001r155b2031],
28	by	IN	O	by	_	0	SENT_17	[p1l167t2001r202b2031],
29	PCR-RFLP	NN	O	pcr-rflp	agent	27	SENT_17	[p1l214t2002r355b2025],
30	.	.	O	.	_	0	SENT_17	[p1l214t2002r355b2025],

1	One	CD	NUMBER	one	num	2	SENT_18	[p1l6t2043r61b2066],
2	hundred	CD	NUMBER	hundred	nsubjpass	7	SENT_18	[p1l87t2041r207b2066],
3	and	CC	NUMBER	and	_	0	SENT_18	[p1l233t2041r284b2066],
4	twelve	CD	NUMBER	twelve	num	5	SENT_18	[p1l310t2041r405b2066],
5	patients	NNS	O	patient	conj_and	2	SENT_18	[p1l431t2042r545b2072],
6	were	VBD	O	be	auxpass	7	SENT_18	[p1l570t2048r641b2066],
7	included	VBN	O	include	_	0	SENT_18	[p1l667t2041r789b2066],
8	in	IN	O	in	_	0	SENT_18	[p1l815t2042r841b2066],
9	this	DT	O	this	det	10	SENT_18	[p1l867t2041r918b2066],
10	study	NN	O	study	prep_in	7	SENT_18	[p1l945t2041r1029b2072],
11	.	.	O	.	_	0	SENT_18	[p1l945t2041r1029b2072],

1	Maximum	NNP	O	Maximum	nn	2	SENT_19	[p1l1056t2042r1202b2066],
2	clopidogrel	NNP	O	clopidogrel	nsubj	10	SENT_19	[p1l1228t2041r1386b2072],
3	non	JJ	O	non	amod	2	SENT_19	[p1l1413t2048r1478b2066],
4	-	:	O	-	_	0	SENT_19	[p1l1413t2048r1478b2066],
5	responsiveness	NN	O	responsiveness	dep	3	SENT_19	[p1l1494t2042r1708b2072],
6	(	CD	PERCENT	(	number	7	SENT_19	[p1l1721t2041r1842b2072],
7	25.90	CD	PERCENT	25.90	num	8	SENT_19	[p1l1721t2041r1842b2072],
8	%	NN	PERCENT	%	dep	5	SENT_19	[p1l1721t2041r1842b2072],
9	)	CD	NUMBER	)	dep	8	SENT_19	[p1l1721t2041r1842b2072],
10	occurred	VBD	O	occur	_	0	SENT_19	[p1l1854t2041r1978b2066],
11	at	IN	O	at	_	0	SENT_19	[p1l1991t2045r2017b2066],
12	2	CD	NUMBER	2	num	13	SENT_19	[p1l2029t2042r2044b2066],
13	h	NN	O	h	prep_at	10	SENT_19	[p1l2059t2041r2075b2066],
14	after	IN	O	after	_	0	SENT_19	[p1l2088t2041r2154b2066],
15	taking	VBG	O	take	prepc_after	10	SENT_19	[p1l6t2081r95b2112],
16	600	CD	NUMBER	600	num	17	SENT_19	[p1l111t2082r162b2106],
17	mg	NN	O	mg	dobj	15	SENT_19	[p1l180t2088r224b2112],
18	of	IN	O	of	_	0	SENT_19	[p1l240t2081r269b2106],
19	the	DT	O	the	det	21	SENT_19	[p1l274t2081r319b2106],
20	loading	VBG	O	load	amod	21	SENT_19	[p1l336t2081r441b2112],
21	dose	NN	O	dose	prep_of	17	SENT_19	[p1l457t2081r520b2106],
22	of	IN	O	of	_	0	SENT_19	[p1l537t2081r566b2106],
23	clopidogrel	NN	O	clopidogrel	prep_of	21	SENT_19	[p1l572t2081r737b2112],
24	.	.	O	.	_	0	SENT_19	[p1l572t2081r737b2112],

1	Although	IN	O	although	mark	3	SENT_20	[p1l753t2081r885b2112],
2	there	EX	O	there	expl	3	SENT_20	[p1l906t2081r980b2106],
3	were	VBD	O	be	advcl	31	SENT_20	[p1l1005t2088r1075b2106],
4	no	DT	O	no	det	6	SENT_20	[p1l1101t2088r1135b2106],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_20	[p1l1160t2081r1308b2112],
6	associations	NNS	O	association	nsubj	3	SENT_20	[p1l1333t2082r1504b2106],
7	between	IN	O	between	_	0	SENT_20	[p1l1530t2081r1652b2106],
8	clopidogrel	NN	O	clopidogrel	nn	9	SENT_20	[p1l1678t2081r1836b2112],
9	responsiveness	NN	O	responsiveness	prep_between	6	SENT_20	[p1l1862t2082r2076b2112],
10	and	CC	O	and	_	0	SENT_20	[p1l2103t2081r2154b2106],
11	polymorphisms	NNS	O	polymorphism	nsubj	3	SENT_20	[p1l6t2121r228b2152],
12	of	IN	O	of	_	0	SENT_20	[p1l250t2121r279b2146],
13	CYP2C19	NN	O	cyp2c19	prep_of	11	SENT_20	[p1l296t2123r423b2150],
14	,	,	O	,	_	0	SENT_20	[p1l296t2123r423b2150],
15	CYP3A5	NN	O	cyp3a5	prep_of	11	SENT_20	[p1l440t2122r551b2150],
16	,	,	O	,	_	0	SENT_20	[p1l440t2122r551b2150],
17	and	CC	O	and	_	0	SENT_20	[p1l568t2121r619b2146],
18	P2Y12	NN	O	p2y12	prep_of	11	SENT_20	[p1l636t2123r721b2146],
19	(	CD	NUMBER	(	num	20	SENT_20	[p1l738t2121r766b2152],
20	P	NN	O	p	npadvmod	21	SENT_20	[p1l738t2121r766b2152],
21	>	JJR	O	>	amod	13	SENT_20	[p1l779t2129r798b2147],
22	0.05	CD	NUMBER	0.05	num	23	SENT_20	[p1l813t2122r890b2152],
23	)	NN	O	)	dep	11	SENT_20	[p1l813t2122r890b2152],
24	,	,	O	,	_	0	SENT_20	[p1l813t2122r890b2152],
25	subjects	NNS	O	subject	nsubj	31	SENT_20	[p1l908t2121r1022b2152],
26	who	WP	O	who	nsubj	30	SENT_20	[p1l1040t2121r1101b2146],
27	were	VBD	O	be	cop	30	SENT_20	[p1l1117t2128r1188b2146],
28	CYP3A5	NNP	O	CYP3A5	nn	30	SENT_20	[p1l1205t2122r1308b2146],
29	genotype	NN	O	genotype	nn	30	SENT_20	[p1l1325t2125r1456b2152],
30	expressor	NN	O	expressor	rcmod	25	SENT_20	[p1l1474t2128r1611b2152],
31	had	VBD	O	have	_	0	SENT_20	[p1l1628t2121r1679b2146],
32	a	DT	O	a	det	34	SENT_20	[p1l1695t2128r1710b2146],
33	greater	JJR	O	greater	amod	34	SENT_20	[p1l1726t2125r1828b2152],
34	inhibition	NN	O	inhibition	dobj	31	SENT_20	[p1l1845t2121r1984b2146],
35	of	IN	O	of	_	0	SENT_20	[p1l2003t2121r2032b2146],
36	platelet	NN	O	platelet	nn	37	SENT_20	[p1l2046t2121r2154b2152],
37	aggregation	NN	O	aggregation	prep_of	34	SENT_20	[p1l996t2161r1170b2191],
38	.	.	O	.	_	0	SENT_20	[p1l996t2161r1170b2191],

1	No	DT	O	no	det	3	SENT_21	[p1l1185t2162r1223b2185],
2	signiﬁcant	NN	O	signiﬁcant	nn	3	SENT_21	[p1l1237t2161r1385b2191],
3	associations	NNS	O	association	nsubjpass	5	SENT_21	[p1l1398t2161r1569b2185],
4	were	VBD	O	be	auxpass	5	SENT_21	[p1l1583t2168r1653b2185],
5	observed	VBN	O	observe	_	0	SENT_21	[p1l1667t2161r1795b2185],
6	between	IN	O	between	_	0	SENT_21	[p1l1809t2161r1931b2185],
7	environmental	JJ	O	environmental	amod	8	SENT_21	[p1l1945t2161r2154b2185],
8	factors	NNS	O	factor	prep_between	5	SENT_21	[p1l722t2200r816b2225],
9	and	CC	O	and	_	0	SENT_21	[p1l830t2200r881b2225],
10	clopidogrel	NN	O	clopidogrel	nn	11	SENT_21	[p1l893t2200r1052b2231],
11	responsiveness	NN	O	responsiveness	prep_between	5	SENT_21	[p1l1065t2201r1279b2231],
12	(	CD	NUMBER	(	num	13	SENT_21	[p1l1292t2200r1321b2231],
13	P	NN	O	p	npadvmod	14	SENT_21	[p1l1292t2200r1321b2231],
14	>	JJR	O	>	amod	11	SENT_21	[p1l1330t2208r1349b2226],
15	0.05	CD	NUMBER	0.05	num	16	SENT_21	[p1l1360t2200r1437b2231],
16	)	NN	O	)	dep	11	SENT_21	[p1l1360t2200r1437b2231],
17	.	.	O	.	_	0	SENT_21	[p1l1360t2200r1437b2231],

1	Our	PRP$	O	we	poss	2	SENT_22	[p1l6t2241r59b2264],
2	results	NNS	O	result	nsubj	3	SENT_22	[p1l72t2240r166b2264],
3	showed	VBD	O	show	_	0	SENT_22	[p1l181t2240r290b2264],
4	that	IN	O	that	complm	18	SENT_22	[p1l304t2240r361b2264],
5	P2Y12	NN	O	p2y12	nn	7	SENT_22	[p1l374t2241r466b2268],
6	,	,	O	,	_	0	SENT_22	[p1l374t2241r466b2268],
7	CYP3A5	NN	O	cyp3a5	nsubj	18	SENT_22	[p1l480t2241r590b2268],
8	,	,	O	,	_	0	SENT_22	[p1l480t2241r590b2268],
9	and	CC	O	and	_	0	SENT_22	[p1l605t2240r656b2264],
10	CYP2C19	NN	O	cyp2c19	nn	11	SENT_22	[p1l671t2241r791b2264],
11	polymorphisms	NNS	O	polymorphism	nsubj	18	SENT_22	[p1l805t2240r1027b2270],
12	along	IN	O	along	_	0	SENT_22	[p1l1042t2240r1120b2270],
13	with	IN	O	with	_	0	SENT_22	[p1l1132t2240r1198b2264],
14	non-genetic	JJ	O	non-genetic	amod	15	SENT_22	[p1l1211t2240r1381b2270],
15	factors	NNS	O	factor	prep_along_with	18	SENT_22	[p1l1396t2240r1490b2264],
16	were	VBD	O	be	cop	18	SENT_22	[p1l1507t2247r1577b2264],
17	not	RB	O	not	neg	18	SENT_22	[p1l1592t2243r1638b2264],
18	responsible	JJ	O	responsible	ccomp	3	SENT_22	[p1l1653t2240r1815b2270],
19	for	IN	O	for	_	0	SENT_22	[p1l1830t2240r1869b2264],
20	the	DT	O	the	det	22	SENT_22	[p1l1882t2240r1927b2264],
21	interindividual	JJ	O	interindividual	amod	22	SENT_22	[p1l1943t2240r2154b2264],
22	variability	NN	O	variability	prep_for	18	SENT_22	[p1l513t2280r798b2339],
23	in	IN	O	in	_	0	SENT_22	[p1l817t2281r868b2326],
24	response	NN	O	response	prep_in	22	SENT_22	[p1l887t2294r1132b2339],
25	to	TO	O	to	_	0	SENT_22	[p1l1152t2287r1205b2327],
26	clopidogrel	NN	O	clopidogrel	prep_to	18	SENT_22	[p1l1224t2280r1534b2339],
27	in	IN	O	in	_	0	SENT_22	[p1l1555t2281r1605b2326],
28	Iranian	JJ	MISC	iranian	amod	29	SENT_22	[p1l1625t2281r1819b2327],
29	population	NN	O	population	prep_in	26	SENT_22	[p1l1839t2280r2154b2339],
30	.	.	O	.	_	0	SENT_22	[p1l1839t2280r2154b2339],

1	1	LS	NUMBER	1	_	0	SENT_23	[p1l10t2620r61b2669],
2	.	.	O	.	_	0	SENT_23	[p1l10t2620r61b2669],

1	Introduction	NN	O	introduction	_	0	SENT_24	[p1l99t2617r513b2669],

1	Percutaneous	JJ	O	percutaneous	amod	3	SENT_25	[p1l107t2790r514b2839],
2	coronary	JJ	O	coronary	amod	3	SENT_25	[p1l547t2802r816b2851],
3	intervention	NN	O	intervention	nsubj	8	SENT_25	[p1l847t2788r1222b2839],
4	(	CD	NUMBER	(	num	6	SENT_25	[p1l1254t2787r1397b2851],
5	PCI	NN	O	pcus	nn	6	SENT_25	[p1l1254t2787r1397b2851],
6	)	NN	O	)	dep	3	SENT_25	[p1l1254t2787r1397b2851],
7	has	VBZ	O	have	aux	8	SENT_25	[p1l1430t2787r1529b2839],
8	improved	VBN	O	improve	_	0	SENT_25	[p1l1563t2787r1854b2852],
9	acute	JJ	O	acute	amod	11	SENT_25	[p1l1886t2795r2048b2839],
10	coronary	JJ	O	coronary	amod	11	SENT_25	[p1l9t2886r278b2935],
11	syndrome	NN	O	syndrome	dobj	8	SENT_25	[p1l315t2871r618b2935],
12	(	CD	NUMBER	(	num	13	SENT_25	[p1l655t2871r819b2935],
13	ACS	NN	O	ac	tmod	8	SENT_25	[p1l655t2871r819b2935],
14	)	CD	NUMBER	)	num	15	SENT_25	[p1l655t2871r819b2935],
15	outcomes	NNS	O	outcome	dep	13	SENT_25	[p1l857t2879r1165b2930],
16	,	,	O	,	_	0	SENT_25	[p1l857t2879r1165b2930],
17	but	CC	O	but	_	0	SENT_25	[p1l1202t2871r1304b2923],
18	thrombosis	NN	O	thrombosis	nsubj	25	SENT_25	[p1l1340t2871r1682b2923],
19	after	IN	O	after	_	0	SENT_25	[p1l1721t2871r1863b2923],
20	stent	JJ	O	stent	amod	21	SENT_25	[p1l1899t2878r2050b2923],
21	placement	NN	O	placement	prep_after	18	SENT_25	[p1l9t2953r329b3018],
22	is	VBZ	O	be	cop	25	SENT_25	[p1l349t2954r393b3005],
23	a	DT	O	a	det	25	SENT_25	[p1l415t2968r446b3005],
24	major	JJ	O	major	amod	25	SENT_25	[p1l468t2954r647b3018],
25	complication	NN	O	complication	conj_but	8	SENT_25	[p1l666t2953r1061b3018],
26	that	WDT	O	that	nsubj	28	SENT_25	[p1l1081t2953r1204b3005],
27	can	MD	O	can	aux	28	SENT_25	[p1l1224t2968r1327b3005],
28	affect	VB	O	affect	rcmod	25	SENT_25	[p1l1348t2953r1515b3005],
29	the	DT	O	the	det	30	SENT_25	[p1l1534t2953r1631b3005],
30	outcome	NN	O	outcome	dobj	28	SENT_25	[p1l1652t2961r1917b3005],
31	and	CC	O	and	_	0	SENT_25	[p1l1938t2953r2048b3005],
32	survival	NN	O	survival	dobj	28	SENT_25	[p1l10t3036r247b3088],
33	of	IN	O	of	_	0	SENT_25	[p1l292t3036r355b3088],
34	ACS	NN	ORGANIZATION	ac	nn	35	SENT_25	[p1l388t3039r505b3088],
35	patients	NNS	O	patient	prep_of	30	SENT_25	[p1l549t3037r808b3101],
36	.	.	O	.	_	0	SENT_25	[p1l549t3037r808b3101],

1	Although	IN	O	although	mark	15	SENT_26	[p1l850t3036r1131b3101],
2	prolonged	JJ	O	prolonged	amod	5	SENT_26	[p1l1175t3036r1482b3101],
3	dual	JJ	O	dual	amod	5	SENT_26	[p1l1526t3036r1655b3088],
4	antiplatelet	JJ	O	antiplatelet	amod	5	SENT_26	[p1l1700t3036r2049b3101],
5	therapy	NN	O	therapy	nsubjpass	15	SENT_26	[p1l8t3120r244b3184],
6	with	IN	O	with	_	0	SENT_26	[p1l277t3120r417b3171],
7	aspirin	NN	O	aspirin	prep_with	5	SENT_26	[p1l453t3120r661b3184],
8	and	CC	O	and	_	0	SENT_26	[p1l696t3120r806b3171],
9	clopidogrel	NN	O	clopidogrel	conj_and	7	SENT_26	[p1l844t3120r1181b3184],
10	in	IN	O	in	_	0	SENT_26	[p1l1219t3120r1276b3171],
11	such	JJ	O	such	amod	12	SENT_26	[p1l1313t3120r1450b3171],
12	patients	NNS	O	patient	prep_in	7	SENT_26	[p1l1487t3120r1728b3184],
13	has	VBZ	O	have	aux	15	SENT_26	[p1l1767t3120r1866b3171],
14	been	VBN	O	be	auxpass	15	SENT_26	[p1l1903t3120r2049b3171],
15	associated	VBN	O	associate	advcl	33	SENT_26	[p1l9t3203r321b3254],
16	with	IN	O	with	_	0	SENT_26	[p1l344t3203r484b3254],
17	better	JJR	O	better	prep_with	15	SENT_26	[p1l506t3203r690b3254],
18	long-term	JJ	O	long-term	amod	20	SENT_26	[p1l711t3203r1016b3267],
19	clinical	JJ	O	clinical	amod	20	SENT_26	[p1l1039t3203r1253b3254],
20	outcomes	NNS	O	outcome	nsubj	21	SENT_26	[p1l1277t3210r1569b3254],
21	[	VBP	O	[	rcmod	17	SENT_26	[p1l1598t3202r1746b3267],
22	l	NN	O	l	nn	24	SENT_26	[p1l1598t3202r1746b3267],
23	,2	CD	NUMBER	,2	num	24	SENT_26	[p1l1598t3202r1746b3267],
24	]	NN	O	]	dobj	21	SENT_26	[p1l1598t3202r1746b3267],
25	,	,	O	,	_	0	SENT_26	[p1l1598t3202r1746b3267],
26	adequate	JJ	O	adequate	amod	28	SENT_26	[p1l1770t3203r2048b3267],
27	antiplatelet	JJ	O	antiplatelet	amod	28	SENT_26	[p1l9t3285r358b3350],
28	effects	NNS	O	effect	nsubjpass	33	SENT_26	[p1l395t3285r589b3337],
29	of	IN	O	of	_	0	SENT_26	[p1l628t3285r691b3337],
30	clopidogrel	NN	O	clopidogrel	prep_of	28	SENT_26	[p1l721t3285r1059b3350],
31	are	VBP	O	be	auxpass	33	SENT_26	[p1l1097t3300r1190b3337],
32	not	RB	O	not	neg	33	SENT_26	[p1l1228t3293r1327b3337],
33	achieved	VBN	O	achieve	_	0	SENT_26	[p1l1364t3285r1631b3337],
34	in	IN	O	in	_	0	SENT_26	[p1l1669t3286r1725b3336],
35	4	CD	PERCENT	4	number	36	SENT_26	[p1l1761t3288r1955b3337],
36	—	CD	PERCENT	—	prep_in	33	SENT_26	[p1l1761t3288r1955b3337],
37	30	CD	PERCENT	30	num	38	SENT_26	[p1l1761t3288r1955b3337],
38	%	NN	PERCENT	%	dep	36	SENT_26	[p1l1761t3288r1955b3337],
39	of	IN	O	of	_	0	SENT_26	[p1l1993t3285r2056b3337],
40	patients	NNS	O	patient	prep_of	38	SENT_26	[p1l9t3370r251b3433],
41	[	CD	NUMBER	[	number	42	SENT_26	[p1l296t3369r444b3433],
42	3,4	CD	NUMBER	3,4	num	43	SENT_26	[p1l296t3369r444b3433],
43	]	NN	O	]	dep	38	SENT_26	[p1l296t3369r444b3433],
44	.	.	O	.	_	0	SENT_26	[p1l296t3369r444b3433],

1	Individual	JJ	O	individual	amod	2	SENT_27	[p1l486t3369r792b3421],
2	differences	NNS	O	difference	nsubjpass	10	SENT_27	[p1l833t3369r1164b3421],
3	in	IN	O	in	_	0	SENT_27	[p1l1205t3370r1262b3420],
4	response	NN	O	response	prep_in	2	SENT_27	[p1l1302t3384r1570b3433],
5	to	TO	O	to	_	0	SENT_27	[p1l1610t3377r1669b3421],
6	clopidogrel	NN	O	clopidogrel	nn	7	SENT_27	[p1l1709t3369r2047b3433],
7	therapy	NN	O	therapy	prep_to	4	SENT_27	[p1l8t3451r244b3516],
8	have	VBP	O	have	aux	10	SENT_27	[p1l288t3451r430b3503],
9	been	VBN	O	be	auxpass	10	SENT_27	[p1l475t3451r621b3503],
10	established	VBN	O	establish	_	0	SENT_27	[p1l665t3451r1007b3503],
11	in	IN	O	in	_	0	SENT_27	[p1l1054t3452r1110b3503],
12	many	JJ	O	many	amod	13	SENT_27	[p1l1156t3466r1326b3516],
13	studies	NNS	O	study	prep_in	10	SENT_27	[p1l1371t3451r1599b3503],
14	.	.	O	.	_	0	SENT_27	[p1l1371t3451r1599b3503],

1	Several	JJ	O	several	amod	2	SENT_28	[p1l1646t3451r1863b3503],
2	drug	NN	O	drug	_	0	SENT_28	[p1l1909t3451r2050b3516],
3	(	CD	NUMBER	(	num	7	SENT_28	[p1l9t3534r545b3599],
4	pharmacokinetic	JJ	O	pharmacokinetic	amod	7	SENT_28	[p1l9t3534r545b3599],
5	and	CC	O	and	_	0	SENT_28	[p1l561t3534r671b3586],
6	pharmacodynamic	JJ	O	pharmacodynamic	amod	7	SENT_28	[p1l689t3534r1280b3599],
7	)	NN	O	)	dep	2	SENT_28	[p1l689t3534r1280b3599],
8	and	CC	O	and	_	0	SENT_28	[p1l1297t3534r1407b3586],
9	patient	NN	O	patient	dep	2	SENT_28	[p1l1425t3535r1640b3599],
10	(	CD	NUMBER	(	num	9	SENT_28	[p1l1656t3534r1778b3599],
11	e.g.	FW	O	e.g.	dep	9	SENT_28	[p1l1656t3534r1778b3599],
12	diabetes	NN	O	diabetes	dep	2	SENT_28	[p1l1796t3534r2047b3586],

1	*	NN	O	*	_	0	SENT_29	[p2l53t22r70b40],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_29	[p2l103t22r464b75],
3	author	NN	O	author	dobj	2	SENT_29	[p2l485t22r649b64],
4	at	IN	O	at	prep	2	SENT_29	[p2l668t29r728b64],
5	:	:	O	:	_	0	SENT_29	[p2l668t29r728b64],
6	71345	CD	NUMBER	71345	num	7	SENT_29	[p2l755t24r906b64],
7	Shiraz	NNP	O	Shiraz	dep	1	SENT_29	[p2l930t22r1091b70],
8	,	,	O	,	_	0	SENT_29	[p2l930t22r1091b70],
9	P.O.	NNP	O	P.O.	nn	10	SENT_29	[p2l1114t24r1204b64],
10	Box	NNP	O	Box	appos	7	SENT_29	[p2l1227t25r1331b64],
11	:	:	O	:	_	0	SENT_29	[p2l1227t25r1331b64],
12	1583	CD	DATE	1583	dep	1	SENT_29	[p2l1360t24r1491b70],
13	,	,	O	,	_	0	SENT_29	[p2l1360t24r1491b70],
14	Iran	NNP	LOCATION	Iran	appos	12	SENT_29	[p2l1513t25r1620b64],
15	.	.	O	.	_	0	SENT_29	[p2l1513t25r1620b64],

1	Tel.	NNP	O	Tel.	_	0	SENT_30	[p2l6t91r107b133],
2	:	:	O	:	_	0	SENT_30	[p2l6t91r107b133],
3	+98 711647433	CD	NUMBER	+98 711647433	number	4	SENT_30	[p2l244t93r567b133],[p2l133t93r220b132],
4	1	CD	NUMBER	1	dep	1	SENT_30	[p2l244t93r567b133],
5	.	.	O	.	_	0	SENT_30	[p2l244t93r567b133],

1	E-mail	NN	O	e-mail	nn	2	SENT_31	[p2l104t161r259b203],
2	addresses	NNS	O	address	_	0	SENT_31	[p2l291t161r530b203],
3	:	:	O	:	_	0	SENT_31	[p2l291t161r530b203],
4	namazisoha@yahoo.com,	NN	O	namazisoha@yahoo.com,	nn	5	SENT_31	[p2l564t161r1181b213],
5	snamazi@sums.ac.ir	NN	O	snamazi@sums.ac.ir	dep	2	SENT_31	[p2l1215t162r1710b203],
6	(	CD	NUMBER	(	dep	5	SENT_31	[p2l1740t161r1797b213],
7	S.	NNP	PERSON	S.	nn	9	SENT_31	[p2l1740t161r1797b213],
8	Namazi	NNP	PERSON	Namazi	nn	9	SENT_31	[p2l1831t161r2048b213],
9	)	NNP	O	)	dep	5	SENT_31	[p2l1831t161r2048b213],
10	,	,	O	,	_	0	SENT_31	[p2l1831t161r2048b213],

1	I	PRP	O	I	nsubj	2	SENT_32	[p2l9t231r486b283],
2	(	VBP	O	(	_	0	SENT_32	[p2l9t231r486b283],
3	ojurij@yahoo.com	NNP	O	ojurij@yahoo.com	nn	7	SENT_32	[p2l9t231r486b283],
4	(	NNP	O	(	nn	7	SENT_32	[p2l507t231r552b283],
5	J.	NNP	PERSON	J.	nn	7	SENT_32	[p2l507t231r552b283],
6	Kojuri	NNP	PERSON	Kojuri	nn	7	SENT_32	[p2l576t231r755b283],
7	)	NN	O	)	dobj	2	SENT_32	[p2l576t231r755b283],
8	,	,	O	,	_	0	SENT_32	[p2l576t231r755b283],
9	anny_daro81@yahoo.com	NN	O	anny_daro81@yahoo.com	nn	11	SENT_32	[p2l777t231r1412b283],
10	(	CD	NUMBER	(	num	11	SENT_32	[p2l1433t231r1497b283],
11	A.	NN	PERSON	a.	appos	7	SENT_32	[p2l1433t231r1497b283],
12	Khalili	NNP	PERSON	Khalili	nn	13	SENT_32	[p2l1521t231r1709b283],
13	)	NNP	O	)	dep	11	SENT_32	[p2l1521t231r1709b283],
14	,	,	O	,	_	0	SENT_32	[p2l1521t231r1709b283],
15	negarazarpira@yahoo.com	NNP	O	negarazarpira@yahoo.com	nn	19	SENT_32	[p2l9t301r660b353],
16	(	NNP	O	(	nn	19	SENT_32	[p2l682t301r750b353],
17	N.	NNP	PERSON	N.	nn	19	SENT_32	[p2l682t301r750b353],
18	Azarpira	NNP	PERSON	Azarpira	nn	19	SENT_32	[p2l771t301r1011b353],
19	)	NN	O	)	appos	7	SENT_32	[p2l771t301r1011b353],
20	.	.	O	.	_	0	SENT_32	[p2l771t301r1011b353],

1	1	CD	NUMBER	1	num	2	SENT_33	[p2l58t363r71b390],
2	Address	NN	O	address	_	0	SENT_33	[p2l103t371r315b413],
3	:	:	O	:	_	0	SENT_33	[p2l103t371r315b413],
4	71345	CD	NUMBER	71345	num	5	SENT_33	[p2l342t373r492b413],
5	Shiraz	NNP	O	Shiraz	dep	2	SENT_33	[p2l516t371r678b419],
6	,	,	O	,	_	0	SENT_33	[p2l516t371r678b419],
7	P.O.	NNP	O	P.O.	nn	8	SENT_33	[p2l700t373r790b413],
8	Box	NNP	O	Box	appos	5	SENT_33	[p2l814t374r917b413],
9	:	:	O	:	_	0	SENT_33	[p2l814t374r917b413],
10	1583	CD	DATE	1583	dep	2	SENT_33	[p2l945t373r1077b419],
11	,	,	O	,	_	0	SENT_33	[p2l945t373r1077b419],
12	Iran	NNP	LOCATION	Iran	appos	10	SENT_33	[p2l1100t374r1207b413],
13	.	.	O	.	_	0	SENT_33	[p2l1100t374r1207b413],

1	Tel.	NNP	O	Tel.	_	0	SENT_34	[p2l1227t371r1328b413],
2	:	:	O	:	_	0	SENT_34	[p2l1227t371r1328b413],
3	+98 711242412	CD	NUMBER	+98 711242412	number	4	SENT_34	[p2l1466t373r1788b413],[p2l1355t373r1442b413],
4	8	CD	NUMBER	8	dep	1	SENT_34	[p2l1466t373r1788b413],
5	.	.	O	.	_	0	SENT_34	[p2l1466t373r1788b413],

1	0006-2952	CD	DURATION	0006-2952	_	0	SENT_35	[p2l8t513r324b567],
2	/	:	O	/	punct	1	SENT_35	[p2l8t513r324b567],
3	$	$	MONEY	$	nsubj	5	SENT_35	[p2l8t513r324b567],
4	—	CD	MONEY	—	num	3	SENT_35	[p2l346t539r372b544],
5	see	VBP	O	see	dep	1	SENT_35	[p2l396t527r471b556],
6	front	JJ	O	front	amod	7	SENT_35	[p2l493t514r614b556],
7	matter	NN	O	matter	dobj	5	SENT_35	[p2l635t521r801b556],
8	©	CD	NUMBER	©	num	11	SENT_35	[p2l823t521r860b556],
9	2012	CD	DATE	2012	num	11	SENT_35	[p2l884t516r1004b556],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	11	SENT_35	[p2l1028t514r1220b556],
11	Inc.	NNP	ORGANIZATION	Inc.	dep	7	SENT_35	[p2l1240t517r1323b556],
12	.	.	O	.	_	0	SENT_35	[p2l1240t517r1323b556],

1	All	DT	O	all	det	2	SENT_36	[p2l1344t514r1410b556],
2	rights	NNS	O	rights	nsubj	3	SENT_36	[p2l1433t514r1572b566],
3	reserved	VBN	O	reserve	_	0	SENT_36	[p2l1595t514r1816b556],
4	.	.	O	.	_	0	SENT_36	[p2l1595t514r1816b556],

1	doi	FW	O	doi	_	0	SENT_37	[p2l8t583r757b636],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_37	[p2l8t583r757b636],
3	/	:	O	/	punct	5	SENT_37	[p2l8t583r757b636],
4	j.	NN	O	j.	nn	5	SENT_37	[p2l8t583r757b636],
5	bcp	NN	O	bcp	dep	2	SENT_37	[p2l8t583r757b636],
6	.2012.01.003	CD	NUMBER	.2012.01.003	dep	2	SENT_37	[p2l8t583r757b636],

1	©	RB	O	©	advmod	2	SENT_38	[p2l997t672r1040b713],
2	2012	CD	DATE	2012	_	0	SENT_38	[p2l1068t667r1206b712],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	4	SENT_38	[p2l1234t665r1458b712],
4	Inc.	NNP	ORGANIZATION	Inc.	dep	2	SENT_38	[p2l1481t668r1578b713],
5	.	.	O	.	_	0	SENT_38	[p2l1481t668r1578b713],

1	All	DT	O	all	det	2	SENT_39	[p2l1601t665r1678b712],
2	rights	NNS	O	rights	nsubj	3	SENT_39	[p2l1704t665r1866b725],
3	reserved	VBN	O	reserve	_	0	SENT_39	[p2l1893t665r2149b713],
4	.	.	O	.	_	0	SENT_39	[p2l1893t665r2149b713],

1	mellitus	NN	O	mellitus	nsubjpass	14	SENT_40	[p2l53t931r322b992],
2	,	,	O	,	_	0	SENT_40	[p2l53t931r322b992],
3	smoking	NN	O	smoking	conj_and	1	SENT_40	[p2l348t931r626b997],
4	,	,	O	,	_	0	SENT_40	[p2l348t931r626b997],
5	obesity	NN	O	obesity	conj_and	1	SENT_40	[p2l652t931r891b997],
6	,	,	O	,	_	0	SENT_40	[p2l652t931r891b997],
7	and	CC	O	and	_	0	SENT_40	[p2l915t931r1028b984],
8	genetics	NNS	O	genetics	nsubjpass	14	SENT_40	[p2l1052t931r1334b997],
9	)	RB	O	)	advmod	10	SENT_40	[p2l1052t931r1334b997],
10	related	JJ	O	related	amod	11	SENT_40	[p2l1358t931r1575b984],
11	factors	NNS	O	factor	dep	8	SENT_40	[p2l1599t930r1807b984],
12	have	VBP	O	have	aux	14	SENT_40	[p2l1833t931r1978b984],
13	been	VBN	O	be	auxpass	14	SENT_40	[p2l2002t931r2152b984],
14	investigated	VBN	O	investigate	_	0	SENT_40	[p2l53t1017r433b1083],
15	that	WDT	O	that	nsubj	18	SENT_40	[p2l453t1017r579b1070],
16	can	MD	O	can	aux	18	SENT_40	[p2l598t1032r704b1070],
17	be	VB	O	be	cop	18	SENT_40	[p2l722t1017r794b1070],
18	responsible	JJ	O	responsible	ccomp	14	SENT_40	[p2l814t1017r1171b1083],
19	for	IN	O	for	_	0	SENT_40	[p2l1191t1016r1279b1070],
20	this	DT	O	this	det	22	SENT_40	[p2l1294t1017r1408b1070],
21	inappropriate	JJ	O	inappropriate	amod	22	SENT_40	[p2l1429t1017r1855b1083],
22	response	NN	O	response	prep_for	18	SENT_40	[p2l1875t1032r2151b1083],
23	to	TO	O	to	_	0	SENT_40	[p2l52t1110r113b1155],
24	clopidogrel	NN	O	clopidogrel	prep_to	18	SENT_40	[p2l127t1102r475b1169],
25	[	CD	NUMBER	[	num	24	SENT_40	[p2l494t1102r646b1169],
26	5,6	CD	NUMBER	5,6	num	27	SENT_40	[p2l494t1102r646b1169],
27	]	NN	O	]	dep	24	SENT_40	[p2l494t1102r646b1169],
28	.	.	O	.	_	0	SENT_40	[p2l494t1102r646b1169],

1	However	RB	O	however	advmod	14	SENT_41	[p2l662t1105r945b1155],
2	the	DT	O	the	det	4	SENT_41	[p2l956t1102r1056b1155],
3	true	JJ	O	true	amod	4	SENT_41	[p2l1069t1110r1196b1155],
4	mechanism	NN	O	mechanism	nsubj	14	SENT_41	[p2l1211t1102r1572b1155],
5	of	IN	O	of	_	0	SENT_41	[p2l1587t1102r1652b1155],
6	inter	NN	O	inter	nn	9	SENT_41	[p2l1658t1102r2150b1155],
7	—	CD	NUMBER	—	num	6	SENT_41	[p2l1658t1102r2150b1155],
8	individual	JJ	O	individual	amod	9	SENT_41	[p2l1658t1102r2150b1155],
9	variability	NN	O	variability	prep_of	4	SENT_41	[p2l51t1189r372b1255],
10	of	IN	O	of	_	0	SENT_41	[p2l394t1189r459b1242],
11	clopidogrel	NN	O	clopidogrel	nn	12	SENT_41	[p2l476t1189r825b1255],
12	responsiveness	NN	O	responsiveness	prep_of	9	SENT_41	[p2l850t1190r1321b1255],
13	has	VBZ	O	have	aux	14	SENT_41	[p2l1347t1189r1449b1242],
14	remained	VBN	O	remain	_	0	SENT_41	[p2l1475t1189r1771b1242],
15	unknown	JJ	O	unknown	acomp	14	SENT_41	[p2l1797t1189r2108b1242],
16	.	.	O	.	_	0	SENT_41	[p2l1797t1189r2108b1242],

1	Clopidogrel	NNP	O	Clopidogrel	nsubj	4	SENT_42	[p2l153t1274r515b1341],
2	is	VBZ	O	be	cop	4	SENT_42	[p2l548t1275r593b1327],
3	a	DT	O	a	det	4	SENT_42	[p2l626t1290r658b1327],
4	prodrug	NN	O	prodrug	_	0	SENT_42	[p2l690t1274r944b1341],
5	which	WDT	O	which	nsubjpass	8	SENT_42	[p2l973t1274r1168b1327],
6	is	VBZ	O	be	auxpass	8	SENT_42	[p2l1200t1275r1245b1327],
7	rapidly	RB	O	rapidly	advmod	8	SENT_42	[p2l1279t1274r1503b1341],
8	absorbed	VBN	O	absorb	rcmod	4	SENT_42	[p2l1533t1274r1821b1327],
9	following	VBG	O	follow	_	0	SENT_42	[p2l1853t1274r2153b1341],
10	oral	JJ	O	oral	amod	11	SENT_42	[p2l53t1360r172b1413],
11	administration	NN	O	administration	prep_following	8	SENT_42	[p2l211t1360r697b1414],
12	.	.	O	.	_	0	SENT_42	[p2l211t1360r697b1414],

1	Two	CD	NUMBER	two	num	4	SENT_43	[p2l735t1364r870b1413],
2	sequential	JJ	O	sequential	amod	4	SENT_43	[p2l910t1360r1236b1427],
3	oxidative	JJ	O	oxidative	amod	4	SENT_43	[p2l1275t1360r1567b1413],
4	steps	NNS	O	step	nsubj	28	SENT_43	[p2l1607t1368r1766b1427],
5	by	IN	O	by	_	0	SENT_43	[p2l1806t1360r1882b1427],
6	hepatic	JJ	O	hepatic	amod	8	SENT_43	[p2l1921t1360r2151b1427],
7	cytochrome	NN	O	cytochrome	nn	8	SENT_43	[p2l53t1447r427b1513],
8	P450	NN	O	p450	prep_by	4	SENT_43	[p2l450t1449r604b1500],
9	(	CD	NUMBER	(	num	11	SENT_43	[p2l627t1447r797b1513],
10	CYP	NN	O	cyp	nn	11	SENT_43	[p2l627t1447r797b1513],
11	)	NN	O	)	nsubjpass	13	SENT_43	[p2l627t1447r797b1513],
12	are	VBP	O	be	auxpass	13	SENT_43	[p2l820t1462r915b1500],
13	required	VBN	O	require	rcmod	8	SENT_43	[p2l939t1447r1206b1513],
14	to	TO	O	to	aux	15	SENT_43	[p2l1228t1455r1289b1500],
15	generate	VB	O	generate	xcomp	13	SENT_43	[p2l1310t1455r1585b1513],
16	a	DT	O	a	det	17	SENT_43	[p2l1608t1462r1640b1500],
17	metabolite	NN	O	metabolite	dobj	15	SENT_43	[p2l1662t1447r2003b1500],
18	that	WDT	O	that	nsubj	22	SENT_43	[p2l2025t1447r2152b1500],
19	is	VBZ	O	be	cop	22	SENT_43	[p2l53t1533r99b1586],
20	an	DT	O	a	det	22	SENT_43	[p2l123t1548r197b1586],
21	active	JJ	O	active	amod	22	SENT_43	[p2l220t1533r405b1586],
22	inhibitor	NN	O	inhibitor	rcmod	17	SENT_43	[p2l429t1533r707b1586],
23	of	IN	O	of	_	0	SENT_43	[p2l728t1532r793b1586],
24	platelet	NN	O	platelet	nn	27	SENT_43	[p2l809t1533r1049b1599],
25	ADP	NN	O	adp	nn	27	SENT_43	[p2l1068t1535r1202b1585],
26	P2Y12	NN	O	p2y12	nn	27	SENT_43	[p2l1224t1535r1420b1585],
27	receptors	NNS	O	receptor	prep_of	22	SENT_43	[p2l1446t1541r1739b1599],
28	[	VBP	O	[	_	0	SENT_43	[p2l1767t1532r1865b1599],
29	7	CD	NUMBER	7	number	30	SENT_43	[p2l1767t1532r1865b1599],
30	]	CD	NUMBER	]	dobj	28	SENT_43	[p2l1767t1532r1865b1599],
31	.	.	O	.	_	0	SENT_43	[p2l1767t1532r1865b1599],

1	CYP1A2	NN	O	cyp1a2	nsubj	22	SENT_44	[p2l1890t1535r2150b1594],
2	,	,	O	,	_	0	SENT_44	[p2l1890t1535r2150b1594],
3	CYP2B6	NN	O	cyp2b6	nsubj	22	SENT_44	[p2l53t1621r310b1679],
4	,	,	O	,	_	0	SENT_44	[p2l53t1621r310b1679],
5	CYP2C9	NN	O	cyp2c9	nsubj	22	SENT_44	[p2l345t1621r601b1679],
6	,	,	O	,	_	0	SENT_44	[p2l345t1621r601b1679],
7	CYP2C19	NN	O	cyp2c19	nsubj	22	SENT_44	[p2l636t1621r933b1679],
8	,	,	O	,	_	0	SENT_44	[p2l636t1621r933b1679],
9	CYP3A4/5	NN	O	cyp3a4/5	nsubj	22	SENT_44	[p2l968t1618r1294b1685],
10	,	,	O	,	_	0	SENT_44	[p2l968t1618r1294b1685],
11	and	CC	O	and	_	0	SENT_44	[p2l1328t1618r1443b1671],
12	glycoprotein	NN	O	glycoprotein	nsubj	22	SENT_44	[p2l1476t1618r1875b1685],
13	paraox	NN	O	paraox	nn	16	SENT_44	[p2l1909t1634r2150b1685],
14	—	NN	O	—	nn	16	SENT_44	[p2l1909t1634r2150b1685],
15	inase	NN	O	inase	nn	16	SENT_44	[p2l53t1706r275b1758],
16	—	NN	O	—	dep	1	SENT_44	[p2l53t1706r275b1758],
17	1	CD	NUMBER	1	num	18	SENT_44	[p2l53t1706r275b1758],
18	[	NN	O	[	dep	1	SENT_44	[p2l305t1705r384b1771],
19	8	CD	NUMBER	8	num	20	SENT_44	[p2l305t1705r384b1771],
20	]	NN	O	]	dep	18	SENT_44	[p2l305t1705r384b1771],
21	are	VBP	O	be	cop	22	SENT_44	[p2l407t1720r502b1758],
22	enzymes	NNS	O	enzyme	_	0	SENT_44	[p2l521t1720r798b1771],
23	regulating	VBG	O	regulate	partmod	22	SENT_44	[p2l818t1705r1142b1771],
24	clopidogrel	NN	O	clopidogrel	nn	25	SENT_44	[p2l1160t1705r1512b1771],
25	transformation	NN	O	transformation	dobj	23	SENT_44	[p2l1532t1705r2010b1758],
26	into	IN	O	into	_	0	SENT_44	[p2l2028t1706r2151b1758],
27	the	DT	O	the	det	29	SENT_44	[p2l52t1790r152b1843],
28	active	JJ	O	active	amod	29	SENT_44	[p2l188t1791r373b1843],
29	metabolite	NN	O	metabolite	prep_into	23	SENT_44	[p2l410t1790r766b1844],
30	.	.	O	.	_	0	SENT_44	[p2l410t1790r766b1844],

1	However	RB	O	however	advmod	12	SENT_45	[p2l804t1794r1102b1852],
2	,	,	O	,	_	0	SENT_45	[p2l804t1794r1102b1852],
3	only	RB	O	only	advmod	6	SENT_45	[p2l1139t1790r1276b1857],
4	a	DT	O	a	det	6	SENT_45	[p2l1310t1806r1342b1843],
5	small	JJ	O	small	amod	6	SENT_45	[p2l1379t1790r1546b1843],
6	proportion	NN	O	proportion	nsubjpass	12	SENT_45	[p2l1583t1791r1923b1857],
7	of	IN	O	of	_	0	SENT_45	[p2l1958t1790r2023b1843],
8	the	DT	O	the	det	10	SENT_45	[p2l2051t1790r2151b1843],
9	administered	VBN	O	administer	amod	10	SENT_45	[p2l53t1876r472b1929],
10	clopidogrel	NN	O	clopidogrel	prep_of	6	SENT_45	[p2l497t1876r850b1943],
11	is	VBZ	O	be	auxpass	12	SENT_45	[p2l876t1877r922b1929],
12	metabolized	VBN	O	metabolize	_	0	SENT_45	[p2l949t1876r1339b1929],
13	by	IN	O	by	_	0	SENT_45	[p2l1364t1876r1440b1943],
14	CYP450	NN	O	cyp450	agent	12	SENT_45	[p2l1463t1879r1718b1930],
15	.	.	O	.	_	0	SENT_45	[p2l1463t1879r1718b1930],

1	The	DT	O	the	det	2	SENT_46	[p2l1742t1876r1857b1929],
2	majority	NN	O	majority	nsubjpass	7	SENT_46	[p2l1882t1877r2153b1943],
3	of	IN	O	of	_	0	SENT_46	[p2l53t1962r118b2016],
4	the	DT	O	the	det	5	SENT_46	[p2l127t1963r227b2016],
5	drug	NN	O	drug	prep_of	2	SENT_46	[p2l246t1963r392b2029],
6	is	VBZ	O	be	auxpass	7	SENT_46	[p2l409t1963r454b2016],
7	hydrolyzed	VBN	O	hydrolyze	_	0	SENT_46	[p2l474t1963r829b2029],
8	by	IN	O	by	_	0	SENT_46	[p2l847t1963r923b2029],
9	esterases	NNS	O	esterase	agent	7	SENT_46	[p2l940t1971r1225b2016],
10	to	TO	O	to	_	0	SENT_46	[p2l1244t1971r1305b2016],
11	an	DT	O	a	det	15	SENT_46	[p2l1324t1978r1398b2016],
12	inactive	JJ	O	inactive	amod	15	SENT_46	[p2l1416t1963r1664b2016],
13	carboxylic	JJ	O	carboxylic	amod	15	SENT_46	[p2l1682t1963r2007b2029],
14	acid	NN	O	acid	nn	15	SENT_46	[p2l2024t1963r2150b2016],
15	derivative	NN	O	derivative	prep_to	7	SENT_46	[p2l53t2049r369b2102],
16	that	WDT	O	that	nsubj	17	SENT_46	[p2l427t2049r554b2102],
17	accounts	VBZ	O	account	rcmod	15	SENT_46	[p2l611t2057r888b2102],
18	for	IN	O	for	_	0	SENT_46	[p2l949t2048r1036b2102],
19	85	CD	PERCENT	85	num	20	SENT_46	[p2l1093t2051r1212b2102],
20	%	NN	PERCENT	%	prep_for	17	SENT_46	[p2l1093t2051r1212b2102],
21	of	IN	O	of	_	0	SENT_46	[p2l1270t2048r1336b2102],
22	the	DT	O	the	det	24	SENT_46	[p2l1386t2049r1486b2102],
23	clopidogrel-related	JJ	O	clopidogrel-related	amod	24	SENT_46	[p2l1545t2049r2150b2115],
24	compounds	NNS	O	compound	prep_of	20	SENT_46	[p2l53t2134r419b2201],
25	circulating	VBG	O	circulate	partmod	24	SENT_46	[p2l464t2134r802b2200],
26	in	IN	O	in	_	0	SENT_46	[p2l844t2135r903b2187],
27	plasma	NN	O	plasma	prep_in	25	SENT_46	[p2l946t2134r1171b2201],
28	[	CD	NUMBER	[	number	29	SENT_46	[p2l1218t2134r1412b2201],
29	9,10	CD	NUMBER	9,10	num	30	SENT_46	[p2l1218t2134r1412b2201],
30	]	NN	O	]	dep	25	SENT_46	[p2l1218t2134r1412b2201],
31	.	.	O	.	_	0	SENT_46	[p2l1218t2134r1412b2201],

1	CYP3A5	NN	O	cyp3a5	nsubjpass	3	SENT_47	[p2l1457t2136r1699b2187],
2	is	VBZ	O	be	auxpass	3	SENT_47	[p2l1746t2135r1791b2187],
3	expressed	VBN	O	express	_	0	SENT_47	[p2l1836t2134r2150b2201],
4	polymorphically	RB	O	polymorphically	advmod	3	SENT_47	[p2l53t2221r574b2287],
5	and	CC	O	and	_	0	SENT_47	[p2l591t2221r706b2274],
6	may	MD	O	may	aux	7	SENT_47	[p2l725t2236r860b2287],
7	account	VB	O	account	conj_and	3	SENT_47	[p2l878t2229r1126b2274],
8	for	IN	O	for	_	0	SENT_47	[p2l1144t2221r1232b2274],
9	up	RB	O	up	quantmod	11	SENT_47	[p2l1248t2236r1326b2287],
10	to	TO	O	to	dep	11	SENT_47	[p2l1345t2229r1406b2274],
11	50	CD	PERCENT	50	num	12	SENT_47	[p2l1426t2224r1544b2274],
12	%	NN	PERCENT	%	prep_for	7	SENT_47	[p2l1426t2224r1544b2274],
13	of	IN	O	of	_	0	SENT_47	[p2l1563t2221r1628b2274],
14	the	DT	O	the	det	18	SENT_47	[p2l1639t2221r1739b2274],
15	total	JJ	O	total	amod	18	SENT_47	[p2l1757t2221r1900b2274],
16	hepatic	JJ	O	hepatic	amod	18	SENT_47	[p2l1921t2221r2151b2287],
17	CYP3A	NN	O	cyp3a	nn	18	SENT_47	[p2l53t2309r261b2359],
18	content	NN	O	content	prep_of	12	SENT_47	[p2l286t2314r527b2359],
19	in	IN	O	in	_	0	SENT_47	[p2l555t2307r613b2359],
20	one	CD	NUMBER	one	number	21	SENT_47	[p2l642t2306r940b2359],
21	—	CD	NUMBER	—	prep_in	18	SENT_47	[p2l642t2306r940b2359],
22	third	JJ	ORDINAL	third	quantmod	21	SENT_47	[p2l642t2306r940b2359],
23	of	IN	O	of	_	0	SENT_47	[p2l969t2306r1034b2359],
24	the	DT	O	the	det	36	SENT_47	[p2l1054t2306r1155b2359],
25	white	JJ	O	white	amod	36	SENT_47	[p2l1182t2306r1363b2359],
26	and	CC	O	and	_	0	SENT_47	[p2l1391t2306r1506b2359],
27	in	IN	O	in	conj_and	25	SENT_47	[p2l1535t2307r1593b2359],
28	half	DT	O	half	det	29	SENT_47	[p2l1622t2306r1837b2359],
29	—	NN	O	—	pobj	27	SENT_47	[p2l1622t2306r1837b2359],
30	of	IN	O	of	_	0	SENT_47	[p2l1622t2306r1837b2359],
31	the	DT	O	the	det	33	SENT_47	[p2l1858t2306r1957b2359],
32	black	JJ	O	black	amod	33	SENT_47	[p2l1986t2306r2153b2359],
33	subjects	NNS	O	subject	prep_of	29	SENT_47	[p2l54t2392r308b2459],
34	[	JJ	O	[	amod	33	SENT_47	[p2l342t2392r577b2459],
35	11,12	CD	NUMBER	11,12	tmod	34	SENT_47	[p2l342t2392r577b2459],
36	]	NN	O	]	prep_of	21	SENT_47	[p2l342t2392r577b2459],
37	.	.	O	.	_	0	SENT_47	[p2l342t2392r577b2459],

1	Several	JJ	O	several	amod	3	SENT_48	[p2l610t2392r835b2445],
2	variant	JJ	O	variant	amod	3	SENT_48	[p2l864t2393r1089b2445],
3	alleles	NNS	O	allele	nsubjpass	6	SENT_48	[p2l1118t2392r1315b2445],
4	have	VBP	O	have	aux	6	SENT_48	[p2l1346t2392r1493b2445],
5	been	VBN	O	be	auxpass	6	SENT_48	[p2l1523t2392r1674b2445],
6	delineated	VBN	O	delineate	_	0	SENT_48	[p2l1704t2392r2035b2445],
7	for	IN	O	for	_	0	SENT_48	[p2l2066t2392r2153b2445],
8	the	DT	O	the	det	10	SENT_48	[p2l52t2479r152b2532],
9	CYP3A5	NN	O	cyp3a5	nn	10	SENT_48	[p2l177t2481r407b2532],
10	gene	NN	O	gene	prep_for	6	SENT_48	[p2l431t2494r594b2545],
11	.	.	O	.	_	0	SENT_48	[p2l431t2494r594b2545],

1	Only	RB	O	only	advmod	2	SENT_49	[p2l620t2479r767b2545],
2	CYP3A5	NN	O	cyp3a5	nsubj	5	SENT_49	[p2l791t2478r1086b2532],
3	*	CD	NUMBER	*	number	4	SENT_49	[p2l791t2478r1086b2532],
4	3	CD	NUMBER	3	dep	2	SENT_49	[p2l791t2478r1086b2532],
5	is	VBZ	O	be	_	0	SENT_49	[p2l1111t2479r1157b2532],
6	at	IN	O	at	_	0	SENT_49	[p2l1183t2487r1242b2532],
7	linkage	NN	O	linkage	nn	8	SENT_49	[p2l1265t2479r1492b2545],
8	disequilibrium	NN	O	disequilibrium	prep_at	5	SENT_49	[p2l1517t2479r1997b2545],
9	.	.	O	.	_	0	SENT_49	[p2l1517t2479r1997b2545],

1	This	DT	O	this	_	0	SENT_50	[p2l2020t2479r2149b2532],

1	904	CD	NUMBER	904	num	3	SENT_51	[p2l342t2621r387b2642],
2	S.	NNP	PERSON	S.	nn	3	SENT_51	[p2l1033t2621r1051b2642],
3	Namazi	NNP	PERSON	Namazi	_	0	SENT_51	[p2l1062t2620r1155b2642],
4	et	FW	O	et	nn	5	SENT_51	[p2l1165t2623r1188b2642],
5	al.	FW	O	al.	dep	3	SENT_51	[p2l1197t2620r1223b2642],
6	/	:	O	/	punct	3	SENT_51	[p2l1227t2620r1239b2647],
7	Biochemical	JJ	O	biochemical	amod	8	SENT_51	[p2l1243t2620r1388b2642],
8	Pharmacology	NN	O	pharmacology	dep	3	SENT_51	[p2l1398t2620r1569b2647],
9	83	CD	NUMBER	83	number	10	SENT_51	[p2l1580t2621r1608b2642],
10	(	CD	NUMBER	(	num	11	SENT_51	[p2l1619t2620r1700b2647],
11	2012	CD	DATE	2012	dep	8	SENT_51	[p2l1619t2620r1700b2647],
12	)	CD	NUMBER	)	number	13	SENT_51	[p2l1619t2620r1700b2647],
13	903-908	CD	NUMBER	903-908	num	11	SENT_51	[p2l1710t2621r1817b2642],

1	allele	NN	O	allele	nsubj	8	SENT_52	[p2l10t2755r180b2810],
2	shows	VBZ	O	show	_	0	SENT_52	[p2l225t2755r424b2810],
3	inter	NN	O	inter	nn	6	SENT_52	[p2l469t2756r622b2810],
4	racial	JJ	O	racial	amod	6	SENT_52	[p2l665t2755r837b2810],
5	group	NN	O	group	nn	6	SENT_52	[p2l881t2771r1068b2823],
6	differences	NNS	O	difference	dobj	2	SENT_52	[p2l1113t2755r1464b2810],
7	and	CC	O	and	_	0	SENT_52	[p2l1509t2755r1625b2810],
8	has	VBZ	O	have	conj_and	2	SENT_52	[p2l1671t2755r1775b2810],
9	functional	JJ	O	functional	amod	10	SENT_52	[p2l1821t2755r2146b2810],
10	relevance	NN	O	relevance	dobj	8	SENT_52	[p2l11t2843r333b2899],
11	.	.	O	.	_	0	SENT_52	[p2l11t2843r333b2899],

1	Other	JJ	O	other	amod	3	SENT_53	[p2l354t2843r536b2898],
2	variant	JJ	O	variant	amod	3	SENT_53	[p2l551t2844r781b2898],
3	alleles	NNS	O	allele	nsubj	9	SENT_53	[p2l798t2843r998b2898],
4	are	VBP	O	be	cop	7	SENT_53	[p2l1019t2859r1116b2898],
5	either	RB	O	either	advmod	7	SENT_53	[p2l1136t2843r1325b2898],
6	very	RB	O	very	advmod	7	SENT_53	[p2l1340t2859r1482b2912],
7	rare	JJ	O	rare	_	0	SENT_53	[p2l1500t2859r1625b2898],
8	or	CC	O	or	_	0	SENT_53	[p2l1645t2859r1711b2898],
9	irrelevant	JJ	O	irrelevant	conj_or	7	SENT_53	[p2l1728t2843r2042b2898],
10	for	IN	O	for	_	0	SENT_53	[p2l2060t2843r2149b2898],
11	enzyme	NN	O	enzyme	nn	12	SENT_53	[p2l10t2948r261b3001],
12	activity	NN	O	activity	prep_for	7	SENT_53	[p2l281t2933r522b3001],
13	(	CD	NUMBER	(	num	14	SENT_53	[p2l540t2932r648b3000],
14	*	NN	O	*	dep	12	SENT_53	[p2l540t2932r648b3000],
15	2	CD	NUMBER	2	dep	14	SENT_53	[p2l540t2932r648b3000],
16	,	,	O	,	_	0	SENT_53	[p2l540t2932r648b3000],
17	*	CD	NUMBER	*	number	18	SENT_53	[p2l669t2932r749b2996],
18	4	CD	NUMBER	4	num	22	SENT_53	[p2l669t2932r749b2996],
19	,	,	O	,	_	0	SENT_53	[p2l669t2932r749b2996],
20	*	CD	NUMBER	*	number	21	SENT_53	[p2l771t2932r833b2987],
21	5	CD	NUMBER	5	num	22	SENT_53	[p2l771t2932r833b2987],
22	*	NN	O	*	appos	12	SENT_53	[p2l855t2932r878b2955],
23	6	CD	NUMBER	6	dep	22	SENT_53	[p2l900t2935r951b2996],
24	,	,	O	,	_	0	SENT_53	[p2l900t2935r951b2996],
25	*	CD	NUMBER	*	num	26	SENT_53	[p2l973t2932r995b2955],
26	7	CD	NUMBER	7	appos	12	SENT_53	[p2l1018t2936r1068b2996],
27	,	,	O	,	_	0	SENT_53	[p2l1018t2936r1068b2996],
28	*	CD	NUMBER	*	number	29	SENT_53	[p2l1089t2932r1152b2987],
29	8	CD	NUMBER	8	appos	26	SENT_53	[p2l1089t2932r1152b2987],
30	and	CC	O	and	_	0	SENT_53	[p2l1174t2932r1290b2987],
31	*	CD	NUMBER	*	number	32	SENT_53	[p2l1311t2932r1402b3000],
32	9	CD	NUMBER	9	num	33	SENT_53	[p2l1311t2932r1402b3000],
33	)	NN	O	)	conj_and	7	SENT_53	[p2l1311t2932r1402b3000],
34	[	CD	NUMBER	[	number	35	SENT_53	[p2l1425t2932r1665b3001],
35	13,14	CD	NUMBER	13,14	num	36	SENT_53	[p2l1425t2932r1665b3001],
36	]	NN	O	]	dep	7	SENT_53	[p2l1425t2932r1665b3001],
37	.	.	O	.	_	0	SENT_53	[p2l1425t2932r1665b3001],

1	CYP3A5	NN	O	cyp3a5	nsubjpass	12	SENT_54	[p2l1686t2932r2093b3001],
2	*	CD	NUMBER	*	number	3	SENT_54	[p2l1686t2932r2093b3001],
3	3	CD	NUMBER	3	amod	1	SENT_54	[p2l1686t2932r2093b3001],
4	/	:	O	/	punct	6	SENT_54	[p2l1686t2932r2093b3001],
5	*	CD	NUMBER	*	num	6	SENT_54	[p2l1686t2932r2093b3001],
6	3	CD	NUMBER	3	dep	3	SENT_54	[p2l1686t2932r2093b3001],
7	a	DT	O	a	det	9	SENT_54	[p2l2114t2948r2147b2987],
8	non-expressor	JJ	O	non-expressor	amod	9	SENT_54	[p2l11t3037r449b3090],
9	genotype	NN	O	genotype	dep	6	SENT_54	[p2l482t3030r780b3090],
10	is	VBZ	O	be	auxpass	12	SENT_54	[p2l819t3022r866b3077],
11	strongly	RB	O	strongly	advmod	12	SENT_54	[p2l906t3022r1170b3090],
12	correlated	VBN	O	correlate	_	0	SENT_54	[p2l1207t3022r1533b3077],
13	with	IN	O	with	_	0	SENT_54	[p2l1570t3022r1718b3077],
14	a	DT	O	a	det	17	SENT_54	[p2l1756t3037r1788b3077],
15	decreased	VBN	O	decrease	amod	17	SENT_54	[p2l1827t3022r2146b3077],
16	CYP3A5	NN	O	cyp3a5	nn	17	SENT_54	[p2l11t3113r257b3165],
17	activity	NN	O	activity	prep_with	12	SENT_54	[p2l314t3111r568b3179],
18	,	,	O	,	_	0	SENT_54	[p2l314t3111r568b3179],
19	whereas	IN	O	whereas	mark	42	SENT_54	[p2l621t3110r890b3165],
20	the	DT	O	the	det	23	SENT_54	[p2l945t3110r1046b3165],
21	wild	JJ	O	wild	amod	23	SENT_54	[p2l1098t3110r1413b3179],
22	—	NN	O	—	nn	23	SENT_54	[p2l1098t3110r1413b3179],
23	type	NN	O	type	dep	28	SENT_54	[p2l1098t3110r1413b3179],
24	CYP3A5	CD	NUMBER	cyp3a5	num	25	SENT_54	[p2l1467t3110r1761b3165],
25	*	NN	O	*	dep	23	SENT_54	[p2l1467t3110r1761b3165],
26	1	CD	NUMBER	1	num	27	SENT_54	[p2l1467t3110r1761b3165],
27	allele	NN	O	allele	dep	28	SENT_54	[p2l1822t3110r1992b3165],
28	(	CD	NUMBER	(	dep	31	SENT_54	[p2l2046t3110r2147b3179],
29	an	DT	O	a	det	30	SENT_54	[p2l2046t3110r2147b3179],
30	expressor	NN	O	expressor	dep	28	SENT_54	[p2l10t3200r361b3268],
31	)	NN	O	)	dep	42	SENT_54	[p2l10t3200r361b3268],
32	,	,	O	,	_	0	SENT_54	[p2l10t3200r361b3268],
33	present	JJ	DATE	present	ccomp	42	SENT_54	[p2l394t3208r635b3268],
34	in	IN	O	in	dep	33	SENT_54	[p2l667t3201r726b3254],
35	either	CC	O	either	preconj	36	SENT_54	[p2l757t3200r948b3255],
36	homozygous	JJ	O	homozygous	amod	39	SENT_54	[p2l977t3200r1385b3268],
37	or	CC	O	or	_	0	SENT_54	[p2l1418t3216r1484b3255],
38	heterozygous	JJ	O	heterozygous	conj_or	36	SENT_54	[p2l1514t3200r1945b3268],
39	form	NN	O	form	pobj	34	SENT_54	[p2l1979t3200r2146b3263],
40	,	,	O	,	_	0	SENT_54	[p2l1979t3200r2146b3263],
41	is	VBZ	O	be	auxpass	42	SENT_54	[p2l11t3290r57b3344],
42	correlated	VBN	O	correlate	advcl	12	SENT_54	[p2l80t3289r405b3344],
43	with	IN	O	with	_	0	SENT_54	[p2l425t3289r574b3344],
44	a	DT	O	a	det	47	SENT_54	[p2l594t3305r626b3344],
45	high	JJ	O	high	amod	47	SENT_54	[p2l648t3289r788b3357],
46	CYP3A5	NN	O	cyp3a5	nn	47	SENT_54	[p2l809t3291r1055b3344],
47	activity	NN	O	activity	prep_with	42	SENT_54	[p2l1079t3290r1334b3357],
48	.	.	O	.	_	0	SENT_54	[p2l1079t3290r1334b3357],

1	Thus	RB	O	thus	advmod	10	SENT_55	[p2l1354t3289r1524b3352],
2	,	,	O	,	_	0	SENT_55	[p2l1354t3289r1524b3352],
3	CYP3A5	NN	O	cyp3a5	nn	4	SENT_55	[p2l1546t3291r1781b3344],
4	expression	NN	O	expression	nsubj	10	SENT_55	[p2l1802t3290r2147b3357],
5	may	MD	O	may	aux	10	SENT_55	[p2l11t3393r148b3446],
6	be	VB	O	be	cop	10	SENT_55	[p2l180t3377r254b3432],
7	the	DT	O	the	det	10	SENT_55	[p2l287t3377r389b3432],
8	most	RBS	O	most	advmod	9	SENT_55	[p2l423t3385r583b3432],
9	important	JJ	O	important	amod	10	SENT_55	[p2l616t3378r941b3446],
10	factor	NN	O	factor	_	0	SENT_55	[p2l974t3377r1160b3432],
11	determining	VBG	O	determine	partmod	10	SENT_55	[p2l1192t3377r1591b3446],
12	the	DT	O	the	det	15	SENT_55	[p2l1623t3377r1724b3432],
13	total	JJ	O	total	amod	15	SENT_55	[p2l1758t3377r1903b3432],
14	CYP3A	NN	O	cyp3a	nn	15	SENT_55	[p2l1939t3380r2150b3432],
15	content	NN	O	content	dobj	11	SENT_55	[p2l10t3474r255b3521],
16	of	IN	O	of	_	0	SENT_55	[p2l282t3466r349b3521],
17	the	DT	O	the	det	22	SENT_55	[p2l369t3466r471b3521],
18	human	JJ	O	human	amod	22	SENT_55	[p2l499t3466r724b3521],
19	liver	NN	O	liver	nn	22	SENT_55	[p2l753t3466r896b3521],
20	[	NN	O	[	nn	22	SENT_55	[p2l926t3466r1165b3535],
21	15,16	CD	NUMBER	15,16	num	22	SENT_55	[p2l926t3466r1165b3535],
22	]	NN	O	]	prep_of	15	SENT_55	[p2l926t3466r1165b3535],
23	.	.	O	.	_	0	SENT_55	[p2l926t3466r1165b3535],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_56	[p2l112t3558r398b3610],
2	isoenzyme	NN	O	isoenzyme	nsubjpass	4	SENT_56	[p2l432t3556r776b3624],
3	is	VBZ	O	be	auxpass	4	SENT_56	[p2l808t3556r854b3610],
4	involved	VBN	O	involve	_	0	SENT_56	[p2l888t3555r1163b3610],
5	in	IN	O	in	_	0	SENT_56	[p2l1196t3556r1255b3610],
6	both	CC	O	both	dep	24	SENT_56	[p2l1286t3555r1432b3610],
7	sequential	JJ	O	sequential	amod	9	SENT_56	[p2l1465t3555r1796b3624],
8	metabolic	JJ	O	metabolic	amod	9	SENT_56	[p2l1829t3555r2148b3610],
9	steps	NNS	O	step	dep	6	SENT_56	[p2l11t3653r173b3713],
10	and	CC	O	and	_	0	SENT_56	[p2l198t3644r314b3699],
11	is	VBZ	O	be	cop	16	SENT_56	[p2l339t3645r386b3699],
12	also	RB	O	also	advmod	16	SENT_56	[p2l411t3644r536b3699],
13	the	DT	O	the	det	16	SENT_56	[p2l559t3644r661b3699],
14	most	RBS	O	most	advmod	15	SENT_56	[p2l685t3653r845b3699],
15	important	JJ	O	important	amod	16	SENT_56	[p2l868t3645r1194b3713],
16	indicator	NN	O	indicator	conj_and	6	SENT_56	[p2l1217t3644r1507b3699],
17	of	IN	O	of	_	0	SENT_56	[p2l1529t3644r1595b3699],
18	the	DT	O	the	det	20	SENT_56	[p2l1611t3644r1712b3699],
19	pharmacoki	NN	O	pharmacokus	nn	20	SENT_56	[p2l1737t3644r2147b3713],
20	—	NN	O	—	prep_of	16	SENT_56	[p2l1737t3644r2147b3713],
21	netic	JJ	O	netic	amod	20	SENT_56	[p2l11t3735r167b3789],
22	and	CC	O	and	_	0	SENT_56	[p2l187t3734r303b3789],
23	pharmacodynamic	JJ	O	pharmacodynamic	conj_and	21	SENT_56	[p2l324t3734r926b3802],
24	responses	NNS	O	response	prep_in	4	SENT_56	[p2l946t3750r1261b3802],
25	to	TO	O	to	_	0	SENT_56	[p2l1282t3742r1344b3789],
26	clopidogrel	NN	O	clopidogrel	nn	27	SENT_56	[p2l1364t3734r1723b3802],
27	[	NN	O	[	prep_to	4	SENT_56	[p2l1747t3734r1888b3802],
28	17	CD	NUMBER	17	num	29	SENT_56	[p2l1747t3734r1888b3802],
29	]	NN	O	]	dep	27	SENT_56	[p2l1747t3734r1888b3802],
30	.	.	O	.	_	0	SENT_56	[p2l1747t3734r1888b3802],

1	At	IN	O	at	_	0	SENT_57	[p2l1907t3736r1980b3789],
2	least	JJS	O	least	pobj	1	SENT_57	[p2l1999t3734r2148b3789],

1	25	CD	NUMBER	25	num	4	SENT_58	[p3l10t20r85b72],
2	single	JJ	O	single	amod	4	SENT_58	[p3l112t17r298b85],
3	nucleotide	NN	O	nucleotide	nn	4	SENT_58	[p3l322t17r660b72],
4	polymorphisms	NNS	O	polymorphism	nsubj	5	SENT_58	[p3l684t17r1188b85],
5	(	VBP	O	(	_	0	SENT_58	[p3l1212t17r1420b85],
6	SNPs	NNS	O	snp	nsubjpass	16	SENT_58	[p3l1212t17r1420b85],
7	)	CD	NUMBER	)	num	6	SENT_58	[p3l1212t17r1420b85],
8	in	IN	O	in	_	0	SENT_58	[p3l1444t18r1503b71],
9	the	DT	O	the	det	10	SENT_58	[p3l1525t17r1627b72],
10	gene	NN	O	gene	prep_in	6	SENT_58	[p3l1649t33r1800b85],
11	coding	VBG	O	code	partmod	10	SENT_58	[p3l1823t17r2038b85],
12	for	IN	O	for	_	0	SENT_58	[p3l2060t17r2149b72],
13	CYP2Cl9	NN	O	cyp2cl9	prep_for	11	SENT_58	[p3l11t108r296b160],
14	have	VBP	O	have	aux	16	SENT_58	[p3l337t105r486b160],
15	been	VBN	O	be	auxpass	16	SENT_58	[p3l525t105r678b160],
16	reported	VBN	O	report	ccomp	5	SENT_58	[p3l717t105r1008b174],
17	,	,	O	,	_	0	SENT_58	[p3l717t105r1008b174],
18	and	CC	O	and	_	0	SENT_58	[p3l1048t105r1164b160],
19	the	DT	O	the	det	22	SENT_58	[p3l1202t105r1304b160],
20	“	JJ	O	“	amod	22	SENT_58	[p3l1344t105r1921b160],
21	loss	NN	O	loss	nn	22	SENT_58	[p3l1344t105r1921b160],
22	—	NN	O	—	nsubj	39	SENT_58	[p3l1344t105r1921b160],
23	of	IN	O	of	_	0	SENT_58	[p3l1344t105r1921b160],
24	—	CD	NUMBER	—	num	25	SENT_58	[p3l1344t105r1921b160],
25	function	NN	O	function	prep_of	22	SENT_58	[p3l1344t105r1921b160],
26	”	CD	NUMBER	”	num	27	SENT_58	[p3l1344t105r1921b160],
27	allele	NN	O	allele	dep	22	SENT_58	[p3l1961t105r2146b169],
28	,	,	O	,	_	0	SENT_58	[p3l1961t105r2146b169],
29	CYP2Cl9	NN	O	cyp2cl9	nn	30	SENT_58	[p3l11t193r365b247],
30	*	NN	O	*	appos	22	SENT_58	[p3l11t193r365b247],
31	2	CD	NUMBER	2	dep	30	SENT_58	[p3l11t193r365b247],
32	in	IN	O	in	_	0	SENT_58	[p3l423t194r483b247],
33	exon	NN	O	exon	prep_in	31	SENT_58	[p3l537t209r691b247],
34	5	CD	NUMBER	5	num	33	SENT_58	[p3l746t196r797b256],
35	,	,	O	,	_	0	SENT_58	[p3l746t196r797b256],
36	is	VBZ	O	be	cop	39	SENT_58	[p3l853t194r899b247],
37	the	DT	O	the	det	39	SENT_58	[p3l955t193r1056b247],
38	most	RBS	O	most	advmod	39	SENT_58	[p3l1111t201r1271b247],
39	common	JJ	O	common	conj_and	5	SENT_58	[p3l1324t209r1607b247],
40	and	CC	O	and	_	0	SENT_58	[p3l1661t193r1777b247],
41	the	DT	O	the	det	44	SENT_58	[p3l1832t193r1933b247],
42	most	RBS	O	most	advmod	43	SENT_58	[p3l1988t201r2148b247],
43	investigated	VBN	O	investigate	amod	44	SENT_58	[p3l11t281r403b350],
44	polymorphism	NN	O	polymorphism	conj_and	5	SENT_58	[p3l459t281r949b350],
45	.	.	O	.	_	0	SENT_58	[p3l459t281r949b350],

1	Carriers	NNS	O	carrier	nsubj	8	SENT_59	[p3l1005t282r1254b336],
2	of	IN	O	of	_	0	SENT_59	[p3l1309t281r1375b336],
3	at	IN	O	at	quantmod	5	SENT_59	[p3l1422t290r1482b336],
4	least	JJS	O	least	mwe	3	SENT_59	[p3l1536t281r1684b336],
5	one	CD	NUMBER	one	num	7	SENT_59	[p3l1738t297r1852b336],
6	lossoffunction	NN	O	lossoffunction	nn	7	SENT_59	[p3l1907t281r2146b336, p3l11t370r279b425],
7	allele	NN	O	allele	prep_of	1	SENT_59	[p3l312t370r482b425],
8	show	VBP	O	show	_	0	SENT_59	[p3l517t370r688b425],
9	a	DT	O	a	det	13	SENT_59	[p3l719t386r751b425],
10	reduced	VBN	O	reduce	amod	13	SENT_59	[p3l786t370r1042b425],
11	platelet	NN	O	platelet	nn	13	SENT_59	[p3l1077t370r1321b439],
12	aggregation	NN	O	aggregation	nn	13	SENT_59	[p3l1353t371r1733b439],
13	response	NN	O	response	dobj	8	SENT_59	[p3l1767t386r2052b439],
14	to	TO	O	to	_	0	SENT_59	[p3l2085t379r2147b425],
15	clopidogrel	NN	O	clopidogrel	prep_to	8	SENT_59	[p3l10t460r369b528],
16	as	IN	O	as	dep	22	SENT_59	[p3l401t476r463b515],
17	compared	VBN	O	compare	_	0	SENT_59	[p3l495t460r815b528],
18	with	IN	O	with	prepc_compared_with	22	SENT_59	[p3l843t460r992b515],
19	non	JJ	O	non	amod	21	SENT_59	[p3l1022t461r1416b515],
20	—	NN	O	—	nn	21	SENT_59	[p3l1022t461r1416b515],
21	carriers	NNS	O	carrier	pobj	22	SENT_59	[p3l1022t461r1416b515],
22	[	VBP	O	[	advcl	8	SENT_59	[p3l1450t460r1715b528],
23	l8	NN	O	l8	dobj	22	SENT_59	[p3l1450t460r1715b528],
24	—	CD	NUMBER	—	number	25	SENT_59	[p3l1450t460r1715b528],
25	21	CD	NUMBER	21	num	26	SENT_59	[p3l1450t460r1715b528],
26	]	NN	O	]	nsubj	22	SENT_59	[p3l1450t460r1715b528],
27	,	,	O	,	_	0	SENT_59	[p3l1450t460r1715b528],
28	whereas	IN	O	whereas	mark	36	SENT_59	[p3l1745t460r2014b515],
29	the	DT	O	the	det	30	SENT_59	[p3l2045t460r2147b515],
30	presence	NN	O	presence	nsubjpass	36	SENT_59	[p3l11t565r294b617],
31	of	IN	O	of	_	0	SENT_59	[p3l334t549r400b604],
32	CYP2C19	NN	O	cyp2c19	prep_of	30	SENT_59	[p3l432t549r813b604],
33	*	CD	NUMBER	*	number	34	SENT_59	[p3l432t549r813b604],
34	17	CD	NUMBER	17	num	32	SENT_59	[p3l432t549r813b604],
35	is	VBZ	O	be	auxpass	36	SENT_59	[p3l848t550r894b604],
36	associated	VBN	O	associate	dep	26	SENT_59	[p3l935t549r1267b604],
37	with	IN	O	with	_	0	SENT_59	[p3l1304t549r1452b604],
38	a	DT	O	a	det	40	SENT_59	[p3l1491t565r1523b604],
39	raised	VBN	O	raise	amod	40	SENT_59	[p3l1563t549r1754b604],
40	risk	NN	O	risk	prep_with	36	SENT_59	[p3l1794t549r1911b604],
41	of	IN	O	of	_	0	SENT_59	[p3l1948t549r2014b604],
42	the	DT	O	the	det	44	SENT_59	[p3l2045t549r2147b604],
43	adverse	JJ	O	adverse	amod	44	SENT_59	[p3l10t637r256b692],
44	effects	NNS	O	effect	prep_of	40	SENT_59	[p3l285t637r491b692],
45	of	IN	O	of	_	0	SENT_59	[p3l521t637r587b692],
46	clopidogrel	NN	O	clopidogrel	prep_of	44	SENT_59	[p3l608t637r967b706],
47	such	JJ	O	such	_	0	SENT_59	[p3l997t637r1143b692],
48	as	IN	O	as	_	0	SENT_59	[p3l1170t653r1232b692],
49	bleeding	VBG	O	bleed	prepc_such_as	46	SENT_59	[p3l1261t637r1539b706],
50	[	CD	NUMBER	[	number	51	SENT_59	[p3l1569t637r1710b706],
51	22	CD	NUMBER	22	num	52	SENT_59	[p3l1569t637r1710b706],
52	]	NN	O	]	dobj	49	SENT_59	[p3l1569t637r1710b706],
53	.	.	O	.	_	0	SENT_59	[p3l1569t637r1710b706],

1	P2Y12	NN	O	p2y12	nn	2	SENT_60	[p3l113t729r312b780],
2	receptor	NN	O	receptor	nsubj	6	SENT_60	[p3l341t734r610b795],
3	is	VBZ	O	be	cop	6	SENT_60	[p3l634t727r681b781],
4	a	DT	O	a	det	6	SENT_60	[p3l708t742r740b781],
5	purinergic	JJ	O	purinergic	amod	6	SENT_60	[p3l766t727r1098b795],
6	receptor	NN	O	receptor	_	0	SENT_60	[p3l1123t734r1406b795],
7	.	.	O	.	_	0	SENT_60	[p3l1123t734r1406b795],

1	It	PRP	O	it	nsubj	2	SENT_61	[p3l1434t729r1479b781],
2	has	VBZ	O	have	_	0	SENT_61	[p3l1504t726r1608b781],
3	a	DT	O	a	det	5	SENT_61	[p3l1635t742r1667b781],
4	pivotal	JJ	O	pivotal	amod	5	SENT_61	[p3l1693t726r1913b795],
5	role	NN	O	role	dobj	2	SENT_61	[p3l1940t726r2061b781],
6	in	IN	O	in	_	0	SENT_61	[p3l2088t727r2147b780],
7	platelet	NN	O	platelet	nn	8	SENT_61	[p3l11t815r255b884],
8	aggregation	NN	O	aggregation	prep_in	5	SENT_61	[p3l277t816r672b884],
9	.	.	O	.	_	0	SENT_61	[p3l277t816r672b884],

1	Activation	NN	O	activation	nsubj	6	SENT_62	[p3l694t816r1026b870],
2	of	IN	O	of	_	0	SENT_62	[p3l1049t815r1115b870],
3	the	DT	O	the	det	5	SENT_62	[p3l1130t815r1232b870],
4	P2Yl2	NN	O	p2yl2	nn	5	SENT_62	[p3l1256t818r1455b870],
5	receptor	NN	O	receptor	prep_of	1	SENT_62	[p3l1482t824r1752b884],
6	leads	VBZ	O	lead	_	0	SENT_62	[p3l1773t815r1935b870],
7	to	TO	O	to	_	0	SENT_62	[p3l1960t824r2022b870],
8	the	DT	O	the	det	9	SENT_62	[p3l2045t815r2147b870],
9	activation	NN	O	activation	prep_to	6	SENT_62	[p3l10t905r330b959],
10	of	IN	O	of	_	0	SENT_62	[p3l356t904r422b959],
11	the	DT	O	the	det	14	SENT_62	[p3l441t904r542b959],
12	glycoprotein	NN	O	glycoprotein	nn	14	SENT_62	[p3l568t904r974b973],
13	(	CD	NUMBER	(	num	14	SENT_62	[p3l1000t904r1137b973],
14	GP	NN	O	gp	prep_of	9	SENT_62	[p3l1000t904r1137b973],
15	)	CD	NUMBER	)	num	17	SENT_62	[p3l1000t904r1137b973],
16	IIb/IIIa	NN	O	iib/iiia	nn	17	SENT_62	[p3l1164t904r1372b973],
17	receptor	NN	O	receptor	dobj	6	SENT_62	[p3l1399t913r1682b973],
18	,	,	O	,	_	0	SENT_62	[p3l1399t913r1682b973],
19	which	WDT	O	which	nsubj	20	SENT_62	[p3l1708t904r1906b959],
20	results	VBZ	O	result	rcmod	17	SENT_62	[p3l1933t904r2146b959],
21	in	IN	O	in	_	0	SENT_62	[p3l11t995r70b1048],
22	the	DT	O	the	det	23	SENT_62	[p3l88t994r189b1049],
23	enhancement	NN	O	enhancement	prep_in	20	SENT_62	[p3l208t994r648b1049],
24	of	IN	O	of	_	0	SENT_62	[p3l665t994r731b1049],
25	platelet	NN	O	platelet	nn	26	SENT_62	[p3l743t994r987b1062],
26	aggregation	NN	O	aggregation	prep_of	23	SENT_62	[p3l1004t995r1398b1062],
27	,	,	O	,	_	0	SENT_62	[p3l1004t995r1398b1062],
28	and	CC	O	and	_	0	SENT_62	[p3l1417t994r1534b1049],
29	the	DT	O	the	det	30	SENT_62	[p3l1552t994r1654b1049],
30	stabilization	NN	O	stabilization	dobj	6	SENT_62	[p3l1673t994r2070b1049],
31	of	IN	O	of	_	0	SENT_62	[p3l2088t994r2154b1049],
32	the	DT	O	the	det	34	SENT_62	[p3l10t1083r111b1138],
33	platelet	NN	O	platelet	nn	34	SENT_62	[p3l139t1083r383b1151],
34	aggregate	NN	O	aggregate	prep_of	30	SENT_62	[p3l409t1091r722b1151],
35	[	CD	NUMBER	[	number	36	SENT_62	[p3l752t1083r893b1151],
36	23	CD	NUMBER	23	num	37	SENT_62	[p3l752t1083r893b1151],
37	]	NN	O	]	dep	30	SENT_62	[p3l752t1083r893b1151],
38	.	.	O	.	_	0	SENT_62	[p3l752t1083r893b1151],

1	P2Y12	NN	O	p2y12	nn	2	SENT_63	[p3l920t1086r1113b1137],
2	gene	NN	O	gene	nsubjpass	4	SENT_63	[p3l1139t1099r1290b1151],
3	is	VBZ	O	be	auxpass	4	SENT_63	[p3l1319t1084r1365b1138],
4	expressed	VBN	O	express	_	0	SENT_63	[p3l1393t1083r1713b1151],
5	polymorphically	RB	O	polymorphically	advmod	4	SENT_63	[p3l1741t1083r2146b1151, p3l10t1171r173b1240],
6	.	.	O	.	_	0	SENT_63	[p3l1741t1083r2146b1151, p3l10t1171r173b1240],

1	T744C	NN	O	t744c	nn	2	SENT_64	[p3l196t1174r401b1226],
2	polymorphism	NN	O	polymorphism	nsubj	3	SENT_64	[p3l424t1171r898b1240],
3	is	VBZ	O	be	_	0	SENT_64	[p3l923t1172r969b1226],
4	in	IN	O	in	_	0	SENT_64	[p3l995t1172r1054b1226],
5	total	JJ	O	total	amod	7	SENT_64	[p3l1077t1171r1222b1226],
6	linkage	NN	O	linkage	nn	7	SENT_64	[p3l1248t1171r1479b1240],
7	disequilibrium	NN	O	disequilibrium	prep_in	3	SENT_64	[p3l1503t1171r1977b1240],
8	with	IN	O	with	_	0	SENT_64	[p3l1999t1171r2147b1226],
9	the	DT	O	the	det	12	SENT_64	[p3l10t1260r112b1315],
10	other	JJ	O	other	amod	12	SENT_64	[p3l139t1260r311b1315],
11	3	CD	NUMBER	3	num	12	SENT_64	[p3l335t1263r369b1315],
12	polymorphisms	NNS	O	polymorphism	prep_with	7	SENT_64	[p3l400t1260r905b1329],
13	of	IN	O	of	_	0	SENT_64	[p3l933t1260r999b1315],
14	the	DT	O	the	det	17	SENT_64	[p3l1018t1260r1120b1315],
15	P2Y12	NN	O	p2y12	nn	17	SENT_64	[p3l1145t1263r1338b1314],
16	receptor	NN	O	receptor	nn	17	SENT_64	[p3l1366t1268r1636b1329],
17	gene	NN	O	gene	prep_of	7	SENT_64	[p3l1660t1276r1811b1329],
18	[	CD	NUMBER	[	number	19	SENT_64	[p3l1842t1260r1983b1329],
19	24	CD	NUMBER	24	num	20	SENT_64	[p3l1842t1260r1983b1329],
20	]	NN	O	]	dep	17	SENT_64	[p3l1842t1260r1983b1329],
21	.	.	O	.	_	0	SENT_64	[p3l1842t1260r1983b1329],

1	Two	CD	NUMBER	two	num	3	SENT_65	[p3l2009t1263r2146b1315],
2	functional	JJ	O	functional	amod	3	SENT_65	[p3l11t1349r336b1404],
3	haplotypes	NNS	O	haplotype	nsubj	4	SENT_65	[p3l368t1349r720b1418],
4	(	VBP	O	(	_	0	SENT_65	[p3l752t1350r859b1418],
5	H1	NN	O	h1	nn	8	SENT_65	[p3l752t1350r859b1418],
6	and	CC	O	and	_	0	SENT_65	[p3l898t1349r1014b1404],
7	H2	NN	O	h2	conj_and	5	SENT_65	[p3l1046t1349r1160b1418],
8	)	NN	O	)	nsubjpass	10	SENT_65	[p3l1046t1349r1160b1418],
9	were	VBD	O	be	auxpass	10	SENT_65	[p3l1190t1365r1349b1404],
10	determined	VBN	O	determine	ccomp	4	SENT_65	[p3l1379t1349r1753b1404],
11	by	IN	O	by	_	0	SENT_65	[p3l1783t1349r1861b1418],
12	Fontana	NNP	PERSON	Fontana	agent	10	SENT_65	[p3l1891t1353r2147b1404],
13	et	FW	O	et	nn	14	SENT_65	[p3l10t1447r70b1493],
14	al.	FW	O	al.	dobj	10	SENT_65	[p3l97t1438r166b1494],
15	.	.	O	.	_	0	SENT_65	[p3l97t1438r166b1494],

1	The	DT	O	the	det	4	SENT_66	[p3l193t1438r310b1493],
2	more	JJR	O	more	amod	4	SENT_66	[p3l339t1454r504b1493],
3	rare	JJ	O	rare	amod	4	SENT_66	[p3l533t1454r658b1493],
4	variant	NN	O	variant	nsubjpass	6	SENT_66	[p3l685t1439r915b1493],
5	is	VBZ	O	be	auxpass	6	SENT_66	[p3l942t1439r988b1493],
6	named	VBN	O	name	_	0	SENT_66	[p3l1018t1438r1236b1493],
7	H2	NN	O	h2	nn	8	SENT_66	[p3l1265t1441r1352b1493],
8	haplotype	NN	O	haplotype	dobj	6	SENT_66	[p3l1383t1438r1720b1507],
9	,	,	O	,	_	0	SENT_66	[p3l1383t1438r1720b1507],
10	whereas	IN	O	whereas	mark	15	SENT_66	[p3l1747t1438r2016b1493],
11	the	DT	O	the	det	13	SENT_66	[p3l2045t1438r2147b1493],
12	wild	JJ	O	wild	amod	13	SENT_66	[p3l9t1528r150b1583],
13	type	NN	O	type	nsubjpass	15	SENT_66	[p3l179t1536r318b1596],
14	is	VBZ	O	be	auxpass	15	SENT_66	[p3l348t1529r394b1583],
15	denoted	VBN	O	denote	advcl	6	SENT_66	[p3l424t1528r685b1583],
16	as	IN	O	as	_	0	SENT_66	[p3l714t1544r777b1583],
17	H1	NN	O	h1	nn	18	SENT_66	[p3l807t1531r887b1582],
18	haplotype	NN	O	haplotype	prep_as	15	SENT_66	[p3l926t1528r1246b1596],
19	[	CD	NUMBER	[	number	20	SENT_66	[p3l1278t1528r1420b1596],
20	25	CD	NUMBER	25	num	21	SENT_66	[p3l1278t1528r1420b1596],
21	]	NN	O	]	dep	15	SENT_66	[p3l1278t1528r1420b1596],
22	.	.	O	.	_	0	SENT_66	[p3l1278t1528r1420b1596],

1	According	VBG	O	accord	_	0	SENT_67	[p3l1447t1528r1773b1596],
2	to	TO	O	to	prepc_according_to	10	SENT_67	[p3l1800t1536r1862b1583],
3	Fontana	NNP	PERSON	Fontana	pobj	10	SENT_67	[p3l1891t1531r2147b1583],
4	et	FW	O	et	nn	5	SENT_67	[p3l10t1625r70b1672],
5	al.	FW	O	al.	dep	3	SENT_67	[p3l97t1617r182b1680],
6	,	,	O	,	_	0	SENT_67	[p3l97t1617r182b1680],
7	the	DT	O	the	det	9	SENT_67	[p3l210t1617r312b1672],
8	H2	NN	O	h2	nn	9	SENT_67	[p3l340t1620r427b1671],
9	haplotype	NN	O	haplotype	nsubj	10	SENT_67	[p3l457t1617r779b1685],
10	(	VBD	O	(	dep	18	SENT_67	[p3l806t1617r865b1685],
11	a	DT	O	a	det	12	SENT_67	[p3l806t1617r865b1685],
12	C	NN	O	c	dobj	10	SENT_67	[p3l893t1620r931b1672],
13	in	IN	O	in	_	0	SENT_67	[p3l959t1618r1018b1671],
14	position	NN	O	position	nn	16	SENT_67	[p3l1045t1618r1306b1685],
15	744	CD	NUMBER	744	num	16	SENT_67	[p3l1334t1617r1478b1685],
16	)	NN	O	)	prep_in	10	SENT_67	[p3l1334t1617r1478b1685],
17	is	VBZ	O	be	auxpass	18	SENT_67	[p3l1506t1618r1552b1672],
18	associated	VBN	O	associate	_	0	SENT_67	[p3l1581t1617r1913b1672],
19	with	IN	O	with	_	0	SENT_67	[p3l1939t1617r2087b1672],
20	a	DT	O	a	det	23	SENT_67	[p3l2115t1633r2147b1672],
21	higher	JJR	O	higher	amod	23	SENT_67	[p3l11t1705r218b1774],
22	maximal	JJ	O	maximal	amod	23	SENT_67	[p3l245t1705r525b1760],
23	aggregation	NN	O	aggregation	prep_with	18	SENT_67	[p3l554t1706r934b1774],
24	in	IN	O	in	_	0	SENT_67	[p3l962t1706r1021b1760],
25	response	NN	O	response	prep_in	23	SENT_67	[p3l1049t1721r1334b1774],
26	to	TO	O	to	_	0	SENT_67	[p3l1362t1713r1423b1760],
27	ADP	NN	O	adp	prep_to	18	SENT_67	[p3l1449t1708r1585b1760],
28	[	CD	NUMBER	[	num	27	SENT_67	[p3l1615t1705r1756b1774],
29	25	CD	NUMBER	25	num	30	SENT_67	[p3l1615t1705r1756b1774],
30	]	NN	O	]	nsubjpass	18	SENT_67	[p3l1615t1705r1756b1774],
31	.	.	O	.	_	0	SENT_67	[p3l1615t1705r1756b1774],

1	Using	VBG	O	use	_	0	SENT_68	[p3l111t1795r294b1863],
2	data	NNS	O	datum	dobj	1	SENT_68	[p3l318t1794r455b1849],
3	from	IN	O	from	_	0	SENT_68	[p3l481t1794r633b1849],
4	previous	JJ	O	previous	amod	5	SENT_68	[p3l660t1795r934b1863],
5	studies	NNS	O	study	prep_from	1	SENT_68	[p3l962t1794r1187b1849],
6	showed	VBD	O	show	dep	1	SENT_68	[p3l1215t1794r1462b1849],
7	that	IN	O	that	complm	31	SENT_68	[p3l1487t1794r1617b1849],
8	polymorphisms	NNS	O	polymorphism	nsubjpass	31	SENT_68	[p3l1641t1794r2146b1863],
9	of	IN	O	of	_	0	SENT_68	[p3l10t1883r77b1938],
10	both	DT	O	both	prep_of	8	SENT_68	[p3l86t1883r232b1938],
11	of	IN	O	of	_	0	SENT_68	[p3l250t1883r316b1938],
12	the	DT	O	the	det	15	SENT_68	[p3l325t1883r427b1938],
13	hepatic	JJ	O	hepatic	amod	15	SENT_68	[p3l445t1883r681b1952],
14	CYP45O	NN	O	cyp45o	nn	15	SENT_68	[p3l698t1886r942b1938],
15	system	NN	O	system	prep_of	10	SENT_68	[p3l960t1892r1185b1952],
16	(	CD	NUMBER	(	num	17	SENT_68	[p3l1203t1884r1479b1952],
17	CYP3A5	NN	O	cyp3a5	dep	10	SENT_68	[p3l1203t1884r1479b1952],
18	,	,	O	,	_	0	SENT_68	[p3l1203t1884r1479b1952],
19	CYP3A4	NN	O	cyp3a4	appos	17	SENT_68	[p3l1499t1886r1749b1947],
20	,	,	O	,	_	0	SENT_68	[p3l1499t1886r1749b1947],
21	CYP2C19	NN	O	cyp2c19	appos	17	SENT_68	[p3l1768t1884r2066b1952],
22	)	CD	NUMBER	)	num	21	SENT_68	[p3l1768t1884r2066b1952],
23	or	CC	O	or	_	0	SENT_68	[p3l2083t1899r2149b1938],
24	within	IN	O	within	conj_or	17	SENT_68	[p3l9t1973r221b2028],
25	the	DT	O	the	det	28	SENT_68	[p3l242t1973r344b2028],
26	platelet	NN	O	platelet	nn	28	SENT_68	[p3l366t1973r610b2041],
27	P2Y12	NN	O	p2y12	nn	28	SENT_68	[p3l631t1976r830b2027],
28	receptor	NN	O	receptor	pobj	24	SENT_68	[p3l855t1981r1126b2041],
29	were	VBD	O	be	auxpass	31	SENT_68	[p3l1143t1989r1303b2028],
30	more	RBR	O	more	advmod	31	SENT_68	[p3l1325t1989r1491b2028],
31	investigated	VBN	O	investigate	ccomp	6	SENT_68	[p3l1513t1973r1906b2041],
32	among	IN	O	among	_	0	SENT_68	[p3l1929t1989r2148b2041],
33	genes	NNS	O	gene	prep_among	31	SENT_68	[p3l9t2078r190b2130],
34	and	CC	O	and	_	0	SENT_68	[p3l215t2062r331b2117],
35	may	MD	O	may	aux	36	SENT_68	[p3l356t2078r493b2130],
36	contribute	VB	O	contribute	dep	1	SENT_68	[p3l514t2062r849b2117],
37	to	TO	O	to	_	0	SENT_68	[p3l872t2070r933b2117],
38	the	DT	O	the	det	39	SENT_68	[p3l956t2062r1058b2117],
39	variability	NN	O	variability	prep_to	36	SENT_68	[p3l1079t2062r1411b2130],
40	in	IN	O	in	_	0	SENT_68	[p3l1433t2063r1492b2116],
41	antiplatelet	JJ	O	antiplatelet	amod	42	SENT_68	[p3l1515t2062r1887b2130],
42	activity	NN	O	activity	prep_in	39	SENT_68	[p3l1907t2063r2148b2130],
43	of	IN	O	of	_	0	SENT_68	[p3l10t2150r77b2205],
44	clopidogrel	NN	O	clopidogrel	prep_of	42	SENT_68	[p3l106t2150r466b2219],
45	[	CD	NUMBER	[	num	44	SENT_68	[p3l508t2150r869b2219],
46	20,25	CD	NUMBER	20,25	num	47	SENT_68	[p3l508t2150r869b2219],
47	—	CD	NUMBER	—	dobj	6	SENT_68	[p3l508t2150r869b2219],
48	30	CD	NUMBER	30	num	49	SENT_68	[p3l508t2150r869b2219],
49	]	NN	O	]	nsubj	1	SENT_68	[p3l508t2150r869b2219],
50	.	.	O	.	_	0	SENT_68	[p3l508t2150r869b2219],

1	These	DT	O	these	det	3	SENT_69	[p3l906t2150r1091b2205],
2	pharmacogenetic	JJ	O	pharmacogenetic	amod	3	SENT_69	[p3l1129t2150r1687b2219],
3	studies	NNS	O	study	nsubj	16	SENT_69	[p3l1724t2150r1950b2205],
4	were	VBD	O	be	auxpass	6	SENT_69	[p3l1987t2166r2147b2205],
5	mainly	RB	O	mainly	advmod	6	SENT_69	[p3l11t2239r233b2308],
6	investigated	VBN	O	investigate	conj_and	6	SENT_69	[p3l258t2239r651b2308],
7	in	IN	O	in	_	0	SENT_69	[p3l676t2240r736b2294],
8	Caucasians	NNPS	MISC	Caucasians	prep_in	6	SENT_69	[p3l760t2240r1111b2294],
9	and	CC	O	and	_	0	SENT_69	[p3l1137t2239r1253b2294],
10	to	TO	O	to	_	0	SENT_69	[p3l1278t2247r1340b2294],
11	a	DT	O	a	det	13	SENT_69	[p3l1365t2255r1397b2294],
12	lesser	JJR	O	lesser	amod	13	SENT_69	[p3l1422t2239r1607b2294],
13	extent	NN	O	extent	prep_to	6	SENT_69	[p3l1629t2247r1834b2294],
14	in	IN	O	in	_	0	SENT_69	[p3l1857t2240r1917b2294],
15	Asians	NNPS	MISC	Asians	prep_in	13	SENT_69	[p3l1938t2240r2146b2294],
16	[	VBP	O	[	_	0	SENT_69	[p3l14t2328r154b2397],
17	30	CD	NUMBER	30	num	18	SENT_69	[p3l14t2328r154b2397],
18	]	CD	NUMBER	]	dobj	16	SENT_69	[p3l14t2328r154b2397],
19	.	.	O	.	_	0	SENT_69	[p3l14t2328r154b2397],

1	We	PRP	O	we	nsubj	4	SENT_70	[p3l180t2332r288b2384],
2	could	MD	O	could	aux	4	SENT_70	[p3l315t2328r489b2384],
3	not	RB	O	not	neg	4	SENT_70	[p3l518t2337r623b2384],
4	ﬁnd	VB	O	ﬁnd	_	0	SENT_70	[p3l649t2328r772b2384],
5	any	DT	O	any	det	7	SENT_70	[p3l800t2344r915b2397],
6	published	VBN	O	publish	amod	7	SENT_70	[p3l941t2329r1257b2397],
7	research	NN	O	research	dobj	4	SENT_70	[p3l1285t2329r1556b2384],
8	on	IN	O	on	_	0	SENT_70	[p3l1582t2344r1660b2384],
9	this	DT	O	this	det	10	SENT_70	[p3l1686t2329r1803b2384],
10	subject	NN	O	subject	prep_on	4	SENT_70	[p3l1832t2329r2062b2397],
11	in	IN	O	in	_	0	SENT_70	[p3l2088t2329r2147b2383],
12	Iran	NNP	LOCATION	Iran	prep_in	10	SENT_70	[p3l11t2421r151b2473],
13	.	.	O	.	_	0	SENT_70	[p3l11t2421r151b2473],

1	Iran	NNP	LOCATION	Iran	nsubj	6	SENT_71	[p3l180t2421r305b2472],
2	is	VBZ	O	be	cop	6	SENT_71	[p3l331t2418r378b2472],
3	a	DT	O	a	det	6	SENT_71	[p3l405t2433r437b2472],
4	Middle	NNP	MISC	Middle	amod	5	SENT_71	[p3l464t2417r688b2472],
5	Eastern	NNP	MISC	Eastern	amod	6	SENT_71	[p3l715t2421r953b2472],
6	country	NN	O	country	_	0	SENT_71	[p3l978t2426r1228b2486],
7	with	IN	O	with	_	0	SENT_71	[p3l1251t2417r1399b2472],
8	many	JJ	O	many	amod	11	SENT_71	[p3l1425t2433r1606b2486],
9	emigrant	JJ	O	emigrant	amod	11	SENT_71	[p3l1630t2418r1923b2486],
10	ethnic	JJ	O	ethnic	amod	11	SENT_71	[p3l1948t2417r2148b2472],
11	groups	NNS	O	group	prep_with	6	SENT_71	[p3l9t2523r227b2575],
12	[	VBP	O	[	dep	11	SENT_71	[p3l286t2507r427b2575],
13	31	CD	NUMBER	31	num	14	SENT_71	[p3l286t2507r427b2575],
14	]	CD	NUMBER	]	dobj	12	SENT_71	[p3l286t2507r427b2575],
15	.	.	O	.	_	0	SENT_71	[p3l286t2507r427b2575],

1	Multivariate	JJ	O	multivariate	amod	3	SENT_72	[p3l484t2507r881b2562],
2	gene	NN	O	gene	nn	3	SENT_72	[p3l934t2523r1085b2575],
3	polymorphisms	NNS	O	polymorphism	nsubjpass	12	SENT_72	[p3l1139t2507r1644b2575],
4	and	CC	O	and	_	0	SENT_72	[p3l1699t2507r1815b2562],
5	different	JJ	O	different	amod	6	SENT_72	[p3l1870t2507r2148b2562],
6	phenotypes	NNS	O	phenotype	nsubjpass	12	SENT_72	[p3l11t2596r384b2664],
7	in	IN	O	in	_	0	SENT_72	[p3l426t2597r485b2650],
8	enzymatic/receptor	NN	O	enzymatic/receptor	nn	9	SENT_72	[p3l526t2596r1159b2664],
9	activities	NNS	O	activity	prep_in	6	SENT_72	[p3l1197t2597r1485b2651],
10	could	MD	O	could	aux	12	SENT_72	[p3l1527t2596r1702b2651],
11	be	VB	O	be	auxpass	12	SENT_72	[p3l1742t2596r1815b2651],
12	observed	VBN	O	observe	_	0	SENT_72	[p3l1857t2596r2146b2651],
13	in	IN	O	in	_	0	SENT_72	[p3l11t2685r70b2739],
14	the	DT	O	the	det	16	SENT_72	[p3l96t2684r197b2739],
15	Iranian	JJ	MISC	iranian	amod	16	SENT_72	[p3l225t2685r451b2739],
16	population	NN	O	population	prep_in	12	SENT_72	[p3l478t2684r842b2753],
17	.	.	O	.	_	0	SENT_72	[p3l478t2684r842b2753],

1	Therefore	RB	O	therefore	advmod	4	SENT_73	[p3l867t2684r1194b2748],
2	,	,	O	,	_	0	SENT_73	[p3l867t2684r1194b2748],
3	we	PRP	O	we	nsubj	4	SENT_73	[p3l1220t2700r1314b2739],
4	conducted	VBD	O	conduct	_	0	SENT_73	[p3l1341t2684r1675b2739],
5	this	DT	O	this	det	6	SENT_73	[p3l1702t2684r1819b2739],
6	survey	NN	O	survey	dobj	4	SENT_73	[p3l1847t2700r2060b2753],
7	to	TO	O	to	aux	8	SENT_73	[p3l2085t2692r2147b2739],
8	determine	VB	O	determine	infmod	6	SENT_73	[p3l10t2773r342b2828],
9	the	DT	O	the	det	10	SENT_73	[p3l386t2773r487b2828],
10	role	NN	O	role	dobj	8	SENT_73	[p3l532t2773r653b2828],
11	of	IN	O	of	_	0	SENT_73	[p3l697t2773r763b2828],
12	the	DT	O	the	det	13	SENT_73	[p3l798t2773r900b2828],
13	three	CD	NUMBER	three	prep_of	10	SENT_73	[p3l943t2773r1110b2828],
14	mentioned	VBN	O	mention	partmod	13	SENT_73	[p3l1155t2773r1503b2828],
15	important	JJ	O	important	amod	17	SENT_73	[p3l1548t2774r1873b2842],
16	genetic	JJ	O	genetic	amod	17	SENT_73	[p3l1914t2774r2148b2842],
17	factors	NNS	O	factor	nsubj	18	SENT_73	[p3l11t2862r225b2918],
18	(	VBP	O	(	ccomp	14	SENT_73	[p3l271t2863r547b2931],
19	CYP3A5	NN	O	cyp3a5	dobj	18	SENT_73	[p3l271t2863r547b2931],
20	,	,	O	,	_	0	SENT_73	[p3l271t2863r547b2931],
21	CYP2C19	NN	O	cyp2c19	conj_and	19	SENT_73	[p3l592t2865r879b2926],
22	,	,	O	,	_	0	SENT_73	[p3l592t2865r879b2926],
23	and	CC	O	and	_	0	SENT_73	[p3l923t2863r1040b2918],
24	P2Y12	NN	O	p2y12	nn	25	SENT_73	[p3l1082t2863r1300b2931],
25	)	NN	O	)	conj_and	19	SENT_73	[p3l1082t2863r1300b2931],
26	in	IN	O	in	_	0	SENT_73	[p3l1345t2863r1404b2917],
27	antiplatelet	JJ	O	antiplatelet	amod	29	SENT_73	[p3l1447t2863r1819b2931],
28	response	NN	O	response	nn	29	SENT_73	[p3l1862t2878r2147b2931],
29	variability	NN	O	variability	prep_in	25	SENT_73	[p3l8t2951r339b3020],
30	of	IN	O	of	_	0	SENT_73	[p3l358t2951r425b3006],
31	clopidogrel	NN	O	clopidogrel	prep_of	29	SENT_73	[p3l437t2951r796b3020],
32	in	IN	O	in	_	0	SENT_73	[p3l817t2952r876b3006],
33	Iranian	JJ	MISC	iranian	amod	34	SENT_73	[p3l896t2952r1123b3006],
34	population	NN	O	population	prep_in	18	SENT_73	[p3l1143t2951r1492b3020],
35	undergoing	VBG	O	undergo	partmod	34	SENT_73	[p3l1512t2951r1882b3020],
36	elective	JJ	O	elective	amod	37	SENT_73	[p3l1900t2951r2147b3006],
37	PCI	NN	O	pcus	dobj	35	SENT_73	[p3l11t3044r125b3095],
38	.	.	O	.	_	0	SENT_73	[p3l11t3044r125b3095],

1	2	LS	NUMBER	2	_	0	SENT_74	[p3l10t3221r65b3273],
2	.	.	O	.	_	0	SENT_74	[p3l10t3221r65b3273],

1	Methods	NNS	O	method	_	0	SENT_75	[p3l105t3218r398b3272],

1	2.1	CD	NUMBER	2.1	_	0	SENT_76	[p3l6t3398r113b3450],
2	.	.	O	.	_	0	SENT_76	[p3l6t3398r113b3450],

1	Patients	NNS	O	patient	_	0	SENT_77	[p3l154t3397r401b3450],

1	The	DT	O	the	det	2	SENT_78	[p3l109t3573r226b3628],
2	patients	NNS	O	patient	nsubj	10	SENT_78	[p3l281t3574r538b3641],
3	admitted	VBD	O	admit	_	0	SENT_78	[p3l593t3573r885b3628],
4	to	TO	O	to	_	0	SENT_78	[p3l939t3581r1001b3628],
5	Kowsar	NNP	LOCATION	Kowsar	nn	6	SENT_78	[p3l1055t3576r1295b3628],
6	Hospital	NNP	LOCATION	Hospital	prep_to	3	SENT_78	[p3l1346t3573r1613b3641],
7	in	IN	O	in	_	0	SENT_78	[p3l1667t3574r1726b3627],
8	Shiraz	NNP	LOCATION	Shiraz	prep_in	3	SENT_78	[p3l1780t3573r1976b3628],
9	and	CC	O	and	_	0	SENT_78	[p3l2030t3573r2146b3628],
10	scheduled	VBN	O	schedule	conj_and	3	SENT_78	[p4l11t17r335b72],
11	for	IN	O	for	_	0	SENT_78	[p4l364t17r453b72],
12	elective	JJ	O	elective	amod	13	SENT_78	[p4l479t17r726b72],
13	PCI	NN	O	pcus	prep_for	10	SENT_78	[p4l755t20r853b72],
14	between	IN	O	between	_	0	SENT_78	[p4l882t17r1159b72],
15	September	NNP	DATE	September	prep_between	13	SENT_78	[p4l1188t17r1536b85],
16	2007	CD	DATE	2007	num	15	SENT_78	[p4l1562t20r1718b72],
17	and	CC	O	and	_	0	SENT_78	[p4l1749t17r1865b72],
18	October	NNP	DATE	October	nsubjpass	21	SENT_78	[p4l1895t17r2149b72],
19	2008	CD	DATE	2008	num	18	SENT_78	[p4l10t108r166b160],
20	were	VBD	O	be	auxpass	21	SENT_78	[p4l185t121r345b160],
21	enrolled	VBN	O	enrol	conj_and	3	SENT_78	[p4l364t105r627b160],
22	in	IN	O	in	_	0	SENT_78	[p4l647t106r706b160],
23	this	DT	O	this	det	24	SENT_78	[p4l723t105r840b160],
24	study	NN	O	study	prep_in	21	SENT_78	[p4l860t105r1052b174],
25	.	.	O	.	_	0	SENT_78	[p4l860t105r1052b174],

1	PCI	NN	O	pcus	nsubjpass	3	SENT_79	[p4l1072t108r1170b160],
2	was	VBD	O	be	auxpass	3	SENT_79	[p4l1188t121r1312b160],
3	performed	VBN	O	perform	_	0	SENT_79	[p4l1332t105r1670b174],
4	for	IN	O	for	_	0	SENT_79	[p4l1689t105r1778b160],
5	all	DT	O	all	det	6	SENT_79	[p4l1794t105r1868b160],
6	patients	NNS	O	patient	prep_for	3	SENT_79	[p4l1888t106r2146b174],
7	with	IN	O	with	_	0	SENT_79	[p4l9t194r157b249],
8	drug	NN	O	drug	nn	11	SENT_79	[p4l207t194r614b263],
9	—	NN	O	—	nn	11	SENT_79	[p4l207t194r614b263],
10	eluting	VBG	O	elute	amod	11	SENT_79	[p4l207t194r614b263],
11	stents	NNS	O	stent	prep_with	6	SENT_79	[p4l664t202r869b249],
12	.	.	O	.	_	0	SENT_79	[p4l664t202r869b249],

1	All	DT	O	all	det	2	SENT_80	[p4l919t194r1005b248],
2	patients	NNS	O	patient	nsubj	3	SENT_80	[p4l1057t195r1314b263],
3	gave	VBD	O	give	_	0	SENT_80	[p4l1366t210r1512b263],
4	written	VBN	O	write	amod	6	SENT_80	[p4l1561t195r1801b249],
5	informed	VBN	O	inform	amod	6	SENT_80	[p4l1852t194r2146b249],
6	consent	NN	O	consent	dobj	3	SENT_80	[p4l10t292r275b339],
7	.	.	O	.	_	0	SENT_80	[p4l10t292r275b339],

1	This	DT	O	this	det	5	SENT_81	[p4l310t284r442b339],
2	cross	JJ	O	cross	amod	5	SENT_81	[p4l480t284r959b339],
3	—	NN	O	—	nn	5	SENT_81	[p4l480t284r959b339],
4	sectional	JJ	O	sectional	amod	5	SENT_81	[p4l480t284r959b339],
5	study	NN	O	study	nsubjpass	7	SENT_81	[p4l996t284r1174b352],
6	was	VBD	O	be	auxpass	7	SENT_81	[p4l1207t299r1331b339],
7	approved	VBN	O	approve	_	0	SENT_81	[p4l1369t283r1670b352],
8	by	IN	O	by	_	0	SENT_81	[p4l1706t283r1784b352],
9	the	DT	O	the	det	11	SENT_81	[p4l1818t284r1920b339],
10	Ethics	NNPS	ORGANIZATION	Ethics	nn	11	SENT_81	[p4l1956t284r2145b339],
11	Committee	NNP	ORGANIZATION	Committee	agent	7	SENT_81	[p4l11t373r367b427],
12	of	IN	ORGANIZATION	of	_	0	SENT_81	[p4l398t372r464b427],
13	Shiraz	NNP	ORGANIZATION	Shiraz	nn	14	SENT_81	[p4l489t372r685b427],
14	University	NNP	ORGANIZATION	University	prep_of	11	SENT_81	[p4l716t373r1050b441],
15	of	IN	ORGANIZATION	of	_	0	SENT_81	[p4l1080t372r1146b427],
16	Medical	NNP	ORGANIZATION	Medical	nn	17	SENT_81	[p4l1170t372r1422b427],
17	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	14	SENT_81	[p4l1455t373r1739b428],
18	.	.	O	.	_	0	SENT_81	[p4l1455t373r1739b428],

1	All	DT	O	all	det	2	SENT_82	[p4l1769t372r1855b427],
2	patients	NNS	O	patient	nsubj	17	SENT_82	[p4l1888t373r2146b441],
3	had	VBD	O	have	aux	4	SENT_82	[p4l11t462r126b517],
4	received	VBN	O	receive	_	0	SENT_82	[p4l152t462r421b517],
5	aspirin	NN	O	aspirin	nn	7	SENT_82	[p4l446t463r666b530],
6	80-325	CD	NUMBER	80-325	num	7	SENT_82	[p4l691t465r929b517],
7	mg	NN	O	mg	dobj	4	SENT_82	[p4l955t478r1054b530],
8	daily	RB	SET	daily	advmod	4	SENT_82	[p4l1078t462r1235b530],
9	for	IN	O	for	_	0	SENT_82	[p4l1258t462r1348b517],
10	21	CD	DURATION	21	num	11	SENT_82	[p4l1373t465r1452b526],
11	week	NN	NUMBER	week	prep_for	4	SENT_82	[p4l1484t462r1656b517],
12	before	IN	O	before	_	0	SENT_82	[p4l1678t462r1881b517],
13	PCI	NN	O	pcus	prep_before	11	SENT_82	[p4l1906t465r2004b517],
14	and	CC	O	and	_	0	SENT_82	[p4l2030t462r2146b517],
15	had	VBD	O	have	aux	17	SENT_82	[p4l11t551r126b606],
16	not	RB	O	not	neg	17	SENT_82	[p4l157t559r262b606],
17	received	VBN	O	receive	conj_and	4	SENT_82	[p4l292t551r560b606],
18	thienopyridine	NN	O	thienopyridine	nn	19	SENT_82	[p4l590t551r1069b619],
19	derivatives	NNS	O	derivative	dobj	17	SENT_82	[p4l1099t551r1451b606],
20	in	IN	O	in	_	0	SENT_82	[p4l1483t552r1541b605],
21	the	DT	DATE	the	det	22	SENT_82	[p4l1570t551r1672b606],
22	week	NN	DATE	week	prep_in	19	SENT_82	[p4l1700t551r1872b606],
23	prior	RB	O	prior	_	0	SENT_82	[p4l1900t552r2058b619],
24	to	TO	O	to	_	0	SENT_82	[p4l2084t559r2147b606],
25	enrollment	NN	O	enrollment	prep_prior_to	17	SENT_82	[p4l10t639r383b695],
26	.	.	O	.	_	0	SENT_82	[p4l10t639r383b695],

1	Patients	NNS	O	patient	nsubj	6	SENT_83	[p4l424t640r680b694],
2	were	VBD	O	be	cop	6	SENT_83	[p4l718t655r877b694],
3	over	IN	O	over	advmod	6	SENT_83	[p4l916t655r1057b694],
4	18	CD	DURATION	18	num	5	SENT_83	[p4l1097t642r1169b694],
5	years	NNS	NUMBER	year	pobj	3	SENT_83	[p4l1208t655r1377b708],
6	old	JJ	DURATION	old	_	0	SENT_83	[p4l1418t639r1531b695],
7	.	.	O	.	_	0	SENT_83	[p4l1418t639r1531b695],

1	Exclusion	NN	MISC	exclusion	nn	2	SENT_84	[p4l1572t639r1879b694],
2	criteria	NNS	O	criterion	nsubj	45	SENT_84	[p4l1918t640r2147b694],
3	were	VBD	O	be	cop	6	SENT_84	[p4l9t744r168b783],
4	acute	JJ	O	acute	amod	6	SENT_84	[p4l209t736r381b783],
5	myocardial	JJ	O	myocardial	amod	6	SENT_84	[p4l423t728r782b797],
6	infarction	NN	O	infarction	_	0	SENT_84	[p4l825t728r1137b783],
7	(	CD	NUMBER	(	num	8	SENT_84	[p4l1177t728r1359b796],
8	AMI	NNP	ORGANIZATION	AMI	dep	6	SENT_84	[p4l1177t728r1359b796],
9	)	CD	NUMBER	)	num	8	SENT_84	[p4l1177t728r1359b796],
10	within	IN	O	within	_	0	SENT_84	[p4l1399t728r1611b783],
11	one	CD	DURATION	one	num	12	SENT_84	[p4l1652t744r1766b783],
12	week	NN	NUMBER	week	prep_within	8	SENT_84	[p4l1806t728r1991b791],
13	,	,	O	,	_	0	SENT_84	[p4l1806t728r1991b791],
14	any	DT	O	any	det	15	SENT_84	[p4l2033t744r2148b797],
15	contraindications	NNS	O	contraindication	conj_or	6	SENT_84	[p4l10t817r572b872],
16	to	TO	O	to	_	0	SENT_84	[p4l624t826r686b872],
17	aspirin	NN	O	aspirin	prep_to	15	SENT_84	[p4l737t818r957b886],
18	or	CC	O	or	_	0	SENT_84	[p4l1008t833r1074b872],
19	clopidogrel	NN	O	clopidogrel	conj_or	17	SENT_84	[p4l1122t817r1497b886],
20	,	,	O	,	_	0	SENT_84	[p4l1122t817r1497b886],
21	thrombocytopenia	NN	O	thrombocytopenia	nn	23	SENT_84	[p4l1549t817r2147b886],
22	(	CD	NUMBER	(	num	23	SENT_84	[p4l10t905r281b974],
23	platelet	NN	O	platelet	dep	24	SENT_84	[p4l10t905r281b974],
24	<	JJR	O	<	conj_or	6	SENT_84	[p4l305t923r348b962],
25	100	CD	NUMBER	100	number	26	SENT_84	[p4l377t908r491b960],
26	x	NN	O	x	amod	24	SENT_84	[p4l520t926r554b959],
27	103	CD	NUMBER	103	num	29	SENT_84	[p4l587t895r689b960],
28	cells/mm3	NN	O	cells/mm3	nn	29	SENT_84	[p4l713t895r1081b974],
29	)	NN	O	)	dep	24	SENT_84	[p4l713t895r1081b974],
30	,	,	O	,	_	0	SENT_84	[p4l713t895r1081b974],
31	anemia	NN	O	anemia	nn	33	SENT_84	[p4l1107t906r1342b960],
32	(	CD	NUMBER	(	num	33	SENT_84	[p4l1367t905r1778b974],
33	hemoglobin	NN	O	hemoglobin	dep	34	SENT_84	[p4l1367t905r1778b974],
34	<	JJR	O	<	conj_or	6	SENT_84	[p4l1802t922r1845b962],
35	10	CD	NUMBER	10	num	37	SENT_84	[p4l1874t908r1947b960],
36	g/dL	NN	O	g/dl	nn	37	SENT_84	[p4l1968t905r2146b974],
37	)	NN	O	)	dep	34	SENT_84	[p4l1968t905r2146b974],
38	,	,	O	,	_	0	SENT_84	[p4l1968t905r2146b974],
39	or	CC	O	or	_	0	SENT_84	[p4l10t1011r76b1050],
40	renal	JJ	O	renal	amod	44	SENT_84	[p4l126t995r286b1050],
41	failure	NN	O	failure	nn	44	SENT_84	[p4l339t995r545b1050],
42	(	NN	O	(	nn	44	SENT_84	[p4l597t995r824b1063],
43	serum	NN	O	serum	nn	44	SENT_84	[p4l597t995r824b1063],
44	creatinine	NN	O	creatinine	dep	45	SENT_84	[p4l875t996r1198b1050],
45	>	JJR	O	>	conj_or	6	SENT_84	[p4l1252t998r1395b1052],
46	2.5	CD	NUMBER	2.5	num	48	SENT_84	[p4l1252t998r1395b1052],
47	mg/dL	NN	O	mg/dl	nn	48	SENT_84	[p4l1421t995r1662b1063],
48	)	NN	O	)	dep	45	SENT_84	[p4l1421t995r1662b1063],
49	.	.	O	.	_	0	SENT_84	[p4l1421t995r1662b1063],

1	Demographic	JJ	O	demographic	amod	2	SENT_85	[p4l1716t995r2147b1063],
2	characteristics	NNS	O	characteristic	nsubjpass	23	SENT_85	[p4l10t1083r492b1147],
3	,	,	O	,	_	0	SENT_85	[p4l10t1083r492b1147],
4	lab	NN	O	lab	nn	5	SENT_85	[p4l517t1083r611b1138],
5	data	NNS	O	datum	conj_and	2	SENT_85	[p4l635t1083r788b1147],
6	,	,	O	,	_	0	SENT_85	[p4l635t1083r788b1147],
7	clinical	JJ	O	clinical	amod	8	SENT_85	[p4l813t1083r1040b1138],
8	information	NN	O	information	conj_and	2	SENT_85	[p4l1066t1083r1464b1147],
9	,	,	O	,	_	0	SENT_85	[p4l1066t1083r1464b1147],
10	diameter	NN	O	diameter	conj_and	2	SENT_85	[p4l1489t1083r1781b1138],
11	and	CC	O	and	_	0	SENT_85	[p4l1802t1083r1919b1138],
12	length	NN	O	length	conj_and	2	SENT_85	[p4l1944t1083r2147b1152],
13	of	IN	O	of	_	0	SENT_85	[p4l11t1173r77b1228],
14	stent	NN	O	stent	prep_of	10	SENT_85	[p4l93t1181r267b1236],
15	,	,	O	,	_	0	SENT_85	[p4l93t1181r267b1236],
16	and	CC	O	and	_	0	SENT_85	[p4l291t1173r407b1228],
17	drug	NN	O	drug	nn	18	SENT_85	[p4l430t1173r579b1241],
18	history	NN	O	history	nsubjpass	23	SENT_85	[p4l600t1173r827b1241],
19	of	IN	O	of	_	0	SENT_85	[p4l848t1173r914b1228],
20	the	DT	O	the	det	21	SENT_85	[p4l929t1173r1031b1228],
21	patients	NNS	O	patient	prep_of	18	SENT_85	[p4l1053t1174r1312b1241],
22	were	VBD	O	be	auxpass	23	SENT_85	[p4l1334t1189r1494b1228],
23	recorded	VBN	O	record	_	0	SENT_85	[p4l1517t1173r1800b1228],
24	from	IN	O	from	_	0	SENT_85	[p4l1824t1173r1976b1228],
25	their	PRP$	O	they	poss	26	SENT_85	[p4l1998t1173r2153b1228],
26	ﬁles	NNS	O	ﬁles	prep_from	23	SENT_85	[p4l11t1261r139b1316],
27	or	CC	O	or	_	0	SENT_85	[p4l177t1277r243b1316],
28	face	NN	O	face	conj_or	26	SENT_85	[p4l278t1261r659b1316],
29	—	CD	NUMBER	—	num	28	SENT_85	[p4l278t1261r659b1316],
30	to	TO	O	to	_	0	SENT_85	[p4l278t1261r659b1316],
31	—	CD	NUMBER	—	num	33	SENT_85	[p4l278t1261r659b1316],
32	face	NN	O	face	nn	33	SENT_85	[p4l278t1261r659b1316],
33	interview	NN	O	interview	prep_to	23	SENT_85	[p4l697t1262r1020b1317],
34	.	.	O	.	_	0	SENT_85	[p4l697t1262r1020b1317],

1	These	DT	O	these	det	2	SENT_86	[p4l1055t1261r1241b1316],
2	factors	NNS	O	factor	nsubj	3	SENT_86	[p4l1279t1261r1493b1316],
3	included	VBD	O	include	_	0	SENT_86	[p4l1532t1261r1829b1317],
4	:	:	O	:	_	0	SENT_86	[p4l1532t1261r1829b1317],
5	age	NN	O	age	dobj	3	SENT_86	[p4l1871t1277r1994b1330],
6	,	,	O	,	_	0	SENT_86	[p4l1871t1277r1994b1330],
7	sex	NN	O	sex	appos	5	SENT_86	[p4l2032t1277r2149b1325],
8	,	,	O	,	_	0	SENT_86	[p4l2032t1277r2149b1325],
9	smoking	NN	O	smoking	appos	5	SENT_86	[p4l12t1350r300b1419],
10	,	,	O	,	_	0	SENT_86	[p4l12t1350r300b1419],
11	diabetes	NN	O	diabetes	nn	12	SENT_86	[p4l344t1350r611b1405],
12	mellitus	NN	O	mellitus	appos	5	SENT_86	[p4l656t1350r934b1414],
13	,	,	O	,	_	0	SENT_86	[p4l656t1350r934b1414],
14	hypertension	NN	O	hypertension	nn	17	SENT_86	[p4l978t1350r1404b1419],
15	(	CD	NUMBER	(	num	17	SENT_86	[p4l1447t1350r2150b1419],
16	BP2140/90mmHg	NN	O	bp2140/90mmhg	nn	17	SENT_86	[p4l1447t1350r2150b1419],
17	)	NN	O	)	appos	5	SENT_86	[p4l1447t1350r2150b1419],
18	,	,	O	,	_	0	SENT_86	[p4l1447t1350r2150b1419],
19	hyperlipidemia	NN	O	hyperlipidemia	nn	21	SENT_86	[p4l11t1439r504b1508],
20	(	NN	O	(	nn	21	SENT_86	[p4l557t1440r773b1508],
21	LDL	NN	O	ldl	appos	5	SENT_86	[p4l557t1440r773b1508],
22	.	.	O	.	_	0	SENT_86	[p4l557t1440r773b1508],

1	—	NN	O	—	_	0	SENT_87	[p4l557t1440r773b1508],
2	.	.	O	.	_	0	SENT_87	[p4l557t1440r773b1508],

1	C	NN	O	c	dep	5	SENT_88	[p4l557t1440r773b1508],
2	2	CD	NUMBER	2	dep	1	SENT_88	[p4l797t1450r840b1503],
3	100	CD	NUMBER	100	num	4	SENT_88	[p4l869t1442r983b1495],
4	mg/dL	NN	O	mg/dl	dep	5	SENT_88	[p4l1005t1439r1247b1508],
5	)	NN	O	)	dep	38	SENT_88	[p4l1005t1439r1247b1508],
6	,	,	O	,	_	0	SENT_88	[p4l1005t1439r1247b1508],
7	body	NN	O	body	nn	12	SENT_88	[p4l1300t1440r1459b1508],
8	mass	NN	O	mass	nn	12	SENT_88	[p4l1512t1455r1671b1495],
9	index	NN	O	index	nn	12	SENT_88	[p4l1726t1439r1904b1495],
10	(	CD	NUMBER	(	num	12	SENT_88	[p4l1955t1440r2149b1508],
11	BMI	NN	O	bmus	nn	12	SENT_88	[p4l1955t1440r2149b1508],
12	)	NN	O	)	appos	5	SENT_88	[p4l1955t1440r2149b1508],
13	,	,	O	,	_	0	SENT_88	[p4l1955t1440r2149b1508],
14	white	JJ	O	white	amod	20	SENT_88	[p4l9t1528r194b1583],
15	blood	NN	O	blood	nn	20	SENT_88	[p4l226t1528r406b1583],
16	cell	NN	O	cell	nn	20	SENT_88	[p4l439t1528r547b1583],
17	(	NN	O	(	nn	20	SENT_88	[p4l581t1529r788b1597],
18	WBC	NN	ORGANIZATION	wbc	nn	20	SENT_88	[p4l581t1529r788b1597],
19	)	NN	O	)	nn	20	SENT_88	[p4l581t1529r788b1597],
20	count	NN	O	count	appos	5	SENT_88	[p4l821t1537r1018b1592],
21	,	,	O	,	_	0	SENT_88	[p4l821t1537r1018b1592],
22	platelet	NN	O	platelet	nn	24	SENT_88	[p4l1051t1528r1296b1597],
23	(	NN	O	(	nn	24	SENT_88	[p4l1327t1529r1490b1597],
24	PLT	NN	O	plt	appos	5	SENT_88	[p4l1327t1529r1490b1597],
25	)	CD	NUMBER	)	num	26	SENT_88	[p4l1327t1529r1490b1597],
26	count	NN	O	count	dep	24	SENT_88	[p4l1523t1537r1719b1592],
27	,	,	O	,	_	0	SENT_88	[p4l1523t1537r1719b1592],
28	multi	NNS	O	multus	appos	5	SENT_88	[p4l1754t1528r1925b1583],
29	vessel	NN	O	vessel	nn	31	SENT_88	[p4l1956t1528r2149b1583],
30	disease	NN	O	disease	nn	31	SENT_88	[p4l11t1618r243b1673],
31	(	NN	O	(	nsubj	38	SENT_88	[p4l291t1618r618b1686],
32	involving	VBG	O	involve	partmod	31	SENT_88	[p4l291t1618r618b1686],
33	2	CD	NUMBER	2	num	37	SENT_88	[p4l665t1621r698b1672],
34	or	CC	O	or	_	0	SENT_88	[p4l749t1634r815b1673],
35	more	JJR	O	more	conj_or	33	SENT_88	[p4l861t1634r1026b1673],
36	coronary	JJ	O	coronary	amod	37	SENT_88	[p4l1074t1634r1360b1686],
37	arteries	NNS	O	artery	dobj	32	SENT_88	[p4l1406t1618r1690b1686],
38	)	VBP	O	)	dep	45	SENT_88	[p4l1406t1618r1690b1686],
39	,	,	O	,	_	0	SENT_88	[p4l1406t1618r1690b1686],
40	multi	JJ	O	multi	amod	42	SENT_88	[p4l1739t1618r1910b1673],
41	vessel	NN	O	vessel	nn	42	SENT_88	[p4l1956t1618r2149b1673],
42	intervention	NN	O	intervention	nsubj	55	SENT_88	[p4l11t1708r411b1762],
43	(	CD	NUMBER	(	num	44	SENT_88	[p4l436t1707r863b1775],
44	Intervention	NN	O	intervention	dep	42	SENT_88	[p4l436t1707r863b1775],
45	involving	VBG	O	involve	_	0	SENT_88	[p4l889t1707r1190b1775],
46	2	CD	NUMBER	2	num	50	SENT_88	[p4l1213t1710r1247b1761],
47	or	CC	O	or	_	0	SENT_88	[p4l1275t1723r1341b1762],
48	more	JJR	O	more	conj_or	46	SENT_88	[p4l1365t1723r1530b1762],
49	coronary	JJ	O	coronary	amod	50	SENT_88	[p4l1555t1723r1842b1775],
50	arteries	NNS	O	artery	dobj	45	SENT_88	[p4l1866t1707r2150b1775],
51	)	RB	O	)	advmod	45	SENT_88	[p4l1866t1707r2150b1775],
52	,	,	O	,	_	0	SENT_88	[p4l1866t1707r2150b1775],
53	and	CC	O	and	_	0	SENT_88	[p4l11t1795r127b1849],
54	LVEF	NN	O	lvef	dep	55	SENT_88	[p4l157t1799r312b1849],
55	<	JJR	O	<	conj_and	45	SENT_88	[p4l341t1798r530b1851],
56	45	CD	PERCENT	45	number	57	SENT_88	[p4l341t1798r530b1851],
57	%	NN	PERCENT	%	amod	55	SENT_88	[p4l341t1798r530b1851],
58	.	.	O	.	_	0	SENT_88	[p4l341t1798r530b1851],

1	2.2	CD	NUMBER	2.2	_	0	SENT_89	[p4l7t1975r114b2027],
2	.	.	O	.	_	0	SENT_89	[p4l7t1975r114b2027],

1	Medications	NNS	MISC	medication	_	0	SENT_90	[p4l154t1972r529b2027],

1	All	DT	O	all	det	2	SENT_91	[p4l110t2151r197b2205],
2	patients	NNS	O	patient	nsubj	3	SENT_91	[p4l232t2152r490b2219],
3	received	VBD	O	receive	_	0	SENT_91	[p4l527t2151r795b2206],
4	a	DT	O	a	dobj	3	SENT_91	[p4l831t2167r863b2206],
5	loading	VBG	O	load	partmod	4	SENT_91	[p4l897t2151r1136b2219],
6	dose	NN	O	dose	nn	12	SENT_91	[p4l1169t2151r1314b2206],
7	(	NN	O	(	nn	12	SENT_91	[p4l1349t2151r1482b2219],
8	LD	NN	O	ld	nn	12	SENT_91	[p4l1349t2151r1482b2219],
9	)	NN	O	)	nn	12	SENT_91	[p4l1349t2151r1482b2219],
10	600	CD	NUMBER	600	num	12	SENT_91	[p4l1518t2154r1635b2206],
11	mg	NN	O	mg	nn	12	SENT_91	[p4l1657t2167r1757b2219],
12	clopidogrel	NN	O	clopidogrel	dobj	5	SENT_91	[p4l1790t2151r2150b2219],
13	(	CD	NUMBER	(	num	15	SENT_91	[p4l11t2232r298b2307],
14	Plavix	NNP	O	Plavix	nn	15	SENT_91	[p4l11t2232r298b2307],
15	®	NNP	O	®	dep	12	SENT_91	[p4l11t2232r298b2307],
16	,	,	O	,	_	0	SENT_91	[p4l11t2232r298b2307],
17	Sanoﬁ	NNP	PERSON	Sanoﬁ	appos	15	SENT_91	[p4l341t2239r835b2307],
18	.	.	O	.	_	0	SENT_91	[p4l341t2239r835b2307],

1	—	NN	O	—	_	0	SENT_92	[p4l341t2239r835b2307],
2	.	.	O	.	_	0	SENT_92	[p4l341t2239r835b2307],

1	Aventis	NNP	ORGANIZATION	Aventis	nsubj	10	SENT_93	[p4l341t2239r835b2307],
2	)	CD	NUMBER	)	num	1	SENT_93	[p4l341t2239r835b2307],
3	at	IN	O	at	advmod	6	SENT_93	[p4l877t2247r937b2294],
4	least	JJS	O	least	pobj	3	SENT_93	[p4l979t2239r1128b2294],
5	24	CD	NUMBER	24	num	6	SENT_93	[p4l1169t2242r1247b2293],
6	h	NN	O	h	rcmod	1	SENT_93	[p4l1269t2239r1307b2293],
7	before	IN	O	before	_	0	SENT_93	[p4l1348t2239r1551b2294],
8	PCI	NNP	O	PCI	prep_before	6	SENT_93	[p4l1594t2242r1709b2302],
9	,	,	O	,	_	0	SENT_93	[p4l1594t2242r1709b2302],
10	followed	VBN	O	follow	_	0	SENT_93	[p4l1752t2239r2032b2294],
11	by	IN	O	by	_	0	SENT_93	[p4l2074t2239r2152b2307],
12	1	CD	NUMBER	1	number	13	SENT_93	[p4l14t2330r39b2382],
13	50	CD	NUMBER	50	num	14	SENT_93	[p4l53t2330r129b2382],
14	mg/day	NN	O	mg/day	prep_by	10	SENT_93	[p4l151t2327r394b2396],
15	of	IN	O	of	_	0	SENT_93	[p4l412t2327r478b2382],
16	clopidogrel	NN	O	clopidogrel	prep_of	14	SENT_93	[p4l489t2327r849b2396],
17	for	IN	O	for	_	0	SENT_93	[p4l869t2327r958b2382],
18	two	CD	DURATION	two	num	19	SENT_93	[p4l975t2335r1097b2382],
19	weeks	NNS	NUMBER	week	prep_for	10	SENT_93	[p4l1115t2327r1315b2382],
20	and	CC	O	and	_	0	SENT_93	[p4l1335t2327r1451b2382],
21	75	CD	NUMBER	75	num	22	SENT_93	[p4l1472t2331r1546b2382],
22	mg/day	NN	O	mg/day	prep_for	10	SENT_93	[p4l1571t2327r1814b2396],
23	thereafter	RB	O	thereafter	advmod	10	SENT_93	[p4l1830t2327r2153b2382],
24	for	IN	O	for	_	0	SENT_93	[p4l11t2416r100b2471],
25	12	CD	DURATION	12	num	26	SENT_93	[p4l126t2419r198b2470],
26	months	NNS	NUMBER	month	prep_for	10	SENT_93	[p4l225t2416r467b2471],
27	after	IN	O	after	_	0	SENT_93	[p4l492t2416r642b2471],
28	PCI	NN	O	pcus	prep_after	26	SENT_93	[p4l665t2419r779b2472],
29	.	.	O	.	_	0	SENT_93	[p4l665t2419r779b2472],

1	Aspirin	NN	O	aspirin	nsubjpass	3	SENT_94	[p4l802t2417r1035b2485],
2	was	VBD	O	be	auxpass	3	SENT_94	[p4l1056t2432r1181b2471],
3	prescribed	VBN	O	prescribe	_	0	SENT_94	[p4l1207t2416r1544b2485],
4	as	IN	O	as	quantmod	5	SENT_94	[p4l1569t2432r1631b2471],
5	325	CD	NUMBER	325	num	6	SENT_94	[p4l1655t2419r1773b2471],
6	mg/day	NN	O	mg/day	dobj	3	SENT_94	[p4l1797t2416r2040b2485],
7	for	IN	O	for	_	0	SENT_94	[p4l2063t2416r2152b2471],
8	one	CD	DURATION	one	num	9	SENT_94	[p4l11t2521r125b2560],
9	week	NN	NUMBER	week	prep_for	6	SENT_94	[p4l144t2505r316b2560],
10	then	RB	O	then	advmod	9	SENT_94	[p4l335t2505r479b2560],
11	80	CD	NUMBER	80	num	12	SENT_94	[p4l500t2508r576b2560],
12	mg/day	NN	O	mg/day	pobj	10	SENT_94	[p4l599t2505r842b2574],
13	for	IN	O	for	_	0	SENT_94	[p4l861t2505r950b2560],
14	an	DT	O	a	det	16	SENT_94	[p4l968t2521r1044b2560],
15	indeﬁnite	JJ	O	indeﬁnite	amod	16	SENT_94	[p4l1064t2505r1373b2560],
16	period	NN	O	period	prep_for	10	SENT_94	[p4l1394t2505r1599b2574],
17	of	IN	O	of	_	0	SENT_94	[p4l1620t2505r1687b2560],
18	time	NN	O	time	prep_of	16	SENT_94	[p4l1699t2506r1845b2560],
19	after	IN	O	after	_	0	SENT_94	[p4l1865t2505r2015b2560],
20	PCI	NNP	O	PCI	prep_after	3	SENT_94	[p4l2034t2508r2149b2561],
21	.	.	O	.	_	0	SENT_94	[p4l2034t2508r2149b2561],

1	Unfractionated	JJ	O	unfractionated	amod	3	SENT_95	[p4l10t2594r495b2649],
2	heparin	NN	O	heparin	nn	3	SENT_95	[p4l544t2594r790b2663],
3	(	NN	O	(	nsubjpass	8	SENT_95	[p4l838t2595r1065b2663],
4	50-70	CD	NUMBER	50-70	num	6	SENT_95	[p4l838t2595r1065b2663],
5	IU/kg	NN	O	iu/kg	nn	6	SENT_95	[p4l1087t2594r1283b2663],
6	)	NN	O	)	dep	3	SENT_95	[p4l1087t2594r1283b2663],
7	was	VBD	O	be	auxpass	8	SENT_95	[p4l1330t2610r1454b2649],
8	administrated	VBN	O	administrate	_	0	SENT_95	[p4l1503t2594r1957b2649],
9	as	IN	O	as	_	0	SENT_95	[p4l2006t2610r2069b2649],
10	a	DT	O	a	det	11	SENT_95	[p4l2118t2610r2151b2649],
11	bolus	NN	O	bolus	prep_as	8	SENT_95	[p4l10t2684r182b2739],
12	to	TO	O	to	_	0	SENT_95	[p4l205t2692r267b2739],
13	all	DT	O	all	det	14	SENT_95	[p4l290t2684r364b2739],
14	patients	NNS	O	patient	prep_to	11	SENT_95	[p4l387t2685r646b2752],
15	in	IN	O	in	_	0	SENT_95	[p4l670t2685r729b2738],
16	the	DT	O	the	det	18	SENT_95	[p4l751t2684r852b2739],
17	catheterization	NN	O	catheterization	nn	18	SENT_95	[p4l875t2684r1364b2739],
18	laboratory	NN	O	laboratory	prep_in	14	SENT_95	[p4l1386t2684r1721b2752],
19	immediately	RB	O	immediately	advmod	8	SENT_95	[p4l1742t2684r2152b2752],
20	before	IN	O	before	_	0	SENT_95	[p4l10t2773r213b2828],
21	stenting	VBG	O	stent	prepc_before	8	SENT_95	[p4l247t2774r523b2841],
22	.	.	O	.	_	0	SENT_95	[p4l247t2774r523b2841],

1	Subjects	NNS	O	subject	nsubjpass	34	SENT_96	[p4l557t2773r822b2841],
2	receiving	VBG	O	receive	dep	1	SENT_96	[p4l856t2774r1151b2841],
3	other	JJ	O	other	amod	4	SENT_96	[p4l1182t2773r1354b2828],
4	drugs	NNS	O	drug	dobj	2	SENT_96	[p4l1385t2773r1562b2841],
5	affecting	VBG	O	affect	xcomp	2	SENT_96	[p4l1595t2773r1876b2841],
6	platelet	NN	O	platelet	nn	7	SENT_96	[p4l1907t2773r2152b2841],
7	activity	NN	O	activity	dobj	5	SENT_96	[p4l11t2862r251b2930],
8	or	CC	O	or	_	0	SENT_96	[p4l271t2877r337b2916],
9	had	VBD	O	have	dep	1	SENT_96	[p4l356t2861r472b2916],
10	a	DT	O	a	det	12	SENT_96	[p4l494t2877r526b2916],
11	major	JJ	O	major	amod	12	SENT_96	[p4l547t2862r736b2930],
12	effect	NN	O	effect	dobj	9	SENT_96	[p4l755t2861r933b2916],
13	on	IN	O	on	prep	12	SENT_96	[p4l953t2877r1031b2916],
14	CYP3A5	NN	O	cyp3a5	dep	20	SENT_96	[p4l1051t2864r1298b2916],
15	and	CC	O	and	_	0	SENT_96	[p4l1322t2861r1438b2916],
16	CYP2C19	NN	O	cyp2c19	conj_and	14	SENT_96	[p4l1460t2864r1746b2916],
17	metabolism	NN	O	metabolism	dep	20	SENT_96	[p4l1769t2861r2151b2916],
18	(	CD	NUMBER	(	num	17	SENT_96	[p4l11t2950r123b3018],
19	i.e.	FW	O	i.e.	nn	20	SENT_96	[p4l11t2950r123b3018],
20	abciximab	FW	O	abciximab	dep	13	SENT_96	[p4l164t2950r512b3013],
21	,	,	O	,	_	0	SENT_96	[p4l164t2950r512b3013],
22	dipyridamole	NN	O	dipyridamole	dep	13	SENT_96	[p4l553t2950r1001b3019],
23	,	,	O	,	_	0	SENT_96	[p4l553t2950r1001b3019],
24	warfarin	NN	O	warfarin	conj_and	20	SENT_96	[p4l1039t2950r1330b3013],
25	,	,	O	,	_	0	SENT_96	[p4l1039t2950r1330b3013],
26	phenytoin	NN	O	phenytoin	dep	13	SENT_96	[p4l1372t2950r1716b3019],
27	,	,	O	,	_	0	SENT_96	[p4l1372t2950r1716b3019],
28	omeprazole	NN	O	omeprazole	dep	13	SENT_96	[p4l1756t2950r2150b3019],
29	,	,	O	,	_	0	SENT_96	[p4l1756t2950r2150b3019],
30	and	CC	O	and	_	0	SENT_96	[p4l11t3039r127b3094],
31	phenobarbital	JJ	O	phenobarbital	amod	32	SENT_96	[p4l157t3039r635b3108],
32	)	NN	O	)	conj_and	20	SENT_96	[p4l157t3039r635b3108],
33	were	VBD	O	be	auxpass	34	SENT_96	[p4l662t3055r822b3094],
34	excluded	VBN	O	exclude	_	0	SENT_96	[p4l850t3039r1139b3094],
35	[	RB	O	[	advmod	34	SENT_96	[p4l1171t3039r1313b3108],
36	32	CD	NUMBER	32	num	37	SENT_96	[p4l1171t3039r1313b3108],
37	]	NN	O	]	dobj	34	SENT_96	[p4l1171t3039r1313b3108],
38	.	.	O	.	_	0	SENT_96	[p4l1171t3039r1313b3108],

1	2.3	CD	NUMBER	2.3	_	0	SENT_97	[p4l7t3221r114b3273],
2	.	.	O	.	_	0	SENT_97	[p4l7t3221r114b3273],

1	Blood	NN	O	blood	nn	2	SENT_98	[p4l154t3218r327b3273],
2	sampling	NN	O	sampling	_	0	SENT_98	[p4l351t3218r636b3286],

1	Blood	NN	O	blood	nn	2	SENT_99	[p4l113t3396r293b3451],
2	samples	NNS	O	sample	nsubjpass	4	SENT_99	[p4l335t3396r594b3465],
3	were	VBD	O	be	auxpass	4	SENT_99	[p4l634t3412r794b3451],
4	collected	VBN	O	collect	_	0	SENT_99	[p4l834t3396r1121b3451],
5	in	IN	O	in	_	0	SENT_99	[p4l1163t3397r1222b3451],
6	tubes	NNS	O	tube	prep_in	4	SENT_99	[p4l1261t3396r1435b3451],
7	containing	VBG	O	contain	partmod	6	SENT_99	[p4l1477t3397r1820b3465],
8	3.8	CD	PERCENT	3.8	number	9	SENT_99	[p4l1857t3399r1997b3452],
9	%	NN	PERCENT	%	amod	10	SENT_99	[p4l1857t3399r1997b3452],
10	NaCitrate	NN	O	nacitrate	dobj	7	SENT_99	[p4l2038t3400r2150b3451, p4l11t3486r241b3540],
11	.	.	O	.	_	0	SENT_99	[p4l2038t3400r2150b3451, p4l11t3486r241b3540],

1	Samples	NNS	O	sample	nsubjpass	3	SENT_100	[p4l266t3485r531b3554],
2	were	VBD	O	be	auxpass	3	SENT_100	[p4l553t3501r713b3540],
3	obtained	VBN	O	obtain	_	0	SENT_100	[p4l736t3485r1018b3540],
4	before	IN	O	before	_	0	SENT_100	[p4l1041t3485r1244b3540],
5	coronary	JJ	O	coronary	amod	6	SENT_100	[p4l1267t3501r1554b3554],
6	intervention	NN	O	intervention	prep_before	3	SENT_100	[p4l1575t3486r1975b3540],
7	from	IN	O	from	_	0	SENT_100	[p4l1998t3485r2151b3540],
8	patients	NNS	O	patient	prep_from	3	SENT_100	[p4l11t3575r269b3643],
9	on	IN	O	on	_	0	SENT_100	[p4l306t3590r384b3629],
10	aspirin	NN	O	aspirin	prep_on	8	SENT_100	[p4l420t3575r640b3643],
11	alone	RB	O	alone	advmod	10	SENT_100	[p4l676t3574r848b3629],
12	(	RB	O	(	advmod	8	SENT_100	[p4l884t3574r1175b3643],
13	baseline	JJ	O	baseline	amod	15	SENT_100	[p4l884t3574r1175b3643],
14	sample	NN	O	sample	nn	15	SENT_100	[p4l1212t3574r1481b3643],
15	)	NN	O	)	dep	8	SENT_100	[p4l1212t3574r1481b3643],
16	,	,	O	,	_	0	SENT_100	[p4l1212t3574r1481b3643],
17	2	CD	NUMBER	2	num	18	SENT_100	[p4l1517t3577r1552b3629],
18	h	NN	O	h	appos	15	SENT_100	[p4l1576t3574r1614b3629],
19	after	IN	O	after	_	0	SENT_100	[p4l1650t3574r1800b3629],
20	taking	VBG	O	take	prepc_after	18	SENT_100	[p4l1833t3574r2035b3643],
21	LD	NN	O	ld	nn	24	SENT_100	[p4l2070t3578r2150b3629],
22	600	CD	NUMBER	600	num	24	SENT_100	[p4l11t3666r128b3718],
23	mg	NN	O	mg	nn	24	SENT_100	[p4l151t3679r251b3732],
24	clopidogrel	NN	O	clopidogrel	dobj	20	SENT_100	[p4l278t3663r654b3732],
25	,	,	O	,	_	0	SENT_100	[p4l278t3663r654b3732],
26	24	CD	NUMBER	24	num	27	SENT_100	[p4l682t3666r760b3718],
27	h	NN	O	h	dobj	20	SENT_100	[p4l783t3663r821b3718],
28	and	CC	O	and	_	0	SENT_100	[p4l848t3663r965b3718],
29	later	RB	DURATION	later	advmod	31	SENT_100	[p4l995t3663r1142b3718],
30	30	CD	DURATION	30	num	31	SENT_100	[p4l1167t3666r1244b3718],
31	days	NNS	NUMBER	day	dobj	20	SENT_100	[p4l1273t3663r1416b3732],
32	after	IN	O	after	_	0	SENT_100	[p4l1446t3663r1596b3718],
33	stenting	VBG	O	stent	prepc_after	20	SENT_100	[p4l1623t3664r1899b3732],
34	.	.	O	.	_	0	SENT_100	[p4l1623t3664r1899b3732],

1	Laboratory	NNP	O	Laboratory	nn	2	SENT_101	[p5l114t17r463b85],
2	procedures	NNS	O	procedure	nsubjpass	11	SENT_101	[p5l498t17r855b85],
3	(	CD	NUMBER	(	num	5	SENT_101	[p5l893t17r1164b85],
4	platelet	NN	O	platelet	nn	5	SENT_101	[p5l893t17r1164b85],
5	aggregation	NN	O	aggregation	dep	2	SENT_101	[p5l1199t18r1579b85],
6	and	CC	O	and	_	0	SENT_101	[p5l1615t17r1731b72],
7	hematology	NN	O	hematology	nn	8	SENT_101	[p5l1769t17r2152b85],
8	assays	NNS	O	assay	dep	2	SENT_101	[p5l11t106r239b174],
9	)	CD	NUMBER	)	dep	2	SENT_101	[p5l11t106r239b174],
10	were	VBD	O	be	auxpass	11	SENT_101	[p5l288t122r447b161],
11	done	VBN	O	do	_	0	SENT_101	[p5l497t106r653b161],
12	within	IN	O	within	_	0	SENT_101	[p5l702t106r914b161],
13	2	CD	NUMBER	2	number	14	SENT_101	[p5l963t106r1143b161],
14	—	CD	NUMBER	—	num	15	SENT_101	[p5l963t106r1143b161],
15	3h	NN	O	3h	prep_within	11	SENT_101	[p5l963t106r1143b161],
16	after	IN	O	after	_	0	SENT_101	[p5l1192t106r1342b161],
17	sampling	NN	O	sampling	prep_after	11	SENT_101	[p5l1390t106r1686b174],
18	to	TO	O	to	aux	19	SENT_101	[p5l1733t114r1795b161],
19	minimize	VB	O	minimize	xcomp	11	SENT_101	[p5l1845t107r2150b161],
20	environmental	JJ	O	environmental	amod	21	SENT_101	[p5l11t194r486b248],
21	effects	NNS	O	effect	dobj	19	SENT_101	[p5l515t194r738b249],
22	.	.	O	.	_	0	SENT_101	[p5l515t194r738b249],

1	2.4	CD	NUMBER	2.4	_	0	SENT_102	[p5l7t375r114b428],
2	.	.	O	.	_	0	SENT_102	[p5l7t375r114b428],

1	Platelet	NN	O	platelet	nn	2	SENT_103	[p5l154t372r388b427],
2	aggregation	NN	O	aggregation	_	0	SENT_103	[p5l412t374r775b441],

1	Platelet	NN	O	platelet	nn	2	SENT_104	[p5l114t551r352b606],
2	aggregation	NN	O	aggregation	nsubjpass	4	SENT_104	[p5l405t552r781b619],
3	was	VBD	O	be	auxpass	4	SENT_104	[p5l833t567r956b606],
4	evaluated	VBN	O	evaluate	_	0	SENT_104	[p5l1013t551r1322b606],
5	by	IN	O	by	_	0	SENT_104	[p5l1376t551r1454b619],
6	light	JJ	O	light	amod	8	SENT_104	[p5l1507t551r1651b619],
7	transmittance	JJ	O	transmittance	amod	8	SENT_104	[p5l1704t552r2150b606],
8	aggregometry	NN	O	aggregometry	agent	4	SENT_104	[p5l11t647r456b708],
9	(	CD	NUMBER	(	num	11	SENT_104	[p5l481t639r663b708],
10	LTA	NN	ORGANIZATION	lta	nn	11	SENT_104	[p5l481t639r663b708],
11	)	NN	O	)	dep	8	SENT_104	[p5l481t639r663b708],
12	.	.	O	.	_	0	SENT_104	[p5l481t639r663b708],

1	The	DT	O	the	det	5	SENT_105	[p5l689t639r805b694],
2	blood	NN	O	blood	nn	5	SENT_105	[p5l832t639r1245b694],
3	—	NN	O	—	nn	5	SENT_105	[p5l832t639r1245b694],
4	citrate	NN	O	citrate	nn	5	SENT_105	[p5l832t639r1245b694],
5	mixture	NN	O	mixture	nsubjpass	7	SENT_105	[p5l1272t640r1525b694],
6	was	VBD	O	be	auxpass	7	SENT_105	[p5l1550t655r1674b694],
7	centrifuged	VBN	O	centrifuge	_	0	SENT_105	[p5l1702t639r2065b708],
8	at	IN	O	at	_	0	SENT_105	[p5l2092t647r2152b694],
9	800	CD	NUMBER	800	num	10	SENT_105	[p5l11t731r127b783],
10	rpm	NN	O	rpm	prep_at	7	SENT_105	[p5l149t744r280b797],
11	for	IN	O	for	_	0	SENT_105	[p5l300t728r388b783],
12	8	CD	DURATION	8	num	13	SENT_105	[p5l407t731r440b783],
13	min	NN	DURATION	min	prep_for	10	SENT_105	[p5l464t729r588b783],
14	to	TO	O	to	aux	15	SENT_105	[p5l607t736r669b783],
15	recover	VB	O	recover	xcomp	7	SENT_105	[p5l689t744r926b783],
16	platelet	NN	O	platelet	nn	17	SENT_105	[p5l944t728r1338b797],
17	—	NN	O	—	nsubj	24	SENT_105	[p5l944t728r1338b797],
18	rich	JJ	O	rich	dep	22	SENT_105	[p5l944t728r1338b797],
19	plasma	NN	O	plasma	nn	22	SENT_105	[p5l1357t728r1584b797],
20	(	CD	NUMBER	(	num	22	SENT_105	[p5l1604t728r1772b797],
21	PRP	NN	O	prp	nn	22	SENT_105	[p5l1604t728r1772b797],
22	)	NN	O	)	xcomp	15	SENT_105	[p5l1604t728r1772b797],
23	and	CC	O	and	_	0	SENT_105	[p5l1792t728r1908b783],
24	further	JJ	O	further	xcomp	15	SENT_105	[p5l1929t728r2153b783],
25	subjected	VBN	O	subject	partmod	24	SENT_105	[p5l12t818r315b886],
26	to	TO	O	to	_	0	SENT_105	[p5l343t826r404b873],
27	centrifugation	NN	O	centrifugation	prep_to	25	SENT_105	[p5l433t817r884b886],
28	at	IN	O	at	_	0	SENT_105	[p5l911t826r971b873],
29	4000	CD	NUMBER	4000	num	30	SENT_105	[p5l995t820r1154b873],
30	rpm	NN	O	rpm	prep_at	25	SENT_105	[p5l1175t833r1306b886],
31	for	IN	O	for	_	0	SENT_105	[p5l1334t817r1422b873],
32	20	CD	DURATION	20	num	33	SENT_105	[p5l1448t820r1525b873],
33	min	NN	DURATION	min	prep_for	30	SENT_105	[p5l1546t818r1670b872],
34	to	TO	O	to	aux	35	SENT_105	[p5l1697t826r1759b873],
35	recover	VB	O	recover	xcomp	25	SENT_105	[p5l1787t833r2024b873],
36	the	DT	O	the	det	38	SENT_105	[p5l2050t818r2150b873],
37	platelet	NN	O	platelet	nn	38	SENT_105	[p5l11t906r429b975],
38	—	NN	O	—	nsubj	43	SENT_105	[p5l11t906r429b975],
39	poor	JJ	O	poor	amod	43	SENT_105	[p5l11t906r429b975],
40	plasma	NN	O	plasma	nn	43	SENT_105	[p5l455t906r682b975],
41	(	CD	NUMBER	(	num	43	SENT_105	[p5l709t906r889b975],
42	PPP	NN	O	ppp	nn	43	SENT_105	[p5l709t906r889b975],
43	)	NN	O	)	xcomp	35	SENT_105	[p5l709t906r889b975],
44	.	.	O	.	_	0	SENT_105	[p5l709t906r889b975],

1	The	DT	O	the	det	2	SENT_106	[p5l915t906r1031b961],
2	PRP	NN	O	prp	nsubjpass	11	SENT_106	[p5l1059t910r1178b961],
3	and	CC	O	and	_	0	SENT_106	[p5l1203t906r1319b961],
4	PPP	NN	ORGANIZATION	ppp	conj_and	2	SENT_106	[p5l1347t910r1461b961],
5	were	VBD	O	be	auxpass	6	SENT_106	[p5l1486t922r1645b961],
6	stored	VBN	O	store	dep	19	SENT_106	[p5l1673t906r1869b961],
7	at	IN	O	at	_	0	SENT_106	[p5l1897t915r1957b961],
8	room	NN	O	room	nn	9	SENT_106	[p5l1984t922r2151b961],
9	temperature	NN	O	temperature	prep_at	6	SENT_106	[p5l10t1004r410b1064],
10	and	CC	O	and	_	0	SENT_106	[p5l426t996r541b1051],
11	used	VBN	O	use	dep	19	SENT_106	[p5l559t996r706b1051],
12	in	IN	O	in	_	0	SENT_106	[p5l724t997r783b1050],
13	2	CD	NUMBER	2	num	15	SENT_106	[p5l799t999r833b1050],
14	h.	NN	O	h.	nn	15	SENT_106	[p5l857t996r910b1051],
15	Platelets	NNS	O	platelet	prep_in	11	SENT_106	[p5l928t996r1196b1051],
16	in	IN	O	in	_	0	SENT_106	[p5l1215t997r1274b1050],
17	PRP	NN	O	prp	prep_in	15	SENT_106	[p5l1290t999r1408b1050],
18	were	VBD	O	be	auxpass	19	SENT_106	[p5l1422t1012r1580b1051],
19	stimulated	VBN	O	stimulate	_	0	SENT_106	[p5l1598t996r1939b1051],
20	with	IN	O	with	_	0	SENT_106	[p5l1955t996r2102b1051],
21	a	DT	O	a	det	23	SENT_106	[p5l2118t1012r2151b1051],
22	ﬁnal	JJ	O	ﬁnal	amod	23	SENT_106	[p5l11t1086r149b1141],
23	concentration	NN	O	concentration	prep_with	19	SENT_106	[p5l178t1087r620b1141],
24	of	IN	O	of	_	0	SENT_106	[p5l648t1086r714b1141],
25	either	CC	O	either	preconj	26	SENT_106	[p5l734t1086r923b1141],
26	5	CD	NUMBER	5	prep_of	23	SENT_106	[p5l949t1089r982b1141],
27	or	CC	O	or	_	0	SENT_106	[p5l1013t1102r1079b1141],
28	20	CD	NUMBER	20	num	29	SENT_106	[p5l1105t1089r1182b1141],
29	pLM	NN	O	plm	conj_or	26	SENT_106	[p5l1207t1089r1319b1157],
30	ADP	NN	O	adp	nn	34	SENT_106	[p5l1345t1088r1481b1140],
31	(	CD	NUMBER	(	num	34	SENT_106	[p5l1508t1086r1754b1154],
32	Helena	NNP	PERSON	Helena	nn	34	SENT_106	[p5l1508t1086r1754b1154],
33	BioSciences	NNP	O	BioSciences	nn	34	SENT_106	[p5l1783t1087r2149b1141],
34	Europe	NNP	LOCATION	Europe	nsubjpass	19	SENT_106	[p5l11t1177r249b1242],
35	,	,	O	,	_	0	SENT_106	[p5l11t1177r249b1242],
36	Sunderland	NNP	ORGANIZATION	Sunderland	appos	34	SENT_106	[p5l275t1173r664b1241],
37	)	CD	NUMBER	)	num	36	SENT_106	[p5l275t1173r664b1241],
38	using	VBG	O	use	partmod	36	SENT_106	[p5l690t1174r863b1242],
39	a	DT	O	a	det	41	SENT_106	[p5l886t1189r918b1228],
40	Helena	NNP	O	Helena	nn	41	SENT_106	[p5l946t1173r1166b1228],
41	laboratories	NNS	O	laboratory	nsubj	42	SENT_106	[p5l1192t1173r1569b1228],
42	PACI	NNP	O	PACI	xcomp	38	SENT_106	[p5l1597t1176r1885b1229],
43	(	CD	NUMBER	(	num	42	SENT_106	[p5l1597t1176r1885b1229],
44	S	NN	O	s	prep	42	SENT_106	[p5l1597t1176r1885b1229],
45	—	CD	NUMBER	—	num	46	SENT_106	[p5l1597t1176r1885b1229],
46	4	CD	NUMBER	4	dep	44	SENT_106	[p5l1597t1176r1885b1229],
47	.	.	O	.	_	0	SENT_106	[p5l1597t1176r1885b1229],

1	Platelet	NN	O	platelet	nn	2	SENT_107	[p5l1913t1173r2152b1228],
2	aggregation	NN	O	aggregation	nsubjpass	4	SENT_107	[p5l11t1263r386b1331],
3	was	VBD	O	be	auxpass	4	SENT_107	[p5l408t1278r531b1317],
4	expressed	VBN	O	express	_	0	SENT_107	[p5l557t1262r874b1331],
5	as	IN	O	as	_	0	SENT_107	[p5l897t1278r960b1317],
6	the	DT	O	the	det	9	SENT_107	[p5l985t1262r1085b1317],
7	maximal	JJ	O	maximal	amod	9	SENT_107	[p5l1110t1262r1388b1317],
8	percent	NN	O	percent	nn	9	SENT_107	[p5l1413t1270r1654b1331],
9	change	NN	O	change	prep_as	4	SENT_107	[p5l1676t1262r1900b1331],
10	in	IN	O	in	_	0	SENT_107	[p5l1924t1263r1984b1317],
11	light	JJ	O	light	amod	12	SENT_107	[p5l2008t1262r2152b1331],
12	transmittance	NN	O	transmittance	prep_in	9	SENT_107	[p5l10t1352r457b1407],
13	from	IN	O	from	_	0	SENT_107	[p5l482t1351r634b1407],
14	baseline	NN	O	baseline	prep_from	4	SENT_107	[p5l658t1351r935b1415],
15	,	,	O	,	_	0	SENT_107	[p5l658t1351r935b1415],
16	using	VBG	O	use	xcomp	4	SENT_107	[p5l960t1352r1132b1420],
17	PPP	NNP	O	PPP	dobj	16	SENT_107	[p5l1157t1355r1271b1406],
18	as	IN	O	as	_	0	SENT_107	[p5l1295t1367r1357b1407],
19	a	DT	O	a	det	20	SENT_107	[p5l1383t1367r1416b1407],
20	reference	NN	O	reference	prep_as	17	SENT_107	[p5l1442t1351r1752b1407],
21	.	.	O	.	_	0	SENT_107	[p5l1442t1351r1752b1407],

1	2.5	CD	NUMBER	2.5	_	0	SENT_108	[p5l7t1533r114b1585],
2	.	.	O	.	_	0	SENT_108	[p5l7t1533r114b1585],

1	Genotyping	VBG	O	genotype	_	0	SENT_109	[p5l157t1531r512b1598],

1	Genomic	JJ	O	genomic	amod	2	SENT_110	[p5l113t1709r399b1763],
2	DNA	NN	O	dna	nsubjpass	4	SENT_110	[p5l419t1711r566b1763],
3	was	VBD	O	be	auxpass	4	SENT_110	[p5l582t1724r706b1763],
4	extracted	VBN	O	extract	_	0	SENT_110	[p5l728t1708r1030b1763],
5	from	IN	O	from	_	0	SENT_110	[p5l1051t1708r1204b1763],
6	buffy	JJ	O	buffy	amod	7	SENT_110	[p5l1223t1708r1391b1777],
7	coat	NN	O	coat	prep_from	4	SENT_110	[p5l1410t1716r1543b1763],
8	by	IN	O	by	_	0	SENT_110	[p5l1562t1708r1639b1777],
9	DNA	NN	O	dna	nn	11	SENT_110	[p5l1659t1711r1806b1763],
10	extraction	NN	O	extraction	nn	11	SENT_110	[p5l1823t1709r2151b1763],
11	kit	NN	O	kit	prep_by	7	SENT_110	[p5l11t1797r94b1852],
12	according	VBG	O	accord	_	0	SENT_110	[p5l126t1797r441b1866],
13	to	TO	O	to	prepc_according_to	4	SENT_110	[p5l471t1805r533b1852],
14	the	DT	O	the	det	15	SENT_110	[p5l566t1797r667b1852],
15	manufacture	NN	O	manufacture	poss	19	SENT_110	[p5l701t1797r1159b1852],
16	’s	POS	O	’s	_	0	SENT_110	[p5l701t1797r1159b1852],
17	instruction	NN	O	instruction	nn	19	SENT_110	[p5l1194t1798r1547b1852],
18	(	NN	O	(	nn	19	SENT_110	[p5l1579t1797r1878b1866],
19	Cinagen	NN	PERSON	cinagen	pobj	4	SENT_110	[p5l1579t1797r1878b1866],
20	,	,	O	,	_	0	SENT_110	[p5l1579t1797r1878b1866],
21	Tehran	NNP	LOCATION	Tehran	nn	23	SENT_110	[p5l1909t1797r2150b1861],
22	,	,	O	,	_	0	SENT_110	[p5l1909t1797r2150b1861],
23	Iran	NNP	LOCATION	Iran	appos	19	SENT_110	[p5l11t1887r178b1955],
24	)	CD	NUMBER	)	num	23	SENT_110	[p5l11t1887r178b1955],
25	.	.	O	.	_	0	SENT_110	[p5l11t1887r178b1955],

1	2.5.1	CD	NUMBER	2.5.1	_	0	SENT_111	[p5l7t2068r169b2119],
2	.	.	O	.	_	0	SENT_111	[p5l7t2068r169b2119],

1	P2Y12	NN	O	p2y12	_	0	SENT_112	[p5l210t2068r403b2118],

1	Genotyping	NN	O	genotyping	nsubjpass	18	SENT_113	[p5l113t2154r489b2221],
2	of	IN	O	of	_	0	SENT_113	[p5l507t2153r574b2208],
3	the	DT	O	the	det	5	SENT_113	[p5l585t2153r687b2208],
4	T744C	NN	O	t744c	nn	5	SENT_113	[p5l706t2156r901b2208],
5	polymorphism	NN	O	polymorphism	prep_of	1	SENT_113	[p5l915t2153r1390b2221],
6	in	IN	O	in	_	0	SENT_113	[p5l1410t2154r1469b2207],
7	intron	NN	O	intron	prep_in	5	SENT_113	[p5l1489t2154r1686b2208],
8	1	CD	NUMBER	1	num	7	SENT_113	[p5l1708t2156r1732b2207],
9	of	IN	O	of	_	0	SENT_113	[p5l1760t2153r1826b2208],
10	the	DT	O	the	det	12	SENT_113	[p5l1838t2153r1940b2208],
11	P2Y12	NN	O	p2y12	nn	12	SENT_113	[p5l1957t2156r2150b2207],
12	receptor	NN	O	receptor	prep_of	7	SENT_113	[p5l11t2249r282b2310],
13	gene	NN	O	gene	nn	16	SENT_113	[p5l306t2257r457b2310],
14	(	CD	NUMBER	(	num	16	SENT_113	[p5l484t2241r865b2309],
15	rs2046934	NN	O	rs2046934	nn	16	SENT_113	[p5l484t2241r865b2309],
16	)	NN	O	)	dep	12	SENT_113	[p5l484t2241r865b2309],
17	was	VBD	O	be	auxpass	18	SENT_113	[p5l890t2257r1015b2296],
18	performed	VBN	O	perform	_	0	SENT_113	[p5l1044t2241r1383b2310],
19	according	VBG	O	accord	_	0	SENT_113	[p5l1411t2241r1725b2310],
20	to	TO	O	to	prepc_according_to	18	SENT_113	[p5l1751t2249r1813b2296],
21	Angiolillo	NNP	O	Angiolillo	pobj	18	SENT_113	[p5l1839t2241r2150b2310],
22	et	FW	O	et	dep	21	SENT_113	[p5l11t2338r71b2385],
23	al.	FW	O	al.	nn	24	SENT_113	[p5l94t2330r163b2385],
24	[	FW	O	[	dep	22	SENT_113	[p5l192t2330r334b2399],
25	24	CD	NUMBER	24	num	26	SENT_113	[p5l192t2330r334b2399],
26	]	NN	O	]	dep	22	SENT_113	[p5l192t2330r334b2399],
27	.	.	O	.	_	0	SENT_113	[p5l192t2330r334b2399],

1	Brieﬂy	NNP	O	Brieﬂy	nsubj	9	SENT_114	[p5l360t2330r582b2399],
2	,	,	O	,	_	0	SENT_114	[p5l360t2330r582b2399],
3	polymerase	NN	O	polymerase	nn	8	SENT_114	[p5l608t2330r981b2399],
4	chain	NN	O	chain	nn	8	SENT_114	[p5l1006t2330r1179b2385],
5	reaction	NN	O	reaction	nn	8	SENT_114	[p5l1204t2331r1465b2385],
6	(	CD	NUMBER	(	num	8	SENT_114	[p5l1489t2330r1662b2398],
7	PCR	NN	O	pcr	nn	8	SENT_114	[p5l1489t2330r1662b2398],
8	)	NN	O	)	appos	1	SENT_114	[p5l1489t2330r1662b2398],
9	included	VBD	O	include	_	0	SENT_114	[p5l1688t2330r1965b2385],
10	a	DT	O	a	det	12	SENT_114	[p5l1990t2346r2022b2385],
11	hot	JJ	O	hot	amod	12	SENT_114	[p5l2047t2330r2152b2385],
12	start	NN	O	start	dobj	9	SENT_114	[p5l12t2428r158b2475],
13	at	IN	O	at	_	0	SENT_114	[p5l184t2428r245b2475],
14	94	CD	NUMBER	94	num	15	SENT_114	[p5l272t2422r350b2475],
15	CC	NN	O	cc	prep_at	9	SENT_114	[p5l373t2422r437b2475],
16	for	IN	O	for	_	0	SENT_114	[p5l465t2419r554b2475],
17	5	CD	DURATION	5	num	18	SENT_114	[p5l581t2423r614b2475],
18	min	NN	DURATION	min	prep_for	15	SENT_114	[p5l639t2420r779b2483],
19	,	,	O	,	_	0	SENT_114	[p5l639t2420r779b2483],
20	35	CD	NUMBER	35	num	21	SENT_114	[p5l806t2422r883b2475],
21	cycles	NNS	O	cycle	conj_and	15	SENT_114	[p5l914t2420r1105b2488],
22	at	IN	O	at	_	0	SENT_114	[p5l1134t2428r1194b2475],
23	94	CD	NUMBER	94	number	24	SENT_114	[p5l1221t2422r1299b2475],
24	°	CD	NUMBER	°	num	25	SENT_114	[p5l1322t2422r1386b2475],
25	C	NN	O	c	prep_at	21	SENT_114	[p5l1322t2422r1386b2475],
26	for	IN	O	for	_	0	SENT_114	[p5l1415t2419r1504b2475],
27	30	CD	NUMBER	30	num	28	SENT_114	[p5l1529t2422r1607b2475],
28	s	NNS	O	s	prep_for	25	SENT_114	[p5l1629t2435r1671b2483],
29	,	,	O	,	_	0	SENT_114	[p5l1629t2435r1671b2483],
30	51	CD	NUMBER	51	num	32	SENT_114	[p5l1701t2423r1769b2475],
31	°	NN	O	°	nn	32	SENT_114	[p5l1800t2422r1865b2475],
32	C	NN	O	c	conj_and	15	SENT_114	[p5l1800t2422r1865b2475],
33	for	IN	O	for	_	0	SENT_114	[p5l1893t2419r1983b2475],
34	30	CD	NUMBER	30	num	35	SENT_114	[p5l2007t2422r2086b2475],
35	s	NNS	O	s	prep_for	32	SENT_114	[p5l2109t2435r2150b2483],
36	,	,	O	,	_	0	SENT_114	[p5l2109t2435r2150b2483],
37	72	CD	NUMBER	72	num	39	SENT_114	[p5l12t2511r86b2563],
38	°	NN	O	°	nn	39	SENT_114	[p5l112t2511r176b2563],
39	C	NN	O	c	conj_and	15	SENT_114	[p5l112t2511r176b2563],
40	for	IN	O	for	_	0	SENT_114	[p5l206t2508r295b2563],
41	30	CD	NUMBER	30	num	42	SENT_114	[p5l322t2511r400b2563],
42	s	NNS	O	s	prep_for	39	SENT_114	[p5l423t2524r464b2572],
43	,	,	O	,	_	0	SENT_114	[p5l423t2524r464b2572],
44	and	CC	O	and	_	0	SENT_114	[p5l495t2508r611b2563],
45	a	DT	O	a	det	47	SENT_114	[p5l641t2524r674b2563],
46	ﬁnal	JJ	O	ﬁnal	amod	47	SENT_114	[p5l704t2508r843b2563],
47	extension	NN	O	extension	conj_and	15	SENT_114	[p5l874t2509r1188b2563],
48	at	IN	O	at	_	0	SENT_114	[p5l1217t2517r1277b2563],
49	72	CD	NUMBER	72	number	50	SENT_114	[p5l1307t2511r1381b2563],
50	°	CD	NUMBER	°	num	51	SENT_114	[p5l1406t2511r1471b2563],
51	C	NN	O	c	prep_at	47	SENT_114	[p5l1406t2511r1471b2563],
52	for	IN	O	for	_	0	SENT_114	[p5l1501t2508r1590b2563],
53	5	CD	DURATION	5	num	54	SENT_114	[p5l1619t2512r1651b2563],
54	min	NN	DURATION	min	prep_for	9	SENT_114	[p5l1676t2509r1816b2572],
55	,	,	O	,	_	0	SENT_114	[p5l1676t2509r1816b2572],
56	using	VBG	O	use	partmod	9	SENT_114	[p5l1847t2509r2021b2577],
57	the	DT	O	the	det	61	SENT_114	[p5l2049t2508r2150b2563],
58	sense	NN	O	sense	nn	61	SENT_114	[p5l12t2614r186b2653],
59	primer	NN	O	primer	nn	61	SENT_114	[p5l245t2599r465b2666],
60	5	CD	NUMBER	5	num	61	SENT_114	[p5l522t2600r1813b2653],
61	’	NN	O	’	dobj	56	SENT_114	[p5l522t2600r1813b2653],
62	.	.	O	.	_	0	SENT_114	[p5l522t2600r1813b2653],

1	—	NN	O	—	_	0	SENT_115	[p5l522t2600r1813b2653],
2	.	.	O	.	_	0	SENT_115	[p5l522t2600r1813b2653],

1	TCTGGTGAAATAAAAAGATTACGTA	NN	O	tctggtgaaataaaaagattacgta	_	0	SENT_116	[p5l522t2600r1813b2653],
2	.	.	O	.	_	0	SENT_116	[p5l522t2600r1813b2653],

1	—	NN	O	—	_	0	SENT_117	[p5l522t2600r1813b2653],
2	.	.	O	.	_	0	SENT_117	[p5l522t2600r1813b2653],

1	3	CD	NUMBER	3	num	2	SENT_118	[p5l522t2600r1813b2653],
2	’	NN	O	’	_	0	SENT_118	[p5l522t2600r1813b2653],
3	and	CC	O	and	_	0	SENT_118	[p5l1874t2598r1990b2653],
4	the	DT	O	the	det	6	SENT_118	[p5l2048t2598r2150b2653],
5	anti	JJ	O	anti	amod	6	SENT_118	[p5l11t2688r342b2742],
6	—	NN	O	—	conj_and	2	SENT_118	[p5l11t2688r342b2742],
7	sense	NN	O	sense	nn	8	SENT_118	[p5l11t2688r342b2742],
8	primer	NN	O	primer	dep	2	SENT_118	[p5l384t2688r604b2755],
9	5	CD	NUMBER	5	num	10	SENT_118	[p5l644t2689r1950b2742],
10	’	NN	O	’	dep	8	SENT_118	[p5l644t2689r1950b2742],
11	.	.	O	.	_	0	SENT_118	[p5l644t2689r1950b2742],

1	—	NN	O	—	_	0	SENT_119	[p5l644t2689r1950b2742],
2	.	.	O	.	_	0	SENT_119	[p5l644t2689r1950b2742],

1	GTCAGAAATGGCCTGTGTATATATG	NN	O	gtcagaaatggcctgtgtatatatg	_	0	SENT_120	[p5l644t2689r1950b2742],
2	.	.	O	.	_	0	SENT_120	[p5l644t2689r1950b2742],

1	—	NN	O	—	_	0	SENT_121	[p5l644t2689r1950b2742],
2	.	.	O	.	_	0	SENT_121	[p5l644t2689r1950b2742],

1	3	CD	NUMBER	3	_	0	SENT_122	[p5l644t2689r1950b2742],
2	’	NN	O	’	dep	1	SENT_122	[p5l644t2689r1950b2742],
3	.	.	O	.	_	0	SENT_122	[p5l644t2689r1950b2742],

1	After	IN	O	after	_	0	SENT_123	[p5l1990t2687r2153b2742],
2	PCR	NN	O	pcr	nn	5	SENT_123	[p5l11t2778r135b2830],
3	and	CC	O	and	_	0	SENT_123	[p5l163t2775r280b2830],
4	restriction	NN	O	restriction	conj_and	2	SENT_123	[p5l312t2776r645b2830],
5	digestion	NN	O	digestion	prep_after	38	SENT_123	[p5l676t2775r972b2844],
6	with	IN	O	with	_	0	SENT_123	[p5l1001t2775r1149b2830],
7	Rsal	JJ	O	rsal	amod	9	SENT_123	[p5l1180t2778r1320b2830],
8	(	NN	O	(	nn	9	SENT_123	[p5l1360t2775r1775b2843],
9	Fermentase	NN	O	fermentase	prep_with	5	SENT_123	[p5l1360t2775r1775b2843],
10	,	,	O	,	_	0	SENT_123	[p5l1360t2775r1775b2843],
11	Lithuania	NNP	LOCATION	Lithuania	nn	12	SENT_123	[p5l1807t2775r2150b2843],
12	)	NNP	O	)	appos	9	SENT_123	[p5l1807t2775r2150b2843],
13	,	,	O	,	_	0	SENT_123	[p5l1807t2775r2150b2843],
14	two	CD	NUMBER	two	num	15	SENT_123	[p5l10t2872r133b2919],
15	fragments	NNS	O	fragment	nsubjpass	38	SENT_123	[p5l173t2864r497b2933],
16	of	IN	O	of	_	0	SENT_123	[p5l537t2864r604b2919],
17	196	CD	NUMBER	196	num	20	SENT_123	[p5l638t2867r753b2919],
18	and	CC	O	and	_	0	SENT_123	[p5l793t2864r910b2919],
19	24	CD	NUMBER	24	num	20	SENT_123	[p5l949t2867r1027b2918],
20	bp	NN	O	bp	prep_of	15	SENT_123	[p5l1048t2864r1127b2933],
21	for	IN	O	for	_	0	SENT_123	[p5l1167t2864r1256b2919],
22	the	DT	O	the	det	24	SENT_123	[p5l1292t2864r1395b2919],
23	C	NN	O	c	nn	24	SENT_123	[p5l1433t2867r1472b2919],
24	allele	NN	O	allele	prep_for	20	SENT_123	[p5l1510t2864r1696b2927],
25	,	,	O	,	_	0	SENT_123	[p5l1510t2864r1696b2927],
26	and	CC	O	and	_	0	SENT_123	[p5l1735t2864r1852b2919],
27	a	DT	O	a	det	29	SENT_123	[p5l1891t2880r1924b2919],
28	single	JJ	O	single	amod	29	SENT_123	[p5l1964t2864r2150b2933],
29	fragment	NN	O	fragment	conj_and	20	SENT_123	[p5l11t2953r306b3022],
30	of	IN	O	of	_	0	SENT_123	[p5l334t2953r400b3008],
31	220	CD	NUMBER	220	num	32	SENT_123	[p5l421t2956r539b3008],
32	bp	NN	O	bp	prep_of	29	SENT_123	[p5l560t2953r639b3022],
33	for	IN	O	for	_	0	SENT_123	[p5l668t2953r757b3008],
34	the	DT	O	the	det	36	SENT_123	[p5l782t2953r884b3008],
35	T	NN	O	t	nn	36	SENT_123	[p5l910t2957r950b3008],
36	allele	NN	O	allele	prep_for	32	SENT_123	[p5l976t2953r1146b3008],
37	were	VBD	O	be	auxpass	38	SENT_123	[p5l1172t2969r1332b3008],
38	obtained	VBN	O	obtain	_	0	SENT_123	[p5l1361t2953r1658b3009],
39	.	.	O	.	_	0	SENT_123	[p5l1361t2953r1658b3009],

1	The	DT	O	the	det	3	SENT_124	[p5l110t3042r229b3097],
2	C	NN	O	c	nn	3	SENT_124	[p5l252t3045r291b3097],
3	allele	NN	O	allele	nsubj	10	SENT_124	[p5l313t3042r487b3097],
4	of	IN	O	of	_	0	SENT_124	[p5l510t3042r577b3097],
5	the	DT	O	the	det	7	SENT_124	[p5l591t3042r695b3097],
6	T744C	NN	O	t744c	nn	7	SENT_124	[p5l718t3045r916b3097],
7	polymorphism	NN	O	polymorphism	prep_of	3	SENT_124	[p5l934t3042r1418b3111],
8	is	VBZ	O	be	cop	10	SENT_124	[p5l1441t3043r1489b3097],
9	a	DT	O	a	det	10	SENT_124	[p5l1512t3058r1544b3097],
10	constituent	NN	O	constituent	_	0	SENT_124	[p5l1568t3043r1944b3097],
11	of	IN	O	of	_	0	SENT_124	[p5l1965t3042r2032b3097],
12	the	DT	O	the	det	14	SENT_124	[p5l2047t3042r2150b3097],
13	minor	JJ	O	minor	amod	14	SENT_124	[p5l11t3133r210b3187],
14	genotype	NN	O	genotype	prep_of	10	SENT_124	[p5l241t3140r545b3200],
15	of	IN	O	of	_	0	SENT_124	[p5l579t3132r646b3187],
16	the	DT	O	the	det	17	SENT_124	[p5l672t3132r775b3187],
17	P2Yl2	NN	O	p2yl2	prep_of	14	SENT_124	[p5l810t3135r1012b3186],
18	previously	RB	DATE	previously	advmod	19	SENT_124	[p5l1049t3132r1395b3200],
19	described	VBN	O	describe	partmod	17	SENT_124	[p5l1428t3132r1744b3187],
20	by	IN	O	by	_	0	SENT_124	[p5l1778t3132r1856b3200],
21	Fontana	NNP	PERSON	Fontana	agent	19	SENT_124	[p5l1889t3135r2151b3187],
22	et	FW	O	et	nn	24	SENT_124	[p5l11t3229r72b3276],
23	al.	FW	O	al.	nn	24	SENT_124	[p5l97t3221r168b3276],
24	[	FW	O	[	dobj	19	SENT_124	[p5l200t3221r344b3289],
25	25	CD	NUMBER	25	num	26	SENT_124	[p5l200t3221r344b3289],
26	]	NN	O	]	dep	10	SENT_124	[p5l200t3221r344b3289],
27	.	.	O	.	_	0	SENT_124	[p5l200t3221r344b3289],

1	S.	NNP	PERSON	S.	nn	2	SENT_125	[p5l343t3365r361b3386],
2	Namazi	NNP	PERSON	Namazi	_	0	SENT_125	[p5l372t3364r464b3386],
3	et	FW	O	et	nn	4	SENT_125	[p5l475t3367r498b3386],
4	al.	FW	O	al.	dep	2	SENT_125	[p5l507t3364r533b3386],
5	/	:	O	/	punct	2	SENT_125	[p5l537t3364r549b3391],
6	Biochemical	JJ	O	biochemical	amod	7	SENT_125	[p5l553t3364r698b3386],
7	Pharmacology	NN	O	pharmacology	dep	2	SENT_125	[p5l708t3364r879b3391],
8	83	CD	NUMBER	83	number	9	SENT_125	[p5l890t3365r918b3386],
9	(	CD	NUMBER	(	num	10	SENT_125	[p5l929t3364r1010b3391],
10	2012	CD	DATE	2012	dep	7	SENT_125	[p5l929t3364r1010b3391],
11	)	CD	NUMBER	)	number	12	SENT_125	[p5l929t3364r1010b3391],
12	903-908 905	CD	NUMBER	903-908 905	num	10	SENT_125	[p5l1774t3365r1817b3386],[p5l1020t3365r1127b3386],

1	2.5.2	CD	NUMBER	2.5.2	_	0	SENT_126	[p5l7t3502r169b3553],
2	.	.	O	.	_	0	SENT_126	[p5l7t3502r169b3553],

1	CYP3A5	NN	O	cyp3a5	_	0	SENT_127	[p5l213t3501r448b3553],

1	Genotyping	NN	O	genotyping	nsubjpass	32	SENT_128	[p6l113t24r489b92],
2	of	IN	O	of	prep	1	SENT_128	[p6l524t23r591b78],
3	the	DT	O	the	det	5	SENT_128	[p6l620t23r722b78],
4	A6986G	NN	O	a6986g	nn	5	SENT_128	[p6l753t26r1001b78],
5	polymorphism	NN	O	polymorphism	dep	18	SENT_128	[p6l1037t23r1512b92],
6	in	IN	O	in	_	0	SENT_128	[p6l1549t24r1608b78],
7	intron	NN	O	intron	prep_in	5	SENT_128	[p6l1646t24r1843b78],
8	3	CD	NUMBER	3	num	7	SENT_128	[p6l1878t26r1912b78],
9	of	IN	O	of	_	0	SENT_128	[p6l1953t23r2019b78],
10	the	DT	O	the	det	13	SENT_128	[p6l2048t23r2150b78],
11	CYP3A5	NN	O	cyp3a5	nn	13	SENT_128	[p6l12t115r247b167],
12	gene	NN	O	gene	nn	13	SENT_128	[p6l280t128r431b181],
13	(	NN	O	(	prep_of	7	SENT_128	[p6l467t112r620b180],
14	A	NN	O	a	dep	18	SENT_128	[p6l467t112r620b180],
15	—	CD	NUMBER	—	num	14	SENT_128	[p6l467t112r620b180],
16	>	JJR	O	>	amod	18	SENT_128	[p6l467t112r620b180],
17	CYP3A5	NN	O	cyp3a5	nn	18	SENT_128	[p6l645t112r939b167],
18	*	NN	O	*	dep	24	SENT_128	[p6l645t112r939b167],
19	1	CD	NUMBER	1	dep	18	SENT_128	[p6l645t112r939b167],
20	and	CC	O	and	_	0	SENT_128	[p6l982t112r1099b167],
21	G	NN	O	g	dep	18	SENT_128	[p6l1134t115r1179b167],
22	—	CD	NUMBER	—	num	24	SENT_128	[p6l1203t137r1266b162],
23	>	JJR	O	>	amod	24	SENT_128	[p6l1203t137r1266b162],
24	CYP3A5	NN	O	cyp3a5	dep	2	SENT_128	[p6l1290t112r1617b180],
25	*	CD	NUMBER	*	number	26	SENT_128	[p6l1290t112r1617b180],
26	3	CD	NUMBER	3	dep	24	SENT_128	[p6l1290t112r1617b180],
27	)	NN	O	)	nn	30	SENT_128	[p6l1290t112r1617b180],
28	(	CD	NUMBER	(	num	30	SENT_128	[p6l1652t112r1991b180],
29	rs776746	NN	O	rs776746	nn	30	SENT_128	[p6l1652t112r1991b180],
30	)	NN	O	)	dep	26	SENT_128	[p6l1652t112r1991b180],
31	was	VBD	O	be	auxpass	32	SENT_128	[p6l2025t128r2149b167],
32	performed	VBN	O	perform	_	0	SENT_128	[p6l11t201r350b270],
33	according	VBG	O	accord	_	0	SENT_128	[p6l374t201r688b270],
34	to	TO	O	to	prepc_according_to	32	SENT_128	[p6l711t210r772b257],
35	Thervet	NNP	O	Thervet	pobj	32	SENT_128	[p6l794t202r1043b257],
36	et	FW	O	et	dep	35	SENT_128	[p6l1065t210r1125b257],
37	al.	FW	O	al.	nn	38	SENT_128	[p6l1148t202r1217b257],
38	[	FW	O	[	dep	36	SENT_128	[p6l1246t201r1388b270],
39	33	CD	NUMBER	33	num	40	SENT_128	[p6l1246t201r1388b270],
40	]	NN	O	]	dep	36	SENT_128	[p6l1246t201r1388b270],
41	.	.	O	.	_	0	SENT_128	[p6l1246t201r1388b270],

1	Ampliﬁcation	NN	O	ampliﬁcation	nsubj	2	SENT_129	[p6l1410t201r1851b270],
2	involved	VBD	O	involve	_	0	SENT_129	[p6l1875t202r2150b257],
3	35	CD	NUMBER	35	num	4	SENT_129	[p6l10t293r86b345],
4	cycles	NNS	O	cycle	dobj	2	SENT_129	[p6l119t290r309b359],
5	of	IN	O	of	_	0	SENT_129	[p6l340t290r407b345],
6	94	CD	NUMBER	94	number	7	SENT_129	[p6l429t293r506b345],
7	°	CD	NUMBER	°	num	8	SENT_129	[p6l529t293r594b345],
8	C	NN	O	c	prep_of	4	SENT_129	[p6l529t293r594b345],
9	for	IN	O	for	_	0	SENT_129	[p6l624t290r713b345],
10	1	CD	DURATION	1	num	11	SENT_129	[p6l744t293r768b345],
11	min	NN	DURATION	min	prep_for	8	SENT_129	[p6l799t291r939b354],
12	,	,	O	,	_	0	SENT_129	[p6l799t291r939b354],
13	60	CD	NUMBER	60	num	15	SENT_129	[p6l970t293r1046b345],
14	°	NN	O	°	nn	15	SENT_129	[p6l1070t293r1134b345],
15	C	NN	O	c	conj_and	4	SENT_129	[p6l1070t293r1134b345],
16	for	IN	O	for	_	0	SENT_129	[p6l1164t290r1253b345],
17	1	CD	DURATION	1	num	18	SENT_129	[p6l1284t293r1308b345],
18	min	NN	DURATION	min	prep_for	15	SENT_129	[p6l1339t291r1479b354],
19	,	,	O	,	_	0	SENT_129	[p6l1339t291r1479b354],
20	and	CC	O	and	_	0	SENT_129	[p6l1509t290r1625b345],
21	70	CD	NUMBER	70	num	23	SENT_129	[p6l1657t293r1733b345],
22	°	NN	O	°	nn	23	SENT_129	[p6l1756t293r1821b345],
23	C	NN	O	c	conj_and	4	SENT_129	[p6l1756t293r1821b345],
24	for	IN	O	for	_	0	SENT_129	[p6l1850t290r1940b345],
25	1	CD	DURATION	1	num	26	SENT_129	[p6l1970t293r1995b345],
26	min	NN	DURATION	min	prep_for	23	SENT_129	[p6l2026t291r2151b345],
27	followed	VBN	O	follow	partmod	26	SENT_129	[p6l11t380r291b435],
28	by	IN	O	by	_	0	SENT_129	[p6l323t380r401b448],
29	a	DT	O	a	det	31	SENT_129	[p6l431t396r464b435],
30	ﬁnal	JJ	O	ﬁnal	amod	31	SENT_129	[p6l497t380r635b435],
31	extension	NN	O	extension	agent	27	SENT_129	[p6l669t381r982b435],
32	at	IN	O	at	_	0	SENT_129	[p6l1013t388r1073b435],
33	72	CD	NUMBER	72	number	34	SENT_129	[p6l1106t383r1180b434],
34	‘’	CD	NUMBER	‘’	num	35	SENT_129	[p6l1206t383r1270b435],
35	C	NN	O	c	prep_at	31	SENT_129	[p6l1206t383r1270b435],
36	for	IN	O	for	_	0	SENT_129	[p6l1302t380r1392b435],
37	7	CD	DURATION	7	num	38	SENT_129	[p6l1423t383r1456b434],
38	min	NN	DURATION	min	prep_for	27	SENT_129	[p6l1481t381r1605b434],
39	using	VBG	O	use	partmod	38	SENT_129	[p6l1637t381r1811b448],
40	the	DT	O	the	det	44	SENT_129	[p6l1841t380r1943b435],
41	sense	NN	O	sense	nn	44	SENT_129	[p6l1976t396r2150b435],
42	primer	NN	O	primer	nn	44	SENT_129	[p6l11t470r232b537],
43	5	CD	NUMBER	5	num	44	SENT_129	[p6l258t471r1271b524],
44	’	NN	O	’	dobj	39	SENT_129	[p6l258t471r1271b524],
45	.	.	O	.	_	0	SENT_129	[p6l258t471r1271b524],

1	—	NN	O	—	_	0	SENT_130	[p6l258t471r1271b524],
2	.	.	O	.	_	0	SENT_130	[p6l258t471r1271b524],

1	CCTGCCTTCAATITI'TCACT	NN	O	cctgccttcaatiti'tcact	_	0	SENT_131	[p6l258t471r1271b524],
2	.	.	O	.	_	0	SENT_131	[p6l258t471r1271b524],

1	—	NN	O	—	_	0	SENT_132	[p6l258t471r1271b524],
2	.	.	O	.	_	0	SENT_132	[p6l258t471r1271b524],

1	3	CD	NUMBER	3	num	2	SENT_133	[p6l258t471r1271b524],
2	’	NN	O	’	_	0	SENT_133	[p6l258t471r1271b524],
3	and	CC	O	and	_	0	SENT_133	[p6l1300t469r1417b524],
4	the	DT	O	the	det	6	SENT_133	[p6l1444t469r1546b524],
5	anti	JJ	O	anti	amod	6	SENT_133	[p6l1573t470r1904b524],
6	—	NN	O	—	conj_and	2	SENT_133	[p6l1573t470r1904b524],
7	sense	NN	O	sense	nn	8	SENT_133	[p6l1573t470r1904b524],
8	primer	NN	O	primer	dep	2	SENT_133	[p6l1932t470r2153b537],
9	5	CD	NUMBER	5	num	10	SENT_133	[p6l12t559r1130b613],
10	’	NN	O	’	dep	8	SENT_133	[p6l12t559r1130b613],
11	.	.	O	.	_	0	SENT_133	[p6l12t559r1130b613],

1	—	NN	O	—	_	0	SENT_134	[p6l12t559r1130b613],
2	.	.	O	.	_	0	SENT_134	[p6l12t559r1130b613],

1	GGTCCAAACAGGGAAGAGGT	NNP	O	GGTCCAAACAGGGAAGAGGT	_	0	SENT_135	[p6l12t559r1130b613],
2	.	.	O	.	_	0	SENT_135	[p6l12t559r1130b613],

1	—	NN	O	—	_	0	SENT_136	[p6l12t559r1130b613],
2	.	.	O	.	_	0	SENT_136	[p6l12t559r1130b613],

1	3	CD	NUMBER	3	_	0	SENT_137	[p6l12t559r1130b613],
2	’	NN	O	’	dep	1	SENT_137	[p6l12t559r1130b613],
3	.	.	O	.	_	0	SENT_137	[p6l12t559r1130b613],

1	A	DT	O	a	det	2	SENT_138	[p6l1194t560r1241b612],
2	product	NN	O	product	nsubjpass	7	SENT_138	[p6l1303t557r1555b626],
3	of	IN	O	of	_	0	SENT_138	[p6l1619t557r1685b612],
4	196	CD	NUMBER	196	num	5	SENT_138	[p6l1745t560r1860b612],
5	bp	NN	O	bp	prep_of	2	SENT_138	[p6l1882t557r1961b626],
6	was	VBD	O	be	auxpass	7	SENT_138	[p6l2025t573r2149b612],
7	obtained	VBN	O	obtain	_	0	SENT_138	[p6l11t646r309b702],
8	.	.	O	.	_	0	SENT_138	[p6l11t646r309b702],

1	After	IN	O	after	_	0	SENT_139	[p6l336t646r498b701],
2	PCR	NN	O	pcr	nn	5	SENT_139	[p6l524t649r648b701],
3	and	CC	O	and	_	0	SENT_139	[p6l673t646r789b701],
4	restriction	NN	O	restriction	conj_and	2	SENT_139	[p6l818t647r1151b701],
5	digestion	NN	O	digestion	prep_after	70	SENT_139	[p6l1179t646r1475b715],
6	with	IN	O	with	_	0	SENT_139	[p6l1501t646r1649b701],
7	Rsa1	NN	O	rsa1	nn	9	SENT_139	[p6l1677t649r1816b701],
8	(	CD	NUMBER	(	num	9	SENT_139	[p6l1853t646r2150b714, p6l10t744r153b799],
9	Fermentase	NN	PERSON	fermentase	prep_with	5	SENT_139	[p6l1853t646r2150b714, p6l10t744r153b799],
10	,	,	O	,	_	0	SENT_139	[p6l1853t646r2150b714, p6l10t744r153b799],
11	Lithuania	NNP	LOCATION	Lithuania	nn	12	SENT_139	[p6l195t735r538b804],
12	)	NNP	O	)	nsubjpass	70	SENT_139	[p6l195t735r538b804],
13	,	,	O	,	_	0	SENT_139	[p6l195t735r538b804],
14	three	CD	NUMBER	three	num	15	SENT_139	[p6l578t735r746b790],
15	fragments	NNS	O	fragment	nn	22	SENT_139	[p6l787t735r1111b804],
16	of	IN	O	of	_	0	SENT_139	[p6l1153t735r1220b790],
17	103	CD	NUMBER	103	prep_of	22	SENT_139	[p6l1256t738r1386b799],
18	,	,	O	,	_	0	SENT_139	[p6l1256t738r1386b799],
19	73	CD	NUMBER	73	num	17	SENT_139	[p6l1429t738r1502b790],
20	and	CC	O	and	_	0	SENT_139	[p6l1545t735r1662b790],
21	20	CD	NUMBER	20	prep_of	22	SENT_139	[p6l1703t738r1780b790],
22	bp	NN	O	bp	appos	12	SENT_139	[p6l1801t735r1880b804],
23	for	IN	O	for	_	0	SENT_139	[p6l1921t735r2011b790],
24	the	DT	O	the	det	26	SENT_139	[p6l2048t735r2150b790],
25	CYP3A5	NN	O	cyp3a5	nn	26	SENT_139	[p6l12t827r247b879],
26	*	NN	O	*	prep_for	22	SENT_139	[p6l255t824r306b879],
27	1	CD	NUMBER	1	dep	22	SENT_139	[p6l255t824r306b879],
28	/	:	O	/	punct	31	SENT_139	[p6l318t824r337b893],
29	*	CD	NUMBER	*	number	30	SENT_139	[p6l347t824r398b879],
30	1	CD	NUMBER	1	num	31	SENT_139	[p6l347t824r398b879],
31	allele	NN	O	allele	dep	27	SENT_139	[p6l426t824r611b888],
32	,	,	O	,	_	0	SENT_139	[p6l426t824r611b888],
33	and	CC	O	and	_	0	SENT_139	[p6l632t824r749b879],
34	two	CD	NUMBER	two	num	35	SENT_139	[p6l770t833r892b879],
35	fragments	NNS	O	fragment	conj_and	31	SENT_139	[p6l914t824r1238b893],
36	of	IN	O	of	_	0	SENT_139	[p6l1259t824r1326b879],
37	103	CD	NUMBER	103	prep_of	35	SENT_139	[p6l1342t827r1473b888],
38	,	,	O	,	_	0	SENT_139	[p6l1342t827r1473b888],
39	93	CD	NUMBER	93	conj_and	31	SENT_139	[p6l1494t827r1569b879],
40	for	IN	O	for	prep	39	SENT_139	[p6l1593t824r1683b879],
41	the	DT	O	the	det	43	SENT_139	[p6l1700t824r1802b879],
42	CYP3A5	NN	O	cyp3a5	nn	43	SENT_139	[p6l1824t827r2059b879],
43	*	NN	O	*	dep	40	SENT_139	[p6l2067t824r2149b893],
44	3	CD	NUMBER	3	dep	43	SENT_139	[p6l2067t824r2149b893],
45	/	:	O	/	punct	43	SENT_139	[p6l2067t824r2149b893],
46	*	CD	NUMBER	*	number	47	SENT_139	[p6l15t914r72b969],
47	3	CD	NUMBER	3	dep	43	SENT_139	[p6l15t914r72b969],
48	allele	NN	O	allele	dep	47	SENT_139	[p6l99t914r269b969],
49	and	CC	O	and	_	0	SENT_139	[p6l295t914r411b969],
50	four	CD	NUMBER	four	num	51	SENT_139	[p6l438t914r570b969],
51	bonds	NNS	O	bond	dep	43	SENT_139	[p6l593t914r785b969],
52	of	IN	O	of	_	0	SENT_139	[p6l812t914r878b969],
53	103	CD	NUMBER	103	prep_of	51	SENT_139	[p6l900t917r1030b977],
54	,	,	O	,	_	0	SENT_139	[p6l900t917r1030b977],
55	93	CD	NUMBER	93	conj_and	31	SENT_139	[p6l1057t917r1151b977],
56	,	,	O	,	_	0	SENT_139	[p6l1057t917r1151b977],
57	73	CD	NUMBER	73	conj_and	31	SENT_139	[p6l1178t917r1270b977],
58	,	,	O	,	_	0	SENT_139	[p6l1178t917r1270b977],
59	and	CC	NUMBER	and	_	0	SENT_139	[p6l1297t914r1413b969],
60	20	CD	NUMBER	20	num	61	SENT_139	[p6l1440t917r1517b969],
61	bp	NN	O	bp	conj_and	31	SENT_139	[p6l1538t914r1617b982],
62	for	IN	O	for	_	0	SENT_139	[p6l1643t914r1732b969],
63	CYP3A5	NN	O	cyp3a5	nn	64	SENT_139	[p6l1757t914r2082b982],
64	*	NN	O	*	prep_for	61	SENT_139	[p6l1757t914r2082b982],
65	1	CD	NUMBER	1	num	64	SENT_139	[p6l1757t914r2082b982],
66	/	:	O	/	punct	31	SENT_139	[p6l1757t914r2082b982],
67	*	CD	NUMBER	*	number	68	SENT_139	[p6l2092t914r2149b969],
68	3	CD	NUMBER	3	num	27	SENT_139	[p6l2092t914r2149b969],
69	were	VBD	O	be	auxpass	70	SENT_139	[p6l9t1018r169b1057],
70	obtained	VBN	O	obtain	_	0	SENT_139	[p6l197t1003r495b1057],
71	.	.	O	.	_	0	SENT_139	[p6l197t1003r495b1057],

1	2.5.3	CD	NUMBER	2.5.3	_	0	SENT_140	[p6l7t1184r169b1236],
2	.	.	O	.	_	0	SENT_140	[p6l7t1184r169b1236],

1	CYP2C19	NN	O	cyp2c19	_	0	SENT_141	[p6l213t1184r485b1235],

1	For	IN	O	for	_	0	SENT_142	[p6l113t1273r215b1324],
2	the	DT	O	the	det	4	SENT_142	[p6l277t1269r379b1324],
3	CYP2C19	NN	O	cyp2c19	nn	4	SENT_142	[p6l445t1269r1182b1338],
4	*	NN	O	*	prep_for	30	SENT_142	[p6l445t1269r1182b1338],
5	2	CD	NUMBER	2	number	6	SENT_142	[p6l445t1269r1182b1338],
6	(	CD	NUMBER	(	num	8	SENT_142	[p6l445t1269r1182b1338],
7	rs4244285	NN	O	rs4244285	nn	8	SENT_142	[p6l445t1269r1182b1338],
8	)	NN	O	)	dep	4	SENT_142	[p6l445t1269r1182b1338],
9	,	,	O	,	_	0	SENT_142	[p6l445t1269r1182b1338],
10	and	CC	O	and	_	0	SENT_142	[p6l1247t1269r1363b1324],
11	CYP2C19	NN	O	cyp2c19	conj_and	4	SENT_142	[p6l1430t1269r1796b1338],
12	*	CD	NUMBER	*	number	13	SENT_142	[p6l1430t1269r1796b1338],
13	3	CD	NUMBER	3	num	14	SENT_142	[p6l1430t1269r1796b1338],
14	(	NN	O	(	dep	11	SENT_142	[p6l1430t1269r1796b1338],
15	134986893	CD	NUMBER	134986893	num	17	SENT_142	[p6l1800t1270r2150b1338],
16	)	NN	O	)	nn	17	SENT_142	[p6l1800t1270r2150b1338],
17	alleles	NNS	O	allele	dep	11	SENT_142	[p6l11t1358r228b1422],
18	,	,	O	,	_	0	SENT_142	[p6l11t1358r228b1422],
19	the	DT	O	the	det	20	SENT_142	[p6l269t1358r371b1413],
20	protocol	NN	O	protocol	nsubjpass	30	SENT_142	[p6l412t1358r678b1427],
21	described	VBN	O	describe	partmod	20	SENT_142	[p6l720t1358r1029b1413],
22	by	IN	O	by	_	0	SENT_142	[p6l1070t1358r1147b1427],
23	Lamba	NNP	PERSON	Lamba	agent	21	SENT_142	[p6l1187t1358r1398b1413],
24	et	FW	O	et	nn	26	SENT_142	[p6l1439t1367r1498b1413],
25	al.	FW	O	al.	nn	26	SENT_142	[p6l1538t1358r1607b1414],
26	[	FW	O	[	dobj	21	SENT_142	[p6l1653t1358r1775b1427],
27	34	CD	NUMBER	34	num	28	SENT_142	[p6l1653t1358r1775b1427],
28	]	NN	O	]	dep	20	SENT_142	[p6l1653t1358r1775b1427],
29	was	VBD	O	be	auxpass	30	SENT_142	[p6l1818t1374r1943b1413],
30	used	VBN	O	use	_	0	SENT_142	[p6l1985t1358r2149b1414],
31	.	.	O	.	_	0	SENT_142	[p6l1985t1358r2149b1414],

1	The	DT	O	the	det	3	SENT_143	[p6l8t1448r125b1503],
2	forward	JJ	O	forward	amod	3	SENT_143	[p6l161t1448r415b1503],
3	primer	NN	O	primer	_	0	SENT_143	[p6l450t1449r670b1516],
4	of	IN	O	of	_	0	SENT_143	[p6l702t1448r769b1503],
5	5	CD	NUMBER	5	num	6	SENT_143	[p6l796t1450r1861b1503],
6	’	NN	O	’	prep_of	3	SENT_143	[p6l796t1450r1861b1503],
7	.	.	O	.	_	0	SENT_143	[p6l796t1450r1861b1503],

1	—	NN	O	—	_	0	SENT_144	[p6l796t1450r1861b1503],
2	.	.	O	.	_	0	SENT_144	[p6l796t1450r1861b1503],

1	AATTACAACCAGAGCTTGGC	NNP	O	AATTACAACCAGAGCTTGGC	_	0	SENT_145	[p6l796t1450r1861b1503],
2	.	.	O	.	_	0	SENT_145	[p6l796t1450r1861b1503],

1	—	NN	O	—	_	0	SENT_146	[p6l796t1450r1861b1503],
2	.	.	O	.	_	0	SENT_146	[p6l796t1450r1861b1503],

1	3	CD	NUMBER	3	_	0	SENT_147	[p6l796t1450r1861b1503],
2	’	NN	O	’	dep	1	SENT_147	[p6l796t1450r1861b1503],
3	and	CC	O	and	_	0	SENT_147	[p6l1898t1448r2014b1503],
4	the	DT	O	the	det	6	SENT_147	[p6l2048t1448r2150b1503],
5	reverse	JJ	O	reverse	amod	6	SENT_147	[p6l11t1553r244b1592],
6	primer	NN	O	primer	dep	1	SENT_147	[p6l281t1538r501b1605],
7	of	IN	O	of	_	0	SENT_147	[p6l535t1537r602b1592],
8	5	CD	NUMBER	5	num	9	SENT_147	[p6l632t1539r1768b1592],
9	’	NN	O	’	prep_of	1	SENT_147	[p6l632t1539r1768b1592],
10	.	.	O	.	_	0	SENT_147	[p6l632t1539r1768b1592],

1	—	NN	O	—	_	0	SENT_148	[p6l632t1539r1768b1592],
2	.	.	O	.	_	0	SENT_148	[p6l632t1539r1768b1592],

1	TATCACTITCCATAAAAGCAAG	NN	O	tatcactitccataaaagcaag	_	0	SENT_149	[p6l632t1539r1768b1592],
2	.	.	O	.	_	0	SENT_149	[p6l632t1539r1768b1592],

1	—	NN	O	—	_	0	SENT_150	[p6l632t1539r1768b1592],
2	.	.	O	.	_	0	SENT_150	[p6l632t1539r1768b1592],

1	3	CD	NUMBER	3	num	2	SENT_151	[p6l632t1539r1768b1592],
2	’	NN	O	’	nsubjpass	4	SENT_151	[p6l632t1539r1768b1592],
3	were	VBD	O	be	auxpass	4	SENT_151	[p6l1805t1553r1965b1592],
4	used	VBN	O	use	_	0	SENT_151	[p6l2002t1537r2150b1592],
5	for	IN	O	for	_	0	SENT_151	[p6l11t1625r100b1680],
6	the	DT	O	the	det	7	SENT_151	[p6l151t1625r252b1680],
7	ampliﬁcation	NN	O	ampliﬁcation	prep_for	4	SENT_151	[p6l306t1625r734b1694],
8	of	IN	O	of	_	0	SENT_151	[p6l786t1625r852b1680],
9	the	DT	O	the	det	13	SENT_151	[p6l897t1625r999b1680],
10	CYP2C19	NN	O	cyp2c19	nn	13	SENT_151	[p6l1053t1625r1392b1680],
11	*	NN	O	*	nn	13	SENT_151	[p6l1053t1625r1392b1680],
12	2	CD	NUMBER	2	num	13	SENT_151	[p6l1053t1625r1392b1680],
13	allele	NN	O	allele	prep_of	7	SENT_151	[p6l1445t1625r1630b1681],
14	.	.	O	.	_	0	SENT_151	[p6l1445t1625r1630b1681],

1	The	DT	O	the	det	2	SENT_152	[p6l1681t1625r1799b1680],
2	PCR	NN	MISC	pcr	nsubjpass	4	SENT_152	[p6l1852t1628r1976b1680],
3	was	VBD	O	be	auxpass	4	SENT_152	[p6l2025t1641r2149b1680],
4	performed	VBN	O	perform	_	0	SENT_152	[p6l11t1714r350b1783],
5	with	IN	O	with	_	0	SENT_152	[p6l369t1714r517b1769],
6	an	DT	O	a	det	8	SENT_152	[p6l537t1730r612b1769],
7	initial	JJ	O	initial	amod	8	SENT_152	[p6l633t1714r818b1769],
8	denaturation	NN	O	denaturation	prep_with	4	SENT_152	[p6l839t1714r1258b1769],
9	at	IN	O	at	_	0	SENT_152	[p6l1278t1722r1338b1769],
10	94	CD	NUMBER	94	number	11	SENT_152	[p6l1357t1717r1435b1769],
11	°	CD	NUMBER	°	num	12	SENT_152	[p6l1458t1717r1523b1769],
12	C	NN	O	c	prep_at	4	SENT_152	[p6l1458t1717r1523b1769],
13	for	IN	O	for	_	0	SENT_152	[p6l1543t1714r1633b1769],
14	5	CD	DURATION	5	num	15	SENT_152	[p6l1652t1717r1684b1769],
15	min	NN	DURATION	min	prep_for	12	SENT_152	[p6l1709t1715r1849b1777],
16	,	,	O	,	_	0	SENT_152	[p6l1709t1715r1849b1777],
17	followed	VBN	O	follow	partmod	12	SENT_152	[p6l1871t1714r2150b1769],
18	by	IN	O	by	_	0	SENT_152	[p6l10t1803r88b1872],
19	35	CD	NUMBER	35	num	20	SENT_152	[p6l109t1806r186b1858],
20	cycles	NNS	O	cycle	agent	17	SENT_152	[p6l214t1803r404b1872],
21	of	IN	O	of	_	0	SENT_152	[p6l429t1803r496b1858],
22	denaturation	NN	O	denaturation	prep_of	20	SENT_152	[p6l512t1803r932b1858],
23	at	IN	O	at	_	0	SENT_152	[p6l956t1812r1015b1858],
24	94	CD	NUMBER	94	number	25	SENT_152	[p6l1039t1806r1117b1858],
25	°	CD	NUMBER	°	num	26	SENT_152	[p6l1139t1806r1204b1858],
26	C	NN	O	c	prep_at	17	SENT_152	[p6l1139t1806r1204b1858],
27	for	IN	O	for	_	0	SENT_152	[p6l1228t1803r1317b1858],
28	1	CD	DURATION	1	num	29	SENT_152	[p6l1343t1806r1367b1858],
29	min	NN	DURATION	min	prep_for	26	SENT_152	[p6l1398t1804r1538b1867],
30	,	,	O	,	_	0	SENT_152	[p6l1398t1804r1538b1867],
31	annealing	NN	O	annealing	prep_at	17	SENT_152	[p6l1563t1803r1880b1872],
32	at	IN	O	at	_	0	SENT_152	[p6l1902t1812r1963b1858],
33	57	CD	NUMBER	57	number	34	SENT_152	[p6l1986t1807r2061b1858],
34	°	CD	NUMBER	°	num	35	SENT_152	[p6l2086t1806r2151b1858],
35	C	NN	O	c	prep_at	31	SENT_152	[p6l2086t1806r2151b1858],
36	for	IN	O	for	_	0	SENT_152	[p6l11t1892r100b1947],
37	30	CD	NUMBER	30	num	38	SENT_152	[p6l121t1895r199b1947],
38	s	NNS	O	s	prep_for	35	SENT_152	[p6l222t1908r263b1956],
39	,	,	O	,	_	0	SENT_152	[p6l222t1908r263b1956],
40	elongation	NN	O	elongation	prep_at	17	SENT_152	[p6l289t1892r631b1961],
41	at	IN	O	at	_	0	SENT_152	[p6l654t1901r714b1947],
42	72	CD	NUMBER	72	number	43	SENT_152	[p6l738t1895r812b1947],
43	°	CD	NUMBER	°	num	44	SENT_152	[p6l838t1895r903b1947],
44	C	NN	O	c	prep_at	40	SENT_152	[p6l838t1895r903b1947],
45	for	IN	O	for	_	0	SENT_152	[p6l926t1892r1016b1947],
46	30	CD	NUMBER	30	num	47	SENT_152	[p6l1037t1895r1115b1947],
47	s	NNS	O	s	prep_for	44	SENT_152	[p6l1137t1908r1179b1956],
48	,	,	O	,	_	0	SENT_152	[p6l1137t1908r1179b1956],
49	and	CC	O	and	_	0	SENT_152	[p6l1204t1892r1320b1947],
50	a	DT	O	a	det	52	SENT_152	[p6l1345t1908r1377b1947],
51	ﬁnal	JJ	O	ﬁnal	amod	52	SENT_152	[p6l1402t1892r1541b1947],
52	extension	NN	O	extension	prep_at	17	SENT_152	[p6l1566t1893r1879b1947],
53	at	IN	O	at	_	0	SENT_152	[p6l1902t1901r1962b1947],
54	72	CD	NUMBER	72	number	55	SENT_152	[p6l1987t1895r2061b1947],
55	°	CD	NUMBER	°	num	56	SENT_152	[p6l2086t1895r2151b1947],
56	C	NN	O	c	prep_at	52	SENT_152	[p6l2086t1895r2151b1947],
57	for	IN	O	for	_	0	SENT_152	[p6l11t1982r100b2037],
58	5	CD	DURATION	5	num	59	SENT_152	[p6l137t1985r170b2037],
59	min	NN	DURATION	min	prep_for	56	SENT_152	[p6l195t1983r335b2037],
60	.	.	O	.	_	0	SENT_152	[p6l195t1983r335b2037],

1	The	DT	O	the	det	3	SENT_153	[p6l371t1982r489b2037],
2	ampliﬁed	JJ	O	ampliﬁed	amod	3	SENT_153	[p6l526t1982r831b2050],
3	products	NNS	O	product	nsubj	4	SENT_153	[p6l870t1982r1151b2050],
4	(	VBP	O	(	dep	9	SENT_153	[p6l1190t1982r1335b2050],
5	169	CD	NUMBER	169	num	7	SENT_153	[p6l1190t1982r1335b2050],
6	bp	NN	O	bp	nn	7	SENT_153	[p6l1357t1982r1461b2050],
7	)	NN	O	)	dobj	4	SENT_153	[p6l1357t1982r1461b2050],
8	were	VBD	O	be	auxpass	9	SENT_153	[p6l1498t1998r1658b2037],
9	digested	VBN	O	digest	_	0	SENT_153	[p6l1696t1982r1966b2050],
10	with	IN	O	with	_	0	SENT_153	[p6l2002t1982r2151b2037],
11	Mspl	NN	O	mspl	prep_with	9	SENT_153	[p6l11t2074r167b2139],
12	(	CD	NUMBER	(	num	13	SENT_153	[p6l196t2071r612b2139],
13	Fermentase	NN	O	fermentase	nsubjpass	9	SENT_153	[p6l196t2071r612b2139],
14	,	,	O	,	_	0	SENT_153	[p6l196t2071r612b2139],
15	Lithuania	NNP	LOCATION	Lithuania	nn	16	SENT_153	[p6l642t2071r984b2139],
16	)	NNP	O	)	appos	13	SENT_153	[p6l642t2071r984b2139],
17	,	,	O	,	_	0	SENT_153	[p6l642t2071r984b2139],
18	restriction	NN	O	restriction	nn	19	SENT_153	[p6l1014t2072r1347b2126],
19	enzyme	NN	O	enzyme	appos	16	SENT_153	[p6l1375t2087r1642b2139],
20	.	.	O	.	_	0	SENT_153	[p6l1375t2087r1642b2139],

1	For	IN	O	for	_	0	SENT_154	[p6l113t2163r215b2214],
2	the	DT	O	the	det	6	SENT_154	[p6l271t2159r373b2214],
3	CYP2C19	NN	O	cyp2c19	nn	6	SENT_154	[p6l433t2159r771b2214],
4	*	NN	O	*	nn	6	SENT_154	[p6l433t2159r771b2214],
5	3	CD	NUMBER	3	num	6	SENT_154	[p6l433t2159r771b2214],
6	variant	NN	O	variant	prep_for	17	SENT_154	[p6l829t2160r1073b2223],
7	,	,	O	,	_	0	SENT_154	[p6l829t2160r1073b2223],
8	the	DT	O	the	det	10	SENT_154	[p6l1132t2159r1234b2214],
9	forward	JJ	O	forward	amod	10	SENT_154	[p6l1293t2159r1547b2214],
10	primer	NN	O	primer	nsubj	17	SENT_154	[p6l1607t2160r1827b2228],
11	was	VBD	O	be	cop	17	SENT_154	[p6l1882t2175r2007b2214],
12	5	CD	NUMBER	5	number	13	SENT_154	[p6l2068t2161r2150b2214, p6l8t2250r1045b2303],
13	’	CD	NUMBER	’	num	17	SENT_154	[p6l2068t2161r2150b2214, p6l8t2250r1045b2303],
14	AAATTGTITCCAACATTTAGCT	NNP	O	AAATTGTITCCAACATTTAGCT	nn	17	SENT_154	[p6l2068t2161r2150b2214, p6l8t2250r1045b2303],
15	—	CD	NUMBER	—	num	17	SENT_154	[p6l2068t2161r2150b2214, p6l8t2250r1045b2303],
16	3	CD	NUMBER	3	amod	17	SENT_154	[p6l2068t2161r2150b2214, p6l8t2250r1045b2303],
17	’	NN	O	’	dep	25	SENT_154	[p6l2068t2161r2150b2214, p6l8t2250r1045b2303],
18	and	CC	O	and	_	0	SENT_154	[p6l1085t2248r1201b2303],
19	the	DT	O	the	det	21	SENT_154	[p6l1239t2248r1341b2303],
20	reverse	JJ	O	reverse	amod	21	SENT_154	[p6l1379t2264r1612b2303],
21	primer	NN	O	primer	dep	25	SENT_154	[p6l1650t2249r1870b2317],
22	was	VBD	O	be	cop	25	SENT_154	[p6l1904t2264r2028b2303],
23	5	CD	NUMBER	5	number	24	SENT_154	[p6l2068t2250r2150b2303, p6l8t2340r1001b2392],
24	’	CD	NUMBER	’	num	25	SENT_154	[p6l2068t2250r2150b2303, p6l8t2340r1001b2392],
25	ACTTCAGGGCTTGGTCAATA	NN	O	acttcagggcttggtcaa	_	0	SENT_154	[p6l2068t2250r2150b2303, p6l8t2340r1001b2392],
26	—	CD	NUMBER	—	tmod	25	SENT_154	[p6l2068t2250r2150b2303, p6l8t2340r1001b2392],
27	3	CD	NUMBER	3	num	28	SENT_154	[p6l2068t2250r2150b2303, p6l8t2340r1001b2392],
28	’	NN	O	’	nsubj	25	SENT_154	[p6l2068t2250r2150b2303, p6l8t2340r1001b2392],
29	.	.	O	.	_	0	SENT_154	[p6l2068t2250r2150b2303, p6l8t2340r1001b2392],

1	The	DT	O	the	det	3	SENT_155	[p6l1035t2337r1152b2391],
2	reaction	NN	O	reaction	nn	3	SENT_155	[p6l1187t2338r1449b2392],
3	conditions	NNS	O	condition	nsubj	6	SENT_155	[p6l1484t2337r1820b2392],
4	were	VBD	O	be	cop	6	SENT_155	[p6l1855t2353r2014b2392],
5	the	DT	O	the	det	6	SENT_155	[p6l2048t2337r2150b2392],
6	same	JJ	O	same	_	0	SENT_155	[p6l12t2441r177b2480],
7	as	IN	O	as	_	0	SENT_155	[p6l215t2441r278b2480],
8	those	DT	O	those	prep_as	6	SENT_155	[p6l317t2425r490b2480],
9	for	IN	O	for	_	0	SENT_155	[p6l529t2425r618b2480],
10	the	DT	O	the	det	12	SENT_155	[p6l654t2425r756b2480],
11	other	JJ	O	other	amod	12	SENT_155	[p6l794t2425r966b2480],
12	alleles	NNS	O	allele	prep_for	8	SENT_155	[p6l1002t2425r1219b2489],
13	,	,	O	,	_	0	SENT_155	[p6l1002t2425r1219b2489],
14	except	IN	O	except	mark	18	SENT_155	[p6l1258t2434r1470b2494],
15	that	DT	O	that	det	16	SENT_155	[p6l1506t2425r1636b2480],
16	annealing	NN	O	annealing	nsubjpass	18	SENT_155	[p6l1673t2425r1989b2494],
17	was	VBD	O	be	auxpass	18	SENT_155	[p6l2025t2441r2149b2480],
18	performed	VBN	O	perform	advcl	6	SENT_155	[p6l11t2515r350b2583],
19	at	IN	O	at	_	0	SENT_155	[p6l384t2523r444b2570],
20	55	CD	NUMBER	55	number	21	SENT_155	[p6l477t2518r551b2570],
21	°	CD	NUMBER	°	num	22	SENT_155	[p6l577t2518r642b2570],
22	C	NN	O	c	prep_at	18	SENT_155	[p6l577t2518r642b2570],
23	and	CC	O	and	_	0	SENT_155	[p6l675t2515r791b2570],
24	the	DT	O	the	det	27	SENT_155	[p6l825t2515r926b2570],
25	271	CD	NUMBER	271	num	27	SENT_155	[p6l960t2518r1071b2569],
26	bp	NN	O	bp	nn	27	SENT_155	[p6l1101t2515r1180b2583],
27	fragment	NN	O	fragment	nsubjpass	29	SENT_155	[p6l1214t2515r1509b2583],
28	was	VBD	O	be	auxpass	29	SENT_155	[p6l1540t2531r1664b2570],
29	digested	VBN	O	digest	conj_and	6	SENT_155	[p6l1700t2515r1970b2583],
30	with	IN	O	with	_	0	SENT_155	[p6l2002t2515r2151b2570],
31	BamHI	NN	O	bamhus	nn	33	SENT_155	[p6l11t2607r225b2659],
32	(	CD	NUMBER	(	num	33	SENT_155	[p6l254t2604r670b2672],
33	Fermentase	NN	O	fermentase	prep_with	29	SENT_155	[p6l254t2604r670b2672],
34	,	,	O	,	_	0	SENT_155	[p6l254t2604r670b2672],
35	Lithuania	NNP	LOCATION	Lithuania	appos	33	SENT_155	[p6l700t2604r1042b2672],
36	)	CD	NUMBER	)	num	35	SENT_155	[p6l700t2604r1042b2672],
37	.	.	O	.	_	0	SENT_155	[p6l700t2604r1042b2672],

1	Samples	NNS	O	sample	nsubjpass	14	SENT_156	[p6l113t2692r378b2761],
2	from	IN	O	from	_	0	SENT_156	[p6l419t2692r572b2747],
3	each	DT	O	each	det	8	SENT_156	[p6l611t2692r757b2747],
4	genotype	NN	O	genotype	nn	8	SENT_156	[p6l795t2700r1093b2761],
5	(	NN	O	(	nn	8	SENT_156	[p6l1132t2692r1409b2760],
6	CYP3A5	NN	O	cyp3a5	nn	8	SENT_156	[p6l1132t2692r1409b2760],
7	,	,	O	,	_	0	SENT_156	[p6l1132t2692r1409b2760],
8	CYP2C19	NN	O	cyp2c19	prep_from	1	SENT_156	[p6l1450t2695r1737b2756],
9	,	,	O	,	_	0	SENT_156	[p6l1450t2695r1737b2756],
10	and	CC	O	and	_	0	SENT_156	[p6l1777t2692r1894b2747],
11	P2Y12	NN	O	p2y12	nn	12	SENT_156	[p6l1931t2692r2150b2760],
12	)	NN	O	)	prep_from	1	SENT_156	[p6l1931t2692r2150b2760],
13	were	VBD	O	be	auxpass	14	SENT_156	[p6l9t2797r169b2836],
14	selected	VBN	O	select	_	0	SENT_156	[p6l193t2781r453b2836],
15	randomly	RB	O	randomly	advmod	14	SENT_156	[p6l476t2781r788b2850],
16	and	CC	O	and	_	0	SENT_156	[p6l810t2781r926b2836],
17	submitted	VBN	O	submit	conj_and	14	SENT_156	[p6l950t2781r1279b2836],
18	for	IN	O	for	_	0	SENT_156	[p6l1302t2781r1392b2836],
19	direct	JJ	O	direct	amod	21	SENT_156	[p6l1412t2781r1598b2836],
20	DNA	NN	O	dna	nn	21	SENT_156	[p6l1620t2783r1767b2836],
21	sequencing	NN	O	sequencing	prep_for	17	SENT_156	[p6l1788t2782r2152b2850],
22	which	WDT	O	which	nsubj	23	SENT_156	[p6l9t2870r208b2924],
23	conﬁrmed	VBD	O	conﬁrmed	rcmod	21	SENT_156	[p6l235t2870r564b2925],
24	our	PRP$	O	we	poss	25	SENT_156	[p6l593t2886r702b2925],
25	results	NNS	O	result	dobj	23	SENT_156	[p6l728t2870r958b2925],
26	.	.	O	.	_	0	SENT_156	[p6l728t2870r958b2925],

1	2.6	CD	NUMBER	2.6	_	0	SENT_157	[p6l7t3052r114b3104],
2	.	.	O	.	_	0	SENT_157	[p6l7t3052r114b3104],

1	Statistical	JJ	O	statistical	amod	2	SENT_158	[p6l154t3049r458b3104],
2	analysis	NN	O	analysis	_	0	SENT_158	[p6l484t3049r729b3117],

1	Continuous	JJ	O	continuous	amod	2	SENT_159	[p6l113t3228r480b3282],
2	variables	NNS	O	variable	nsubjpass	4	SENT_159	[p6l511t3227r800b3282],
3	are	VBP	O	be	auxpass	4	SENT_159	[p6l834t3243r931b3282],
4	presented	VBN	O	present	_	0	SENT_159	[p6l964t3227r1282b3296],
5	as	IN	O	as	_	0	SENT_159	[p6l1315t3243r1378b3282],
6	mean	NN	O	mean	prep_as	4	SENT_159	[p6l1412t3243r1589b3282],
7	1	CD	NUMBER	1	num	6	SENT_159	[p6l1611t3235r1657b3282],
8	:	:	O	:	_	0	SENT_159	[p6l1611t3235r1657b3282],
9	SD	NN	O	sd	dep	6	SENT_159	[p6l1679t3230r1774b3283],
10	.	.	O	.	_	0	SENT_159	[p6l1679t3230r1774b3283],

1	Categorical	JJ	O	categorical	amod	2	SENT_160	[p6l1806t3227r2150b3296],
2	variables	NNS	O	variable	nsubjpass	4	SENT_160	[p6l9t3317r287b3372],
3	are	VBP	O	be	auxpass	4	SENT_160	[p6l327t3332r421b3372],
4	reported	VBN	O	report	_	0	SENT_160	[p6l462t3317r727b3385],
5	as	IN	O	as	_	0	SENT_160	[p6l767t3332r827b3372],
6	counts	NNS	O	count	prep_as	4	SENT_160	[p6l869t3325r1072b3372],
7	(	CD	NUMBER	(	num	9	SENT_160	[p6l1112t3317r1518b3385],
8	percentage	NN	O	percentage	nn	9	SENT_160	[p6l1112t3317r1518b3385],
9	)	NN	O	)	dep	6	SENT_160	[p6l1112t3317r1518b3385],
10	.	.	O	.	_	0	SENT_160	[p6l1112t3317r1518b3385],

1	The	DT	O	the	det	2	SENT_161	[p6l1556t3317r1669b3372],
2	patients	NNS	O	patient	nsubjpass	4	SENT_161	[p6l1710t3317r1958b3385],
3	were	VBD	O	be	auxpass	4	SENT_161	[p6l1997t3332r2151b3372],
4	divided	VBN	O	divide	_	0	SENT_161	[p6l11t3405r240b3460],
5	into	IN	O	into	_	0	SENT_161	[p6l261t3406r381b3460],
6	non	JJ	O	non	amod	8	SENT_161	[p6l401t3405r905b3474],
7	—	NN	O	—	nn	8	SENT_161	[p6l401t3405r905b3474],
8	responders	NNS	O	responder	prep_into	4	SENT_161	[p6l401t3405r905b3474],
9	,	,	O	,	_	0	SENT_161	[p6l401t3405r905b3474],
10	semi	JJ	O	semi	amod	12	SENT_161	[p6l927t3405r1444b3474],
11	—	NN	O	—	nn	12	SENT_161	[p6l927t3405r1444b3474],
12	responders	NNS	O	responder	prep_into	4	SENT_161	[p6l927t3405r1444b3474],
13	and	CC	O	and	_	0	SENT_161	[p6l1465t3405r1576b3460],
14	responders	NNS	O	responder	prep_into	4	SENT_161	[p6l1597t3405r1938b3474],
15	on	IN	O	on	_	0	SENT_161	[p6l1959t3421r2034b3460],
16	the	DT	O	the	det	17	SENT_161	[p6l2052t3405r2150b3460],
17	basis	NN	O	basis	prep_on	4	SENT_161	[p6l10t3495r162b3550],
18	of	IN	O	of	_	0	SENT_161	[p6l181t3495r245b3550],
19	the	DT	O	the	det	22	SENT_161	[p6l256t3495r354b3550],
20	relative	JJ	O	relative	amod	22	SENT_161	[p6l374t3495r606b3550],
21	platelet	NN	O	platelet	nn	22	SENT_161	[p6l625t3495r860b3563],
22	inhibition	NN	O	inhibition	prep_of	17	SENT_161	[p6l877t3495r1181b3550],
23	(	CD	NUMBER	(	num	25	SENT_161	[p6l1200t3495r1323b3563],
24	RI	NN	O	rus	nn	25	SENT_161	[p6l1200t3495r1323b3563],
25	)	NN	O	)	dep	22	SENT_161	[p6l1200t3495r1323b3563],
26	.	.	O	.	_	0	SENT_161	[p6l1200t3495r1323b3563],

1	The	DT	O	the	det	2	SENT_162	[p6l1340t3495r1453b3550],
2	Kolmogorov	NNP	O	Kolmogorov	_	0	SENT_162	[p6l1472t3495r2152b3563],
3	.	.	O	.	_	0	SENT_162	[p6l1472t3495r2152b3563],

1	—	NN	O	—	_	0	SENT_163	[p6l1472t3495r2152b3563],
2	.	.	O	.	_	0	SENT_163	[p6l1472t3495r2152b3563],

1	Smirnov	NNP	PERSON	Smirnov	nn	2	SENT_164	[p6l1472t3495r2152b3563],
2	test	NN	O	test	nsubjpass	4	SENT_164	[p7l10t25r124b72],
3	was	VBD	O	be	auxpass	4	SENT_164	[p7l148t33r268b72],
4	used	VBN	O	use	_	0	SENT_164	[p7l297t17r439b72],
5	to	TO	O	to	aux	6	SENT_164	[p7l466t25r526b72],
6	assess	VB	O	assess	xcomp	4	SENT_164	[p7l552t33r739b72],
7	conformity	NN	O	conformity	dobj	6	SENT_164	[p7l767t17r1112b85],
8	with	IN	O	with	_	0	SENT_164	[p7l1135t17r1278b72],
9	a	DT	O	a	det	11	SENT_164	[p7l1304t33r1335b72],
10	normal	JJ	O	normal	amod	11	SENT_164	[p7l1363t17r1583b72],
11	distribution	NN	O	distribution	prep_with	6	SENT_164	[p7l1611t17r1991b72],
12	.	.	O	.	_	0	SENT_164	[p7l1611t17r1991b72],

1	Comparisons	NNS	O	comparison	nsubjpass	3	SENT_165	[p7l113t106r525b174],
2	were	VBD	O	be	auxpass	3	SENT_165	[p7l568t121r727b160],
3	made	VBN	O	make	_	0	SENT_165	[p7l771t105r945b160],
4	between	IN	O	between	_	0	SENT_165	[p7l989t105r1264b160],
5	continuous	JJ	O	continuous	amod	6	SENT_165	[p7l1307t106r1661b160],
6	variables	NNS	O	variable	prep_between	3	SENT_165	[p7l1704t105r1989b160],
7	and	CC	O	and	_	0	SENT_165	[p7l2035t105r2150b160],
8	groups	NNS	O	group	prep_between	3	SENT_165	[p7l10t210r225b263],
9	by	IN	O	by	_	0	SENT_165	[p7l252t194r330b263],
10	one	CD	NUMBER	one	num	12	SENT_165	[p7l354t210r467b249],
11	way	NN	O	way	nn	12	SENT_165	[p7l492t210r625b263],
12	ANOVA	NNP	ORGANIZATION	ANOVA	agent	3	SENT_165	[p7l648t196r902b250],
13	.	.	O	.	_	0	SENT_165	[p7l648t196r902b250],

1	Pearson	NNP	PERSON	Pearson	nn	2	SENT_166	[p7l929t198r1179b249],
2	Chi	NNP	PERSON	Chi	_	0	SENT_166	[p7l1204t194r1553b263],
3	.	.	O	.	_	0	SENT_166	[p7l1204t194r1553b263],

1	—	NN	O	—	_	0	SENT_167	[p7l1204t194r1553b263],
2	.	.	O	.	_	0	SENT_167	[p7l1204t194r1553b263],

1	Square	NN	O	square	nsubjpass	8	SENT_168	[p7l1204t194r1553b263],
2	and	CC	O	and	_	0	SENT_168	[p7l1579t194r1694b249],
3	Fisher	NNP	PERSON	Fisher	poss	6	SENT_168	[p7l1721t194r1957b249],
4	’s	POS	O	’s	_	0	SENT_168	[p7l1721t194r1957b249],
5	exact	JJ	O	exact	amod	6	SENT_168	[p7l1984t202r2152b249],
6	tests	NNS	O	test	conj_and	1	SENT_168	[p7l10t292r157b339],
7	were	VBD	O	be	auxpass	8	SENT_168	[p7l185t299r343b339],
8	utilized	VBN	O	utilize	_	0	SENT_168	[p7l373t284r611b339],
9	for	IN	O	for	_	0	SENT_168	[p7l641t283r731b339],
10	comparisons	NNS	O	comparison	prep_for	8	SENT_168	[p7l757t284r1159b352],
11	between	IN	O	between	_	0	SENT_168	[p7l1189t283r1464b339],
12	categorical	JJ	O	categorical	amod	13	SENT_168	[p7l1493t284r1836b352],
13	variables	NNS	O	variable	prep_between	10	SENT_168	[p7l1864t284r2149b339],
14	and	CC	O	and	_	0	SENT_168	[p7l11t372r126b427],
15	the	DT	O	the	det	16	SENT_168	[p7l142t372r243b427],
16	groups	NNS	O	group	conj_and	13	SENT_168	[p7l258t388r489b441],
17	.	.	O	.	_	0	SENT_168	[p7l258t388r489b441],

1	The	DT	O	the	det	4	SENT_169	[p7l504t372r620b427],
2	t	NN	O	t	nn	4	SENT_169	[p7l636t381r807b427],
3	—	CD	NUMBER	—	num	4	SENT_169	[p7l636t381r807b427],
4	test	NN	O	test	nsubjpass	6	SENT_169	[p7l636t381r807b427],
5	was	VBD	O	be	auxpass	6	SENT_169	[p7l820t388r944b427],
6	used	VBN	O	use	_	0	SENT_169	[p7l961t372r1107b427],
7	to	TO	O	to	aux	8	SENT_169	[p7l1123t381r1185b427],
8	compare	VB	O	compare	xcomp	6	SENT_169	[p7l1201t388r1476b441],
9	the	DT	O	the	det	10	SENT_169	[p7l1492t372r1592b427],
10	degree	NN	O	degree	dobj	8	SENT_169	[p7l1608t372r1820b441],
11	of	IN	O	of	_	0	SENT_169	[p7l1836t372r1903b427],
12	platelet	NN	O	platelet	nn	13	SENT_169	[p7l1911t372r2152b441],
13	inhibition	NN	O	inhibition	prep_of	10	SENT_169	[p7l11t462r323b517],
14	between	IN	O	between	_	0	SENT_169	[p7l348t462r622b517],
15	the	DT	O	the	det	16	SENT_169	[p7l647t462r748b517],
16	expressor	NN	O	expressor	prep_between	13	SENT_169	[p7l774t478r1083b530],
17	and	CC	O	and	_	0	SENT_169	[p7l1105t462r1221b517],
18	the	DT	O	the	det	23	SENT_169	[p7l1247t462r1347b517],
19	non	JJ	O	non	amod	23	SENT_169	[p7l1373t478r1833b530],
20	—	NN	O	—	nn	23	SENT_169	[p7l1373t478r1833b530],
21	expressor	NN	O	expressor	nn	23	SENT_169	[p7l1373t478r1833b530],
22	genotype	NN	O	genotype	nn	23	SENT_169	[p7l1856t470r2150b530],
23	groups	NNS	O	group	prep_between	13	SENT_169	[p7l10t567r242b619],
24	.	.	O	.	_	0	SENT_169	[p7l10t567r242b619],

1	The	DT	O	the	det	2	SENT_170	[p7l266t551r382b606],
2	association	NN	O	association	nsubjpass	13	SENT_170	[p7l408t552r761b606],
3	between	IN	O	between	_	0	SENT_170	[p7l787t551r1061b606],
4	length	NN	O	length	prep_between	2	SENT_170	[p7l1087t551r1288b619],
5	and	CC	O	and	_	0	SENT_170	[p7l1313t551r1429b606],
6	diameter	NN	O	diameter	conj_and	4	SENT_170	[p7l1455t551r1743b606],
7	of	IN	O	of	_	0	SENT_170	[p7l1767t551r1833b606],
8	stent	NN	O	stent	nn	11	SENT_170	[p7l1852t559r2010b606],
9	and	CC	O	and	_	0	SENT_170	[p7l2035t551r2150b606],
10	clopidogrel	NN	O	clopidogrel	nn	11	SENT_170	[p7l11t639r366b708],
11	responsiveness	NN	O	responsiveness	prep_of	4	SENT_170	[p7l402t640r881b708],
12	was	VBD	O	be	auxpass	13	SENT_170	[p7l915t655r1039b694],
13	found	VBN	O	find	_	0	SENT_170	[p7l1075t639r1259b694],
14	by	IN	O	by	_	0	SENT_170	[p7l1293t639r1370b708],
15	Mann	NNP	PERSON	Mann	agent	13	SENT_170	[p7l1404t639r1907b708],
16	.	.	O	.	_	0	SENT_170	[p7l1404t639r1907b708],

1	—	NN	O	—	_	0	SENT_171	[p7l1404t639r1907b708],
2	.	.	O	.	_	0	SENT_171	[p7l1404t639r1907b708],

1	Whitney	NNP	PERSON	Whitney	nn	2	SENT_172	[p7l1404t639r1907b708],
2	U	NNP	O	U	nsubj	3	SENT_172	[p7l1942t643r1988b694],
3	test	NN	O	test	_	0	SENT_172	[p7l2018t647r2148b695],
4	.	.	O	.	_	0	SENT_172	[p7l2018t647r2148b695],

1	Since	IN	O	since	mark	6	SENT_173	[p7l11t729r175b783],
2	the	DT	O	the	det	3	SENT_173	[p7l197t728r298b783],
3	patients	NNS	O	patient	nsubj	6	SENT_173	[p7l321t729r575b797],
4	might	MD	O	might	aux	6	SENT_173	[p7l599t728r788b797],
5	have	VB	O	have	aux	6	SENT_173	[p7l808t728r956b783],
6	received	VBN	O	receive	advcl	18	SENT_173	[p7l979t728r1245b783],
7	more	JJR	O	more	mwe	8	SENT_173	[p7l1267t744r1432b783],
8	than	IN	O	than	quantmod	9	SENT_173	[p7l1453t728r1597b783],
9	one	CD	NUMBER	one	num	10	SENT_173	[p7l1619t744r1732b783],
10	stent	NN	O	stent	dobj	6	SENT_173	[p7l1755t736r1927b792],
11	,	,	O	,	_	0	SENT_173	[p7l1755t736r1927b792],
12	length	NN	O	length	nsubjpass	18	SENT_173	[p7l1950t728r2151b797],
13	and	CC	O	and	_	0	SENT_173	[p7l11t818r126b873],
14	diameter	NN	O	diameter	nsubjpass	18	SENT_173	[p7l154t818r442b873],
15	of	IN	O	of	_	0	SENT_173	[p7l467t817r533b873],
16	stent	NN	O	stent	prep_of	12	SENT_173	[p7l553t826r710b873],
17	were	VBD	O	be	auxpass	18	SENT_173	[p7l734t833r893b873],
18	indicated	VBN	O	indicate	_	0	SENT_173	[p7l920t818r1213b873],
19	as	IN	O	as	_	0	SENT_173	[p7l1241t833r1303b873],
20	average	NN	O	average	prep_as	18	SENT_173	[p7l1331t833r1575b886],
21	of	IN	O	of	_	0	SENT_173	[p7l1603t817r1669b873],
22	maximal	JJ	O	maximal	amod	24	SENT_173	[p7l1688t818r1965b873],
23	stent	NN	O	stent	nn	24	SENT_173	[p7l1994t826r2152b873],
24	length	NN	O	length	prep_of	20	SENT_173	[p7l11t906r213b975],
25	(	CD	NUMBER	(	dep	24	SENT_173	[p7l234t906r325b975],
26	or	CC	O	or	_	0	SENT_173	[p7l234t906r325b975],
27	diameter	NN	O	diameter	nn	28	SENT_173	[p7l344t906r671b975],
28	)	NN	O	)	prep_of	20	SENT_173	[p7l344t906r671b975],
29	,	,	O	,	_	0	SENT_173	[p7l344t906r671b975],
30	average	NN	O	average	appos	28	SENT_173	[p7l692t922r937b975],
31	of	IN	O	of	_	0	SENT_173	[p7l959t906r1025b961],
32	minimal	JJ	O	minimal	amod	38	SENT_173	[p7l1039t906r1305b961],
33	stent	NN	O	stent	nn	38	SENT_173	[p7l1328t915r1485b961],
34	length	NN	O	length	nn	38	SENT_173	[p7l1506t906r1707b975],
35	(	CD	NUMBER	(	num	34	SENT_173	[p7l1728t907r1819b975],
36	or	CC	O	or	_	0	SENT_173	[p7l1728t907r1819b975],
37	diameter	NN	O	diameter	nn	38	SENT_173	[p7l1839t906r2150b975],
38	)	NN	O	)	prep_of	30	SENT_173	[p7l1839t906r2150b975],
39	and	CC	O	and	_	0	SENT_173	[p7l11t996r126b1051],
40	also	RB	O	also	advmod	30	SENT_173	[p7l152t996r276b1051],
41	average	NN	O	average	conj_and	30	SENT_173	[p7l301t1012r545b1064],
42	of	IN	O	of	_	0	SENT_173	[p7l571t996r637b1051],
43	total	JJ	O	total	amod	46	SENT_173	[p7l654t996r799b1051],
44	stent	JJ	O	stent	amod	46	SENT_173	[p7l825t1004r983b1051],
45	length	NN	O	length	nn	46	SENT_173	[p7l1008t996r1209b1064],
46	(	NN	O	(	prep_of	41	SENT_173	[p7l1234t996r1325b1064],
47	or	CC	O	or	_	0	SENT_173	[p7l1234t996r1325b1064],
48	diameter	NN	O	diameter	nn	49	SENT_173	[p7l1349t996r1676b1064],
49	)	NN	O	)	prep_of	41	SENT_173	[p7l1349t996r1676b1064],
50	.	.	O	.	_	0	SENT_173	[p7l1349t996r1676b1064],

1	P	NN	O	p	npadvmod	2	SENT_174	[p7l111t1088r151b1139],
2	<	JJR	O	<	dep	5	SENT_174	[p7l171t1101r215b1142],
3	0.05	CD	NUMBER	0.05	nsubjpass	5	SENT_174	[p7l240t1088r371b1140],
4	was	VBD	O	be	auxpass	5	SENT_174	[p7l401t1101r526b1140],
5	considered	VBN	O	consider	_	0	SENT_174	[p7l555t1085r906b1140],
6	signiﬁcant	NN	O	signiﬁcant	dobj	5	SENT_174	[p7l935t1085r1285b1153],
7	.	.	O	.	_	0	SENT_174	[p7l935t1085r1285b1153],

1	Analyses	NNS	O	analysis	nsubjpass	3	SENT_175	[p7l1312t1085r1595b1153],
2	were	VBD	O	be	auxpass	3	SENT_175	[p7l1623t1101r1782b1140],
3	performed	VBN	O	perform	_	0	SENT_175	[p7l1811t1085r2150b1153],
4	using	VBG	O	use	xcomp	3	SENT_175	[p7l11t1174r184b1242],
5	SPSS	NNP	ORGANIZATION	SPSS	nn	6	SENT_175	[p7l212t1176r356b1228],
6	version	NN	O	version	nsubj	9	SENT_175	[p7l383t1174r620b1228],
7	13	CD	NUMBER	13	num	9	SENT_175	[p7l651t1176r722b1228],
8	statistical	JJ	O	statistical	amod	9	SENT_175	[p7l755t1173r1063b1228],
9	software	NN	O	software	xcomp	4	SENT_175	[p7l1093t1173r1387b1229],
10	.	.	O	.	_	0	SENT_175	[p7l1093t1173r1387b1229],

1	2.7	CD	NUMBER	2.7	_	0	SENT_176	[p7l7t1354r114b1407],
2	.	.	O	.	_	0	SENT_176	[p7l7t1354r114b1407],

1	Deﬁnition	NN	O	deﬁnition	_	0	SENT_177	[p7l154t1351r458b1420],
2	of	IN	O	of	_	0	SENT_177	[p7l487t1351r554b1420],
3	clopidogrel	NN	O	clopidogrel	nn	4	SENT_177	[p7l570t1351r908b1420],
4	responsiveness	NN	O	responsiveness	prep_of	1	SENT_177	[p7l934t1353r1389b1420],

1	Responsiveness	NN	O	responsiveness	nsubjpass	3	SENT_178	[p7l113t1531r625b1598],
2	was	VBD	O	be	auxpass	3	SENT_178	[p7l707t1546r832b1585],
3	deﬁned	VBN	O	deﬁned	_	0	SENT_178	[p7l916t1530r1159b1585],
4	as	IN	O	as	_	0	SENT_178	[p7l1241t1546r1304b1585],
5	the	DT	O	the	det	11	SENT_178	[p7l1386t1530r1490b1585],
6	relative	JJ	O	relative	amod	11	SENT_178	[p7l1572t1530r1819b1585],
7	platelet	NN	O	platelet	nn	11	SENT_178	[p7l1901t1530r2152b1598],
8	inhibition	NN	O	inhibition	nn	11	SENT_178	[p7l11t1619r335b1674],
9	(	CD	NUMBER	(	num	11	SENT_178	[p7l361t1619r477b1687],
10	RI	NN	O	rus	nn	11	SENT_178	[p7l361t1619r477b1687],
11	)	NN	O	)	prep_as	3	SENT_178	[p7l361t1619r477b1687],
12	induced	VBN	O	induce	partmod	11	SENT_178	[p7l503t1619r764b1674],
13	by	IN	O	by	_	0	SENT_178	[p7l790t1619r869b1687],
14	the	DT	O	the	det	15	SENT_178	[p7l893t1619r996b1674],
15	addition	NN	O	addition	agent	12	SENT_178	[p7l1023t1619r1296b1674],
16	of	IN	O	of	_	0	SENT_178	[p7l1323t1619r1390b1674],
17	clopidogrel	NN	O	clopidogrel	prep_of	15	SENT_178	[p7l1408t1619r1793b1687],
18	.	.	O	.	_	0	SENT_178	[p7l1408t1619r1793b1687],

1	R1	NN	O	r1	_	0	SENT_179	[p7l1822t1622r1881b1673],
2	=	JJ	O	=	amod	1	SENT_179	[p7l1906t1642r1939b1658],
3	[	CD	NUMBER	[	number	4	SENT_179	[p7l1965t1619r2150b1687],
4	(	CD	NUMBER	(	dep	1	SENT_179	[p7l1965t1619r2150b1687],
5	pre	JJ	O	pre	amod	7	SENT_179	[p7l1965t1619r2150b1687],
6	—	NN	O	—	nn	7	SENT_179	[p7l1965t1619r2150b1687],
7	treatment	NN	O	treatment	dep	4	SENT_179	[p7l10t1715r341b1762],
8	aggregation	NN	O	aggregation	nn	10	SENT_179	[p7l384t1708r773b1776],
9	—	NN	O	—	nn	10	SENT_179	[p7l798t1742r841b1746],
10	posttreatment	NN	O	posttreatment	dep	1	SENT_179	[p7l867t1715r1340b1776],
11	aggregation	NN	O	aggregation	dep	10	SENT_179	[p7l1383t1707r2150b1776, p7l11t1804r182b1851],
12	)	CD	NUMBER	)	num	11	SENT_179	[p7l1383t1707r2150b1776, p7l11t1804r182b1851],
13	/	:	O	/	punct	16	SENT_179	[p7l1383t1707r2150b1776, p7l11t1804r182b1851],
14	(	CD	NUMBER	(	num	16	SENT_179	[p7l1383t1707r2150b1776, p7l11t1804r182b1851],
15	pretreatment	NN	O	pretreatment	nn	16	SENT_179	[p7l1383t1707r2150b1776, p7l11t1804r182b1851],
16	aggregation	NN	O	aggregation	dep	11	SENT_179	[p7l207t1796r644b1865],
17	)	CD	NUMBER	)	number	18	SENT_179	[p7l207t1796r644b1865],
18	]	CD	NUMBER	]	dep	1	SENT_179	[p7l207t1796r644b1865],
19	x	NN	O	x	dep	18	SENT_179	[p7l679t1816r713b1850],
20	100	CD	NUMBER	100	num	19	SENT_179	[p7l746t1799r878b1852],
21	.	.	O	.	_	0	SENT_179	[p7l746t1799r878b1852],

1	For	IN	O	for	_	0	SENT_180	[p7l113t1889r215b1940],
2	both	DT	O	both	preconj	3	SENT_180	[p7l241t1885r388b1940],
3	5	CD	NUMBER	5	prep_for	9	SENT_180	[p7l418t1889r450b1940],
4	and	CC	O	and	_	0	SENT_180	[p7l482t1885r598b1940],
5	20	CD	NUMBER	20	num	8	SENT_180	[p7l628t1888r705b1940],
6	MM	NN	O	mm	nn	8	SENT_180	[p7l731t1889r844b1957],
7	ADP	NN	O	adp	nn	8	SENT_180	[p7l872t1885r1296b1940],
8	—	NN	O	—	conj_and	3	SENT_180	[p7l872t1885r1296b1940],
9	induced	VBD	O	induce	_	0	SENT_180	[p7l872t1885r1296b1940],
10	aggregation	NN	O	aggregation	nsubj	9	SENT_180	[p7l1326t1886r1721b1954],
11	,	,	O	,	_	0	SENT_180	[p7l1326t1886r1721b1954],
12	non	JJ	O	non	amod	14	SENT_180	[p7l1751t1901r2150b1954],
13	—	NN	O	—	nn	14	SENT_180	[p7l1751t1901r2150b1954],
14	respon	NN	O	respon	appos	10	SENT_180	[p7l1751t1901r2150b1954],
15	—	CD	NUMBER	—	num	16	SENT_180	[p7l1751t1901r2150b1954],
16	ders	NNS	O	der	nsubjpass	18	SENT_180	[p7l11t1973r144b2028],
17	were	VBD	O	be	auxpass	18	SENT_180	[p7l205t1989r365b2028],
18	deﬁned	VBN	O	deﬁned	rcmod	14	SENT_180	[p7l427t1973r666b2028],
19	as	IN	O	as	_	0	SENT_180	[p7l728t1989r791b2028],
20	those	DT	O	those	det	21	SENT_180	[p7l853t1973r1027b2028],
21	patients	NNS	O	patient	prep_as	18	SENT_180	[p7l1089t1974r1347b2042],
22	with	IN	O	with	_	0	SENT_180	[p7l1408t1973r1556b2028],
23	R1	NN	O	r1	prep_with	21	SENT_180	[p7l1618t1977r1677b2028],
24	<	JJR	O	<	amod	14	SENT_180	[p7l1703t1990r1746b2030],
25	10	CD	PERCENT	10	num	26	SENT_180	[p7l1775t1976r1908b2037],
26	%	NN	PERCENT	%	dep	24	SENT_180	[p7l1775t1976r1908b2037],
27	,	,	O	,	_	0	SENT_180	[p7l1775t1976r1908b2037],
28	semiresponders	NNS	O	semiresponder	conj_and	14	SENT_180	[p7l1972t1974r2150b2028, p7l11t2063r366b2131],
29	as	IN	O	as	_	0	SENT_180	[p7l403t2079r466b2118],
30	those	DT	O	those	prep_as	28	SENT_180	[p7l503t2063r676b2118],
31	with	IN	O	with	_	0	SENT_180	[p7l711t2063r860b2118],
32	R1	NN	O	r1	prep_with	30	SENT_180	[p7l896t2066r955b2117],
33	=	JJ	O	=	amod	32	SENT_180	[p7l978t2086r1012b2102],
34	10-30	CD	PERCENT	10-30	num	35	SENT_180	[p7l1038t2066r1294b2126],
35	%	NN	PERCENT	%	dep	33	SENT_180	[p7l1038t2066r1294b2126],
36	,	,	O	,	_	0	SENT_180	[p7l1038t2066r1294b2126],
37	and	CC	O	and	_	0	SENT_180	[p7l1331t2063r1447b2118],
38	responders	NNS	O	responder	conj_and	14	SENT_180	[p7l1485t2063r1840b2131],
39	as	IN	O	as	_	0	SENT_180	[p7l1877t2079r1940b2118],
40	those	DT	O	those	prep_as	38	SENT_180	[p7l1977t2063r2150b2118],
41	with	IN	O	with	_	0	SENT_180	[p7l9t2152r158b2207],
42	R1	NN	O	r1	prep_with	40	SENT_180	[p7l186t2155r245b2206],
43	>	RBR	O	>	amod	42	SENT_180	[p7l271t2169r315b2209],
44	30	CD	PERCENT	30	num	45	SENT_180	[p7l339t2155r461b2207],
45	%	NN	PERCENT	%	dep	43	SENT_180	[p7l339t2155r461b2207],
46	[	CD	NUMBER	[	number	47	SENT_180	[p7l492t2152r733b2220],
47	35,36	CD	NUMBER	35,36	num	48	SENT_180	[p7l492t2152r733b2220],
48	]	NN	O	]	dep	38	SENT_180	[p7l492t2152r733b2220],
49	.	.	O	.	_	0	SENT_180	[p7l492t2152r733b2220],

1	3	LS	NUMBER	3	_	0	SENT_181	[p7l8t2255r64b2306],
2	.	.	O	.	_	0	SENT_181	[p7l8t2255r64b2306],

1	Results	NNS	O	result	_	0	SENT_182	[p7l103t2252r346b2306],

1	3.1	CD	NUMBER	3.1	_	0	SENT_183	[p7l7t2432r112b2484],
2	.	.	O	.	_	0	SENT_183	[p7l7t2432r112b2484],

1	Patient	NN	O	patient	_	0	SENT_184	[p7l153t2430r374b2484],
2	and	CC	O	and	_	0	SENT_184	[p7l398t2429r512b2484],
3	procedural	JJ	O	procedural	amod	4	SENT_184	[p7l534t2429r870b2498],
4	characteristics	NNS	O	characteristic	conj_and	1	SENT_184	[p7l896t2429r1339b2484],

1	One	CD	NUMBER	one	num	2	SENT_185	[p7l112t2607r542b2662],
2	—	NN	O	—	nsubjpass	8	SENT_185	[p7l112t2607r542b2662],
3	hundred	CD	NUMBER	hundred	nn	6	SENT_185	[p7l112t2607r542b2662],
4	and	CC	NUMBER	and	_	0	SENT_185	[p7l570t2607r686b2662],
5	twelve	CD	NUMBER	twelve	nn	6	SENT_185	[p7l714t2607r929b2662],
6	patients	NNS	O	patient	dep	2	SENT_185	[p7l957t2608r1215b2676],
7	were	VBD	O	be	auxpass	8	SENT_185	[p7l1242t2623r1401b2662],
8	enrolled	VBN	O	enrol	_	0	SENT_185	[p7l1429t2607r1693b2662],
9	in	IN	O	in	_	0	SENT_185	[p7l1721t2608r1780b2662],
10	this	DT	O	this	det	11	SENT_185	[p7l1807t2607r1923b2662],
11	study	NN	O	study	prep_in	8	SENT_185	[p7l1953t2607r2144b2676],
12	.	.	O	.	_	0	SENT_185	[p7l1953t2607r2144b2676],

1	Demographic	JJ	O	demographic	amod	2	SENT_186	[p7l10t2697r442b2765],
2	characteristics	NNS	O	characteristic	nsubjpass	17	SENT_186	[p7l479t2697r961b2760],
3	,	,	O	,	_	0	SENT_186	[p7l479t2697r961b2760],
4	clinical	JJ	O	clinical	amod	5	SENT_186	[p7l1000t2697r1227b2752],
5	information	NN	O	information	conj_and	2	SENT_186	[p7l1267t2697r1665b2760],
6	,	,	O	,	_	0	SENT_186	[p7l1267t2697r1665b2760],
7	lab	NN	O	lab	nn	8	SENT_186	[p7l1705t2697r1798b2752],
8	data	NNS	O	datum	conj_and	2	SENT_186	[p7l1837t2697r1990b2760],
9	,	,	O	,	_	0	SENT_186	[p7l1837t2697r1990b2760],
10	and	CC	O	and	_	0	SENT_186	[p7l2029t2697r2145b2752],
11	procedural	JJ	O	procedural	amod	12	SENT_186	[p7l10t2786r356b2854],
12	information	NN	O	information	conj_and	2	SENT_186	[p7l386t2786r769b2841],
13	of	IN	O	of	_	0	SENT_186	[p7l797t2786r864b2841],
14	the	DT	O	the	det	15	SENT_186	[p7l883t2786r985b2841],
15	patients	NNS	O	patient	prep_of	12	SENT_186	[p7l1014t2787r1271b2854],
16	are	VBP	O	be	auxpass	17	SENT_186	[p7l1301t2802r1398b2841],
17	shown	VBN	O	show	_	0	SENT_186	[p7l1427t2786r1639b2841],
18	in	IN	O	in	_	0	SENT_186	[p7l1668t2787r1727b2840],
19	Table	NNP	O	Table	prep_in	17	SENT_186	[p7l1752t2786r1925b2841],
20	1	CD	NUMBER	1	num	19	SENT_186	[p7l1957t2789r2006b2841],
21	.	.	O	.	_	0	SENT_186	[p7l1957t2789r2006b2841],

1	According	VBG	O	accord	_	0	SENT_187	[p7l109t2874r435b2943],
2	to	TO	O	to	prepc_according_to	14	SENT_187	[p7l470t2882r532b2929],
3	our	PRP$	O	we	poss	4	SENT_187	[p7l569t2890r677b2929],
4	results	NNS	O	result	pobj	14	SENT_187	[p7l713t2874r942b2938],
5	,	,	O	,	_	0	SENT_187	[p7l713t2874r942b2938],
6	25.90	CD	PERCENT	25.90	num	7	SENT_187	[p7l979t2877r1200b2930],
7	%	NN	PERCENT	%	nsubj	14	SENT_187	[p7l979t2877r1200b2930],
8	and	CC	O	and	_	0	SENT_187	[p7l1237t2874r1353b2929],
9	28.60	CD	PERCENT	28.60	num	10	SENT_187	[p7l1390t2877r1611b2930],
10	%	NN	PERCENT	%	nsubj	14	SENT_187	[p7l1390t2877r1611b2930],
11	of	IN	O	of	_	0	SENT_187	[p7l1648t2874r1714b2929],
12	our	PRP$	O	we	poss	13	SENT_187	[p7l1744t2890r1852b2929],
13	patients	NNS	O	patient	prep_of	10	SENT_187	[p7l1887t2875r2145b2943],
14	obtained	VBD	O	obtain	_	0	SENT_187	[p7l10t2963r291b3018],
15	the	DT	O	the	det	17	SENT_187	[p7l321t2963r423b3018],
16	maximum	NN	O	maximum	nn	17	SENT_187	[p7l453t2964r784b3018],
17	rate	NN	O	rate	dobj	14	SENT_187	[p7l814t2971r937b3018],
18	of	IN	O	of	_	0	SENT_187	[p7l968t2963r1034b3018],
19	clopidogrel	NN	O	clopidogrel	nn	20	SENT_187	[p7l1056t2963r1414b3032],
20	nonresponsiveness	NN	O	nonresponsiveness	prep_of	17	SENT_187	[p7l1446t2964r2056b3032],
21	at	IN	O	at	_	0	SENT_187	[p7l2087t2971r2147b3018],
22	2	CD	NUMBER	2	num	23	SENT_187	[p7l10t3055r44b3107],
23	h	NN	O	h	prep_at	20	SENT_187	[p7l68t3052r106b3107],
24	after	IN	O	after	_	0	SENT_187	[p7l136t3052r286b3107],
25	taking	VBG	O	take	prepc_after	14	SENT_187	[p7l313t3052r515b3121],
26	600	CD	NUMBER	600	num	27	SENT_187	[p7l543t3055r660b3107],
27	mg	NN	O	mg	dobj	25	SENT_187	[p7l683t3068r783b3121],
28	of	IN	O	of	_	0	SENT_187	[p7l811t3052r877b3107],
29	clopidogrel	NN	O	clopidogrel	prep_of	27	SENT_187	[p7l900t3052r1259b3121],
30	measured	VBN	O	measure	partmod	29	SENT_187	[p7l1290t3052r1605b3107],
31	by	IN	O	by	_	0	SENT_187	[p7l1635t3052r1712b3121],
32	Sand	NN	O	sand	nn	35	SENT_187	[p7l1742t3052r1899b3107],
33	20	CD	TIME	20	num	35	SENT_187	[p7l1929t3055r2006b3107],
34	p.M	NN	TIME	p.m	nn	35	SENT_187	[p7l2032t3056r2144b3124],
35	ADP	NN	O	adp	agent	30	SENT_187	[p7l7t3143r157b3204],
36	,	,	O	,	_	0	SENT_187	[p7l7t3143r157b3204],
37	respectively	RB	O	respectively	advmod	30	SENT_187	[p7l188t3140r591b3209],
38	.	.	O	.	_	0	SENT_187	[p7l188t3140r591b3209],

1	A	DT	O	a	det	3	SENT_188	[p7l619t3143r665b3195],
2	strong	JJ	O	strong	amod	3	SENT_188	[p7l693t3149r896b3209],
3	correlation	NN	O	correlation	dep	13	SENT_188	[p7l925t3140r1276b3195],
4	between	IN	O	between	_	0	SENT_188	[p7l1304t3140r1582b3195],
5	the	DT	O	the	det	7	SENT_188	[p7l1610t3140r1711b3195],
6	two	CD	NUMBER	two	num	7	SENT_188	[p7l1741t3149r1863b3195],
7	concentrations	NNS	O	concentration	prep_between	3	SENT_188	[p7l1892t3156r2145b3195, p7l9t3231r258b3285],
8	of	IN	O	of	_	0	SENT_188	[p7l287t3230r353b3285],
9	ADP	NN	ORGANIZATION	adp	nn	10	SENT_188	[p7l371t3232r507b3284],
10	agonist	NN	O	agonist	prep_of	7	SENT_188	[p7l534t3231r767b3298],
11	(	CD	NUMBER	(	num	12	SENT_188	[p7l795t3230r858b3298],
12	P	NN	O	p	dep	13	SENT_188	[p7l795t3230r858b3298],
13	<	JJR	O	<	dep	21	SENT_188	[p7l879t3247r922b3287],
14	0.001	CD	NUMBER	0.001	dep	13	SENT_188	[p7l947t3233r1137b3293],
15	,	,	O	,	_	0	SENT_188	[p7l947t3233r1137b3293],
16	r	NN	O	r	appos	14	SENT_188	[p7l1167t3246r1194b3284],
17	=	JJ	O	=	amod	19	SENT_188	[p7l1212t3253r1245b3269],
18	0.88	CD	NUMBER	0.88	tmod	17	SENT_188	[p7l1267t3230r1428b3298],
19	)	NN	O	)	nsubjpass	21	SENT_188	[p7l1267t3230r1428b3298],
20	was	VBD	O	be	auxpass	21	SENT_188	[p7l1455t3246r1579b3285],
21	observed	VBN	O	observe	_	0	SENT_188	[p7l1609t3230r1914b3285],
22	.	.	O	.	_	0	SENT_188	[p7l1609t3230r1914b3285],

1	There	EX	O	there	expl	2	SENT_189	[p7l109t3319r292b3374],
2	were	VBD	O	be	_	0	SENT_189	[p7l315t3335r475b3374],
3	no	DT	O	no	det	5	SENT_189	[p7l501t3335r578b3374],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_189	[p7l605t3319r940b3387],
5	differences	NNS	O	difference	nsubj	2	SENT_189	[p7l964t3319r1315b3374],
6	in	IN	O	in	_	0	SENT_189	[p7l1342t3320r1401b3373],
7	patient	NN	O	patient	nn	8	SENT_189	[p7l1427t3320r1656b3387],
8	characteristics	NNS	O	characteristic	prep_in	5	SENT_189	[p7l1680t3319r2145b3374],
9	between	IN	O	between	_	0	SENT_189	[p7l9t3407r286b3462],
10	non	JJ	O	non	amod	12	SENT_189	[p7l357t3407r881b3476],
11	—	NN	O	—	nn	12	SENT_189	[p7l357t3407r881b3476],
12	responders	NNS	O	responder	prep_between	8	SENT_189	[p7l357t3407r881b3476],
13	,	,	O	,	_	0	SENT_189	[p7l357t3407r881b3476],
14	semi	NNS	O	semus	nn	15	SENT_189	[p7l955t3408r1103b3462],
15	responders	NNS	O	responder	prep_between	8	SENT_189	[p7l1176t3407r1530b3476],
16	and	CC	O	and	_	0	SENT_189	[p7l1602t3407r1718b3462],
17	responders	NNS	O	responder	prep_between	8	SENT_189	[p7l1791t3407r2145b3476],
18	(	CD	NUMBER	(	num	19	SENT_189	[p7l10t3496r74b3564],
19	P	NN	O	p	npadvmod	20	SENT_189	[p7l10t3496r74b3564],
20	>	JJR	O	>	amod	17	SENT_189	[p7l95t3513r138b3553],
21	0.05	CD	NUMBER	0.05	num	22	SENT_189	[p7l162t3496r338b3564],
22	)	NN	O	)	dep	17	SENT_189	[p7l162t3496r338b3564],
23	.	.	O	.	_	0	SENT_189	[p7l162t3496r338b3564],

1	Ninety	CD	NUMBER	ninety	nsubj	8	SENT_190	[p7l369t3496r782b3565],
2	—	CD	NUMBER	—	number	3	SENT_190	[p7l369t3496r782b3565],
3	three	CD	NUMBER	three	npadvmod	1	SENT_190	[p7l369t3496r782b3565],
4	of	IN	O	of	_	0	SENT_190	[p7l811t3496r877b3551],
5	our	PRP$	O	we	poss	6	SENT_190	[p7l899t3512r1008b3551],
6	patients	NNS	O	patient	prep_of	1	SENT_190	[p7l1034t3497r1292b3565],
7	had	VBD	O	have	aux	8	SENT_190	[p7l1323t3496r1438b3551],
8	received	VBN	O	receive	_	0	SENT_190	[p7l1468t3496r1737b3551],
9	at	IN	O	at	quantmod	11	SENT_190	[p7l1766t3504r1827b3551],
10	least	JJS	O	least	mwe	9	SENT_190	[p7l1855t3496r2004b3551],
11	one	CD	NUMBER	one	num	12	SENT_190	[p7l2032t3512r2146b3551],
12	drug	NN	O	drug	dobj	8	SENT_190	[p7l10t3585r158b3654],
13	that	WDT	O	that	nsubj	15	SENT_190	[p7l186t3585r315b3640],
14	could	MD	O	could	aux	15	SENT_190	[p7l344t3585r519b3640],
15	affect	VB	O	affect	rcmod	12	SENT_190	[p7l549t3585r727b3640],
16	clopidogrel	NN	O	clopidogrel	nn	17	SENT_190	[p7l756t3585r1115b3654],
17	metabolism	NN	O	metabolism	dobj	15	SENT_190	[p7l1146t3585r1543b3641],
18	.	.	O	.	_	0	SENT_190	[p7l1146t3585r1543b3641],

1	But	CC	O	but	cc	6	SENT_191	[p7l1575t3589r1682b3640],
2	the	DT	O	the	det	3	SENT_191	[p7l1711t3585r1812b3640],
3	results	NNS	O	result	nsubj	6	SENT_191	[p7l1843t3585r2056b3640],
4	of	IN	O	of	_	0	SENT_191	[p7l2087t3585r2153b3640],
5	LTA	NN	ORGANIZATION	lta	prep_of	6	SENT_191	[p7l10t3677r129b3729],
6	showed	VBD	O	show	dep	14	SENT_191	[p7l155t3674r401b3729],
7	that	IN	O	that	complm	10	SENT_191	[p7l429t3674r558b3729],
8	these	DT	O	these	det	9	SENT_191	[p7l583t3674r753b3729],
9	drugs	NNS	O	drug	nsubj	10	SENT_191	[p7l781t3674r958b3743],
10	had	VBD	O	have	ccomp	6	SENT_191	[p7l987t3674r1103b3729],
11	no	DT	O	no	det	13	SENT_191	[p7l1131t3690r1208b3729],
12	signiﬁcant	JJ	O	signiﬁcant	amod	13	SENT_191	[p7l1237t3674r1571b3743],
13	effects	NNS	O	effect	dobj	10	SENT_191	[p7l1597t3674r1804b3729],
14	(	VBP	O	(	_	0	SENT_191	[p7l1833t3674r1897b3743],
15	P	NN	O	p	dep	16	SENT_191	[p7l1833t3674r1897b3743],
16	>	JJR	O	>	dobj	14	SENT_191	[p7l1918t3691r1961b3731],
17	0.05	CD	NUMBER	0.05	num	18	SENT_191	[p7l1986t3675r2145b3743],
18	)	NN	O	)	nsubj	14	SENT_191	[p7l1986t3675r2145b3743],

1	on	IN	O	on	_	0	SENT_192	[p8l10t33r88b72],
2	clopidogrel	NN	O	clopidogrel	nn	3	SENT_192	[p8l115t17r475b85],
3	responsiveness	NN	O	responsiveness	pobj	1	SENT_192	[p8l504t18r1006b85],
4	.	.	O	.	_	0	SENT_192	[p8l504t18r1006b85],

1	3.2	CD	NUMBER	3.2	_	0	SENT_193	[p8l7t198r112b251],
2	.	.	O	.	_	0	SENT_193	[p8l7t198r112b251],

1	P2Y12	NN	O	p2y12	_	0	SENT_194	[p8l153t198r346b250],
2	genetic	JJ	O	genetic	amod	3	SENT_194	[p8l368t196r593b264],
3	polymorphism	NN	O	polymorphism	dep	1	SENT_194	[p8l614t195r1060b264],

1	In	IN	O	in	_	0	SENT_195	[p8l112t377r172b428],
2	the	DT	O	the	det	4	SENT_195	[p8l231t373r332b428],
3	whole	JJ	O	whole	amod	4	SENT_195	[p8l390t373r588b428],
4	population	NN	O	population	prep_in	20	SENT_195	[p8l648t373r998b442],
5	of	IN	O	of	_	0	SENT_195	[p8l1057t373r1123b428],
6	112	CD	NUMBER	112	num	7	SENT_195	[p8l1178t376r1291b428],
7	patients	NNS	O	patient	prep_of	4	SENT_195	[p8l1354t374r1628b442],
8	,	,	O	,	_	0	SENT_195	[p8l1354t374r1628b442],
9	the	DT	O	the	det	11	SENT_195	[p8l1688t373r1789b428],
10	genotype	NN	O	genotype	nn	11	SENT_195	[p8l1848t382r2146b442],
11	distribution	NN	O	distribution	nsubj	20	SENT_195	[p8l10t462r391b517],
12	of	IN	O	of	_	0	SENT_195	[p8l425t462r491b517],
13	the	DT	O	the	det	15	SENT_195	[p8l517t462r618b517],
14	T744C	NN	O	t744c	nn	15	SENT_195	[p8l653t465r847b517],
15	polymorphism	NN	O	polymorphism	prep_of	11	SENT_195	[p8l877t462r1351b531],
16	of	IN	O	of	_	0	SENT_195	[p8l1385t462r1451b517],
17	the	DT	O	the	det	19	SENT_195	[p8l1477t462r1579b517],
18	P2Y12	NN	O	p2y12	nn	19	SENT_195	[p8l1611t465r1804b517],
19	gene	NN	O	gene	prep_of	15	SENT_195	[p8l1836t478r1987b531],
20	was	VBD	O	be	_	0	SENT_195	[p8l2020t478r2145b517],
21	as	IN	O	as	mark	22	SENT_195	[p8l10t568r72b607],
22	follows	VBZ	O	follow	advcl	20	SENT_195	[p8l106t552r358b607],
23	:	:	O	:	_	0	SENT_195	[p8l106t552r358b607],
24	104	CD	NUMBER	104	num	25	SENT_195	[p8l400t555r515b607],
25	patients	NNS	O	patient	dep	32	SENT_195	[p8l547t553r805b620],
26	(	IN	O	(	dep	32	SENT_195	[p8l839t552r1071b620],
27	92.9	CD	PERCENT	92.9	num	28	SENT_195	[p8l839t552r1071b620],
28	%	NN	PERCENT	%	nsubj	32	SENT_195	[p8l839t552r1071b620],
29	)	CD	NUMBER	)	dep	28	SENT_195	[p8l839t552r1071b620],
30	were	VBD	O	be	cop	32	SENT_195	[p8l1102t568r1261b607],
31	CC	NN	O	cc	nn	32	SENT_195	[p8l1294t555r1375b607],
32	homozygotes	NNS	O	homozygote	advcl	41	SENT_195	[p8l1408t552r1852b620],
33	,	,	O	,	_	0	SENT_195	[p8l1408t552r1852b620],
34	8	CD	PERCENT	8	num	35	SENT_195	[p8l1887t555r1920b607],
35	(	NN	PERCENT	(	appos	32	SENT_195	[p8l1955t552r2146b620],
36	7.1	CD	PERCENT	7.1	number	37	SENT_195	[p8l1955t552r2146b620],
37	%	NN	PERCENT	%	amod	35	SENT_195	[p8l1955t552r2146b620],
38	)	CD	NUMBER	)	nsubj	41	SENT_195	[p8l1955t552r2146b620],
39	were	VBD	O	be	cop	41	SENT_195	[p8l8t657r167b696],
40	CT	NN	O	ct	nn	41	SENT_195	[p8l189t644r269b696],
41	heterozygotes	NNS	O	heterozygote	ccomp	22	SENT_195	[p8l289t641r741b709],
42	and	CC	O	and	_	0	SENT_195	[p8l764t641r880b696],
43	was	VBD	O	be	cop	45	SENT_195	[p8l901t657r1025b696],
44	TT	NN	O	tt	nn	45	SENT_195	[p8l1046t644r1125b695],
45	homozygotes	NNS	O	homozygote	conj_and	22	SENT_195	[p8l1146t641r1591b709],
46	.	.	O	.	_	0	SENT_195	[p8l1146t641r1591b709],

1	Since	IN	O	since	mark	8	SENT_196	[p8l1614t642r1796b704],
2	,	,	O	,	_	0	SENT_196	[p8l1614t642r1796b704],
3	no	DT	O	no	det	4	SENT_196	[p8l1819t657r1896b696],
4	patient	NN	O	patient	nsubj	8	SENT_196	[p8l1919t642r2147b709],
5	was	VBD	O	be	cop	8	SENT_196	[p8l8t745r132b784],
6	a	DT	O	a	det	8	SENT_196	[p8l154t745r186b784],
7	wild	JJ	O	wild	amod	8	SENT_196	[p8l205t729r347b784],
8	type	NN	O	type	advcl	25	SENT_196	[p8l367t737r507b798],
9	and	CC	O	and	_	0	SENT_196	[p8l528t729r645b784],
10	the	DT	O	the	det	11	SENT_196	[p8l665t729r767b784],
11	number	NN	O	number	nsubj	17	SENT_196	[p8l788t729r1043b784],
12	of	IN	O	of	_	0	SENT_196	[p8l1061t729r1128b784],
13	heterozygote	NN	O	heterozygote	nn	14	SENT_196	[p8l1141t729r1562b798],
14	patients	NNS	O	patient	prep_of	11	SENT_196	[p8l1583t730r1841b798],
15	was	VBD	O	be	cop	17	SENT_196	[p8l1862t745r1986b784],
16	very	RB	O	very	advmod	17	SENT_196	[p8l2006t745r2147b798],
17	few	JJ	O	few	advcl	25	SENT_196	[p8l10t818r141b882],
18	,	,	O	,	_	0	SENT_196	[p8l10t818r141b882],
19	statistical	JJ	O	statistical	amod	20	SENT_196	[p8l200t818r508b873],
20	analysis	NN	O	analysis	nsubj	25	SENT_196	[p8l567t818r822b887],
21	on	IN	O	on	_	0	SENT_196	[p8l881t834r959b873],
22	this	DT	O	this	det	23	SENT_196	[p8l1016t818r1133b873],
23	population	NN	O	population	prep_on	20	SENT_196	[p8l1192t818r1542b887],
24	was	VBD	O	be	cop	25	SENT_196	[p8l1598t834r1722b873],
25	impossible	JJ	O	impossible	_	0	SENT_196	[p8l1782t818r2145b887],
26	.	.	O	.	_	0	SENT_196	[p8l1782t818r2145b887],

1	Therefore	RB	O	therefore	advmod	13	SENT_197	[p8l7t907r334b971],
2	,	,	O	,	_	0	SENT_197	[p8l7t907r334b971],
3	the	DT	O	the	det	4	SENT_197	[p8l394t907r496b962],
4	relation	NN	O	relation	nsubjpass	13	SENT_197	[p8l557t907r806b962],
5	between	IN	O	between	_	0	SENT_197	[p8l865t907r1143b962],
6	genetic	JJ	O	genetic	amod	7	SENT_197	[p8l1202t908r1435b976],
7	polymorphism	NN	O	polymorphism	prep_between	4	SENT_197	[p8l1495t907r1969b976],
8	and	CC	O	and	_	0	SENT_197	[p8l2029t907r2145b962],
9	clopidogrel	NN	O	clopidogrel	nn	10	SENT_197	[p8l10t996r369b1065],
10	responsiveness	NN	O	responsiveness	prep_between	4	SENT_197	[p8l431t997r917b1065],
11	was	VBD	O	be	auxpass	13	SENT_197	[p8l977t1012r1101b1051],
12	not	RB	O	not	neg	13	SENT_197	[p8l1164t1005r1269b1051],
13	investigated	VBN	O	investigate	_	0	SENT_197	[p8l1329t996r1738b1065],
14	.	.	O	.	_	0	SENT_197	[p8l1329t996r1738b1065],

1	The	DT	O	the	det	3	SENT_198	[p8l1798t996r1915b1051],
2	allele	NN	O	allele	nn	3	SENT_198	[p8l1976t996r2145b1051],
3	frequencies	NNS	O	frequency	nsubj	4	SENT_198	[p8l10t1086r380b1154],
4	were	VBD	O	be	_	0	SENT_198	[p8l407t1102r567b1141],
5	in	IN	O	in	_	0	SENT_198	[p8l595t1087r654b1140],
6	Hardy	NNP	LOCATION	Hardy	prep_in	4	SENT_198	[p8l683t1086r1239b1154],
7	.	.	O	.	_	0	SENT_198	[p8l683t1086r1239b1154],

1	—	NN	O	—	_	0	SENT_199	[p8l683t1086r1239b1154],
2	.	.	O	.	_	0	SENT_199	[p8l683t1086r1239b1154],

1	Weinberg	NNP	PERSON	Weinberg	_	0	SENT_200	[p8l683t1086r1239b1154],
2	equilibrium	NN	O	equilibrium	dep	1	SENT_200	[p8l1265t1086r1660b1154],
3	.	.	O	.	_	0	SENT_200	[p8l1265t1086r1660b1154],

1	3.3	CD	NUMBER	3.3	_	0	SENT_201	[p8l7t1267r112b1320],
2	.	.	O	.	_	0	SENT_201	[p8l7t1267r112b1320],

1	CYP3A5	NN	O	cyp3a5	_	0	SENT_202	[p8l156t1267r391b1319],
2	genetic	JJ	O	genetic	amod	3	SENT_202	[p8l413t1265r637b1333],
3	polymorphism	NN	O	polymorphism	dep	1	SENT_202	[p8l658t1264r1104b1333],

1	The	DT	O	the	det	2	SENT_203	[p8l109t1442r226b1497],
2	frequencies	NNS	O	frequency	_	0	SENT_203	[p8l245t1442r615b1511],
3	of	IN	O	of	_	0	SENT_203	[p8l636t1442r702b1497],
4	CYP3A5	NN	O	cyp3a5	nn	5	SENT_203	[p8l714t1445r949b1497],
5	*	NN	O	*	prep_of	2	SENT_203	[p8l972t1442r1054b1511],
6	1	CD	NUMBER	1	dep	5	SENT_203	[p8l972t1442r1054b1511],
7	/	:	O	/	punct	9	SENT_203	[p8l972t1442r1054b1511],
8	*	CD	NUMBER	*	num	9	SENT_203	[p8l1064t1442r1137b1506],
9	1	CD	NUMBER	1	dep	5	SENT_203	[p8l1064t1442r1137b1506],
10	,	,	O	,	_	0	SENT_203	[p8l1064t1442r1137b1506],
11	CYP3A5	NN	O	cyp3a5	nn	12	SENT_203	[p8l1158t1445r1393b1497],
12	*	NN	O	*	appos	9	SENT_203	[p8l1415t1442r1498b1511],
13	1	CD	NUMBER	1	dep	9	SENT_203	[p8l1415t1442r1498b1511],
14	/	:	O	/	punct	9	SENT_203	[p8l1415t1442r1498b1511],
15	*	CD	NUMBER	*	number	16	SENT_203	[p8l1507t1442r1581b1506],
16	3	CD	NUMBER	3	dep	2	SENT_203	[p8l1507t1442r1581b1506],
17	,	,	O	,	_	0	SENT_203	[p8l1507t1442r1581b1506],
18	and	CC	O	and	_	0	SENT_203	[p8l1601t1442r1717b1497],
19	CYP3A5	NN	O	cyp3a5	conj_and	16	SENT_203	[p8l1738t1445r1973b1497],
20	*	CD	NUMBER	*	number	21	SENT_203	[p8l1996t1442r2078b1511],
21	3	CD	NUMBER	3	dep	19	SENT_203	[p8l1996t1442r2078b1511],
22	/	:	O	/	punct	2	SENT_203	[p8l1996t1442r2078b1511],
23	*	CD	NUMBER	*	number	24	SENT_203	[p8l2088t1442r2145b1497],
24	3	CD	NUMBER	3	num	25	SENT_203	[p8l2088t1442r2145b1497],
25	genotypes	NNS	O	genotype	nsubj	28	SENT_203	[p8l9t1540r337b1600],
26	were	VBD	O	be	cop	28	SENT_203	[p8l366t1548r525b1587],
27	8.00	CD	PERCENT	8.00	num	28	SENT_203	[p8l555t1535r733b1587],
28	%	NN	PERCENT	%	dep	2	SENT_203	[p8l555t1535r733b1587],
29	(	CD	NUMBER	(	number	30	SENT_203	[p8l763t1532r1015b1600],
30	9/112	CD	NUMBER	9/112	num	31	SENT_203	[p8l763t1532r1015b1600],
31	)	NN	O	)	dep	28	SENT_203	[p8l763t1532r1015b1600],
32	,	,	O	,	_	0	SENT_203	[p8l763t1532r1015b1600],
33	37.50	CD	PERCENT	37.50	num	34	SENT_203	[p8l1045t1535r1267b1587],
34	%	NN	PERCENT	%	conj_and	28	SENT_203	[p8l1045t1535r1267b1587],
35	(	CD	NUMBER	(	number	36	SENT_203	[p8l1296t1532r1590b1600],
36	42/112	CD	NUMBER	42/112	num	37	SENT_203	[p8l1296t1532r1590b1600],
37	)	NN	O	)	dep	34	SENT_203	[p8l1296t1532r1590b1600],
38	,	,	O	,	_	0	SENT_203	[p8l1296t1532r1590b1600],
39	and	CC	O	and	_	0	SENT_203	[p8l1621t1532r1737b1587],
40	54.50	CD	PERCENT	54.50	num	41	SENT_203	[p8l1767t1535r1987b1587],
41	%	NN	PERCENT	%	conj_and	28	SENT_203	[p8l1767t1535r1987b1587],
42	(	CD	NUMBER	(	number	43	SENT_203	[p8l2017t1532r2145b1600],
43	61	CD	NUMBER	61	num	41	SENT_203	[p8l2017t1532r2145b1600],
44	/	:	O	/	punct	46	SENT_203	[p8l2017t1532r2145b1600],
45	112	CD	NUMBER	112	num	46	SENT_203	[p8l13t1621r170b1689],
46	)	NN	O	)	dep	41	SENT_203	[p8l13t1621r170b1689],
47	,	,	O	,	_	0	SENT_203	[p8l13t1621r170b1689],
48	respectively	RB	O	respectively	advmod	28	SENT_203	[p8l201t1621r604b1689],
49	.	.	O	.	_	0	SENT_203	[p8l201t1621r604b1689],

1	There	EX	O	there	expl	2	SENT_204	[p8l632t1621r815b1676],
2	was	VBD	O	be	_	0	SENT_204	[p8l843t1637r967b1676],
3	no	DT	O	no	det	5	SENT_204	[p8l999t1637r1076b1676],
4	signiﬁcant	NN	O	signiﬁcant	nn	5	SENT_204	[p8l1107t1621r1442b1689],
5	difference	NN	O	difference	nsubj	2	SENT_204	[p8l1471t1621r1792b1676],
6	in	IN	O	in	_	0	SENT_204	[p8l1822t1622r1881b1675],
7	CYP3A5	NN	O	cyp3a5	nn	9	SENT_204	[p8l1911t1623r2146b1676],
8	gene	NN	O	gene	nn	9	SENT_204	[p8l9t1726r159b1779],
9	polymorphism	NN	O	polymorphism	prep_in	5	SENT_204	[p8l205t1710r680b1779],
10	among	IN	O	among	_	0	SENT_204	[p8l725t1726r945b1779],
11	clopidogrel	NN	O	clopidogrel	nn	14	SENT_204	[p8l989t1710r1348b1779],
12	non	JJ	O	non	amod	14	SENT_204	[p8l1396t1710r1920b1779],
13	—	NN	O	—	nn	14	SENT_204	[p8l1396t1710r1920b1779],
14	responders	NNS	O	responder	prep_among	9	SENT_204	[p8l1396t1710r1920b1779],
15	,	,	O	,	_	0	SENT_204	[p8l1396t1710r1920b1779],
16	semiTable	JJ	O	semitable	amod	5	SENT_204	[p8l1968t1711r2145b1765, p8l6t1933r153b1976],

1	1	CD	NUMBER	1	_	0	SENT_205	[p8l176t1935r200b1976],
2	Demographic	JJ	O	demographic	amod	6	SENT_205	[p8l9t2004r367b2058],
3	,	,	O	,	_	0	SENT_205	[p8l9t2004r367b2058],
4	clinical	JJ	O	clinical	amod	6	SENT_205	[p8l405t2004r600b2054],
5	,	,	O	,	_	0	SENT_205	[p8l405t2004r600b2054],
6	laboratory	NN	O	laboratory	nn	9	SENT_205	[p8l638t2004r906b2058],
7	and	CC	O	and	_	0	SENT_205	[p8l943t2004r1036b2047],
8	procedural	JJ	O	procedural	nn	9	SENT_205	[p8l1074t2004r1352b2058],
9	information	NN	O	information	dep	1	SENT_205	[p8l1391t2004r1698b2047],
10	of	IN	O	of	_	0	SENT_205	[p8l1735t2004r1788b2047],
11	the	DT	O	the	det	12	SENT_205	[p8l1819t2004r1901b2047],
12	patients	NNS	O	patient	prep_of	9	SENT_205	[p8l1939t2005r2145b2058],
13	(	IN	O	(	dep	14	SENT_205	[p8l9t2075r246b2129],
14	N	NN	O	n	dep	1	SENT_205	[p8l9t2075r246b2129],
15	=	JJ	O	=	amod	14	SENT_205	[p8l9t2075r246b2129],
16	112	CD	NUMBER	112	num	17	SENT_205	[p8l9t2075r246b2129],
17	)	NN	O	)	dep	14	SENT_205	[p8l9t2075r246b2129],
18	.	.	O	.	_	0	SENT_205	[p8l9t2075r246b2129],

1	Age	NNP	O	Age	dep	131	SENT_206	[p8l53t2198r149b2251],
2	(	CD	NUMBER	(	dep	131	SENT_206	[p8l172t2196r360b2251],
3	years	NNS	NUMBER	year	dep	131	SENT_206	[p8l172t2196r360b2251],
4	)	RB	O	)	dep	131	SENT_206	[p8l172t2196r360b2251],
5	,	,	O	,	_	0	SENT_206	[p8l172t2196r360b2251],
6	mean	NN	O	mean	dep	131	SENT_206	[p8l384t2209r526b2240],
7	:	:	O	:	_	0	SENT_206	[p8l539t2203r575b2240],
8	l	NN	O	l	dep	131	SENT_206	[p8l539t2203r575b2240],
9	:	:	O	:	_	0	SENT_206	[p8l539t2203r575b2240],
10	SD	NN	O	sd	dep	131	SENT_206	[p8l589t2198r652b2240],
11	58	CD	NUMBER	58	dep	131	SENT_206	[p8l1855t2198r1915b2240],
12	i	FW	O	i	dep	131	SENT_206	[p8l1930t2203r1967b2240],
13	11	CD	NUMBER	11	dep	131	SENT_206	[p8l1983t2198r2033b2240],
14	Sex	NN	ORGANIZATION	sex	dep	131	SENT_206	[p8l56t2272r143b2314],
15	Male	NN	ORGANIZATION	male	dep	131	SENT_206	[p8l56t2340r193b2391],
16	,	,	O	,	_	0	SENT_206	[p8l56t2340r193b2391],
17	n	NN	O	n	dep	131	SENT_206	[p8l217t2353r245b2384],
18	(	CD	PERCENT	(	dep	131	SENT_206	[p8l268t2341r341b2394],
19	%	NN	PERCENT	%	dep	131	SENT_206	[p8l268t2341r341b2394],
20	)	CD	NUMBER	)	dep	131	SENT_206	[p8l268t2341r341b2394],
21	79	CD	NUMBER	79	dep	131	SENT_206	[p8l1855t2343r1916b2384],
22	(	NN	O	(	dep	131	SENT_206	[p8l1939t2341r2042b2394],
23	70	CD	NUMBER	70	dep	131	SENT_206	[p8l1939t2341r2042b2394],
24	)	CD	NUMBER	)	dep	131	SENT_206	[p8l1939t2341r2042b2394],
25	Female	JJ	O	female	dep	131	SENT_206	[p8l56t2412r251b2462],
26	,	,	O	,	_	0	SENT_206	[p8l56t2412r251b2462],
27	n	NN	O	n	dep	131	SENT_206	[p8l274t2424r302b2455],
28	(	CD	PERCENT	(	dep	131	SENT_206	[p8l325t2412r398b2466],
29	%	NN	PERCENT	%	dep	131	SENT_206	[p8l325t2412r398b2466],
30	)	CD	NUMBER	)	dep	131	SENT_206	[p8l325t2412r398b2466],
31	33	CD	NUMBER	33	dep	131	SENT_206	[p8l1853t2414r1914b2455],
32	(	NN	O	(	dep	131	SENT_206	[p8l1939t2412r2043b2466],
33	29	CD	NUMBER	29	dep	131	SENT_206	[p8l1939t2412r2043b2466],
34	)	CD	NUMBER	)	dep	131	SENT_206	[p8l1939t2412r2043b2466],
35	Smoking	NN	O	smoking	dep	131	SENT_206	[p8l56t2483r291b2538],
36	,	,	O	,	_	0	SENT_206	[p8l56t2483r291b2538],
37	n	NN	O	n	dep	131	SENT_206	[p8l314t2496r342b2527],
38	(	CD	PERCENT	(	dep	131	SENT_206	[p8l365t2483r439b2537],
39	%	NN	PERCENT	%	dep	131	SENT_206	[p8l365t2483r439b2537],
40	)	CD	NUMBER	)	dep	131	SENT_206	[p8l365t2483r439b2537],
41	47	CD	NUMBER	47	dep	131	SENT_206	[p8l1853t2485r1915b2526],
42	(	NN	O	(	dep	131	SENT_206	[p8l1939t2483r2043b2537],
43	42	CD	NUMBER	42	dep	131	SENT_206	[p8l1939t2483r2043b2537],
44	)	CD	NUMBER	)	dep	131	SENT_206	[p8l1939t2483r2043b2537],
45	Diabetes	NNP	O	Diabetes	dep	131	SENT_206	[p8l56t2553r276b2597],
46	mellitus	NN	O	mellitus	dep	131	SENT_206	[p8l301t2553r522b2604],
47	,	,	O	,	_	0	SENT_206	[p8l301t2553r522b2604],
48	n	NN	O	n	dep	131	SENT_206	[p8l545t2566r573b2597],
49	(	CD	PERCENT	(	dep	131	SENT_206	[p8l596t2554r670b2608],
50	%	NN	PERCENT	%	dep	131	SENT_206	[p8l596t2554r670b2608],
51	)	CD	NUMBER	)	dep	131	SENT_206	[p8l596t2554r670b2608],
52	21	CD	NUMBER	21	dep	131	SENT_206	[p8l1854t2556r1910b2597],
53	(	NN	O	(	dep	131	SENT_206	[p8l1939t2554r2043b2607],
54	19	CD	NUMBER	19	dep	131	SENT_206	[p8l1939t2554r2043b2607],
55	)	CD	NUMBER	)	dep	131	SENT_206	[p8l1939t2554r2043b2607],
56	HTN5	NN	O	htn5	dep	131	SENT_206	[p8l56t2623r190b2668],
57	‘	CD	NUMBER	‘	dep	131	SENT_206	[p8l56t2623r190b2668],
58	(	CD	NUMBER	(	dep	131	SENT_206	[p8l213t2625r760b2679],
59	BP2140/90mmHg	NN	O	bp2140/90mmhg	dep	131	SENT_206	[p8l213t2625r760b2679],
60	)	NN	O	)	dep	131	SENT_206	[p8l213t2625r760b2679],
61	,	,	O	,	_	0	SENT_206	[p8l213t2625r760b2679],
62	n	NN	O	n	dep	131	SENT_206	[p8l784t2637r812b2668],
63	(	CD	PERCENT	(	dep	131	SENT_206	[p8l835t2625r908b2679],
64	%	NN	PERCENT	%	dep	131	SENT_206	[p8l835t2625r908b2679],
65	)	CD	NUMBER	)	dep	131	SENT_206	[p8l835t2625r908b2679],
66	57	CD	NUMBER	57	dep	131	SENT_206	[p8l1855t2628r1915b2668],
67	(	NN	O	(	dep	131	SENT_206	[p8l1939t2625r2043b2679],
68	51	CD	NUMBER	51	dep	131	SENT_206	[p8l1939t2625r2043b2679],
69	)	CD	NUMBER	)	dep	131	SENT_206	[p8l1939t2625r2043b2679],
70	Hyper	JJ	O	hyper	dep	131	SENT_206	[p8l56t2699r213b2751],
71	lipidemia	NN	O	lipidemia	dep	131	SENT_206	[p8l234t2696r477b2751],
72	(	NN	O	(	dep	131	SENT_206	[p8l499t2696r671b2750],
73	LDL-C	NN	O	ldl-c	dep	131	SENT_206	[p8l499t2696r671b2750],
74	2	CD	NUMBER	2	dep	131	SENT_206	[p8l686t2704r721b2747],
75	100	CD	NUMBER	100	dep	131	SENT_206	[p8l739t2698r830b2740],
76	mg/dL	NN	O	mg/dl	dep	131	SENT_206	[p8l844t2696r1037b2751],
77	)	NN	O	)	dep	131	SENT_206	[p8l844t2696r1037b2751],
78	,	,	O	,	_	0	SENT_206	[p8l844t2696r1037b2751],
79	n	NN	O	n	dep	131	SENT_206	[p8l1060t2709r1088b2740],
80	(	CD	PERCENT	(	dep	131	SENT_206	[p8l1111t2696r1185b2750],
81	%	NN	PERCENT	%	dep	131	SENT_206	[p8l1111t2696r1185b2750],
82	)	CD	NUMBER	)	dep	131	SENT_206	[p8l1111t2696r1185b2750],
83	76	CD	NUMBER	76	dep	131	SENT_206	[p8l1855t2699r1916b2740],
84	(	NN	O	(	dep	131	SENT_206	[p8l1939t2696r2043b2750],
85	68	CD	NUMBER	68	dep	131	SENT_206	[p8l1939t2696r2043b2750],
86	)	CD	NUMBER	)	dep	131	SENT_206	[p8l1939t2696r2043b2750],
87	BMIb	NN	O	bmib	dep	131	SENT_206	[p8l56t2757r181b2810],
88	(	CD	NUMBER	(	dep	131	SENT_206	[p8l204t2759r413b2821],
89	kg/m2	NN	O	kg/m2	dep	131	SENT_206	[p8l204t2759r413b2821],
90	)	NN	O	)	dep	131	SENT_206	[p8l204t2759r413b2821],
91	,	,	O	,	_	0	SENT_206	[p8l204t2759r413b2821],
92	mean	VB	O	mean	dep	131	SENT_206	[p8l437t2780r578b2811],
93	i	FW	O	i	dep	131	SENT_206	[p8l591t2774r628b2810],
94	SD	NN	O	sd	dep	131	SENT_206	[p8l642t2769r705b2811],
95	26.3	CD	NUMBER	26.3	dep	131	SENT_206	[p8l1854t2769r1961b2811],
96	:	:	O	:	_	0	SENT_206	[p8l1977t2774r2013b2810],
97	l	NN	O	l	dep	131	SENT_206	[p8l1977t2774r2013b2810],
98	:	:	O	:	_	0	SENT_206	[p8l1977t2774r2013b2810],
99	5.0	CD	NUMBER	5.0	dep	131	SENT_206	[p8l2027t2769r2099b2811],
100	Multi	NNP	O	Multi	dep	131	SENT_206	[p8l56t2838r193b2881],
101	vessel	NN	O	vessel	dep	131	SENT_206	[p8l216t2837r369b2881],
102	disease	NN	O	disease	dep	131	SENT_206	[p8l393t2836r611b2888],
103	‘	NN	O	‘	dep	131	SENT_206	[p8l393t2836r611b2888],
104	,	,	O	,	_	0	SENT_206	[p8l393t2836r611b2888],
105	n	NN	O	n	dep	131	SENT_206	[p8l635t2850r663b2881],
106	(	CD	PERCENT	(	dep	131	SENT_206	[p8l686t2837r759b2892],
107	%	NN	PERCENT	%	dep	131	SENT_206	[p8l686t2837r759b2892],
108	)	CD	NUMBER	)	dep	131	SENT_206	[p8l686t2837r759b2892],
109	34	CD	NUMBER	34	dep	131	SENT_206	[p8l1853t2840r1917b2881],
110	(	NN	O	(	dep	131	SENT_206	[p8l1939t2838r2042b2891],
111	30	CD	NUMBER	30	dep	131	SENT_206	[p8l1939t2838r2042b2891],
112	)	CD	NUMBER	)	dep	131	SENT_206	[p8l1939t2838r2042b2891],
113	LVEFe	NN	O	lvefe	dep	131	SENT_206	[p8l56t2907r376b2959],
114	<	JJR	O	<	dep	131	SENT_206	[p8l56t2907r376b2959],
115	45	CD	PERCENT	45	dep	131	SENT_206	[p8l56t2907r376b2959],
116	%	NN	PERCENT	%	dep	131	SENT_206	[p8l56t2907r376b2959],
117	,	,	O	,	_	0	SENT_206	[p8l56t2907r376b2959],
118	n	NN	O	n	dep	131	SENT_206	[p8l399t2921r427b2952],
119	(	CD	PERCENT	(	dep	131	SENT_206	[p8l450t2909r523b2963],
120	%	NN	PERCENT	%	dep	131	SENT_206	[p8l450t2909r523b2963],
121	)	CD	NUMBER	)	dep	131	SENT_206	[p8l450t2909r523b2963],
122	10	CD	NUMBER	10	dep	131	SENT_206	[p8l1857t2911r1916b2952],
123	(	CD	NUMBER	(	dep	131	SENT_206	[p8l1939t2909r2010b2963],
124	9	CD	NUMBER	9	dep	131	SENT_206	[p8l1939t2909r2010b2963],
125	)	NN	O	)	dep	131	SENT_206	[p8l1939t2909r2010b2963],
126	WBCf	NN	O	wbcf	dep	131	SENT_206	[p8l53t2970r198b3024],
127	(	NN	O	(	dep	131	SENT_206	[p8l216t2980r270b3035],
128	X	NN	O	x	dep	131	SENT_206	[p8l216t2980r270b3035],
129	1000	CD	DATE	1000	dep	131	SENT_206	[p8l283t2980r426b3035],
130	/	:	O	/	dep	131	SENT_206	[p8l283t2980r426b3035],
131	p.	NN	O	p.	_	0	SENT_206	[p8l434t2980r533b3037],
132	.	.	O	.	_	0	SENT_206	[p8l434t2980r533b3037],

1	L	NN	O	l	nn	2	SENT_207	[p8l434t2980r533b3037],
2	)	NN	O	)	_	0	SENT_207	[p8l434t2980r533b3037],
3	,	,	O	,	_	0	SENT_207	[p8l434t2980r533b3037],
4	mean	NN	O	mean	appos	2	SENT_207	[p8l557t2993r698b3024],
5	II	CD	NUMBER	ii	num	4	SENT_207	[p8l711t2987r748b3024],
6	:	:	O	:	_	0	SENT_207	[p8l711t2987r748b3024],
7	so	RB	O	so	quantmod	9	SENT_207	[p8l762t2982r825b3024],
8	7.2	CD	NUMBER	7.2	number	9	SENT_207	[p8l1855t2982r1928b3025],
9	3	CD	NUMBER	3	dep	2	SENT_207	[p8l1944t2987r1980b3024],
10	:	:	O	:	_	0	SENT_207	[p8l1944t2987r1980b3024],
11	1.9	CD	NUMBER	1.9	num	12	SENT_207	[p8l1996t2982r2065b3025],
12	PLTg	NN	O	pltg	dep	9	SENT_207	[p8l56t3050r168b3095],
13	(	CD	NUMBER	(	num	14	SENT_207	[p8l189t3051r507b3108],
14	>	JJR	O	>	dep	15	SENT_207	[p8l189t3051r507b3108],
15	<	JJR	O	<	dep	12	SENT_207	[p8l189t3051r507b3108],
16	1000/p	CD	NUMBER	1000/p	dep	12	SENT_207	[p8l189t3051r507b3108],
17	.	.	O	.	_	0	SENT_207	[p8l189t3051r507b3108],

1	L	NN	O	l	nn	2	SENT_208	[p8l189t3051r507b3108],
2	)	NN	O	)	_	0	SENT_208	[p8l189t3051r507b3108],
3	,	,	O	,	_	0	SENT_208	[p8l189t3051r507b3108],
4	mean	VB	O	mean	dep	7	SENT_208	[p8l531t3064r672b3095],
5	3	CD	NUMBER	3	dobj	4	SENT_208	[p8l685t3058r722b3095],
6	:	:	O	:	_	0	SENT_208	[p8l685t3058r722b3095],
7	SD	NN	O	sd	appos	2	SENT_208	[p8l735t3054r798b3095],
8	230	CD	NUMBER	230	num	7	SENT_208	[p8l1854t3054r1949b3095],
9	i	FW	O	i	dep	7	SENT_208	[p8l1962t3058r1999b3095],
10	64	CD	NUMBER	64	num	11	SENT_208	[p8l2013t3054r2072b3095],
11	Length	NN	O	length	dep	7	SENT_208	[p8l56t3123r230b3177],
12	of	IN	O	of	prep	11	SENT_208	[p8l252t3122r305b3166],
13	drug-eluting	JJ	O	drug-eluting	amod	14	SENT_208	[p8l322t3123r647b3177],
14	stent	NN	O	stent	dep	25	SENT_208	[p8l669t3129r797b3166],
15	(	CD	NUMBER	(	num	17	SENT_208	[p8l819t3123r974b3177],
16	mm	NN	O	mm	nn	17	SENT_208	[p8l819t3123r974b3177],
17	)	NN	O	)	dep	14	SENT_208	[p8l819t3123r974b3177],
18	,	,	O	,	_	0	SENT_208	[p8l819t3123r974b3177],
19	meaniSD	NNP	O	meaniSD	nn	20	SENT_208	[p8l997t3125r1265b3166],
20	Average	NNP	O	Average	appos	17	SENT_208	[p8l103t3196r311b3248],
21	of	IN	O	of	_	0	SENT_208	[p8l334t3194r387b3238],
22	the	DT	O	the	det	23	SENT_208	[p8l403t3194r484b3238],
23	lengths	NNS	O	length	prep_of	20	SENT_208	[p8l507t3194r694b3248],
24	21.6	CD	NUMBER	21.6	dep	25	SENT_208	[p8l1854t3196r1963b3238],
25	i	FW	O	i	dep	32	SENT_208	[p8l1977t3201r2013b3237],
26	7.2	CD	NUMBER	7.2	num	27	SENT_208	[p8l2027t3196r2097b3238],
27	Average	NN	O	average	dep	25	SENT_208	[p8l103t3266r311b3319],
28	of	IN	O	of	_	0	SENT_208	[p8l334t3264r387b3308],
29	the	DT	O	the	det	31	SENT_208	[p8l403t3264r484b3308],
30	smallest	JJS	O	smallest	amod	31	SENT_208	[p8l508t3264r721b3308],
31	lengths	NNS	O	length	prep_of	27	SENT_208	[p8l743t3264r930b3319],
32	19.2	CD	NUMBER	19.2	dep	33	SENT_208	[p8l1857t3267r1961b3308],
33	i	FW	O	i	dep	41	SENT_208	[p8l1977t3271r2013b3308],
34	8.2	CD	NUMBER	8.2	num	35	SENT_208	[p8l2027t3267r2097b3308],
35	Average	NN	O	average	dep	33	SENT_208	[p8l103t3338r311b3391],
36	of	IN	O	of	_	0	SENT_208	[p8l334t3336r387b3380],
37	the	DT	O	the	det	39	SENT_208	[p8l403t3336r484b3380],
38	largest	JJS	O	largest	amod	39	SENT_208	[p8l507t3336r680b3391],
39	lengths	NNS	O	length	prep_of	35	SENT_208	[p8l702t3336r889b3391],
40	24.0	CD	NUMBER	24.0	num	41	SENT_208	[p8l1854t3338r1963b3380],
41	:1	CD	NUMBER	:1	dep	12	SENT_208	[p8l1976t3343r2013b3379],
42	:	:	O	:	_	0	SENT_208	[p8l1976t3343r2013b3379],
43	8.1	CD	NUMBER	8.1	num	44	SENT_208	[p8l2026t3338r2092b3380],
44	Diameter	NN	O	diameter	dep	50	SENT_208	[p8l56t3407r296b3450],
45	of	IN	O	of	_	0	SENT_208	[p8l317t3406r370b3450],
46	drug-eluting	JJ	O	drug-eluting	amod	47	SENT_208	[p8l387t3406r712b3461],
47	stent	NN	O	stent	prep_of	44	SENT_208	[p8l734t3413r862b3450],
48	(	CD	NUMBER	(	num	49	SENT_208	[p8l883t3407r1039b3460],
49	mm	NN	O	mm	dep	50	SENT_208	[p8l883t3407r1039b3460],
50	)	NN	O	)	dep	57	SENT_208	[p8l883t3407r1039b3460],
51	,	,	O	,	_	0	SENT_208	[p8l883t3407r1039b3460],
52	meaniSD	NNP	O	meaniSD	nn	53	SENT_208	[p8l1062t3409r1330b3450],
53	Average	NNP	O	Average	appos	50	SENT_208	[p8l103t3480r311b3532],
54	of	IN	O	of	_	0	SENT_208	[p8l334t3478r387b3521],
55	the	DT	O	the	det	56	SENT_208	[p8l403t3478r484b3521],
56	diameters	NNS	O	diameter	prep_of	50	SENT_208	[p8l507t3478r763b3521],
57	3.1	CD	NUMBER	3.1	dep	59	SENT_208	[p8l1853t3480r1923b3522],
58	:	:	O	:	_	0	SENT_208	[p8l1944t3484r1980b3521],
59	l	NN	O	l	dep	41	SENT_208	[p8l1944t3484r1980b3521],
60	:	:	O	:	_	0	SENT_208	[p8l1944t3484r1980b3521],
61	1.3	CD	NUMBER	1.3	num	62	SENT_208	[p8l1996t3480r2064b3522],
62	Average	NN	O	average	dep	68	SENT_208	[p8l103t3551r311b3604],
63	of	IN	O	of	_	0	SENT_208	[p8l334t3549r387b3593],
64	the	DT	O	the	det	66	SENT_208	[p8l403t3549r484b3593],
65	smallest	JJS	O	smallest	amod	66	SENT_208	[p8l508t3549r721b3593],
66	diameters	NNS	O	diameter	prep_of	62	SENT_208	[p8l743t3549r999b3593],
67	2.9	CD	NUMBER	2.9	dep	68	SENT_208	[p8l1854t3551r1929b3593],
68	i	FW	O	i	dep	76	SENT_208	[p8l1944t3556r1980b3592],
69	0.7	CD	NUMBER	0.7	num	70	SENT_208	[p8l1994t3551r2064b3593],
70	Average	NN	O	average	dep	68	SENT_208	[p8l103t3622r311b3674],
71	of	IN	O	of	_	0	SENT_208	[p8l334t3620r387b3663],
72	the	DT	O	the	det	74	SENT_208	[p8l403t3620r484b3663],
73	largest	JJS	O	largest	amod	74	SENT_208	[p8l507t3620r680b3674],
74	diameters	NNS	O	diameter	prep_of	70	SENT_208	[p8l702t3620r958b3663],
75	3.3	CD	NUMBER	3.3	num	76	SENT_208	[p8l1853t3622r1927b3664],
76	3:27	CD	TIME	3:27	dep	59	SENT_208	[p8l1944t3622r2065b3664],

1	3	CD	NUMBER	3	nsubj	2	SENT_209	[p9l59t20r79b40],
2	Hypertension	NN	O	hypertension	_	0	SENT_209	[p9l114t22r475b76],
3	.	.	O	.	_	0	SENT_209	[p9l114t22r475b76],
4	'	''	O	'	_	0	SENT_209	[p9l59t82r81b111],

1	9	CD	NUMBER	9	num	2	SENT_210	[p9l59t82r81b111],
2	Body	NN	O	body	_	0	SENT_210	[p9l116t91r244b146],
3	mass	NN	O	mass	nn	4	SENT_210	[p9l266t104r393b135],
4	index	NN	O	index	dep	2	SENT_210	[p9l417t91r571b135],
5	.	.	O	.	_	0	SENT_210	[p9l417t91r571b135],

1	C	NN	O	c	nn	2	SENT_211	[p9l59t161r77b182],
2	Involving	NN	O	involving	_	0	SENT_211	[p9l112t163r353b217],
3	2	CD	NUMBER	2	dep	2	SENT_211	[p9l374t165r401b206],
4	or	CC	O	or	_	0	SENT_211	[p9l426t175r479b206],
5	more	JJR	O	more	dep	2	SENT_211	[p9l500t175r633b206],
6	coronary	JJ	O	coronary	amod	7	SENT_211	[p9l655t175r884b217],
7	arteries	NNS	O	artery	dep	3	SENT_211	[p9l905t164r1112b207],
8	.	.	O	.	_	0	SENT_211	[p9l905t164r1112b207],

1	dlntervention	NN	O	dlntervention	_	0	SENT_212	[p9l9t225r354b278],
2	involving	VBG	O	involve	partmod	1	SENT_212	[p9l377t234r618b289],
3	2	CD	NUMBER	2	num	7	SENT_212	[p9l638t236r666b277],
4	or	CC	O	or	_	0	SENT_212	[p9l691t247r744b278],
5	more	JJR	O	more	num	7	SENT_212	[p9l765t247r897b278],
6	coronary	JJ	O	coronary	amod	7	SENT_212	[p9l920t247r1148b289],
7	arteries	NNS	O	artery	dobj	2	SENT_212	[p9l1169t235r1376b278],
8	.	.	O	.	_	0	SENT_212	[p9l1169t235r1376b278],

1	6	CD	NUMBER	6	_	0	SENT_213	[p9l59t303r79b324],
2	Left	VBN	O	leave	partmod	1	SENT_213	[p9l114t304r209b348],
3	ventricular	JJ	O	ventricular	amod	5	SENT_213	[p9l228t304r514b348],
4	ejection	NN	O	ejection	nn	5	SENT_213	[p9l535t305r739b359],
5	fraction	NN	O	fraction	dobj	2	SENT_213	[p9l761t304r972b348],
6	.	.	O	.	_	0	SENT_213	[p9l761t304r972b348],

1	f	LS	O	f	dep	2	SENT_214	[p9l59t366r76b395],
2	White	NNP	O	White	_	0	SENT_214	[p9l103t376r262b419],
3	blood	NN	O	blood	prep	2	SENT_214	[p9l285t376r428b419],
4	cells	NNS	O	cell	dep	3	SENT_214	[p9l451t376r575b420],
5	.	.	O	.	_	0	SENT_214	[p9l451t376r575b420],

1	g	NN	O	g	nn	2	SENT_215	[p9l58t446r81b475],
2	Platelets	NNS	O	platelet	_	0	SENT_215	[p9l115t448r345b492],
3	.	.	O	.	_	0	SENT_215	[p9l115t448r345b492],

1	906	CD	NUMBER	906	num	3	SENT_216	[p9l342t568r386b589],
2	S.	NNP	PERSON	S.	nn	3	SENT_216	[p9l1033t568r1051b589],
3	Namazi	NNP	PERSON	Namazi	_	0	SENT_216	[p9l1062t567r1155b589],
4	et	FW	O	et	nn	5	SENT_216	[p9l1165t570r1188b589],
5	al.	FW	O	al.	dep	3	SENT_216	[p9l1197t567r1223b589],
6	/	:	O	/	punct	3	SENT_216	[p9l1227t567r1239b594],
7	Biochemical	JJ	O	biochemical	amod	8	SENT_216	[p9l1243t567r1388b589],
8	Pharmacology	NN	O	pharmacology	dep	3	SENT_216	[p9l1398t567r1569b594],
9	83	CD	NUMBER	83	number	10	SENT_216	[p9l1580t568r1608b589],
10	(	CD	NUMBER	(	num	11	SENT_216	[p9l1619t567r1700b594],
11	2012	CD	DATE	2012	dep	8	SENT_216	[p9l1619t567r1700b594],
12	)	CD	NUMBER	)	number	13	SENT_216	[p9l1619t567r1700b594],
13	903-908	CD	NUMBER	903-908	num	11	SENT_216	[p9l1710t568r1817b589],

1	Expressor	NNP	O	Expressor	_	0	SENT_217	[p9l845t689r1216b769],
2	genotype	NN	O	genotype	dep	1	SENT_217	[p9l1246t692r1576b769],

1	Platelet	NN	O	platelet	nn	2	SENT_218	[p9l155t1432r207b1675],
2	aggregation	NN	O	aggregation	_	0	SENT_218	[p9l155t1016r223b1414],
3	,	,	O	,	_	0	SENT_218	[p9l155t1016r223b1414],
4	%	NN	O	%	appos	2	SENT_218	[p9l155t923r207b994],
5	(	CD	NUMBER	(	dep	2	SENT_218	[p9l241t1542r306b1568],
6	by	IN	O	by	_	0	SENT_218	[p9l241t1447r309b1524],
7	ADP	NN	O	adp	nn	10	SENT_218	[p9l241t1277r294b1432],
8	20	CD	TIME	20	num	10	SENT_218	[p9l241t1188r294b1263],
9	pM	NN	TIME	pm	nn	10	SENT_218	[p9l241t1025r309b1167],
10	)	NN	O	)	prep_by	5	SENT_218	[p9l241t1025r309b1167],

1	B	NN	O	b	nn	2	SENT_219	[p9l567t1888r765b1931],
2	q	NN	O	q	_	0	SENT_219	[p9l567t1888r765b1931],
3	+	CC	O	+	_	0	SENT_219	[p9l567t1888r765b1931],
4	2	CD	NUMBER	2	num	5	SENT_219	[p9l1017t1891r1042b1931],
5	I1	NN	O	i1	conj_+	2	SENT_219	[p9l1054t1888r1086b1931],
6	24	CD	NUMBER	24	num	7	SENT_219	[p9l1382t1888r1438b1931],
7	h	NN	O	h	dep	2	SENT_219	[p9l1450t1888r1481b1931],
8	30	CD	NUMBER	30	dep	7	SENT_219	[p9l1764t1888r1819b1931],
9	(	NN	O	(	prep	8	SENT_219	[p9l1831t1888r1862b1931],
10	1	CD	NUMBER	1	dep	9	SENT_219	[p9l1831t1888r1862b1931],
11	'	''	O	'	_	0	SENT_219	[p9l703t1981r869b2033],

1	I.	NN	O	i.	_	0	SENT_220	[p9l703t1981r869b2033],
2	‘	CD	NUMBER	‘	num	1	SENT_220	[p9l703t1981r869b2033],
3	i	FW	O	i	dep	1	SENT_220	[p9l703t1981r869b2033],
4	:	:	O	:	_	0	SENT_220	[p9l703t1981r869b2033],
5	ne	NN	O	ne	dep	1	SENT_220	[p9l703t1981r869b2033],
6	of	IN	O	of	_	0	SENT_220	[p9l888t1981r959b2033],
7	platelet	NN	O	platelet	nn	8	SENT_220	[p9l971t1981r1209b2049],
8	aggregation	NN	O	aggregation	prep_of	5	SENT_220	[p9l1228t1981r1607b2049],
9	t-est	IN	O	t-est	amod	8	SENT_220	[p9l1628t1984r1742b2033],

1	Noon-expiressor	JJ	O	noon-expiressor	amod	2	SENT_221	[p9l758t2203r1296b2283],
2	genotype	NN	O	genotype	_	0	SENT_221	[p9l1326t2206r1656b2283],

1	Platelet	NN	O	platelet	nn	2	SENT_222	[p9l158t2966r211b3210],
2	aggregation	NN	O	aggregation	_	0	SENT_222	[p9l158t2551r229b2948],
3	,	,	O	,	_	0	SENT_222	[p9l158t2551r229b2948],
4	%	NN	O	%	appos	2	SENT_222	[p9l158t2458r211b2529],
5	(	CD	NUMBER	(	num	4	SENT_222	[p9l247t3077r312b3102],
6	by	IN	O	by	_	0	SENT_222	[p9l244t2982r315b3059],
7	ADP	NN	O	adp	prep_by	4	SENT_222	[p9l244t2812r300b2969],
8	20	CD	NUMBER	20	num	10	SENT_222	[p9l244t2720r300b2797],
9	y	NN	O	y	nn	10	SENT_222	[p9l244t2560r315b2702],
10	q	NN	O	q	dep	2	SENT_222	[p9l244t2560r315b2702],
11	+	CC	O	+	rcmod	10	SENT_222	[p9l244t2560r315b2702],

1	Baseline	NN	O	baseline	_	0	SENT_223	[p9l561t3425r759b3471],
2	'	''	O	'	_	0	SENT_223	[p9l1005t3428r1033b3471],
3	2	CD	NUMBER	2	num	4	SENT_223	[p9l1005t3428r1033b3471],
4	q	NN	O	q	dep	1	SENT_223	[p9l1045t3425r1077b3471],
5	+	CC	O	+	_	0	SENT_223	[p9l1045t3425r1077b3471],
6	24	CD	NUMBER	24	num	7	SENT_223	[p9l1376t3428r1431b3471],
7	I1	NN	O	i1	conj_+	4	SENT_223	[p9l1443t3425r1474b3471],
8	30	CD	NUMBER	30	num	9	SENT_223	[p9l1760t3428r1813b3471],
9	id	NN	O	id	dep	1	SENT_223	[p9l1826t3425r1856b3471],

1	Time	NNP	O	Time	_	0	SENT_224	[p9l697t3541r860b3594],
2	of	IN	O	of	_	0	SENT_224	[p9l882t3541r953b3594],
3	platelet	NN	O	platelet	nn	5	SENT_224	[p9l965t3541r1203b3608],
4	aggregation	NN	O	aggregation	nn	5	SENT_224	[p9l1221t3541r1598b3608],
5	test	NN	O	test	prep_of	1	SENT_224	[p9l1619t3547r1733b3594],

1	Fig	NN	O	fig	_	0	SENT_225	[p10l6t47r99b101],
2	.	.	O	.	_	0	SENT_225	[p10l6t47r99b101],

1	1	LS	NUMBER	1	_	0	SENT_226	[p10l116t49r159b91],
2	.	.	O	.	_	0	SENT_226	[p10l116t49r159b91],

1	Plot	NN	O	plot	nsubj	5	SENT_227	[p10l175t47r274b91],
2	of	IN	PERCENT	of	_	0	SENT_227	[p10l288t47r342b91],
3	%	NN	PERCENT	%	nn	4	SENT_227	[p10l351t49r383b91],
4	platelet	NN	O	platelet	prep_of	1	SENT_227	[p10l399t47r595b101],
5	aggregation	NN	O	aggregation	_	0	SENT_227	[p10l609t48r914b101],
6	at	IN	O	at	_	0	SENT_227	[p10l929t53r977b91],
7	20	CD	TIME	20	num	9	SENT_227	[p10l992t49r1054b91],
8	p.M	NN	TIME	p.m	nn	9	SENT_227	[p10l1075t50r1165b104],
9	ADP	NN	O	adp	prep_at	5	SENT_227	[p10l1179t49r1289b90],
10	vs.	CC	O	vs.	prep	9	SENT_227	[p10l1303t60r1364b91],
11	time	NN	O	time	dep	10	SENT_227	[p10l1381t48r1498b91],
12	for	IN	O	for	_	0	SENT_227	[p10l1514t47r1585b91],
13	the	DT	O	the	det	14	SENT_227	[p10l1599t47r1680b91],
14	expressor	NN	O	expressor	prep_for	5	SENT_227	[p10l1696t60r1947b101],
15	and	CC	O	and	_	0	SENT_227	[p10l1961t47r2054b91],
16	the	DT	O	the	det	20	SENT_227	[p10l2070t47r2151b91],
17	non	JJ	O	non	amod	20	SENT_227	[p10l7t131r381b173],
18	—	NN	O	—	nn	20	SENT_227	[p10l7t131r381b173],
19	expressor	NN	O	expressor	nn	20	SENT_227	[p10l7t131r381b173],
20	groups	NNS	O	group	prep_for	5	SENT_227	[p10l393t131r581b173],
21	.	.	O	.	_	0	SENT_227	[p10l393t131r581b173],

1	There	EX	O	there	expl	2	SENT_228	[p10l595t118r742b162],
2	was	VBD	O	be	dep	15	SENT_228	[p10l755t131r855b162],
3	signiﬁcant	JJ	O	signiﬁcant	amod	4	SENT_228	[p10l871t118r1140b173],
4	differences	NNS	O	difference	nsubj	2	SENT_228	[p10l1154t118r1436b162],
5	at	IN	O	at	_	0	SENT_228	[p10l1452t125r1500b162],
6	all	DT	O	all	det	7	SENT_228	[p10l1512t118r1572b162],
7	points	NNS	O	point	prep_at	4	SENT_228	[p10l1588t119r1746b173],
8	compared	VBN	O	compare	_	0	SENT_228	[p10l1762t118r2019b173],
9	with	IN	O	with	prepc_compared_with	7	SENT_228	[p10l2032t118r2151b162],
10	the	DT	O	the	det	11	SENT_228	[p10l6t190r88b233],
11	baseline	NN	O	baseline	pobj	7	SENT_228	[p10l110t190r322b233],
12	in	IN	O	in	_	0	SENT_228	[p10l346t190r393b233],
13	both	DT	O	both	det	14	SENT_228	[p10l415t190r533b233],
14	groups	NNS	O	group	prep_in	11	SENT_228	[p10l554t202r729b244],
15	(	VBP	O	(	_	0	SENT_228	[p10l753t190r805b244],
16	P	NN	O	p	dep	17	SENT_228	[p10l753t190r805b244],
17	<	JJR	O	<	dobj	15	SENT_228	[p10l821t203r856b235],
18	0.001	CD	NUMBER	0.001	num	19	SENT_228	[p10l876t190r1049b244],
19	)	NN	O	)	nsubj	15	SENT_228	[p10l876t190r1049b244],
20	.	.	O	.	_	0	SENT_228	[p10l876t190r1049b244],

1	responders	NNS	O	responder	_	0	SENT_229	[p10l8t399r379b467],
2	,	,	O	,	_	0	SENT_229	[p10l8t399r379b467],
3	and	CC	O	and	_	0	SENT_229	[p10l402t399r519b454],
4	responders	NNS	O	responder	conj_and	1	SENT_229	[p10l541t399r896b467],
5	(	CD	NUMBER	(	num	6	SENT_229	[p10l919t399r983b467],
6	P	NN	O	p	dep	7	SENT_229	[p10l919t399r983b467],
7	>	JJR	O	>	dep	1	SENT_229	[p10l1004t415r1047b456],
8	0.05	CD	NUMBER	0.05	num	9	SENT_229	[p10l1072t399r1248b467],
9	)	NN	O	)	dep	7	SENT_229	[p10l1072t399r1248b467],
10	.	.	O	.	_	0	SENT_229	[p10l1072t399r1248b467],

1	The	DT	O	the	det	3	SENT_230	[p10l1268t399r1385b454],
2	allele	NN	O	allele	nn	3	SENT_230	[p10l1407t399r1577b454],
3	frequencies	NNS	O	frequency	nsubj	4	SENT_230	[p10l1599t398r1970b467],
4	were	VBD	O	be	_	0	SENT_230	[p10l1991t414r2151b454],
5	in	IN	O	in	_	0	SENT_230	[p10l8t488r67b542],
6	Hardy	NNP	LOCATION	Hardy	prep_in	4	SENT_230	[p10l96t487r653b556],
7	.	.	O	.	_	0	SENT_230	[p10l96t487r653b556],

1	—	NN	O	—	_	0	SENT_231	[p10l96t487r653b556],
2	.	.	O	.	_	0	SENT_231	[p10l96t487r653b556],

1	Weinberg	NNP	PERSON	Weinberg	_	0	SENT_232	[p10l96t487r653b556],
2	equilibrium	NN	O	equilibrium	dep	1	SENT_232	[p10l680t487r1077b556],
3	.	.	O	.	_	0	SENT_232	[p10l680t487r1077b556],

1	Since	IN	O	since	mark	12	SENT_233	[p10l110t578r290b640],
2	,	,	O	,	_	0	SENT_233	[p10l110t578r290b640],
3	the	DT	O	the	det	5	SENT_233	[p10l310t577r411b632],
4	CYP3A5	NN	O	cyp3a5	nn	5	SENT_233	[p10l432t579r665b632],
5	*	NN	O	*	nsubjpass	12	SENT_233	[p10l688t577r739b631],
6	1	CD	NUMBER	1	dep	5	SENT_233	[p10l688t577r739b631],
7	/	:	O	/	punct	9	SENT_233	[p10l750t577r770b645],
8	*	CD	NUMBER	*	num	9	SENT_233	[p10l779t577r830b631],
9	1	CD	NUMBER	1	dep	5	SENT_233	[p10l779t577r830b631],
10	genotype	NN	O	genotype	dep	9	SENT_233	[p10l856t585r1151b645],
11	was	VBD	O	be	auxpass	12	SENT_233	[p10l1169t593r1294b632],
12	observed	VBN	O	observe	advcl	20	SENT_233	[p10l1315t577r1602b632],
13	in	IN	O	in	_	0	SENT_233	[p10l1623t578r1682b631],
14	9	CD	NUMBER	9	num	15	SENT_233	[p10l1701t580r1737b632],
15	patients	NNS	O	patient	prep_in	12	SENT_233	[p10l1758t578r2030b645],
16	,	,	O	,	_	0	SENT_233	[p10l1758t578r2030b645],
17	the	DT	O	the	det	18	SENT_233	[p10l2050t577r2151b632],
18	subjects	NNS	O	subject	nsubjpass	20	SENT_233	[p10l8t666r265b734],
19	were	VBD	O	be	auxpass	20	SENT_233	[p10l313t682r472b721],
20	divided	VBN	O	divide	_	0	SENT_233	[p10l521t666r757b721],
21	into	IN	O	into	_	0	SENT_233	[p10l808t667r932b721],
22	two	CD	NUMBER	two	num	24	SENT_233	[p10l980t674r1102b721],
23	genotype	NN	O	genotype	nn	24	SENT_233	[p10l1150t674r1446b734],
24	groups	NNS	O	group	prep_into	20	SENT_233	[p10l1494t682r1731b734],
25	;	:	O	;	_	0	SENT_233	[p10l1494t682r1731b734],
26	those	DT	O	those	nsubj	30	SENT_233	[p10l1784t666r1957b721],
27	with	IN	O	with	_	0	SENT_233	[p10l2004t666r2152b721],
28	expressor	NN	O	expressor	nn	29	SENT_233	[p10l7t770r317b823],
29	alleles	NNS	O	allele	prep_with	26	SENT_233	[p10l361t754r559b809],
30	(	VBP	O	(	parataxis	20	SENT_233	[p10l608t754r780b823],
31	*	NN	O	*	dobj	30	SENT_233	[p10l608t754r780b823],
32	1	CD	NUMBER	1	dep	31	SENT_233	[p10l608t754r780b823],
33	/	:	O	/	punct	49	SENT_233	[p10l608t754r780b823],
34	*	CD	NUMBER	*	number	35	SENT_233	[p10l608t754r780b823],
35	1	CD	NUMBER	1	nsubj	49	SENT_233	[p10l608t754r780b823],
36	and	CC	O	and	_	0	SENT_233	[p10l834t754r1106b823],
37	*	CD	NUMBER	*	number	38	SENT_233	[p10l834t754r1106b823],
38	1	CD	NUMBER	1	nsubj	49	SENT_233	[p10l834t754r1106b823],
39	/	:	O	/	punct	42	SENT_233	[p10l834t754r1106b823],
40	*	CD	NUMBER	*	number	41	SENT_233	[p10l834t754r1106b823],
41	3	CD	NUMBER	3	num	42	SENT_233	[p10l834t754r1106b823],
42	alleles	NNS	O	allele	dep	35	SENT_233	[p10l1157t754r1381b822],
43	)	NN	O	)	dep	42	SENT_233	[p10l1157t754r1381b822],
44	and	CC	O	and	_	0	SENT_233	[p10l1428t754r1544b809],
45	those	DT	O	those	dep	35	SENT_233	[p10l1591t754r1763b809],
46	with	IN	O	with	_	0	SENT_233	[p10l1809t754r1956b809],
47	nonexpressor	JJ	O	nonexpressor	amod	48	SENT_233	[p10l2003t770r2151b809, p10l7t859r317b912],
48	alleles	NNS	O	allele	prep_with	45	SENT_233	[p10l358t843r556b898],
49	(	VBP	O	(	dep	31	SENT_233	[p10l601t843r779b912],
50	*	CD	NUMBER	*	number	51	SENT_233	[p10l601t843r779b912],
51	3	CD	NUMBER	3	dobj	49	SENT_233	[p10l601t843r779b912],
52	/	:	O	/	punct	49	SENT_233	[p10l601t843r779b912],
53	*	CD	NUMBER	*	number	54	SENT_233	[p10l601t843r779b912],
54	3	CD	NUMBER	3	num	55	SENT_233	[p10l601t843r779b912],
55	alleles	NNS	O	allele	dep	31	SENT_233	[p10l823t843r1062b912],
56	)	CD	NUMBER	)	dep	55	SENT_233	[p10l823t843r1062b912],
57	.	.	O	.	_	0	SENT_233	[p10l823t843r1062b912],

1	The	DT	O	the	det	3	SENT_234	[p10l1105t843r1221b898],
2	two	CD	NUMBER	two	num	3	SENT_234	[p10l1265t851r1387b898],
3	groups	NNS	O	group	nsubj	6	SENT_234	[p10l1429t859r1646b912],
4	did	VBD	O	do	aux	6	SENT_234	[p10l1691t843r1790b898],
5	not	RB	O	not	neg	6	SENT_234	[p10l1835t851r1939b898],
6	differ	VB	O	differ	_	0	SENT_234	[p10l1982t843r2153b898],
7	signiﬁcantly	RB	O	signiﬁcantly	amod	17	SENT_234	[p10l8t932r400b1001],
8	in	IN	O	in	_	0	SENT_234	[p10l417t933r476b987],
9	terms	NNS	O	term	prep_in	7	SENT_234	[p10l493t941r675b988],
10	of	IN	O	of	_	0	SENT_234	[p10l695t932r761b988],
11	age	NN	O	age	prep_of	9	SENT_234	[p10l771t948r892b1001],
12	,	,	O	,	_	0	SENT_234	[p10l771t948r892b1001],
13	BMI	NN	O	bmus	conj_and	11	SENT_234	[p10l912t936r1036b987],
14	and	CC	O	and	_	0	SENT_234	[p10l1055t932r1170b988],
15	sex	NN	O	sex	conj_and	11	SENT_234	[p10l1190t948r1293b988],
16	(	JJ	O	(	amod	17	SENT_234	[p10l1310t933r1374b1001],
17	P	NN	O	p	dobj	6	SENT_234	[p10l1310t933r1374b1001],
18	>	JJR	O	>	tmod	6	SENT_234	[p10l1394t949r1437b990],
19	0.05	CD	NUMBER	0.05	num	20	SENT_234	[p10l1462t933r1636b1001],
20	)	NN	O	)	dep	18	SENT_234	[p10l1462t933r1636b1001],
21	.	.	O	.	_	0	SENT_234	[p10l1462t933r1636b1001],

1	There	EX	O	there	expl	2	SENT_235	[p10l1653t933r1834b988],
2	were	VBD	O	be	_	0	SENT_235	[p10l1850t948r2009b988],
3	also	RB	O	also	advmod	2	SENT_235	[p10l2027t933r2151b988],
4	no	DT	O	no	det	6	SENT_235	[p10l8t1037r85b1076],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_235	[p10l122t1021r453b1090],
6	differences	NNS	O	difference	nsubj	2	SENT_235	[p10l489t1021r837b1076],
7	between	IN	O	between	_	0	SENT_235	[p10l873t1021r1148b1076],
8	these	DT	O	these	det	9	SENT_235	[p10l1184t1021r1353b1076],
9	groups	NNS	O	group	prep_between	6	SENT_235	[p10l1388t1037r1604b1090],
10	and	CC	O	and	_	0	SENT_235	[p10l1642t1021r1758b1076],
11	clopidogrel	NN	O	clopidogrel	conj_and	9	SENT_235	[p10l1795t1021r2150b1090],

1	Elli	NNP	PERSON	Elli	_	0	SENT_236	[p10l349t1223r447b1260],
2	:	:	O	:	_	0	SENT_236	[p10l349t1223r447b1260],

1	Change	NNP	O	Change	_	0	SENT_237	[p10l155t2060r217b2282],
2	in	IN	O	in	_	0	SENT_237	[p10l155t1989r201b2045],
3	platelet	NN	O	platelet	nn	4	SENT_237	[p10l155t1753r217b1968],
4	agg	NN	O	agg	prep_in	1	SENT_237	[p10l167t1636r217b1738],
5	‘	NN	O	‘	nn	7	SENT_237	[p10l167t1636r217b1738],
6	'	''	O	'	_	0	SENT_237	[p10l167t1673r169b1691],
7	*	NN	O	*	dep	4	SENT_237	[p10l167t1673r169b1691],
8	!	.	O	!	_	0	SENT_237	[p10l167t1580r201b1658],

1	o	NN	O	o	_	0	SENT_238	[p10l167t1580r201b1658],
2	+	CC	O	+	_	0	SENT_238	[p10l167t1580r201b1658],
3	gatinii	NN	O	gatinius	conj_+	1	SENT_238	[p10l155t1380r217b1593],
4	,	,	O	,	_	0	SENT_238	[p10l155t1380r217b1593],
5	%	NN	O	%	appos	1	SENT_238	[p10l155t1294r201b1359],
6	(	CD	NUMBER	(	num	5	SENT_238	[p10l232t2007r293b2032],
7	by	IN	O	by	_	0	SENT_238	[p10l232t1922r294b1990],
8	w	NN	O	w	prep_by	5	SENT_238	[p10l232t1768r278b1910],
9	!	.	O	!	_	0	SENT_238	[p10l232t1768r278b1910],

1	o	NN	O	o	_	0	SENT_239	[p10l232t1768r278b1910],
2	+	CC	O	+	_	0	SENT_239	[p10l232t1768r278b1910],
3	20	CD	NUMBER	20	conj_+	1	SENT_239	[p10l232t1688r278b1756],
4	}	CD	NUMBER	}	num	6	SENT_239	[p10l232t1543r294b1670],
5	uM	NN	O	um	nn	6	SENT_239	[p10l232t1543r294b1670],
6	)	NN	O	)	dep	1	SENT_239	[p10l232t1543r294b1670],

1	Time	NNP	O	Time	_	0	SENT_240	[p10l469t2525r617b2575],
2	of	IN	O	of	_	0	SENT_240	[p10l635t2525r700b2575],
3	platelet	NN	O	platelet	nn	4	SENT_240	[p10l709t2525r925b2586],
4	‘	NN	O	‘	prep_of	1	SENT_240	[p10l709t2525r925b2586],
5	aggregation	NN	O	aggregation	nn	6	SENT_240	[p10l937t2525r1280b2586],
6	test	NN	O	test	dep	1	SENT_240	[p10l1299t2531r1401b2575],
7	after	IN	O	after	_	0	SENT_240	[p10l1419t2525r1564b2575],
8	baseline	NN	O	baseline	prep_after	6	SENT_240	[p10l1576t2525r1807b2575],

1	Fig	NN	O	fig	_	0	SENT_241	[p10l6t2667r99b2722],
2	.	.	O	.	_	0	SENT_241	[p10l6t2667r99b2722],

1	2	LS	NUMBER	2	_	0	SENT_242	[p10l114t2670r158b2711],
2	.	.	O	.	_	0	SENT_242	[p10l114t2670r158b2711],

1	The	DT	O	the	det	16	SENT_243	[p10l171t2667r265b2711],
2	percentage	NN	O	percentage	amod	16	SENT_243	[p10l281t2674r565b2722],
3	of	IN	O	of	_	0	SENT_243	[p10l581t2667r634b2711],
4	platelet	NN	O	platelet	nn	6	SENT_243	[p10l643t2667r839b2722],
5	aggregation	NN	O	aggregation	nn	6	SENT_243	[p10l853t2668r1158b2722],
6	inhibition	NN	O	inhibition	prep_of	2	SENT_243	[p10l1173t2667r1427b2711],
7	vs.	CC	O	vs.	prep	6	SENT_243	[p10l1441t2680r1502b2711],
8	time	NN	O	time	dep	7	SENT_243	[p10l1518t2668r1636b2711],
9	after	IN	O	after	_	0	SENT_243	[p10l1651t2667r1771b2711],
10	taking	VBG	O	take	prepc_after	2	SENT_243	[p10l1784t2667r1946b2722],
11	600	CD	NUMBER	600	num	13	SENT_243	[p10l1960t2670r2054b2711],
12	mg	NN	O	mg	nn	13	SENT_243	[p10l2072t2680r2152b2722],
13	clopidogrel	NN	O	clopidogrel	nsubj	15	SENT_243	[p10l7t2739r295b2793],
14	(	CD	NUMBER	(	num	15	SENT_243	[p10l334t2739r462b2793],
15	ADP	NN	ORGANIZATION	adp	xcomp	10	SENT_243	[p10l334t2739r462b2793],
16	concentration	NN	O	concentration	nsubj	17	SENT_243	[p10l500t2739r859b2782],
17	=	JJ	O	=	_	0	SENT_243	[p10l875t2757r902b2770],
18	20	CD	NUMBER	20	num	21	SENT_243	[p10l920t2741r982b2782],
19	p.	NN	O	p.	nn	21	SENT_243	[p10l1003t2739r1128b2795],
20	M	NN	O	m	nn	21	SENT_243	[p10l1003t2739r1128b2795],
21	)	NN	O	)	dobj	17	SENT_243	[p10l1003t2739r1128b2795],
22	.	.	O	.	_	0	SENT_243	[p10l1003t2739r1128b2795],

1	There	EX	O	there	expl	2	SENT_244	[p10l1164t2739r1311b2782],
2	was	VBD	O	be	dep	16	SENT_244	[p10l1347t2751r1447b2782],
3	no	DT	O	no	det	5	SENT_244	[p10l1487t2751r1549b2782],
4	signiﬁcant	NN	O	signiﬁcant	nn	5	SENT_244	[p10l1588t2739r1857b2793],
5	difference	NN	O	difference	nsubj	2	SENT_244	[p10l1893t2739r2151b2782],
6	between	IN	O	between	_	0	SENT_244	[p10l6t2810r229b2854],
7	the	DT	O	the	det	9	SENT_244	[p10l251t2810r333b2854],
8	CYP3A5	NN	O	cyp3a5	nn	9	SENT_244	[p10l356t2812r544b2854],
9	expressor	NN	O	expressor	prep_between	5	SENT_244	[p10l567t2823r818b2865],
10	and	CC	O	and	_	0	SENT_244	[p10l838t2810r932b2854],
11	the	DT	O	the	det	15	SENT_244	[p10l955t2810r1036b2854],
12	non	JJ	O	non	amod	15	SENT_244	[p10l1059t2823r1433b2865],
13	—	NN	O	—	nn	15	SENT_244	[p10l1059t2823r1433b2865],
14	expressor	NN	O	expressor	nn	15	SENT_244	[p10l1059t2823r1433b2865],
15	groups	NNS	O	group	prep_between	5	SENT_244	[p10l1453t2823r1628b2865],
16	(	VBP	O	(	_	0	SENT_244	[p10l1652t2810r1704b2864],
17	P	NN	O	p	dep	18	SENT_244	[p10l1652t2810r1704b2864],
18	>	JJR	O	>	dobj	16	SENT_244	[p10l1720t2823r1755b2855],
19	0.05	CD	NUMBER	0.05	num	20	SENT_244	[p10l1775t2810r1916b2864],
20	)	NN	O	)	nsubj	16	SENT_244	[p10l1775t2810r1916b2864],
21	.	.	O	.	_	0	SENT_244	[p10l1775t2810r1916b2864],

1	non	JJ	O	non	amod	3	SENT_245	[p10l9t3019r641b3086],
2	—	NN	O	—	nn	3	SENT_245	[p10l9t3019r641b3086],
3	responsiveness	NN	O	responsiveness	_	0	SENT_245	[p10l9t3019r641b3086],
4	(	CD	NUMBER	(	num	5	SENT_245	[p10l671t3018r735b3086],
5	P	NN	O	p	dep	6	SENT_245	[p10l671t3018r735b3086],
6	>	JJR	O	>	dep	3	SENT_245	[p10l755t3034r798b3075],
7	0.05	CD	NUMBER	0.05	num	8	SENT_245	[p10l824t3018r997b3086],
8	)	NN	O	)	dep	6	SENT_245	[p10l824t3018r997b3086],
9	.	.	O	.	_	0	SENT_245	[p10l824t3018r997b3086],

1	The	DT	O	the	det	2	SENT_246	[p10l1025t3018r1141b3073],
2	inhibition	NN	O	inhibition	nsubjpass	10	SENT_246	[p10l1172t3018r1483b3073],
3	of	IN	O	of	_	0	SENT_246	[p10l1513t3018r1579b3073],
4	platelet	NN	O	platelet	nn	5	SENT_246	[p10l1601t3018r1842b3086],
5	aggregation	NN	O	aggregation	prep_of	2	SENT_246	[p10l1871t3034r2145b3086, p10l8t3107r133b3161],
6	after	IN	O	after	_	0	SENT_246	[p10l150t3106r299b3161],
7	clopidogrel	NN	O	clopidogrel	nn	8	SENT_246	[p10l313t3106r667b3175],
8	treatment	NN	O	treatment	prep_after	5	SENT_246	[p10l684t3114r1004b3161],
9	was	VBD	O	be	auxpass	10	SENT_246	[p10l1018t3122r1141b3161],
10	evaluated	VBN	O	evaluate	dep	38	SENT_246	[p10l1159t3106r1469b3161],
11	in	IN	O	in	_	0	SENT_246	[p10l1486t3107r1545b3161],
12	both	CC	O	both	preconj	14	SENT_246	[p10l1560t3106r1706b3161],
13	the	DT	O	the	det	14	SENT_246	[p10l1722t3106r1822b3161],
14	expressor	NN	O	expressor	prep_in	10	SENT_246	[p10l1840t3122r2148b3175],
15	and	CC	O	and	_	0	SENT_246	[p10l9t3195r124b3250],
16	the	DT	O	the	det	20	SENT_246	[p10l145t3195r246b3250],
17	non	JJ	O	non	amod	20	SENT_246	[p10l267t3211r727b3264],
18	—	NN	O	—	nn	20	SENT_246	[p10l267t3211r727b3264],
19	expressor	NN	O	expressor	nn	20	SENT_246	[p10l267t3211r727b3264],
20	groups	NNS	O	group	conj_and	14	SENT_246	[p10l744t3211r960b3264],
21	and	CC	O	and	_	0	SENT_246	[p10l981t3195r1097b3250],
22	was	VBD	O	be	auxpass	23	SENT_246	[p10l1116t3211r1240b3250],
23	found	VBN	O	find	conj_and	10	SENT_246	[p10l1262t3195r1446b3250],
24	to	TO	O	to	aux	26	SENT_246	[p10l1466t3203r1528b3250],
25	be	VB	O	be	cop	26	SENT_246	[p10l1548t3195r1621b3250],
26	signiﬁcant	JJ	O	signiﬁcant	xcomp	23	SENT_246	[p10l1643t3195r1973b3264],
27	at	IN	O	at	_	0	SENT_246	[p10l1992t3203r2052b3250],
28	all	DT	O	all	det	29	SENT_246	[p10l2071t3195r2145b3250],
29	points	NNS	O	point	prep_at	26	SENT_246	[p10l9t3285r205b3353],
30	compared	VBN	O	compare	_	0	SENT_246	[p10l238t3285r554b3353],
31	with	IN	O	with	prepc_compared_with	29	SENT_246	[p10l585t3285r732b3340],
32	the	DT	O	the	det	33	SENT_246	[p10l762t3284r863b3340],
33	baseline	NN	O	baseline	pobj	29	SENT_246	[p10l895t3285r1156b3340],
34	in	IN	O	in	_	0	SENT_246	[p10l1189t3285r1248b3339],
35	the	DT	O	the	predet	37	SENT_246	[p10l1279t3284r1379b3340],
36	both	DT	O	both	det	37	SENT_246	[p10l1411t3285r1556b3340],
37	groups	NNS	O	group	prep_in	33	SENT_246	[p10l1586t3300r1801b3353],
38	(	VBP	O	(	_	0	SENT_246	[p10l1836t3285r1899b3353],
39	P	NN	O	p	dep	40	SENT_246	[p10l1836t3285r1899b3353],
40	<	JJR	O	<	dobj	38	SENT_246	[p10l1919t3301r1962b3342],
41	0.05	CD	NUMBER	0.05	num	44	SENT_246	[p10l1987t3285r2146b3353],
42	)	NN	O	)	nn	44	SENT_246	[p10l1987t3285r2146b3353],
43	(	CD	NUMBER	(	num	44	SENT_246	[p10l9t3374r140b3442],
44	Fig	NN	O	fig	nsubj	38	SENT_246	[p10l9t3374r140b3442],
45	.	.	O	.	_	0	SENT_246	[p10l9t3374r140b3442],

1	1	CD	NUMBER	1	_	0	SENT_247	[p10l164t3374r237b3442],
2	)	NN	O	)	dep	1	SENT_247	[p10l164t3374r237b3442],
3	.	.	O	.	_	0	SENT_247	[p10l164t3374r237b3442],

1	Thereafter	RB	O	thereafter	advmod	20	SENT_248	[p10l254t3373r599b3437],
2	,	,	O	,	_	0	SENT_248	[p10l254t3373r599b3437],
3	the	DT	O	the	det	4	SENT_248	[p10l618t3373r719b3428],
4	efﬁcacy	NN	O	efﬁcacy	nsubjpass	20	SENT_248	[p10l738t3373r979b3442],
5	of	IN	O	of	_	0	SENT_248	[p10l997t3373r1063b3428],
6	clopidogrel	NN	O	clopidogrel	prep_of	4	SENT_248	[p10l1073t3373r1428b3442],
7	in	IN	O	in	_	0	SENT_248	[p10l1448t3374r1507b3428],
8	terms	NNS	O	term	prep_in	6	SENT_248	[p10l1524t3382r1707b3428],
9	of	IN	O	of	_	0	SENT_248	[p10l1726t3373r1792b3428],
10	the	DT	O	the	det	11	SENT_248	[p10l1802t3373r1903b3428],
11	change	NN	O	change	prep_of	8	SENT_248	[p10l1922t3373r2145b3442],
12	in	IN	O	in	_	0	SENT_248	[p10l9t3464r69b3517],
13	aggregation	NN	O	aggregation	prep_in	11	SENT_248	[p10l88t3464r463b3531],
14	from	IN	O	from	_	0	SENT_248	[p10l482t3463r634b3518],
15	baseline	NN	O	baseline	nn	18	SENT_248	[p10l652t3463r913b3518],
16	(	CD	NUMBER	(	num	18	SENT_248	[p10l933t3463r1044b3531],
17	R1	NN	O	r1	nn	18	SENT_248	[p10l933t3463r1044b3531],
18	)	NN	O	)	prep_from	13	SENT_248	[p10l933t3463r1044b3531],
19	was	VBD	O	be	auxpass	20	SENT_248	[p10l1063t3479r1186b3518],
20	compared	VBN	O	compare	_	0	SENT_248	[p10l1207t3463r1524b3531],
21	between	IN	O	between	_	0	SENT_248	[p10l1543t3463r1817b3518],
22	these	DT	O	these	det	24	SENT_248	[p10l1836t3463r2004b3518],
23	two	CD	NUMBER	two	num	24	SENT_248	[p10l2024t3471r2145b3518],
24	groups	NNS	O	group	prep_between	20	SENT_248	[p10l8t3568r240b3620],
25	.	.	O	.	_	0	SENT_248	[p10l8t3568r240b3620],

1	Although	IN	O	although	mark	4	SENT_249	[p10l274t3552r583b3620],
2	,	,	O	,	_	0	SENT_249	[p10l274t3552r583b3620],
3	there	EX	O	there	expl	4	SENT_249	[p10l619t3552r784b3607],
4	were	VBD	O	be	advcl	19	SENT_249	[p10l818t3568r976b3607],
5	no	DT	O	no	det	7	SENT_249	[p10l1012t3568r1089b3607],
6	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_249	[p10l1125t3552r1455b3620],
7	differences	NNS	O	difference	iobj	4	SENT_249	[p10l1489t3552r1836b3607],
8	between	IN	O	between	_	0	SENT_249	[p10l1871t3552r2145b3607],
9	them	PRP	O	they	prep_between	7	SENT_249	[p10l8t3640r175b3695],
10	(	RB	O	(	advmod	7	SENT_249	[p10l190t3640r254b3708],
11	P	NN	O	p	dep	12	SENT_249	[p10l190t3640r254b3708],
12	>	JJR	O	>	dep	7	SENT_249	[p10l274t3657r317b3697],
13	0.05	CD	NUMBER	0.05	num	14	SENT_249	[p10l342t3640r516b3709],
14	)	NN	O	)	dep	12	SENT_249	[p10l342t3640r516b3709],
15	,	,	O	,	_	0	SENT_249	[p10l342t3640r516b3709],
16	CYP3A5	NN	O	cyp3a5	nn	18	SENT_249	[p10l533t3643r765b3695],
17	expressor	NN	O	expressor	nn	18	SENT_249	[p10l781t3656r1090b3709],
18	group	NN	O	group	nsubj	19	SENT_249	[p10l1102t3656r1287b3709],
19	showed	VBD	O	show	_	0	SENT_249	[p10l1305t3640r1549b3695],
20	a	DT	O	a	det	22	SENT_249	[p10l1566t3656r1598b3695],
21	higher	JJR	O	higher	amod	22	SENT_249	[p10l1615t3640r1820b3709],
22	inhibition	NN	O	inhibition	dobj	19	SENT_249	[p10l1835t3640r2146b3695],
23	of	IN	O	of	_	0	SENT_249	[p10l9t3729r75b3784],
24	platelet	NN	O	platelet	nn	25	SENT_249	[p10l93t3729r333b3798],
25	aggregation	NN	O	aggregation	prep_of	22	SENT_249	[p10l357t3730r733b3798],
26	(	CD	NUMBER	(	num	27	SENT_249	[p10l757t3729r887b3798],
27	Fig	NN	O	fig	dep	25	SENT_249	[p10l757t3729r887b3798],
28	.	.	O	.	_	0	SENT_249	[p10l757t3729r887b3798],

1	2	CD	NUMBER	2	num	2	SENT_250	[p10l914t3729r992b3797],
2	)	CD	NUMBER	)	_	0	SENT_250	[p10l914t3729r992b3797],
3	.	.	O	.	_	0	SENT_250	[p10l914t3729r992b3797],

1	3.4	CD	NUMBER	3.4	_	0	SENT_251	[p11l6t101r111b154],
2	.	.	O	.	_	0	SENT_251	[p11l6t101r111b154],

1	CYPZC	NNP	O	CYPZC	_	0	SENT_252	[p11l155t101r354b153],
2	19	CD	NUMBER	19	num	1	SENT_252	[p11l360t101r427b153],
3	genetic	JJ	O	genetic	amod	4	SENT_252	[p11l449t100r674b167],
4	polymorphism	NN	O	polymorphism	dep	1	SENT_252	[p11l694t98r1140b167],

1	The	DT	O	the	det	3	SENT_253	[p11l108t277r225b332],
2	allele	NN	O	allele	nn	3	SENT_253	[p11l248t277r418b332],
3	frequencies	NNS	O	frequency	nsubj	19	SENT_253	[p11l441t277r810b345],
4	of	IN	O	of	_	0	SENT_253	[p11l835t277r901b332],
5	CYP2C19	NN	O	cyp2c19	nn	6	SENT_253	[p11l917t277r1270b340],
6	*	NN	O	*	prep_of	3	SENT_253	[p11l917t277r1270b340],
7	1	CD	NUMBER	1	num	6	SENT_253	[p11l917t277r1270b340],
8	,	,	O	,	_	0	SENT_253	[p11l917t277r1270b340],
9	CYP2C19	NN	O	cyp2c19	nn	10	SENT_253	[p11l1295t277r1648b340],
10	*	NN	O	*	conj_and	3	SENT_253	[p11l1295t277r1648b340],
11	2	CD	NUMBER	2	dep	10	SENT_253	[p11l1295t277r1648b340],
12	,	,	O	,	_	0	SENT_253	[p11l1295t277r1648b340],
13	and	CC	O	and	_	0	SENT_253	[p11l1672t277r1785b332],
14	CYP2C19	NN	O	cyp2c19	conj_and	3	SENT_253	[p11l1807t277r2144b332],
15	*	CD	NUMBER	*	number	16	SENT_253	[p11l1807t277r2144b332],
16	3	CD	NUMBER	3	dep	14	SENT_253	[p11l1807t277r2144b332],
17	were	VBD	O	be	cop	19	SENT_253	[p11l7t381r167b420],
18	88.99	CD	PERCENT	88.99	num	19	SENT_253	[p11l210t368r446b429],
19	%	NN	PERCENT	%	_	0	SENT_253	[p11l210t368r446b429],
20	,	,	O	,	_	0	SENT_253	[p11l210t368r446b429],
21	10.09	CD	PERCENT	10.09	num	22	SENT_253	[p11l493t368r725b429],
22	%	NN	PERCENT	%	conj_and	19	SENT_253	[p11l493t368r725b429],
23	,	,	O	,	_	0	SENT_253	[p11l493t368r725b429],
24	and	CC	O	and	_	0	SENT_253	[p11l768t365r884b420],
25	0.91	CD	PERCENT	0.91	num	26	SENT_253	[p11l927t368r1122b429],
26	%	NN	PERCENT	%	conj_and	19	SENT_253	[p11l927t368r1122b429],
27	,	,	O	,	_	0	SENT_253	[p11l927t368r1122b429],
28	respectively	RB	O	respectively	advmod	19	SENT_253	[p11l1165t365r1569b434],
29	.	.	O	.	_	0	SENT_253	[p11l1165t365r1569b434],

1	Due	JJ	O	due	_	0	SENT_254	[p11l1613t369r1738b420],
2	to	TO	O	to	_	0	SENT_254	[p11l1780t373r1842b420],
3	the	DT	O	the	det	5	SENT_254	[p11l1884t365r1986b420],
4	low	JJ	O	low	amod	5	SENT_254	[p11l2029t365r2147b420],
5	frequency	NN	O	frequency	prep_due_to	15	SENT_254	[p11l9t454r331b523],
6	of	IN	O	of	_	0	SENT_254	[p11l357t454r423b509],
7	CYP2C19	NN	O	cyp2c19	prep_of	5	SENT_254	[p11l444t454r797b517],
8	*	CD	NUMBER	*	number	9	SENT_254	[p11l444t454r797b517],
9	3	CD	NUMBER	3	num	7	SENT_254	[p11l444t454r797b517],
10	,	,	O	,	_	0	SENT_254	[p11l444t454r797b517],
11	the	DT	O	the	det	13	SENT_254	[p11l825t454r927b509],
12	statistical	JJ	O	statistical	amod	13	SENT_254	[p11l955t454r1263b509],
13	analysis	NN	O	analysis	nsubjpass	15	SENT_254	[p11l1291t454r1547b523],
14	was	VBD	O	be	auxpass	15	SENT_254	[p11l1574t470r1699b509],
15	based	VBN	O	base	_	0	SENT_254	[p11l1727t454r1911b509],
16	on	IN	O	on	_	0	SENT_254	[p11l1939t470r2017b509],
17	the	DT	O	the	det	18	SENT_254	[p11l2044t454r2145b509],
18	comparison	NN	O	comparison	prep_on	15	SENT_254	[p11l9t544r386b612],
19	between	IN	O	between	_	0	SENT_254	[p11l407t543r685b598],
20	the	DT	O	the	det	21	SENT_254	[p11l705t543r806b598],
21	patients	NNS	O	patient	prep_between	18	SENT_254	[p11l829t544r1086b612],
22	with	IN	O	with	_	0	SENT_254	[p11l1108t543r1256b598],
23	the	DT	O	the	det	25	SENT_254	[p11l1277t543r1378b598],
24	wild	JJ	O	wild	amod	25	SENT_254	[p11l1398t543r1539b598],
25	type	NN	O	type	prep_with	15	SENT_254	[p11l1561t552r1701b612],
26	1	CD	NUMBER	1	number	27	SENT_254	[p11l1726t543r1812b612],
27	*	CD	NUMBER	*	amod	25	SENT_254	[p11l1726t543r1812b612],
28	/	:	O	/	punct	40	SENT_254	[p11l1726t543r1812b612],
29	1	CD	NUMBER	1	num	30	SENT_254	[p11l1822t543r1883b598],
30	*	NN	O	*	dep	40	SENT_254	[p11l1822t543r1883b598],
31	and	CC	O	and	_	0	SENT_254	[p11l1906t543r2022b598],
32	the	DT	O	the	det	33	SENT_254	[p11l2044t543r2145b598],
33	patients	NNS	O	patient	dep	40	SENT_254	[p11l9t633r267b701],
34	with	IN	O	with	_	0	SENT_254	[p11l316t632r465b687],
35	21	CD	NUMBER	21	prep_with	33	SENT_254	[p11l516t635r596b696],
36	variant	JJ	O	variant	amod	40	SENT_254	[p11l652t633r881b687],
37	allele	NN	O	allele	nn	40	SENT_254	[p11l929t632r1099b687],
38	(	CD	NUMBER	(	num	40	SENT_254	[p11l1149t632r1596b701],
39	CYP2C19X/Y	NN	O	cyp2c19x/y	nn	40	SENT_254	[p11l1149t632r1596b701],
40	)	NN	O	)	dep	27	SENT_254	[p11l1149t632r1596b701],
41	.	.	O	.	_	0	SENT_254	[p11l1149t632r1596b701],

1	The	DT	O	the	det	3	SENT_255	[p11l1644t632r1761b687],
2	signiﬁcant	NN	O	signiﬁcant	nn	3	SENT_255	[p11l1812t632r2146b701],
3	difference	NN	O	difference	nsubjpass	14	SENT_255	[p11l9t722r330b777],
4	between	IN	O	between	_	0	SENT_255	[p11l371t722r649b777],
5	the	DT	O	the	det	7	SENT_255	[p11l689t722r791b777],
6	mentioned	VBN	O	mention	amod	7	SENT_255	[p11l834t722r1181b777],
7	groups	NNS	O	group	prep_between	3	SENT_255	[p11l1223t738r1441b790],
8	and	CC	O	and	_	0	SENT_255	[p11l1484t722r1600b777],
9	the	DT	O	the	det	11	SENT_255	[p11l1641t722r1743b777],
10	clopidogrel	NN	O	clopidogrel	nn	11	SENT_255	[p11l1785t722r2144b790],
11	responsiveness	NN	O	responsiveness	conj_and	7	SENT_255	[p11l9t812r495b879],
12	was	VBD	O	be	auxpass	14	SENT_255	[p11l515t827r640b866],
13	not	RB	O	not	neg	14	SENT_255	[p11l663t819r768b866],
14	observed	VBN	O	observe	_	0	SENT_255	[p11l787t811r1076b866],
15	(	CD	NUMBER	(	num	16	SENT_255	[p11l1098t811r1162b879],
16	P	NN	O	p	npadvmod	17	SENT_255	[p11l1098t811r1162b879],
17	>	JJR	O	>	acomp	14	SENT_255	[p11l1183t827r1226b868],
18	0.05	CD	NUMBER	0.05	num	19	SENT_255	[p11l1251t811r1427b879],
19	)	NN	O	)	dep	17	SENT_255	[p11l1251t811r1427b879],
20	.	.	O	.	_	0	SENT_255	[p11l1251t811r1427b879],

1	The	DT	O	the	det	3	SENT_256	[p11l1446t811r1563b866],
2	allele	NN	O	allele	nn	3	SENT_256	[p11l1584t811r1753b866],
3	frequencies	NNS	O	frequency	nsubj	4	SENT_256	[p11l1774t811r2144b879],
4	were	VBD	O	be	_	0	SENT_256	[p11l7t915r167b954],
5	in	IN	O	in	_	0	SENT_256	[p11l196t900r255b954],
6	Hardy	NNP	LOCATION	Hardy	prep_in	4	SENT_256	[p11l283t899r839b968],
7	.	.	O	.	_	0	SENT_256	[p11l283t899r839b968],

1	—	NN	O	—	_	0	SENT_257	[p11l283t899r839b968],
2	.	.	O	.	_	0	SENT_257	[p11l283t899r839b968],

1	Weinberg	NNP	PERSON	Weinberg	_	0	SENT_258	[p11l283t899r839b968],
2	equilibrium	NN	O	equilibrium	dep	1	SENT_258	[p11l866t899r1261b968],
3	.	.	O	.	_	0	SENT_258	[p11l866t899r1261b968],

1	4	LS	NUMBER	4	_	0	SENT_259	[p11l6t1126r64b1177],
2	.	.	O	.	_	0	SENT_259	[p11l6t1126r64b1177],

1	Discussion	NN	O	discussion	_	0	SENT_260	[p11l103t1122r464b1177],

1	Individual	JJ	O	individual	amod	2	SENT_261	[p11l111t1300r431b1355],
2	variability	NN	O	variability	nsubj	10	SENT_261	[p11l455t1300r782b1368],
3	in	IN	O	in	_	0	SENT_261	[p11l807t1301r866b1354],
4	the	DT	O	the	det	5	SENT_261	[p11l890t1300r990b1355],
5	rate	NN	O	rate	prep_in	2	SENT_261	[p11l1017t1308r1139b1355],
6	of	IN	O	of	_	0	SENT_261	[p11l1165t1300r1231b1355],
7	platelet	NN	O	platelet	nn	8	SENT_261	[p11l1249t1300r1490b1368],
8	reactivity	NN	O	reactivity	prep_of	5	SENT_261	[p11l1514t1301r1816b1368],
9	obviously	RB	O	obviously	advmod	10	SENT_261	[p11l1840t1300r2147b1368],
10	inﬂuences	VBZ	O	inﬂuences	_	0	SENT_261	[p11l9t1388r330b1443],
11	normal	JJ	O	normal	amod	12	SENT_261	[p11l374t1388r600b1443],
12	hemostasis	NN	O	hemostasis	dobj	10	SENT_261	[p11l643t1388r996b1443],
13	and	CC	O	and	_	0	SENT_261	[p11l1038t1388r1153b1443],
14	the	DT	O	the	det	16	SENT_261	[p11l1195t1388r1296b1443],
15	pathological	JJ	O	pathological	amod	16	SENT_261	[p11l1338t1388r1726b1457],
16	outcome	NN	O	outcome	conj_and	12	SENT_261	[p11l1769t1396r2046b1443],
17	of	IN	O	of	_	0	SENT_261	[p11l2087t1388r2154b1443],
18	thrombosis	NN	O	thrombosis	prep_of	16	SENT_261	[p11l8t1477r383b1532],
19	.	.	O	.	_	0	SENT_261	[p11l8t1477r383b1532],

1	Such	JJ	O	such	amod	3	SENT_262	[p11l422t1477r572b1532],
2	individual	JJ	O	individual	amod	3	SENT_262	[p11l610t1477r929b1532],
3	variability	NN	O	variability	nsubj	12	SENT_262	[p11l965t1477r1291b1546],
4	is	VBZ	O	be	auxpass	6	SENT_262	[p11l1327t1478r1373b1532],
5	largely	RB	O	largely	advmod	6	SENT_262	[p11l1412t1477r1627b1546],
6	determined	VBN	O	determine	rcmod	3	SENT_262	[p11l1664t1477r2032b1532],
7	by	IN	O	by	_	0	SENT_262	[p11l2070t1477r2147b1546],
8	environmental	JJ	O	environmental	amod	11	SENT_262	[p11l9t1566r477b1621],
9	and	CC	O	and	_	0	SENT_262	[p11l510t1566r625b1621],
10	genetic	JJ	O	genetic	amod	11	SENT_262	[p11l657t1567r888b1635],
11	factors	NNS	O	factor	agent	6	SENT_262	[p11l920t1566r1131b1621],
12	[	VBP	O	[	_	0	SENT_262	[p11l1168t1566r1322b1635],
13	5,6	CD	NUMBER	5,6	number	14	SENT_262	[p11l1168t1566r1322b1635],
14	]	CD	NUMBER	]	dobj	12	SENT_262	[p11l1168t1566r1322b1635],
15	.	.	O	.	_	0	SENT_262	[p11l1168t1566r1322b1635],

1	A	DT	O	a	det	3	SENT_263	[p11l1354t1569r1401b1621],
2	signiﬁcant	JJ	O	signiﬁcant	amod	3	SENT_263	[p11l1432t1566r1762b1635],
3	association	NN	O	association	nsubjpass	15	SENT_263	[p11l1793t1567r2146b1621],
4	between	IN	O	between	_	0	SENT_263	[p11l8t1655r283b1710],
5	environmental	JJ	O	environmental	amod	6	SENT_263	[p11l297t1655r765b1710],
6	factors	NNS	O	factor	prep_between	3	SENT_263	[p11l781t1655r993b1710],
7	and	CC	O	and	_	0	SENT_263	[p11l1008t1655r1123b1710],
8	anti	JJ	O	anti	amod	10	SENT_263	[p11l1139t1656r1259b1710],
9	platelet	NN	O	platelet	nn	10	SENT_263	[p11l1275t1655r1516b1724],
10	effect	NN	O	effect	conj_and	3	SENT_263	[p11l1529t1655r1704b1710],
11	of	IN	O	of	_	0	SENT_263	[p11l1718t1655r1784b1710],
12	clopidogrel	NN	O	clopidogrel	prep_of	10	SENT_263	[p11l1791t1655r2145b1724],
13	was	VBD	O	be	auxpass	15	SENT_263	[p11l7t1761r131b1800],
14	not	RB	O	not	neg	15	SENT_263	[p11l151t1753r256b1800],
15	observed	VBN	O	observe	_	0	SENT_263	[p11l273t1745r559b1800],
16	in	IN	O	in	_	0	SENT_263	[p11l579t1746r638b1799],
17	our	PRP$	O	we	poss	18	SENT_263	[p11l656t1761r764b1800],
18	patients	NNS	O	patient	prep_in	15	SENT_263	[p11l780t1746r1050b1813],
19	.	.	O	.	_	0	SENT_263	[p11l780t1746r1050b1813],

1	This	DT	O	this	det	2	SENT_264	[p11l1068t1745r1199b1800],
2	ﬁnding	NN	O	ﬁnding	nsubj	3	SENT_264	[p11l1219t1745r1444b1813],
3	was	VBD	O	be	dep	13	SENT_264	[p11l1459t1761r1582b1800],
4	in	IN	O	in	_	0	SENT_264	[p11l1603t1746r1662b1799],
5	line	NN	O	line	prep_in	3	SENT_264	[p11l1680t1745r1796b1800],
6	with	IN	O	with	_	0	SENT_264	[p11l1813t1745r1960b1800],
7	other	JJ	O	other	amod	8	SENT_264	[p11l1978t1745r2148b1800],
8	studies	NNS	O	study	prep_with	3	SENT_264	[p11l10t1834r232b1889],
9	performed	VBN	O	perform	partmod	8	SENT_264	[p11l259t1834r593b1902],
10	in	IN	O	in	_	0	SENT_264	[p11l620t1835r679b1888],
11	various	JJ	O	various	amod	12	SENT_264	[p11l701t1835r933b1889],
12	populations	NNS	O	population	prep_in	9	SENT_264	[p11l960t1834r1335b1902],
13	[	VBP	O	[	_	0	SENT_264	[p11l1364t1834r1626b1902],
14	36	CD	NUMBER	36	num	15	SENT_264	[p11l1364t1834r1626b1902],
15	—	CD	NUMBER	—	dobj	13	SENT_264	[p11l1364t1834r1626b1902],
16	38	CD	NUMBER	38	num	17	SENT_264	[p11l1364t1834r1626b1902],
17	]	NN	O	]	nsubj	13	SENT_264	[p11l1364t1834r1626b1902],
18	.	.	O	.	_	0	SENT_264	[p11l1364t1834r1626b1902],

1	Besides	IN	O	besides	_	0	SENT_265	[p11l111t1922r348b1977],
2	environmental	JJ	O	environmental	amod	3	SENT_265	[p11l387t1922r861b1977],
3	parameters	NNS	O	parameter	prep_besides	8	SENT_265	[p11l900t1930r1280b1991],
4	,	,	O	,	_	0	SENT_265	[p11l900t1930r1280b1991],
5	genetic	JJ	O	genetic	amod	6	SENT_265	[p11l1318t1923r1551b1991],
6	factors	NNS	O	factor	nsubj	8	SENT_265	[p11l1589t1922r1803b1977],
7	also	RB	O	also	advmod	8	SENT_265	[p11l1842t1922r1967b1977],
8	contribute	VBP	O	contribute	_	0	SENT_265	[p11l2005t1938r2145b1977, p11l8t2011r228b2066],
9	to	TO	O	to	_	0	SENT_265	[p11l247t2019r309b2066],
10	the	DT	O	the	det	11	SENT_265	[p11l329t2011r431b2066],
11	variability	NN	O	variability	prep_to	8	SENT_265	[p11l448t2011r780b2080],
12	in	IN	O	in	_	0	SENT_265	[p11l798t2012r858b2065],
13	response	NN	O	response	prep_in	11	SENT_265	[p11l878t2027r1162b2080],
14	to	TO	O	to	_	0	SENT_265	[p11l1182t2019r1243b2066],
15	clopidogrel	NN	O	clopidogrel	nn	16	SENT_265	[p11l1264t2011r1623b2080],
16	[	NN	O	[	prep_to	8	SENT_265	[p11l1647t2011r2010b2080],
17	25	CD	NUMBER	25	number	18	SENT_265	[p11l1647t2011r2010b2080],
18	—	CD	NUMBER	—	dep	16	SENT_265	[p11l1647t2011r2010b2080],
19	30,39	CD	NUMBER	30,39	num	20	SENT_265	[p11l1647t2011r2010b2080],
20	]	NN	O	]	dep	18	SENT_265	[p11l1647t2011r2010b2080],
21	.	.	O	.	_	0	SENT_265	[p11l1647t2011r2010b2080],

1	The	DT	O	the	det	2	SENT_266	[p11l2028t2011r2145b2066],
2	effects	NNS	O	effect	nsubjpass	7	SENT_266	[p11l9t2100r215b2155],
3	of	IN	O	of	_	0	SENT_266	[p11l252t2100r318b2155],
4	genetics	NNS	O	genetics	prep_of	2	SENT_266	[p11l344t2101r607b2169],
5	can	MD	O	can	aux	7	SENT_266	[p11l644t2116r753b2155],
6	be	VB	O	be	auxpass	7	SENT_266	[p11l787t2100r861b2155],
7	deﬁned	VBN	O	deﬁned	_	0	SENT_266	[p11l896t2100r1135b2155],
8	by	IN	O	by	_	0	SENT_266	[p11l1169t2100r1247b2169],
9	either	CC	O	either	preconj	10	SENT_266	[p11l1281t2100r1471b2155],
10	pharmacokinetic	JJ	O	pharmacokinetic	amod	13	SENT_266	[p11l1505t2100r2047b2169],
11	or	CC	O	or	_	0	SENT_266	[p11l2081t2116r2148b2155],
12	pharmacodynamic	JJ	O	pharmacodynamic	amod	13	SENT_266	[p11l9t2190r612b2258],
13	parameters	NNS	O	parameter	agent	7	SENT_266	[p11l631t2198r1012b2258],
14	.	.	O	.	_	0	SENT_266	[p11l631t2198r1012b2258],

1	In	IN	O	in	_	0	SENT_267	[p11l1033t2193r1093b2244],
2	our	PRP$	O	we	poss	3	SENT_267	[p11l1113t2206r1222b2245],
3	survey	NN	O	survey	prep_in	15	SENT_267	[p11l1240t2206r1453b2258],
4	the	DT	O	the	det	5	SENT_267	[p11l1471t2190r1573b2245],
5	polymorphism	NN	O	polymorphism	nsubjpass	15	SENT_267	[p11l1593t2190r2067b2258],
6	of	IN	O	of	_	0	SENT_267	[p11l2087t2190r2153b2245],
7	P2Y12	NN	O	p2y12	nn	9	SENT_267	[p11l7t2282r200b2333],
8	receptor	NN	O	receptor	nn	9	SENT_267	[p11l225t2287r495b2347],
9	gene	NN	O	gene	prep_of	5	SENT_267	[p11l516t2295r666b2347],
10	in	IN	O	in	_	0	SENT_267	[p11l692t2280r751b2333],
11	the	DT	O	the	det	13	SENT_267	[p11l775t2279r877b2334],
12	pharmacodynamic	JJ	O	pharmacodynamic	amod	13	SENT_267	[p11l901t2279r1503b2347],
13	site	NN	O	site	prep_in	9	SENT_267	[p11l1529t2280r1639b2334],
14	was	VBD	O	be	auxpass	15	SENT_267	[p11l1662t2295r1787b2334],
15	examined	VBN	O	examine	_	0	SENT_267	[p11l1813t2279r2144b2334],
16	.	.	O	.	_	0	SENT_267	[p11l1813t2279r2144b2334],

1	Since	IN	O	since	mark	7	SENT_268	[p11l9t2368r175b2422],
2	no	DT	O	no	det	3	SENT_268	[p11l196t2383r273b2422],
3	patient	NN	O	patient	nsubj	7	SENT_268	[p11l293t2368r522b2436],
4	was	VBD	O	be	cop	7	SENT_268	[p11l538t2383r663b2422],
5	a	DT	O	a	det	7	SENT_268	[p11l684t2383r716b2422],
6	wild	JJ	O	wild	amod	7	SENT_268	[p11l734t2367r875b2422],
7	type	NN	O	type	advcl	27	SENT_268	[p11l895t2375r1035b2436],
8	and	CC	O	and	_	0	SENT_268	[p11l1055t2367r1171b2422],
9	more	JJR	O	more	mwe	10	SENT_268	[p11l1192t2383r1357b2422],
10	than	IN	O	than	quantmod	11	SENT_268	[p11l1376t2367r1521b2422],
11	92	CD	PERCENT	92	num	12	SENT_268	[p11l1540t2370r1662b2422],
12	%	NN	PERCENT	%	nsubj	16	SENT_268	[p11l1540t2370r1662b2422],
13	of	IN	O	of	_	0	SENT_268	[p11l1682t2367r1748b2422],
14	our	PRP$	O	we	poss	15	SENT_268	[p11l1760t2383r1869b2422],
15	patients	NNS	O	patient	prep_of	12	SENT_268	[p11l1887t2368r2144b2436],
16	had	VBD	O	have	advcl	27	SENT_268	[p11l9t2456r125b2511],
17	CC	NN	O	cc	nn	18	SENT_268	[p11l153t2459r234b2511],
18	genotype	NN	O	genotype	dobj	16	SENT_268	[p11l259t2464r557b2525],
19	for	IN	O	for	_	0	SENT_268	[p11l584t2456r673b2511],
20	P2Y12	NN	O	p2y12	nn	22	SENT_268	[p11l695t2459r888b2511],
21	receptor	NN	O	receptor	nn	22	SENT_268	[p11l916t2464r1185b2525],
22	gene	NN	O	gene	prep_for	18	SENT_268	[p11l1209t2472r1375b2525],
23	,	,	O	,	_	0	SENT_268	[p11l1209t2472r1375b2525],
24	statistical	JJ	O	statistical	amod	25	SENT_268	[p11l1403t2456r1711b2511],
25	analysis	NN	O	analysis	nsubj	27	SENT_268	[p11l1738t2456r1993b2525],
26	was	VBD	O	be	cop	27	SENT_268	[p11l2020t2472r2144b2511],
27	impossible	JJ	O	impossible	_	0	SENT_268	[p11l9t2546r372b2614],
28	.	.	O	.	_	0	SENT_268	[p11l9t2546r372b2614],

1	In	IN	O	in	_	0	SENT_269	[p11l400t2549r459b2600],
2	the	DT	O	the	det	3	SENT_269	[p11l484t2546r586b2601],
3	case	NN	O	case	prep_in	13	SENT_269	[p11l612t2561r746b2601],
4	of	IN	O	of	_	0	SENT_269	[p11l771t2545r838b2601],
5	a	DT	O	a	det	8	SENT_269	[p11l856t2561r888b2601],
6	larger	JJR	O	larger	amod	8	SENT_269	[p11l914t2545r1102b2614],
7	sample	NN	O	sample	nn	8	SENT_269	[p11l1125t2546r1354b2614],
8	size	NN	O	size	prep_of	3	SENT_269	[p11l1380t2546r1515b2609],
9	,	,	O	,	_	0	SENT_269	[p11l1380t2546r1515b2609],
10	we	PRP	O	we	nsubj	20	SENT_269	[p11l1540t2561r1634b2601],
11	could	MD	O	could	aux	13	SENT_269	[p11l1660t2546r1834b2601],
12	probably	RB	O	probably	advmod	13	SENT_269	[p11l1860t2546r2147b2614],
13	ﬁnd	VB	O	ﬁnd	_	0	SENT_269	[p11l9t2634r132b2689],
14	more	JJR	O	more	amod	16	SENT_269	[p11l184t2650r349b2689],
15	gene	NN	O	gene	nn	16	SENT_269	[p11l398t2650r549b2703],
16	variations	NNS	O	variation	dobj	13	SENT_269	[p11l597t2635r916b2689],
17	and	CC	O	and	_	0	SENT_269	[p11l968t2634r1084b2689],
18	could	MD	O	could	aux	20	SENT_269	[p11l1135t2634r1309b2689],
19	probably	RB	O	probably	advmod	20	SENT_269	[p11l1360t2634r1646b2703],
20	ﬁnd	VB	O	ﬁnd	conj_and	13	SENT_269	[p11l1695t2634r1818b2689],
21	different	JJ	O	different	amod	23	SENT_269	[p11l1868t2634r2146b2689],
22	statistical	JJ	O	statistical	amod	23	SENT_269	[p11l10t2724r317b2779],
23	results	NNS	O	result	dobj	20	SENT_269	[p11l351t2724r580b2779],
24	.	.	O	.	_	0	SENT_269	[p11l351t2724r580b2779],

1	A	DT	O	a	det	2	SENT_270	[p11l611t2726r658b2778],
2	study	NN	O	study	nsubj	7	SENT_270	[p11l689t2724r866b2792],
3	by	IN	O	by	_	0	SENT_270	[p11l896t2724r974b2792],
4	Angiolillo	NNP	O	Angiolillo	prep_by	2	SENT_270	[p11l1002t2724r1313b2792],
5	et	FW	O	et	nn	6	SENT_270	[p11l1345t2732r1405b2779],
6	al.	FW	O	al.	dep	4	SENT_270	[p11l1436t2724r1505b2779],
7	showed	VBD	O	show	_	0	SENT_270	[p11l1540t2724r1787b2779],
8	that	IN	O	that	complm	10	SENT_270	[p11l1818t2724r1948b2779],
9	there	EX	O	there	expl	10	SENT_270	[p11l1978t2724r2145b2779],
10	were	VBD	O	be	ccomp	7	SENT_270	[p11l7t2829r167b2868],
11	no	DT	O	no	det	13	SENT_270	[p11l194t2829r271b2868],
12	signiﬁcant	JJ	O	signiﬁcant	amod	13	SENT_270	[p11l299t2813r634b2881],
13	differences	NNS	O	difference	nsubj	10	SENT_270	[p11l660t2813r1011b2868],
14	between	IN	O	between	_	0	SENT_270	[p11l1038t2813r1316b2868],
15	TT	NN	O	tt	nn	16	SENT_270	[p11l1339t2816r1418b2867],
16	genotype	NN	O	genotype	prep_between	13	SENT_270	[p11l1443t2821r1741b2881],
17	and	CC	O	and	_	0	SENT_270	[p11l1767t2813r1883b2868],
18	C	NN	O	c	nn	20	SENT_270	[p11l1911t2816r1949b2868],
19	allele	NN	O	allele	nn	20	SENT_270	[p11l1976t2813r2145b2868],
20	carriers	NNS	O	carrier	nsubj	21	SENT_270	[p11l9t2902r249b2956],
21	(	VBP	O	(	conj_and	10	SENT_270	[p11l309t2901r415b2969],
22	CT	NN	O	ct	nn	25	SENT_270	[p11l309t2901r415b2969],
23	and	CC	O	and	_	0	SENT_270	[p11l471t2901r587b2956],
24	CC	NN	MISC	cc	nn	25	SENT_270	[p11l646t2901r752b2969],
25	)	NN	O	)	dobj	21	SENT_270	[p11l646t2901r752b2969],
26	in	IN	O	in	_	0	SENT_270	[p11l810t2902r870b2956],
27	clopidogrel	NN	O	clopidogrel	nn	28	SENT_270	[p11l928t2901r1287b2970],
28	response	NN	O	response	prep_in	21	SENT_270	[p11l1346t2917r1630b2970],
29	in	IN	O	in	_	0	SENT_270	[p11l1689t2902r1748b2956],
30	a	DT	O	a	det	32	SENT_270	[p11l1806t2917r1838b2956],
31	Spanish	JJ	LOCATION	spanish	amod	32	SENT_270	[p11l1897t2901r2146b2970],
32	population	NN	O	population	prep_in	28	SENT_270	[p11l9t2990r374b3059],
33	.	.	O	.	_	0	SENT_270	[p11l9t2990r374b3059],

1	In	IN	O	in	_	0	SENT_271	[p11l406t2994r466b3045],
2	their	PRP$	O	they	poss	3	SENT_271	[p11l496t2990r650b3045],
3	survey	NN	O	survey	prep_in	10	SENT_271	[p11l678t3006r905b3059],
4	,	,	O	,	_	0	SENT_271	[p11l678t3006r905b3059],
5	the	DT	O	the	det	7	SENT_271	[p11l936t2990r1038b3045],
6	genotype	NN	O	genotype	nn	7	SENT_271	[p11l1067t2998r1365b3059],
7	distribution	NN	O	distribution	nsubj	10	SENT_271	[p11l1395t2990r1776b3045],
8	was	VBD	O	be	cop	10	SENT_271	[p11l1804t3006r1929b3045],
9	22/36	CD	PERCENT	22/36	number	10	SENT_271	[p11l1960t2990r2145b3059],
10	(	CD	PERCENT	(	dep	26	SENT_271	[p11l9t3080r241b3148],
11	61.1	CD	PERCENT	61.1	num	12	SENT_271	[p11l9t3080r241b3148],
12	%	NN	PERCENT	%	dep	10	SENT_271	[p11l9t3080r241b3148],
13	)	CD	NUMBER	)	num	15	SENT_271	[p11l9t3080r241b3148],
14	TT	NN	O	tt	nn	15	SENT_271	[p11l281t3083r361b3134],
15	genotype	NN	O	genotype	dep	10	SENT_271	[p11l401t3088r714b3148],
16	,	,	O	,	_	0	SENT_271	[p11l401t3088r714b3148],
17	and	CC	O	and	_	0	SENT_271	[p11l758t3080r874b3135],
18	14/36	CD	PERCENT	14/36	conj_and	10	SENT_271	[p11l921t3079r1102b3148],
19	(	CD	PERCENT	(	number	20	SENT_271	[p11l1146t3080r1377b3148],
20	38.9	CD	PERCENT	38.9	num	21	SENT_271	[p11l1146t3080r1377b3148],
21	%	NN	PERCENT	%	dep	18	SENT_271	[p11l1146t3080r1377b3148],
22	)	CD	NUMBER	)	num	25	SENT_271	[p11l1146t3080r1377b3148],
23	C	NN	O	c	nn	25	SENT_271	[p11l1421t3082r1459b3135],
24	allele	NN	O	allele	nn	25	SENT_271	[p11l1502t3080r1671b3135],
25	carriers	NNS	O	carrier	nsubj	26	SENT_271	[p11l1715t3080r1955b3135],
26	[	VBP	O	[	_	0	SENT_271	[p11l2003t3079r2144b3148],
27	24	CD	NUMBER	24	num	28	SENT_271	[p11l2003t3079r2144b3148],
28	]	CD	NUMBER	]	dobj	26	SENT_271	[p11l2003t3079r2144b3148],
29	.	.	O	.	_	0	SENT_271	[p11l2003t3079r2144b3148],

1	Another	DT	O	another	det	2	SENT_272	[p11l6t3168r270b3223],
2	study	NN	O	study	nsubj	63	SENT_272	[p11l295t3168r473b3237],
3	by	IN	O	by	_	0	SENT_272	[p11l498t3168r575b3237],
4	Alessi	NNP	PERSON	Alessi	prep_by	2	SENT_272	[p11l599t3168r785b3223],
5	et	FW	O	et	nn	6	SENT_272	[p11l813t3177r873b3223],
6	al.	FW	O	al.	nsubj	14	SENT_272	[p11l898t3168r967b3224],
7	in	IN	O	in	_	0	SENT_272	[p11l997t3169r1056b3223],
8	a	DT	O	a	det	10	SENT_272	[p11l1082t3184r1115b3223],
9	French	JJ	MISC	french	amod	10	SENT_272	[p11l1142t3168r1358b3223],
10	population	NN	O	population	prep_in	6	SENT_272	[p11l1385t3168r1735b3237],
11	also	RB	O	also	advmod	14	SENT_272	[p11l1761t3168r1886b3223],
12	did	VBD	O	do	aux	14	SENT_272	[p11l1914t3168r2014b3223],
13	not	RB	O	not	neg	14	SENT_272	[p11l2042t3177r2147b3223],
14	show	VB	O	show	rcmod	2	SENT_272	[p11l10t3258r180b3313],
15	any	DT	O	any	det	16	SENT_272	[p11l221t3274r336b3326],
16	inﬂuence	NN	O	inﬂuence	dobj	14	SENT_272	[p11l378t3258r673b3313],
17	of	IN	O	of	_	0	SENT_272	[p11l716t3258r782b3313],
18	the	DT	O	the	det	20	SENT_272	[p11l816t3258r918b3313],
19	T744C	NN	O	t744c	nn	20	SENT_272	[p11l961t3261r1155b3313],
20	polymorphism	NN	O	polymorphism	prep_of	16	SENT_272	[p11l1193t3258r1667b3326],
21	of	IN	O	of	_	0	SENT_272	[p11l1709t3258r1776b3313],
22	the	DT	O	the	det	25	SENT_272	[p11l1810t3258r1912b3313],
23	P2Y12	NN	O	p2y12	nn	25	SENT_272	[p11l1952t3261r2145b3312],
24	receptor	NN	O	receptor	nn	25	SENT_272	[p11l9t3355r279b3415],
25	gene	NN	O	gene	prep_of	20	SENT_272	[p11l310t3363r461b3415],
26	in	IN	O	in	_	0	SENT_272	[p11l496t3348r555b3401],
27	response	NN	O	response	prep_in	25	SENT_272	[p11l591t3363r875b3415],
28	to	TO	O	to	_	0	SENT_272	[p11l909t3355r971b3402],
29	clopidogrel	NN	O	clopidogrel	prep_to	14	SENT_272	[p11l1006t3347r1381b3415],
30	,	,	O	,	_	0	SENT_272	[p11l1006t3347r1381b3415],
31	whereas	IN	O	whereas	mark	55	SENT_272	[p11l1415t3347r1684b3402],
32	in	IN	O	in	_	0	SENT_272	[p11l1720t3348r1779b3401],
33	the	DT	O	the	det	35	SENT_272	[p11l1813t3347r1915b3402],
34	whole	JJ	O	whole	amod	35	SENT_272	[p11l1947t3347r2145b3402],
35	population	NN	O	population	prep_in	55	SENT_272	[p11l9t3435r359b3504],
36	of	IN	O	of	_	0	SENT_272	[p11l391t3435r456b3490],
37	597	CD	NUMBER	597	num	38	SENT_272	[p11l482t3438r598b3490],
38	patients	NNS	O	patient	prep_of	35	SENT_272	[p11l631t3436r906b3504],
39	,	,	O	,	_	0	SENT_272	[p11l631t3436r906b3504],
40	13	CD	NUMBER	13	num	41	SENT_272	[p11l941t3438r1012b3490],
41	patients	NNS	O	patient	tmod	55	SENT_272	[p11l1048t3436r1306b3504],
42	(	IN	O	(	_	0	SENT_272	[p11l1338t3435r1471b3504],
43	2	CD	PERCENT	2	num	44	SENT_272	[p11l1338t3435r1471b3504],
44	%	NN	PERCENT	%	prep_(	47	SENT_272	[p11l1338t3435r1471b3504],
45	)	CD	NUMBER	)	nsubj	47	SENT_272	[p11l1338t3435r1471b3504],
46	were	VBD	O	be	cop	47	SENT_272	[p11l1501t3451r1661b3490],
47	CC	NN	O	cc	rcmod	41	SENT_272	[p11l1693t3438r1789b3499],
48	,	,	O	,	_	0	SENT_272	[p11l1693t3438r1789b3499],
49	125	CD	PERCENT	125	number	50	SENT_272	[p11l1824t3438r1937b3490],
50	(	CD	PERCENT	(	appos	47	SENT_272	[p11l1971t3435r2145b3503],
51	21	CD	PERCENT	21	num	52	SENT_272	[p11l1971t3435r2145b3503],
52	%	NN	PERCENT	%	dep	50	SENT_272	[p11l1971t3435r2145b3503],
53	)	CD	NUMBER	)	nsubj	55	SENT_272	[p11l1971t3435r2145b3503],
54	were	VBD	O	be	cop	55	SENT_272	[p11l7t3540r167b3579],
55	CT	NN	O	ct	advcl	14	SENT_272	[p11l218t3527r297b3579],
56	and	CC	O	and	_	0	SENT_272	[p11l347t3524r463b3579],
57	459	CD	PERCENT	459	number	58	SENT_272	[p11l513t3527r632b3579],
58	(	CD	PERCENT	(	conj_and	55	SENT_272	[p11l684t3524r858b3593],
59	77	CD	PERCENT	77	num	60	SENT_272	[p11l684t3524r858b3593],
60	%	NN	PERCENT	%	dep	58	SENT_272	[p11l684t3524r858b3593],
61	)	CD	NUMBER	)	dep	58	SENT_272	[p11l684t3524r858b3593],
62	were	VBD	O	be	cop	63	SENT_272	[p11l908t3540r1067b3579],
63	TT	NN	O	tt	_	0	SENT_272	[p11l1116t3528r1195b3579],
64	[	CD	NUMBER	[	num	63	SENT_272	[p11l1248t3524r1388b3593],
65	40	CD	NUMBER	40	num	66	SENT_272	[p11l1248t3524r1388b3593],
66	]	NN	O	]	dep	63	SENT_272	[p11l1248t3524r1388b3593],
67	.	.	O	.	_	0	SENT_272	[p11l1248t3524r1388b3593],

1	The	DT	O	the	det	4	SENT_273	[p11l1438t3524r1555b3579],
2	P2Y12	NN	O	p2y12	nn	4	SENT_273	[p11l1604t3527r1797b3579],
3	genotype	NN	O	genotype	nn	4	SENT_273	[p11l1847t3532r2145b3593],
4	distribution	NN	O	distribution	nsubj	17	SENT_273	[p11l9t3614r390b3669],
5	in	IN	O	in	_	0	SENT_273	[p11l409t3614r468b3668],
6	a	DT	O	a	det	7	SENT_273	[p11l487t3629r519b3669],
7	study	NN	O	study	prep_in	4	SENT_273	[p11l538t3614r715b3682],
8	by	IN	O	by	_	0	SENT_273	[p11l732t3614r810b3682],
9	Lee	NNP	PERSON	Lee	prep_by	7	SENT_273	[p11l828t3617r931b3669],
10	et	FW	O	et	nn	11	SENT_273	[p11l950t3622r1010b3669],
11	al.	FW	O	al.	dep	9	SENT_273	[p11l1027t3614r1096b3669],
12	in	IN	O	in	_	0	SENT_273	[p11l1117t3614r1177b3668],
13	a	DT	O	a	det	15	SENT_273	[p11l1195t3629r1227b3669],
14	Korean	JJ	LOCATION	korean	amod	15	SENT_273	[p11l1246t3617r1472b3669],
15	population	NN	O	population	prep_in	11	SENT_273	[p11l1491t3613r1840b3682],
16	was	VBD	O	be	cop	17	SENT_273	[p11l1857t3629r1981b3669],
17	258	CD	NUMBER	258	_	0	SENT_273	[p11l2001t3613r2144b3682],
18	/	:	O	/	punct	34	SENT_273	[p11l2001t3613r2144b3682],
19	385	CD	PERCENT	385	number	20	SENT_273	[p11l8t3705r125b3757],
20	(	CD	PERCENT	(	dep	34	SENT_273	[p11l147t3703r320b3771],
21	67	CD	PERCENT	67	num	22	SENT_273	[p11l147t3703r320b3771],
22	%	NN	PERCENT	%	dep	20	SENT_273	[p11l147t3703r320b3771],
23	)	CD	NUMBER	)	num	25	SENT_273	[p11l147t3703r320b3771],
24	TT	NN	O	tt	nn	25	SENT_273	[p11l337t3706r416b3757],
25	genotype	NN	O	genotype	dep	20	SENT_273	[p11l432t3711r730b3771],
26	and	CC	O	and	_	0	SENT_273	[p11l749t3702r865b3757],
27	127/385	CD	PERCENT	127/385	number	28	SENT_273	[p11l888t3702r1149b3771],
28	(	CD	PERCENT	(	conj_and	20	SENT_273	[p11l1171t3702r1345b3771],
29	33	CD	PERCENT	33	num	30	SENT_273	[p11l1171t3702r1345b3771],
30	%	NN	PERCENT	%	dep	28	SENT_273	[p11l1171t3702r1345b3771],
31	)	CD	NUMBER	)	num	34	SENT_273	[p11l1171t3702r1345b3771],
32	C	NN	O	c	nn	34	SENT_273	[p11l1364t3705r1402b3757],
33	allele	NN	O	allele	nn	34	SENT_273	[p11l1420t3702r1590b3757],
34	carriers	NNS	O	carrier	dep	17	SENT_273	[p11l1609t3703r1849b3757],
35	and	CC	O	and	_	0	SENT_273	[p11l1869t3702r1986b3757],
36	they	PRP	O	they	nsubj	37	SENT_273	[p11l2005t3702r2147b3771],
37	found	VBD	O	find	conj_and	17	SENT_273	[p12l9t17r194b72],
38	no	DT	O	no	det	40	SENT_273	[p12l218t33r295b72],
39	signiﬁcant	JJ	O	signiﬁcant	amod	40	SENT_273	[p12l318t17r653b85],
40	association	NN	O	association	dobj	37	SENT_273	[p12l674t18r1032b72],
41	between	IN	O	between	_	0	SENT_273	[p12l1053t17r1330b72],
42	P2Y12	NN	O	p2y12	nn	44	SENT_273	[p12l1350t20r1543b71],
43	receptor	NN	O	receptor	nn	44	SENT_273	[p12l1566t25r1836b85],
44	gene	NN	O	gene	prep_between	40	SENT_273	[p12l1855t33r2006b85],
45	and	CC	O	and	_	0	SENT_273	[p12l2029t17r2145b72],
46	clopidogrel	NN	O	clopidogrel	nn	47	SENT_273	[p12l9t106r368b174],
47	responsiveness	NN	O	responsiveness	dobj	37	SENT_273	[p12l402t107r887b174],
48	[	CD	NUMBER	[	number	49	SENT_273	[p12l924t106r1064b174],
49	30	CD	NUMBER	30	num	50	SENT_273	[p12l924t106r1064b174],
50	]	NN	O	]	dep	47	SENT_273	[p12l924t106r1064b174],
51	.	.	O	.	_	0	SENT_273	[p12l924t106r1064b174],

1	In	IN	O	in	_	0	SENT_274	[p12l1099t109r1158b160],
2	a	DT	O	a	det	4	SENT_274	[p12l1191t122r1223b161],
3	different	JJ	O	different	amod	4	SENT_274	[p12l1255t106r1533b161],
4	study	NN	O	study	prep_in	13	SENT_274	[p12l1565t106r1743b174],
5	in	IN	O	in	_	0	SENT_274	[p12l1774t107r1833b160],
6	a	DT	O	a	det	8	SENT_274	[p12l1865t122r1897b161],
7	French	JJ	MISC	french	amod	8	SENT_274	[p12l1930t106r2146b161],
8	population	NN	O	population	prep_in	4	SENT_274	[p12l9t194r374b263],
9	,	,	O	,	_	0	SENT_274	[p12l9t194r374b263],
10	Fontana	NNP	PERSON	Fontana	nsubj	13	SENT_274	[p12l416t198r672b249],
11	et	FW	O	et	nn	12	SENT_274	[p12l712t202r772b249],
12	al.	FW	O	al.	dep	10	SENT_274	[p12l811t194r880b250],
13	indicated	VBD	O	indicate	_	0	SENT_274	[p12l923t194r1220b249],
14	that	IN	O	that	complm	28	SENT_274	[p12l1260t194r1390b249],
15	carriers	NNS	O	carrier	nsubj	28	SENT_274	[p12l1429t195r1670b249],
16	of	IN	O	of	_	0	SENT_274	[p12l1712t194r1778b249],
17	the	DT	O	the	det	19	SENT_274	[p12l1810t194r1912b249],
18	minor	JJ	O	minor	amod	19	SENT_274	[p12l1952t195r2148b249],
19	haplotype	NN	O	haplotype	prep_of	15	SENT_274	[p12l9t283r331b352],
20	(	CD	NUMBER	(	num	23	SENT_274	[p12l375t283r488b351],
21	H2	NN	O	h2	nn	23	SENT_274	[p12l375t283r488b351],
22	haplotype	NN	O	haplotype	nn	23	SENT_274	[p12l535t283r882b352],
23	)	NN	O	)	nsubj	25	SENT_274	[p12l535t283r882b352],
24	had	VBD	O	have	aux	25	SENT_274	[p12l927t283r1042b338],
25	increased	VBN	O	increase	rcmod	19	SENT_274	[p12l1088t283r1392b338],
26	ADP	NN	O	adp	nn	27	SENT_274	[p12l1434t283r1858b338],
27	—	NN	O	—	dobj	25	SENT_274	[p12l1434t283r1858b338],
28	induced	VBD	O	induce	ccomp	13	SENT_274	[p12l1434t283r1858b338],
29	platelet	NN	O	platelet	nn	30	SENT_274	[p12l1902t283r2146b352],
30	aggregation	NN	O	aggregation	dobj	28	SENT_274	[p12l9t373r389b441],
31	[	CD	NUMBER	[	number	32	SENT_274	[p12l454t372r595b441],
32	41	CD	NUMBER	41	num	33	SENT_274	[p12l454t372r595b441],
33	]	NN	O	]	dep	28	SENT_274	[p12l454t372r595b441],
34	.	.	O	.	_	0	SENT_274	[p12l454t372r595b441],

1	However	RB	O	however	advmod	17	SENT_275	[p12l659t376r962b436],
2	,	,	O	,	_	0	SENT_275	[p12l659t376r962b436],
3	previous	JJ	O	previous	amod	4	SENT_275	[p12l1025t373r1300b441],
4	studies	NNS	O	study	nsubj	17	SENT_275	[p12l1364t373r1589b428],
5	on	IN	O	on	_	0	SENT_275	[p12l1653t388r1731b428],
6	the	DT	O	the	det	8	SENT_275	[p12l1792t373r1893b428],
7	T744C	NN	O	t744c	nn	8	SENT_275	[p12l1956t375r2151b428],
8	polymorphism	NN	O	polymorphism	prep_on	4	SENT_275	[p12l9t461r483b530],
9	of	IN	O	of	_	0	SENT_275	[p12l524t461r590b516],
10	the	DT	O	the	det	13	SENT_275	[p12l622t461r723b516],
11	P2Y12	NN	O	p2y12	nn	13	SENT_275	[p12l761t464r954b516],
12	receptor	NN	O	receptor	nn	13	SENT_275	[p12l995t470r1265b530],
13	gene	NN	O	gene	prep_of	8	SENT_275	[p12l1301t477r1468b530],
14	,	,	O	,	_	0	SENT_275	[p12l1301t477r1468b530],
15	did	VBD	O	do	aux	17	SENT_275	[p12l1509t461r1609b516],
16	not	RB	O	not	neg	17	SENT_275	[p12l1650t470r1755b516],
17	report	VB	O	report	_	0	SENT_275	[p12l1795t470r1993b530],
18	any	DT	O	any	det	19	SENT_275	[p12l2032t477r2147b530],
19	relationship	NN	O	relationship	dobj	17	SENT_275	[p12l9t551r395b619],
20	between	IN	O	between	_	0	SENT_275	[p12l422t551r700b606],
21	the	DT	O	the	det	24	SENT_275	[p12l727t551r829b606],
22	non	JJ	O	non	amod	24	SENT_275	[p12l857t552r1251b606],
23	—	NN	O	—	nn	24	SENT_275	[p12l857t552r1251b606],
24	carriers	NNS	O	carrier	prep_between	19	SENT_275	[p12l857t552r1251b606],
25	and	CC	O	and	_	0	SENT_275	[p12l1280t551r1396b606],
26	the	DT	O	the	det	27	SENT_275	[p12l1424t551r1526b606],
27	carriers	NNS	O	carrier	conj_and	19	SENT_275	[p12l1554t552r1794b606],
28	of	IN	O	of	_	0	SENT_275	[p12l1823t551r1890b606],
29	C	NN	O	c	nn	30	SENT_275	[p12l1910t554r1948b606],
30	allele	NN	O	allele	prep_of	27	SENT_275	[p12l1976t551r2145b606],
31	[	CD	NUMBER	[	number	32	SENT_275	[p12l12t640r349b708],
32	24,30,40	CD	NUMBER	24,30,40	num	33	SENT_275	[p12l12t640r349b708],
33	]	NN	O	]	dep	27	SENT_275	[p12l12t640r349b708],
34	.	.	O	.	_	0	SENT_275	[p12l12t640r349b708],

1	As	IN	O	as	mark	2	SENT_276	[p12l390t642r465b695],
2	indicated	VBN	O	indicate	advcl	9	SENT_276	[p12l509t640r806b695],
3	above	IN	O	above	prep	2	SENT_276	[p12l848t640r1052b703],
4	,	,	O	,	_	0	SENT_276	[p12l848t640r1052b703],
5	TT	NN	O	tt	nn	6	SENT_276	[p12l1093t643r1172b694],
6	genotype	NN	O	genotype	nsubj	9	SENT_276	[p12l1211t648r1509b708],
7	of	IN	O	of	_	0	SENT_276	[p12l1551t640r1617b695],
8	P2Y12	NN	O	p2y12	prep_of	6	SENT_276	[p12l1650t643r1843b694],
9	had	VBD	O	have	_	0	SENT_276	[p12l1886t640r2001b695],
10	the	DT	O	the	det	12	SENT_276	[p12l2044t640r2145b695],
11	highest	JJS	O	highest	amod	12	SENT_276	[p12l9t728r245b797],
12	frequency	NN	O	frequency	dobj	9	SENT_276	[p12l274t728r595b797],
13	among	IN	O	among	_	0	SENT_276	[p12l622t744r842b797],
14	other	JJ	O	other	amod	15	SENT_276	[p12l870t728r1042b783],
15	populations	NNS	O	population	prep_among	12	SENT_276	[p12l1069t728r1465b797],
16	,	,	O	,	_	0	SENT_276	[p12l1069t728r1465b797],
17	while	IN	O	while	mark	22	SENT_276	[p12l1494t728r1673b783],
18	this	DT	O	this	det	19	SENT_276	[p12l1702t728r1818b783],
19	genotype	NN	O	genotype	nsubjpass	22	SENT_276	[p12l1847t736r2145b797],
20	was	VBD	O	be	auxpass	22	SENT_276	[p12l7t833r132b872],
21	not	RB	O	not	neg	22	SENT_276	[p12l177t825r281b872],
22	found	VBN	O	find	advcl	9	SENT_276	[p12l324t817r509b872],
23	in	IN	O	in	_	0	SENT_276	[p12l553t818r612b871],
24	our	PRP$	O	we	poss	25	SENT_276	[p12l656t833r764b872],
25	patients	NNS	O	patient	prep_in	22	SENT_276	[p12l805t818r1080b886],
26	.	.	O	.	_	0	SENT_276	[p12l805t818r1080b886],

1	Interestingly	RB	O	interestingly	advmod	5	SENT_277	[p12l1125t817r1549b886],
2	,	,	O	,	_	0	SENT_277	[p12l1125t817r1549b886],
3	clopidogrel	NN	O	clopidogrel	nn	4	SENT_277	[p12l1593t817r1952b886],
4	nonresponsiveness	NN	O	nonresponsiveness	nsubj	5	SENT_277	[p12l1997t833r2145b872, p12l9t907r495b975],
5	was	VBD	O	be	_	0	SENT_277	[p12l515t922r639b961],
6	in	IN	O	in	_	0	SENT_277	[p12l661t907r720b961],
7	the	DT	O	the	det	9	SENT_277	[p12l739t906r841b961],
8	range	NN	O	range	nn	9	SENT_277	[p12l862t922r1040b975],
9	(	NN	O	(	prep_in	5	SENT_277	[p12l1060t907r1316b975],
10	4	CD	PERCENT	4	number	11	SENT_277	[p12l1060t907r1316b975],
11	—	CD	PERCENT	—	amod	9	SENT_277	[p12l1060t907r1316b975],
12	30	CD	PERCENT	30	num	13	SENT_277	[p12l1060t907r1316b975],
13	%	NN	PERCENT	%	dep	11	SENT_277	[p12l1060t907r1316b975],
14	)	CD	NUMBER	)	nsubj	19	SENT_277	[p12l1060t907r1316b975],
15	reported	VBN	O	report	partmod	14	SENT_277	[p12l1337t906r1612b975],
16	by	IN	O	by	_	0	SENT_277	[p12l1632t906r1709b975],
17	other	JJ	O	other	amod	18	SENT_277	[p12l1728t906r1900b961],
18	studies	NNS	O	study	agent	15	SENT_277	[p12l1918t906r2144b961],
19	[	VBP	O	[	rcmod	9	SENT_277	[p12l12t995r170b1064],
20	3,4	CD	NUMBER	3,4	number	21	SENT_277	[p12l12t995r170b1064],
21	]	CD	NUMBER	]	dobj	19	SENT_277	[p12l12t995r170b1064],
22	,	,	O	,	_	0	SENT_277	[p12l12t995r170b1064],
23	though	IN	O	though	mark	27	SENT_277	[p12l198t995r427b1064],
24	all	DT	O	all	det	26	SENT_277	[p12l454t995r528b1050],
25	our	PRP$	O	we	poss	26	SENT_277	[p12l558t1011r666b1050],
26	patients	NNS	O	patient	nsubj	27	SENT_277	[p12l692t996r950b1064],
27	carried	VBD	O	carry	advcl	5	SENT_277	[p12l980t995r1202b1050],
28	C	NN	O	c	nn	29	SENT_277	[p12l1231t998r1270b1050],
29	allele	NN	O	allele	dobj	27	SENT_277	[p12l1297t995r1482b1051],
30	.	.	O	.	_	0	SENT_277	[p12l1297t995r1482b1051],

1	Another	DT	O	another	det	3	SENT_278	[p12l108t1085r372b1140],
2	genetic	JJ	O	genetic	amod	3	SENT_278	[p12l387t1086r620b1153],
3	factor	NN	O	factor	nsubj	10	SENT_278	[p12l639t1085r825b1140],
4	evaluated	VBN	O	evaluate	partmod	3	SENT_278	[p12l841t1085r1153b1140],
5	in	IN	O	in	_	0	SENT_278	[p12l1173t1086r1232b1139],
6	this	DT	O	this	det	7	SENT_278	[p12l1250t1085r1367b1140],
7	study	NN	O	study	prep_in	4	SENT_278	[p12l1388t1085r1565b1153],
8	was	VBD	O	be	cop	10	SENT_278	[p12l1581t1101r1705b1140],
9	CYP3A5	NN	O	cyp3a5	nn	10	SENT_278	[p12l1726t1087r1961b1140],
10	gene	NN	O	gene	_	0	SENT_278	[p12l1977t1101r2144b1153],
11	.	.	O	.	_	0	SENT_278	[p12l1977t1101r2144b1153],

1	In	IN	O	in	_	0	SENT_279	[p12l9t1177r69b1228],
2	our	PRP$	O	we	poss	3	SENT_279	[p12l97t1190r205b1229],
3	study	NN	O	study	prep_in	9	SENT_279	[p12l231t1174r423b1242],
4	,	,	O	,	_	0	SENT_279	[p12l231t1174r423b1242],
5	most	JJS	O	most	nsubj	9	SENT_279	[p12l451t1182r611b1229],
6	of	IN	O	of	_	0	SENT_279	[p12l637t1174r703b1229],
7	the	DT	O	the	det	8	SENT_279	[p12l722t1174r824b1229],
8	patients	NNS	O	patient	prep_of	5	SENT_279	[p12l852t1175r1110b1242],
9	had	VBD	O	have	_	0	SENT_279	[p12l1139t1174r1255b1229],
10	CYP	NNP	O	CYP	dobj	9	SENT_279	[p12l1283t1174r1495b1242],
11	*	CD	NUMBER	*	number	12	SENT_279	[p12l1283t1174r1495b1242],
12	3	CD	NUMBER	3	amod	10	SENT_279	[p12l1283t1174r1495b1242],
13	/	:	O	/	punct	14	SENT_279	[p12l1283t1174r1495b1242],
14	*	CD	NUMBER	*	dep	12	SENT_279	[p12l1504t1174r1561b1229],
15	3	CD	NUMBER	3	num	16	SENT_279	[p12l1504t1174r1561b1229],
16	genotype	NN	O	genotype	dep	14	SENT_279	[p12l1589t1182r1902b1242],
17	.	.	O	.	_	0	SENT_279	[p12l1589t1182r1902b1242],

1	Due	JJ	O	due	_	0	SENT_280	[p12l1931t1177r2056b1229],
2	to	TO	O	to	prep	1	SENT_280	[p12l2083t1182r2145b1229],

1	S.	NNP	PERSON	S.	nn	2	SENT_281	[p12l343t1318r361b1339],
2	Namazi	NNP	PERSON	Namazi	_	0	SENT_281	[p12l372t1317r464b1339],
3	et	FW	O	et	nn	4	SENT_281	[p12l475t1320r498b1339],
4	al.	FW	O	al.	dep	2	SENT_281	[p12l507t1317r533b1339],
5	/	:	O	/	punct	2	SENT_281	[p12l537t1317r549b1344],
6	Biochemical	JJ	O	biochemical	amod	7	SENT_281	[p12l553t1317r698b1339],
7	Pharmacology	NN	O	pharmacology	dep	2	SENT_281	[p12l708t1317r879b1344],
8	83	CD	NUMBER	83	number	9	SENT_281	[p12l890t1318r918b1339],
9	(	CD	NUMBER	(	num	10	SENT_281	[p12l929t1317r1010b1344],
10	2012	CD	DATE	2012	dep	7	SENT_281	[p12l929t1317r1010b1344],
11	)	CD	NUMBER	)	number	12	SENT_281	[p12l929t1317r1010b1344],
12	903-908 907	CD	NUMBER	903-908 907	num	10	SENT_281	[p12l1773t1318r1817b1339],[p12l1020t1318r1126b1339],

1	the	DT	O	the	det	2	SENT_282	[p12l14t1452r115b1506],
2	effect	NN	O	effect	nsubj	16	SENT_282	[p12l138t1452r315b1506],
3	of	IN	O	of	_	0	SENT_282	[p12l335t1452r401b1506],
4	this	DT	O	this	det	5	SENT_282	[p12l415t1452r532b1506],
5	genotype	NN	O	genotype	prep_of	2	SENT_282	[p12l554t1460r851b1519],
6	in	IN	O	in	_	0	SENT_282	[p12l873t1453r932b1505],
7	metabolizing	VBG	O	metabolize	prepc_in	5	SENT_282	[p12l953t1452r1375b1519],
8	clopidogrel	NN	O	clopidogrel	dobj	7	SENT_282	[p12l1396t1452r1753b1519],
9	to	TO	O	to	_	0	SENT_282	[p12l1776t1460r1838b1506],
10	its	PRP$	O	its	poss	12	SENT_282	[p12l1860t1453r1933b1506],
11	active	JJ	O	active	amod	12	SENT_282	[p12l1956t1453r2144b1506],
12	metabolite	NN	O	metabolite	prep_to	7	SENT_282	[p12l15t1538r377b1601],
13	,	,	O	,	_	0	SENT_282	[p12l15t1538r377b1601],
14	it	PRP	O	it	nsubj	16	SENT_282	[p12l406t1539r450b1592],
15	could	MD	O	could	aux	16	SENT_282	[p12l477t1538r651b1592],
16	lead	VB	O	lead	_	0	SENT_282	[p12l679t1538r810b1592],
17	to	TO	O	to	_	0	SENT_282	[p12l838t1546r900b1592],
18	a	DT	O	a	det	21	SENT_282	[p12l928t1554r960b1592],
19	poor	JJ	O	poor	amod	21	SENT_282	[p12l989t1554r1135b1606],
20	clopidogrel	NN	O	clopidogrel	nn	21	SENT_282	[p12l1161t1538r1519b1606],
21	effect	NN	O	effect	prep_to	16	SENT_282	[p12l1548t1538r1739b1593],
22	.	.	O	.	_	0	SENT_282	[p12l1548t1538r1739b1593],

1	There	EX	O	there	expl	2	SENT_283	[p12l114t1625r296b1679],
2	are	VBP	O	be	_	0	SENT_283	[p12l323t1641r420b1679],
3	several	JJ	O	several	amod	4	SENT_283	[p12l448t1625r671b1679],
4	studies	NNS	O	study	nsubj	2	SENT_283	[p12l701t1625r926b1679],
5	investigated	VBD	O	investigate	rcmod	4	SENT_283	[p12l954t1625r1346b1693],
6	the	DT	O	the	det	7	SENT_283	[p12l1374t1625r1475b1679],
7	inﬂuence	NN	O	inﬂuence	dobj	5	SENT_283	[p12l1503t1625r1797b1679],
8	of	IN	O	of	_	0	SENT_283	[p12l1824t1625r1890b1679],
9	CYP3A5	NN	O	cyp3a5	nn	10	SENT_283	[p12l1911t1627r2145b1679],
10	polymorphisms	NNS	O	polymorphism	prep_of	7	SENT_283	[p12l15t1712r518b1780],
11	on	IN	O	on	_	0	SENT_283	[p12l558t1728r635b1767],
12	antiplatelet	JJ	O	antiplatelet	amod	13	SENT_283	[p12l673t1713r1044b1780],
13	effect	NN	O	effect	prep_on	5	SENT_283	[p12l1081t1712r1258b1767],
14	of	IN	O	of	_	0	SENT_283	[p12l1295t1712r1361b1767],
15	clopidogrel	NN	O	clopidogrel	prep_of	13	SENT_283	[p12l1392t1712r1766b1780],
16	.	.	O	.	_	0	SENT_283	[p12l1392t1712r1766b1780],

1	Suh	NNP	PERSON	Suh	nsubj	10	SENT_284	[p12l1806t1713r1923b1767],
2	et	FW	O	et	nn	3	SENT_284	[p12l1961t1721r2021b1767],
3	al.	FW	O	al.	dep	1	SENT_284	[p12l2058t1712r2143b1775],
4	,	,	O	,	_	0	SENT_284	[p12l2058t1712r2143b1775],
5	investigating	VBG	O	investigate	partmod	10	SENT_284	[p12l15t1800r433b1867],
6	a	DT	O	a	det	8	SENT_284	[p12l456t1815r488b1853],
7	Korean	JJ	LOCATION	korean	amod	8	SENT_284	[p12l514t1803r738b1853],
8	population	NN	O	population	dobj	5	SENT_284	[p12l763t1799r1127b1867],
9	,	,	O	,	_	0	SENT_284	[p12l763t1799r1127b1867],
10	indicated	VBD	O	indicate	_	0	SENT_284	[p12l1153t1799r1449b1853],
11	that	IN	O	that	complm	14	SENT_284	[p12l1475t1799r1603b1853],
12	atherothrombotic	JJ	O	atherothrombotic	amod	13	SENT_284	[p12l1627t1799r2144b1853, p12l14t1888r92b1941],
13	events	NNS	O	event	nsubj	14	SENT_284	[p12l119t1895r324b1941],
14	occurred	VBD	O	occur	ccomp	10	SENT_284	[p12l353t1887r633b1941],
15	more	RBR	O	more	advmod	16	SENT_284	[p12l661t1902r825b1941],
16	frequently	RB	O	frequently	advmod	14	SENT_284	[p12l853t1887r1188b1954],
17	among	IN	O	among	_	0	SENT_284	[p12l1213t1902r1432b1954],
18	the	DT	O	the	det	19	SENT_284	[p12l1456t1887r1558b1941],
19	patients	NNS	O	patient	prep_among	14	SENT_284	[p12l1586t1888r1842b1954],
20	with	IN	O	with	_	0	SENT_284	[p12l1869t1887r2017b1941],
21	the	DT	O	the	det	23	SENT_284	[p12l2043t1887r2144b1941],
22	non-expressor	JJ	O	non-expressor	amod	23	SENT_284	[p12l15t1989r479b2041],
23	genotype	NN	O	genotype	prep_with	19	SENT_284	[p12l508t1982r820b2041],
24	.	.	O	.	_	0	SENT_284	[p12l508t1982r820b2041],

1	In	IN	O	in	_	0	SENT_285	[p12l854t1977r914b2027],
2	their	PRP$	O	they	poss	3	SENT_285	[p12l944t1974r1098b2028],
3	study	NN	O	study	prep_in	8	SENT_285	[p12l1128t1974r1319b2041],
4	,	,	O	,	_	0	SENT_285	[p12l1128t1974r1319b2041],
5	CYP3A5	NN	O	cyp3a5	nn	7	SENT_285	[p12l1352t1976r1586b2028],
6	expressor	NN	O	expressor	nn	7	SENT_285	[p12l1618t1989r1929b2041],
7	group	NN	O	group	nsubj	8	SENT_285	[p12l1957t1989r2144b2041],
8	showed	VBD	O	show	_	0	SENT_285	[p12l16t2060r262b2114],
9	more	RBR	O	more	advmod	8	SENT_285	[p12l288t2076r453b2114],
10	inhibition	NN	O	inhibition	dobj	8	SENT_285	[p12l478t2060r793b2114],
11	of	IN	O	of	_	0	SENT_285	[p12l817t2060r882b2114],
12	platelet	NN	O	platelet	nn	13	SENT_285	[p12l900t2060r1143b2128],
13	aggregation	NN	O	aggregation	prep_of	10	SENT_285	[p12l1166t2061r1544b2128],
14	than	IN	O	than	_	0	SENT_285	[p12l1568t2060r1713b2114],
15	CYP3A5	NN	O	cyp3a5	nn	16	SENT_285	[p12l1738t2063r1971b2114],
16	nonexpressors	NNS	O	nonexpressor	prep_than	8	SENT_285	[p12l1997t2076r2144b2114, p12l15t2163r354b2215],
17	after	IN	O	after	_	0	SENT_285	[p12l420t2147r569b2201],
18	clopidogrel	NN	O	clopidogrel	nn	19	SENT_285	[p12l631t2147r989b2215],
19	treatment	NN	O	treatment	prep_after	8	SENT_285	[p12l1053t2155r1390b2210],
20	,	,	O	,	_	0	SENT_285	[p12l1053t2155r1390b2210],
21	though	IN	O	though	mark	28	SENT_285	[p12l1454t2147r1682b2215],
22	it	PRP	O	it	nsubj	28	SENT_285	[p12l1746t2148r1790b2201],
23	was	VBD	O	be	cop	28	SENT_285	[p12l1851t2163r1975b2201],
24	not	RB	O	not	neg	28	SENT_285	[p12l2041t2155r2145b2201],
25	signiﬁcant	JJ	O	signiﬁcant	amod	28	SENT_285	[p12l16t2234r350b2302],
26	[	NN	O	[	dep	25	SENT_285	[p12l390t2234r531b2302],
27	27	CD	NUMBER	27	num	26	SENT_285	[p12l390t2234r531b2302],
28	]	NN	O	]	advcl	8	SENT_285	[p12l390t2234r531b2302],
29	.	.	O	.	_	0	SENT_285	[p12l390t2234r531b2302],

1	Kim	NNP	PERSON	Kim	nsubj	12	SENT_286	[p12l571t2235r698b2288],
2	et	FW	O	et	nn	3	SENT_286	[p12l736t2243r796b2288],
3	al.	FW	O	al.	dep	1	SENT_286	[p12l833t2234r919b2297],
4	,	,	O	,	_	0	SENT_286	[p12l833t2234r919b2297],
5	in	IN	O	in	_	0	SENT_286	[p12l959t2235r1017b2288],
6	a	DT	O	a	det	7	SENT_286	[p12l1056t2250r1088b2288],
7	study	NN	O	study	prep_in	1	SENT_286	[p12l1127t2234r1304b2302],
8	in	IN	O	in	_	0	SENT_286	[p12l1342t2235r1400b2288],
9	South	NNP	LOCATION	South	nn	10	SENT_286	[p12l1439t2234r1622b2288],
10	Korea	NNP	LOCATION	Korea	prep_in	7	SENT_286	[p12l1660t2238r1857b2297],
11	,	,	O	,	_	0	SENT_286	[p12l1660t2238r1857b2297],
12	showed	VBD	O	show	_	0	SENT_286	[p12l1898t2234r2144b2288],
13	that	IN	O	that	complm	24	SENT_286	[p12l14t2321r144b2375],
14	the	DT	O	the	det	15	SENT_286	[p12l162t2321r263b2375],
15	presence	NN	O	presence	nsubj	24	SENT_286	[p12l285t2337r567b2389],
16	of	IN	O	of	_	0	SENT_286	[p12l588t2321r654b2375],
17	CYP3A5	NN	O	cyp3a5	prep_of	15	SENT_286	[p12l668t2321r967b2375],
18	*	CD	NUMBER	*	number	19	SENT_286	[p12l668t2321r967b2375],
19	3	CD	NUMBER	3	num	20	SENT_286	[p12l668t2321r967b2375],
20	allele	NN	O	allele	dep	17	SENT_286	[p12l988t2321r1157b2375],
21	was	VBD	O	be	cop	24	SENT_286	[p12l1176t2337r1300b2375],
22	not	RB	O	not	neg	24	SENT_286	[p12l1322t2330r1427b2375],
23	a	DT	O	a	det	24	SENT_286	[p12l1446t2337r1478b2375],
24	factor	NN	O	factor	ccomp	12	SENT_286	[p12l1499t2321r1685b2375],
25	causing	VBG	O	cause	partmod	24	SENT_286	[p12l1703t2322r1946b2389],
26	interindividual	JJ	O	interindividual	amod	27	SENT_286	[p12l1966t2322r2144b2375, p12l15t2409r338b2463],
27	variability	NN	O	variability	dobj	25	SENT_286	[p12l365t2409r695b2476],
28	in	IN	O	in	_	0	SENT_286	[p12l722t2410r781b2462],
29	the	DT	O	the	det	31	SENT_286	[p12l809t2409r910b2463],
30	clopidogrel	NN	O	clopidogrel	nn	31	SENT_286	[p12l938t2409r1296b2476],
31	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	27	SENT_286	[p12l1326t2409r1896b2476],
32	and	CC	O	and	_	0	SENT_286	[p12l1925t2409r2041b2463],
33	its	PRP$	O	its	poss	35	SENT_286	[p12l2070t2410r2143b2463],
34	antiplatelet	JJ	O	antiplatelet	amod	35	SENT_286	[p12l15t2496r386b2563],
35	effect	NN	O	effect	dobj	25	SENT_286	[p12l407t2496r583b2550],
36	[	CD	NUMBER	[	number	37	SENT_286	[p12l609t2496r749b2563],
37	28	CD	NUMBER	28	num	38	SENT_286	[p12l609t2496r749b2563],
38	]	NN	O	]	dep	35	SENT_286	[p12l609t2496r749b2563],
39	.	.	O	.	_	0	SENT_286	[p12l609t2496r749b2563],

1	Moreover	RB	O	moreover	advmod	15	SENT_287	[p12l774t2499r1098b2558],
2	,	,	O	,	_	0	SENT_287	[p12l774t2499r1098b2558],
3	the	DT	O	the	det	4	SENT_287	[p12l1120t2496r1222b2550],
4	results	NNS	O	result	poss	10	SENT_287	[p12l1245t2496r1457b2550],
5	of	IN	O	of	_	0	SENT_287	[p12l1481t2496r1547b2550],
6	Frere	NNP	PERSON	Frere	prep_of	4	SENT_287	[p12l1563t2499r1724b2550],
7	et	FW	O	et	nn	8	SENT_287	[p12l1747t2504r1806b2550],
8	al.	FW	O	al.	dep	6	SENT_287	[p12l1827t2496r1944b2550],
9	's	POS	O	's	_	0	SENT_287	[p12l1827t2496r1944b2550],
10	study	NN	O	study	nsubj	15	SENT_287	[p12l1969t2496r2146b2563],
11	in	IN	O	in	_	0	SENT_287	[p12l15t2583r74b2636],
12	a	DT	O	a	det	14	SENT_287	[p12l102t2598r134b2636],
13	French	JJ	MISC	french	amod	14	SENT_287	[p12l163t2582r378b2636],
14	population	NN	O	population	prep_in	10	SENT_287	[p12l407t2582r755b2650],
15	showed	VBD	O	show	_	0	SENT_287	[p12l784t2582r1030b2636],
16	that	IN	O	that	complm	23	SENT_287	[p12l1058t2582r1187b2636],
17	CYP3A5	NN	O	cyp3a5	nsubj	23	SENT_287	[p12l1215t2582r1515b2636],
18	*	CD	NUMBER	*	num	17	SENT_287	[p12l1215t2582r1515b2636],
19	3	CD	NUMBER	3	num	20	SENT_287	[p12l1215t2582r1515b2636],
20	polymorphism	NN	O	polymorphism	dep	17	SENT_287	[p12l1544t2582r2016b2650],
21	did	VBD	O	do	aux	23	SENT_287	[p12l2044t2582r2144b2636],
22	not	RB	O	not	neg	23	SENT_287	[p12l15t2677r120b2723],
23	inﬂuence	VB	O	inﬂuence	ccomp	15	SENT_287	[p12l173t2669r467b2723],
24	the	DT	O	the	det	29	SENT_287	[p12l521t2669r622b2723],
25	post	NN	O	post	nn	29	SENT_287	[p12l677t2677r1167b2737],
26	—	NN	O	—	nn	29	SENT_287	[p12l677t2677r1167b2737],
27	treatment	NN	O	treatment	nn	29	SENT_287	[p12l677t2677r1167b2737],
28	platelet	NN	O	platelet	nn	29	SENT_287	[p12l1219t2669r1463b2737],
29	reactivity	NN	O	reactivity	dobj	23	SENT_287	[p12l1516t2670r1820b2737],
30	and	CC	O	and	_	0	SENT_287	[p12l1873t2669r1989b2723],
31	the	DT	O	the	det	33	SENT_287	[p12l2043t2669r2144b2723],
32	clopidogrel	NN	O	clopidogrel	nn	33	SENT_287	[p12l15t2756r373b2824],
33	response	NN	O	response	dobj	23	SENT_287	[p12l417t2772r700b2824],
34	[	CD	NUMBER	[	number	35	SENT_287	[p12l746t2756r886b2824],
35	42	CD	NUMBER	42	num	36	SENT_287	[p12l746t2756r886b2824],
36	]	NN	O	]	dep	33	SENT_287	[p12l746t2756r886b2824],
37	.	.	O	.	_	0	SENT_287	[p12l746t2756r886b2824],

1	In	IN	O	in	_	0	SENT_288	[p12l931t2760r991b2810],
2	our	PRP$	O	we	poss	3	SENT_288	[p12l1033t2772r1141b2810],
3	study	NN	O	study	prep_in	9	SENT_288	[p12l1182t2756r1372b2824],
4	,	,	O	,	_	0	SENT_288	[p12l1182t2756r1372b2824],
5	the	DT	O	the	det	8	SENT_288	[p12l1415t2756r1516b2810],
6	CYP3A5	NN	O	cyp3a5	nn	8	SENT_288	[p12l1560t2759r1794b2810],
7	expressor	NN	O	expressor	nn	8	SENT_288	[p12l1835t2772r2146b2824],
8	genotype	NN	O	genotype	nsubj	9	SENT_288	[p12l14t2852r311b2911],
9	showed	VBD	O	show	_	0	SENT_288	[p12l361t2843r607b2897],
10	a	DT	O	a	det	12	SENT_288	[p12l655t2859r688b2897],
11	higher	JJR	O	higher	amod	12	SENT_288	[p12l736t2843r943b2911],
12	inhibition	NN	O	inhibition	dobj	9	SENT_288	[p12l990t2843r1305b2897],
13	of	IN	O	of	_	0	SENT_288	[p12l1353t2843r1419b2897],
14	platelet	NN	O	platelet	nn	15	SENT_288	[p12l1460t2843r1703b2911],
15	aggregation	NN	O	aggregation	prep_of	12	SENT_288	[p12l1750t2844r2143b2911],
16	,	,	O	,	_	0	SENT_288	[p12l1750t2844r2143b2911],
17	though	IN	O	though	mark	21	SENT_288	[p12l14t2931r243b2998],
18	it	PRP	O	it	nsubj	21	SENT_288	[p12l268t2932r312b2985],
19	was	VBD	O	be	cop	21	SENT_288	[p12l335t2946r459b2985],
20	not	RB	O	not	neg	21	SENT_288	[p12l487t2939r591b2985],
21	signiﬁcant	JJ	O	signiﬁcant	advcl	9	SENT_288	[p12l617t2931r965b2998],
22	.	.	O	.	_	0	SENT_288	[p12l617t2931r965b2998],

1	Therefore	RB	O	therefore	advmod	18	SENT_289	[p12l989t2931r1315b2993],
2	,	,	O	,	_	0	SENT_289	[p12l989t2931r1315b2993],
3	the	DT	O	the	det	4	SENT_289	[p12l1341t2931r1442b2985],
4	lack	NN	O	lack	nsubj	18	SENT_289	[p12l1469t2931r1596b2985],
5	of	IN	O	of	_	0	SENT_289	[p12l1620t2931r1686b2985],
6	association	NN	O	association	prep_of	4	SENT_289	[p12l1704t2932r2060b2985],
7	of	IN	O	of	_	0	SENT_289	[p12l2086t2931r2152b2985],
8	CYP3A5	NN	O	cyp3a5	nn	9	SENT_289	[p12l16t3020r250b3072],
9	polymorphism	NN	O	polymorphism	prep_of	6	SENT_289	[p12l279t3018r752b3085],
10	in	IN	O	in	_	0	SENT_289	[p12l781t3019r840b3071],
11	response	NN	O	response	prep_in	9	SENT_289	[p12l870t3033r1153b3085],
12	to	TO	O	to	_	0	SENT_289	[p12l1182t3026r1243b3072],
13	clopidogrel	NN	O	clopidogrel	prep_to	11	SENT_289	[p12l1274t3018r1632b3085],
14	in	IN	O	in	_	0	SENT_289	[p12l1662t3019r1721b3071],
15	our	PRP$	O	we	poss	16	SENT_289	[p12l1750t3034r1858b3072],
16	patients	NNS	O	patient	prep_in	13	SENT_289	[p12l1886t3019r2143b3085],
17	was	VBD	O	be	cop	18	SENT_289	[p12l13t3120r137b3158],
18	consistent	JJ	O	consistent	_	0	SENT_289	[p12l171t3105r500b3158],
19	with	IN	O	with	_	0	SENT_289	[p12l529t3104r676b3158],
20	other	JJ	O	other	amod	21	SENT_289	[p12l709t3104r880b3158],
21	studies	NNS	O	study	prep_with	18	SENT_289	[p12l911t3104r1136b3158],
22	performed	VBN	O	perform	partmod	21	SENT_289	[p12l1170t3104r1507b3172],
23	in	IN	O	in	_	0	SENT_289	[p12l1540t3105r1598b3158],
24	various	JJ	O	various	amod	25	SENT_289	[p12l1629t3105r1863b3158],
25	populations	NNS	O	population	prep_in	22	SENT_289	[p12l1897t3104r2144b3172, p12l14t3192r170b3245],
26	[	VBP	O	[	dep	21	SENT_289	[p12l219t3191r556b3259],
27	27,28,42	CD	NUMBER	27,28,42	num	28	SENT_289	[p12l219t3191r556b3259],
28	]	CD	NUMBER	]	dobj	26	SENT_289	[p12l219t3191r556b3259],
29	,	,	O	,	_	0	SENT_289	[p12l219t3191r556b3259],
30	whereas	IN	O	whereas	mark	38	SENT_289	[p12l598t3191r867b3245],
31	CYP3A5	NN	O	cyp3a5	nn	33	SENT_289	[p12l913t3193r1146b3245],
32	allele	NN	O	allele	nn	33	SENT_289	[p12l1190t3191r1359b3245],
33	frequencies	NNS	O	frequency	nsubj	38	SENT_289	[p12l1403t3191r1771b3259],
34	in	IN	O	in	_	0	SENT_289	[p12l1817t3192r1876b3245],
35	Iranian	JJ	MISC	iranian	amod	36	SENT_289	[p12l1919t3192r2145b3245],
36	population	NN	O	population	prep_in	33	SENT_289	[p12l15t3278r364b3346],
37	were	VBD	O	be	cop	38	SENT_289	[p12l380t3294r539b3332],
38	different	JJ	O	different	dep	21	SENT_289	[p12l558t3278r835b3332],
39	compared	VBN	O	compare	_	0	SENT_289	[p12l853t3278r1172b3346],
40	to	TO	O	to	prepc_compared_to	38	SENT_289	[p12l1190t3287r1252b3332],
41	Asians	NNPS	MISC	Asians	pobj	38	SENT_289	[p12l1268t3279r1474b3332],
42	and	CC	O	and	_	0	SENT_289	[p12l1494t3278r1610b3332],
43	Caucasians	NNPS	MISC	Caucasians	conj_and	41	SENT_289	[p12l1630t3279r1979b3332],
44	[	CD	NUMBER	[	number	45	SENT_289	[p12l2002t3278r2142b3346],
45	43	CD	NUMBER	43	num	46	SENT_289	[p12l2002t3278r2142b3346],
46	]	NN	O	]	dep	41	SENT_289	[p12l2002t3278r2142b3346],
47	.	.	O	.	_	0	SENT_289	[p12l2002t3278r2142b3346],

1	Pervious	JJ	O	pervious	amod	2	SENT_290	[p12l117t3366r389b3419],
2	studies	NNS	O	study	nsubj	3	SENT_290	[p12l420t3365r645b3419],
3	conducted	VBN	O	conduct	_	0	SENT_290	[p12l676t3365r1010b3419],
4	in	IN	O	in	_	0	SENT_290	[p12l1040t3366r1099b3419],
5	different	JJ	O	different	amod	6	SENT_290	[p12l1129t3365r1406b3419],
6	populations	NNS	O	population	prep_in	3	SENT_290	[p12l1435t3365r1813b3433],
7	including	VBG	O	include	_	0	SENT_290	[p12l1845t3365r2146b3433],
8	Japanese	JJ	MISC	japanese	amod	11	SENT_290	[p12l7t3456r294b3520],
9	[	NN	O	[	nn	11	SENT_290	[p12l340t3453r580b3520],
10	44,45	CD	NUMBER	44,45	num	11	SENT_290	[p12l340t3453r580b3520],
11	]	NN	O	]	prep_including	6	SENT_290	[p12l340t3453r580b3520],
12	,	,	O	,	_	0	SENT_290	[p12l340t3453r580b3520],
13	Chinese	JJ	MISC	chinese	amod	14	SENT_290	[p12l624t3453r872b3507],
14	[	NN	O	[	appos	6	SENT_290	[p12l919t3453r1158b3520],
15	18,46	CD	NUMBER	18,46	num	16	SENT_290	[p12l919t3453r1158b3520],
16	]	NN	O	]	dep	14	SENT_290	[p12l919t3453r1158b3520],
17	,	,	O	,	_	0	SENT_290	[p12l919t3453r1158b3520],
18	Korean	JJ	MISC	korean	amod	19	SENT_290	[p12l1201t3456r1426b3507],
19	[	NN	O	[	appos	6	SENT_290	[p12l1472t3453r1711b3520],
20	47,48	CD	NUMBER	47,48	num	21	SENT_290	[p12l1472t3453r1711b3520],
21	]	NN	O	]	dep	19	SENT_290	[p12l1472t3453r1711b3520],
22	.	.	O	.	_	0	SENT_290	[p12l1472t3453r1711b3520],

1	Italian	JJ	MISC	italian	amod	2	SENT_291	[p12l1755t3453r1957b3507],
2	[	NN	O	[	nsubj	17	SENT_291	[p12l2003t3453r2143b3520],
3	49	CD	NUMBER	49	num	4	SENT_291	[p12l2003t3453r2143b3520],
4	]	NN	O	]	dep	2	SENT_291	[p12l2003t3453r2143b3520],
5	,	,	O	,	_	0	SENT_291	[p12l2003t3453r2143b3520],
6	Germany	NNP	LOCATION	Germany	nsubj	17	SENT_291	[p12l15t3543r310b3607],
7	[	CD	NUMBER	[	number	8	SENT_291	[p12l340t3540r480b3607],
8	50	CD	NUMBER	50	num	9	SENT_291	[p12l340t3540r480b3607],
9	]	NN	O	]	dep	6	SENT_291	[p12l340t3540r480b3607],
10	,	,	O	,	_	0	SENT_291	[p12l340t3540r480b3607],
11	and	CC	O	and	_	0	SENT_291	[p12l509t3540r625b3594],
12	French	JJ	MISC	french	amod	13	SENT_291	[p12l654t3540r870b3594],
13	[	NN	O	[	nsubj	17	SENT_291	[p12l900t3540r1041b3607],
14	51	CD	NUMBER	51	num	15	SENT_291	[p12l900t3540r1041b3607],
15	]	NN	O	]	dep	13	SENT_291	[p12l900t3540r1041b3607],
16	,	,	O	,	_	0	SENT_291	[p12l900t3540r1041b3607],
17	reported	VBD	O	report	ccomp	45	SENT_291	[p12l1071t3540r1345b3607],
18	that	IN	O	that	complm	38	SENT_291	[p12l1373t3540r1502b3594],
19	among	IN	O	among	_	0	SENT_291	[p12l1530t3555r1748b3607],
20	the	DT	O	the	det	22	SENT_291	[p12l1774t3540r1876b3594],
21	healthy	JJ	O	healthy	amod	22	SENT_291	[p12l1904t3540r2145b3607],
22	cases	NNS	O	case	prep_among	38	SENT_291	[p12l15t3642r179b3680],
23	and	CC	O	and	_	0	SENT_291	[p12l208t3626r323b3680],
24	patients	NNS	O	patient	prep_among	38	SENT_291	[p12l352t3627r609b3694],
25	treated	VBN	O	treat	partmod	22	SENT_291	[p12l637t3626r865b3680],
26	with	IN	O	with	_	0	SENT_291	[p12l891t3626r1039b3680],
27	clopidogrel	NN	O	clopidogrel	prep_with	25	SENT_291	[p12l1067t3626r1441b3694],
28	,	,	O	,	_	0	SENT_291	[p12l1067t3626r1441b3694],
29	carriers	NNS	O	carrier	nsubj	38	SENT_291	[p12l1469t3627r1709b3680],
30	with	IN	O	with	_	0	SENT_291	[p12l1736t3626r1884b3680],
31	at	IN	O	at	quantmod	33	SENT_291	[p12l1910t3634r1970b3680],
32	least	JJS	O	least	mwe	31	SENT_291	[p12l1997t3626r2145b3680],
33	one	CD	NUMBER	one	num	34	SENT_291	[p12l15t3729r129b3767],
34	variant	NN	O	variant	prep_with	29	SENT_291	[p12l157t3714r385b3767],
35	of	IN	O	of	_	0	SENT_291	[p12l414t3713r480b3767],
36	CYP2C19	NN	O	cyp2c19	nn	37	SENT_291	[p12l503t3716r773b3767],
37	alleles	NNS	O	allele	prep_of	34	SENT_291	[p12l802t3713r1002b3767],
38	(	VBP	O	(	ccomp	17	SENT_291	[p12l1033t3713r1140b3780],
39	2	CD	NUMBER	2	number	40	SENT_291	[p12l1033t3713r1140b3780],
40	*	CD	NUMBER	*	dobj	38	SENT_291	[p12l1033t3713r1140b3780],
41	,	,	O	,	_	0	SENT_291	[p12l1033t3713r1140b3780],
42	3	CD	NUMBER	3	num	44	SENT_291	[p12l1169t3713r1262b3780],
43	*	NN	O	*	nn	44	SENT_291	[p12l1169t3713r1262b3780],
44	)	NN	O	)	nsubj	45	SENT_291	[p12l1169t3713r1262b3780],
45	had	VBD	O	have	_	0	SENT_291	[p12l1292t3713r1407b3767],
46	a	DT	O	a	det	49	SENT_291	[p12l1437t3729r1469b3767],
47	reduced	VBN	O	reduce	amod	49	SENT_291	[p12l1499t3713r1755b3767],
48	clopidogrel	NN	O	clopidogrel	nn	49	SENT_291	[p12l1786t3713r2143b3781],
49	response	NN	O	response	dobj	45	SENT_291	[p13l15t32r299b84],
50	due	JJ	O	due	_	0	SENT_291	[p13l339t16r455b70],
51	to	TO	O	to	_	0	SENT_291	[p13l494t25r556b70],
52	decreased	VBN	O	decrease	amod	53	SENT_291	[p13l596t16r915b70],
53	formation	NN	O	formation	prep_due_to	49	SENT_291	[p13l956t16r1275b70],
54	of	IN	O	of	_	0	SENT_291	[p13l1314t16r1380b70],
55	the	DT	O	the	det	57	SENT_291	[p13l1412t16r1513b70],
56	active	JJ	O	active	amod	57	SENT_291	[p13l1553t17r1741b70],
57	metabolite	NN	O	metabolite	prep_of	53	SENT_291	[p13l1782t16r2143b71],
58	.	.	O	.	_	0	SENT_291	[p13l1782t16r2143b71],

1	Therefore	RB	O	therefore	advmod	5	SENT_292	[p13l12t103r338b166],
2	,	,	O	,	_	0	SENT_292	[p13l12t103r338b166],
3	this	DT	O	this	nsubjpass	5	SENT_292	[p13l361t103r477b157],
4	is	VBZ	O	be	auxpass	5	SENT_292	[p13l501t104r548b157],
5	translated	VBN	O	translate	_	0	SENT_292	[p13l571t103r895b157],
6	into	IN	O	into	_	0	SENT_292	[p13l919t104r1043b157],
7	the	DT	O	the	det	10	SENT_292	[p13l1065t103r1166b157],
8	higher	JJR	O	higher	amod	10	SENT_292	[p13l1189t103r1396b171],
9	relative	JJ	O	relative	amod	10	SENT_292	[p13l1417t103r1657b157],
10	risk	NN	O	risk	prep_into	5	SENT_292	[p13l1681t103r1797b157],
11	of	IN	O	of	_	0	SENT_292	[p13l1818t103r1884b157],
12	adverse	JJ	O	adverse	amod	14	SENT_292	[p13l1899t103r2144b157],
13	cardiovascular	JJ	O	cardiovascular	amod	14	SENT_292	[p13l15t191r483b245],
14	events	NNS	O	event	prep_of	10	SENT_292	[p13l507t199r712b245],
15	by	IN	O	by	_	0	SENT_292	[p13l739t191r816b258],
16	a	DT	O	a	det	17	SENT_292	[p13l840t207r872b245],
17	factor	NN	O	factor	agent	5	SENT_292	[p13l899t191r1084b245],
18	of	IN	O	of	_	0	SENT_292	[p13l1107t191r1173b245],
19	1.53-3	CD	NUMBER	1.53-3	num	20	SENT_292	[p13l1195t194r1507b245],
20	.69	CD	NUMBER	.69	prep_of	17	SENT_292	[p13l1195t194r1507b245],
21	among	IN	O	among	_	0	SENT_292	[p13l1534t206r1753b258],
22	the	DT	O	the	det	23	SENT_292	[p13l1776t191r1877b245],
23	carriers	NNS	O	carrier	prep_among	5	SENT_292	[p13l1904t192r2143b245],
24	of	IN	O	of	_	0	SENT_292	[p13l15t278r81b332],
25	the	DT	O	the	det	28	SENT_292	[p13l103t278r204b332],
26	loss-of	JJ	O	loss-of	amod	28	SENT_292	[p13l234t278r452b332],
27	function	NN	O	function	nn	28	SENT_292	[p13l475t278r742b332],
28	alleles	NNS	O	allele	prep_of	23	SENT_292	[p13l772t278r971b332],
29	as	IN	O	as	mark	36	SENT_292	[p13l1002t293r1064b332],
30	compared	VBN	O	compare	_	0	SENT_292	[p13l1095t278r1414b345],
31	with	IN	O	with	prepc_compared_with	36	SENT_292	[p13l1442t278r1590b332],
32	the	DT	O	the	det	34	SENT_292	[p13l1619t278r1720b332],
33	non	JJ	O	non	amod	34	SENT_292	[p13l1751t279r2143b332],
34	—	NN	O	—	pobj	36	SENT_292	[p13l1751t279r2143b332],
35	carriers	NNS	O	carrier	nsubj	36	SENT_292	[p13l1751t279r2143b332],
36	[	VBP	O	[	advcl	5	SENT_292	[p13l18t364r380b432],
37	19,52	CD	NUMBER	19,52	number	38	SENT_292	[p13l18t364r380b432],
38	—	CD	NUMBER	—	dobj	36	SENT_292	[p13l18t364r380b432],
39	54	CD	NUMBER	54	num	40	SENT_292	[p13l18t364r380b432],
40	]	NN	O	]	dep	38	SENT_292	[p13l18t364r380b432],
41	.	.	O	.	_	0	SENT_292	[p13l18t364r380b432],

1	Moreover	RB	O	moreover	advmod	8	SENT_293	[p13l432t368r756b427],
2	,	,	O	,	_	0	SENT_293	[p13l432t368r756b427],
3	these	DT	O	these	det	5	SENT_293	[p13l806t364r975b418],
4	fundamental	JJ	O	fundamental	amod	5	SENT_293	[p13l1026t364r1436b418],
5	ﬁndings	NNS	O	ﬁndings	nsubjpass	8	SENT_293	[p13l1487t364r1742b432],
6	have	VBP	O	have	aux	8	SENT_293	[p13l1794t364r1942b418],
7	been	VBN	O	be	auxpass	8	SENT_293	[p13l1992t364r2145b418],
8	validated	VBN	O	validate	_	0	SENT_293	[p13l13t451r310b505],
9	by	IN	O	by	_	0	SENT_293	[p13l345t451r422b519],
10	a	DT	O	a	det	13	SENT_293	[p13l456t467r488b505],
11	recent	JJ	O	recent	amod	13	SENT_293	[p13l523t459r724b505],
12	meta	NN	O	meta	nn	13	SENT_293	[p13l758t459r918b505],
13	analysis	NN	O	analysis	agent	8	SENT_293	[p13l953t451r1208b519],
14	of	IN	O	of	_	0	SENT_293	[p13l1243t451r1310b505],
15	data	NNS	O	datum	prep_of	13	SENT_293	[p13l1337t451r1474b505],
16	from	IN	O	from	_	0	SENT_293	[p13l1509t451r1661b505],
17	nine	CD	NUMBER	nine	num	19	SENT_293	[p13l1696t452r1834b505],
18	pharmacogenetic	JJ	O	pharmacogenetic	amod	19	SENT_293	[p13l1869t451r2144b519, p13l15t539r319b606],
19	investigations	NNS	O	investigation	nsubj	22	SENT_293	[p13l348t539r795b606],
20	of	IN	O	of	_	0	SENT_293	[p13l825t538r890b592],
21	clopidogrel	NN	O	clopidogrel	prep_of	19	SENT_293	[p13l911t538r1269b606],
22	involving	VBG	O	involve	prepc_from	8	SENT_293	[p13l1299t538r1598b606],
23	9685	NN	NUMBER	9685	nn	24	SENT_293	[p13l1625t541r1782b592],
24	cases	NNS	O	case	dobj	22	SENT_293	[p13l1813t554r1977b592],
25	who	WP	O	who	nsubj	30	SENT_293	[p13l2005t538r2144b592],
26	had	VBD	O	have	rcmod	24	SENT_293	[p13l15t626r131b680],
27	an	DT	O	a	det	28	SENT_293	[p13l173t641r248b680],
28	ACS	NN	O	ac	dobj	26	SENT_293	[p13l288t628r411b680],
29	or	CC	O	or	_	0	SENT_293	[p13l454t641r519b680],
30	underwent	VBD	O	undergo	rcmod	24	SENT_293	[p13l559t626r914b680],
31	PCI	NNP	O	PCI	nsubj	34	SENT_293	[p13l955t629r1054b680],
32	[	CD	NUMBER	[	number	33	SENT_293	[p13l1100t626r1241b693],
33	55	CD	NUMBER	55	num	34	SENT_293	[p13l1100t626r1241b693],
34	]	NN	O	]	xcomp	30	SENT_293	[p13l1100t626r1241b693],
35	.	.	O	.	_	0	SENT_293	[p13l1100t626r1241b693],

1	On	IN	O	on	_	0	SENT_294	[p13l1285t629r1374b680],
2	the	DT	O	the	det	3	SENT_294	[p13l1415t626r1517b680],
3	contrary	NN	O	contrary	prep_on	15	SENT_294	[p13l1559t634r1831b693],
4	to	TO	O	to	_	0	SENT_294	[p13l1871t634r1933b680],
5	these	DT	O	these	prep_to	3	SENT_294	[p13l1975t626r2144b680],
6	mentioned	VBN	O	mention	partmod	5	SENT_294	[p13l15t713r363b767],
7	studies	NNS	O	study	dobj	6	SENT_294	[p13l395t713r636b775],
8	,	,	O	,	_	0	SENT_294	[p13l395t713r636b775],
9	our	PRP$	O	we	poss	10	SENT_294	[p13l668t728r776b767],
10	study	NN	O	study	nsubj	15	SENT_294	[p13l806t713r983b780],
11	and	CC	O	and	_	0	SENT_294	[p13l1012t713r1128b767],
12	other	JJ	O	other	amod	14	SENT_294	[p13l1160t713r1331b767],
13	limited	JJ	O	limited	amod	14	SENT_294	[p13l1361t713r1589b767],
14	surveys	NNS	O	survey	conj_and	10	SENT_294	[p13l1621t728r1862b780],
15	demonstrated	VBD	O	demonstrate	_	0	SENT_294	[p13l1895t713r2144b767, p13l16t800r238b854],
16	that	IN	O	that	complm	23	SENT_294	[p13l287t800r416b854],
17	CYP2C19	NN	O	cyp2c19	nn	20	SENT_294	[p13l465t803r736b854],
18	loss-of	JJ	O	loss-of	amod	20	SENT_294	[p13l785t800r1003b854],
19	function	NN	O	function	nn	20	SENT_294	[p13l1045t800r1313b854],
20	alleles	NNS	O	allele	nsubj	23	SENT_294	[p13l1361t800r1561b854],
21	did	VBD	O	do	aux	23	SENT_294	[p13l1611t800r1711b854],
22	not	RB	O	not	neg	23	SENT_294	[p13l1761t808r1866b854],
23	have	VB	O	have	ccomp	15	SENT_294	[p13l1914t800r2062b854],
24	a	DT	O	a	det	26	SENT_294	[p13l2112t816r2144b854],
25	signiﬁcant	JJ	O	signiﬁcant	amod	26	SENT_294	[p13l16t887r350b955],
26	effect	NN	O	effect	dobj	23	SENT_294	[p13l369t887r546b941],
27	on	IN	O	on	_	0	SENT_294	[p13l566t903r643b941],
28	clopidogrel	NN	O	clopidogrel	nn	29	SENT_294	[p13l664t887r1022b955],
29	response	NN	O	response	prep_on	26	SENT_294	[p13l1044t903r1343b955],
30	.	.	O	.	_	0	SENT_294	[p13l1044t903r1343b955],

1	Wallentin	NNP	O	Wallentin	nsubj	17	SENT_295	[p13l1362t887r1682b941],
2	et	FW	O	et	nn	3	SENT_295	[p13l1703t895r1762b941],
3	al.	FW	O	al.	dep	1	SENT_295	[p13l1782t887r1850b942],
4	in	IN	O	in	_	0	SENT_295	[p13l1873t888r1932b941],
5	a	DT	O	a	det	6	SENT_295	[p13l1953t903r1985b941],
6	substudy	NN	O	substudy	prep_in	3	SENT_295	[p13l2006t887r2143b941, p13l16t975r193b1042],
7	of	IN	O	of	_	0	SENT_295	[p13l252t974r317b1029],
8	the	DT	O	the	det	10	SENT_295	[p13l370t975r471b1029],
9	PLATO	NNP	O	PLATO	nn	10	SENT_295	[p13l532t977r737b1029],
10	Trial	NN	O	trial	prep_of	6	SENT_295	[p13l796t975r940b1029],
11	(	CD	NUMBER	(	num	13	SENT_295	[p13l1002t975r1306b1042],
12	PLATelet	NN	O	platelet	nn	13	SENT_295	[p13l1002t975r1306b1042],
13	inhibition	NN	O	inhibition	dep	1	SENT_295	[p13l1366t975r1681b1029],
14	and	CC	O	and	_	0	SENT_295	[p13l1741t974r1856b1029],
15	patient	NN	O	patient	nn	16	SENT_295	[p13l1918t975r2146b1042],
16	Outcomes	NNS	O	outcome	dep	1	SENT_295	[p13l15t1062r362b1129],
17	)	VBP	O	)	_	0	SENT_295	[p13l15t1062r362b1129],
18	demonstrated	VBN	O	demonstrate	dep	17	SENT_295	[p13l451t1061r900b1115],
19	that	IN	O	that	complm	32	SENT_295	[p13l988t1061r1117b1115],
20	the	DT	O	the	det	21	SENT_295	[p13l1205t1061r1306b1115],
21	relationship	NN	O	relationship	nsubj	32	SENT_295	[p13l1395t1061r1780b1129],
22	between	IN	O	between	_	0	SENT_295	[p13l1868t1061r2144b1115],
23	CYP2C19	NN	O	cyp2c19	nn	24	SENT_295	[p13l16t1149r352b1203],
24	*	NN	O	*	prep_between	21	SENT_295	[p13l16t1149r352b1203],
25	2	CD	NUMBER	2	num	26	SENT_295	[p13l16t1149r352b1203],
26	polymorphism	NN	O	polymorphism	dep	24	SENT_295	[p13l374t1149r847b1216],
27	and	CC	O	and	_	0	SENT_295	[p13l865t1149r980b1203],
28	clopidogrel	NN	O	clopidogrel	nn	29	SENT_295	[p13l1000t1149r1358b1216],
29	effect	NN	O	effect	prep_between	21	SENT_295	[p13l1377t1149r1554b1203],
30	is	VBZ	O	be	cop	32	SENT_295	[p13l1572t1150r1619b1203],
31	time	NN	O	time	advmod	32	SENT_295	[p13l1638t1150r1784b1203],
32	dependent	JJ	O	dependent	ccomp	18	SENT_295	[p13l1802t1149r2146b1216],
33	and	CC	O	and	_	0	SENT_295	[p13l15t1236r131b1290],
34	the	DT	O	the	det	38	SENT_295	[p13l154t1236r255b1290],
35	CYP2C19	NN	O	cyp2c19	nn	38	SENT_295	[p13l280t1236r616b1290],
36	*	NN	O	*	nn	38	SENT_295	[p13l280t1236r616b1290],
37	2	CD	NUMBER	2	num	38	SENT_295	[p13l280t1236r616b1290],
38	variant	NN	O	variant	nsubj	39	SENT_295	[p13l638t1237r867b1290],
39	had	VBD	O	have	conj_and	32	SENT_295	[p13l889t1236r1004b1290],
40	no	DT	O	no	det	42	SENT_295	[p13l1029t1251r1106b1290],
41	signiﬁcant	JJ	O	signiﬁcant	amod	42	SENT_295	[p13l1130t1236r1464b1303],
42	effect	NN	O	effect	dobj	39	SENT_295	[p13l1486t1236r1663b1290],
43	on	IN	O	on	_	0	SENT_295	[p13l1685t1251r1763b1290],
44	clopidogrel	NN	O	clopidogrel	nn	45	SENT_295	[p13l1786t1236r2143b1303],
45	response	NN	O	response	prep_on	42	SENT_295	[p13l15t1338r299b1390],
46	in	IN	O	in	_	0	SENT_295	[p13l336t1323r395b1376],
47	a	DT	O	a	det	51	SENT_295	[p13l431t1338r463b1376],
48	long	JJ	O	long	amod	51	SENT_295	[p13l500t1322r822b1390],
49	—	NN	O	—	nn	51	SENT_295	[p13l500t1322r822b1390],
50	term	NN	O	term	nn	51	SENT_295	[p13l500t1322r822b1390],
51	therapy	NN	O	therapy	prep_in	39	SENT_295	[p13l858t1322r1107b1390],
52	[	CD	NUMBER	[	number	53	SENT_295	[p13l1145t1322r1286b1390],
53	56	CD	NUMBER	56	num	54	SENT_295	[p13l1145t1322r1286b1390],
54	]	NN	O	]	dep	39	SENT_295	[p13l1145t1322r1286b1390],
55	.	.	O	.	_	0	SENT_295	[p13l1145t1322r1286b1390],

1	In	IN	O	in	_	0	SENT_296	[p13l1325t1326r1384b1376],
2	a	DT	O	a	det	18	SENT_296	[p13l1421t1338r1453b1376],
3	randomized	VBN	O	randomize	dep	18	SENT_296	[p13l1490t1322r1889b1385],
4	,	,	O	,	_	0	SENT_296	[p13l1490t1322r1889b1385],
5	double	JJ	O	double	amod	9	SENT_296	[p13l1926t1322r2144b1376],
6	blind	JJ	O	blind	amod	9	SENT_296	[p13l14t1409r194b1472],
7	,	,	O	,	_	0	SENT_296	[p13l14t1409r194b1472],
8	placebo-controlled	JJ	O	placebo-controlled	amod	9	SENT_296	[p13l223t1409r828b1477],
9	trial	NN	O	trial	dobj	3	SENT_296	[p13l856t1409r985b1463],
10	performed	VBN	O	perform	partmod	9	SENT_296	[p13l1015t1409r1352b1477],
11	in	IN	O	in	_	0	SENT_296	[p13l1381t1410r1440b1463],
12	patients	NNS	O	patient	prep_in	10	SENT_296	[p13l1468t1410r1725b1477],
13	of	IN	O	of	_	0	SENT_296	[p13l1755t1409r1821b1463],
14	European	JJ	MISC	european	prep_of	12	SENT_296	[p13l1842t1413r2145b1477],
15	and	CC	O	and	_	0	SENT_296	[p13l15t1497r131b1551],
16	Latin	JJ	MISC	latin	amod	17	SENT_296	[p13l160t1497r317b1551],
17	American	JJ	MISC	american	dep	18	SENT_296	[p13l342t1497r651b1551],
18	ancestry	NN	O	ancestry	prep_in	45	SENT_296	[p13l678t1505r964b1564],
19	,	,	O	,	_	0	SENT_296	[p13l678t1505r964b1564],
20	Pare	VB	O	pare	csubj	45	SENT_296	[p13l993t1500r1129b1551],
21	G	NN	O	g	dobj	20	SENT_296	[p13l1158t1499r1202b1551],
22	et	FW	O	et	nn	21	SENT_296	[p13l1231t1505r1290b1551],
23	al.	FW	O	al.	dep	21	SENT_296	[p13l1317t1497r1386b1551],
24	reported	VBN	O	report	dep	20	SENT_296	[p13l1415t1497r1690b1564],
25	that	IN	O	that	complm	30	SENT_296	[p13l1717t1497r1846b1551],
26	CYP2C19	NN	O	cyp2c19	nn	27	SENT_296	[p13l1874t1499r2145b1551],
27	genotype	NN	O	genotype	nsubj	30	SENT_296	[p13l14t1592r311b1651],
28	did	VBD	O	do	aux	30	SENT_296	[p13l334t1583r434b1637],
29	not	RB	O	not	neg	30	SENT_296	[p13l458t1592r562b1637],
30	have	VB	O	have	ccomp	24	SENT_296	[p13l585t1583r733b1637],
31	a	DT	O	a	det	33	SENT_296	[p13l757t1599r789b1637],
32	signiﬁcant	JJ	O	signiﬁcant	amod	33	SENT_296	[p13l813t1583r1147b1651],
33	inﬂuence	NN	O	inﬂuence	dobj	30	SENT_296	[p13l1169t1583r1463b1637],
34	on	IN	O	on	_	0	SENT_296	[p13l1486t1599r1564b1637],
35	clopidogrel	NN	O	clopidogrel	nn	36	SENT_296	[p13l1587t1583r1944b1651],
36	effect	NN	O	effect	prep_on	33	SENT_296	[p13l1969t1583r2145b1637],
37	and	CC	O	and	_	0	SENT_296	[p13l15t1671r131b1725],
38	consequently	RB	O	consequently	advmod	30	SENT_296	[p13l150t1671r580b1738],
39	did	VBD	O	do	aux	41	SENT_296	[p13l597t1671r696b1725],
40	not	RB	O	not	neg	41	SENT_296	[p13l716t1679r820b1725],
41	show	VB	O	show	conj_and	30	SENT_296	[p13l838t1671r1009b1725],
42	adverse	JJ	O	adverse	amod	44	SENT_296	[p13l1025t1671r1270b1725],
43	cardiovascular	JJ	O	cardiovascular	amod	44	SENT_296	[p13l1289t1671r1757b1725],
44	events	NNS	O	event	dobj	41	SENT_296	[p13l1773t1679r1979b1725],
45	[	VBP	O	[	_	0	SENT_296	[p13l2002t1671r2142b1738],
46	57	CD	NUMBER	57	number	47	SENT_296	[p13l2002t1671r2142b1738],
47	]	CD	NUMBER	]	dobj	45	SENT_296	[p13l2002t1671r2142b1738],
48	.	.	O	.	_	0	SENT_296	[p13l2002t1671r2142b1738],

1	In	IN	O	in	_	0	SENT_297	[p13l15t1761r75b1811],
2	another	DT	O	another	det	3	SENT_297	[p13l104t1758r354b1812],
3	study	NN	O	study	prep_in	17	SENT_297	[p13l382t1758r558b1825],
4	carried	VBD	O	carry	partmod	3	SENT_297	[p13l587t1758r809b1812],
5	out	RP	O	out	prt	4	SENT_297	[p13l837t1766r943b1812],
6	in	IN	O	in	_	0	SENT_297	[p13l971t1759r1030b1811],
7	79	CD	NUMBER	79	num	8	SENT_297	[p13l1060t1761r1135b1812],
8	patients	NNS	O	patient	prep_in	4	SENT_297	[p13l1165t1759r1423b1825],
9	with	IN	O	with	_	0	SENT_297	[p13l1451t1758r1598b1812],
10	CAD	NN	O	cad	prep_with	8	SENT_297	[p13l1627t1760r1777b1820],
11	,	,	O	,	_	0	SENT_297	[p13l1627t1760r1777b1820],
12	CYP2C19	NN	O	cyp2c19	nn	13	SENT_297	[p13l1807t1758r2144b1812],
13	*	NN	O	*	nsubj	17	SENT_297	[p13l1807t1758r2144b1812],
14	2	CD	NUMBER	2	number	16	SENT_297	[p13l1807t1758r2144b1812],
15	loss-of	JJ	O	loss-of	dep	16	SENT_297	[p13l15t1844r234b1898],
16	function	NN	O	function	amod	13	SENT_297	[p13l266t1844r533b1898],
17	had	VBD	O	have	_	0	SENT_297	[p13l573t1844r688b1898],
18	no	DT	O	no	det	20	SENT_297	[p13l729t1860r805b1898],
19	signiﬁcant	JJ	O	signiﬁcant	amod	20	SENT_297	[p13l846t1844r1180b1912],
20	impact	NN	O	impact	dobj	17	SENT_297	[p13l1219t1845r1440b1912],
21	on	IN	O	on	_	0	SENT_297	[p13l1478t1860r1556b1898],
22	clopidogrel	NN	O	clopidogrel	nn	24	SENT_297	[p13l1595t1844r1953b1912],
23	antiplatelet	JJ	O	antiplatelet	amod	24	SENT_297	[p13l1993t1845r2144b1898, p13l15t1931r259b1999],
24	effect	NN	O	effect	prep_on	20	SENT_297	[p13l285t1931r462b1985],
25	[	CD	NUMBER	[	number	26	SENT_297	[p13l492t1931r633b1999],
26	58	CD	NUMBER	58	num	27	SENT_297	[p13l492t1931r633b1999],
27	]	NN	O	]	dep	24	SENT_297	[p13l492t1931r633b1999],
28	.	.	O	.	_	0	SENT_297	[p13l492t1931r633b1999],

1	Numerous	JJ	O	numerous	amod	2	SENT_298	[p13l117t2022r449b2073],
2	factors	NNS	O	factor	nsubj	4	SENT_298	[p13l478t2018r691b2073],
3	can	MD	O	can	aux	4	SENT_298	[p13l719t2034r827b2073],
4	explain	VB	O	explain	_	0	SENT_298	[p13l854t2019r1089b2086],
5	the	DT	O	the	det	6	SENT_298	[p13l1114t2019r1215b2073],
6	discrepancies	NNS	O	discrepancy	dobj	4	SENT_298	[p13l1242t2019r1674b2086],
7	of	IN	O	of	_	0	SENT_298	[p13l1702t2018r1768b2073],
8	the	DT	O	the	det	9	SENT_298	[p13l1786t2019r1888b2073],
9	results	NNS	O	result	prep_of	6	SENT_298	[p13l1915t2019r2144b2081],
10	,	,	O	,	_	0	SENT_298	[p13l1915t2019r2144b2081],
11	including	VBG	O	include	_	0	SENT_298	[p13l15t2105r317b2173],
12	the	DT	O	the	det	14	SENT_298	[p13l362t2105r463b2159],
13	study	NN	O	study	nn	14	SENT_298	[p13l511t2105r688b2173],
14	design	NN	O	design	prep_including	6	SENT_298	[p13l734t2105r956b2173],
15	,	,	O	,	_	0	SENT_298	[p13l734t2105r956b2173],
16	the	DT	O	the	det	17	SENT_298	[p13l1004t2105r1105b2159],
17	participation	NN	O	participation	appos	14	SENT_298	[p13l1152t2106r1566b2173],
18	of	IN	O	of	_	0	SENT_298	[p13l1612t2105r1678b2159],
19	ACS	NN	ORGANIZATION	ac	nn	20	SENT_298	[p13l1715t2108r1838b2159],
20	patients	NNS	O	patient	prep_of	17	SENT_298	[p13l1886t2106r2143b2173],
21	undergoing	VBG	O	undergo	dep	20	SENT_298	[p13l15t2193r384b2260],
22	or	CC	O	or	_	0	SENT_298	[p13l440t2208r506b2247],
23	not	RB	O	not	conj_or	21	SENT_298	[p13l562t2201r667b2247],
24	undergoing	VBG	O	undergo	dep	21	SENT_298	[p13l723t2193r1091b2260],
25	PCI	NNP	O	PCI	dobj	24	SENT_298	[p13l1148t2196r1263b2255],
26	,	,	O	,	_	0	SENT_298	[p13l1148t2196r1263b2255],
27	the	DT	O	the	det	28	SENT_298	[p13l1321t2193r1422b2247],
28	method	NN	O	method	appos	25	SENT_298	[p13l1481t2193r1728b2247],
29	of	IN	O	of	_	0	SENT_298	[p13l1786t2193r1851b2247],
30	platelet	NN	O	platelet	nn	32	SENT_298	[p13l1902t2193r2146b2260],
31	aggregation	NN	O	aggregation	nn	32	SENT_298	[p13l15t2281r394b2347],
32	assay	NN	O	assay	prep_of	28	SENT_298	[p13l437t2295r623b2347],
33	,	,	O	,	_	0	SENT_298	[p13l437t2295r623b2347],
34	the	DT	O	the	det	35	SENT_298	[p13l668t2280r769b2334],
35	duration	NN	O	duration	appos	25	SENT_298	[p13l814t2280r1089b2334],
36	of	IN	O	of	_	0	SENT_298	[p13l1133t2280r1199b2334],
37	follow-up	NN	O	follow-up	prep_of	35	SENT_298	[p13l1236t2280r1565b2347],
38	,	,	O	,	_	0	SENT_298	[p13l1236t2280r1565b2347],
39	the	DT	O	the	det	40	SENT_298	[p13l1609t2280r1710b2334],
40	variation	NN	O	variation	appos	25	SENT_298	[p13l1753t2281r2042b2334],
41	of	IN	O	of	_	0	SENT_298	[p13l2086t2280r2152b2334],
42	clopidogrel	NN	O	clopidogrel	nn	43	SENT_298	[p13l15t2366r373b2434],
43	maintenance	NN	O	maintenance	prep_of	40	SENT_298	[p13l406t2367r822b2420],
44	or	CC	O	or	_	0	SENT_298	[p13l854t2382r920b2420],
45	loading	VBG	O	load	dep	21	SENT_298	[p13l950t2366r1187b2434],
46	doses	NNS	O	dose	dobj	45	SENT_298	[p13l1218t2366r1409b2429],
47	,	,	O	,	_	0	SENT_298	[p13l1218t2366r1409b2429],
48	the	DT	O	the	det	50	SENT_298	[p13l1442t2366r1543b2420],
49	efﬁcacy	NN	O	efﬁcacy	nn	50	SENT_298	[p13l1575t2366r1819b2434],
50	outcome	NN	O	outcome	conj_and	46	SENT_298	[p13l1849t2374r2143b2429],
51	,	,	O	,	_	0	SENT_298	[p13l1849t2374r2143b2429],
52	and	CC	O	and	_	0	SENT_298	[p13l15t2453r131b2507],
53	ﬁnally	RB	O	ﬁnally	advmod	46	SENT_298	[p13l160t2453r360b2521],
54	the	DT	O	the	det	55	SENT_298	[p13l386t2453r488b2507],
55	population	NN	O	population	conj_and	46	SENT_298	[p13l516t2453r865b2521],
56	or	CC	O	or	_	0	SENT_298	[p13l892t2469r958b2507],
57	the	DT	O	the	det	58	SENT_298	[p13l983t2453r1084b2507],
58	race	NN	O	race	conj_and	46	SENT_298	[p13l1113t2469r1243b2507],
59	studied	VBN	O	study	partmod	58	SENT_298	[p13l1272t2453r1524b2508],
60	.	.	O	.	_	0	SENT_298	[p13l1272t2453r1524b2508],

1	Different	JJ	O	different	amod	2	SENT_299	[p13l1553t2453r1839b2507],
2	distributions	NNS	O	distribution	nsubjpass	11	SENT_299	[p13l1866t2453r2144b2507, p13l14t2541r170b2595],
3	of	IN	O	of	_	0	SENT_299	[p13l189t2540r255b2595],
4	CYP2C19	NN	O	cyp2c19	nn	5	SENT_299	[p13l267t2540r604b2595],
5	*	NN	O	*	prep_of	2	SENT_299	[p13l267t2540r604b2595],
6	2	CD	NUMBER	2	num	8	SENT_299	[p13l267t2540r604b2595],
7	allele	NN	O	allele	nn	8	SENT_299	[p13l622t2540r790b2595],
8	frequency	NN	O	frequency	dep	5	SENT_299	[p13l809t2540r1129b2608],
9	have	VBP	O	have	aux	11	SENT_299	[p13l1147t2541r1295b2595],
10	been	VBN	O	be	auxpass	11	SENT_299	[p13l1313t2541r1466b2595],
11	observed	VBN	O	observe	_	0	SENT_299	[p13l1484t2541r1773b2595],
12	in	IN	O	in	_	0	SENT_299	[p13l1792t2541r1851b2594],
13	different	JJ	O	different	amod	15	SENT_299	[p13l1868t2540r2146b2595],
14	racial	JJ	O	racial	amod	15	SENT_299	[p13l15t2627r188b2681],
15	groups	NNS	O	group	prep_in	11	SENT_299	[p13l220t2643r454b2695],
16	.	.	O	.	_	0	SENT_299	[p13l220t2643r454b2695],

1	The	DT	O	the	det	3	SENT_300	[p13l486t2627r603b2681],
2	allelic	JJ	O	allelic	amod	3	SENT_300	[p13l635t2627r824b2681],
3	frequency	NN	O	frequency	nsubj	10	SENT_300	[p13l856t2627r1177b2695],
4	of	IN	O	of	_	0	SENT_300	[p13l1208t2627r1274b2681],
5	CYP2C19	NN	O	cyp2c19	nn	6	SENT_300	[p13l1300t2627r1637b2681],
6	*	NN	O	*	prep_of	3	SENT_300	[p13l1300t2627r1637b2681],
7	2	CD	NUMBER	2	num	6	SENT_300	[p13l1300t2627r1637b2681],
8	is	VBZ	O	be	cop	10	SENT_300	[p13l1670t2628r1717b2681],
9	signiﬁcantly	RB	O	signiﬁcantly	advmod	10	SENT_300	[p13l1752t2627r2146b2695],
10	higher	JJR	O	higher	_	0	SENT_300	[p13l15t2715r222b2782],
11	in	IN	O	in	_	0	SENT_300	[p13l260t2716r319b2768],
12	the	DT	O	the	det	15	SENT_300	[p13l358t2715r459b2769],
13	Asian	JJ	LOCATION	asian	amod	15	SENT_300	[p13l496t2716r673b2769],
14	(	NN	O	(	nn	15	SENT_300	[p13l712t2715r939b2782],
15	~	NN	O	~	prep_in	10	SENT_300	[p13l712t2715r939b2782],
16	30	CD	PERCENT	30	number	17	SENT_300	[p13l712t2715r939b2782],
17	%	NN	PERCENT	%	amod	15	SENT_300	[p13l712t2715r939b2782],
18	)	CD	NUMBER	)	npadvmod	19	SENT_300	[p13l712t2715r939b2782],
19	than	IN	O	than	advmod	15	SENT_300	[p13l979t2715r1123b2769],
20	in	IN	O	in	_	0	SENT_300	[p13l1163t2716r1222b2768],
21	Caucasian	JJ	MISC	caucasian	amod	23	SENT_300	[p13l1261t2716r1581b2769],
22	(	NN	O	(	nn	23	SENT_300	[p13l1620t2715r1847b2782],
23	~	NN	O	~	prep_in	15	SENT_300	[p13l1620t2715r1847b2782],
24	13	CD	PERCENT	13	number	25	SENT_300	[p13l1620t2715r1847b2782],
25	%	NN	PERCENT	%	amod	23	SENT_300	[p13l1620t2715r1847b2782],
26	)	CD	NUMBER	)	tmod	10	SENT_300	[p13l1620t2715r1847b2782],
27	and	CC	O	and	_	0	SENT_300	[p13l1888t2715r2003b2769],
28	the	DT	O	the	det	29	SENT_300	[p13l2043t2715r2144b2769],
29	Africo	NNP	MISC	Africo	tmod	10	SENT_300	[p13l12t2802r543b2856],
30	.	.	O	.	_	0	SENT_300	[p13l12t2802r543b2856],

1	—	NN	O	—	_	0	SENT_301	[p13l12t2802r543b2856],
2	.	.	O	.	_	0	SENT_301	[p13l12t2802r543b2856],

1	American	JJ	MISC	american	amod	3	SENT_302	[p13l12t2802r543b2856],
2	(	NN	O	(	nn	3	SENT_302	[p13l561t2802r788b2869],
3	~	NN	O	~	_	0	SENT_302	[p13l561t2802r788b2869],
4	18	CD	PERCENT	18	num	5	SENT_302	[p13l561t2802r788b2869],
5	%	NN	PERCENT	%	dep	3	SENT_302	[p13l561t2802r788b2869],
6	)	CD	NUMBER	)	num	7	SENT_302	[p13l561t2802r788b2869],
7	populations	NNS	O	population	dep	5	SENT_302	[p13l807t2802r1202b2869],
8	.	.	O	.	_	0	SENT_302	[p13l807t2802r1202b2869],

1	The	DT	O	the	det	3	SENT_303	[p13l1219t2802r1335b2856],
2	CYP2C19	NN	O	cyp2c19	nn	3	SENT_303	[p13l1355t2802r1691b2856],
3	*	NN	O	*	nsubjpass	8	SENT_303	[p13l1355t2802r1691b2856],
4	3	CD	NUMBER	3	number	5	SENT_303	[p13l1355t2802r1691b2856],
5	variant	NN	O	variant	amod	3	SENT_303	[p13l1708t2803r1936b2856],
6	is	VBZ	O	be	auxpass	8	SENT_303	[p13l1954t2803r2000b2856],
7	also	RB	O	also	advmod	8	SENT_303	[p13l2020t2802r2144b2856],
8	presented	VBN	O	present	_	0	SENT_303	[p13l15t2888r332b2956],
9	with	IN	O	with	_	0	SENT_303	[p13l365t2888r513b2942],
10	more	JJR	O	more	amod	11	SENT_303	[p13l546t2904r711b2942],
11	frequency	NN	O	frequency	prep_with	8	SENT_303	[p13l745t2888r1066b2956],
12	in	IN	O	in	_	0	SENT_303	[p13l1099t2889r1158b2942],
13	the	DT	O	the	det	14	SENT_303	[p13l1190t2888r1291b2942],
14	Asians	NNPS	MISC	Asians	prep_in	11	SENT_303	[p13l1323t2889r1529b2942],
15	(	CD	NUMBER	(	num	16	SENT_303	[p13l1564t2888r1791b2955],
16	~	NN	O	~	dobj	8	SENT_303	[p13l1564t2888r1791b2955],
17	10	CD	PERCENT	10	number	18	SENT_303	[p13l1564t2888r1791b2955],
18	%	NN	PERCENT	%	amod	16	SENT_303	[p13l1564t2888r1791b2955],
19	)	CD	NUMBER	)	nsubj	25	SENT_303	[p13l1564t2888r1791b2955],
20	compared	VBN	O	compare	_	0	SENT_303	[p13l1825t2888r2144b2956],
21	with	IN	O	with	prepc_compared_with	19	SENT_303	[p13l13t2975r161b3029],
22	other	JJ	O	other	amod	24	SENT_303	[p13l186t2975r358b3029],
23	racial	JJ	O	racial	amod	24	SENT_303	[p13l382t2975r554b3029],
24	groups	NNS	O	group	pobj	19	SENT_303	[p13l580t2991r797b3043],
25	(	VBP	O	(	rcmod	16	SENT_303	[p13l825t2975r1065b3042],
26	~	NN	O	~	dep	25	SENT_303	[p13l825t2975r1065b3042],
27	<	JJR	PERCENT	<	amod	29	SENT_303	[p13l825t2975r1065b3042],
28	l	NN	PERCENT	l	nn	29	SENT_303	[p13l825t2975r1065b3042],
29	%	NN	PERCENT	%	dobj	26	SENT_303	[p13l825t2975r1065b3042],
30	)	CD	NUMBER	)	number	31	SENT_303	[p13l825t2975r1065b3042],
31	[	CD	NUMBER	[	dep	33	SENT_303	[p13l1094t2975r1530b3043],
32	44	CD	NUMBER	44	number	33	SENT_303	[p13l1094t2975r1530b3043],
33	—	NN	O	—	amod	29	SENT_303	[p13l1094t2975r1530b3043],
34	48,59	CD	NUMBER	48,59	number	35	SENT_303	[p13l1094t2975r1530b3043],
35	—	CD	NUMBER	—	prep	33	SENT_303	[p13l1094t2975r1530b3043],
36	61	CD	NUMBER	61	num	37	SENT_303	[p13l1094t2975r1530b3043],
37	]	NN	O	]	dep	35	SENT_303	[p13l1548t2975r1580b3043],
38	.	.	O	.	_	0	SENT_303	[p13l1548t2975r1580b3043],

1	In	IN	O	in	_	0	SENT_304	[p13l1607t2978r1668b3029],
2	our	PRP$	O	we	poss	3	SENT_304	[p13l1693t2991r1801b3029],
3	study	NN	O	study	prep_in	19	SENT_304	[p13l1826t2975r2017b3043],
4	,	,	O	,	_	0	SENT_304	[p13l1826t2975r2017b3043],
5	the	DT	O	the	det	6	SENT_304	[p13l2043t2975r2144b3029],
6	frequency	NN	O	frequency	appos	3	SENT_304	[p13l15t3062r336b3130],
7	of	IN	O	of	_	0	SENT_304	[p13l358t3062r424b3116],
8	CYP2C19	NN	O	cyp2c19	nn	9	SENT_304	[p13l440t3062r776b3116],
9	*	NN	O	*	prep_of	6	SENT_304	[p13l440t3062r776b3116],
10	2	CD	NUMBER	2	num	11	SENT_304	[p13l440t3062r776b3116],
11	allele	NN	O	allele	nsubj	19	SENT_304	[p13l799t3062r968b3116],
12	(	CD	PERCENT	(	num	14	SENT_304	[p13l992t3062r1263b3130],
13	10.09	CD	PERCENT	10.09	num	14	SENT_304	[p13l992t3062r1263b3130],
14	%	NN	PERCENT	%	dep	11	SENT_304	[p13l992t3062r1263b3130],
15	)	CD	NUMBER	)	dep	11	SENT_304	[p13l992t3062r1263b3130],
16	in	IN	O	in	_	0	SENT_304	[p13l1286t3063r1345b3116],
17	patients	NNS	O	patient	prep_in	15	SENT_304	[p13l1368t3063r1625b3130],
18	was	VBD	O	be	cop	19	SENT_304	[p13l1648t3078r1772b3116],
19	lower	JJR	O	lower	_	0	SENT_304	[p13l1797t3062r1980b3116],
20	than	IN	O	than	_	0	SENT_304	[p13l2000t3062r2145b3116],
21	other	JJ	O	other	amod	22	SENT_304	[p13l15t3149r187b3203],
22	populations	NNS	O	population	prep_than	19	SENT_304	[p13l213t3149r608b3217],
23	.	.	O	.	_	0	SENT_304	[p13l213t3149r608b3217],

1	Therefore	RB	O	therefore	advmod	40	SENT_305	[p13l635t3149r961b3212],
2	,	,	O	,	_	0	SENT_305	[p13l635t3149r961b3212],
3	considering	VBG	O	consider	partmod	40	SENT_305	[p13l990t3149r1364b3217],
4	that	IN	O	that	complm	10	SENT_305	[p13l1390t3149r1519b3203],
5	CYP2C19	NN	O	cyp2c19	nn	6	SENT_305	[p13l1547t3152r1818b3203],
6	polymorphisms	NNS	O	polymorphism	nsubj	10	SENT_305	[p13l1846t3149r2144b3217, p13l15t3237r243b3304],
7	to	TO	O	to	aux	10	SENT_305	[p13l290t3245r352b3291],
8	be	VB	O	be	cop	10	SENT_305	[p13l399t3237r472b3291],
9	only	RB	O	only	advmod	10	SENT_305	[p13l520t3237r659b3304],
10	responsible	JJ	O	responsible	ccomp	3	SENT_305	[p13l705t3237r1072b3304],
11	for	IN	O	for	_	0	SENT_305	[p13l1120t3237r1209b3291],
12	approximately	RB	O	approximately	quantmod	13	SENT_305	[p13l1253t3237r1724b3304],
13	12	CD	PERCENT	12	num	14	SENT_305	[p13l1773t3240r1891b3291],
14	%	NN	PERCENT	%	prep_for	10	SENT_305	[p13l1773t3240r1891b3291],
15	of	IN	O	of	_	0	SENT_305	[p13l1938t3237r2003b3291],
16	the	DT	O	the	det	17	SENT_305	[p13l2043t3237r2144b3291],
17	variability	NN	O	variability	prep_of	14	SENT_305	[p13l13t3324r343b3391],
18	in	IN	O	in	_	0	SENT_305	[p13l389t3325r449b3377],
19	clopidogrel	NN	O	clopidogrel	nn	21	SENT_305	[p13l495t3324r853b3391],
20	antiplatelet	JJ	O	antiplatelet	amod	21	SENT_305	[p13l901t3324r1272b3391],
21	effect	NN	O	effect	prep_in	17	SENT_305	[p13l1318t3324r1494b3378],
22	[	CD	NUMBER	[	number	23	SENT_305	[p13l1544t3324r1665b3391],
23	53	CD	NUMBER	53	num	24	SENT_305	[p13l1544t3324r1665b3391],
24	]	NN	O	]	dep	21	SENT_305	[p13l1544t3324r1665b3391],
25	and	CC	O	and	_	0	SENT_305	[p13l1716t3324r1832b3378],
26	the	DT	O	the	det	28	SENT_305	[p13l1879t3324r1981b3378],
27	low	JJ	O	low	amod	28	SENT_305	[p13l2028t3324r2146b3378],
28	frequency	NN	O	frequency	prep_in	17	SENT_305	[p13l10t3412r332b3480],
29	of	IN	O	of	_	0	SENT_305	[p13l352t3412r418b3467],
30	the	DT	O	the	det	34	SENT_305	[p13l432t3412r533b3467],
31	CYP2C19	NN	O	cyp2c19	nn	34	SENT_305	[p13l556t3412r894b3467],
32	*	NN	O	*	nn	34	SENT_305	[p13l556t3412r894b3467],
33	2	CD	NUMBER	2	num	34	SENT_305	[p13l556t3412r894b3467],
34	variant	NN	O	variant	prep_of	28	SENT_305	[p13l914t3413r1144b3467],
35	in	IN	O	in	_	0	SENT_305	[p13l1165t3413r1224b3466],
36	our	PRP$	O	we	poss	37	SENT_305	[p13l1246t3428r1355b3467],
37	population	NN	O	population	prep_in	10	SENT_305	[p13l1374t3412r1739b3480],
38	,	,	O	,	_	0	SENT_305	[p13l1374t3412r1739b3480],
39	we	PRP	O	we	nsubj	40	SENT_305	[p13l1760t3428r1854b3467],
40	believed	VBD	O	believe	_	0	SENT_305	[p13l1876t3412r2145b3467],
41	that	IN	O	that	complm	47	SENT_305	[p13l9t3500r139b3555],
42	this	DT	O	this	det	44	SENT_305	[p13l159t3500r276b3555],
43	genetic	JJ	O	genetic	amod	44	SENT_305	[p13l297t3501r531b3569],
44	polymorphism	NN	O	polymorphism	nsubj	47	SENT_305	[p13l552t3500r1027b3569],
45	does	VBZ	O	do	aux	47	SENT_305	[p13l1049t3500r1192b3555],
46	not	RB	O	not	neg	47	SENT_305	[p13l1217t3508r1321b3555],
47	have	VB	O	have	ccomp	40	SENT_305	[p13l1342t3500r1492b3555],
48	a	DT	O	a	det	50	SENT_305	[p13l1514t3516r1546b3555],
49	signiﬁcant	JJ	O	signiﬁcant	amod	50	SENT_305	[p13l1569t3500r1904b3569],
50	impact	NN	O	impact	dobj	47	SENT_305	[p13l1925t3501r2147b3569],
51	on	IN	O	on	_	0	SENT_305	[p13l10t3605r88b3644],
52	clopidogrel	NN	O	clopidogrel	nn	53	SENT_305	[p13l106t3589r465b3658],
53	responsiveness	NN	O	responsiveness	prep_on	50	SENT_305	[p13l486t3590r971b3658],
54	in	IN	O	in	_	0	SENT_305	[p13l991t3590r1051b3644],
55	the	DT	O	the	det	57	SENT_305	[p13l1068t3589r1170b3644],
56	Iranian	JJ	MISC	iranian	amod	57	SENT_305	[p13l1190t3590r1416b3644],
57	population	NN	O	population	prep_in	53	SENT_305	[p13l1434t3589r1799b3658],
58	.	.	O	.	_	0	SENT_305	[p13l1434t3589r1799b3658],

1	Moreover	RB	O	moreover	advmod	12	SENT_306	[p13l1820t3593r2145b3653],
2	,	,	O	,	_	0	SENT_306	[p13l1820t3593r2145b3653],
3	the	DT	O	the	det	4	SENT_306	[p13l9t3678r111b3732],
4	results	NNS	O	result	nsubj	12	SENT_306	[p13l141t3678r354b3732],
5	of	IN	O	of	_	0	SENT_306	[p13l385t3677r451b3732],
6	other	JJ	O	other	amod	7	SENT_306	[p13l474t3678r646b3732],
7	studies	NNS	O	study	prep_of	4	SENT_306	[p13l675t3678r900b3732],
8	conducted	VBN	O	conduct	partmod	7	SENT_306	[p13l932t3678r1266b3732],
9	in	IN	O	in	_	0	SENT_306	[p13l1297t3678r1357b3731],
10	Iran	NNP	LOCATION	Iran	prep_in	8	SENT_306	[p13l1387t3681r1528b3740],
11	,	,	O	,	_	0	SENT_306	[p13l1387t3681r1528b3740],
12	indicated	VBD	O	indicate	_	0	SENT_306	[p13l1559t3678r1856b3732],
13	that	IN	O	that	complm	21	SENT_306	[p13l1886t3678r2016b3732],
14	the	DT	O	the	det	16	SENT_306	[p13l2044t3678r2146b3732],
15	allele	NN	O	allele	nn	16	SENT_306	[p14l10t19r179b74],
16	frequencies	NNS	O	frequency	nsubj	21	SENT_306	[p14l207t19r576b88],
17	of	IN	O	of	_	0	SENT_306	[p14l605t19r671b74],
18	CYP2C19	NN	O	cyp2c19	prep_of	16	SENT_306	[p14l692t22r963b74],
19	were	VBD	O	be	cop	21	SENT_306	[p14l988t35r1148b74],
20	more	JJR	O	more	advmod	21	SENT_306	[p14l1176t35r1342b74],
21	similar	JJ	O	similar	ccomp	12	SENT_306	[p14l1370t19r1593b74],
22	to	TO	O	to	_	0	SENT_306	[p14l1618t28r1679b74],
23	Caucasians	NNPS	MISC	Caucasians	prep_to	21	SENT_306	[p14l1708t20r2058b74],
24	in	IN	O	in	_	0	SENT_306	[p14l2087t20r2146b74],
25	spite	NN	O	spite	_	0	SENT_306	[p14l11t110r163b177],
26	of	IN	O	of	_	0	SENT_306	[p14l191t109r257b164],
27	Iran	NNP	LOCATION	Iran	nn	28	SENT_306	[p14l278t112r404b164],
28	location	NN	O	location	prep_in_spite_of	21	SENT_306	[p14l432t109r689b164],
29	in	IN	O	in	_	0	SENT_306	[p14l718t110r777b163],
30	Asia	NNP	LOCATION	Asia	prep_in	21	SENT_306	[p14l802t110r936b164],
31	[	CD	NUMBER	[	num	30	SENT_306	[p14l967t109r1207b177],
32	62,63	CD	NUMBER	62,63	num	33	SENT_306	[p14l967t109r1207b177],
33	]	NN	O	]	dep	21	SENT_306	[p14l967t109r1207b177],
34	.	.	O	.	_	0	SENT_306	[p14l967t109r1207b177],

1	Our	PRP$	O	we	poss	2	SENT_307	[p14l112t201r231b253],
2	study	NN	O	study	nsubj	3	SENT_307	[p14l263t198r440b266],
3	had	VBD	O	have	_	0	SENT_307	[p14l472t198r588b253],
4	some	DT	O	some	det	5	SENT_307	[p14l623t214r790b253],
5	limitations	NNS	O	limitation	dobj	3	SENT_307	[p14l824t198r1188b253],
6	.	.	O	.	_	0	SENT_307	[p14l824t198r1188b253],

1	Firstly	RB	O	firstly	advmod	8	SENT_308	[p14l1224t198r1438b266],
2	,	,	O	,	_	0	SENT_308	[p14l1224t198r1438b266],
3	the	DT	O	the	det	5	SENT_308	[p14l1471t198r1573b253],
4	sample	NN	O	sample	nn	5	SENT_308	[p14l1607t198r1835b266],
5	size	NN	O	size	nsubjpass	8	SENT_308	[p14l1869t199r1989b253],
6	was	VBD	O	be	auxpass	8	SENT_308	[p14l2020t214r2145b253],
7	relatively	RB	O	relatively	advmod	8	SENT_308	[p14l10t286r313b355],
8	limited	VBN	O	limit	_	0	SENT_308	[p14l343t286r588b342],
9	.	.	O	.	_	0	SENT_308	[p14l343t286r588b342],

1	In	IN	O	in	_	0	SENT_309	[p14l620t290r680b341],
2	a	DT	O	a	det	4	SENT_309	[p14l711t302r743b341],
3	larger	JJR	O	larger	amod	4	SENT_309	[p14l774t286r962b355],
4	population	NN	O	population	prep_in	12	SENT_309	[p14l990t286r1355b355],
5	,	,	O	,	_	0	SENT_309	[p14l990t286r1355b355],
6	the	DT	O	the	det	7	SENT_309	[p14l1386t286r1488b341],
7	results	NNS	O	result	nsubj	12	SENT_309	[p14l1520t286r1732b341],
8	would	MD	O	would	aux	12	SENT_309	[p14l1762t286r1965b341],
9	have	VB	O	have	aux	12	SENT_309	[p14l1997t286r2146b341],
10	been	VBN	O	be	cop	12	SENT_309	[p14l9t375r163b430],
11	more	RBR	O	more	advmod	12	SENT_309	[p14l182t391r347b430],
12	reliable	JJ	O	reliable	_	0	SENT_309	[p14l367t375r621b431],
13	.	.	O	.	_	0	SENT_309	[p14l367t375r621b431],

1	Secondly	RB	O	secondly	advmod	4	SENT_310	[p14l642t375r944b444],
2	,	,	O	,	_	0	SENT_310	[p14l642t375r944b444],
3	there	EX	O	there	expl	4	SENT_310	[p14l964t375r1131b430],
4	was	VBD	O	be	_	0	SENT_310	[p14l1148t391r1272b430],
5	limitation	NN	O	limitation	nsubj	4	SENT_310	[p14l1293t375r1611b430],
6	in	IN	O	in	_	0	SENT_310	[p14l1630t376r1690b429],
7	access	NN	O	access	prep_in	5	SENT_310	[p14l1708t391r1907b430],
8	to	TO	O	to	aux	9	SENT_310	[p14l1926t383r1988b430],
9	ﬂow	VB	O	ﬂow	infmod	5	SENT_310	[p14l2008t375r2148b430],
10	cytometer	NN	O	cytometer	dobj	9	SENT_310	[p14l10t473r358b533],
11	;	:	O	;	_	0	SENT_310	[p14l10t473r358b533],
12	and	CC	O	and	_	0	SENT_310	[p14l383t464r499b519],
13	ﬁnally	RB	O	ﬁnally	advmod	18	SENT_310	[p14l521t464r736b533],
14	,	,	O	,	_	0	SENT_310	[p14l521t464r736b533],
15	we	PRP	O	we	nsubj	18	SENT_310	[p14l755t480r849b519],
16	did	VBD	O	do	aux	18	SENT_310	[p14l870t464r969b519],
17	not	RB	O	not	neg	18	SENT_310	[p14l991t473r1096b519],
18	determine	VB	O	determine	conj_and	4	SENT_310	[p14l1115t464r1447b519],
19	the	DT	O	the	det	21	SENT_310	[p14l1467t464r1569b519],
20	active	JJ	O	active	amod	21	SENT_310	[p14l1589t465r1778b519],
21	metabolite	NN	O	metabolite	dobj	18	SENT_310	[p14l1799t464r2146b519],
22	of	IN	O	of	_	0	SENT_310	[p14l10t553r76b608],
23	clopidogrel	NN	O	clopidogrel	prep_of	21	SENT_310	[p14l114t553r473b622],
24	in	IN	O	in	_	0	SENT_310	[p14l520t554r579b608],
25	patient	NN	O	patient	poss	27	SENT_310	[p14l625t554r899b622],
26	’s	POS	O	’s	_	0	SENT_310	[p14l625t554r899b622],
27	plasma	NN	O	plasma	prep_in	18	SENT_310	[p14l946t553r1176b622],
28	directly	RB	O	directly	advmod	18	SENT_310	[p14l1221t553r1481b622],
29	,	,	O	,	_	0	SENT_310	[p14l1221t553r1481b622],
30	although	IN	O	although	mark	32	SENT_310	[p14l1528t553r1814b622],
31	we	PRP	O	we	nsubj	32	SENT_310	[p14l1858t569r1952b608],
32	used	VBD	O	use	advcl	18	SENT_310	[p14l1997t553r2145b608],
33	platelet	NN	O	platelet	nn	35	SENT_310	[p14l10t643r254b711],
34	aggregation	NN	O	aggregation	nn	35	SENT_310	[p14l286t644r666b711],
35	test	NN	O	test	dobj	32	SENT_310	[p14l700t651r818b698],
36	with	IN	O	with	_	0	SENT_310	[p14l849t643r998b698],
37	ADP	NN	O	adp	prep_with	32	SENT_310	[p14l1028t645r1165b697],
38	as	IN	O	as	_	0	SENT_310	[p14l1197t659r1260b698],
39	an	DT	O	a	det	41	SENT_310	[p14l1295t659r1371b698],
40	indirect	JJ	O	indirect	amod	41	SENT_310	[p14l1405t643r1654b698],
41	marker	NN	O	marker	prep_as	32	SENT_310	[p14l1687t643r1920b698],
42	of	IN	O	of	_	0	SENT_310	[p14l1952t643r2018b698],
43	the	DT	O	the	det	45	SENT_310	[p14l2044t643r2146b698],
44	active	JJ	O	active	amod	45	SENT_310	[p14l10t733r198b786],
45	metabolite	NN	O	metabolite	prep_of	41	SENT_310	[p14l227t732r589b786],
46	.	.	O	.	_	0	SENT_310	[p14l227t732r589b786],

1	In	IN	O	in	_	0	SENT_311	[p14l112t823r172b874],
2	conclusion	NN	O	conclusion	prep_in	9	SENT_311	[p14l192t819r553b883],
3	,	,	O	,	_	0	SENT_311	[p14l192t819r553b883],
4	the	DT	O	the	det	5	SENT_311	[p14l574t819r675b874],
5	goal	NN	O	goal	nsubj	9	SENT_311	[p14l695t819r827b888],
6	of	IN	O	of	_	0	SENT_311	[p14l849t819r915b874],
7	our	PRP$	O	we	poss	8	SENT_311	[p14l928t835r1037b874],
8	study	NN	O	study	prep_of	5	SENT_311	[p14l1056t819r1234b888],
9	was	VBD	O	be	_	0	SENT_311	[p14l1252t835r1376b874],
10	to	TO	O	to	aux	11	SENT_311	[p14l1398t827r1460b874],
11	ﬁnd	VB	O	ﬁnd	xcomp	9	SENT_311	[p14l1481t819r1604b874],
12	out	RP	O	out	prt	11	SENT_311	[p14l1626t827r1731b874],
13	the	DT	O	the	det	14	SENT_311	[p14l1751t819r1852b874],
14	effective	JJ	O	effective	dobj	11	SENT_311	[p14l1873t819r2146b874],
15	and	CC	O	and	_	0	SENT_311	[p14l10t908r126b963],
16	consequently	RB	O	consequently	advmod	14	SENT_311	[p14l150t908r582b977],
17	the	DT	O	the	det	19	SENT_311	[p14l604t908r705b963],
18	predictive	JJ	O	predictive	amod	19	SENT_311	[p14l730t908r1052b977],
19	parameters	NNS	O	parameter	conj_and	14	SENT_311	[p14l1076t916r1440b977],
20	acting	VBG	O	act	partmod	19	SENT_311	[p14l1465t909r1662b977],
21	on	IN	O	on	dep	28	SENT_311	[p14l1684t924r1762b963],
22	clopidogrel	NN	O	clopidogrel	nn	23	SENT_311	[p14l1786t908r2145b977],
23	responsiveness	NN	O	responsiveness	pobj	21	SENT_311	[p14l10t998r495b1066],
24	and	CC	O	and	_	0	SENT_311	[p14l544t997r660b1052],
25	thus	RB	O	thus	conj_and	21	SENT_311	[p14l707t997r845b1052],
26	post	JJ	O	post	amod	28	SENT_311	[p14l893t1006r1029b1066],
27	stent	NN	O	stent	nn	28	SENT_311	[p14l1076t1006r1235b1052],
28	thrombosis	NN	O	thrombosis	dobj	20	SENT_311	[p14l1281t997r1644b1052],
29	in	IN	O	in	_	0	SENT_311	[p14l1692t998r1751b1052],
30	an	DT	O	a	det	32	SENT_311	[p14l1798t1013r1873b1052],
31	Iranian	JJ	MISC	iranian	amod	32	SENT_311	[p14l1920t998r2146b1052],
32	population	NN	O	population	prep_in	28	SENT_311	[p14l10t1086r375b1155],
33	.	.	O	.	_	0	SENT_311	[p14l10t1086r375b1155],

1	We	PRP	O	we	nsubj	2	SENT_312	[p14l414t1090r523b1141],
2	studied	VBD	O	study	_	0	SENT_312	[p14l565t1086r801b1141],
3	non	JJ	O	non	amod	6	SENT_312	[p14l843t1087r1229b1155],
4	—	JJ	O	—	amod	6	SENT_312	[p14l843t1087r1229b1155],
5	genetic	JJ	O	genetic	amod	6	SENT_312	[p14l843t1087r1229b1155],
6	factors	NNS	O	factor	dobj	2	SENT_312	[p14l1269t1086r1500b1150],
7	,	,	O	,	_	0	SENT_312	[p14l1269t1086r1500b1150],
8	which	WDT	O	which	nsubj	9	SENT_312	[p14l1540t1086r1739b1141],
9	showed	VBD	O	show	rcmod	6	SENT_312	[p14l1779t1086r2026b1141],
10	no	DT	O	no	det	12	SENT_312	[p14l2069t1102r2146b1141],
11	signiﬁcant	JJ	O	signiﬁcant	amod	12	SENT_312	[p14l11t1176r345b1244],
12	association	NN	O	association	dobj	9	SENT_312	[p14l362t1177r735b1231],
13	.	.	O	.	_	0	SENT_312	[p14l362t1177r735b1231],

1	We	PRP	O	we	nsubjpass	16	SENT_313	[p14l752t1179r861b1231],
2	also	RB	O	also	advmod	3	SENT_313	[p14l879t1176r1004b1231],
3	studied	VBD	O	study	_	0	SENT_313	[p14l1024t1176r1261b1231],
4	three	CD	NUMBER	three	num	6	SENT_313	[p14l1279t1176r1446b1231],
5	genetic	JJ	O	genetic	amod	6	SENT_313	[p14l1464t1177r1697b1244],
6	factors	NNS	O	factor	dobj	3	SENT_313	[p14l1716t1176r1930b1231],
7	which	WDT	O	which	nsubjpass	10	SENT_313	[p14l1948t1176r2146b1231],
8	were	VBD	O	be	auxpass	10	SENT_313	[p14l8t1281r167b1320],
9	more	RBR	O	more	advmod	10	SENT_313	[p14l200t1281r365b1320],
10	investigated	VBN	O	investigate	rcmod	6	SENT_313	[p14l398t1265r790b1333],
11	in	IN	O	in	_	0	SENT_313	[p14l823t1266r882b1319],
12	other	JJ	O	other	amod	13	SENT_313	[p14l914t1265r1086b1320],
13	populations	NNS	O	population	prep_in	10	SENT_313	[p14l1115t1265r1495b1333],
14	and	CC	O	and	_	0	SENT_313	[p14l1529t1265r1645b1320],
15	were	VBD	O	be	auxpass	16	SENT_313	[p14l1675t1281r1835b1320],
16	found	VBN	O	find	conj_and	3	SENT_313	[p14l1867t1265r2052b1320],
17	to	TO	O	to	aux	18	SENT_313	[p14l2083t1273r2146b1320],
18	have	VB	O	have	xcomp	16	SENT_313	[p14l10t1353r159b1408],
19	no	DT	O	no	det	21	SENT_313	[p14l190t1369r267b1408],
20	signiﬁcant	JJ	O	signiﬁcant	amod	21	SENT_313	[p14l299t1353r634b1422],
21	association	NN	O	association	dobj	18	SENT_313	[p14l663t1354r1021b1408],
22	with	IN	O	with	_	0	SENT_313	[p14l1050t1353r1198b1408],
23	clopidogrel	NN	O	clopidogrel	nn	25	SENT_313	[p14l1228t1353r1587b1422],
24	non	JJ	O	non	amod	25	SENT_313	[p14l1620t1354r2146b1422],
25	—	NN	O	—	nn	28	SENT_313	[p14l1620t1354r2146b1422],
26	responsive	JJ	O	responsive	amod	28	SENT_313	[p14l1620t1354r2146b1422],
27	—	NN	O	—	nn	28	SENT_313	[p14l1620t1354r2146b1422],
28	ness	NN	O	ness	prep_with	21	SENT_313	[p14l10t1458r163b1497],
29	.	.	O	.	_	0	SENT_313	[p14l10t1458r163b1497],

1	Due	JJ	O	due	_	0	SENT_314	[p14l188t1445r313b1497],
2	to	TO	O	to	_	0	SENT_314	[p14l336t1450r398b1497],
3	the	DT	O	the	det	4	SENT_314	[p14l420t1442r522b1497],
4	importance	NN	O	importance	prep_due_to	35	SENT_314	[p14l546t1443r914b1511],
5	of	IN	O	of	_	0	SENT_314	[p14l937t1442r1004b1497],
6	post	NN	O	post	nn	8	SENT_314	[p14l1020t1450r1156b1511],
7	stent	NN	O	stent	nn	8	SENT_314	[p14l1179t1450r1338b1497],
8	thrombosis	NN	O	thrombosis	prep_of	4	SENT_314	[p14l1360t1442r1739b1505],
9	,	,	O	,	_	0	SENT_314	[p14l1360t1442r1739b1505],
10	the	DT	O	the	det	11	SENT_314	[p14l1763t1442r1865b1497],
11	effect	NN	O	effect	prep_of	4	SENT_314	[p14l1888t1442r2065b1497],
12	of	IN	O	of	_	0	SENT_314	[p14l2087t1442r2153b1497],
13	other	JJ	O	other	amod	14	SENT_314	[p14l10t1531r182b1586],
14	factors	NNS	O	factor	prep_of	11	SENT_314	[p14l214t1531r428b1586],
15	such	JJ	O	such	_	0	SENT_314	[p14l465t1531r611b1586],
16	as	IN	O	as	_	0	SENT_314	[p14l645t1547r707b1586],
17	glycoprotein	NN	O	glycoprotein	nn	19	SENT_314	[p14l743t1531r1149b1600],
18	paraoxinase	NN	O	paraoxinase	nn	19	SENT_314	[p14l1184t1532r1656b1600],
19	—	NN	O	—	prep_such_as	14	SENT_314	[p14l1184t1532r1656b1600],
20	1	CD	NUMBER	1	dep	19	SENT_314	[p14l1184t1532r1656b1600],
21	,	,	O	,	_	0	SENT_314	[p14l1184t1532r1656b1600],
22	GPIIb/Illa	NN	O	gpiib/illa	conj_and	8	SENT_314	[p14l1692t1531r1994b1600],
23	,	,	O	,	_	0	SENT_314	[p14l1692t1531r1994b1600],
24	and	CC	O	and	_	0	SENT_314	[p14l2029t1531r2145b1586],
25	also	RB	O	also	advmod	8	SENT_314	[p14l10t1620r134b1675],
26	gene	NN	O	gene	conj_and	8	SENT_314	[p14l168t1636r319b1689],
27	modulating	VBG	O	modulate	partmod	4	SENT_314	[p14l355t1620r728b1689],
28	clopidogrel	NN	O	clopidogrel	nn	29	SENT_314	[p14l761t1620r1120b1689],
29	absorption	NN	O	absorption	dobj	27	SENT_314	[p14l1156t1620r1502b1689],
30	(	CD	NUMBER	(	num	32	SENT_314	[p14l1537t1621r1787b1689],
31	ABCB1	NN	O	abcb1	nn	32	SENT_314	[p14l1537t1621r1787b1689],
32	)	NN	O	)	nsubjpass	35	SENT_314	[p14l1537t1621r1787b1689],
33	should	MD	O	should	aux	35	SENT_314	[p14l1823t1620r2037b1675],
34	be	VB	O	be	auxpass	35	SENT_314	[p14l2072t1620r2146b1675],
35	investigated	VBN	O	investigate	_	0	SENT_314	[p14l10t1710r419b1778],
36	.	.	O	.	_	0	SENT_314	[p14l10t1710r419b1778],

1	Conﬂict	NN	O	conﬂict	_	0	SENT_315	[p14l9t1932r271b1987],
2	of	IN	O	of	_	0	SENT_315	[p14l296t1932r368b1987],
3	interest	NN	O	interest	prep_of	1	SENT_315	[p14l389t1932r652b1987],

1	All	DT	O	all	det	2	SENT_316	[p14l109t2110r195b2164],
2	authors	NNS	O	author	nsubj	3	SENT_316	[p14l224t2110r467b2165],
3	had	VBD	O	have	_	0	SENT_316	[p14l496t2110r612b2165],
4	not	RB	O	not	neg	6	SENT_316	[p14l642t2118r747b2165],
5	any	DT	O	any	det	6	SENT_316	[p14l773t2126r888b2179],
6	conﬂict	NN	O	conﬂict	dobj	3	SENT_316	[p14l915t2110r1153b2165],
7	of	IN	O	of	_	0	SENT_316	[p14l1180t2110r1246b2165],
8	interest	NN	O	interest	prep_of	6	SENT_316	[p14l1267t2111r1528b2165],
9	.	.	O	.	_	0	SENT_316	[p14l1267t2111r1528b2165],

1	Acknowledgement	NN	O	acknowledgement	_	0	SENT_317	[p14l6t2333r624b2402],

1	This	DT	O	this	det	2	SENT_318	[p14l109t2513r241b2568],
2	study	NN	O	study	nsubjpass	4	SENT_318	[p14l264t2513r441b2582],
3	was	VBD	O	be	auxpass	4	SENT_318	[p14l459t2529r584b2568],
4	supported	VBN	O	support	_	0	SENT_318	[p14l607t2513r933b2582],
5	by	IN	O	by	_	0	SENT_318	[p14l954t2513r1031b2582],
6	Pharmaceutical	NNP	ORGANIZATION	Pharmaceutical	nn	9	SENT_318	[p14l1052t2513r1549b2568],
7	Sciences	NNP	ORGANIZATION	Sciences	nn	9	SENT_318	[p14l1571t2514r1838b2568],
8	Research	NNP	ORGANIZATION	Research	nn	9	SENT_318	[p14l1860t2513r2146b2568],
9	Center	NNP	ORGANIZATION	Center	agent	4	SENT_318	[p14l10t2605r221b2657],
10	of	IN	ORGANIZATION	of	_	0	SENT_318	[p14l276t2602r342b2657],
11	Shiraz	NNP	ORGANIZATION	Shiraz	nn	12	SENT_318	[p14l392t2602r587b2657],
12	University	NNP	ORGANIZATION	University	prep_of	9	SENT_318	[p14l644t2603r978b2671],
13	of	IN	ORGANIZATION	of	_	0	SENT_318	[p14l1034t2602r1100b2657],
14	Medical	NNP	ORGANIZATION	Medical	nn	15	SENT_318	[p14l1150t2602r1402b2657],
15	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	12	SENT_318	[p14l1460t2603r1744b2666],
16	,	,	O	,	_	0	SENT_318	[p14l1460t2603r1744b2666],
17	Transplant	NNP	ORGANIZATION	Transplant	nn	19	SENT_318	[p14l1799t2602r2147b2671],
18	Research	NNP	ORGANIZATION	Research	nn	19	SENT_318	[p14l10t2690r296b2745],
19	Center	NNP	ORGANIZATION	Center	prep_of	12	SENT_318	[p14l337t2693r561b2753],
20	,	,	O	,	_	0	SENT_318	[p14l337t2693r561b2753],
21	and	CC	O	and	_	0	SENT_318	[p14l603t2691r719b2745],
22	Pharmaceutical	NNP	ORGANIZATION	Pharmaceutical	nn	25	SENT_318	[p14l761t2691r1258b2745],
23	Sciences	NNP	ORGANIZATION	Sciences	nn	25	SENT_318	[p14l1300t2691r1568b2745],
24	Research	NNP	ORGANIZATION	Research	nn	25	SENT_318	[p14l1610t2691r1896b2745],
25	Center	NNP	ORGANIZATION	Center	conj_and	15	SENT_318	[p14l1937t2693r2148b2745],
26	of	IN	ORGANIZATION	of	_	0	SENT_318	[p14l10t2778r76b2833],
27	Tehran	NNP	ORGANIZATION	Tehran	nn	28	SENT_318	[p14l104t2778r330b2833],
28	University	NNP	ORGANIZATION	University	prep_of	25	SENT_318	[p14l368t2779r703b2847],
29	of	IN	ORGANIZATION	of	_	0	SENT_318	[p14l741t2778r807b2833],
30	Medical	NNP	ORGANIZATION	Medical	nn	31	SENT_318	[p14l839t2778r1091b2833],
31	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	28	SENT_318	[p14l1132t2779r1415b2834],
32	.	.	O	.	_	0	SENT_318	[p14l1132t2779r1415b2834],

1	The	DT	O	the	det	2	SENT_319	[p14l1454t2778r1571b2833],
2	authors	NNS	O	author	nsubj	3	SENT_319	[p14l1610t2778r1853b2833],
3	wish	VBP	O	wish	_	0	SENT_319	[p14l1892t2778r2046b2833],
4	to	TO	O	to	aux	5	SENT_319	[p14l2084t2787r2146b2833],
5	thank	VB	O	thank	xcomp	3	SENT_319	[p14l9t2868r194b2923],
6	the	DT	O	the	det	10	SENT_319	[p14l213t2868r315b2923],
7	Clinical	JJ	ORGANIZATION	clinical	amod	10	SENT_319	[p14l337t2868r572b2923],
8	Research	NNP	ORGANIZATION	Research	nn	10	SENT_319	[p14l595t2868r881b2923],
9	Development	NNP	ORGANIZATION	Development	nn	10	SENT_319	[p14l902t2868r1336b2936],
10	Center	NNP	ORGANIZATION	Center	dobj	5	SENT_319	[p14l1356t2871r1580b2931],
11	,	,	O	,	_	0	SENT_319	[p14l1356t2871r1580b2931],
12	Kowsar	NNP	LOCATION	Kowsar	nn	13	SENT_319	[p14l1603t2871r1843b2923],
13	Hospital	NNP	LOCATION	Hospital	conj_and	10	SENT_319	[p14l1863t2868r2145b2936],
14	,	,	O	,	_	0	SENT_319	[p14l1863t2868r2145b2936],
15	and	CC	O	and	_	0	SENT_319	[p14l10t2957r126b3012],
16	Hemophilia	NNP	ORGANIZATION	Hemophilia	nn	17	SENT_319	[p14l145t2957r521b3025],
17	Center	NNP	ORGANIZATION	Center	conj_and	10	SENT_319	[p14l539t2960r751b3012],
18	of	IN	O	of	_	0	SENT_319	[p14l767t2957r833b3012],
19	Dastgheib	NNP	LOCATION	Dastgheib	nn	20	SENT_319	[p14l845t2957r1165b3025],
20	Hospital	NNP	LOCATION	Hospital	prep_of	17	SENT_319	[p14l1185t2957r1450b3025],
21	for	IN	O	for	_	0	SENT_319	[p14l1471t2957r1560b3012],
22	their	PRP$	O	they	poss	23	SENT_319	[p14l1576t2957r1730b3012],
23	cooperation	NN	O	cooperation	prep_for	20	SENT_319	[p14l1747t2958r2145b3025],
24	.	.	O	.	_	0	SENT_319	[p14l1747t2958r2145b3025],

1	We	PRP	O	we	nsubj	3	SENT_320	[p14l7t3049r115b3100],
2	especially	RB	O	especially	advmod	3	SENT_320	[p14l144t3045r461b3114],
3	thank	VB	O	thank	_	0	SENT_320	[p14l488t3045r673b3100],
4	Dr.	NNP	O	Dr.	nn	5	SENT_320	[p14l700t3049r790b3101],
5	Vessal	NNP	PERSON	Vessal	dobj	3	SENT_320	[p14l817t3045r1019b3100],
6	for	IN	O	for	_	0	SENT_320	[p14l1050t3045r1139b3100],
7	proof	NN	O	proof	prep_for	5	SENT_320	[p14l1165t3045r1341b3114],
8	reading	VBG	O	read	partmod	7	SENT_320	[p14l1363t3045r1606b3114],
9	the	DT	O	the	det	10	SENT_320	[p14l1632t3045r1734b3100],
10	manuscript	NN	O	manuscript	dobj	8	SENT_320	[p14l1763t3046r2144b3114],
11	.	.	O	.	_	0	SENT_320	[p14l1763t3046r2144b3114],

1	This	DT	O	this	det	2	SENT_321	[p14l7t3134r139b3189],
2	manuscript	NN	O	manuscript	nsubj	12	SENT_321	[p14l169t3135r536b3203],
3	is	VBZ	O	be	cop	12	SENT_321	[p14l564t3135r610b3189],
4	a	DT	O	a	det	5	SENT_321	[p14l639t3150r672b3189],
5	part	NN	O	part	poss	12	SENT_321	[p14l700t3142r830b3203],
6	of	IN	O	of	_	0	SENT_321	[p14l858t3134r924b3189],
7	Andia	NNP	O	Andia	nn	10	SENT_321	[p14l941t3134r1129b3189],
8	I	PRP	O	I	npadvmod	9	SENT_321	[p14l1157t3134r1409b3189],
9	<	JJR	O	<	amod	10	SENT_321	[p14l1157t3134r1409b3189],
10	halili	NNS	O	halilus	prep_of	5	SENT_321	[p14l1157t3134r1409b3189],
11	’s	POS	O	’s	_	0	SENT_321	[p14l1157t3134r1409b3189],
12	Pharm	NN	O	pharm	_	0	SENT_321	[p14l1439t3134r1730b3190],
13	.	.	O	.	_	0	SENT_321	[p14l1439t3134r1730b3190],

1	D.	NNP	O	D.	_	0	SENT_322	[p14l1439t3134r1730b3190],
2	thesis	NN	O	thesis	dep	1	SENT_322	[p14l1759t3134r1961b3190],
3	.	.	O	.	_	0	SENT_322	[p14l1759t3134r1961b3190],

1	References	NNS	O	reference	_	0	SENT_323	[p14l9t3357r377b3412],

1	[	NN	O	[	_	0	SENT_324	[p15l40t63r104b118],
2	1	CD	NUMBER	1	num	1	SENT_324	[p15l40t63r104b118],
3	]	CD	NUMBER	]	num	5	SENT_324	[p15l40t63r104b118],
4	Mehta	NNP	ORGANIZATION	Mehta	nn	5	SENT_324	[p15l140t64r303b107],
5	SR	NN	ORGANIZATION	sr	dep	1	SENT_324	[p15l333t66r405b114],
6	,	,	O	,	_	0	SENT_324	[p15l333t66r405b114],
7	Yusuf	NNP	PERSON	Yusuf	nn	8	SENT_324	[p15l433t63r584b107],
8	S	NNP	PERSON	S	appos	5	SENT_324	[p15l608t66r646b114],
9	,	,	O	,	_	0	SENT_324	[p15l608t66r646b114],
10	Peters	NNP	PERSON	Peters	nn	12	SENT_324	[p15l676t66r831b107],
11	R	NNP	O	R	nn	12	SENT_324	[p15l862t66r922b118],
12	]	NN	O	]	appos	5	SENT_324	[p15l862t66r922b118],
13	,	,	O	,	_	0	SENT_324	[p15l862t66r922b118],
14	Bertrand	NNP	PERSON	Bertrand	nn	15	SENT_324	[p15l952t64r1176b107],
15	ME	NNP	PERSON	ME	appos	5	SENT_324	[p15l1206t66r1299b114],
16	,	,	O	,	_	0	SENT_324	[p15l1206t66r1299b114],
17	Lewis	NNP	PERSON	Lewis	nn	18	SENT_324	[p15l1329t64r1473b107],
18	BS	NNP	O	BS	appos	5	SENT_324	[p15l1503t66r1575b114],
19	,	,	O	,	_	0	SENT_324	[p15l1503t66r1575b114],
20	Natarajan	NNP	PERSON	Natarajan	nn	21	SENT_324	[p15l1605t64r1856b118],
21	MK	NNP	PERSON	MK	appos	5	SENT_324	[p15l1886t66r1983b114],
22	,	,	O	,	_	0	SENT_324	[p15l1886t66r1983b114],
23	et	FW	O	et	nn	24	SENT_324	[p15l2014t70r2061b107],
24	al.	FW	O	al.	appos	5	SENT_324	[p15l2090t64r2145b108],
25	.	.	O	.	_	0	SENT_324	[p15l2090t64r2145b108],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_325	[p15l140t130r434b185],
2	in	IN	O	in	_	0	SENT_325	[p15l470t131r518b173],
3	Unstable	JJ	O	unstable	amod	4	SENT_325	[p15l552t130r779b174],
4	angina	NN	O	angina	prep_in	1	SENT_325	[p15l813t131r985b185],
5	to	TO	O	to	aux	6	SENT_325	[p15l1020t137r1069b174],
6	prevent	VB	O	prevent	infmod	1	SENT_325	[p15l1104t137r1303b185],
7	Recurrent	JJ	O	recurrent	amod	8	SENT_325	[p15l1337t133r1590b174],
8	Events	NNS	O	event	dobj	6	SENT_325	[p15l1624t133r1792b174],
9	trial	NN	O	trial	nn	11	SENT_325	[p15l1827t130r1931b174],
10	(	CD	NUMBER	(	num	11	SENT_325	[p15l1967t130r2146b184],
11	CURE	NN	O	cure	tmod	6	SENT_325	[p15l1967t130r2146b184],
12	)	CD	NUMBER	)	num	13	SENT_325	[p15l1967t130r2146b184],
13	Investigators	NNS	O	investigator	dep	11	SENT_325	[p15l140t196r485b250],
14	.	.	O	.	_	0	SENT_325	[p15l140t196r485b250],

1	Effects	NNS	O	effect	nsubj	8	SENT_326	[p15l512t195r679b239],
2	of	IN	O	of	_	0	SENT_326	[p15l705t195r758b239],
3	pretreatment	NN	O	pretreatment	prep_of	1	SENT_326	[p15l778t202r1123b250],
4	with	IN	O	with	_	0	SENT_326	[p15l1145t195r1264b239],
5	clopidogrel	NN	O	clopidogrel	prep_with	3	SENT_326	[p15l1289t195r1576b250],
6	and	CC	O	and	_	0	SENT_326	[p15l1602t196r1695b239],
7	aspirin	NN	O	aspirin	conj_and	5	SENT_326	[p15l1721t196r1897b250],
8	followed	VBN	O	follow	_	0	SENT_326	[p15l1923t195r2146b239],
9	by	IN	O	by	_	0	SENT_326	[p15l139t262r201b316],
10	long-term	JJ	O	long-term	amod	11	SENT_326	[p15l228t262r487b316],
11	therapy	NN	O	therapy	prep_by	8	SENT_326	[p15l513t262r712b316],
12	in	IN	O	in	_	0	SENT_326	[p15l740t263r787b305],
13	patients	NNS	O	patient	prep_in	8	SENT_326	[p15l814t263r1020b316],
14	undergoing	VBG	O	undergo	partmod	13	SENT_326	[p15l1049t262r1345b316],
15	percutaneous	JJ	O	percutaneous	amod	17	SENT_326	[p15l1371t269r1719b316],
16	coronary	JJ	O	coronary	amod	17	SENT_326	[p15l1747t275r1976b316],
17	intervention	NN	O	intervention	dobj	14	SENT_326	[p15l2002t263r2146b306, p15l138t329r350b372],
18	:	:	O	:	_	0	SENT_326	[p15l2002t263r2146b306, p15l138t329r350b372],
19	the	DT	O	the	det	20	SENT_326	[p15l376t328r458b372],
20	PCI	NN	O	pcus	dep	17	SENT_326	[p15l481t330r725b372],
21	.	.	O	.	_	0	SENT_326	[p15l481t330r725b372],

1	—	NN	O	—	_	0	SENT_327	[p15l481t330r725b372],
2	.	.	O	.	_	0	SENT_327	[p15l481t330r725b372],

1	CURE	VB	O	cure	_	0	SENT_328	[p15l481t330r725b372],
2	study	NN	O	study	dobj	1	SENT_328	[p15l748t328r901b383],
3	.	.	O	.	_	0	SENT_328	[p15l748t328r901b383],

1	Lancet	NNP	O	Lancet	_	0	SENT_329	[p15l925t331r1092b372],
2	2001	CD	DATE	2001	num	1	SENT_329	[p15l1113t330r1233b372],
3	;	:	O	;	_	0	SENT_329	[p15l1248t330r1589b378],
4	358:527	CD	NUMBER	358:527	number	5	SENT_329	[p15l1248t330r1589b378],
5	—	CD	NUMBER	—	dep	1	SENT_329	[p15l1248t330r1589b378],
6	33	CD	NUMBER	33	dep	5	SENT_329	[p15l1248t330r1589b378],
7	.	.	O	.	_	0	SENT_329	[p15l1248t330r1589b378],

1	[	NN	O	[	_	0	SENT_330	[p15l40t394r104b448],
2	2	CD	NUMBER	2	num	1	SENT_330	[p15l40t394r104b448],
3	]	CD	NUMBER	]	num	5	SENT_330	[p15l40t394r104b448],
4	Steinhubl	NNP	O	Steinhubl	nn	5	SENT_330	[p15l140t394r385b437],
5	SR	NN	O	sr	dep	1	SENT_330	[p15l407t396r480b444],
6	,	,	O	,	_	0	SENT_330	[p15l407t396r480b444],
7	Berger	NNP	PERSON	Berger	nn	8	SENT_330	[p15l502t397r669b448],
8	PB	NN	O	pb	appos	5	SENT_330	[p15l689t397r763b444],
9	,	,	O	,	_	0	SENT_330	[p15l689t397r763b444],
10	Mann	NNP	PERSON	Mann	nn	11	SENT_330	[p15l786t397r933b437],
11	JT	NNP	O	JT	appos	5	SENT_330	[p15l948t396r1012b448],
12	,	,	O	,	_	0	SENT_330	[p15l948t396r1012b448],
13	Fry	NNP	O	Fry	nn	14	SENT_330	[p15l1034t396r1114b448],
14	ETA	NNP	O	ETA	appos	5	SENT_330	[p15l1135t396r1244b444],
15	,	,	O	,	_	0	SENT_330	[p15l1135t396r1244b444],
16	DeLago	NNP	PERSON	DeLago	nn	17	SENT_330	[p15l1267t397r1452b448],
17	A	NNP	O	A	appos	5	SENT_330	[p15l1472t396r1520b444],
18	,	,	O	,	_	0	SENT_330	[p15l1472t396r1520b444],
19	Wilmer	NNP	PERSON	Wilmer	nn	20	SENT_330	[p15l1539t394r1738b437],
20	C	NNP	PERSON	C	appos	5	SENT_330	[p15l1758t396r1800b444],
21	,	,	O	,	_	0	SENT_330	[p15l1758t396r1800b444],
22	et	FW	O	et	nn	23	SENT_330	[p15l1822t400r1870b437],
23	al.	FW	O	al.	appos	5	SENT_330	[p15l1890t394r1945b438],
24	.	.	O	.	_	0	SENT_330	[p15l1890t394r1945b438],

1	CREDO	NNP	O	CREDO	_	0	SENT_331	[p15l1968t396r2146b437],
2	Investigators	NNS	O	investigator	dep	1	SENT_331	[p15l140t460r485b514],
3	.	.	O	.	_	0	SENT_331	[p15l140t460r485b514],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_332	[p15l517t459r811b514],
2	for	IN	O	for	_	0	SENT_332	[p15l843t459r914b503],
3	the	DT	O	the	det	4	SENT_332	[p15l943t459r1024b503],
4	Reduction	NN	O	reduction	prep_for	1	SENT_332	[p15l1055t459r1315b503],
5	of	IN	O	of	_	0	SENT_332	[p15l1345t459r1398b503],
6	Events	NNS	O	event	prep_of	1	SENT_332	[p15l1423t462r1590b503],
7	during	IN	O	during	_	0	SENT_332	[p15l1622t459r1791b514],
8	Observation	NN	O	observation	prep_during	6	SENT_332	[p15l1821t459r2145b503],
9	.	.	O	.	_	0	SENT_332	[p15l1821t459r2145b503],

1	Early	RB	O	early	advmod	3	SENT_333	[p15l140t526r269b580],
2	and	CC	O	and	cc	1	SENT_333	[p15l299t526r392b569],
3	sustained	VBD	O	sustain	_	0	SENT_333	[p15l423t526r668b569],
4	dual	JJ	O	dual	amod	7	SENT_333	[p15l699t526r809b569],
5	oral	JJ	O	oral	amod	7	SENT_333	[p15l840t526r937b569],
6	antiplatelet	JJ	O	antiplatelet	amod	7	SENT_333	[p15l968t526r1266b580],
7	therapy	NN	O	therapy	dep	3	SENT_333	[p15l1294t526r1494b580],
8	following	VBG	O	follow	_	0	SENT_333	[p15l1524t525r1768b580],
9	percutaneous	JJ	O	percutaneous	amod	11	SENT_333	[p15l1798t532r2145b580],
10	coronary	JJ	O	coronary	amod	11	SENT_333	[p15l140t605r368b647],
11	intervention	NN	O	intervention	prep_following	7	SENT_333	[p15l382t593r717b636],
12	:	:	O	:	_	0	SENT_333	[p15l382t593r717b636],
13	a	DT	O	a	nsubj	14	SENT_333	[p15l737t605r762b636],
14	randomized	VBN	O	randomize	parataxis	3	SENT_333	[p15l777t592r1086b636],
15	controlled	JJ	O	controlled	ccomp	14	SENT_333	[p15l1101t592r1363b636],
16	trial	NN	O	trial	iobj	15	SENT_333	[p15l1378t592r1482b636],
17	(	CD	NUMBER	(	num	19	SENT_333	[p15l1498t592r1760b647],
18	CREDO	NN	O	credo	nn	19	SENT_333	[p15l1498t592r1760b647],
19	)	NN	O	)	dobj	15	SENT_333	[p15l1498t592r1760b647],
20	.	.	O	.	_	0	SENT_333	[p15l1498t592r1760b647],

1	J	NNP	O	J	nn	4	SENT_334	[p15l1498t592r1760b647],
2	Am	NNP	O	Am	nn	4	SENT_334	[p15l1773t594r1861b635],
3	Med	NNP	O	Med	nn	4	SENT_334	[p15l1877t592r1988b636],
4	Assoc	NNP	O	Assoc	_	0	SENT_334	[p15l2001t594r2147b636],
5	2002	CD	DATE	2002	num	4	SENT_334	[p15l140t660r648b708],
6	;	:	O	;	_	0	SENT_334	[p15l140t660r648b708],
7	288:2411	CD	NUMBER	288:2411	number	8	SENT_334	[p15l140t660r648b708],
8	—	CD	NUMBER	—	dep	4	SENT_334	[p15l140t660r648b708],
9	20	CD	NUMBER	20	dep	8	SENT_334	[p15l140t660r648b708],
10	.	.	O	.	_	0	SENT_334	[p15l140t660r648b708],

1	[	NN	O	[	nn	3	SENT_335	[p15l40t724r104b778],
2	3	CD	NUMBER	3	num	3	SENT_335	[p15l40t724r104b778],
3	]	NN	O	]	_	0	SENT_335	[p15l40t724r104b778],
4	Nguyen	NNP	ORGANIZATION	Nguyen	nn	5	SENT_335	[p15l140t727r338b778],
5	TA	NNP	ORGANIZATION	TA	dep	3	SENT_335	[p15l357t726r437b774],
6	,	,	O	,	_	0	SENT_335	[p15l357t726r437b774],
7	Diodati	NNP	O	Diodati	nn	8	SENT_335	[p15l460t724r646b767],
8	JG	NNP	O	JG	appos	5	SENT_335	[p15l663t726r735b778],
9	,	,	O	,	_	0	SENT_335	[p15l663t726r735b778],
10	Pharand	NNP	O	Pharand	nn	12	SENT_335	[p15l758t724r969b767],
11	C.	NNP	O	C.	nn	12	SENT_335	[p15l992t726r1035b768],
12	Resistance	NNP	O	Resistance	appos	5	SENT_335	[p15l1059t725r1327b767],
13	to	TO	O	to	_	0	SENT_335	[p15l1349t730r1399b767],
14	clopidogrel	NN	O	clopidogrel	prep_to	12	SENT_335	[p15l1421t724r1725b778],
15	:	:	O	:	_	0	SENT_335	[p15l1421t724r1725b778],
16	a	DT	O	a	det	17	SENT_335	[p15l1752t736r1778b767],
17	review	NN	O	review	dep	3	SENT_335	[p15l1800t724r1975b767],
18	of	IN	O	of	_	0	SENT_335	[p15l1996t724r2049b767],
19	the	DT	O	the	det	20	SENT_335	[p15l2065t724r2146b767],
20	evidence	NN	O	evidence	prep_of	17	SENT_335	[p15l140t789r416b844],
21	.	.	O	.	_	0	SENT_335	[p15l140t789r416b844],

1	J	NNP	O	J	nn	4	SENT_336	[p15l140t789r416b844],
2	Am	NNP	O	Am	nn	4	SENT_336	[p15l437t791r525b833],
3	Coll	NNP	O	Coll	nn	4	SENT_336	[p15l548t789r643b833],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_336	[p15l667t789r848b833],
5	2005	CD	DATE	2005	num	4	SENT_336	[p15l872t792r1348b840],
6	;	:	O	;	_	0	SENT_336	[p15l872t792r1348b840],
7	45:1157	CD	NUMBER	45:1157	number	8	SENT_336	[p15l872t792r1348b840],
8	—	CD	NUMBER	—	dep	4	SENT_336	[p15l872t792r1348b840],
9	64	CD	NUMBER	64	dep	8	SENT_336	[p15l872t792r1348b840],
10	.	.	O	.	_	0	SENT_336	[p15l872t792r1348b840],

1	[	NN	O	[	nn	5	SENT_337	[p15l40t855r104b910],
2	4	CD	NUMBER	4	num	5	SENT_337	[p15l40t855r104b910],
3	]	CD	NUMBER	]	num	5	SENT_337	[p15l40t855r104b910],
4	Barsky	NNP	PERSON	Barsky	nn	5	SENT_337	[p15l140t856r311b910],
5	AA	NNP	O	AA	_	0	SENT_337	[p15l338t857r424b906],
6	,	,	O	,	_	0	SENT_337	[p15l338t857r424b906],
7	Arora	NNP	PERSON	Arora	nn	8	SENT_337	[p15l452t858r595b899],
8	RR	NNP	O	RR	appos	5	SENT_337	[p15l625t858r703b900],
9	.	.	O	.	_	0	SENT_337	[p15l625t858r703b900],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_338	[p15l735t856r1029b910],
2	resistance	NN	O	resistance	_	0	SENT_338	[p15l1061t856r1334b900],
3	:	:	O	:	_	0	SENT_338	[p15l1061t856r1334b900],
4	myth	NN	O	myth	dep	2	SENT_338	[p15l1369t856r1504b910],
5	or	CC	O	or	_	0	SENT_338	[p15l1535t868r1587b899],
6	reality	NN	O	reality	dep	2	SENT_338	[p15l1616t856r1838b910],
7	.	.	O	.	_	0	SENT_338	[p15l1616t856r1838b910],

1	J	NNP	O	J	nn	2	SENT_339	[p15l1616t856r1838b910],
2	Cardiovasc	NNP	O	Cardiovasc	_	0	SENT_339	[p15l1869t856r2147b899],

1	Pharmacol	NNP	O	Pharmacol	nn	2	SENT_340	[p15l140t922r411b966],
2	Ther	NNP	O	Ther	_	0	SENT_340	[p15l432t922r551b966],
3	2006	CD	DATE	2006	num	2	SENT_340	[p15l572t924r714b973],
4	;	:	O	;	_	0	SENT_340	[p15l572t924r714b973],
5	1	CD	NUMBER	1	number	6	SENT_340	[p15l725t925r745b965],
6	1:47	CD	TIME	1:47	dep	2	SENT_340	[p15l758t924r982b966],
7	-53	CD	NUMBER	-53	dep	6	SENT_340	[p15l758t924r982b966],
8	.	.	O	.	_	0	SENT_340	[p15l758t924r982b966],

1	[	NN	O	[	nn	5	SENT_341	[p15l40t987r104b1042],
2	5	CD	NUMBER	5	num	5	SENT_341	[p15l40t987r104b1042],
3	]	CD	NUMBER	]	num	5	SENT_341	[p15l40t987r104b1042],
4	Camilleri	NNP	PERSON	Camilleri	nn	5	SENT_341	[p15l140t987r372b1031],
5	E	NNP	O	E	_	0	SENT_341	[p15l390t988r636b1042],
6	,	,	O	,	_	0	SENT_341	[p15l390t988r636b1042],
7	Jacquin	NNP	PERSON	Jacquin	nn	8	SENT_341	[p15l390t988r636b1042],
8	L	NNP	PERSON	L	appos	5	SENT_341	[p15l652t990r689b1038],
9	,	,	O	,	_	0	SENT_341	[p15l652t990r689b1038],
10	Paganelli	NNP	PERSON	Paganelli	nn	11	SENT_341	[p15l706t987r937b1042],
11	F	NN	O	f	appos	5	SENT_341	[p15l955t990r992b1038],
12	,	,	O	,	_	0	SENT_341	[p15l955t990r992b1038],
13	Bonello	NNP	PERSON	Bonello	nn	17	SENT_341	[p15l1010t987r1201b1031],
14	L.	NNP	O	L.	nn	17	SENT_341	[p15l1218t990r1254b1031],
15	Personalized	NNP	O	Personalized	nn	17	SENT_341	[p15l1272t987r1598b1031],
16	antiplatelet	JJ	O	antiplatelet	amod	17	SENT_341	[p15l1615t987r1913b1042],
17	therapy	NN	O	therapy	appos	5	SENT_341	[p15l1928t988r2142b1042],
18	:	:	O	:	_	0	SENT_341	[p15l1928t988r2142b1042],

1	review	NN	O	review	_	0	SENT_342	[p15l140t1055r315b1098],
2	of	IN	O	of	_	0	SENT_342	[p15l336t1054r389b1098],
3	the	DT	O	the	det	6	SENT_342	[p15l405t1054r486b1098],
4	latest	JJS	O	latest	amod	6	SENT_342	[p15l510t1054r651b1098],
5	clinical	JJ	O	clinical	amod	6	SENT_342	[p15l672t1054r854b1098],
6	evidence	NN	O	evidence	prep_of	1	SENT_342	[p15l877t1054r1116b1098],
7	.	.	O	.	_	0	SENT_342	[p15l877t1054r1116b1098],

1	Curr	NNP	MISC	Curr	nn	3	SENT_343	[p15l1140t1056r1252b1098],
2	Cardiol	NNP	MISC	Cardiol	nn	3	SENT_343	[p15l1273t1054r1454b1098],
3	Rep	NNP	MISC	Rep	_	0	SENT_343	[p15l1478t1057r1572b1108],
4	2011	CD	DATE	2011	num	3	SENT_343	[p15l1594t1056r2070b1104],
5	;	:	O	;	_	0	SENT_343	[p15l1594t1056r2070b1104],
6	13:296	CD	NUMBER	13:296	number	7	SENT_343	[p15l1594t1056r2070b1104],
7	-302	CD	NUMBER	-302	dep	3	SENT_343	[p15l1594t1056r2070b1104],
8	.	.	O	.	_	0	SENT_343	[p15l1594t1056r2070b1104],

1	[	NN	O	[	nn	3	SENT_344	[p15l40t1120r104b1175],
2	6	CD	NUMBER	6	num	3	SENT_344	[p15l40t1120r104b1175],
3	]	NN	O	]	_	0	SENT_344	[p15l40t1120r104b1175],
4	Angiolillo	NNP	O	Angiolillo	nn	5	SENT_344	[p15l138t1120r387b1175],
5	DJ	NNP	O	DJ	dep	3	SENT_344	[p15l402t1123r468b1175],
6	,	,	O	,	_	0	SENT_344	[p15l402t1123r468b1175],
7	Fernandez-Ortiz	NNP	O	Fernandez-Ortiz	nn	8	SENT_344	[p15l484t1120r903b1164],
8	A	NNP	O	A	appos	5	SENT_344	[p15l915t1122r963b1170],
9	,	,	O	,	_	0	SENT_344	[p15l915t1122r963b1170],
10	Bernardo	NNP	PERSON	Bernardo	nn	11	SENT_344	[p15l979t1120r1213b1164],
11	E	NNP	PERSON	E	appos	5	SENT_344	[p15l1228t1123r1268b1170],
12	,	,	O	,	_	0	SENT_344	[p15l1228t1123r1268b1170],
13	Alfonso	NNP	PERSON	Alfonso	nn	14	SENT_344	[p15l1281t1120r1475b1164],
14	F	NN	PERSON	f	appos	5	SENT_344	[p15l1490t1123r1527b1170],
15	,	,	O	,	_	0	SENT_344	[p15l1490t1123r1527b1170],
16	Macaya	NN	O	macaya	nn	17	SENT_344	[p15l1543t1123r1739b1175],
17	C	NN	O	c	appos	5	SENT_344	[p15l1753t1122r1796b1170],
18	,	,	O	,	_	0	SENT_344	[p15l1753t1122r1796b1170],
19	Bass	NNP	O	Bass	nn	20	SENT_344	[p15l1811t1123r1920b1164],
20	TA	NNP	O	TA	appos	5	SENT_344	[p15l1934t1122r2013b1170],
21	,	,	O	,	_	0	SENT_344	[p15l1934t1122r2013b1170],
22	et	FW	O	et	nn	23	SENT_344	[p15l2029t1127r2076b1164],
23	al.	FW	O	al.	appos	5	SENT_344	[p15l2090t1120r2145b1164],
24	.	.	O	.	_	0	SENT_344	[p15l2090t1120r2145b1164],

1	Variability	NN	O	variability	_	0	SENT_345	[p15l138t1186r410b1240],
2	in	IN	O	in	_	0	SENT_345	[p15l433t1186r481b1229],
3	individual	JJ	O	individual	amod	4	SENT_345	[p15l504t1186r763b1229],
4	responsiveness	NN	O	responsiveness	prep_in	1	SENT_345	[p15l789t1187r1177b1240],
5	to	TO	O	to	_	0	SENT_345	[p15l1202t1192r1251b1229],
6	clopidogrel	NN	O	clopidogrel	prep_to	4	SENT_345	[p15l1275t1186r1579b1240],
7	:	:	O	:	_	0	SENT_345	[p15l1275t1186r1579b1240],
8	clinical	JJ	O	clinical	amod	9	SENT_345	[p15l1607t1186r1789b1229],
9	implications	NNS	O	implication	dep	1	SENT_345	[p15l1814t1186r2146b1240],
10	,	,	O	,	_	0	SENT_345	[p15l1814t1186r2146b1240],
11	management	NN	O	management	conj_and	9	SENT_345	[p15l140t1258r491b1306],
12	,	,	O	,	_	0	SENT_345	[p15l140t1258r491b1306],
13	and	CC	O	and	_	0	SENT_345	[p15l514t1251r607b1295],
14	future	JJ	DATE	future	amod	15	SENT_345	[p15l630t1251r787b1295],
15	perspectives	NNS	O	perspective	dep	1	SENT_345	[p15l810t1252r1143b1306],
16	.	.	O	.	_	0	SENT_345	[p15l810t1252r1143b1306],

1	J	NNP	O	J	nn	4	SENT_346	[p15l1160t1254r1181b1306],
2	Am	NNP	O	Am	nn	4	SENT_346	[p15l1201t1253r1289b1295],
3	Coll	NNP	O	Coll	nn	4	SENT_346	[p15l1312t1251r1407b1295],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_346	[p15l1431t1251r1612b1295],
5	2007	CD	DATE	2007	num	4	SENT_346	[p15l1635t1254r2111b1302],
6	;	:	O	;	_	0	SENT_346	[p15l1635t1254r2111b1302],
7	49:1505	CD	NUMBER	49:1505	number	8	SENT_346	[p15l1635t1254r2111b1302],
8	—	CD	NUMBER	—	dep	4	SENT_346	[p15l1635t1254r2111b1302],
9	16	CD	NUMBER	16	dep	8	SENT_346	[p15l1635t1254r2111b1302],
10	.	.	O	.	_	0	SENT_346	[p15l1635t1254r2111b1302],

1	[	NN	O	[	nn	4	SENT_347	[p15l40t1317r104b1372],
2	7	CD	NUMBER	7	num	4	SENT_347	[p15l40t1317r104b1372],
3	]	NN	O	]	nn	4	SENT_347	[p15l40t1317r104b1372],
4	Sibbing	NN	O	sibbing	_	0	SENT_347	[p15l140t1318r331b1372],
5	D	NN	O	d	dep	4	SENT_347	[p15l358t1320r407b1368],
6	,	,	O	,	_	0	SENT_347	[p15l358t1320r407b1368],
7	Kastrati	NNP	PERSON	Kastrati	nn	9	SENT_347	[p15l436t1318r633b1361],
8	A.	NNP	PERSON	A.	nn	9	SENT_347	[p15l660t1320r707b1362],
9	Risk	NNP	PERSON	Risk	appos	4	SENT_347	[p15l737t1318r842b1361],
10	of	IN	O	of	prep	9	SENT_347	[p15l869t1317r922b1361],
11	combining	VBG	O	combine	dep	10	SENT_347	[p15l943t1318r1218b1372],
12	PPIs	NNS	O	ppi	dobj	11	SENT_347	[p15l1244t1320r1346b1361],
13	with	IN	O	with	_	0	SENT_347	[p15l1373t1318r1492b1361],
14	thienopyridines	NNS	O	thienopyridine	prep_with	12	SENT_347	[p15l1518t1318r1943b1372],
15	:	:	O	:	_	0	SENT_347	[p15l1518t1318r1943b1372],
16	fact	NN	O	fact	dep	12	SENT_347	[p15l1975t1317r2069b1361],
17	or	CC	O	or	cc	11	SENT_347	[p15l2095t1330r2148b1361],

1	ﬁction	NN	O	ﬁction	_	0	SENT_348	[p15l140t1384r315b1428],
2	.	.	O	.	_	0	SENT_348	[p15l140t1384r315b1428],

1	Lancet	NNP	O	Lancet	_	0	SENT_349	[p15l339t1387r506b1428],
2	2009	CD	DATE	2009	num	1	SENT_349	[p15l527t1386r970b1435],
3	;	:	O	;	_	0	SENT_349	[p15l527t1386r970b1435],
4	374:952	CD	NUMBER	374:952	number	5	SENT_349	[p15l527t1386r970b1435],
5	—	CD	NUMBER	—	dep	1	SENT_349	[p15l527t1386r970b1435],
6	4	CD	NUMBER	4	dep	5	SENT_349	[p15l527t1386r970b1435],
7	.	.	O	.	_	0	SENT_349	[p15l527t1386r970b1435],

1	[	NN	O	[	nn	5	SENT_350	[p15l40t1450r104b1505],
2	8	CD	NUMBER	8	num	5	SENT_350	[p15l40t1450r104b1505],
3	]	CD	NUMBER	]	num	5	SENT_350	[p15l40t1450r104b1505],
4	Campo	NNP	O	Campo	nn	5	SENT_350	[p15l140t1452r317b1505],
5	G	NNP	O	G	_	0	SENT_350	[p15l338t1452r387b1500],
6	,	,	O	,	_	0	SENT_350	[p15l338t1452r387b1500],
7	Miccoli	NNP	PERSON	Miccoli	nn	8	SENT_350	[p15l408t1450r594b1494],
8	M	NNP	O	M	appos	5	SENT_350	[p15l616t1453r677b1500],
9	,	,	O	,	_	0	SENT_350	[p15l616t1453r677b1500],
10	Tebaldi	NNP	PERSON	Tebaldi	nn	11	SENT_350	[p15l696t1450r885b1494],
11	M	NNP	O	M	appos	8	SENT_350	[p15l907t1453r968b1500],
12	,	,	O	,	_	0	SENT_350	[p15l907t1453r968b1500],
13	Marchesini	NNP	PERSON	Marchesini	nn	14	SENT_350	[p15l990t1450r1275b1494],
14	J	NNP	PERSON	J	appos	8	SENT_350	[p15l1289t1453r1322b1505],
15	,	,	O	,	_	0	SENT_350	[p15l1289t1453r1322b1505],
16	Fileti	NNP	O	Fileti	nn	17	SENT_350	[p15l1344t1450r1470b1494],
17	L	NNP	O	L	appos	8	SENT_350	[p15l1492t1453r1528b1500],
18	,	,	O	,	_	0	SENT_350	[p15l1492t1453r1528b1500],
19	Monti	NNP	PERSON	Monti	nn	20	SENT_350	[p15l1550t1451r1703b1494],
20	M	NNP	O	M	appos	8	SENT_350	[p15l1724t1453r1786b1500],
21	,	,	O	,	_	0	SENT_350	[p15l1724t1453r1786b1500],
22	et	FW	O	et	nn	23	SENT_350	[p15l1807t1457r1854b1494],
23	al.	FW	O	al.	appos	8	SENT_350	[p15l1874t1450r1929b1494],
24	.	.	O	.	_	0	SENT_350	[p15l1874t1450r1929b1494],

1	Genetic	JJ	O	genetic	amod	2	SENT_351	[p15l1952t1451r2147b1494],
2	determinants	NNS	O	determinant	_	0	SENT_351	[p15l140t1516r485b1559],
3	of	IN	O	of	_	0	SENT_351	[p15l562t1516r615b1559],
4	on-clopidogrel	JJ	O	on-clopidogrel	amod	7	SENT_351	[p15l684t1516r1061b1570],
5	high	JJ	O	high	amod	7	SENT_351	[p15l1137t1516r1250b1570],
6	platelet	NN	O	platelet	nn	7	SENT_351	[p15l1325t1516r1521b1570],
7	reactivity	NN	O	reactivity	prep_of	2	SENT_351	[p15l1596t1517r1851b1570],
8	.	.	O	.	_	0	SENT_351	[p15l1596t1517r1851b1570],

1	Platelets	NNS	O	platelet	_	0	SENT_352	[p15l1928t1516r2145b1559],
2	2011	CD	DATE	2011	num	1	SENT_352	[p15l140t1584r616b1632],
3	;	:	O	;	_	0	SENT_352	[p15l140t1584r616b1632],
4	22:399	CD	NUMBER	22:399	number	5	SENT_352	[p15l140t1584r616b1632],
5	-407	CD	NUMBER	-407	dep	1	SENT_352	[p15l140t1584r616b1632],
6	.	.	O	.	_	0	SENT_352	[p15l140t1584r616b1632],

1	[	NN	O	[	nn	3	SENT_353	[p15l40t1647r104b1702],
2	9	CD	NUMBER	9	num	3	SENT_353	[p15l40t1647r104b1702],
3	]	NN	O	]	_	0	SENT_353	[p15l40t1647r104b1702],
4	Clarke	NNP	PERSON	Clarke	nn	5	SENT_353	[p15l140t1648r300b1691],
5	TA	NNP	O	TA	dep	3	SENT_353	[p15l319t1650r399b1698],
6	,	,	O	,	_	0	SENT_353	[p15l319t1650r399b1698],
7	Waskell	NNP	LOCATION	Waskell	nn	8	SENT_353	[p15l418t1648r624b1691],
8	LA.	NNP	LOCATION	LA.	appos	5	SENT_353	[p15l646t1650r720b1692],
9	.	.	O	.	_	0	SENT_353	[p15l646t1650r720b1692],

1	The	DT	O	the	det	2	SENT_354	[p15l741t1648r835b1691],
2	metabolism	NN	O	metabolism	nsubjpass	14	SENT_354	[p15l856t1648r1161b1691],
3	of	IN	O	of	_	0	SENT_354	[p15l1183t1647r1235b1691],
4	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_354	[p15l1251t1648r1538b1702],
5	is	VBZ	O	be	auxpass	6	SENT_354	[p15l1560t1648r1598b1691],
6	catalyzed	VBN	O	catalyze	_	0	SENT_354	[p15l1620t1648r1863b1702],
7	by	IN	O	by	_	0	SENT_354	[p15l1883t1648r1946b1702],
8	human	JJ	O	human	amod	11	SENT_354	[p15l1966t1648r2146b1691],
9	cytochrome	NN	O	cytochrome	nn	11	SENT_354	[p15l140t1714r445b1769],
10	P450	NN	O	p450	nn	11	SENT_354	[p15l476t1716r601b1758],
11	3A	NN	O	3a	agent	6	SENT_354	[p15l631t1716r700b1758],
12	and	CC	O	and	_	0	SENT_354	[p15l728t1714r822b1758],
13	is	VBZ	O	be	auxpass	14	SENT_354	[p15l852t1715r890b1758],
14	inhibited	VBN	O	inhibit	conj_and	6	SENT_354	[p15l921t1714r1153b1758],
15	by	IN	O	by	_	0	SENT_354	[p15l1184t1714r1246b1769],
16	atorvastatin	NN	O	atorvastatin	agent	14	SENT_354	[p15l1275t1715r1597b1758],
17	.	.	O	.	_	0	SENT_354	[p15l1275t1715r1597b1758],

1	Drug	NN	O	drug	nn	3	SENT_355	[p15l1629t1717r1755b1769],
2	Metab	NNP	O	Metab	nn	3	SENT_355	[p15l1784t1714r1945b1758],
3	Dispos	NNP	O	Dispos	_	0	SENT_355	[p15l1977t1715r2145b1769],
4	2003	CD	DATE	2003	num	3	SENT_355	[p15l140t1782r517b1830],
5	;	:	O	;	_	0	SENT_355	[p15l140t1782r517b1830],
6	31:53	CD	NUMBER	31:53	number	7	SENT_355	[p15l140t1782r517b1830],
7	—	CD	NUMBER	—	dep	3	SENT_355	[p15l140t1782r517b1830],
8	9	CD	NUMBER	9	dep	7	SENT_355	[p15l140t1782r517b1830],
9	.	.	O	.	_	0	SENT_355	[p15l140t1782r517b1830],

1	[	NN	O	[	nn	6	SENT_356	[p15l12t1846r109b1900],
2	10	CD	NUMBER	10	num	6	SENT_356	[p15l12t1846r109b1900],
3	]	CD	NUMBER	]	num	6	SENT_356	[p15l12t1846r109b1900],
4	Antiplatelet	NNP	O	Antiplatelet	nn	6	SENT_356	[p15l142t1846r449b1900],
5	Drug	NNP	O	Drug	nn	6	SENT_356	[p15l493t1849r619b1900],
6	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_356	[p15l663t1846r957b1900],
7	Pathway	NN	O	pathway	nn	10	SENT_356	[p15l1004t1846r1226b1900],
8	(	CD	NUMBER	(	num	10	SENT_356	[p15l1270t1846r1389b1900],
9	PK	NN	O	pk	nn	10	SENT_356	[p15l1270t1846r1389b1900],
10	)	NN	O	)	dep	6	SENT_356	[p15l1270t1846r1389b1900],
11	.	.	O	.	_	0	SENT_356	[p15l1270t1846r1389b1900],

1	http://www.pharmgkb.org/	NN	O	http://www.pharmgkb.org/	_	0	SENT_357	[p15l1435t1846r2146b1900],

1	search/pathway/platelet	JJ	O	search/pathway/platelet	_	0	SENT_358	[p15l145t1912r1484b1967],
2	/	:	O	/	punct	3	SENT_358	[p15l145t1912r1484b1967],
3	platelet-clopidogrel-pk	NN	O	platelet-clopidogrel-pk	dep	1	SENT_358	[p15l145t1912r1484b1967],
4	.	.	O	.	_	0	SENT_358	[p15l145t1912r1484b1967],

1	jsp	NN	O	jsp	nn	2	SENT_359	[p15l145t1912r1484b1967],
2	[	NN	O	[	nsubj	3	SENT_359	[p15l1510t1912r1750b1967],
3	accessed	VBD	O	access	_	0	SENT_359	[p15l1510t1912r1750b1967],
4	20.11.09	CD	DATE	20.11.09	num	5	SENT_359	[p15l1773t1912r2026b1967],
5	]	NN	O	]	dobj	3	SENT_359	[p15l1773t1912r2026b1967],
6	.	.	O	.	_	0	SENT_359	[p15l1773t1912r2026b1967],

1	908	CD	NUMBER	908	num	3	SENT_360	[p15l342t2043r386b2064],
2	S.	NNP	PERSON	S.	nn	3	SENT_360	[p15l1033t2043r1051b2064],
3	Namazi	NNP	PERSON	Namazi	_	0	SENT_360	[p15l1062t2042r1155b2064],
4	et	FW	O	et	nn	5	SENT_360	[p15l1165t2045r1188b2064],
5	al.	FW	O	al.	dep	3	SENT_360	[p15l1197t2042r1223b2064],
6	/	:	O	/	punct	3	SENT_360	[p15l1227t2042r1239b2069],
7	Biochemical	JJ	O	biochemical	amod	8	SENT_360	[p15l1243t2042r1388b2064],
8	Pharmacology	NN	O	pharmacology	dep	3	SENT_360	[p15l1398t2042r1569b2069],
9	83	CD	NUMBER	83	number	10	SENT_360	[p15l1580t2043r1608b2064],
10	(	CD	NUMBER	(	num	11	SENT_360	[p15l1619t2042r1700b2069],
11	2012	CD	DATE	2012	dep	8	SENT_360	[p15l1619t2042r1700b2069],
12	)	CD	NUMBER	)	number	13	SENT_360	[p15l1619t2042r1700b2069],
13	903-908	CD	NUMBER	903-908	num	11	SENT_360	[p15l1710t2043r1817b2064],

1	[	NN	O	[	_	0	SENT_361	[p15l6t2166r104b2221],
2	11	CD	NUMBER	11	num	1	SENT_361	[p15l6t2166r104b2221],
3	]	CD	NUMBER	]	num	5	SENT_361	[p15l6t2166r104b2221],
4	Kuehl	NNP	PERSON	Kuehl	nn	5	SENT_361	[p15l140t2166r287b2210],
5	P	NN	O	p	dep	1	SENT_361	[p15l303t2169r343b2217],
6	,	,	O	,	_	0	SENT_361	[p15l303t2169r343b2217],
7	ZhangJ	NN	O	zhangj	appos	5	SENT_361	[p15l358t2166r558b2221],
8	,	,	O	,	_	0	SENT_361	[p15l358t2166r558b2221],
9	Lin	NNP	PERSON	Lin	nn	10	SENT_361	[p15l574t2167r650b2210],
10	Y	NN	PERSON	y	appos	5	SENT_361	[p15l663t2169r708b2217],
11	,	,	O	,	_	0	SENT_361	[p15l663t2169r708b2217],
12	Lamba	NNP	PERSON	Lamba	nn	13	SENT_361	[p15l724t2166r893b2210],
13	J	NNP	PERSON	J	appos	5	SENT_361	[p15l901t2169r934b2221],
14	,	,	O	,	_	0	SENT_361	[p15l901t2169r934b2221],
15	Assem	NNP	O	Assem	nn	16	SENT_361	[p15l948t2168r1117b2210],
16	M	NNP	O	M	appos	5	SENT_361	[p15l1133t2169r1194b2217],
17	,	,	O	,	_	0	SENT_361	[p15l1133t2169r1194b2217],
18	Schuetz	NNP	PERSON	Schuetz	nn	19	SENT_361	[p15l1210t2166r1410b2210],
19	J	NNP	PERSON	J	appos	5	SENT_361	[p15l1419t2169r1452b2221],
20	,	,	O	,	_	0	SENT_361	[p15l1419t2169r1452b2221],
21	et	FW	O	et	nn	22	SENT_361	[p15l1468t2173r1516b2210],
22	al.	FW	O	al.	appos	5	SENT_361	[p15l1530t2166r1585b2210],
23	.	.	O	.	_	0	SENT_361	[p15l1530t2166r1585b2210],

1	Sequence	NN	O	sequence	nn	2	SENT_362	[p15l1602t2169r1844b2221],
2	diversity	NN	O	diversity	_	0	SENT_362	[p15l1860t2166r2086b2221],
3	in	IN	O	in	_	0	SENT_362	[p15l2101t2167r2149b2210],
4	CYP3A	NN	O	cyp3a	nn	5	SENT_362	[p15l140t2235r309b2277],
5	promoters	NNS	O	promoter	prep_in	2	SENT_362	[p15l334t2240r601b2287],
6	and	CC	O	and	_	0	SENT_362	[p15l629t2233r722b2277],
7	characterization	NN	O	characterization	prep_in	2	SENT_362	[p15l750t2233r1170b2277],
8	of	IN	O	of	_	0	SENT_362	[p15l1197t2233r1250b2277],
9	the	DT	O	the	det	11	SENT_362	[p15l1270t2233r1352b2277],
10	genetic	JJ	O	genetic	amod	11	SENT_362	[p15l1377t2234r1565b2287],
11	basis	NN	O	basis	prep_of	2	SENT_362	[p15l1590t2233r1716b2277],
12	of	IN	O	of	_	0	SENT_362	[p15l1745t2233r1798b2277],
13	polymorphic	JJ	O	polymorphic	amod	15	SENT_362	[p15l1818t2233r2149b2287],
14	CYP3A5	NN	O	cyp3a5	nn	15	SENT_362	[p15l140t2301r338b2343],
15	expression	NN	O	expression	prep_of	11	SENT_362	[p15l363t2300r653b2354],
16	.	.	O	.	_	0	SENT_362	[p15l363t2300r653b2354],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_363	[p15l676t2302r766b2343],
2	Genet	NNP	PERSON	Genet	_	0	SENT_363	[p15l788t2301r941b2343],
3	2001	CD	DATE	2001	num	2	SENT_363	[p15l962t2301r1407b2349],
4	;	:	O	;	_	0	SENT_363	[p15l962t2301r1407b2349],
5	27:383	CD	NUMBER	27:383	number	6	SENT_363	[p15l962t2301r1407b2349],
6	—	CD	NUMBER	—	dep	2	SENT_363	[p15l962t2301r1407b2349],
7	91	CD	NUMBER	91	dep	6	SENT_363	[p15l962t2301r1407b2349],
8	.	.	O	.	_	0	SENT_363	[p15l962t2301r1407b2349],

1	[	NN	O	[	nn	5	SENT_364	[p15l6t2365r104b2419],
2	12	CD	NUMBER	12	num	5	SENT_364	[p15l6t2365r104b2419],
3	]	CD	NUMBER	]	num	5	SENT_364	[p15l6t2365r104b2419],
4	Evans	NNP	O	Evans	nn	5	SENT_364	[p15l140t2368r287b2408],
5	WE	NNP	O	WE	_	0	SENT_364	[p15l314t2368r416b2415],
6	,	,	O	,	_	0	SENT_364	[p15l314t2368r416b2415],
7	McLeod	NNP	PERSON	McLeod	nn	8	SENT_364	[p15l445t2365r645b2408],
8	HL	NNS	O	hl	appos	5	SENT_364	[p15l674t2368r754b2409],
9	.	.	O	.	_	0	SENT_364	[p15l674t2368r754b2409],

1	Pharmacogenomics	NNP	O	Pharmacogenomics	_	0	SENT_365	[p15l783t2365r1457b2419],
2	—	CD	NUMBER	—	num	3	SENT_365	[p15l783t2365r1457b2419],
3	drug	NN	O	drug	dep	1	SENT_365	[p15l783t2365r1457b2419],
4	disposition	NN	O	disposition	dep	3	SENT_365	[p15l1485t2365r1782b2419],
5	,	,	O	,	_	0	SENT_365	[p15l1485t2365r1782b2419],
6	drug	NN	O	drug	nn	7	SENT_365	[p15l1812t2365r1930b2419],
7	targets	NNS	O	target	appos	4	SENT_365	[p15l1958t2371r2147b2419],
8	,	,	O	,	_	0	SENT_365	[p15l1958t2371r2147b2419],

1	and	CC	O	and	_	0	SENT_366	[p15l139t2431r233b2474],
2	side	JJ	O	side	amod	3	SENT_366	[p15l256t2431r357b2474],
3	effects	NNS	O	effect	dep	1	SENT_366	[p15l381t2431r560b2475],
4	.	.	O	.	_	0	SENT_366	[p15l381t2431r560b2475],

1	N	NN	O	n	nn	3	SENT_367	[p15l584t2433r621b2474],
2	Engl	NNP	O	Engl	nn	3	SENT_367	[p15l645t2431r792b2485],
3	]	NNP	O	]	nsubj	4	SENT_367	[p15l645t2431r792b2485],
4	Med	VBD	O	med	_	0	SENT_367	[p15l814t2431r926b2474],
5	2003	CD	DATE	2003	dobj	4	SENT_367	[p15l949t2433r1427b2481],
6	;	:	O	;	_	0	SENT_367	[p15l949t2433r1427b2481],
7	348:538	CD	NUMBER	348:538	number	8	SENT_367	[p15l949t2433r1427b2481],
8	—	CD	NUMBER	—	dep	5	SENT_367	[p15l949t2433r1427b2481],
9	49	CD	NUMBER	49	dep	8	SENT_367	[p15l949t2433r1427b2481],
10	.	.	O	.	_	0	SENT_367	[p15l949t2433r1427b2481],

1	[	RB	O	[	dep	5	SENT_368	[p15l6t2496r104b2551],
2	13	CD	NUMBER	13	num	5	SENT_368	[p15l6t2496r104b2551],
3	]	CD	NUMBER	]	num	5	SENT_368	[p15l6t2496r104b2551],
4	Xie	NNP	O	Xie	nn	5	SENT_368	[p15l138t2497r221b2540],
5	HG	NNP	O	HG	_	0	SENT_368	[p15l251t2499r342b2547],
6	,	,	O	,	_	0	SENT_368	[p15l251t2499r342b2547],
7	Wood	NNP	O	Wood	nn	8	SENT_368	[p15l370t2497r525b2540],
8	AJ	NNP	O	AJ	appos	5	SENT_368	[p15l552t2499r618b2551],
9	,	,	O	,	_	0	SENT_368	[p15l552t2499r618b2551],
10	Kim	NNP	PERSON	Kim	nn	11	SENT_368	[p15l649t2497r751b2540],
11	RB	NN	O	rb	appos	5	SENT_368	[p15l781t2499r859b2547],
12	,	,	O	,	_	0	SENT_368	[p15l781t2499r859b2547],
13	Stein	NNP	PERSON	Stein	nn	14	SENT_368	[p15l890t2497r1017b2540],
14	CM	NN	O	cm	appos	11	SENT_368	[p15l1048t2499r1144b2547],
15	,	,	O	,	_	0	SENT_368	[p15l1048t2499r1144b2547],
16	Wilkinson	NNP	PERSON	Wilkinson	nn	17	SENT_368	[p15l1172t2497r1438b2540],
17	GR	NN	O	gr	appos	11	SENT_368	[p15l1468t2499r1551b2541],
18	.	.	O	.	_	0	SENT_368	[p15l1468t2499r1551b2541],

1	Genetic	JJ	O	genetic	amod	2	SENT_369	[p15l1582t2497r1778b2540],
2	variability	NN	O	variability	_	0	SENT_369	[p15l1806t2497r2072b2551],
3	in	IN	O	in	_	0	SENT_369	[p15l2101t2497r2148b2540],
4	CYP3A5	NN	O	cyp3a5	prep_in	2	SENT_369	[p15l140t2565r338b2607],
5	and	CC	O	and	_	0	SENT_369	[p15l363t2563r456b2607],
6	its	PRP$	O	its	poss	8	SENT_369	[p15l480t2564r538b2607],
7	possible	JJ	O	possible	amod	8	SENT_369	[p15l562t2563r771b2618],
8	consequences	NNS	O	consequence	prep_in	2	SENT_369	[p15l794t2576r1164b2618],
9	.	.	O	.	_	0	SENT_369	[p15l794t2576r1164b2618],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_370	[p15l1189t2563r1692b2618],
2	2004	CD	DATE	2004	num	1	SENT_370	[p15l1715t2565r2127b2613],
3	;	:	O	;	_	0	SENT_370	[p15l1715t2565r2127b2613],
4	5:243	CD	NUMBER	5:243	number	5	SENT_370	[p15l1715t2565r2127b2613],
5	—	CD	NUMBER	—	dep	1	SENT_370	[p15l1715t2565r2127b2613],
6	72	CD	NUMBER	72	dep	5	SENT_370	[p15l1715t2565r2127b2613],
7	.	.	O	.	_	0	SENT_370	[p15l1715t2565r2127b2613],

1	[	RB	O	[	advmod	2	SENT_371	[p15l6t2629r104b2684],
2	14	CD	NUMBER	14	_	0	SENT_371	[p15l6t2629r104b2684],
3	]	CD	NUMBER	]	num	5	SENT_371	[p15l6t2629r104b2684],
4	Balram	NN	PERSON	balram	nn	5	SENT_371	[p15l140t2629r322b2673],
5	C	NN	PERSON	c	dep	2	SENT_371	[p15l353t2631r395b2679],
6	,	,	O	,	_	0	SENT_371	[p15l353t2631r395b2679],
7	Zhou	NNP	O	Zhou	nn	8	SENT_371	[p15l425t2629r554b2673],
8	Q	NNP	O	Q	appos	5	SENT_371	[p15l585t2631r634b2681],
9	,	,	O	,	_	0	SENT_371	[p15l585t2631r634b2681],
10	Cheung	NNP	ORGANIZATION	Cheung	nn	11	SENT_371	[p15l665t2629r859b2684],
11	YB	NNP	ORGANIZATION	YB	appos	5	SENT_371	[p15l887t2632r966b2680],
12	,	,	O	,	_	0	SENT_371	[p15l887t2632r966b2680],
13	Lee	NNP	PERSON	Lee	nn	14	SENT_371	[p15l997t2632r1080b2673],
14	EJ	NNP	O	EJ	appos	5	SENT_371	[p15l1111t2632r1169b2684],
15	.	.	O	.	_	0	SENT_371	[p15l1111t2632r1169b2684],

1	CYP3A5	NN	O	cyp3a5	_	0	SENT_372	[p15l1201t2629r1455b2673],
2	*	CD	NUMBER	*	number	6	SENT_372	[p15l1201t2629r1455b2673],
3	3	CD	NUMBER	3	number	6	SENT_372	[p15l1201t2629r1455b2673],
4	and	CC	O	and	_	0	SENT_372	[p15l1488t2629r1582b2673],
5	*	CD	NUMBER	*	conj_and	6	SENT_372	[p15l1613t2629r1664b2673],
6	6	CD	NUMBER	6	num	9	SENT_372	[p15l1613t2629r1664b2673],
7	single	JJ	O	single	amod	9	SENT_372	[p15l1696t2629r1846b2684],
8	nucleotide	NN	O	nucleotide	nn	9	SENT_372	[p15l1876t2629r2148b2673],
9	polymorphisms	NNS	O	polymorphism	dep	1	SENT_372	[p15l140t2695r545b2749],
10	in	IN	O	in	_	0	SENT_372	[p15l579t2696r627b2738],
11	three	CD	NUMBER	three	num	14	SENT_372	[p15l659t2695r793b2738],
12	distinct	JJ	O	distinct	amod	14	SENT_372	[p15l826t2695r1021b2738],
13	Asian	JJ	LOCATION	asian	amod	14	SENT_372	[p15l1050t2695r1192b2738],
14	populations	NNS	O	population	prep_in	9	SENT_372	[p15l1225t2695r1543b2749],
15	.	.	O	.	_	0	SENT_372	[p15l1225t2695r1543b2749],

1	EurJ	NN	O	eurj	nn	2	SENT_373	[p15l1578t2698r1710b2749],
2	Clin	NN	O	clin	_	0	SENT_373	[p15l1743t2695r1842b2738],
3	Pharmacol	NNP	O	Pharmacol	dep	2	SENT_373	[p15l1875t2695r2147b2738],
4	2003	CD	DATE	2003	num	3	SENT_373	[p15l139t2763r551b2811],
5	;	:	O	;	_	0	SENT_373	[p15l139t2763r551b2811],
6	59:123	CD	NUMBER	59:123	number	7	SENT_373	[p15l139t2763r551b2811],
7	—	CD	NUMBER	—	dep	2	SENT_373	[p15l139t2763r551b2811],
8	6	CD	NUMBER	6	dep	7	SENT_373	[p15l139t2763r551b2811],
9	.	.	O	.	_	0	SENT_373	[p15l139t2763r551b2811],

1	[	RB	O	[	advmod	4	SENT_374	[p15l6t2826r104b2881],
2	15	CD	NUMBER	15	number	3	SENT_374	[p15l6t2826r104b2881],
3	]	CD	NUMBER	]	num	4	SENT_374	[p15l6t2826r104b2881],
4	Jouna	NNP	PERSON	Jouna	_	0	SENT_374	[p15l133t2826r351b2881],
5	'	POS	O	'	_	0	SENT_374	[p15l133t2826r351b2881],
6	1	CD	NUMBER	1	num	4	SENT_374	[p15l133t2826r351b2881],
7	'	''	O	'	_	0	SENT_374	[p15l133t2826r351b2881],
8	di	FW	O	di	npadvmod	4	SENT_374	[p15l133t2826r351b2881],
9	Y	NN	O	y	dep	8	SENT_374	[p15l365t2829r411b2877],
10	,	,	O	,	_	0	SENT_374	[p15l365t2829r411b2877],
11	Hyrailles	NNP	O	Hyrailles	nn	12	SENT_374	[p15l428t2827r655b2881],
12	V	NNP	O	V	appos	9	SENT_374	[p15l670t2829r719b2877],
13	,	,	O	,	_	0	SENT_374	[p15l670t2829r719b2877],
14	Gervot	NNP	PERSON	Gervot	nn	15	SENT_374	[p15l736t2829r909b2870],
15	L	NNP	PERSON	L	appos	9	SENT_374	[p15l925t2829r961b2877],
16	,	,	O	,	_	0	SENT_374	[p15l925t2829r961b2877],
17	Maurel	NNP	PERSON	Maurel	nn	19	SENT_374	[p15l978t2827r1160b2870],
18	P.	NNP	O	P.	nn	19	SENT_374	[p15l1177t2829r1218b2871],
19	Detection	NN	O	detection	appos	9	SENT_374	[p15l1235t2827r1484b2870],
20	of	IN	O	of	_	0	SENT_374	[p15l1500t2827r1553b2870],
21	CYP3A5	NN	O	cyp3a5	nn	23	SENT_374	[p15l1563t2829r1761b2870],
22	allelic	JJ	O	allelic	amod	23	SENT_374	[p15l1779t2827r1931b2870],
23	variant	NN	O	variant	prep_of	4	SENT_374	[p15l1945t2827r2144b2871],
24	:	:	O	:	_	0	SENT_374	[p15l1945t2827r2144b2871],
25	a	DT	O	a	det	26	SENT_374	[p15l139t2906r165b2937],
26	candidate	NN	O	candidate	dep	23	SENT_374	[p15l187t2893r439b2937],
27	for	IN	O	for	_	0	SENT_374	[p15l461t2893r532b2937],
28	the	DT	O	the	det	30	SENT_374	[p15l552t2893r633b2937],
29	polymorphic	JJ	O	polymorphic	amod	30	SENT_374	[p15l655t2893r986b2948],
30	expression	NN	O	expression	prep_for	4	SENT_374	[p15l1007t2894r1284b2948],
31	of	IN	O	of	_	0	SENT_374	[p15l1306t2893r1359b2937],
32	the	DT	O	the	det	33	SENT_374	[p15l1374t2893r1456b2937],
33	protein	NN	O	protein	prep_of	4	SENT_374	[p15l1477t2894r1677b2948],
34	.	.	O	.	_	0	SENT_374	[p15l1477t2894r1677b2948],

1	Biochem	NNP	ORGANIZATION	Biochem	nn	4	SENT_375	[p15l1700t2893r1923b2937],
2	Biophys	NNP	ORGANIZATION	Biophys	nn	4	SENT_375	[p15l1944t2893r2147b2948],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_375	[p15l140t2961r225b3002],
4	Commun	NNP	ORGANIZATION	Commun	_	0	SENT_375	[p15l249t2961r485b3002],
5	1996	CD	DATE	1996	num	4	SENT_375	[p15l510t2961r985b3009],
6	;	:	O	;	_	0	SENT_375	[p15l510t2961r985b3009],
7	221:466	CD	NUMBER	221:466	number	8	SENT_375	[p15l510t2961r985b3009],
8	—	CD	NUMBER	—	dep	4	SENT_375	[p15l510t2961r985b3009],
9	70	CD	NUMBER	70	dep	8	SENT_375	[p15l510t2961r985b3009],
10	.	.	O	.	_	0	SENT_375	[p15l510t2961r985b3009],

1	[	RB	O	[	advmod	4	SENT_376	[p15l6t3025r104b3079],
2	16	CD	NUMBER	16	number	3	SENT_376	[p15l6t3025r104b3079],
3	]	CD	NUMBER	]	num	4	SENT_376	[p15l6t3025r104b3079],
4	van	NN	PERSON	van	_	0	SENT_376	[p15l138t3038r231b3069],
5	Schaik	NNP	PERSON	Schaik	nn	6	SENT_376	[p15l256t3025r423b3069],
6	RH	NNP	PERSON	RH	dep	4	SENT_376	[p15l447t3028r533b3075],
7	,	,	O	,	_	0	SENT_376	[p15l447t3028r533b3075],
8	van	NNP	PERSON	van	nn	11	SENT_376	[p15l558t3038r651b3069],
9	der	NNP	PERSON	der	nn	11	SENT_376	[p15l676t3025r761b3069],
10	Heiden	NNP	PERSON	Heiden	nn	11	SENT_376	[p15l785t3025r968b3069],
11	IP	NNP	O	IP	appos	4	SENT_376	[p15l994t3028r1052b3075],
12	,	,	O	,	_	0	SENT_376	[p15l994t3028r1052b3075],
13	van	NNP	PERSON	van	nn	15	SENT_376	[p15l1077t3038r1170b3069],
14	den	NN	PERSON	den	nn	15	SENT_376	[p15l1196t3025r1290b3069],
15	Anker	NNP	PERSON	Anker	appos	11	SENT_376	[p15l1313t3025r1468b3069],
16	JN	NN	O	jn	dep	15	SENT_376	[p15l1485t3028r1561b3079],
17	,	,	O	,	_	0	SENT_376	[p15l1485t3028r1561b3079],
18	Lindemans	NNP	O	Lindemans	nn	20	SENT_376	[p15l1587t3025r1867b3069],
19	J.	NNP	O	J.	nn	20	SENT_376	[p15l1887t3028r1920b3079],
20	CYP3A5	NNP	O	CYP3A5	appos	11	SENT_376	[p15l1948t3027r2146b3069],
21	variant	JJ	O	variant	amod	23	SENT_376	[p15l138t3092r322b3135],
22	allele	NN	O	allele	nn	23	SENT_376	[p15l343t3091r478b3135],
23	frequencies	NNS	O	frequency	dep	4	SENT_376	[p15l501t3091r797b3146],
24	in	IN	O	in	_	0	SENT_376	[p15l820t3092r868b3134],
25	Dutch	JJ	MISC	dutch	amod	26	SENT_376	[p15l889t3091r1043b3135],
26	Caucasians	NNPS	MISC	Caucasians	prep_in	23	SENT_376	[p15l1063t3092r1358b3135],
27	.	.	O	.	_	0	SENT_376	[p15l1063t3092r1358b3135],

1	Clin	NNP	O	Clin	nn	2	SENT_377	[p15l1381t3091r1481b3135],
2	Chem	NNP	O	Chem	_	0	SENT_377	[p15l1501t3091r1648b3135],
3	2002	CD	DATE	2002	num	2	SENT_377	[p15l1669t3093r2147b3142],
4	;	:	O	;	_	0	SENT_377	[p15l1669t3093r2147b3142],
5	48:1668	CD	NUMBER	48:1668	number	6	SENT_377	[p15l1669t3093r2147b3142],
6	—	CD	NUMBER	—	dep	2	SENT_377	[p15l1669t3093r2147b3142],
7	71	CD	NUMBER	71	dep	6	SENT_377	[p15l1669t3093r2147b3142],
8	.	.	O	.	_	0	SENT_377	[p15l1669t3093r2147b3142],

1	[	NN	O	[	_	0	SENT_378	[p15l6t3157r104b3211],
2	17	CD	NUMBER	17	number	3	SENT_378	[p15l6t3157r104b3211],
3	]	CD	NUMBER	]	dep	1	SENT_378	[p15l6t3157r104b3211],
4	Steinhubl	NNP	O	Steinhubl	nn	5	SENT_378	[p15l140t3157r386b3200],
5	SR.	NNP	O	SR.	dep	3	SENT_378	[p15l417t3159r490b3201],
6	.	.	O	.	_	0	SENT_378	[p15l417t3159r490b3201],

1	Genotyping	NN	O	genotyping	_	0	SENT_379	[p15l522t3158r835b3211],
2	,	,	O	,	_	0	SENT_379	[p15l522t3158r835b3211],
3	clopidogrel	NN	O	clopidogrel	nn	4	SENT_379	[p15l865t3157r1154b3211],
4	metabolism	NN	O	metabolism	conj_and	1	SENT_379	[p15l1186t3157r1504b3207],
5	,	,	O	,	_	0	SENT_379	[p15l1186t3157r1504b3207],
6	and	CC	O	and	_	0	SENT_379	[p15l1535t3157r1628b3200],
7	the	DT	O	the	det	8	SENT_379	[p15l1659t3157r1740b3200],
8	search	NN	O	search	conj_and	1	SENT_379	[p15l1771t3157r1936b3200],
9	for	IN	O	for	_	0	SENT_379	[p15l1966t3157r2038b3200],
10	the	DT	O	the	det	12	SENT_379	[p15l2067t3157r2148b3200],
11	therapeutic	JJ	O	therapeutic	amod	12	SENT_379	[p15l139t3223r437b3277],
12	window	NN	O	window	prep_for	8	SENT_379	[p15l458t3223r670b3267],
13	of	IN	O	of	_	0	SENT_379	[p15l692t3223r745b3267],
14	thienopyridines	NNS	O	thienopyridine	prep_of	12	SENT_379	[p15l761t3223r1184b3277],
15	.	.	O	.	_	0	SENT_379	[p15l761t3223r1184b3277],

1	Circulation	NN	O	circulation	_	0	SENT_380	[p15l1208t3223r1491b3267],
2	2010	CD	DATE	2010	num	1	SENT_380	[p15l1513t3225r1958b3273],
3	;	:	O	;	_	0	SENT_380	[p15l1513t3225r1958b3273],
4	121:481	CD	NUMBER	121:481	number	5	SENT_380	[p15l1513t3225r1958b3273],
5	—	CD	NUMBER	—	dep	1	SENT_380	[p15l1513t3225r1958b3273],
6	3	CD	NUMBER	3	dep	5	SENT_380	[p15l1513t3225r1958b3273],
7	.	.	O	.	_	0	SENT_380	[p15l1513t3225r1958b3273],

1	[	NN	O	[	nn	5	SENT_381	[p15l6t3288r104b3343],
2	18	CD	NUMBER	18	num	5	SENT_381	[p15l6t3288r104b3343],
3	]	CD	NUMBER	]	num	5	SENT_381	[p15l6t3288r104b3343],
4	Chen	NNP	PERSON	Chen	nn	5	SENT_381	[p15l140t3289r269b3332],
5	H	NNP	PERSON	H	_	0	SENT_381	[p15l285t3291r336b3339],
6	,	,	O	,	_	0	SENT_381	[p15l285t3291r336b3339],
7	Yan	NNP	PERSON	Yan	nn	8	SENT_381	[p15l350t3291r447b3332],
8	W	NNP	O	W	appos	5	SENT_381	[p15l461t3291r531b3339],
9	,	,	O	,	_	0	SENT_381	[p15l461t3291r531b3339],
10	Wu	NNP	O	Wu	nn	11	SENT_381	[p15l545t3291r637b3332],
11	XY	NN	O	xy	appos	8	SENT_381	[p15l651t3291r734b3333],
12	.	.	O	.	_	0	SENT_381	[p15l651t3291r734b3333],

1	Relationships	NNPS	O	Relationships	_	0	SENT_382	[p15l751t3289r1098b3343],
2	of	IN	O	of	_	0	SENT_382	[p15l1115t3288r1168b3332],
3	blood	NN	O	blood	nn	5	SENT_382	[p15l1177t3289r1321b3332],
4	stasis	NN	O	stasis	nn	5	SENT_382	[p15l1339t3289r1477b3332],
5	syndrome	NN	O	syndrome	prep_of	1	SENT_382	[p15l1495t3289r1764b3343],
6	,	,	O	,	_	0	SENT_382	[p15l1495t3289r1764b3343],
7	CYP2C19	NN	O	cyp2c19	nn	9	SENT_382	[p15l1781t3291r2010b3332],
8	gene	NN	O	gene	nn	9	SENT_382	[p15l2027t3301r2148b3343],
9	polymorphism	NN	O	polymorphism	appos	5	SENT_382	[p15l140t3355r521b3410],
10	with	IN	O	with	_	0	SENT_382	[p15l538t3355r657b3399],
11	clopidogrel	NN	O	clopidogrel	nn	12	SENT_382	[p15l676t3355r964b3410],
12	resistance	NN	O	resistance	prep_with	1	SENT_382	[p15l985t3356r1242b3399],
13	and	CC	O	and	_	0	SENT_382	[p15l1262t3355r1355b3399],
14	post	NN	O	post	conj_and	12	SENT_382	[p15l1375t3357r1589b3410],
15	.	.	O	.	_	0	SENT_382	[p15l1375t3357r1589b3410],

1	—	NN	O	—	_	0	SENT_383	[p15l1375t3357r1589b3410],
2	.	.	O	.	_	0	SENT_383	[p15l1375t3357r1589b3410],

1	PCI	NN	O	pcus	_	0	SENT_384	[p15l1375t3357r1589b3410],
2	prognosis	NN	O	prognosis	dep	1	SENT_384	[p15l1610t3356r1872b3410],
3	.	.	O	.	_	0	SENT_384	[p15l1610t3356r1872b3410],

1	Zhongguo	NNP	PERSON	Zhongguo	nn	5	SENT_385	[p15l1891t3355r2148b3410],
2	Zhong	NNP	PERSON	Zhong	nn	5	SENT_385	[p15l139t3421r300b3476],
3	Xi	NN	PERSON	xi	nn	5	SENT_385	[p15l320t3422r372b3464],
4	Yi	NNP	PERSON	Yi	nn	5	SENT_385	[p15l393t3422r443b3464],
5	Jie	NNP	PERSON	Jie	_	0	SENT_385	[p15l460t3422r527b3476],
6	He	PRP	O	he	dep	5	SENT_385	[p15l550t3424r618b3465],
7	Za	NNP	O	Za	nn	8	SENT_385	[p15l639t3424r698b3465],
8	Zhi	NNP	O	Zhi	dep	6	SENT_385	[p15l720t3421r800b3464],
9	2010	CD	DATE	2010	num	11	SENT_385	[p15l823t3423r1267b3471],
10	;	:	O	;	_	0	SENT_385	[p15l823t3423r1267b3471],
11	30:1245	CD	NUMBER	30:1245	dep	5	SENT_385	[p15l823t3423r1267b3471],
12	—	CD	NUMBER	—	number	13	SENT_385	[p15l823t3423r1267b3471],
13	9	CD	NUMBER	9	dep	11	SENT_385	[p15l823t3423r1267b3471],
14	.	.	O	.	_	0	SENT_385	[p15l823t3423r1267b3471],

1	[	NN	O	[	nsubj	13	SENT_386	[p15l6t3487r104b3541],
2	19	CD	NUMBER	19	num	1	SENT_386	[p15l6t3487r104b3541],
3	]	CD	NUMBER	]	num	5	SENT_386	[p15l6t3487r104b3541],
4	Mega	JJ	O	mega	amod	5	SENT_386	[p15l140t3490r279b3541],
5	JL	NN	O	jl	dep	1	SENT_386	[p15l289t3490r350b3541],
6	,	,	O	,	_	0	SENT_386	[p15l289t3490r350b3541],
7	Close	NNP	O	Close	nn	8	SENT_386	[p15l369t3487r503b3530],
8	SL	NNP	O	SL	nsubj	13	SENT_386	[p15l521t3489r587b3537],
9	,	,	O	,	_	0	SENT_386	[p15l521t3489r587b3537],
10	Wiviott	NNP	PERSON	Wiviott	nn	11	SENT_386	[p15l603t3488r801b3530],
11	SD	NN	O	sd	appos	8	SENT_386	[p15l817t3489r896b3537],
12	,	,	O	,	_	0	SENT_386	[p15l817t3489r896b3537],
13	Shen	VBN	PERSON	shen	_	0	SENT_386	[p15l914t3487r1038b3530],
14	L	NN	PERSON	l	dobj	13	SENT_386	[p15l1055t3490r1092b3537],
15	,	,	O	,	_	0	SENT_386	[p15l1055t3490r1092b3537],
16	Hockett	NNP	PERSON	Hockett	nn	17	SENT_386	[p15l1110t3487r1312b3530],
17	RD	NNP	O	RD	appos	14	SENT_386	[p15l1328t3490r1413b3537],
18	,	,	O	,	_	0	SENT_386	[p15l1328t3490r1413b3537],
19	Brandt	NNP	PERSON	Brandt	nn	20	SENT_386	[p15l1431t3487r1604b3530],
20	JT	NNP	O	JT	appos	14	SENT_386	[p15l1614t3490r1679b3541],
21	,	,	O	,	_	0	SENT_386	[p15l1614t3490r1679b3541],
22	et	FW	O	et	nn	23	SENT_386	[p15l1697t3493r1744b3530],
23	al.	FW	O	al.	appos	14	SENT_386	[p15l1761t3487r1816b3531],
24	.	.	O	.	_	0	SENT_386	[p15l1761t3487r1816b3531],

1	Cytochrome	NN	O	cytochrome	nn	3	SENT_387	[p15l1835t3487r2148b3541],
2	p-450	NN	O	p-450	nn	3	SENT_387	[p15l140t3555r292b3607],
3	polymorphisms	NNS	O	polymorphism	_	0	SENT_387	[p15l347t3553r752b3607],
4	and	CC	O	and	_	0	SENT_387	[p15l809t3553r902b3597],
5	response	NN	O	response	conj_and	3	SENT_387	[p15l959t3566r1187b3607],
6	to	TO	O	to	_	0	SENT_387	[p15l1242t3560r1292b3597],
7	clopidogrel	NN	O	clopidogrel	prep_to	3	SENT_387	[p15l1348t3553r1649b3607],
8	.	.	O	.	_	0	SENT_387	[p15l1348t3553r1649b3607],

1	N	NN	O	n	nn	3	SENT_388	[p15l1706t3556r1744b3596],
2	Engl	NNP	O	Engl	nn	3	SENT_388	[p15l1800t3553r1910b3607],
3	J	NNP	O	J	nsubj	4	SENT_388	[p15l1959t3556r1980b3607],
4	Med	VBD	O	med	_	0	SENT_388	[p15l2036t3553r2148b3597],
5	2009	CD	DATE	2009	dobj	4	SENT_388	[p15l139t3621r617b3669],
6	;	:	O	;	_	0	SENT_388	[p15l139t3621r617b3669],
7	360:354	CD	NUMBER	360:354	number	8	SENT_388	[p15l139t3621r617b3669],
8	—	CD	NUMBER	—	dep	5	SENT_388	[p15l139t3621r617b3669],
9	62	CD	NUMBER	62	dep	8	SENT_388	[p15l139t3621r617b3669],
10	.	.	O	.	_	0	SENT_388	[p15l139t3621r617b3669],

1	[	RB	O	[	advmod	3	SENT_389	[p15l6t3685r104b3740],
2	20	CD	NUMBER	20	number	3	SENT_389	[p15l6t3685r104b3740],
3	]	CD	NUMBER	]	_	0	SENT_389	[p15l6t3685r104b3740],
4	Pettersen	NNP	ORGANIZATION	Pettersen	nn	5	SENT_389	[p15l139t3688r381b3729],
5	AA	NNP	ORGANIZATION	AA	dep	3	SENT_389	[p15l401t3687r487b3735],
6	,	,	O	,	_	0	SENT_389	[p15l401t3687r487b3735],
7	Arnesen	NNP	PERSON	Arnesen	nn	8	SENT_389	[p15l508t3687r720b3729],
8	H	NNP	PERSON	H	appos	3	SENT_389	[p15l743t3688r794b3735],
9	,	,	O	,	_	0	SENT_389	[p15l743t3688r794b3735],
10	Opstad	NNP	O	Opstad	nn	11	SENT_389	[p15l817t3685r997b3740],
11	TB	NN	O	tb	appos	8	SENT_389	[p15l1017t3688r1095b3735],
12	,	,	O	,	_	0	SENT_389	[p15l1017t3688r1095b3735],
13	Seljeﬂot	NNP	O	Seljeﬂot	nn	16	SENT_389	[p15l1118t3685r1326b3740],
14	I.	NNP	O	I.	nn	16	SENT_389	[p15l1348t3688r1374b3729],
15	The	NNP	O	The	nn	16	SENT_389	[p15l1395t3685r1490b3729],
16	inﬂuence	NN	O	inﬂuence	appos	8	SENT_389	[p15l1512t3685r1749b3729],
17	of	IN	O	of	_	0	SENT_389	[p15l1772t3685r1826b3729],
18	CYP	NN	O	cyp	nn	20	SENT_389	[p15l1842t3687r1940b3729],
19	2C19	NN	O	2c19	nn	20	SENT_389	[p15l1962t3685r2146b3729],
20	*	NN	O	*	prep_of	16	SENT_389	[p15l1962t3685r2146b3729],
21	2	CD	NUMBER	2	num	22	SENT_389	[p15l1962t3685r2146b3729],
22	polymorphism	NN	O	polymorphism	dep	3	SENT_389	[p15l139t3750r520b3805],
23	on	IN	O	on	_	0	SENT_389	[p15l547t3763r610b3794],
24	platelet	NN	O	platelet	nn	26	SENT_389	[p15l637t3750r833b3805],
25	function	NN	O	function	nn	26	SENT_389	[p15l860t3750r1075b3794],
26	testing	NN	O	testing	prep_on	22	SENT_389	[p15l1102t3751r1279b3805],
27	during	IN	O	during	_	0	SENT_389	[p15l1305t3750r1476b3805],
28	single	JJ	O	single	amod	30	SENT_389	[p15l1503t3750r1652b3805],
29	antiplatelet	JJ	O	antiplatelet	amod	30	SENT_389	[p15l1679t3750r1978b3805],
30	treatment	NN	O	treatment	prep_during	26	SENT_389	[p15l2004t3757r2147b3794, p16l139t20r274b57],

1	with	IN	O	with	_	0	SENT_390	[p16l294t13r414b57],
2	clopidogrel	NN	O	clopidogrel	pobj	1	SENT_390	[p16l436t13r737b67],
3	.	.	O	.	_	0	SENT_390	[p16l436t13r737b67],

1	Thromb	NNP	O	Thromb	_	0	SENT_391	[p16l759t13r1001b67],
2	]	CD	NUMBER	]	num	1	SENT_391	[p16l759t13r1001b67],
3	2011	CD	DATE	2011	num	5	SENT_391	[p16l1023t15r1144b57],
4	;	:	O	;	_	0	SENT_391	[p16l1159t15r1270b63],
5	9:4	CD	NUMBER	9:4	dep	1	SENT_391	[p16l1159t15r1270b63],
6	.	.	O	.	_	0	SENT_391	[p16l1159t15r1270b63],

1	[	NN	O	[	nn	4	SENT_392	[p16l6t79r104b134],
2	21	CD	NUMBER	21	num	4	SENT_392	[p16l6t79r104b134],
3	]	NN	O	]	nn	4	SENT_392	[p16l6t79r104b134],
4	jeong	NN	O	jeong	tmod	11	SENT_392	[p16l133t82r281b134],
5	YH	NN	O	yh	dep	4	SENT_392	[p16l310t82r398b129],
6	,	,	O	,	_	0	SENT_392	[p16l310t82r398b129],
7	Kim	NNP	PERSON	Kim	nsubj	11	SENT_392	[p16l431t80r534b122],
8	IS	VBZ	O	be	cop	11	SENT_392	[p16l566t81r621b130],
9	,	,	O	,	_	0	SENT_392	[p16l566t81r621b130],
10	Park	NNP	O	Park	nn	11	SENT_392	[p16l655t79r768b123],
11	Y	NN	O	y	_	0	SENT_392	[p16l796t82r842b129],
12	,	,	O	,	_	0	SENT_392	[p16l796t82r842b129],
13	Kang	NNP	PERSON	Kang	nn	14	SENT_392	[p16l875t82r1003b134],
14	MK	NNP	O	MK	appos	11	SENT_392	[p16l1035t82r1133b129],
15	,	,	O	,	_	0	SENT_392	[p16l1035t82r1133b129],
16	Koh	NNP	LOCATION	Koh	nn	17	SENT_392	[p16l1166t79r1265b123],
17	JS	NNP	LOCATION	JS	appos	11	SENT_392	[p16l1290t81r1352b134],
18	,	,	O	,	_	0	SENT_392	[p16l1290t81r1352b134],
19	Hwang	NNP	PERSON	Hwang	nn	21	SENT_392	[p16l1386t82r1568b134],
20	S	NNP	O	S	nn	21	SENT_392	[p16l1599t81r1655b134],
21	]	NN	O	]	appos	11	SENT_392	[p16l1599t81r1655b134],
22	,	,	O	,	_	0	SENT_392	[p16l1599t81r1655b134],
23	et	FW	O	et	nn	24	SENT_392	[p16l1688t86r1736b123],
24	al.	FW	O	al.	appos	11	SENT_392	[p16l1767t79r1823b123],
25	.	.	O	.	_	0	SENT_392	[p16l1767t79r1823b123],

1	Carriage	NN	O	carriage	nsubjpass	7	SENT_393	[p16l1856t80r2068b134],
2	of	IN	O	of	_	0	SENT_393	[p16l2101t79r2154b123],
3	cytochrome	NN	O	cytochrome	nn	5	SENT_393	[p16l140t145r446b199],
4	2C19	NN	O	2c19	nn	5	SENT_393	[p16l472t147r601b188],
5	polymorphism	NN	O	polymorphism	prep_of	1	SENT_393	[p16l628t145r1009b199],
6	is	VBZ	O	be	auxpass	7	SENT_393	[p16l1036t146r1073b188],
7	associated	VBN	O	associate	_	0	SENT_393	[p16l1100t145r1366b188],
8	with	IN	O	with	_	0	SENT_393	[p16l1392t145r1511b188],
9	risk	NN	O	risk	prep_with	7	SENT_393	[p16l1538t145r1632b188],
10	of	IN	O	of	_	0	SENT_393	[p16l1657t145r1710b188],
11	high	JJ	O	high	amod	14	SENT_393	[p16l1730t145r1843b199],
12	posttreatment	NN	O	posttreatment	nn	14	SENT_393	[p16l1869t151r2148b199, p16l140t218r275b255],
13	platelet	NN	O	platelet	nn	14	SENT_393	[p16l288t211r485b265],
14	reactivity	NN	O	reactivity	prep_of	9	SENT_393	[p16l499t212r743b265],
15	on	IN	O	on	_	0	SENT_393	[p16l757t224r820b255],
16	high	JJ	O	high	amod	18	SENT_393	[p16l835t211r948b265],
17	maintenance-dose	JJ	O	maintenance-dose	amod	18	SENT_393	[p16l962t211r1441b255],
18	clopidogrel	NN	O	clopidogrel	prep_on	14	SENT_393	[p16l1456t211r1744b265],
19	of	IN	O	of	_	0	SENT_393	[p16l1760t211r1813b255],
20	1	CD	NUMBER	1	number	21	SENT_393	[p16l1824t213r1844b254],
21	50	CD	NUMBER	50	num	22	SENT_393	[p16l1855t213r1916b255],
22	mg/day	NN	O	mg/day	prep_of	18	SENT_393	[p16l1934t211r2144b265],
23	:	:	O	:	_	0	SENT_393	[p16l1934t211r2144b265],
24	results	NNS	O	result	dep	22	SENT_393	[p16l140t277r311b320],
25	of	IN	O	of	_	0	SENT_393	[p16l326t276r379b320],
26	the	DT	O	the	det	31	SENT_393	[p16l387t277r468b320],
27	ACCEL-DOUBLE	NN	O	accel-double	nn	31	SENT_393	[p16l481t278r885b320],
28	(	CD	NUMBER	(	num	31	SENT_393	[p16l899t277r1221b331],
29	Accelerated	NNP	O	Accelerated	nn	31	SENT_393	[p16l899t277r1221b331],
30	Platelet	NN	O	platelet	nn	31	SENT_393	[p16l1236t277r1430b320],
31	Inhibition	NN	O	inhibition	prep_of	24	SENT_393	[p16l1444t277r1698b320],
32	by	IN	O	by	_	0	SENT_393	[p16l1712t277r1774b331],
33	a	DT	O	a	det	35	SENT_393	[p16l1787t289r1813b320],
34	Double	JJ	O	double	amod	35	SENT_393	[p16l1827t277r2010b320],
35	Dose	NN	O	dose	prep_by	31	SENT_393	[p16l2025t279r2148b320],
36	of	IN	O	of	_	0	SENT_393	[p16l140t343r193b387],
37	Clopidogrel	NNP	O	Clopidogrel	prep_of	35	SENT_393	[p16l221t343r516b398],
38	According	VBG	O	accord	_	0	SENT_393	[p16l549t343r811b398],
39	to	TO	O	to	prepc_according_to	7	SENT_393	[p16l844t350r893b387],
40	Gene	NNP	O	Gene	pobj	7	SENT_393	[p16l928t345r1057b387],
41	Polymorphism	NN	O	polymorphism	nn	43	SENT_393	[p16l1092t343r1491b398],
42	)	NN	O	)	nn	43	SENT_393	[p16l1092t343r1491b398],
43	study	NN	O	study	dep	40	SENT_393	[p16l1526t343r1680b398],
44	.	.	O	.	_	0	SENT_393	[p16l1526t343r1680b398],

1	JACC	NNP	O	JACC	nn	3	SENT_394	[p16l1709t345r1836b398],
2	Cardiovasc	NNP	O	Cardiovasc	nn	3	SENT_394	[p16l1870t343r2149b387],
3	Interv	NNP	O	Interv	_	0	SENT_394	[p16l140t412r294b453],
4	2010	CD	DATE	2010	num	3	SENT_394	[p16l315t411r726b459],
5	;	:	O	;	_	0	SENT_394	[p16l315t411r726b459],
6	3:731	CD	NUMBER	3:731	number	7	SENT_394	[p16l315t411r726b459],
7	—	CD	NUMBER	—	dep	3	SENT_394	[p16l315t411r726b459],
8	41	CD	NUMBER	41	dep	7	SENT_394	[p16l315t411r726b459],
9	.	.	O	.	_	0	SENT_394	[p16l315t411r726b459],

1	[	NN	O	[	_	0	SENT_395	[p16l6t475r104b529],
2	22	CD	NUMBER	22	num	1	SENT_395	[p16l6t475r104b529],
3	]	CD	NUMBER	]	num	5	SENT_395	[p16l6t475r104b529],
4	Sibbing	NN	O	sibbing	nn	5	SENT_395	[p16l140t475r332b529],
5	D	NN	O	d	dep	1	SENT_395	[p16l357t478r406b525],
6	,	,	O	,	_	0	SENT_395	[p16l357t478r406b525],
7	Koch	NNP	PERSON	Koch	nn	8	SENT_395	[p16l433t475r559b518],
8	W	NNP	O	W	appos	5	SENT_395	[p16l583t478r653b525],
9	,	,	O	,	_	0	SENT_395	[p16l583t478r653b525],
10	Gebhard	NNP	ORGANIZATION	Gebhard	nn	11	SENT_395	[p16l680t475r899b518],
11	D	NNP	ORGANIZATION	D	appos	5	SENT_395	[p16l926t477r974b525],
12	,	,	O	,	_	0	SENT_395	[p16l926t477r974b525],
13	Schuster	NNP	ORGANIZATION	Schuster	nn	14	SENT_395	[p16l1002t475r1224b518],
14	T	NN	ORGANIZATION	t	appos	5	SENT_395	[p16l1246t478r1289b525],
15	,	,	O	,	_	0	SENT_395	[p16l1246t478r1289b525],
16	Braun	NNP	PERSON	Braun	nn	17	SENT_395	[p16l1315t478r1467b518],
17	S	NNP	O	S	appos	5	SENT_395	[p16l1494t477r1531b525],
18	,	,	O	,	_	0	SENT_395	[p16l1494t477r1531b525],
19	Stegherr	NNP	PERSON	Stegherr	nn	20	SENT_395	[p16l1558t475r1777b529],
20	J	NNP	PERSON	J	appos	5	SENT_395	[p16l1795t478r1828b529],
21	,	,	O	,	_	0	SENT_395	[p16l1795t478r1828b529],
22	et	FW	O	et	nn	23	SENT_395	[p16l1855t481r1903b518],
23	al.	FW	O	al.	appos	5	SENT_395	[p16l1927t475r1983b519],
24	.	.	O	.	_	0	SENT_395	[p16l1927t475r1983b519],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_396	[p16l2010t477r2148b529, p16l140t541r334b585],
2	2C19	NN	O	2c19	_	0	SENT_396	[p16l364t541r582b585],
3	*	CD	NUMBER	*	number	4	SENT_396	[p16l364t541r582b585],
4	17	CD	NUMBER	17	dep	2	SENT_396	[p16l364t541r582b585],
5	allelic	JJ	O	allelic	amod	2	SENT_396	[p16l614t541r766b585],
6	variant	NN	O	variant	tmod	5	SENT_396	[p16l794t542r989b591],
7	,	,	O	,	_	0	SENT_396	[p16l794t542r989b591],
8	platelet	NN	O	platelet	nn	9	SENT_396	[p16l1020t541r1216b595],
9	aggregation	NN	O	aggregation	appos	6	SENT_396	[p16l1245t542r1562b595],
10	,	,	O	,	_	0	SENT_396	[p16l1245t542r1562b595],
11	bleeding	VBG	O	bleed	partmod	2	SENT_396	[p16l1592t541r1815b595],
12	events	NNS	O	event	dobj	11	SENT_396	[p16l1845t548r2024b591],
13	,	,	O	,	_	0	SENT_396	[p16l1845t548r2024b591],
14	and	CC	O	and	_	0	SENT_396	[p16l2054t541r2148b585],
15	stent	NN	O	stent	nn	16	SENT_396	[p16l140t613r269b650],
16	thrombosis	NN	O	thrombosis	conj_and	12	SENT_396	[p16l292t607r584b650],
17	in	IN	O	in	_	0	SENT_396	[p16l611t607r658b650],
18	clopidogrel-treated	JJ	O	clopidogrel-treated	amod	19	SENT_396	[p16l683t607r1183b661],
19	patients	NNS	O	patient	prep_in	16	SENT_396	[p16l1209t607r1416b661],
20	with	IN	O	with	_	0	SENT_396	[p16l1441t607r1560b650],
21	coronary	JJ	O	coronary	amod	23	SENT_396	[p16l1585t619r1814b661],
22	stent	NN	O	stent	nn	23	SENT_396	[p16l1839t613r1967b650],
23	placement	NN	O	placement	prep_with	2	SENT_396	[p16l1992t607r2148b661, p16l140t680r286b717],
24	.	.	O	.	_	0	SENT_396	[p16l1992t607r2148b661, p16l140t680r286b717],

1	Circulation	NN	O	circulation	_	0	SENT_397	[p16l310t673r593b717],
2	2010	CD	DATE	2010	num	1	SENT_397	[p16l616t675r1060b723],
3	;	:	O	;	_	0	SENT_397	[p16l616t675r1060b723],
4	121:512	CD	NUMBER	121:512	number	5	SENT_397	[p16l616t675r1060b723],
5	—	CD	NUMBER	—	dep	1	SENT_397	[p16l616t675r1060b723],
6	8	CD	NUMBER	8	dep	5	SENT_397	[p16l616t675r1060b723],
7	.	.	O	.	_	0	SENT_397	[p16l616t675r1060b723],

1	[	NN	O	[	nn	5	SENT_398	[p16l6t738r104b793],
2	23	CD	NUMBER	23	num	5	SENT_398	[p16l6t738r104b793],
3	]	CD	NUMBER	]	num	5	SENT_398	[p16l6t738r104b793],
4	Cattaneo	NNP	PERSON	Cattaneo	nn	5	SENT_398	[p16l140t741r367b782],
5	M.	NNP	O	M.	_	0	SENT_398	[p16l396t741r457b782],
6	Platelet	NN	O	platelet	nn	8	SENT_398	[p16l487t738r681b782],
7	P2	NN	O	p2	nn	8	SENT_398	[p16l709t741r767b782],
8	receptors	NNS	O	receptor	dep	5	SENT_398	[p16l798t745r1054b793],
9	:	:	O	:	_	0	SENT_398	[p16l798t745r1054b793],
10	old	JJ	O	old	amod	13	SENT_398	[p16l1087t738r1166b782],
11	and	CC	O	and	_	0	SENT_398	[p16l1194t738r1287b782],
12	new	JJ	O	new	conj_and	10	SENT_398	[p16l1317t751r1426b782],
13	targets	NNS	O	target	dep	5	SENT_398	[p16l1452t745r1628b793],
14	for	IN	O	for	_	0	SENT_398	[p16l1658t738r1730b782],
15	antithrombotic	JJ	O	antithrombotic	amod	16	SENT_398	[p16l1756t738r2149b782],
16	drugs	NNS	O	drug	prep_for	13	SENT_398	[p16l140t805r296b859],
17	.	.	O	.	_	0	SENT_398	[p16l140t805r296b859],

1	Expert	NN	O	expert	nn	4	SENT_399	[p16l319t808r487b859],
2	Rev	NN	O	rev	nn	4	SENT_399	[p16l509t808r602b849],
3	Cardiovasc	NNP	O	Cardiovasc	nn	4	SENT_399	[p16l623t805r902b849],
4	Ther	NNP	O	Ther	_	0	SENT_399	[p16l922t805r1041b849],
5	2007	CD	DATE	2007	num	4	SENT_399	[p16l1061t807r1440b855],
6	;	:	O	;	_	0	SENT_399	[p16l1061t807r1440b855],
7	5:45	CD	TIME	5:45	number	8	SENT_399	[p16l1061t807r1440b855],
8	—	CD	NUMBER	—	dep	4	SENT_399	[p16l1061t807r1440b855],
9	55	CD	NUMBER	55	dep	8	SENT_399	[p16l1061t807r1440b855],
10	.	.	O	.	_	0	SENT_399	[p16l1061t807r1440b855],

1	[	NN	O	[	_	0	SENT_400	[p16l6t871r104b926],
2	24	CD	NUMBER	24	num	1	SENT_400	[p16l6t871r104b926],
3	]	CD	NUMBER	]	num	6	SENT_400	[p16l6t871r104b926],
4	Angiolillo	NN	O	angiolillo	nn	6	SENT_400	[p16l137t871r387b926],
5	D	NN	O	d	nn	6	SENT_400	[p16l403t874r470b926],
6	]	NN	O	]	dep	1	SENT_400	[p16l403t874r470b926],
7	,	,	O	,	_	0	SENT_400	[p16l403t874r470b926],
8	Fernandez	NNP	PERSON	Fernandez	appos	6	SENT_400	[p16l487t871r908b915],
9	.	.	O	.	_	0	SENT_400	[p16l487t871r908b915],

1	—	NN	O	—	_	0	SENT_401	[p16l487t871r908b915],
2	.	.	O	.	_	0	SENT_401	[p16l487t871r908b915],

1	Ortiz	NNP	PERSON	Ortiz	nn	2	SENT_402	[p16l487t871r908b915],
2	A	NNP	O	A	_	0	SENT_402	[p16l922t873r970b921],
3	,	,	O	,	_	0	SENT_402	[p16l922t873r970b921],
4	Bernardo	NNP	PERSON	Bernardo	nn	5	SENT_402	[p16l986t871r1222b915],
5	E	NNP	PERSON	E	appos	2	SENT_402	[p16l1238t874r1278b922],
6	,	,	O	,	_	0	SENT_402	[p16l1238t874r1278b922],
7	Ramirez	NNP	PERSON	Ramirez	nn	8	SENT_402	[p16l1295t869r1506b915],
8	C	NNP	O	C	appos	5	SENT_402	[p16l1522t873r1565b921],
9	,	,	O	,	_	0	SENT_402	[p16l1522t873r1565b921],
10	Cavallari	NNP	PERSON	Cavallari	nn	11	SENT_402	[p16l1582t871r1805b915],
11	U	NNP	O	U	appos	5	SENT_402	[p16l1821t874r1872b921],
12	,	,	O	,	_	0	SENT_402	[p16l1821t874r1872b921],
13	Trabetti	NNP	O	Trabetti	nn	14	SENT_402	[p16l1886t871r2090b915],
14	E	NNP	O	E	appos	5	SENT_402	[p16l2107t874r2147b921],
15	,	,	O	,	_	0	SENT_402	[p16l2107t874r2147b921],
16	et	FW	O	et	nn	17	SENT_402	[p16l140t943r188b980],
17	al.	FW	O	al.	appos	5	SENT_402	[p16l203t937r259b981],
18	.	.	O	.	_	0	SENT_402	[p16l203t937r259b981],

1	Lack	NN	O	lack	_	0	SENT_403	[p16l277t937r391b980],
2	of	IN	O	of	_	0	SENT_403	[p16l406t937r459b980],
3	association	NN	O	association	prep_of	1	SENT_403	[p16l469t938r756b980],
4	between	IN	O	between	_	0	SENT_403	[p16l772t937r995b980],
5	the	DT	O	the	det	10	SENT_403	[p16l1011t937r1093b980],
6	P2Y1	NN	O	p2y1	nn	10	SENT_403	[p16l1109t939r1231b980],
7	2	CD	NUMBER	2	num	10	SENT_403	[p16l1242t939r1269b980],
8	receptor	NN	O	receptor	nn	10	SENT_403	[p16l1288t943r1505b991],
9	gene	NN	O	gene	nn	10	SENT_403	[p16l1519t949r1640b991],
10	polymorphism	NN	O	polymorphism	prep_between	3	SENT_403	[p16l1657t937r2038b991],
11	and	CC	O	and	_	0	SENT_403	[p16l2054t937r2148b980],
12	platelet	NN	O	platelet	nn	13	SENT_403	[p16l140t1003r336b1057],
13	response	NN	O	response	conj_and	10	SENT_403	[p16l367t1016r596b1057],
14	to	TO	O	to	_	0	SENT_403	[p16l628t1010r678b1047],
15	clopidogrel	NN	O	clopidogrel	prep_to	1	SENT_403	[p16l710t1003r998b1057],
16	in	IN	O	in	_	0	SENT_403	[p16l1032t1004r1079b1046],
17	patients	NNS	O	patient	prep_in	1	SENT_403	[p16l1111t1004r1318b1057],
18	with	IN	O	with	_	0	SENT_403	[p16l1350t1003r1469b1047],
19	coronary	JJ	O	coronary	amod	21	SENT_403	[p16l1502t1016r1731b1057],
20	artery	NN	O	artery	nn	21	SENT_403	[p16l1762t1010r1917b1057],
21	disease	NN	O	disease	prep_with	17	SENT_403	[p16l1948t1003r2147b1047],
22	.	.	O	.	_	0	SENT_403	[p16l1948t1003r2147b1047],

1	Thromb	NNP	O	Thromb	nn	2	SENT_404	[p16l137t1069r342b1112],
2	Res	NNP	O	Res	_	0	SENT_404	[p16l366t1071r450b1112],
3	2005	CD	DATE	2005	num	2	SENT_404	[p16l474t1071r918b1119],
4	;	:	O	;	_	0	SENT_404	[p16l474t1071r918b1119],
5	116:491	CD	NUMBER	116:491	num	6	SENT_404	[p16l474t1071r918b1119],
6	—	NN	O	—	dep	2	SENT_404	[p16l474t1071r918b1119],
7	7	CD	NUMBER	7	dep	6	SENT_404	[p16l474t1071r918b1119],
8	.	.	O	.	_	0	SENT_404	[p16l474t1071r918b1119],

1	[	NN	O	[	_	0	SENT_405	[p16l6t1135r104b1190],
2	25	CD	NUMBER	25	num	1	SENT_405	[p16l6t1135r104b1190],
3	]	CD	NUMBER	]	num	5	SENT_405	[p16l6t1135r104b1190],
4	Fontana	NNP	ORGANIZATION	Fontana	nn	5	SENT_405	[p16l140t1138r346b1179],
5	P	NN	ORGANIZATION	p	dep	1	SENT_405	[p16l373t1138r413b1185],
6	,	,	O	,	_	0	SENT_405	[p16l373t1138r413b1185],
7	Dupont	NNP	ORGANIZATION	Dupont	nn	8	SENT_405	[p16l441t1138r634b1190],
8	A	NNP	O	A	appos	5	SENT_405	[p16l658t1137r706b1186],
9	,	,	O	,	_	0	SENT_405	[p16l658t1137r706b1186],
10	Gandrille	NNP	O	Gandrille	nn	11	SENT_405	[p16l734t1135r971b1179],
11	S	NNP	O	S	appos	5	SENT_405	[p16l999t1137r1036b1185],
12	,	,	O	,	_	0	SENT_405	[p16l999t1137r1036b1185],
13	Bachelot-Loza	NNP	O	Bachelot-Loza	nn	14	SENT_405	[p16l1064t1135r1426b1179],
14	C	NNP	O	C	appos	5	SENT_405	[p16l1454t1137r1496b1185],
15	,	,	O	,	_	0	SENT_405	[p16l1454t1137r1496b1185],
16	Reny	NNP	PERSON	Reny	nn	17	SENT_405	[p16l1524t1138r1651b1190],
17	JL	NNP	PERSON	JL	appos	5	SENT_405	[p16l1670t1138r1732b1190],
18	,	,	O	,	_	0	SENT_405	[p16l1670t1138r1732b1190],
19	Aiach	NNP	O	Aiach	nn	20	SENT_405	[p16l1757t1135r1902b1179],
20	M	NNP	O	M	appos	5	SENT_405	[p16l1929t1138r1990b1185],
21	,	,	O	,	_	0	SENT_405	[p16l1929t1138r1990b1185],
22	et	FW	O	et	nn	23	SENT_405	[p16l2018t1142r2066b1179],
23	al.	FW	O	al.	appos	5	SENT_405	[p16l2092t1135r2147b1179],
24	.	.	O	.	_	0	SENT_405	[p16l2092t1135r2147b1179],

1	Adenosine	NN	LOCATION	adenosine	nn	3	SENT_406	[p16l137t1201r409b1245],
2	diphosphate	NN	O	diphosphate	nn	3	SENT_406	[p16l423t1201r976b1256],
3	—	NN	O	—	nsubj	4	SENT_406	[p16l423t1201r976b1256],
4	induced	VBD	O	induce	_	0	SENT_406	[p16l423t1201r976b1256],
5	platelet	NN	O	platelet	nn	6	SENT_406	[p16l991t1201r1187b1256],
6	aggregation	NN	O	aggregation	nsubjpass	8	SENT_406	[p16l1201t1202r1505b1256],
7	is	VBZ	O	be	auxpass	8	SENT_406	[p16l1520t1202r1558b1245],
8	associated	VBN	O	associate	ccomp	4	SENT_406	[p16l1573t1201r1839b1245],
9	with	IN	O	with	_	0	SENT_406	[p16l1853t1201r1972b1245],
10	P2Y12	NN	O	p2y12	nn	13	SENT_406	[p16l1986t1203r2146b1244],
11	gene	NN	O	gene	nn	13	SENT_406	[p16l139t1280r260b1321],
12	sequence	NN	O	sequence	nn	13	SENT_406	[p16l283t1280r521b1321],
13	variations	NNS	O	variation	prep_with	8	SENT_406	[p16l543t1268r799b1311],
14	in	IN	O	in	_	0	SENT_406	[p16l823t1268r871b1310],
15	healthy	JJ	O	healthy	amod	16	SENT_406	[p16l894t1267r1088b1321],
16	subjects	NNS	O	subject	prep_in	8	SENT_406	[p16l1110t1267r1331b1321],
17	.	.	O	.	_	0	SENT_406	[p16l1110t1267r1331b1321],

1	Circulation	NN	O	circulation	_	0	SENT_407	[p16l1356t1267r1639b1311],
2	2003	CD	DATE	2003	num	1	SENT_407	[p16l1661t1269r2138b1317],
3	;	:	O	;	_	0	SENT_407	[p16l1661t1269r2138b1317],
4	108:989	CD	NUMBER	108:989	number	5	SENT_407	[p16l1661t1269r2138b1317],
5	—	CD	NUMBER	—	dep	1	SENT_407	[p16l1661t1269r2138b1317],
6	95	CD	NUMBER	95	dep	5	SENT_407	[p16l1661t1269r2138b1317],
7	.	.	O	.	_	0	SENT_407	[p16l1661t1269r2138b1317],

1	[	NN	O	[	_	0	SENT_408	[p16l6t1333r104b1387],
2	26	CD	NUMBER	26	num	1	SENT_408	[p16l6t1333r104b1387],
3	]	CD	NUMBER	]	num	5	SENT_408	[p16l6t1333r104b1387],
4	Lev	NN	O	lev	nn	5	SENT_408	[p16l140t1336r226b1377],
5	EI	NN	O	eus	dep	1	SENT_408	[p16l249t1336r307b1383],
6	,	,	O	,	_	0	SENT_408	[p16l249t1336r307b1383],
7	Patel	NNP	ORGANIZATION	Patel	nn	8	SENT_408	[p16l332t1333r457b1377],
8	RT	NN	ORGANIZATION	rt	appos	5	SENT_408	[p16l482t1336r557b1383],
9	,	,	O	,	_	0	SENT_408	[p16l482t1336r557b1383],
10	Guthikonda	NNP	PERSON	Guthikonda	nn	11	SENT_408	[p16l582t1333r886b1377],
11	S	NNP	O	S	appos	5	SENT_408	[p16l910t1335r948b1383],
12	,	,	O	,	_	0	SENT_408	[p16l910t1335r948b1383],
13	Lopez	NNP	PERSON	Lopez	nn	14	SENT_408	[p16l973t1336r1121b1387],
14	D	NNP	PERSON	D	appos	5	SENT_408	[p16l1146t1336r1195b1383],
15	,	,	O	,	_	0	SENT_408	[p16l1146t1336r1195b1383],
16	Bray	NNP	LOCATION	Bray	nn	17	SENT_408	[p16l1220t1336r1335b1387],
17	PF	NNP	LOCATION	PF	appos	5	SENT_408	[p16l1359t1336r1428b1383],
18	,	,	O	,	_	0	SENT_408	[p16l1359t1336r1428b1383],
19	Kleiman	NNP	PERSON	Kleiman	nn	20	SENT_408	[p16l1453t1333r1666b1377],
20	NS	NNP	O	NS	appos	5	SENT_408	[p16l1690t1335r1770b1377],
21	.	.	O	.	_	0	SENT_408	[p16l1690t1335r1770b1377],

1	Genetic	JJ	O	genetic	amod	2	SENT_409	[p16l1796t1334r1991b1377],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_409	[p16l2015t1333r2147b1387, p16l140t1399r431b1453],
3	of	IN	O	of	_	0	SENT_409	[p16l450t1398r503b1442],
4	the	DT	O	the	det	7	SENT_409	[p16l515t1399r597b1442],
5	platelet	NN	O	platelet	nn	7	SENT_409	[p16l615t1399r811b1453],
6	receptors	NNS	O	receptor	nn	7	SENT_409	[p16l828t1405r1068b1453],
7	P2Y	NN	O	p2y	prep_of	2	SENT_409	[p16l1088t1399r1304b1453],
8	(	CD	NUMBER	(	number	9	SENT_409	[p16l1088t1399r1304b1453],
9	12	CD	NUMBER	12	num	10	SENT_409	[p16l1088t1399r1304b1453],
10	)	NN	O	)	dep	7	SENT_409	[p16l1088t1399r1304b1453],
11	,	,	O	,	_	0	SENT_409	[p16l1088t1399r1304b1453],
12	P2Y	NN	O	p2y	nn	13	SENT_409	[p16l1323t1399r1493b1453],
13	(	NN	O	(	conj_and	7	SENT_409	[p16l1323t1399r1493b1453],
14	1	CD	NUMBER	1	num	15	SENT_409	[p16l1323t1399r1493b1453],
15	)	NN	O	)	dep	13	SENT_409	[p16l1323t1399r1493b1453],
16	and	CC	O	and	_	0	SENT_409	[p16l1511t1399r1605b1442],
17	GP	NN	O	gp	nn	18	SENT_409	[p16l1624t1401r1693b1442],
18	Illa	NN	PERSON	illum	conj_and	7	SENT_409	[p16l1710t1401r1789b1442],
19	and	CC	O	and	_	0	SENT_409	[p16l1807t1399r1900b1442],
20	response	NN	O	response	conj_and	7	SENT_409	[p16l1920t1411r2148b1453],
21	to	TO	O	to	_	0	SENT_409	[p16l139t1472r189b1509],
22	aspirin	NN	O	aspirin	prep_to	18	SENT_409	[p16l211t1466r388b1520],
23	and	CC	O	and	_	0	SENT_409	[p16l410t1465r504b1509],
24	clopidogrel	NN	O	clopidogrel	conj_and	22	SENT_409	[p16l527t1465r829b1520],
25	.	.	O	.	_	0	SENT_409	[p16l527t1465r829b1520],

1	Thromb	NNP	O	Thromb	nn	2	SENT_410	[p16l850t1465r1055b1509],
2	Res	NNP	O	Res	_	0	SENT_410	[p16l1078t1468r1163b1509],
3	2007	CD	DATE	2007	num	2	SENT_410	[p16l1187t1467r1664b1515],
4	;	:	O	;	_	0	SENT_410	[p16l1187t1467r1664b1515],
5	119:355	CD	NUMBER	119:355	number	6	SENT_410	[p16l1187t1467r1664b1515],
6	—	CD	NUMBER	—	dep	2	SENT_410	[p16l1187t1467r1664b1515],
7	60	CD	NUMBER	60	dep	6	SENT_410	[p16l1187t1467r1664b1515],
8	.	.	O	.	_	0	SENT_410	[p16l1187t1467r1664b1515],

1	[	NN	O	[	nn	5	SENT_411	[p16l6t1530r104b1585],
2	27	CD	NUMBER	27	num	5	SENT_411	[p16l6t1530r104b1585],
3	]	CD	NUMBER	]	num	5	SENT_411	[p16l6t1530r104b1585],
4	Suh	NNP	O	Suh	nn	5	SENT_411	[p16l140t1531r234b1574],
5	JW	NNP	O	JW	_	0	SENT_411	[p16l252t1533r344b1585],
6	,	,	O	,	_	0	SENT_411	[p16l252t1533r344b1585],
7	Koo	NNP	LOCATION	Koo	nn	8	SENT_411	[p16l370t1533r467b1574],
8	BK	NNP	LOCATION	BK	appos	5	SENT_411	[p16l492t1533r571b1581],
9	,	,	O	,	_	0	SENT_411	[p16l492t1533r571b1581],
10	Zhang	NNP	PERSON	Zhang	nn	11	SENT_411	[p16l596t1530r756b1585],
11	SY	NNP	PERSON	SY	appos	5	SENT_411	[p16l779t1533r852b1581],
12	,	,	O	,	_	0	SENT_411	[p16l779t1533r852b1581],
13	Park	NNP	O	Park	nn	14	SENT_411	[p16l879t1530r992b1574],
14	KW	NNP	O	KW	appos	5	SENT_411	[p16l1016t1533r1120b1581],
15	,	,	O	,	_	0	SENT_411	[p16l1016t1533r1120b1581],
16	Cho	NNP	PERSON	Cho	nn	17	SENT_411	[p16l1146t1530r1242b1574],
17	JY	NN	PERSON	jy	appos	5	SENT_411	[p16l1261t1533r1328b1585],
18	,	,	O	,	_	0	SENT_411	[p16l1261t1533r1328b1585],
19	Jang	NNP	PERSON	Jang	appos	5	SENT_411	[p16l1347t1533r1464b1585],
20	I	PRP	O	I	nsubj	21	SENT_411	[p16l1488t1533r1532b1585],
21	]	VBP	O	]	rcmod	19	SENT_411	[p16l1488t1533r1532b1585],
22	,	,	O	,	_	0	SENT_411	[p16l1488t1533r1532b1585],
23	et	FW	O	et	nn	24	SENT_411	[p16l1558t1537r1606b1574],
24	al.	FW	O	al.	appos	19	SENT_411	[p16l1630t1531r1685b1574],
25	.	.	O	.	_	0	SENT_411	[p16l1630t1531r1685b1574],

1	Increased	VBN	O	increase	amod	2	SENT_412	[p16l1712t1530r1957b1574],
2	risk	NN	O	risk	nsubj	6	SENT_412	[p16l1983t1531r2077b1574],
3	of	IN	O	of	_	0	SENT_412	[p16l2101t1530r2154b1574],
4	atherothrombotic	JJ	O	atherothrombotic	amod	5	SENT_412	[p16l139t1597r600b1641],
5	events	NNS	O	event	prep_of	2	SENT_412	[p16l631t1604r797b1641],
6	associated	VBN	O	associate	_	0	SENT_412	[p16l830t1597r1096b1641],
7	with	IN	O	with	_	0	SENT_412	[p16l1127t1597r1247b1641],
8	cytochrome	NN	O	cytochrome	nn	11	SENT_412	[p16l1278t1597r1584b1651],
9	P450	NN	O	p450	nn	11	SENT_412	[p16l1617t1599r1744b1641],
10	3A5	NN	O	3a5	nn	11	SENT_412	[p16l1775t1599r1873b1641],
11	polymorphism	NN	O	polymorphism	prep_with	6	SENT_412	[p16l1907t1597r2148b1651, p16l140t1663r299b1718],
12	in	IN	O	in	_	0	SENT_412	[p16l322t1664r370b1706],
13	patients	NNS	O	patient	prep_in	6	SENT_412	[p16l392t1664r599b1718],
14	taking	VBG	O	take	partmod	13	SENT_412	[p16l623t1663r785b1718],
15	clopidogrel	NN	O	clopidogrel	dobj	14	SENT_412	[p16l806t1663r1107b1718],
16	.	.	O	.	_	0	SENT_412	[p16l806t1663r1107b1718],

1	CMA	NNP	ORGANIZATION	CMA	_	0	SENT_413	[p16l1131t1665r1270b1718],
2	]	CD	NUMBER	]	num	1	SENT_413	[p16l1131t1665r1270b1718],
3	2006	CD	DATE	2006	dep	1	SENT_413	[p16l1292t1665r1803b1713],
4	;	:	O	;	_	0	SENT_413	[p16l1292t1665r1803b1713],
5	174:1715	CD	NUMBER	174:1715	number	6	SENT_413	[p16l1292t1665r1803b1713],
6	—	CD	NUMBER	—	dep	1	SENT_413	[p16l1292t1665r1803b1713],
7	22	CD	NUMBER	22	dep	6	SENT_413	[p16l1292t1665r1803b1713],
8	.	.	O	.	_	0	SENT_413	[p16l1292t1665r1803b1713],

1	[	NN	O	[	_	0	SENT_414	[p16l6t1729r104b1783],
2	28	CD	NUMBER	28	num	1	SENT_414	[p16l6t1729r104b1783],
3	]	CD	NUMBER	]	num	5	SENT_414	[p16l6t1729r104b1783],
4	Kim	NNP	PERSON	Kim	nn	5	SENT_414	[p16l140t1730r242b1772],
5	KA	NN	PERSON	ka	dep	1	SENT_414	[p16l265t1731r347b1779],
6	,	,	O	,	_	0	SENT_414	[p16l265t1731r347b1779],
7	Park	NNP	O	Park	nn	8	SENT_414	[p16l371t1729r485b1772],
8	PW	NNP	O	PW	appos	5	SENT_414	[p16l507t1732r606b1779],
9	,	,	O	,	_	0	SENT_414	[p16l507t1732r606b1779],
10	Park	NNP	O	Park	nn	11	SENT_414	[p16l630t1729r743b1772],
11	JY	NN	O	jy	appos	5	SENT_414	[p16l758t1732r826b1783],
12	.	.	O	.	_	0	SENT_414	[p16l758t1732r826b1783],

1	Effect	NN	O	effect	_	0	SENT_415	[p16l850t1729r995b1772],
2	of	IN	O	of	_	0	SENT_415	[p16l1017t1729r1070b1772],
3	CYP3A5	NN	O	cyp3a5	prep_of	1	SENT_415	[p16l1087t1729r1342b1772],
4	*	CD	NUMBER	*	number	5	SENT_415	[p16l1087t1729r1342b1772],
5	3	CD	NUMBER	3	num	6	SENT_415	[p16l1087t1729r1342b1772],
6	genotype	NN	O	genotype	dep	1	SENT_415	[p16l1366t1735r1606b1783],
7	on	IN	O	on	_	0	SENT_415	[p16l1629t1741r1692b1772],
8	the	DT	O	the	det	9	SENT_415	[p16l1714t1729r1796b1772],
9	pharmacol	NN	O	pharmacol	prep_on	6	SENT_415	[p16l1819t1729r2148b1783, p16l140t1795r290b1838],
10	<	JJR	O	<	amod	11	SENT_415	[p16l1819t1729r2148b1783, p16l140t1795r290b1838],
11	inetics	NNS	O	inetic	dep	9	SENT_415	[p16l1819t1729r2148b1783, p16l140t1795r290b1838],
12	and	CC	O	and	_	0	SENT_415	[p16l320t1794r414b1838],
13	antiplatelet	JJ	O	antiplatelet	amod	14	SENT_415	[p16l443t1794r742b1849],
14	effect	NN	O	effect	conj_and	9	SENT_415	[p16l771t1794r913b1838],
15	of	IN	O	of	_	0	SENT_415	[p16l942t1794r995b1838],
16	clopidogrel	NN	O	clopidogrel	prep_of	14	SENT_415	[p16l1018t1794r1307b1849],
17	in	IN	O	in	_	0	SENT_415	[p16l1338t1795r1385b1838],
18	healthy	JJ	O	healthy	amod	19	SENT_415	[p16l1415t1794r1609b1849],
19	subjects	NNS	O	subject	prep_in	16	SENT_415	[p16l1638t1795r1860b1849],
20	.	.	O	.	_	0	SENT_415	[p16l1638t1795r1860b1849],

1	Eur	NNP	O	Eur	nn	4	SENT_416	[p16l1891t1797r2019b1849],
2	]	NNP	O	]	nn	4	SENT_416	[p16l1891t1797r2019b1849],
3	Clin	NNP	O	Clin	nn	4	SENT_416	[p16l2049t1795r2149b1838],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_416	[p16l140t1861r412b1904],
5	2008	CD	DATE	2008	num	4	SENT_416	[p16l435t1863r880b1911],
6	;	:	O	;	_	0	SENT_416	[p16l435t1863r880b1911],
7	64:589	CD	NUMBER	64:589	number	8	SENT_416	[p16l435t1863r880b1911],
8	—	CD	NUMBER	—	dep	4	SENT_416	[p16l435t1863r880b1911],
9	97	CD	NUMBER	97	dep	8	SENT_416	[p16l435t1863r880b1911],
10	.	.	O	.	_	0	SENT_416	[p16l435t1863r880b1911],

1	[	NN	O	[	_	0	SENT_417	[p16l6t1927r104b1982],
2	29	CD	NUMBER	29	num	1	SENT_417	[p16l6t1927r104b1982],
3	]	CD	NUMBER	]	num	5	SENT_417	[p16l6t1927r104b1982],
4	Trenk	NN	PERSON	trenk	nn	5	SENT_417	[p16l137t1927r288b1971],
5	D	NN	PERSON	d	dep	1	SENT_417	[p16l316t1930r365b1977],
6	,	,	O	,	_	0	SENT_417	[p16l316t1930r365b1977],
7	Hochholzer	NNP	PERSON	Hochholzer	nn	8	SENT_417	[p16l397t1927r695b1971],
8	W	NNP	PERSON	W	appos	5	SENT_417	[p16l721t1930r791b1977],
9	,	,	O	,	_	0	SENT_417	[p16l721t1930r791b1977],
10	Fromm	NNP	ORGANIZATION	Fromm	nn	11	SENT_417	[p16l822t1930r1007b1971],
11	MF	NN	ORGANIZATION	mf	appos	5	SENT_417	[p16l1037t1930r1127b1978],
12	,	,	O	,	_	0	SENT_417	[p16l1037t1930r1127b1978],
13	Chialda	NNP	ORGANIZATION	Chialda	nn	14	SENT_417	[p16l1158t1927r1350b1971],
14	LE	NNP	ORGANIZATION	LE	appos	5	SENT_417	[p16l1381t1930r1449b1977],
15	,	,	O	,	_	0	SENT_417	[p16l1381t1930r1449b1977],
16	Pahl	NNP	PERSON	Pahl	nn	17	SENT_417	[p16l1480t1927r1588b1971],
17	A	NNP	O	A	appos	5	SENT_417	[p16l1617t1929r1665b1978],
18	,	,	O	,	_	0	SENT_417	[p16l1617t1929r1665b1978],
19	Valina	NNP	ORGANIZATION	Valina	nn	20	SENT_417	[p16l1693t1927r1857b1971],
20	CM	NN	O	cm	appos	5	SENT_417	[p16l1888t1929r1984b1977],
21	,	,	O	,	_	0	SENT_417	[p16l1888t1929r1984b1977],
22	et	FW	O	et	nn	23	SENT_417	[p16l2014t1934r2062b1971],
23	al.	FW	O	al.	appos	5	SENT_417	[p16l2092t1927r2147b1971],
24	.	.	O	.	_	0	SENT_417	[p16l2092t1927r2147b1971],

1	Cytochrome	NN	O	cytochrome	nn	3	SENT_418	[p16l140t1993r453b2047],
2	P450	NN	O	p450	nn	3	SENT_418	[p16l490t1995r616b2037],
3	2C19	NN	O	2c19	_	0	SENT_418	[p16l653t1995r782b2037],
4	681	CD	NUMBER	681	num	5	SENT_418	[p16l820t1995r908b2037],
5	G	NN	O	g	npadvmod	6	SENT_418	[p16l919t1995r1038b2038],
6	>	JJR	O	>	dep	3	SENT_418	[p16l919t1995r1038b2038],
7	A	DT	O	a	det	8	SENT_418	[p16l919t1995r1038b2038],
8	polymorphism	NN	O	polymorphism	dep	16	SENT_418	[p16l1073t1993r1454b2048],
9	and	CC	O	and	_	0	SENT_418	[p16l1490t1993r1583b2037],
10	high	JJ	O	high	dep	16	SENT_418	[p16l1621t1993r1733b2048],
11	on	IN	O	on	_	0	SENT_418	[p16l1770t1993r2147b2048],
12	—	CD	NUMBER	—	num	13	SENT_418	[p16l1770t1993r2147b2048],
13	clopidogrel	NN	O	clopidogrel	prep_on	10	SENT_418	[p16l1770t1993r2147b2048],
14	platelet	NN	O	platelet	nn	15	SENT_418	[p16l140t2059r336b2113],
15	reactivity	NN	O	reactivity	nsubj	16	SENT_418	[p16l354t2060r599b2113],
16	associated	VBN	O	associate	ccomp	6	SENT_418	[p16l617t2059r883b2103],
17	with	IN	O	with	_	0	SENT_418	[p16l900t2059r1020b2103],
18	adverse	JJ	O	adverse	amod	21	SENT_418	[p16l1038t2059r1236b2103],
19	1-year	JJ	DURATION	1-year	amod	21	SENT_418	[p16l1257t2061r1422b2113],
20	clinical	JJ	O	clinical	amod	21	SENT_418	[p16l1439t2059r1621b2103],
21	outcome	NN	O	outcome	prep_with	16	SENT_418	[p16l1641t2066r1866b2103],
22	of	IN	O	of	_	0	SENT_418	[p16l1884t2059r1937b2103],
23	elective	JJ	O	elective	amod	26	SENT_418	[p16l1950t2059r2148b2103],
24	percutaneous	JJ	O	percutaneous	amod	26	SENT_418	[p16l140t2132r489b2179],
25	coronary	JJ	O	coronary	amod	26	SENT_418	[p16l509t2138r738b2179],
26	intervention	NN	O	intervention	prep_of	21	SENT_418	[p16l756t2126r1077b2169],
27	with	IN	O	with	prep	6	SENT_418	[p16l1094t2125r1213b2169],
28	drug-eluting	NN	O	drug-eluting	dep	27	SENT_418	[p16l1231t2125r1558b2179],
29	or	CC	O	or	_	0	SENT_418	[p16l1575t2138r1628b2169],
30	bare-metal	JJ	O	bare-metal	amod	31	SENT_418	[p16l1644t2125r1929b2169],
31	stents	NNS	O	stent	conj_or	28	SENT_418	[p16l1949t2128r2148b2179],
32	.	.	O	.	_	0	SENT_418	[p16l1949t2128r2148b2179],
33	]	SYM	O	]	dep	3	SENT_418	[p16l1949t2128r2148b2179],

1	Am	VBP	O	be	dep	3	SENT_419	[p16l137t2192r226b2234],
2	Coll	NNP	O	Coll	nn	3	SENT_419	[p16l249t2191r344b2234],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_419	[p16l368t2191r550b2234],
4	2008	CD	DATE	2008	num	3	SENT_419	[p16l573t2193r1050b2241],
5	;	:	O	;	_	0	SENT_419	[p16l573t2193r1050b2241],
6	51:1925	CD	NUMBER	51:1925	dep	3	SENT_419	[p16l573t2193r1050b2241],
7	—	CD	NUMBER	—	num	8	SENT_419	[p16l573t2193r1050b2241],
8	34	CD	NUMBER	34	dep	6	SENT_419	[p16l573t2193r1050b2241],
9	.	.	O	.	_	0	SENT_419	[p16l573t2193r1050b2241],

1	[	RB	O	[	advmod	6	SENT_420	[p16l6t2257r104b2312],
2	30	CD	NUMBER	30	number	3	SENT_420	[p16l6t2257r104b2312],
3	]	CD	NUMBER	]	num	6	SENT_420	[p16l6t2257r104b2312],
4	Lee	NNP	PERSON	Lee	nn	6	SENT_420	[p16l139t2260r223b2301],
5	]	CD	NUMBER	]	num	6	SENT_420	[p16l244t2260r330b2312],
6	M	NN	O	m	_	0	SENT_420	[p16l244t2260r330b2312],
7	,	,	O	,	_	0	SENT_420	[p16l244t2260r330b2312],
8	Park	NNP	O	Park	nn	9	SENT_420	[p16l359t2257r472b2301],
9	S	NNP	O	S	appos	6	SENT_420	[p16l499t2259r536b2307],
10	,	,	O	,	_	0	SENT_420	[p16l499t2259r536b2307],
11	Shin	NNP	PERSON	Shin	nn	13	SENT_420	[p16l565t2257r677b2301],
12	D	NNP	O	D	nn	13	SENT_420	[p16l705t2260r772b2312],
13	]	NNP	O	]	appos	9	SENT_420	[p16l705t2260r772b2312],
14	,	,	O	,	_	0	SENT_420	[p16l705t2260r772b2312],
15	Choi	NNP	PERSON	Choi	nn	16	SENT_420	[p16l800t2257r913b2301],
16	D	NNP	PERSON	D	appos	9	SENT_420	[p16l942t2260r991b2307],
17	,	,	O	,	_	0	SENT_420	[p16l942t2260r991b2307],
18	Shim	NNP	PERSON	Shim	nn	19	SENT_420	[p16l1020t2257r1150b2301],
19	CY	NNP	O	CY	appos	9	SENT_420	[p16l1177t2259r1255b2307],
20	,	,	O	,	_	0	SENT_420	[p16l1177t2259r1255b2307],
21	Ko	NNP	O	Ko	nn	22	SENT_420	[p16l1284t2260r1348b2301],
22	YG	NNP	O	YG	appos	9	SENT_420	[p16l1374t2259r1460b2307],
23	,	,	O	,	_	0	SENT_420	[p16l1374t2259r1460b2307],
24	et	FW	O	et	nn	25	SENT_420	[p16l1488t2264r1536b2301],
25	al.	FW	O	al.	appos	9	SENT_420	[p16l1563t2257r1618b2301],
26	.	.	O	.	_	0	SENT_420	[p16l1563t2257r1618b2301],

1	Relation	NN	O	relation	_	0	SENT_421	[p16l1648t2257r1860b2301],
2	of	IN	O	of	_	0	SENT_421	[p16l1888t2257r1941b2301],
3	genetic	JJ	O	genetic	amod	4	SENT_421	[p16l1961t2258r2149b2312],
4	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_421	[p16l139t2322r544b2377],
5	in	IN	O	in	_	0	SENT_421	[p16l561t2323r608b2366],
6	the	DT	O	the	det	9	SENT_421	[p16l623t2322r704b2366],
7	cytochrome	NN	O	cytochrome	nn	9	SENT_421	[p16l720t2322r1026b2377],
8	P450	NN	O	p450	nn	9	SENT_421	[p16l1042t2325r1168b2366],
9	gene	NN	O	gene	prep_in	1	SENT_421	[p16l1182t2335r1303b2377],
10	with	IN	O	with	_	0	SENT_421	[p16l1318t2323r1437b2366],
11	clopidogrel	NN	O	clopidogrel	nn	12	SENT_421	[p16l1452t2322r1740b2377],
12	resistance	NN	O	resistance	prep_with	9	SENT_421	[p16l1756t2323r2014b2366],
13	after	IN	O	after	_	0	SENT_421	[p16l2030t2322r2150b2366],
14	drug-eluting	JJ	O	drug-eluting	amod	16	SENT_421	[p16l139t2389r465b2443],
15	stent	NN	O	stent	nn	16	SENT_421	[p16l488t2396r616b2433],
16	implantation	NN	O	implantation	prep_after	1	SENT_421	[p16l638t2389r974b2443],
17	in	IN	O	in	_	0	SENT_421	[p16l997t2390r1044b2432],
18	Koreans	NNPS	LOCATION	Koreans	prep_in	16	SENT_421	[p16l1066t2392r1285b2433],
19	.	.	O	.	_	0	SENT_421	[p16l1066t2392r1285b2433],

1	Am	VBP	O	be	dep	3	SENT_422	[p16l1307t2391r1432b2443],
2	]	CD	NUMBER	]	num	3	SENT_422	[p16l1307t2391r1432b2443],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_422	[p16l1455t2389r1637b2433],
4	2009	CD	DATE	2009	num	3	SENT_422	[p16l1660t2391r2104b2439],
5	;	:	O	;	_	0	SENT_422	[p16l1660t2391r2104b2439],
6	104:46	CD	NUMBER	104:46	dep	3	SENT_422	[p16l1660t2391r2104b2439],
7	—	CD	NUMBER	—	num	8	SENT_422	[p16l1660t2391r2104b2439],
8	51	CD	NUMBER	51	dep	6	SENT_422	[p16l1660t2391r2104b2439],
9	.	.	O	.	_	0	SENT_422	[p16l1660t2391r2104b2439],

1	[	NN	O	[	dep	5	SENT_423	[p16l6t2455r104b2510],
2	31	CD	NUMBER	31	num	3	SENT_423	[p16l6t2455r104b2510],
3	]	CD	NUMBER	]	dep	1	SENT_423	[p16l6t2455r104b2510],
4	Farjadian	NNP	MISC	Farjadian	dep	5	SENT_423	[p16l140t2455r379b2510],
5	S	NN	O	s	dep	17	SENT_423	[p16l395t2457r432b2506],
6	,	,	O	,	_	0	SENT_423	[p16l395t2457r432b2506],
7	Ota	NN	PERSON	ota	nn	8	SENT_423	[p16l449t2457r537b2499],
8	M	NN	O	m	appos	5	SENT_423	[p16l553t2458r614b2505],
9	,	,	O	,	_	0	SENT_423	[p16l553t2458r614b2505],
10	Inoko	NN	PERSON	inoko	nn	11	SENT_423	[p16l631t2455r774b2499],
11	H	NN	PERSON	h	appos	5	SENT_423	[p16l790t2458r841b2505],
12	,	,	O	,	_	0	SENT_423	[p16l790t2458r841b2505],
13	Ghaderi	NNP	PERSON	Ghaderi	nn	15	SENT_423	[p16l857t2455r1060b2499],
14	A.	NNP	O	A.	nn	15	SENT_423	[p16l1075t2457r1123b2499],
15	The	NNP	O	The	appos	5	SENT_423	[p16l1137t2455r1231b2499],
16	genetic	JJ	O	genetic	amod	17	SENT_423	[p16l1246t2456r1433b2510],
17	relationship	NN	O	relationship	dep	25	SENT_423	[p16l1449t2455r1759b2510],
18	among	IN	O	among	_	0	SENT_423	[p16l1775t2468r1952b2510],
19	Iranian	JJ	MISC	iranian	amod	21	SENT_423	[p16l1967t2456r2149b2499],
20	ethnic	JJ	O	ethnic	amod	21	SENT_423	[p16l140t2521r300b2564],
21	groups	NNS	O	group	prep_among	17	SENT_423	[p16l320t2533r511b2575],
22	:	:	O	:	_	0	SENT_423	[p16l320t2533r511b2575],
23	an	DT	O	a	det	25	SENT_423	[p16l537t2533r598b2564],
24	anthropological	JJ	O	anthropological	amod	25	SENT_423	[p16l620t2521r1026b2575],
25	view	NN	O	view	_	0	SENT_423	[p16l1046t2522r1171b2564],
26	based	VBN	O	base	partmod	25	SENT_423	[p16l1190t2521r1338b2564],
27	on	IN	O	on	_	0	SENT_423	[p16l1360t2533r1423b2564],
28	HLA	NN	O	hlum	nn	29	SENT_423	[p16l1444t2523r1551b2564],
29	class	NN	O	class	prep_on	26	SENT_423	[p16l1570t2521r1690b2564],
30	II	CD	NUMBER	ii	num	32	SENT_423	[p16l1713t2524r1743b2564],
31	gene	NN	O	gene	nn	32	SENT_423	[p16l1764t2533r1885b2575],
32	polymorphism	NN	O	polymorphism	dep	29	SENT_423	[p16l1907t2521r2148b2575, p16l140t2586r311b2641],
33	.	.	O	.	_	0	SENT_423	[p16l1907t2521r2148b2575, p16l140t2586r311b2641],

1	Mole	NNP	O	Mole	nn	3	SENT_424	[p16l335t2586r463b2630],
2	Biol	NNP	O	Biol	nn	3	SENT_424	[p16l486t2586r581b2630],
3	Rep	NNP	O	Rep	_	0	SENT_424	[p16l605t2589r699b2641],
4	2009	CD	DATE	2009	num	3	SENT_424	[p16l722t2589r1199b2637],
5	;	:	O	;	_	0	SENT_424	[p16l722t2589r1199b2637],
6	36:1943	CD	NUMBER	36:1943	number	7	SENT_424	[p16l722t2589r1199b2637],
7	—	CD	NUMBER	—	dep	3	SENT_424	[p16l722t2589r1199b2637],
8	50	CD	NUMBER	50	dep	7	SENT_424	[p16l722t2589r1199b2637],
9	.	.	O	.	_	0	SENT_424	[p16l722t2589r1199b2637],

1	[	NN	O	[	_	0	SENT_425	[p16l6t2652r104b2707],
2	32	CD	NUMBER	32	num	1	SENT_425	[p16l6t2652r104b2707],
3	]	CD	NUMBER	]	num	5	SENT_425	[p16l6t2652r104b2707],
4	Lacy	NNP	O	Lacy	nn	5	SENT_425	[p16l140t2655r254b2707],
5	CF	NN	O	cf	dep	1	SENT_425	[p16l275t2655r347b2703],
6	,	,	O	,	_	0	SENT_425	[p16l275t2655r347b2703],
7	Armstrong	NNP	ORGANIZATION	Armstrong	nn	8	SENT_425	[p16l368t2654r648b2707],
8	LL	NNP	ORGANIZATION	LL	appos	5	SENT_425	[p16l669t2655r734b2703],
9	,	,	O	,	_	0	SENT_425	[p16l669t2655r734b2703],
10	Goldman	NNP	ORGANIZATION	Goldman	nn	11	SENT_425	[p16l758t2653r994b2696],
11	MP	NNP	O	MP	appos	5	SENT_425	[p16l1017t2655r1110b2703],
12	,	,	O	,	_	0	SENT_425	[p16l1017t2655r1110b2703],
13	Lance	NNP	PERSON	Lance	nn	14	SENT_425	[p16l1134t2655r1279b2696],
14	LA.	NNP	PERSON	LA.	appos	5	SENT_425	[p16l1302t2654r1376b2697],
15	.	.	O	.	_	0	SENT_425	[p16l1302t2654r1376b2697],

1	Drug	NN	O	drug	_	0	SENT_426	[p16l1400t2655r1526b2707],
2	information	NN	O	information	dep	1	SENT_426	[p16l1548t2652r1856b2696],
3	handbook	NN	O	handbook	dep	2	SENT_426	[p16l1879t2653r2147b2703],
4	,	,	O	,	_	0	SENT_426	[p16l1879t2653r2147b2703],

1	19th	JJ	ORDINAL	19th	amod	2	SENT_427	[p16l142t2719r258b2763],
2	ed.	NN	O	ed.	_	0	SENT_427	[p16l280t2719r365b2769],
3	,	,	O	,	_	0	SENT_427	[p16l280t2719r365b2769],
4	Hudson	NNP	LOCATION	Hudson	appos	2	SENT_427	[p16l389t2719r599b2769],
5	,	,	O	,	_	0	SENT_427	[p16l389t2719r599b2769],
6	Ohio	NNP	LOCATION	Ohio	appos	2	SENT_427	[p16l623t2719r759b2763],
7	:	:	O	:	_	0	SENT_427	[p16l623t2719r759b2763],
8	Lexi-comp	NN	O	lexi-comp	dep	2	SENT_427	[p16l786t2720r1069b2774],
9	,	,	O	,	_	0	SENT_427	[p16l786t2720r1069b2774],
10	Inc	NNP	ORGANIZATION	Inc	appos	8	SENT_427	[p16l1093t2722r1184b2769],
11	;	:	O	;	_	0	SENT_427	[p16l1093t2722r1184b2769],
12	2010-2011	CD	DATE	2010-2011	dep	8	SENT_427	[p16l1210t2721r1515b2763],
13	.	.	O	.	_	0	SENT_427	[p16l1210t2721r1515b2763],

1	[	NN	O	[	nn	4	SENT_428	[p16l6t2784r104b2839],
2	33	CD	NUMBER	33	num	4	SENT_428	[p16l6t2784r104b2839],
3	]	NN	O	]	nn	4	SENT_428	[p16l6t2784r104b2839],
4	Thervet	NN	O	thervet	_	0	SENT_428	[p16l137t2785r337b2828],
5	E	NN	O	e	dep	4	SENT_428	[p16l360t2787r400b2835],
6	,	,	O	,	_	0	SENT_428	[p16l360t2787r400b2835],
7	Anglicheau	NN	PERSON	anglicheau	nn	8	SENT_428	[p16l423t2784r713b2839],
8	D	NN	O	d	appos	5	SENT_428	[p16l737t2787r786b2835],
9	,	,	O	,	_	0	SENT_428	[p16l737t2787r786b2835],
10	King	NNP	O	King	nn	11	SENT_428	[p16l812t2785r927b2839],
11	B	NNP	O	B	appos	5	SENT_428	[p16l950t2787r993b2835],
12	,	,	O	,	_	0	SENT_428	[p16l950t2787r993b2835],
13	Schlageter	NNP	PERSON	Schlageter	nn	14	SENT_428	[p16l1018t2784r1288b2839],
14	MH	NNP	O	MH	appos	5	SENT_428	[p16l1310t2787r1414b2835],
15	,	,	O	,	_	0	SENT_428	[p16l1310t2787r1414b2835],
16	Cassinat	NNP	PERSON	Cassinat	nn	17	SENT_428	[p16l1439t2785r1653b2828],
17	B	NNP	O	B	appos	5	SENT_428	[p16l1676t2787r1719b2835],
18	,	,	O	,	_	0	SENT_428	[p16l1676t2787r1719b2835],
19	Beaune	NNP	LOCATION	Beaune	nn	20	SENT_428	[p16l1744t2787r1931b2828],
20	P	NN	O	p	appos	5	SENT_428	[p16l1956t2787r1996b2835],
21	,	,	O	,	_	0	SENT_428	[p16l1956t2787r1996b2835],
22	et	FW	O	et	nn	23	SENT_428	[p16l2020t2791r2069b2828],
23	al.	FW	O	al.	appos	5	SENT_428	[p16l2092t2785r2147b2828],
24	.	.	O	.	_	0	SENT_428	[p16l2092t2785r2147b2828],

1	Impact	NN	O	impact	_	0	SENT_429	[p16l140t2854r319b2905],
2	of	IN	O	of	_	0	SENT_429	[p16l341t2851r394b2895],
3	cytochrome	NN	O	cytochrome	nn	5	SENT_429	[p16l410t2851r716b2905],
4	P450	NN	O	p450	nn	5	SENT_429	[p16l739t2853r866b2895],
5	3A5	NN	O	3a5	prep_of	1	SENT_429	[p16l887t2853r986b2895],
6	genetic	JJ	O	genetic	amod	7	SENT_429	[p16l1010t2852r1197b2905],
7	polymorphism	NN	O	polymorphism	dep	1	SENT_429	[p16l1219t2851r1600b2905],
8	on	IN	O	on	_	0	SENT_429	[p16l1623t2864r1686b2895],
9	tacrolimus	NN	O	tacrolimus	nn	10	SENT_429	[p16l1707t2851r1982b2895],
10	doses	NNS	O	dose	prep_on	7	SENT_429	[p16l2006t2851r2147b2895],
11	and	CC	O	and	_	0	SENT_429	[p16l139t2917r233b2961],
12	concentration-to-dose	JJ	O	concentration-to-dose	amod	13	SENT_429	[p16l259t2917r837b2961],
13	ratio	NN	O	ratio	dep	1	SENT_429	[p16l863t2918r982b2961],
14	in	IN	O	in	_	0	SENT_429	[p16l1008t2918r1055b2960],
15	renal	JJ	O	renal	amod	17	SENT_429	[p16l1080t2917r1209b2961],
16	transplant	NN	O	transplant	nn	17	SENT_429	[p16l1235t2917r1502b2971],
17	recipients	NNS	O	recipient	prep_in	13	SENT_429	[p16l1527t2918r1793b2971],
18	.	.	O	.	_	0	SENT_429	[p16l1527t2918r1793b2971],

1	Transplantation	NN	O	transplantation	_	0	SENT_430	[p16l1817t2917r2147b2971, p16l139t2983r241b3026],
2	2003	CD	DATE	2003	num	1	SENT_430	[p16l263t2985r707b3033],
3	;	:	O	;	_	0	SENT_430	[p16l263t2985r707b3033],
4	76:1233	CD	NUMBER	76:1233	number	5	SENT_430	[p16l263t2985r707b3033],
5	—	CD	NUMBER	—	dep	1	SENT_430	[p16l263t2985r707b3033],
6	5	CD	NUMBER	5	dep	5	SENT_430	[p16l263t2985r707b3033],
7	.	.	O	.	_	0	SENT_430	[p16l263t2985r707b3033],

1	[	NN	O	[	_	0	SENT_431	[p16l6t3049r104b3104],
2	34	CD	NUMBER	34	num	1	SENT_431	[p16l6t3049r104b3104],
3	]	CD	NUMBER	]	num	6	SENT_431	[p16l6t3049r104b3104],
4	Lamba	NNP	PERSON	Lamba	nn	6	SENT_431	[p16l140t3049r309b3093],
5	]	CD	NUMBER	]	num	6	SENT_431	[p16l320t3052r389b3104],
6	K	NNP	O	K	dep	1	SENT_431	[p16l320t3052r389b3104],
7	,	,	O	,	_	0	SENT_431	[p16l320t3052r389b3104],
8	Dhiman	NNP	O	Dhiman	nn	9	SENT_431	[p16l408t3049r613b3093],
9	RK	NNP	O	RK	appos	6	SENT_431	[p16l631t3052r711b3099],
10	,	,	O	,	_	0	SENT_431	[p16l631t3052r711b3099],
11	Kohli	NNP	ORGANIZATION	Kohli	nn	12	SENT_431	[p16l730t3049r862b3093],
12	KK	NNP	ORGANIZATION	KK	appos	6	SENT_431	[p16l880t3052r962b3093],
13	.	.	O	.	_	0	SENT_431	[p16l880t3052r962b3093],

1	CYP2C19	NN	O	cyp2c19	_	0	SENT_432	[p16l981t3051r1211b3093],
2	genetic	JJ	O	genetic	amod	3	SENT_432	[p16l1228t3050r1416b3104],
3	mutations	NNS	O	mutation	dep	1	SENT_432	[p16l1433t3050r1696b3093],
4	in	IN	O	in	_	0	SENT_432	[p16l1715t3050r1763b3092],
5	North	NNP	MISC	North	nn	6	SENT_432	[p16l1780t3049r1929b3093],
6	Indians	NNPS	MISC	Indians	prep_in	3	SENT_432	[p16l1946t3049r2147b3093],
7	.	.	O	.	_	0	SENT_432	[p16l1946t3049r2147b3093],

1	Clin	NNP	O	Clin	nn	3	SENT_433	[p16l140t3115r239b3158],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_433	[p16l261t3114r534b3158],
3	Ther	NNP	O	Ther	_	0	SENT_433	[p16l555t3114r674b3158],
4	2000	CD	DATE	2000	num	3	SENT_433	[p16l695t3117r1139b3165],
5	;	:	O	;	_	0	SENT_433	[p16l695t3117r1139b3165],
6	68:328	CD	NUMBER	68:328	number	7	SENT_433	[p16l695t3117r1139b3165],
7	—	CD	NUMBER	—	dep	3	SENT_433	[p16l695t3117r1139b3165],
8	35	CD	NUMBER	35	dep	7	SENT_433	[p16l695t3117r1139b3165],
9	.	.	O	.	_	0	SENT_433	[p16l695t3117r1139b3165],

1	[	NN	O	[	dep	5	SENT_434	[p16l6t3181r104b3235],
2	35	CD	NUMBER	35	num	3	SENT_434	[p16l6t3181r104b3235],
3	]	CD	NUMBER	]	dep	1	SENT_434	[p16l6t3181r104b3235],
4	Muller	NNP	O	Muller	dep	5	SENT_434	[p16l140t3181r312b3225],
5	I	PRP	O	I	dep	32	SENT_434	[p16l336t3184r362b3231],
6	,	,	O	,	_	0	SENT_434	[p16l336t3184r362b3231],
7	Besta	NNP	O	Besta	nn	8	SENT_434	[p16l389t3184r525b3225],
8	F	NN	O	f	appos	5	SENT_434	[p16l550t3184r588b3231],
9	,	,	O	,	_	0	SENT_434	[p16l550t3184r588b3231],
10	Schulz	NNP	PERSON	Schulz	nn	11	SENT_434	[p16l614t3181r780b3225],
11	C	NNP	O	C	appos	5	SENT_434	[p16l807t3183r849b3231],
12	,	,	O	,	_	0	SENT_434	[p16l807t3183r849b3231],
13	Massberg	NNP	LOCATION	Massberg	nn	14	SENT_434	[p16l876t3181r1123b3235],
14	S	NNP	LOCATION	S	appos	5	SENT_434	[p16l1148t3183r1185b3231],
15	,	,	O	,	_	0	SENT_434	[p16l1148t3183r1185b3231],
16	Schonig	NNP	O	Schonig	nn	17	SENT_434	[p16l1212t3181r1414b3235],
17	A	NNP	O	A	appos	5	SENT_434	[p16l1436t3183r1484b3231],
18	,	,	O	,	_	0	SENT_434	[p16l1436t3183r1484b3231],
19	Gawaz	NNP	PERSON	Gawaz	nn	21	SENT_434	[p16l1511t3183r1683b3225],
20	M.	NNP	PERSON	M.	nn	21	SENT_434	[p16l1708t3184r1770b3225],
21	Prevalence	NN	PERSON	prevalence	dep	26	SENT_434	[p16l1797t3181r2075b3225],
22	of	IN	O	of	_	0	SENT_434	[p16l2101t3181r2154b3225],
23	clopidogrel	NN	O	clopidogrel	prep_of	21	SENT_434	[p16l140t3247r428b3302],
24	non	JJ	O	non	amod	25	SENT_434	[p16l469t3247r877b3302],
25	—	NN	O	—	dep	26	SENT_434	[p16l469t3247r877b3302],
26	responders	NNS	O	responder	dep	32	SENT_434	[p16l469t3247r877b3302],
27	among	IN	O	among	_	0	SENT_434	[p16l918t3260r1094b3302],
28	patients	NNS	O	patient	prep_among	26	SENT_434	[p16l1133t3248r1341b3302],
29	with	IN	O	with	_	0	SENT_434	[p16l1380t3247r1499b3291],
30	stable	JJ	O	stable	amod	31	SENT_434	[p16l1540t3247r1691b3291],
31	angina	NN	O	angina	prep_with	28	SENT_434	[p16l1731t3248r1903b3302],
32	pectoris	NN	O	pectoris	_	0	SENT_434	[p16l1943t3248r2147b3302],
33	scheduled	VBN	O	schedule	partmod	32	SENT_434	[p16l140t3313r400b3356],
34	for	IN	O	for	_	0	SENT_434	[p16l459t3313r531b3356],
35	elective	JJ	O	elective	amod	38	SENT_434	[p16l587t3313r785b3356],
36	coronary	JJ	O	coronary	amod	38	SENT_434	[p16l843t3325r1073b3367],
37	stent	NN	O	stent	nn	38	SENT_434	[p16l1130t3319r1258b3356],
38	placement	NN	O	placement	prep_for	33	SENT_434	[p16l1316t3313r1599b3367],
39	.	.	O	.	_	0	SENT_434	[p16l1316t3313r1599b3367],

1	Thromb	NNP	O	Thromb	nn	2	SENT_435	[p16l1656t3313r1861b3356],
2	Haemost	NNP	O	Haemost	_	0	SENT_435	[p16l1920t3316r2149b3356],
3	2003	CD	DATE	2003	num	2	SENT_435	[p16l139t3381r551b3429],
4	;	:	O	;	_	0	SENT_435	[p16l139t3381r551b3429],
5	89:783	CD	NUMBER	89:783	num	6	SENT_435	[p16l139t3381r551b3429],
6	—	NN	O	—	dep	2	SENT_435	[p16l139t3381r551b3429],
7	7	CD	NUMBER	7	dep	6	SENT_435	[p16l139t3381r551b3429],
8	.	.	O	.	_	0	SENT_435	[p16l139t3381r551b3429],

1	[	NN	O	[	nn	5	SENT_436	[p16l6t3444r104b3499],
2	36	CD	NUMBER	36	num	5	SENT_436	[p16l6t3444r104b3499],
3	]	CD	NUMBER	]	num	5	SENT_436	[p16l6t3444r104b3499],
4	Samara	NNP	ORGANIZATION	Samara	nn	5	SENT_436	[p16l140t3447r330b3488],
5	WM	NNP	ORGANIZATION	WM	_	0	SENT_436	[p16l349t3447r472b3495],
6	,	,	O	,	_	0	SENT_436	[p16l349t3447r472b3495],
7	Bliden	NNP	PERSON	Bliden	nn	8	SENT_436	[p16l495t3445r657b3488],
8	KP	NNP	O	KP	appos	5	SENT_436	[p16l679t3447r756b3495],
9	,	,	O	,	_	0	SENT_436	[p16l679t3447r756b3495],
10	Tantry	NNP	LOCATION	Tantry	nn	11	SENT_436	[p16l776t3447r947b3499],
11	US	NNP	LOCATION	US	appos	5	SENT_436	[p16l967t3447r1046b3495],
12	,	,	O	,	_	0	SENT_436	[p16l967t3447r1046b3495],
13	Gurbel	NNP	LOCATION	Gurbel	nn	14	SENT_436	[p16l1069t3445r1241b3488],
14	PA.	NNP	LOCATION	PA.	appos	5	SENT_436	[p16l1265t3447r1342b3489],
15	.	.	O	.	_	0	SENT_436	[p16l1265t3447r1342b3489],

1	The	DT	O	the	det	2	SENT_437	[p16l1362t3445r1456b3488],
2	difference	NN	O	difference	_	0	SENT_437	[p16l1479t3444r1736b3488],
3	between	IN	O	between	_	0	SENT_437	[p16l1758t3445r1980b3488],
4	clopidogrel	NN	O	clopidogrel	nn	5	SENT_437	[p16l2002t3445r2148b3499, p16l140t3511r301b3566],
5	responsiveness	NN	O	responsiveness	prep_between	2	SENT_437	[p16l338t3512r727b3566],
6	and	CC	O	and	_	0	SENT_437	[p16l764t3511r857b3555],
7	posttreatment	NN	O	posttreatment	nn	9	SENT_437	[p16l893t3518r1265b3566],
8	platelet	NN	O	platelet	nn	9	SENT_437	[p16l1300t3511r1496b3566],
9	reactivity	NN	O	reactivity	prep_between	2	SENT_437	[p16l1531t3512r1787b3566],
10	.	.	O	.	_	0	SENT_437	[p16l1531t3512r1787b3566],

1	Thromb	NNP	O	Thromb	nn	2	SENT_438	[p16l1821t3511r2026b3555],
2	Res	NNP	O	Res	_	0	SENT_438	[p16l2062t3514r2147b3555],
3	2005	CD	DATE	2005	num	2	SENT_438	[p16l139t3579r584b3627],
4	;	:	O	;	_	0	SENT_438	[p16l139t3579r584b3627],
5	115:89	CD	NUMBER	115:89	number	6	SENT_438	[p16l139t3579r584b3627],
6	—	CD	NUMBER	—	dep	2	SENT_438	[p16l139t3579r584b3627],
7	94	CD	NUMBER	94	dep	6	SENT_438	[p16l139t3579r584b3627],
8	.	.	O	.	_	0	SENT_438	[p16l139t3579r584b3627],

1	[	NN	O	[	_	0	SENT_439	[p16l6t3643r104b3697],
2	37	CD	NUMBER	37	num	1	SENT_439	[p16l6t3643r104b3697],
3	]	CD	NUMBER	]	num	5	SENT_439	[p16l6t3643r104b3697],
4	Gurbel	NNP	ORGANIZATION	Gurbel	nn	5	SENT_439	[p16l140t3643r313b3687],
5	PA	NN	ORGANIZATION	pa	dep	1	SENT_439	[p16l335t3645r412b3693],
6	,	,	O	,	_	0	SENT_439	[p16l335t3645r412b3693],
7	Bliden	NNP	PERSON	Bliden	nn	8	SENT_439	[p16l434t3643r596b3687],
8	KP	NNP	O	KP	appos	5	SENT_439	[p16l618t3646r695b3693],
9	,	,	O	,	_	0	SENT_439	[p16l618t3646r695b3693],
10	Hiatt	NNP	PERSON	Hiatt	nn	11	SENT_439	[p16l717t3644r846b3687],
11	BL	NN	O	bl	appos	5	SENT_439	[p16l866t3646r937b3693],
12	,	,	O	,	_	0	SENT_439	[p16l866t3646r937b3693],
13	O'Connor	NNP	PERSON	O'Connor	nn	14	SENT_439	[p16l959t3645r1200b3687],
14	CM	NN	O	cm	appos	5	SENT_439	[p16l1220t3645r1316b3687],
15	.	.	O	.	_	0	SENT_439	[p16l1220t3645r1316b3687],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_440	[p16l1339t3643r1634b3697],
2	for	IN	O	for	_	0	SENT_440	[p16l1657t3643r1728b3687],
3	coronary	JJ	O	coronary	amod	4	SENT_440	[p16l1747t3656r1977b3697],
4	stenting	NN	O	stenting	prep_for	1	SENT_440	[p16l1998t3650r2148b3687, p16l140t3710r234b3763],
5	:	:	O	:	_	0	SENT_440	[p16l1998t3650r2148b3687, p16l140t3710r234b3763],
6	response	NN	O	response	nn	7	SENT_440	[p16l273t3722r501b3763],
7	variability	NN	O	variability	conj_and	1	SENT_440	[p16l534t3709r811b3763],
8	,	,	O	,	_	0	SENT_440	[p16l534t3709r811b3763],
9	drug	NN	O	drug	nn	10	SENT_440	[p16l846t3709r965b3763],
10	resistance	NN	O	resistance	appos	7	SENT_440	[p16l998t3710r1268b3759],
11	,	,	O	,	_	0	SENT_440	[p16l998t3710r1268b3759],
12	and	CC	O	and	_	0	SENT_440	[p16l1303t3709r1396b3753],
13	the	DT	O	the	det	14	SENT_440	[p16l1431t3709r1512b3753],
14	effect	NN	O	effect	conj_and	1	SENT_440	[p16l1547t3709r1689b3753],
15	of	IN	O	of	_	0	SENT_440	[p16l1722t3709r1775b3753],
16	pretreatment	NN	O	pretreatment	nn	18	SENT_440	[p16l1803t3716r2149b3763],
17	platelet	NN	O	platelet	nn	18	SENT_440	[p16l140t3775r336b3829],
18	reactivity	NN	O	reactivity	prep_of	14	SENT_440	[p16l358t3775r614b3829],
19	.	.	O	.	_	0	SENT_440	[p16l358t3775r614b3829],

1	Circulation	NN	O	circulation	_	0	SENT_441	[p16l638t3775r922b3818],
2	2003	CD	DATE	2003	num	1	SENT_441	[p16l944t3777r1453b3825],
3	;	:	O	;	_	0	SENT_441	[p16l944t3777r1453b3825],
4	107:2908	CD	NUMBER	107:2908	number	5	SENT_441	[p16l944t3777r1453b3825],
5	—	CD	NUMBER	—	dep	1	SENT_441	[p16l944t3777r1453b3825],
6	13	CD	NUMBER	13	dep	5	SENT_441	[p16l944t3777r1453b3825],
7	.	.	O	.	_	0	SENT_441	[p16l944t3777r1453b3825],

1	[	NN	O	[	_	0	SENT_442	[p17l6t15r104b70],
2	38	CD	NUMBER	38	num	1	SENT_442	[p17l6t15r104b70],
3	]	CD	NUMBER	]	num	5	SENT_442	[p17l6t15r104b70],
4	Lev	NN	O	lev	nn	5	SENT_442	[p17l139t18r225b59],
5	EI	NN	O	eus	dep	1	SENT_442	[p17l241t18r299b66],
6	,	,	O	,	_	0	SENT_442	[p17l241t18r299b66],
7	Patel	NNP	ORGANIZATION	Patel	nn	8	SENT_442	[p17l316t15r441b59],
8	RT	NN	ORGANIZATION	rt	appos	5	SENT_442	[p17l458t18r533b66],
9	,	,	O	,	_	0	SENT_442	[p17l458t18r533b66],
10	Maresh	NNP	PERSON	Maresh	nn	11	SENT_442	[p17l550t16r741b59],
11	KJ	NNP	PERSON	KJ	appos	5	SENT_442	[p17l757t18r820b70],
12	,	,	O	,	_	0	SENT_442	[p17l757t18r820b70],
13	Guthikonda	NNP	LOCATION	Guthikonda	nn	14	SENT_442	[p17l837t15r1141b59],
14	S	NNP	LOCATION	S	appos	5	SENT_442	[p17l1158t18r1195b66],
15	,	,	O	,	_	0	SENT_442	[p17l1158t18r1195b66],
16	Granada	NNP	PERSON	Granada	nn	17	SENT_442	[p17l1212t15r1428b59],
17	J	NNP	PERSON	J	appos	5	SENT_442	[p17l1438t18r1471b70],
18	,	,	O	,	_	0	SENT_442	[p17l1438t18r1471b70],
19	DeLao	NNP	PERSON	DeLao	nn	20	SENT_442	[p17l1488t18r1644b59],
20	T	NN	O	t	appos	5	SENT_442	[p17l1658t18r1701b66],
21	,	,	O	,	_	0	SENT_442	[p17l1658t18r1701b66],
22	et	FW	O	et	nn	23	SENT_442	[p17l1717t22r1766b59],
23	al.	FW	O	al.	appos	5	SENT_442	[p17l1781t16r1836b59],
24	.	.	O	.	_	0	SENT_442	[p17l1781t16r1836b59],

1	Aspirin	NN	O	aspirin	nn	5	SENT_443	[p17l1852t16r2038b70],
2	and	CC	O	and	_	0	SENT_443	[p17l2054t15r2147b59],
3	clopidogrel	NN	O	clopidogrel	conj_and	1	SENT_443	[p17l139t82r427b136],
4	drug	NN	O	drug	nn	5	SENT_443	[p17l463t82r582b136],
5	response	NN	O	response	_	0	SENT_443	[p17l616t95r844b136],
6	in	IN	O	in	_	0	SENT_443	[p17l880t83r927b125],
7	patients	NNS	O	patient	prep_in	5	SENT_443	[p17l962t83r1168b136],
8	undergoing	VBG	O	undergo	partmod	7	SENT_443	[p17l1204t82r1501b136],
9	percutaneous	JJ	O	percutaneous	amod	11	SENT_443	[p17l1535t89r1884b136],
10	coronary	JJ	O	coronary	amod	11	SENT_443	[p17l1920t95r2149b136],
11	intervention	NN	O	intervention	dobj	8	SENT_443	[p17l139t149r475b192],
12	:	:	O	:	_	0	SENT_443	[p17l139t149r475b192],
13	the	DT	O	the	det	14	SENT_443	[p17l536t148r617b192],
14	role	NN	O	role	dep	5	SENT_443	[p17l673t148r771b192],
15	of	IN	O	of	_	0	SENT_443	[p17l827t148r881b192],
16	dual	JJ	O	dual	amod	18	SENT_443	[p17l931t148r1041b192],
17	drug	NN	O	drug	nn	18	SENT_443	[p17l1097t148r1217b203],
18	resistance	NN	O	resistance	prep_of	14	SENT_443	[p17l1272t149r1542b192],
19	.	.	O	.	_	0	SENT_443	[p17l1272t149r1542b192],

1	J	NNP	O	J	nn	4	SENT_444	[p17l1593t151r1613b203],
2	Am	NNP	O	Am	nn	4	SENT_444	[p17l1668t150r1756b191],
3	Coll	NNP	O	Coll	nn	4	SENT_444	[p17l1812t148r1908b192],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_444	[p17l1965t148r2147b192],
5	2006	CD	DATE	2006	num	4	SENT_444	[p17l139t216r550b264],
6	;	:	O	;	_	0	SENT_444	[p17l139t216r550b264],
7	47:27	CD	NUMBER	47:27	number	8	SENT_444	[p17l139t216r550b264],
8	—	CD	NUMBER	—	dep	4	SENT_444	[p17l139t216r550b264],
9	33	CD	NUMBER	33	dep	8	SENT_444	[p17l139t216r550b264],
10	.	.	O	.	_	0	SENT_444	[p17l139t216r550b264],

1	[	NN	O	[	_	0	SENT_445	[p17l6t280r104b334],
2	39	CD	NUMBER	39	number	3	SENT_445	[p17l6t280r104b334],
3	]	CD	NUMBER	]	num	4	SENT_445	[p17l6t280r104b334],
4	Rozalsl	NN	O	rozalsl	npadvmod	5	SENT_445	[p17l139t280r350b323],
5	<	JJR	O	<	amod	1	SENT_445	[p17l139t280r350b323],
6	i	FW	O	i	dep	1	SENT_445	[p17l139t280r350b323],
7	M	NN	O	m	amod	1	SENT_445	[p17l374t283r435b330],
8	,	,	O	,	_	0	SENT_445	[p17l374t283r435b330],
9	Boncler	NN	O	boncler	nn	10	SENT_445	[p17l459t280r654b323],
10	M	NN	O	m	appos	1	SENT_445	[p17l675t283r737b330],
11	,	,	O	,	_	0	SENT_445	[p17l675t283r737b330],
12	Luzak	NN	PERSON	luzak	nn	13	SENT_445	[p17l760t280r910b323],
13	B	NN	PERSON	b	appos	10	SENT_445	[p17l931t283r973b330],
14	,	,	O	,	_	0	SENT_445	[p17l931t283r973b330],
15	Watala	NNP	LOCATION	Watala	nn	18	SENT_445	[p17l995t280r1180b323],
16	C.	NNP	O	C.	nn	18	SENT_445	[p17l1202t282r1245b324],
17	Genetic	NNP	O	Genetic	nn	18	SENT_445	[p17l1269t281r1464b323],
18	factors	NNS	O	factor	nsubj	19	SENT_445	[p17l1487t280r1659b323],
19	underlying	VBG	O	underlie	dep	1	SENT_445	[p17l1683t280r1966b334],
20	differential	JJ	O	differential	amod	23	SENT_445	[p17l1987t280r2147b323, p17l139t346r283b389],
21	blood	NN	O	blood	nn	23	SENT_445	[p17l306t346r450b389],
22	platelet	NN	O	platelet	nn	23	SENT_445	[p17l473t346r670b400],
23	sensitivity	NN	O	sensitivity	dobj	19	SENT_445	[p17l692t346r959b400],
24	to	TO	O	to	_	0	SENT_445	[p17l980t352r1030b389],
25	inhibitors	NNS	O	inhibitor	prep_to	19	SENT_445	[p17l1053t346r1316b390],
26	.	.	O	.	_	0	SENT_445	[p17l1053t346r1316b390],

1	Pharmacol	NNP	O	Pharmacol	nn	2	SENT_446	[p17l1341t346r1613b389],
2	Rep	NNP	O	Rep	_	0	SENT_446	[p17l1636t348r1730b400],
3	2005	CD	DATE	2005	num	2	SENT_446	[p17l1753t348r2131b396],
4	;	:	O	;	_	0	SENT_446	[p17l1753t348r2131b396],
5	57:1	CD	NUMBER	57:1	number	6	SENT_446	[p17l1753t348r2131b396],
6	—	CD	NUMBER	—	dep	2	SENT_446	[p17l1753t348r2131b396],
7	13	CD	NUMBER	13	dep	6	SENT_446	[p17l1753t348r2131b396],
8	.	.	O	.	_	0	SENT_446	[p17l1753t348r2131b396],

1	[	RB	O	[	advmod	2	SENT_447	[p17l6t412r103b467],
2	40	CD	NUMBER	40	_	0	SENT_447	[p17l6t412r103b467],
3	]	CD	NUMBER	]	num	5	SENT_447	[p17l6t412r103b467],
4	Cuisset	NN	O	cuisset	nn	5	SENT_447	[p17l139t413r323b456],
5	T	NN	O	t	dep	2	SENT_447	[p17l341t415r384b462],
6	,	,	O	,	_	0	SENT_447	[p17l341t415r384b462],
7	Frere	NNP	ORGANIZATION	Frere	nn	8	SENT_447	[p17l406t415r535b456],
8	C	NNP	ORGANIZATION	C	appos	5	SENT_447	[p17l557t414r600b462],
9	,	,	O	,	_	0	SENT_447	[p17l557t414r600b462],
10	Quilici	NNP	PERSON	Quilici	nn	11	SENT_447	[p17l622t412r788b464],
11	J	NNP	PERSON	J	appos	5	SENT_447	[p17l802t415r835b467],
12	,	,	O	,	_	0	SENT_447	[p17l802t415r835b467],
13	Morange	NNP	ORGANIZATION	Morange	nn	14	SENT_447	[p17l857t415r1085b467],
14	PE	NNP	ORGANIZATION	PE	appos	5	SENT_447	[p17l1107t415r1179b462],
15	,	,	O	,	_	0	SENT_447	[p17l1107t415r1179b462],
16	Saut	NNP	O	Saut	nn	17	SENT_447	[p17l1201t414r1312b456],
17	N	NNP	O	N	appos	5	SENT_447	[p17l1332t415r1382b462],
18	,	,	O	,	_	0	SENT_447	[p17l1332t415r1382b462],
19	Lambert	NNP	PERSON	Lambert	nn	20	SENT_447	[p17l1404t412r1619b456],
20	M	NNP	O	M	appos	5	SENT_447	[p17l1639t415r1701b462],
21	,	,	O	,	_	0	SENT_447	[p17l1639t415r1701b462],
22	et	FW	O	et	nn	23	SENT_447	[p17l1723t419r1770b456],
23	al.	FW	O	al.	appos	5	SENT_447	[p17l1790t412r1846b456],
24	.	.	O	.	_	0	SENT_447	[p17l1790t412r1846b456],

1	Role	NN	O	role	_	0	SENT_448	[p17l1868t412r1977b456],
2	of	IN	O	of	_	0	SENT_448	[p17l1999t412r2052b456],
3	the	DT	O	the	det	5	SENT_448	[p17l2066t412r2147b456],
4	T744C	NN	O	t744c	nn	5	SENT_448	[p17l136t480r301b522],
5	polymorphism	NN	O	polymorphism	prep_of	1	SENT_448	[p17l327t478r708b533],
6	of	IN	O	of	_	0	SENT_448	[p17l734t478r787b522],
7	the	DT	O	the	det	9	SENT_448	[p17l808t478r889b522],
8	P2Y12	NN	O	p2y12	nn	9	SENT_448	[p17l917t480r1076b521],
9	gene	NN	O	gene	prep_of	1	SENT_448	[p17l1104t491r1225b533],
10	on	IN	O	on	_	0	SENT_448	[p17l1252t491r1315b522],
11	platelet	NN	O	platelet	nn	12	SENT_448	[p17l1341t478r1537b533],
12	response	NN	O	response	prep_on	1	SENT_448	[p17l1563t491r1792b533],
13	to	TO	O	to	_	0	SENT_448	[p17l1818t485r1868b522],
14	a	DT	O	a	det	17	SENT_448	[p17l1894t491r1920b522],
15	600-mg	JJ	O	600-mg	amod	17	SENT_448	[p17l1947t480r2149b533],
16	loading	NN	O	loading	nn	17	SENT_448	[p17l139t544r330b598],
17	dose	NN	O	dose	prep_to	1	SENT_448	[p17l355t544r471b587],
18	of	IN	O	of	_	0	SENT_448	[p17l498t544r551b587],
19	clopidogrel	NN	O	clopidogrel	prep_of	1	SENT_448	[p17l571t544r858b598],
20	in	IN	O	in	_	0	SENT_448	[p17l886t544r933b587],
21	597	CD	NUMBER	597	num	22	SENT_448	[p17l960t546r1053b587],
22	patients	NNS	O	patient	prep_in	1	SENT_448	[p17l1080t545r1287b598],
23	with	IN	O	with	_	0	SENT_448	[p17l1313t544r1431b587],
24	non	JJ	O	non	prep_with	1	SENT_448	[p17l1458t546r1885b598],
25	.	.	O	.	_	0	SENT_448	[p17l1458t546r1885b598],

1	—	NN	O	—	_	0	SENT_449	[p17l1458t546r1885b598],
2	.	.	O	.	_	0	SENT_449	[p17l1458t546r1885b598],

1	ST	JJ	O	st	_	0	SENT_450	[p17l1458t546r1885b598],
2	.	.	O	.	_	0	SENT_450	[p17l1458t546r1885b598],

1	—	NN	O	—	_	0	SENT_451	[p17l1458t546r1885b598],
2	.	.	O	.	_	0	SENT_451	[p17l1458t546r1885b598],

1	segment	NN	O	segment	nn	2	SENT_452	[p17l1458t546r1885b598],
2	elevation	NN	O	elevation	_	0	SENT_452	[p17l1911t544r2148b587],
3	acute	JJ	O	acute	amod	5	SENT_452	[p17l138t616r276b654],
4	coronary	JJ	O	coronary	amod	5	SENT_452	[p17l299t623r529b664],
5	syndrome	NN	O	syndrome	dep	2	SENT_452	[p17l551t610r821b664],
6	.	.	O	.	_	0	SENT_452	[p17l551t610r821b664],

1	Thromb	NNP	O	Thromb	nn	2	SENT_453	[p17l842t610r1047b654],
2	Res	NNP	O	Res	_	0	SENT_453	[p17l1070t613r1155b654],
3	2007	CD	DATE	2007	num	2	SENT_453	[p17l1178t612r1622b660],
4	;	:	O	;	_	0	SENT_453	[p17l1178t612r1622b660],
5	120:893	CD	NUMBER	120:893	number	6	SENT_453	[p17l1178t612r1622b660],
6	—	CD	NUMBER	—	dep	2	SENT_453	[p17l1178t612r1622b660],
7	9	CD	NUMBER	9	dep	6	SENT_453	[p17l1178t612r1622b660],
8	.	.	O	.	_	0	SENT_453	[p17l1178t612r1622b660],

1	[	NN	O	[	_	0	SENT_454	[p17l6t675r104b730],
2	41	CD	NUMBER	41	num	1	SENT_454	[p17l6t675r104b730],
3	]	CD	NUMBER	]	num	5	SENT_454	[p17l6t675r104b730],
4	Fontana	NNP	ORGANIZATION	Fontana	nn	5	SENT_454	[p17l139t678r345b719],
5	P	NN	ORGANIZATION	p	dep	1	SENT_454	[p17l364t678r405b726],
6	,	,	O	,	_	0	SENT_454	[p17l364t678r405b726],
7	Gaussem	NNP	ORGANIZATION	Gaussem	nn	8	SENT_454	[p17l425t678r658b719],
8	P	NN	ORGANIZATION	p	appos	5	SENT_454	[p17l677t678r718b726],
9	,	,	O	,	_	0	SENT_454	[p17l677t678r718b726],
10	Aiach	NNP	O	Aiach	nn	11	SENT_454	[p17l735t676r879b719],
11	M	NNP	O	M	appos	5	SENT_454	[p17l899t678r960b726],
12	,	,	O	,	_	0	SENT_454	[p17l899t678r960b726],
13	Fiessinger	NNP	O	Fiessinger	nn	14	SENT_454	[p17l980t676r1239b730],
14	JN	NN	O	jn	appos	5	SENT_454	[p17l1249t678r1324b730],
15	,	,	O	,	_	0	SENT_454	[p17l1249t678r1324b730],
16	Emmerich	NNP	PERSON	Emmerich	nn	17	SENT_454	[p17l1344t676r1654b730],
17	]	NNP	O	]	appos	5	SENT_454	[p17l1344t676r1654b730],
18	,	,	O	,	_	0	SENT_454	[p17l1344t676r1654b730],
19	Reny	NNP	PERSON	Reny	nn	20	SENT_454	[p17l1674t678r1801b730],
20	JL	NNP	PERSON	JL	appos	5	SENT_454	[p17l1813t678r1874b730],
21	.	.	O	.	_	0	SENT_454	[p17l1813t678r1874b730],

1	P2Y12	NN	O	p2y12	nn	3	SENT_455	[p17l1895t678r2055b719],
2	H2	NN	O	h2	nn	3	SENT_455	[p17l2077t678r2146b719],
3	Haplotype	NN	O	haplotype	nsubjpass	5	SENT_455	[p17l139t742r406b797],
4	is	VBZ	O	be	auxpass	5	SENT_455	[p17l423t743r461b786],
5	associated	VBN	O	associate	_	0	SENT_455	[p17l478t742r744b786],
6	with	IN	O	with	_	0	SENT_455	[p17l760t742r879b786],
7	peripheral	JJ	O	peripheral	amod	9	SENT_455	[p17l895t742r1161b797],
8	arterial	JJ	O	arterial	amod	9	SENT_455	[p17l1179t742r1365b786],
9	disease	NN	O	disease	prep_with	5	SENT_455	[p17l1382t742r1584b786],
10	:	:	O	:	_	0	SENT_455	[p17l1382t742r1584b786],
11	a	DT	O	a	det	15	SENT_455	[p17l1605t755r1631b786],
12	case	NN	O	case	nn	15	SENT_455	[p17l1648t742r1975b786],
13	—	CD	NUMBER	—	num	15	SENT_455	[p17l1648t742r1975b786],
14	control	NN	O	control	nn	15	SENT_455	[p17l1648t742r1975b786],
15	study	NN	O	study	dep	9	SENT_455	[p17l1993t742r2147b797],
16	.	.	O	.	_	0	SENT_455	[p17l1993t742r2147b797],

1	Circulation	NN	O	circulation	_	0	SENT_456	[p17l139t807r423b851],
2	2003	CD	DATE	2003	num	1	SENT_456	[p17l445t810r922b858],
3	;	:	O	;	_	0	SENT_456	[p17l445t810r922b858],
4	108:2971	CD	NUMBER	108:2971	number	5	SENT_456	[p17l445t810r922b858],
5	—	CD	NUMBER	—	dep	1	SENT_456	[p17l445t810r922b858],
6	3	CD	NUMBER	3	dep	5	SENT_456	[p17l445t810r922b858],
7	.	.	O	.	_	0	SENT_456	[p17l445t810r922b858],

1	[	NN	O	[	nn	5	SENT_457	[p17l6t874r104b928],
2	42	CD	NUMBER	42	num	5	SENT_457	[p17l6t874r104b928],
3	]	CD	NUMBER	]	num	5	SENT_457	[p17l6t874r104b928],
4	Frere	NNP	O	Frere	nn	5	SENT_457	[p17l139t877r269b918],
5	C	NNP	O	C	_	0	SENT_457	[p17l291t876r334b924],
6	,	,	O	,	_	0	SENT_457	[p17l291t876r334b924],
7	Cuisset	NNP	ORGANIZATION	Cuisset	nn	8	SENT_457	[p17l356t875r540b918],
8	T	NN	ORGANIZATION	t	appos	5	SENT_457	[p17l558t877r601b924],
9	,	,	O	,	_	0	SENT_457	[p17l558t877r601b924],
10	Morange	NNP	ORGANIZATION	Morange	nn	11	SENT_457	[p17l623t877r851b928],
11	PE	NNP	ORGANIZATION	PE	appos	8	SENT_457	[p17l873t877r945b924],
12	,	,	O	,	_	0	SENT_457	[p17l873t877r945b924],
13	Quilici	NNP	PERSON	Quilici	nn	14	SENT_457	[p17l967t874r1134b926],
14	J	NNP	PERSON	J	appos	8	SENT_457	[p17l1149t877r1182b928],
15	,	,	O	,	_	0	SENT_457	[p17l1149t877r1182b928],
16	Camoin-Jau	NNP	O	Camoin-Jau	nn	17	SENT_457	[p17l1204t875r1504b928],
17	L	NNP	O	L	appos	8	SENT_457	[p17l1526t877r1563b924],
18	,	,	O	,	_	0	SENT_457	[p17l1526t877r1563b924],
19	Saut	NNP	O	Saut	nn	20	SENT_457	[p17l1585t876r1696b918],
20	N	NNP	O	N	appos	8	SENT_457	[p17l1717t877r1767b924],
21	,	,	O	,	_	0	SENT_457	[p17l1717t877r1767b924],
22	et	FW	O	et	nn	23	SENT_457	[p17l1789t881r1838b918],
23	al.	FW	O	al.	appos	8	SENT_457	[p17l1857t874r1913b918],
24	.	.	O	.	_	0	SENT_457	[p17l1857t874r1913b918],

1	Effect	NN	O	effect	_	0	SENT_458	[p17l1936t874r2080b918],
2	of	IN	O	of	_	0	SENT_458	[p17l2101t874r2154b918],
3	cytochrome	NN	O	cytochrome	nn	5	SENT_458	[p17l139t940r445b994],
4	P450	NN	O	p450	nn	5	SENT_458	[p17l467t942r594b984],
5	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_458	[p17l616t940r1021b995],
6	on	IN	O	on	_	0	SENT_458	[p17l1043t953r1106b984],
7	platelet	NN	O	platelet	nn	8	SENT_458	[p17l1127t940r1323b995],
8	reactivity	NN	O	reactivity	prep_on	5	SENT_458	[p17l1344t941r1589b994],
9	after	IN	O	after	_	0	SENT_458	[p17l1610t940r1731b984],
10	treatment	NN	O	treatment	prep_after	8	SENT_458	[p17l1750t947r2010b984],
11	with	IN	O	with	_	0	SENT_458	[p17l2029t940r2148b984],
12	clopidogrel	NN	O	clopidogrel	prep_with	1	SENT_458	[p17l139t1006r427b1060],
13	in	IN	O	in	_	0	SENT_458	[p17l451t1007r499b1049],
14	acute	JJ	O	acute	amod	16	SENT_458	[p17l521t1012r659b1049],
15	coronary	JJ	O	coronary	amod	16	SENT_458	[p17l682t1018r912b1060],
16	syndrome	NN	O	syndrome	prep_in	1	SENT_458	[p17l934t1006r1203b1060],
17	.	.	O	.	_	0	SENT_458	[p17l934t1006r1203b1060],

1	Am	VBP	O	be	dep	3	SENT_459	[p17l1225t1008r1349b1060],
2	]	CD	NUMBER	]	num	3	SENT_459	[p17l1225t1008r1349b1060],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_459	[p17l1373t1006r1555b1049],
4	2008	CD	DATE	2008	num	3	SENT_459	[p17l1578t1008r2088b1056],
5	;	:	O	;	_	0	SENT_459	[p17l1578t1008r2088b1056],
6	101:1088	CD	NUMBER	101:1088	dep	3	SENT_459	[p17l1578t1008r2088b1056],
7	—	CD	NUMBER	—	num	8	SENT_459	[p17l1578t1008r2088b1056],
8	93	CD	NUMBER	93	dep	6	SENT_459	[p17l1578t1008r2088b1056],
9	.	.	O	.	_	0	SENT_459	[p17l1578t1008r2088b1056],

1	[	NN	O	[	nn	4	SENT_460	[p17l6t1072r104b1126],
2	43	CD	NUMBER	43	num	4	SENT_460	[p17l6t1072r104b1126],
3	]	NN	O	]	nn	4	SENT_460	[p17l6t1072r104b1126],
4	Azarpira	NN	O	azarpira	_	0	SENT_460	[p17l137t1073r357b1126],
5	N	NN	O	n	dep	4	SENT_460	[p17l386t1075r436b1122],
6	,	,	O	,	_	0	SENT_460	[p17l386t1075r436b1122],
7	Namazi	NNP	PERSON	Namazi	nn	8	SENT_460	[p17l466t1073r660b1116],
8	S	NNP	O	S	appos	5	SENT_460	[p17l690t1074r728b1122],
9	,	,	O	,	_	0	SENT_460	[p17l690t1074r728b1122],
10	Khalili	NNP	PERSON	Khalili	nn	11	SENT_460	[p17l758t1072r922b1116],
11	A	NNP	O	A	appos	5	SENT_460	[p17l949t1074r997b1122],
12	,	,	O	,	_	0	SENT_460	[p17l949t1074r997b1122],
13	Tabesh	NNP	PERSON	Tabesh	nn	15	SENT_460	[p17l1024t1072r1207b1116],
14	M.	NNP	O	M.	nn	15	SENT_460	[p17l1236t1075r1297b1116],
15	The	NNP	O	The	appos	5	SENT_460	[p17l1325t1072r1419b1116],
16	investigation	NN	O	investigation	dep	4	SENT_460	[p17l1448t1073r1785b1126],
17	of	IN	O	of	_	0	SENT_460	[p17l1813t1072r1866b1116],
18	allele	NN	O	allele	nn	21	SENT_460	[p17l1889t1072r2025b1116],
19	and	CC	O	and	_	0	SENT_460	[p17l2054t1072r2147b1116],
20	genotype	NN	O	genotype	conj_and	18	SENT_460	[p17l138t1144r377b1192],
21	frequencies	NNS	O	frequency	prep_of	16	SENT_460	[p17l399t1137r696b1192],
22	of	IN	O	of	_	0	SENT_460	[p17l719t1137r772b1181],
23	CYP3A5	NN	O	cyp3a5	nn	24	SENT_460	[p17l787t1140r986b1181],
24	(	NN	O	(	prep_of	21	SENT_460	[p17l1009t1137r1181b1192],
25	1	CD	NUMBER	1	number	26	SENT_460	[p17l1009t1137r1181b1192],
26	*	CD	NUMBER	*	dep	4	SENT_460	[p17l1009t1137r1181b1192],
27	/	:	O	/	punct	30	SENT_460	[p17l1009t1137r1181b1192],
28	3	CD	NUMBER	3	num	30	SENT_460	[p17l1009t1137r1181b1192],
29	*	NN	O	*	nn	30	SENT_460	[p17l1009t1137r1181b1192],
30	)	NN	O	)	dep	26	SENT_460	[p17l1009t1137r1181b1192],
31	and	CC	O	and	_	0	SENT_460	[p17l1202t1138r1296b1181],
32	P2Y12	NN	O	p2y12	nn	35	SENT_460	[p17l1318t1140r1478b1181],
33	(	CD	NUMBER	(	num	35	SENT_460	[p17l1501t1138r1705b1192],
34	T744C	NN	O	t744c	nn	35	SENT_460	[p17l1501t1138r1705b1192],
35	)	NN	O	)	dep	26	SENT_460	[p17l1501t1138r1705b1192],
36	in	IN	O	in	_	0	SENT_460	[p17l1727t1138r1774b1181],
37	Iran	NNP	LOCATION	Iran	prep_in	26	SENT_460	[p17l1795t1140r1908b1182],
38	.	.	O	.	_	0	SENT_460	[p17l1795t1140r1908b1182],

1	Mol	NNP	O	Mol	nn	3	SENT_461	[p17l1931t1138r2029b1181],
2	Biol	NNP	O	Biol	nn	3	SENT_461	[p17l2052t1138r2147b1181],
3	Rep	NNP	O	Rep	_	0	SENT_461	[p17l139t1207r233b1259],
4	2010	CD	DATE	2010	dep	3	SENT_461	[p17l256t1206r395b1248],
5	.	.	O	.	_	0	SENT_461	[p17l256t1206r395b1248],

1	[	NN	O	[	nn	5	SENT_462	[p17l6t1270r104b1325],
2	44	CD	NUMBER	44	num	5	SENT_462	[p17l6t1270r104b1325],
3	]	CD	NUMBER	]	num	5	SENT_462	[p17l6t1270r104b1325],
4	Yamamoto	NNP	PERSON	Yamamoto	nn	5	SENT_462	[p17l137t1273r419b1314],
5	K	NNP	PERSON	K	_	0	SENT_462	[p17l436t1273r481b1320],
6	,	,	O	,	_	0	SENT_462	[p17l436t1273r481b1320],
7	Hokimoto	NNP	LOCATION	Hokimoto	nn	8	SENT_462	[p17l498t1270r754b1314],
8	S	NNP	LOCATION	S	appos	5	SENT_462	[p17l771t1272r808b1320],
9	,	,	O	,	_	0	SENT_462	[p17l771t1272r808b1320],
10	Chitose	NNP	ORGANIZATION	Chitose	nn	11	SENT_462	[p17l825t1270r1015b1314],
11	T	NN	ORGANIZATION	t	appos	8	SENT_462	[p17l1028t1273r1071b1320],
12	,	,	O	,	_	0	SENT_462	[p17l1028t1273r1071b1320],
13	Morita	NNP	PERSON	Morita	nn	14	SENT_462	[p17l1088t1271r1260b1314],
14	K	NNP	PERSON	K	appos	8	SENT_462	[p17l1277t1273r1321b1320],
15	,	,	O	,	_	0	SENT_462	[p17l1277t1273r1321b1320],
16	Ono	NNP	PERSON	Ono	nn	17	SENT_462	[p17l1338t1272r1441b1314],
17	T	NN	O	t	appos	8	SENT_462	[p17l1455t1273r1497b1320],
18	,	,	O	,	_	0	SENT_462	[p17l1455t1273r1497b1320],
19	Kaikita	NNP	PERSON	Kaikita	nn	20	SENT_462	[p17l1515t1270r1693b1314],
20	K	NNP	PERSON	K	appos	8	SENT_462	[p17l1709t1273r1755b1320],
21	,	,	O	,	_	0	SENT_462	[p17l1709t1273r1755b1320],
22	et	FW	O	et	nn	23	SENT_462	[p17l1771t1277r1819b1314],
23	al.	FW	O	al.	appos	8	SENT_462	[p17l1834t1270r1889b1314],
24	.	.	O	.	_	0	SENT_462	[p17l1834t1270r1889b1314],

1	Impact	NN	O	impact	_	0	SENT_463	[p17l1907t1273r2086b1325],
2	of	IN	O	of	_	0	SENT_463	[p17l2101t1270r2154b1314],
3	CYP2C19	NN	O	cyp2c19	nn	4	SENT_463	[p17l139t1338r369b1379],
4	polymorphism	NN	O	polymorphism	prep_of	1	SENT_463	[p17l391t1336r771b1390],
5	on	IN	O	on	_	0	SENT_463	[p17l791t1348r854b1379],
6	residual	JJ	O	residual	amod	8	SENT_463	[p17l874t1336r1079b1379],
7	platelet	NN	O	platelet	nn	8	SENT_463	[p17l1100t1336r1296b1390],
8	reactivity	NN	O	reactivity	prep_on	1	SENT_463	[p17l1316t1337r1561b1390],
9	in	IN	O	in	_	0	SENT_463	[p17l1581t1337r1628b1379],
10	patients	NNS	O	patient	prep_in	8	SENT_463	[p17l1649t1337r1855b1390],
11	with	IN	O	with	_	0	SENT_463	[p17l1875t1336r1994b1379],
12	coronary	JJ	O	coronary	amod	14	SENT_463	[p17l2014t1348r2147b1379, p17l139t1415r254b1456],
13	heart	NN	O	heart	nn	14	SENT_463	[p17l277t1402r411b1446],
14	disease	NN	O	disease	prep_with	10	SENT_463	[p17l433t1402r618b1446],
15	during	IN	O	during	_	0	SENT_463	[p17l642t1402r813b1456],
16	antiplatelet	JJ	O	antiplatelet	amod	17	SENT_463	[p17l833t1402r1132b1456],
17	therapy	NN	O	therapy	prep_during	14	SENT_463	[p17l1153t1402r1403b1456],
18	.	.	O	.	_	0	SENT_463	[p17l1153t1402r1403b1456],

1	J	NNP	O	J	nn	2	SENT_464	[p17l1153t1402r1403b1456],
2	Cardiol	NNP	O	Cardiol	_	0	SENT_464	[p17l1426t1402r1608b1446],
3	2011	CD	DATE	2011	num	2	SENT_464	[p17l1631t1404r2109b1452],
4	;	:	O	;	_	0	SENT_464	[p17l1631t1404r2109b1452],
5	57:194	CD	NUMBER	57:194	number	6	SENT_464	[p17l1631t1404r2109b1452],
6	-201	CD	NUMBER	-201	dep	2	SENT_464	[p17l1631t1404r2109b1452],
7	.	.	O	.	_	0	SENT_464	[p17l1631t1404r2109b1452],

1	[	NN	O	[	_	0	SENT_465	[p17l6t1467r104b1522],
2	45	CD	NUMBER	45	num	1	SENT_465	[p17l6t1467r104b1522],
3	]	CD	NUMBER	]	num	5	SENT_465	[p17l6t1467r104b1522],
4	Sawada	NNP	PERSON	Sawada	nn	5	SENT_465	[p17l139t1468r336b1511],
5	T	NN	PERSON	t	dep	1	SENT_465	[p17l358t1470r400b1518],
6	,	,	O	,	_	0	SENT_465	[p17l358t1470r400b1518],
7	Shinke	NN	ORGANIZATION	shinke	nn	8	SENT_465	[p17l426t1468r598b1511],
8	T	NN	ORGANIZATION	t	appos	5	SENT_465	[p17l620t1470r662b1518],
9	,	,	O	,	_	0	SENT_465	[p17l620t1470r662b1518],
10	Shite	NN	PERSON	shite	nn	11	SENT_465	[p17l687t1468r814b1511],
11	J	NN	PERSON	j	appos	5	SENT_465	[p17l832t1470r866b1522],
12	,	,	O	,	_	0	SENT_465	[p17l832t1470r866b1522],
13	Honjo	NNP	PERSON	Honjo	nn	14	SENT_465	[p17l890t1468r1044b1522],
14	T	NN	O	t	appos	5	SENT_465	[p17l1066t1470r1109b1518],
15	,	,	O	,	_	0	SENT_465	[p17l1066t1470r1109b1518],
16	Haraguchi	NNP	PERSON	Haraguchi	nn	17	SENT_465	[p17l1134t1468r1397b1522],
17	Y	NN	PERSON	y	appos	5	SENT_465	[p17l1420t1470r1465b1518],
18	,	,	O	,	_	0	SENT_465	[p17l1420t1470r1465b1518],
19	Nishio	NNP	PERSON	Nishio	nn	20	SENT_465	[p17l1490t1468r1654b1511],
20	R	NNP	O	R	appos	5	SENT_465	[p17l1678t1470r1722b1518],
21	,	,	O	,	_	0	SENT_465	[p17l1678t1470r1722b1518],
22	et	FW	O	et	nn	23	SENT_465	[p17l1747t1474r1795b1511],
23	al.	FW	O	al.	appos	5	SENT_465	[p17l1818t1468r1873b1512],
24	.	.	O	.	_	0	SENT_465	[p17l1818t1468r1873b1512],

1	Impact	NN	O	impact	dep	8	SENT_466	[p17l1899t1470r2078b1522],
2	of	IN	O	of	_	0	SENT_466	[p17l2101t1467r2154b1511],
3	cytochrome	NN	O	cytochrome	nn	5	SENT_466	[p17l139t1534r445b1588],
4	P450	NN	O	p450	nn	5	SENT_466	[p17l466t1536r592b1578],
5	2C19	NN	O	2c19	prep_of	1	SENT_466	[p17l612t1534r796b1578],
6	*	NN	O	*	dep	8	SENT_466	[p17l612t1534r796b1578],
7	2	CD	NUMBER	2	num	6	SENT_466	[p17l612t1534r796b1578],
8	polymorphism	NN	O	polymorphism	dep	14	SENT_466	[p17l818t1534r1199b1589],
9	on	IN	O	on	_	0	SENT_466	[p17l1218t1547r1281b1578],
10	intra	JJ	O	intra	amod	13	SENT_466	[p17l1301t1535r1578b1578],
11	—	NN	O	—	nn	13	SENT_466	[p17l1301t1535r1578b1578],
12	stent	NN	O	stent	nn	13	SENT_466	[p17l1301t1535r1578b1578],
13	thrombus	NN	O	thrombus	prep_on	8	SENT_466	[p17l1596t1534r1848b1578],
14	after	IN	O	after	_	0	SENT_466	[p17l1868t1534r1989b1578],
15	drugeluting	VBG	O	drugelute	pcomp	14	SENT_466	[p17l2007t1534r2147b1589, p17l139t1600r321b1654],
16	stent	NN	O	stent	nn	17	SENT_466	[p17l347t1606r475b1643],
17	implantation	NN	O	implantation	dobj	15	SENT_466	[p17l500t1599r836b1654],
18	in	IN	O	in	_	0	SENT_466	[p17l862t1600r909b1643],
19	Japanese	JJ	MISC	japanese	amod	20	SENT_466	[p17l928t1602r1160b1654],
20	patients	NNS	O	patient	prep_in	15	SENT_466	[p17l1186t1600r1393b1654],
21	receiving	VBG	O	receive	partmod	20	SENT_466	[p17l1421t1600r1657b1654],
22	clopidogrel	NN	O	clopidogrel	dobj	21	SENT_466	[p17l1681t1599r1983b1654],
23	.	.	O	.	_	0	SENT_466	[p17l1681t1599r1983b1654],

1	CircJ	NNP	O	CircJ	_	0	SENT_467	[p17l2010t1600r2147b1654],
2	2010	CD	DATE	2010	num	1	SENT_467	[p17l139t1668r583b1716],
3	;	:	O	;	_	0	SENT_467	[p17l139t1668r583b1716],
4	75:99	CD	NUMBER	75:99	num	5	SENT_467	[p17l139t1668r583b1716],
5	—	NN	O	—	dep	1	SENT_467	[p17l139t1668r583b1716],
6	105	CD	NUMBER	105	dep	5	SENT_467	[p17l139t1668r583b1716],
7	.	.	O	.	_	0	SENT_467	[p17l139t1668r583b1716],

1	[	RB	O	[	dep	5	SENT_468	[p17l6t1732r104b1787],
2	46	CD	NUMBER	46	num	5	SENT_468	[p17l6t1732r104b1787],
3	]	CD	NUMBER	]	num	5	SENT_468	[p17l6t1732r104b1787],
4	Liu	NNP	O	Liu	nn	5	SENT_468	[p17l139t1733r215b1776],
5	XL	NNP	O	XL	_	0	SENT_468	[p17l243t1735r319b1783],
6	,	,	O	,	_	0	SENT_468	[p17l243t1735r319b1783],
7	Wang	NNP	PERSON	Wang	nn	8	SENT_468	[p17l348t1735r501b1787],
8	ZJ	NNP	PERSON	ZJ	appos	5	SENT_468	[p17l528t1735r588b1787],
9	,	,	O	,	_	0	SENT_468	[p17l528t1735r588b1787],
10	Yang	NNP	PERSON	Yang	nn	11	SENT_468	[p17l616t1735r745b1787],
11	Q	NNP	O	Q	appos	5	SENT_468	[p17l774t1734r823b1784],
12	,	,	O	,	_	0	SENT_468	[p17l774t1734r823b1784],
13	Ge	NNP	O	Ge	nn	14	SENT_468	[p17l854t1734r919b1776],
14	HL	NNS	O	hl	appos	11	SENT_468	[p17l949t1735r1029b1782],
15	,	,	O	,	_	0	SENT_468	[p17l949t1735r1029b1782],
16	Gao	NNP	O	Gao	nn	17	SENT_468	[p17l1059t1734r1156b1776],
17	F	NN	O	f	appos	11	SENT_468	[p17l1187t1735r1224b1782],
18	,	,	O	,	_	0	SENT_468	[p17l1187t1735r1224b1782],
19	Liu	NNP	O	Liu	nn	20	SENT_468	[p17l1255t1733r1331b1776],
20	YY	NNP	O	YY	appos	11	SENT_468	[p17l1358t1735r1439b1782],
21	,	,	O	,	_	0	SENT_468	[p17l1358t1735r1439b1782],
22	et	FW	O	et	nn	23	SENT_468	[p17l1469t1739r1517b1776],
23	al.	FW	O	al.	appos	11	SENT_468	[p17l1546t1732r1601b1776],
24	.	.	O	.	_	0	SENT_468	[p17l1546t1732r1601b1776],

1	Impact	NN	O	impact	_	0	SENT_469	[p17l1632t1735r1811b1787],
2	of	IN	O	of	_	0	SENT_469	[p17l1840t1732r1893b1776],
3	CYP2C19	NN	O	cyp2c19	nn	4	SENT_469	[p17l1917t1734r2147b1776],
4	polymorphism	NN	O	polymorphism	prep_of	1	SENT_469	[p17l139t1798r520b1852],
5	and	CC	O	and	_	0	SENT_469	[p17l536t1798r629b1841],
6	smoking	NN	O	smoking	prep_of	1	SENT_469	[p17l646t1798r866b1852],
7	on	IN	O	on	_	0	SENT_469	[p17l881t1810r944b1841],
8	response	NN	O	response	prep_on	1	SENT_469	[p17l960t1810r1188b1852],
9	to	TO	O	to	_	0	SENT_469	[p17l1204t1804r1254b1841],
10	clopidogrel	NN	O	clopidogrel	prep_to	8	SENT_469	[p17l1270t1798r1558b1852],
11	in	IN	O	in	_	0	SENT_469	[p17l1575t1799r1622b1841],
12	patients	NNS	O	patient	prep_in	1	SENT_469	[p17l1638t1799r1845b1852],
13	with	IN	O	with	_	0	SENT_469	[p17l1860t1798r1980b1841],
14	stable	JJ	O	stable	amod	17	SENT_469	[p17l1996t1798r2147b1841],
15	coronary	JJ	O	coronary	amod	17	SENT_469	[p17l139t1877r368b1918],
16	artery	NN	O	artery	nn	17	SENT_469	[p17l390t1871r545b1918],
17	disease	NN	O	disease	prep_with	12	SENT_469	[p17l567t1864r765b1908],
18	.	.	O	.	_	0	SENT_469	[p17l567t1864r765b1908],

1	Chin	NNP	O	Chin	nn	2	SENT_470	[p17l790t1864r906b1908],
2	MedJ	NNP	O	MedJ	_	0	SENT_470	[p17l929t1864r1077b1918],
3	2010	CD	DATE	2010	num	2	SENT_470	[p17l1100t1866r1611b1914],
4	;	:	O	;	_	0	SENT_470	[p17l1100t1866r1611b1914],
5	123:3178	CD	NUMBER	123:3178	number	6	SENT_470	[p17l1100t1866r1611b1914],
6	—	CD	NUMBER	—	dep	2	SENT_470	[p17l1100t1866r1611b1914],
7	83	CD	NUMBER	83	dep	6	SENT_470	[p17l1100t1866r1611b1914],
8	.	.	O	.	_	0	SENT_470	[p17l1100t1866r1611b1914],

1	[	NN	O	[	_	0	SENT_471	[p17l6t1929r102b1984],
2	47	CD	NUMBER	47	num	3	SENT_471	[p17l6t1929r102b1984],
3	]	CD	NUMBER	]	dep	1	SENT_471	[p17l6t1929r102b1984],
4	Oh	UH	O	oh	dep	5	SENT_471	[p17l137t1930r209b1973],
5	IY	NN	O	iy	rcmod	3	SENT_471	[p17l222t1932r282b1980],
6	,	,	O	,	_	0	SENT_471	[p17l222t1932r282b1980],
7	Park	NNP	O	Park	nn	8	SENT_471	[p17l297t1930r409b1973],
8	KW	NNP	O	KW	appos	3	SENT_471	[p17l421t1932r524b1980],
9	,	,	O	,	_	0	SENT_471	[p17l421t1932r524b1980],
10	Kang	NNP	PERSON	Kang	nn	11	SENT_471	[p17l539t1932r666b1984],
11	SH	NNP	O	SH	appos	8	SENT_471	[p17l678t1932r758b1980],
12	,	,	O	,	_	0	SENT_471	[p17l678t1932r758b1980],
13	Parl	NNP	O	Parl	dep	1	SENT_471	[p17l773t1930r940b1984],
14	<	JJR	O	<	amod	15	SENT_471	[p17l773t1930r940b1984],
15	JJ	NN	O	jj	dep	13	SENT_471	[p17l773t1930r940b1984],
16	,	,	O	,	_	0	SENT_471	[p17l773t1930r940b1984],
17	Na	NN	O	na	nn	18	SENT_471	[p17l955t1932r1022b1973],
18	SH	NN	O	sh	appos	1	SENT_471	[p17l1036t1932r1115b1980],
19	,	,	O	,	_	0	SENT_471	[p17l1036t1932r1115b1980],
20	Kang	NNP	PERSON	Kang	nn	21	SENT_471	[p17l1130t1932r1258b1984],
21	HJ	NNP	PERSON	HJ	appos	1	SENT_471	[p17l1270t1932r1338b1984],
22	,	,	O	,	_	0	SENT_471	[p17l1270t1932r1338b1984],
23	et	FW	O	et	nn	24	SENT_471	[p17l1352t1936r1400b1973],
24	al.	FW	O	al.	appos	1	SENT_471	[p17l1413t1930r1467b1974],
25	.	.	O	.	_	0	SENT_471	[p17l1413t1930r1467b1974],

1	Association	NNP	O	Association	nsubj	18	SENT_472	[p17l1480t1930r1772b1973],
2	of	IN	O	of	_	0	SENT_472	[p17l1785t1930r1839b1973],
3	cytochrome	NN	O	cytochrome	nn	6	SENT_472	[p17l1846t1930r2148b1984],
4	P450	NN	O	p450	nn	6	SENT_472	[p17l137t1998r263b2040],
5	2C19	NN	O	2c19	nn	6	SENT_472	[p17l284t1996r466b2040],
6	*	NN	O	*	prep_of	1	SENT_472	[p17l284t1996r466b2040],
7	2	CD	NUMBER	2	num	8	SENT_472	[p17l284t1996r466b2040],
8	polymorphism	NN	O	polymorphism	dep	6	SENT_472	[p17l489t1996r864b2051],
9	with	IN	O	with	_	0	SENT_472	[p17l884t1996r1002b2040],
10	clopidogrel	NN	O	clopidogrel	nn	12	SENT_472	[p17l1023t1996r1307b2051],
11	response	NN	O	response	nn	12	SENT_472	[p17l1329t2009r1554b2051],
12	variability	NN	O	variability	prep_with	8	SENT_472	[p17l1574t1996r1835b2051],
13	and	CC	O	and	_	0	SENT_472	[p17l1855t1996r1948b2040],
14	cardiovascular	JJ	O	cardiovascular	amod	15	SENT_472	[p17l1969t1996r2147b2040, p17l135t2062r348b2106],
15	events	NNS	O	event	conj_and	6	SENT_472	[p17l367t2069r531b2106],
16	in	IN	O	in	_	0	SENT_472	[p17l552t2063r600b2105],
17	Koreans	NNPS	LOCATION	Koreans	prep_in	15	SENT_472	[p17l619t2065r821b2106],
18	treated	VBN	O	treat	_	0	SENT_472	[p17l842t2062r1023b2106],
19	with	IN	O	with	_	0	SENT_472	[p17l1042t2062r1160b2106],
20	drug	NN	O	drug	nn	23	SENT_472	[p17l1180t2062r1501b2117],
21	—	NN	O	—	nn	23	SENT_472	[p17l1180t2062r1501b2117],
22	eluting	VBG	O	elute	amod	23	SENT_472	[p17l1180t2062r1501b2117],
23	stents	NNS	O	stent	prep_with	18	SENT_472	[p17l1520t2069r1683b2106],
24	.	.	O	.	_	0	SENT_472	[p17l1520t2069r1683b2106],

1	Heart	NNP	O	Heart	_	0	SENT_473	[p17l1704t2065r1846b2106],
2	2011	CD	DATE	2011	dep	1	SENT_473	[p17l1864t2064r2003b2106],
3	.	.	O	.	_	0	SENT_473	[p17l1864t2064r2003b2106],

1	[	NN	O	[	nn	5	SENT_474	[p17l6t2128r104b2182],
2	48	CD	NUMBER	48	num	5	SENT_474	[p17l6t2128r104b2182],
3	]	CD	NUMBER	]	num	5	SENT_474	[p17l6t2128r104b2182],
4	Hwang	NNP	O	Hwang	nn	5	SENT_474	[p17l139t2131r322b2182],
5	SJ	NNP	O	SJ	_	0	SENT_474	[p17l344t2130r399b2182],
6	,	,	O	,	_	0	SENT_474	[p17l344t2130r399b2182],
7	Jeong	NNP	PERSON	Jeong	nn	8	SENT_474	[p17l417t2131r565b2182],
8	YH	NNP	O	YH	appos	5	SENT_474	[p17l585t2130r673b2178],
9	,	,	O	,	_	0	SENT_474	[p17l585t2130r673b2178],
10	Kim	NNP	PERSON	Kim	nsubj	11	SENT_474	[p17l697t2128r799b2171],
11	IS	VBZ	O	be	dep	5	SENT_474	[p17l822t2130r877b2178],
12	,	,	O	,	_	0	SENT_474	[p17l822t2130r877b2178],
13	Koh	NNP	PERSON	Koh	nn	14	SENT_474	[p17l901t2128r1000b2171],
14	JS	NNP	O	JS	appos	5	SENT_474	[p17l1017t2130r1079b2182],
15	,	,	O	,	_	0	SENT_474	[p17l1017t2130r1079b2182],
16	Kang	NNP	PERSON	Kang	nn	17	SENT_474	[p17l1103t2131r1231b2182],
17	MK	NNP	O	MK	appos	5	SENT_474	[p17l1253t2131r1351b2178],
18	,	,	O	,	_	0	SENT_474	[p17l1253t2131r1351b2178],
19	Park	NNP	O	Park	nn	20	SENT_474	[p17l1375t2128r1489b2171],
20	Y	NN	O	y	appos	5	SENT_474	[p17l1508t2131r1553b2178],
21	,	,	O	,	_	0	SENT_474	[p17l1508t2131r1553b2178],
22	et	FW	O	et	nn	23	SENT_474	[p17l1577t2134r1625b2171],
23	al.	FW	O	al.	appos	5	SENT_474	[p17l1647t2128r1702b2172],
24	.	.	O	.	_	0	SENT_474	[p17l1647t2128r1702b2172],

1	The	DT	O	the	det	4	SENT_475	[p17l1724t2128r1818b2171],
2	cytochrome	NN	O	cytochrome	nn	4	SENT_475	[p17l1841t2128r2147b2182],
3	2C19	NN	O	2c19	nn	4	SENT_475	[p17l139t2194r323b2238],
4	*	NN	O	*	nsubj	10	SENT_475	[p17l139t2194r323b2238],
5	2	CD	NUMBER	2	dep	4	SENT_475	[p17l139t2194r323b2238],
6	and	CC	O	and	_	0	SENT_475	[p17l342t2194r435b2238],
7	*	CD	NUMBER	*	number	8	SENT_475	[p17l453t2194r503b2238],
8	3	CD	NUMBER	3	num	9	SENT_475	[p17l453t2194r503b2238],
9	alleles	NNS	O	allele	conj_and	4	SENT_475	[p17l522t2194r682b2238],
10	attenuate	VBP	O	attenuate	_	0	SENT_475	[p17l700t2200r946b2238],
11	response	NN	O	response	dobj	10	SENT_475	[p17l963t2207r1191b2248],
12	to	TO	O	to	_	0	SENT_475	[p17l1208t2201r1258b2238],
13	clopidogrel	NN	O	clopidogrel	prep_to	11	SENT_475	[p17l1274t2194r1563b2248],
14	similarly	RB	O	similarly	advmod	10	SENT_475	[p17l1580t2194r1807b2248],
15	in	IN	O	in	_	0	SENT_475	[p17l1823t2195r1872b2237],
16	East	JJ	MISC	east	amod	18	SENT_475	[p17l1888t2197r1993b2238],
17	Asian	JJ	MISC	asian	amod	18	SENT_475	[p17l2006t2195r2148b2238],
18	patients	NNS	O	patient	prep_in	10	SENT_475	[p17l139t2260r346b2314],
19	undergoing	VBG	O	undergo	partmod	18	SENT_475	[p17l362t2260r659b2314],
20	elective	JJ	O	elective	amod	23	SENT_475	[p17l673t2260r871b2303],
21	percutaneous	JJ	O	percutaneous	amod	23	SENT_475	[p17l887t2266r1235b2314],
22	coronary	JJ	O	coronary	amod	23	SENT_475	[p17l1251t2272r1481b2314],
23	intervention	NN	O	intervention	dobj	19	SENT_475	[p17l1495t2260r1828b2304],
24	.	.	O	.	_	0	SENT_475	[p17l1495t2260r1828b2304],

1	Thromb	NNP	O	Thromb	nn	2	SENT_476	[p17l1842t2260r2046b2303],
2	Res	NNP	O	Res	_	0	SENT_476	[p17l2062t2262r2147b2303],
3	2011	CD	DATE	2011	num	2	SENT_476	[p17l139t2328r260b2370],
4	;	:	O	;	_	0	SENT_476	[p17l275t2328r551b2376],
5	127:23	CD	NUMBER	127:23	number	6	SENT_476	[p17l275t2328r551b2376],
6	—	CD	NUMBER	—	dep	2	SENT_476	[p17l275t2328r551b2376],
7	8	CD	NUMBER	8	dep	6	SENT_476	[p17l275t2328r551b2376],
8	.	.	O	.	_	0	SENT_476	[p17l275t2328r551b2376],

1	[	NN	O	[	_	0	SENT_477	[p17l6t2391r104b2446],
2	49	CD	NUMBER	49	num	1	SENT_477	[p17l6t2391r104b2446],
3	]	CD	NUMBER	]	num	5	SENT_477	[p17l6t2391r104b2446],
4	Soﬁ	NN	O	soﬁ	nn	5	SENT_477	[p17l139t2391r231b2435],
5	F	NN	O	f	dep	1	SENT_477	[p17l252t2394r290b2442],
6	,	,	O	,	_	0	SENT_477	[p17l252t2394r290b2442],
7	Giusti	NNP	PERSON	Giusti	nn	8	SENT_477	[p17l311t2392r461b2435],
8	B	NNP	PERSON	B	appos	5	SENT_477	[p17l482t2394r524b2442],
9	,	,	O	,	_	0	SENT_477	[p17l482t2394r524b2442],
10	Marcucci	NNP	PERSON	Marcucci	nn	11	SENT_477	[p17l546t2392r779b2435],
11	R	NNP	PERSON	R	appos	5	SENT_477	[p17l800t2394r843b2442],
12	,	,	O	,	_	0	SENT_477	[p17l800t2394r843b2442],
13	Gori	NNP	ORGANIZATION	Gori	nn	14	SENT_477	[p17l863t2392r971b2435],
14	AM	NNP	ORGANIZATION	AM	appos	5	SENT_477	[p17l989t2393r1091b2442],
15	,	,	O	,	_	0	SENT_477	[p17l989t2393r1091b2442],
16	Abbate	NNP	ORGANIZATION	Abbate	nn	17	SENT_477	[p17l1109t2391r1291b2435],
17	R	NNP	ORGANIZATION	R	appos	5	SENT_477	[p17l1312t2394r1354b2442],
18	,	,	O	,	_	0	SENT_477	[p17l1312t2394r1354b2442],
19	Gensini	NNP	O	Gensini	nn	20	SENT_477	[p17l1375t2392r1569b2435],
20	GF	NN	O	gf	appos	5	SENT_477	[p17l1589t2394r1667b2435],
21	.	.	O	.	_	0	SENT_477	[p17l1589t2394r1667b2435],

1	Cytochrome	NN	O	cytochrome	nn	4	SENT_478	[p17l1688t2391r2001b2446],
2	P450	NN	O	p450	nn	4	SENT_478	[p17l2021t2394r2147b2435],
3	2C19	NN	O	2c19	nn	4	SENT_478	[p17l139t2458r323b2502],
4	*	NN	O	*	_	0	SENT_478	[p17l139t2458r323b2502],
5	2	CD	NUMBER	2	num	6	SENT_478	[p17l139t2458r323b2502],
6	polymorphism	NN	O	polymorphism	dep	4	SENT_478	[p17l362t2458r742b2512],
7	and	CC	O	and	_	0	SENT_478	[p17l779t2458r872b2502],
8	cardiovascular	JJ	O	cardiovascular	amod	9	SENT_478	[p17l909t2458r1286b2502],
9	recurrences	NNS	O	recurrence	conj_and	4	SENT_478	[p17l1321t2471r1621b2502],
10	in	IN	O	in	_	0	SENT_478	[p17l1659t2459r1707b2501],
11	patients	NNS	O	patient	prep_in	9	SENT_478	[p17l1743t2459r1950b2512],
12	taking	VBG	O	take	partmod	4	SENT_478	[p17l1987t2458r2149b2512],
13	clopidogrel	NN	O	clopidogrel	dobj	12	SENT_478	[p17l139t2524r444b2579],
14	:	:	O	:	_	0	SENT_478	[p17l139t2524r444b2579],
15	a	DT	O	a	det	16	SENT_478	[p17l471t2537r497b2568],
16	meta-analysis	NN	O	meta-analysis	dep	13	SENT_478	[p17l520t2524r893b2579],
17	.	.	O	.	_	0	SENT_478	[p17l520t2524r893b2579],

1	Pharmacogenomicsj	NNP	O	Pharmacogenomicsj	_	0	SENT_479	[p17l918t2524r1459b2579],
2	2011	CD	DATE	2011	num	1	SENT_479	[p17l1481t2526r1959b2575],
3	;	:	O	;	_	0	SENT_479	[p17l1481t2526r1959b2575],
4	11:199	CD	NUMBER	11:199	number	5	SENT_479	[p17l1481t2526r1959b2575],
5	-206	CD	NUMBER	-206	dep	1	SENT_479	[p17l1481t2526r1959b2575],
6	.	.	O	.	_	0	SENT_479	[p17l1481t2526r1959b2575],

1	[	RB	O	[	advmod	2	SENT_480	[p17l6t2590r103b2644],
2	50	CD	NUMBER	50	_	0	SENT_480	[p17l6t2590r103b2644],
3	]	CD	NUMBER	]	num	5	SENT_480	[p17l6t2590r103b2644],
4	Sibbing	NN	O	sibbing	nn	5	SENT_480	[p17l139t2590r331b2644],
5	D	NN	O	d	dep	2	SENT_480	[p17l351t2593r400b2640],
6	,	,	O	,	_	0	SENT_480	[p17l351t2593r400b2640],
7	Stegherr	NN	PERSON	stegherr	nn	8	SENT_480	[p17l423t2590r642b2644],
8	J	NN	PERSON	j	appos	5	SENT_480	[p17l655t2593r688b2644],
9	,	,	O	,	_	0	SENT_480	[p17l655t2593r688b2644],
10	Latz	NNP	PERSON	Latz	nn	11	SENT_480	[p17l710t2593r813b2633],
11	W	NNP	O	W	appos	5	SENT_480	[p17l833t2592r903b2640],
12	,	,	O	,	_	0	SENT_480	[p17l833t2592r903b2640],
13	Koch	NNP	PERSON	Koch	nn	14	SENT_480	[p17l925t2590r1051b2633],
14	W	NNP	O	W	appos	5	SENT_480	[p17l1071t2593r1141b2640],
15	,	,	O	,	_	0	SENT_480	[p17l1071t2593r1141b2640],
16	Mehilli	NNP	PERSON	Mehilli	nn	17	SENT_480	[p17l1163t2590r1344b2633],
17	J	NNP	PERSON	J	appos	5	SENT_480	[p17l1359t2593r1392b2644],
18	,	,	O	,	_	0	SENT_480	[p17l1359t2593r1392b2644],
19	Dorrler	NNP	O	Dorrler	nn	20	SENT_480	[p17l1414t2590r1601b2633],
20	K	NNP	O	K	appos	5	SENT_480	[p17l1621t2593r1666b2640],
21	,	,	O	,	_	0	SENT_480	[p17l1621t2593r1666b2640],
22	et	FW	O	et	nn	23	SENT_480	[p17l1688t2596r1735b2633],
23	al.	FW	O	al.	appos	5	SENT_480	[p17l1756t2590r1811b2634],
24	.	.	O	.	_	0	SENT_480	[p17l1756t2590r1811b2634],

1	Cytochrome	NN	O	cytochrome	nn	5	SENT_481	[p17l1835t2590r2148b2644],
2	P450	NN	O	p450	nn	5	SENT_481	[p17l139t2658r265b2700],
3	2C19	NN	O	2c19	nn	5	SENT_481	[p17l294t2658r423b2700],
4	loss-of-function	NN	O	loss-of-function	nn	5	SENT_481	[p17l453t2656r866b2700],
5	polymorphism	NN	O	polymorphism	_	0	SENT_481	[p17l894t2656r1275b2710],
6	and	CC	O	and	_	0	SENT_481	[p17l1303t2656r1396b2700],
7	stent	NN	O	stent	nn	8	SENT_481	[p17l1427t2662r1555b2700],
8	thrombosis	NN	O	thrombosis	conj_and	5	SENT_481	[p17l1583t2656r1874b2700],
9	following	VBG	O	follow	_	0	SENT_481	[p17l1904t2656r2149b2710],
10	percutaneous	JJ	O	percutaneous	amod	12	SENT_481	[p17l139t2728r488b2776],
11	coronary	JJ	O	coronary	amod	12	SENT_481	[p17l511t2734r740b2776],
12	intervention	NN	O	intervention	prep_following	5	SENT_481	[p17l763t2722r1095b2766],
13	.	.	O	.	_	0	SENT_481	[p17l763t2722r1095b2766],

1	Eur	NNP	O	Eur	nn	2	SENT_482	[p17l1119t2724r1206b2765],
2	Heart	NNP	O	Heart	_	0	SENT_482	[p17l1228t2724r1406b2776],
3	]	CD	NUMBER	]	num	4	SENT_482	[p17l1228t2724r1406b2776],
4	2009	CD	DATE	2009	dep	2	SENT_482	[p17l1429t2724r1873b2772],
5	;	:	O	;	_	0	SENT_482	[p17l1429t2724r1873b2772],
6	30:916	CD	NUMBER	30:916	number	7	SENT_482	[p17l1429t2724r1873b2772],
7	—	CD	NUMBER	—	dep	2	SENT_482	[p17l1429t2724r1873b2772],
8	22	CD	NUMBER	22	dep	7	SENT_482	[p17l1429t2724r1873b2772],
9	.	.	O	.	_	0	SENT_482	[p17l1429t2724r1873b2772],

1	[	NN	O	[	nn	5	SENT_483	[p17l6t2788r104b2843],
2	51	CD	NUMBER	51	num	5	SENT_483	[p17l6t2788r104b2843],
3	]	CD	NUMBER	]	num	5	SENT_483	[p17l6t2788r104b2843],
4	Bonello	NNP	PERSON	Bonello	nn	5	SENT_483	[p17l139t2788r331b2832],
5	L	NNP	PERSON	L	_	0	SENT_483	[p17l363t2791r400b2838],
6	,	,	O	,	_	0	SENT_483	[p17l363t2791r400b2838],
7	Armero	NNP	LOCATION	Armero	nn	8	SENT_483	[p17l430t2790r625b2832],
8	S	NNP	O	S	appos	5	SENT_483	[p17l658t2790r695b2838],
9	,	,	O	,	_	0	SENT_483	[p17l658t2790r695b2838],
10	Ait	NNP	PERSON	Ait	nn	12	SENT_483	[p17l725t2789r801b2832],
11	Mokhtar	NNP	PERSON	Mokhtar	nn	12	SENT_483	[p17l831t2788r1053b2832],
12	O	NNP	PERSON	O	appos	8	SENT_483	[p17l1083t2790r1132b2838],
13	,	,	O	,	_	0	SENT_483	[p17l1083t2790r1132b2838],
14	Mancini	NNP	PERSON	Mancini	nn	15	SENT_483	[p17l1164t2789r1372b2832],
15	J	NNP	PERSON	J	appos	8	SENT_483	[p17l1398t2791r1431b2843],
16	,	,	O	,	_	0	SENT_483	[p17l1398t2791r1431b2843],
17	Aldebert	NNP	PERSON	Aldebert	nn	18	SENT_483	[p17l1461t2788r1685b2832],
18	P	NN	PERSON	p	appos	8	SENT_483	[p17l1715t2791r1756b2838],
19	,	,	O	,	_	0	SENT_483	[p17l1715t2791r1756b2838],
20	Saut	NNP	O	Saut	nn	21	SENT_483	[p17l1788t2790r1900b2832],
21	N	NNP	O	N	appos	8	SENT_483	[p17l1930t2791r1981b2838],
22	,	,	O	,	_	0	SENT_483	[p17l1930t2791r1981b2838],
23	et	FW	O	et	nn	24	SENT_483	[p17l2013t2795r2061b2832],
24	al.	FW	O	al.	appos	8	SENT_483	[p17l2091t2788r2146b2832],
25	.	.	O	.	_	0	SENT_483	[p17l2091t2788r2146b2832],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_484	[p17l139t2854r434b2909],
2	loading	VBG	O	load	partmod	1	SENT_484	[p17l453t2854r645b2909],
3	dose	NN	O	dose	nn	4	SENT_484	[p17l661t2854r777b2898],
4	adjustment	NN	O	adjustment	dobj	2	SENT_484	[p17l795t2854r1091b2909],
5	according	VBG	O	accord	_	0	SENT_484	[p17l1107t2854r1359b2909],
6	to	TO	O	to	prepc_according_to	2	SENT_484	[p17l1375t2861r1425b2898],
7	platelet	NN	O	platelet	nn	9	SENT_484	[p17l1442t2854r1638b2909],
8	reactivity	NN	O	reactivity	nn	9	SENT_484	[p17l1655t2855r1900b2909],
9	monitoring	NN	O	monitoring	pobj	2	SENT_484	[p17l1917t2855r2147b2898, p17l139t2921r219b2974],
10	in	IN	O	in	_	0	SENT_484	[p17l239t2921r286b2963],
11	patients	NNS	O	patient	prep_in	9	SENT_484	[p17l306t2921r513b2974],
12	carrying	VBG	O	carry	partmod	11	SENT_484	[p17l535t2921r748b2974],
13	the	DT	O	the	det	17	SENT_484	[p17l767t2920r848b2964],
14	2C19	NN	O	2c19	nn	17	SENT_484	[p17l869t2920r1053b2964],
15	*	NN	O	*	nn	17	SENT_484	[p17l869t2920r1053b2964],
16	2	CD	NUMBER	2	num	17	SENT_484	[p17l869t2920r1053b2964],
17	loss	NN	O	loss	dobj	12	SENT_484	[p17l1076t2920r1171b2964],
18	of	IN	O	of	_	0	SENT_484	[p17l1192t2920r1245b2964],
19	function	NN	O	function	nn	20	SENT_484	[p17l1260t2920r1475b2964],
20	polymorphism	NN	O	polymorphism	prep_of	17	SENT_484	[p17l1496t2920r1888b2974],
21	.	.	O	.	_	0	SENT_484	[p17l1496t2920r1888b2974],

1	J	NNP	O	J	nn	4	SENT_485	[p17l1903t2923r1924b2974],
2	Am	NNP	O	Am	nn	4	SENT_485	[p17l1942t2922r2031b2963],
3	Coll	NNP	O	Coll	nn	4	SENT_485	[p17l2051t2920r2147b2964],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_485	[p17l139t2986r321b3030],
5	2010	CD	DATE	2010	num	4	SENT_485	[p17l345t2988r789b3036],
6	;	:	O	;	_	0	SENT_485	[p17l345t2988r789b3036],
7	56:1630	CD	NUMBER	56:1630	number	8	SENT_485	[p17l345t2988r789b3036],
8	—	CD	NUMBER	—	dep	4	SENT_485	[p17l345t2988r789b3036],
9	6	CD	NUMBER	6	dep	8	SENT_485	[p17l345t2988r789b3036],
10	.	.	O	.	_	0	SENT_485	[p17l345t2988r789b3036],

1	[	NN	O	[	nn	5	SENT_486	[p17l6t3051r104b3106],
2	52	CD	NUMBER	52	num	5	SENT_486	[p17l6t3051r104b3106],
3	]	CD	NUMBER	]	num	5	SENT_486	[p17l6t3051r104b3106],
4	Collet	NNP	ORGANIZATION	Collet	nn	5	SENT_486	[p17l139t3052r287b3095],
5	JP	NNP	ORGANIZATION	JP	_	0	SENT_486	[p17l297t3054r362b3106],
6	,	,	O	,	_	0	SENT_486	[p17l297t3054r362b3106],
7	HulotJS	NNP	O	HulotJS	appos	5	SENT_486	[p17l380t3052r596b3106],
8	,	,	O	,	_	0	SENT_486	[p17l380t3052r596b3106],
9	Pena	NNP	PERSON	Pena	nn	10	SENT_486	[p17l614t3054r734b3095],
10	A	NNP	O	A	appos	7	SENT_486	[p17l749t3054r797b3102],
11	,	,	O	,	_	0	SENT_486	[p17l749t3054r797b3102],
12	Villard	NNP	ORGANIZATION	Villard	nn	13	SENT_486	[p17l813t3052r986b3095],
13	E	NNP	ORGANIZATION	E	appos	7	SENT_486	[p17l1004t3054r1043b3102],
14	,	,	O	,	_	0	SENT_486	[p17l1004t3054r1043b3102],
15	Esteve	NNP	O	Esteve	nn	16	SENT_486	[p17l1061t3054r1226b3095],
16	JB	NNP	O	JB	appos	7	SENT_486	[p17l1236t3054r1303b3106],
17	,	,	O	,	_	0	SENT_486	[p17l1236t3054r1303b3106],
18	Silvain	NNP	PERSON	Silvain	nn	19	SENT_486	[p17l1321t3052r1493b3095],
19	J	NNP	PERSON	J	appos	7	SENT_486	[p17l1503t3054r1536b3106],
20	,	,	O	,	_	0	SENT_486	[p17l1503t3054r1536b3106],
21	et	FW	O	et	nn	22	SENT_486	[p17l1553t3058r1601b3095],
22	al.	FW	O	al.	appos	7	SENT_486	[p17l1617t3052r1672b3096],
23	.	.	O	.	_	0	SENT_486	[p17l1617t3052r1672b3096],

1	Cytochrome	NN	O	cytochrome	nn	4	SENT_487	[p17l1691t3052r2004b3106],
2	P450	NN	O	p450	nn	4	SENT_487	[p17l2021t3054r2148b3095],
3	2C19	NN	O	2c19	nn	4	SENT_487	[p17l139t3120r268b3162],
4	polymorphism	NN	O	polymorphism	_	0	SENT_487	[p17l287t3118r667b3173],
5	in	IN	O	in	_	0	SENT_487	[p17l686t3119r733b3161],
6	young	JJ	O	young	amod	7	SENT_487	[p17l749t3131r910b3173],
7	patients	NNS	O	patient	prep_in	4	SENT_487	[p17l927t3119r1134b3173],
8	treated	VBN	O	treat	partmod	7	SENT_487	[p17l1153t3118r1337b3162],
9	with	IN	O	with	_	0	SENT_487	[p17l1353t3118r1472b3162],
10	clopidogrel	NN	O	clopidogrel	prep_with	8	SENT_487	[p17l1490t3118r1778b3173],
11	after	IN	O	after	_	0	SENT_487	[p17l1796t3118r1917b3162],
12	myocardial	JJ	O	myocardial	amod	13	SENT_487	[p17l1933t3131r2147b3173, p17l139t3183r232b3227],
13	infarction	NN	O	infarction	prep_after	8	SENT_487	[p17l256t3183r522b3227],
14	:	:	O	:	_	0	SENT_487	[p17l256t3183r522b3227],
15	a	DT	O	a	det	16	SENT_487	[p17l549t3196r575b3227],
16	cohort	NN	O	cohort	dep	4	SENT_487	[p17l597t3183r764b3227],
17	study	NN	O	study	dep	16	SENT_487	[p17l787t3183r941b3238],
18	.	.	O	.	_	0	SENT_487	[p17l787t3183r941b3238],

1	Lancet	NNP	O	Lancet	_	0	SENT_488	[p17l965t3186r1132b3227],
2	2009	CD	DATE	2009	num	1	SENT_488	[p17l1153t3186r1630b3234],
3	;	:	O	;	_	0	SENT_488	[p17l1153t3186r1630b3234],
4	373:309	CD	NUMBER	373:309	number	5	SENT_488	[p17l1153t3186r1630b3234],
5	—	CD	NUMBER	—	dep	1	SENT_488	[p17l1153t3186r1630b3234],
6	17	CD	NUMBER	17	dep	5	SENT_488	[p17l1153t3186r1630b3234],
7	.	.	O	.	_	0	SENT_488	[p17l1153t3186r1630b3234],

1	[	NN	O	[	dep	18	SENT_489	[p17l6t3250r104b3304],
2	53	CD	NUMBER	53	num	5	SENT_489	[p17l6t3250r104b3304],
3	]	CD	NUMBER	]	num	5	SENT_489	[p17l6t3250r104b3304],
4	Shuldiner	NNP	PERSON	Shuldiner	nn	5	SENT_489	[p17l139t3250r390b3294],
5	AR	NNS	O	ar	dep	1	SENT_489	[p17l405t3252r489b3300],
6	,	,	O	,	_	0	SENT_489	[p17l405t3252r489b3300],
7	O’Connell	NN	O	o’connell	nn	8	SENT_489	[p17l509t3250r757b3294],
8	JR	NN	O	jr	appos	5	SENT_489	[p17l771t3253r839b3304],
9	,	,	O	,	_	0	SENT_489	[p17l771t3253r839b3304],
10	Bliden	NNP	PERSON	Bliden	nn	11	SENT_489	[p17l859t3250r1022b3294],
11	KP	NNP	O	KP	appos	5	SENT_489	[p17l1041t3253r1118b3300],
12	,	,	O	,	_	0	SENT_489	[p17l1041t3253r1118b3300],
13	Gandhi	NNP	PERSON	Gandhi	nn	14	SENT_489	[p17l1138t3250r1323b3294],
14	A	NNP	O	A	appos	5	SENT_489	[p17l1341t3252r1389b3300],
15	,	,	O	,	_	0	SENT_489	[p17l1341t3252r1389b3300],
16	Ryan	NNP	PERSON	Ryan	appos	5	SENT_489	[p17l1410t3253r1537b3304],
17	I	PRP	PERSON	I	nsubj	18	SENT_489	[p17l1556t3253r1601b3300],
18	(	VBP	O	(	_	0	SENT_489	[p17l1556t3253r1601b3300],
19	,	,	O	,	_	0	SENT_489	[p17l1556t3253r1601b3300],
20	Horenstein	NNP	PERSON	Horenstein	dep	21	SENT_489	[p17l1622t3251r1907b3294],
21	RB	NN	O	rb	ccomp	18	SENT_489	[p17l1926t3253r2004b3300],
22	,	,	O	,	_	0	SENT_489	[p17l1926t3253r2004b3300],
23	et	FW	O	et	nn	24	SENT_489	[p17l2025t3257r2073b3294],
24	al.	FW	O	al.	appos	21	SENT_489	[p17l2091t3250r2146b3294],
25	.	.	O	.	_	0	SENT_489	[p17l2091t3250r2146b3294],

1	Association	NNP	O	Association	_	0	SENT_490	[p17l137t3317r434b3360],
2	of	IN	O	of	_	0	SENT_490	[p17l459t3316r512b3360],
3	cytochrome	NN	O	cytochrome	nn	6	SENT_490	[p17l532t3316r838b3370],
4	P450	NN	O	p450	nn	6	SENT_490	[p17l863t3318r990b3360],
5	2C19	NN	O	2c19	nn	6	SENT_490	[p17l1015t3318r1144b3360],
6	genotype	NN	O	genotype	prep_of	1	SENT_490	[p17l1169t3323r1409b3371],
7	with	IN	O	with	_	0	SENT_490	[p17l1433t3316r1552b3360],
8	the	DT	O	the	det	10	SENT_490	[p17l1576t3316r1658b3360],
9	antiplatelet	JJ	O	antiplatelet	amod	10	SENT_490	[p17l1684t3316r1982b3371],
10	effect	NN	O	effect	prep_with	1	SENT_490	[p17l2006t3316r2149b3360],
11	and	CC	O	and	_	0	SENT_490	[p17l139t3382r232b3425],
12	clinical	JJ	O	clinical	amod	13	SENT_490	[p17l248t3382r430b3425],
13	efﬁcacy	NN	O	efﬁcacy	conj_and	10	SENT_490	[p17l446t3382r643b3436],
14	of	IN	O	of	_	0	SENT_490	[p17l657t3382r710b3425],
15	clopidogrel	NN	O	clopidogrel	nn	16	SENT_490	[p17l720t3382r1008b3436],
16	therapy	NN	O	therapy	prep_of	1	SENT_490	[p17l1024t3382r1266b3436],
17	.	.	O	.	_	0	SENT_490	[p17l1024t3382r1266b3436],

1	J	NNP	O	J	nn	4	SENT_491	[p17l1024t3382r1266b3436],
2	Am	NNP	O	Am	nn	4	SENT_491	[p17l1279t3384r1368b3425],
3	Med	NNP	O	Med	nn	4	SENT_491	[p17l1383t3382r1495b3425],
4	Assoc	NNP	O	Assoc	_	0	SENT_491	[p17l1509t3384r1655b3425],
5	2009	CD	DATE	2009	num	4	SENT_491	[p17l1669t3384r2146b3432],
6	;	:	O	;	_	0	SENT_491	[p17l1669t3384r2146b3432],
7	302:849	CD	NUMBER	302:849	number	8	SENT_491	[p17l1669t3384r2146b3432],
8	—	CD	NUMBER	—	dep	4	SENT_491	[p17l1669t3384r2146b3432],
9	57	CD	NUMBER	57	dep	8	SENT_491	[p17l1669t3384r2146b3432],
10	.	.	O	.	_	0	SENT_491	[p17l1669t3384r2146b3432],

1	[	NN	O	[	_	0	SENT_492	[p17l6t3447r104b3502],
2	54	CD	NUMBER	54	num	1	SENT_492	[p17l6t3447r104b3502],
3	]	CD	NUMBER	]	num	5	SENT_492	[p17l6t3447r104b3502],
4	Simon	NNP	PERSON	Simon	nn	5	SENT_492	[p17l139t3448r301b3491],
5	T	NN	PERSON	t	dep	1	SENT_492	[p17l315t3450r357b3498],
6	,	,	O	,	_	0	SENT_492	[p17l315t3450r357b3498],
7	Verstuyft	NNP	O	Verstuyft	nn	8	SENT_492	[p17l372t3447r614b3502],
8	C	NNP	O	C	appos	5	SENT_492	[p17l630t3450r673b3498],
9	,	,	O	,	_	0	SENT_492	[p17l630t3450r673b3498],
10	Mary-Krause	NNP	O	Mary-Krause	nn	11	SENT_492	[p17l690t3450r1024b3502],
11	M	NNP	O	M	appos	5	SENT_492	[p17l1041t3450r1102b3498],
12	,	,	O	,	_	0	SENT_492	[p17l1041t3450r1102b3498],
13	Quteineh	NNP	O	Quteineh	nn	14	SENT_492	[p17l1120t3448r1357b3500],
14	L	NNP	O	L	appos	5	SENT_492	[p17l1373t3450r1410b3498],
15	,	,	O	,	_	0	SENT_492	[p17l1373t3450r1410b3498],
16	Drouet	NNP	PERSON	Drouet	nn	17	SENT_492	[p17l1427t3450r1604b3491],
17	E	NNP	PERSON	E	appos	5	SENT_492	[p17l1621t3450r1660b3498],
18	,	,	O	,	_	0	SENT_492	[p17l1621t3450r1660b3498],
19	Meneveau	NNP	ORGANIZATION	Meneveau	nn	20	SENT_492	[p17l1677t3450r1944b3491],
20	N	NNP	ORGANIZATION	N	appos	5	SENT_492	[p17l1961t3450r2011b3498],
21	,	,	O	,	_	0	SENT_492	[p17l1961t3450r2011b3498],
22	et	FW	O	et	nn	23	SENT_492	[p17l2028t3454r2076b3491],
23	al.	FW	O	al.	appos	5	SENT_492	[p17l2091t3448r2146b3491],
24	.	.	O	.	_	0	SENT_492	[p17l2091t3448r2146b3491],

1	French	JJ	MISC	french	amod	2	SENT_493	[p17l139t3514r313b3557],
2	Registry	NN	MISC	registry	_	0	SENT_493	[p17l338t3514r548b3568],
3	of	IN	MISC	of	_	0	SENT_493	[p17l572t3513r625b3557],
4	Acute	JJ	MISC	acute	amod	5	SENT_493	[p17l641t3516r789b3557],
5	ST-Elevation	NN	O	st-elevation	prep_of	2	SENT_493	[p17l815t3514r1139b3557],
6	and	CC	O	and	_	0	SENT_493	[p17l1163t3514r1256b3557],
7	Non-ST-Elevation	NN	O	non-st-elevation	conj_and	5	SENT_493	[p17l1282t3514r1737b3557],
8	Myocardial	JJ	O	myocardial	amod	11	SENT_493	[p17l1762t3514r2051b3568],
9	Infarction	NN	O	infarction	nn	11	SENT_493	[p17l2077t3516r2147b3557, p17l139t3580r339b3624],
10	(	NN	O	(	nn	11	SENT_493	[p17l362t3580r621b3634],
11	FAST-MI	NN	O	fast-mi	dep	2	SENT_493	[p17l362t3580r621b3634],
12	)	CD	NUMBER	)	num	13	SENT_493	[p17l362t3580r621b3634],
13	Investigators	NNS	O	investigator	dep	11	SENT_493	[p17l645t3581r991b3635],
14	.	.	O	.	_	0	SENT_493	[p17l645t3581r991b3635],

1	Genetic	JJ	O	genetic	amod	2	SENT_494	[p17l1016t3581r1212b3624],
2	determinants	NNS	O	determinant	_	0	SENT_494	[p17l1235t3580r1581b3624],
3	of	IN	O	of	_	0	SENT_494	[p17l1606t3580r1659b3624],
4	response	NN	O	response	prep_of	2	SENT_494	[p17l1677t3593r1905b3635],
5	to	TO	O	to	_	0	SENT_494	[p17l1928t3587r1978b3624],
6	clopidogrel	NN	O	clopidogrel	nn	9	SENT_494	[p17l2001t3580r2147b3635, p17l139t3646r301b3701],
7	and	CC	O	and	_	0	SENT_494	[p17l324t3646r417b3690],
8	cardiovascular	JJ	O	cardiovascular	nn	9	SENT_494	[p17l440t3646r817b3690],
9	events	NNS	O	event	prep_to	2	SENT_494	[p17l839t3653r1018b3690],
10	.	.	O	.	_	0	SENT_494	[p17l839t3653r1018b3690],

1	N	NN	O	n	nn	2	SENT_495	[p17l1042t3649r1079b3689],
2	EnglJ	NN	O	englj	nsubj	3	SENT_495	[p17l1103t3646r1249b3701],
3	Med	VBD	O	med	_	0	SENT_495	[p17l1273t3646r1384b3690],
4	2009	CD	DATE	2009	dobj	3	SENT_495	[p17l1407t3648r1884b3697],
5	;	:	O	;	_	0	SENT_495	[p17l1407t3648r1884b3697],
6	360:363	CD	NUMBER	360:363	number	7	SENT_495	[p17l1407t3648r1884b3697],
7	—	CD	NUMBER	—	dep	4	SENT_495	[p17l1407t3648r1884b3697],
8	75	CD	NUMBER	75	dep	7	SENT_495	[p17l1407t3648r1884b3697],
9	.	.	O	.	_	0	SENT_495	[p17l1407t3648r1884b3697],

1	[	NN	O	[	_	0	SENT_496	[p17l6t3712r104b3766],
2	55	CD	NUMBER	55	num	1	SENT_496	[p17l6t3712r104b3766],
3	]	CD	NUMBER	]	num	5	SENT_496	[p17l6t3712r104b3766],
4	Mega	JJ	O	mega	amod	5	SENT_496	[p17l139t3715r278b3766],
5	JL	NN	O	jl	dep	1	SENT_496	[p17l289t3715r351b3766],
6	,	,	O	,	_	0	SENT_496	[p17l289t3715r351b3766],
7	Simon	NNP	PERSON	Simon	nn	8	SENT_496	[p17l370t3713r532b3756],
8	T	NN	PERSON	t	appos	5	SENT_496	[p17l547t3715r589b3762],
9	,	,	O	,	_	0	SENT_496	[p17l547t3715r589b3762],
10	Collet	NNP	ORGANIZATION	Collet	nn	11	SENT_496	[p17l608t3712r757b3756],
11	JP	NNP	ORGANIZATION	JP	appos	5	SENT_496	[p17l767t3715r832b3766],
12	,	,	O	,	_	0	SENT_496	[p17l767t3715r832b3766],
13	Anderson	NNP	PERSON	Anderson	nn	14	SENT_496	[p17l848t3712r1096b3756],
14	JL	NNP	O	JL	appos	5	SENT_496	[p17l1107t3715r1168b3766],
15	,	,	O	,	_	0	SENT_496	[p17l1107t3715r1168b3766],
16	Antman	NNP	ORGANIZATION	Antman	nn	17	SENT_496	[p17l1185t3714r1393b3756],
17	EM	NNP	ORGANIZATION	EM	appos	5	SENT_496	[p17l1411t3715r1504b3762],
18	,	,	O	,	_	0	SENT_496	[p17l1411t3715r1504b3762],
19	Bliden	NNP	PERSON	Bliden	nn	20	SENT_496	[p17l1523t3712r1685b3756],
20	K	NNP	PERSON	K	appos	5	SENT_496	[p17l1703t3715r1748b3762],
21	,	,	O	,	_	0	SENT_496	[p17l1703t3715r1748b3762],
22	et	FW	O	et	nn	23	SENT_496	[p17l1767t3719r1815b3756],
23	al.	FW	O	al.	appos	5	SENT_496	[p17l1831t3712r1887b3756],
24	.	.	O	.	_	0	SENT_496	[p17l1831t3712r1887b3756],

1	Reducedfunction	NN	O	reducedfunction	nn	3	SENT_497	[p17l1906t3712r2147b3756, p17l139t3778r355b3822],
2	CYP2C19	NN	O	cyp2c19	nn	3	SENT_497	[p17l386t3780r616b3822],
3	genotype	NN	O	genotype	_	0	SENT_497	[p17l648t3785r886b3832],
4	and	CC	O	and	dep	5	SENT_497	[p17l919t3778r1012b3822],
5	risk	NN	O	risk	dep	12	SENT_497	[p17l1044t3778r1139b3822],
6	of	IN	O	of	_	0	SENT_497	[p17l1168t3778r1222b3822],
7	adverse	JJ	O	adverse	amod	9	SENT_497	[p17l1247t3778r1444b3822],
8	clinical	JJ	O	clinical	amod	9	SENT_497	[p17l1476t3778r1658b3822],
9	outcomes	NNS	O	outcome	prep_of	5	SENT_497	[p17l1691t3785r1940b3822],
10	among	IN	O	among	_	0	SENT_497	[p17l1972t3791r2148b3832],
11	patients	NNS	O	patient	prep_among	9	SENT_497	[p18l139t18r346b72],
12	treated	VBN	O	treat	dep	3	SENT_497	[p18l373t18r557b61],
13	with	IN	O	with	_	0	SENT_497	[p18l583t18r702b61],
14	clopidogrel	NN	O	clopidogrel	prep_with	12	SENT_497	[p18l729t18r1017b72],
15	predominantly	RB	O	predominantly	amod	14	SENT_497	[p18l1045t18r1431b72],
16	for	IN	O	for	prep	15	SENT_497	[p18l1457t17r1528b61],
17	PCI	NNP	O	PCI	dep	16	SENT_497	[p18l1553t20r1648b62],
18	:	:	O	:	_	0	SENT_497	[p18l1553t20r1648b62],
19	a	DT	O	a	det	20	SENT_497	[p18l1679t30r1706b61],
20	meta-analysis	NN	O	meta-analysis	dep	17	SENT_497	[p18l1732t18r2106b72],
21	.	.	O	.	_	0	SENT_497	[p18l1732t18r2106b72],
22	]	SYM	O	]	dep	3	SENT_497	[p18l2127t20r2147b72],

1	Am	VBP	O	be	dep	3	SENT_498	[p18l137t86r225b127],
2	Med	NNP	O	Med	nn	3	SENT_498	[p18l248t84r360b128],
3	Assoc	NNP	O	Assoc	_	0	SENT_498	[p18l381t86r527b128],
4	2010	CD	DATE	2010	num	3	SENT_498	[p18l549t86r1058b134],
5	;	:	O	;	_	0	SENT_498	[p18l549t86r1058b134],
6	304:1821	CD	NUMBER	304:1821	dep	3	SENT_498	[p18l549t86r1058b134],
7	—	CD	NUMBER	—	num	8	SENT_498	[p18l549t86r1058b134],
8	30	CD	NUMBER	30	dep	6	SENT_498	[p18l549t86r1058b134],
9	.	.	O	.	_	0	SENT_498	[p18l549t86r1058b134],

1	[	NN	O	[	nn	4	SENT_499	[p18l6t149r104b204],
2	56	CD	NUMBER	56	num	4	SENT_499	[p18l6t149r104b204],
3	]	NN	O	]	nn	4	SENT_499	[p18l6t149r104b204],
4	Wallentin	NN	PERSON	wallentin	_	0	SENT_499	[p18l137t149r395b193],
5	L	NN	PERSON	l	dep	4	SENT_499	[p18l410t152r447b200],
6	,	,	O	,	_	0	SENT_499	[p18l410t152r447b200],
7	James	NNP	PERSON	James	nn	8	SENT_499	[p18l457t152r614b204],
8	S	NNP	PERSON	S	appos	5	SENT_499	[p18l630t152r668b200],
9	,	,	O	,	_	0	SENT_499	[p18l630t152r668b200],
10	Storey	NNP	PERSON	Storey	nn	11	SENT_499	[p18l685t152r848b204],
11	RF	NNP	PERSON	RF	appos	5	SENT_499	[p18l863t152r935b200],
12	,	,	O	,	_	0	SENT_499	[p18l863t152r935b200],
13	Armstrong	NNP	ORGANIZATION	Armstrong	nn	14	SENT_499	[p18l949t151r1228b204],
14	M	NNP	ORGANIZATION	M	appos	5	SENT_499	[p18l1243t152r1304b200],
15	,	,	O	,	_	0	SENT_499	[p18l1243t152r1304b200],
16	Barratt	NNP	PERSON	Barratt	nn	18	SENT_499	[p18l1321t152r1500b193],
17	B	NNP	O	B	nn	18	SENT_499	[p18l1515t152r1575b204],
18	]	NN	O	]	appos	5	SENT_499	[p18l1515t152r1575b204],
19	,	,	O	,	_	0	SENT_499	[p18l1515t152r1575b204],
20	Horrow	NNP	PERSON	Horrow	nn	21	SENT_499	[p18l1592t152r1830b204],
21	]	NNP	O	]	appos	5	SENT_499	[p18l1592t152r1830b204],
22	,	,	O	,	_	0	SENT_499	[p18l1592t152r1830b204],
23	et	FW	O	et	nn	24	SENT_499	[p18l1847t156r1894b193],
24	al.	FW	O	al.	appos	5	SENT_499	[p18l1909t149r1964b193],
25	.	.	O	.	_	0	SENT_499	[p18l1909t149r1964b193],

1	PLATO	NNP	ORGANIZATION	PLATO	_	0	SENT_500	[p18l1982t151r2147b193],
2	investigators	NNS	O	investigator	dep	1	SENT_500	[p18l139t217r485b270],
3	.	.	O	.	_	0	SENT_500	[p18l139t217r485b270],

1	Effect	NN	O	effect	_	0	SENT_501	[p18l505t216r650b260],
2	of	IN	O	of	_	0	SENT_501	[p18l667t216r721b260],
3	CYP2C19	NN	O	cyp2c19	nn	8	SENT_501	[p18l733t218r962b260],
4	and	CC	O	and	_	0	SENT_501	[p18l982t216r1075b260],
5	ABCB1	NN	O	abcb1	nn	8	SENT_501	[p18l1092t218r1257b260],
6	single	JJ	O	single	amod	8	SENT_501	[p18l1282t216r1432b270],
7	nucleotide	NN	O	nucleotide	nn	8	SENT_501	[p18l1451t216r1723b260],
8	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_501	[p18l1742t216r2147b270],
9	on	IN	O	on	_	0	SENT_501	[p18l139t295r202b326],
10	outcomes	NNS	O	outcome	prep_on	1	SENT_501	[p18l225t289r474b326],
11	of	IN	O	of	_	0	SENT_501	[p18l498t282r551b326],
12	treatment	NN	O	treatment	prep_of	10	SENT_501	[p18l568t289r828b326],
13	with	IN	O	with	_	0	SENT_501	[p18l848t282r967b326],
14	ticagrelor	NN	O	ticagrelor	prep_with	12	SENT_501	[p18l990t282r1239b337],
15	versus	CC	O	versus	prep	14	SENT_501	[p18l1259t295r1423b326],
16	clopidogrel	NN	O	clopidogrel	dep	15	SENT_501	[p18l1448t282r1736b337],
17	for	IN	O	for	_	0	SENT_501	[p18l1761t282r1832b326],
18	acute	JJ	O	acute	amod	20	SENT_501	[p18l1853t289r1991b326],
19	coronary	JJ	O	coronary	amod	20	SENT_501	[p18l2014t295r2147b326, p18l139t360r255b402],
20	syndromes	NNS	O	syndrome	prep_for	16	SENT_501	[p18l317t348r616b402],
21	:	:	O	:	_	0	SENT_501	[p18l317t348r616b402],
22	a	DT	O	a	det	24	SENT_501	[p18l682t360r708b391],
23	genetic	JJ	O	genetic	amod	24	SENT_501	[p18l770t349r957b402],
24	substudy	NN	O	substudy	dep	1	SENT_501	[p18l1020t348r1256b402],
25	of	IN	O	of	_	0	SENT_501	[p18l1317t348r1371b391],
26	the	DT	O	the	det	28	SENT_501	[p18l1427t348r1508b391],
27	PLATO	NNP	O	PLATO	nn	28	SENT_501	[p18l1572t350r1737b391],
28	trial	NN	O	trial	prep_of	24	SENT_501	[p18l1800t348r1917b392],
29	.	.	O	.	_	0	SENT_501	[p18l1800t348r1917b392],

1	Lancet	NNP	O	Lancet	nn	2	SENT_502	[p18l1981t351r2149b391],
2	20l0	NN	O	20l0	_	0	SENT_502	[p18l139t416r616b464],
3	;	:	O	;	_	0	SENT_502	[p18l139t416r616b464],
4	376:1320	CD	NUMBER	376:1320	number	5	SENT_502	[p18l139t416r616b464],
5	—	CD	NUMBER	—	dep	2	SENT_502	[p18l139t416r616b464],
6	8	CD	NUMBER	8	dep	5	SENT_502	[p18l139t416r616b464],
7	.	.	O	.	_	0	SENT_502	[p18l139t416r616b464],

1	[	NN	O	[	_	0	SENT_503	[p18l6t479r104b534],
2	57	CD	NUMBER	57	num	1	SENT_503	[p18l6t479r104b534],
3	]	CD	NUMBER	]	num	5	SENT_503	[p18l6t479r104b534],
4	Pare	NN	O	pare	nn	5	SENT_503	[p18l139t482r249b523],
5	G	NN	O	g	dep	1	SENT_503	[p18l278t482r327b530],
6	,	,	O	,	_	0	SENT_503	[p18l278t482r327b530],
7	Mehta	NNP	ORGANIZATION	Mehta	nn	8	SENT_503	[p18l356t480r520b523],
8	SR	NN	ORGANIZATION	sr	appos	5	SENT_503	[p18l548t482r621b530],
9	,	,	O	,	_	0	SENT_503	[p18l548t482r621b530],
10	Yusuf	NNP	PERSON	Yusuf	nn	11	SENT_503	[p18l648t480r800b523],
11	S	NNP	PERSON	S	appos	5	SENT_503	[p18l822t482r860b530],
12	,	,	O	,	_	0	SENT_503	[p18l822t482r860b530],
13	Anand	NNP	O	Anand	nn	14	SENT_503	[p18l887t480r1054b523],
14	SS	NNP	O	SS	appos	5	SENT_503	[p18l1083t482r1150b530],
15	,	,	O	,	_	0	SENT_503	[p18l1083t482r1150b530],
16	Connolly	NNP	PERSON	Connolly	nn	18	SENT_503	[p18l1179t480r1409b534],
17	S	NNP	O	S	nn	18	SENT_503	[p18l1436t482r1492b534],
18	]	NN	O	]	appos	5	SENT_503	[p18l1436t482r1492b534],
19	,	,	O	,	_	0	SENT_503	[p18l1436t482r1492b534],
20	Hirsh	NNP	PERSON	Hirsh	nn	21	SENT_503	[p18l1521t480r1659b523],
21	]	NNP	O	]	appos	5	SENT_503	[p18l1681t482r1714b534],
22	,	,	O	,	_	0	SENT_503	[p18l1681t482r1714b534],
23	et	FW	O	et	nn	24	SENT_503	[p18l1743t486r1791b523],
24	al.	FW	O	al.	appos	5	SENT_503	[p18l1818t480r1874b524],
25	.	.	O	.	_	0	SENT_503	[p18l1818t480r1874b524],

1	Effects	NNS	O	effect	_	0	SENT_504	[p18l1903t479r2071b523],
2	of	IN	O	of	_	0	SENT_504	[p18l2101t479r2154b523],
3	CYP2C19	NN	O	cyp2c19	nn	4	SENT_504	[p18l139t548r369b590],
4	genotype	NN	O	genotype	prep_of	1	SENT_504	[p18l403t553r643b601],
5	on	IN	O	on	_	0	SENT_504	[p18l677t559r740b590],
6	outcomes	NNS	O	outcome	prep_on	1	SENT_504	[p18l774t553r1023b590],
7	of	IN	O	of	_	0	SENT_504	[p18l1058t546r1111b590],
8	clopidogrel	NN	O	clopidogrel	nn	9	SENT_504	[p18l1140t546r1428b601],
9	treatment	NN	O	treatment	prep_of	6	SENT_504	[p18l1463t553r1734b590],
10	.	.	O	.	_	0	SENT_504	[p18l1463t553r1734b590],

1	N	NN	O	n	nn	3	SENT_505	[p18l1770t549r1807b589],
2	Engl	NNP	O	Engl	nn	3	SENT_505	[p18l1843t546r1952b601],
3	]	NNP	O	]	nsubj	4	SENT_505	[p18l1980t549r2000b601],
4	Med	VBD	O	med	_	0	SENT_505	[p18l2035t546r2147b590],
5	20l0	CD	NUMBER	20l0	dobj	4	SENT_505	[p18l139t614r649b662],
6	;	:	O	;	_	0	SENT_505	[p18l139t614r649b662],
7	363:1704	CD	NUMBER	363:1704	number	8	SENT_505	[p18l139t614r649b662],
8	—	CD	NUMBER	—	dep	5	SENT_505	[p18l139t614r649b662],
9	14	CD	NUMBER	14	dep	8	SENT_505	[p18l139t614r649b662],
10	.	.	O	.	_	0	SENT_505	[p18l139t614r649b662],

1	[	NN	O	[	nn	5	SENT_506	[p18l6t678r104b732],
2	58	CD	NUMBER	58	num	5	SENT_506	[p18l6t678r104b732],
3	]	NNP	O	]	nn	5	SENT_506	[p18l6t678r104b732],
4	Smith	NNP	ORGANIZATION	Smith	nn	5	SENT_506	[p18l139t678r291b722],
5	SMG	NNP	ORGANIZATION	SMG	_	0	SENT_506	[p18l308t680r439b728],
6	,	,	O	,	_	0	SENT_506	[p18l308t680r439b728],
7	Buckland	NNP	ORGANIZATION	Buckland	nn	8	SENT_506	[p18l459t678r696b722],
8	R	NNP	ORGANIZATION	R	appos	5	SENT_506	[p18l714t681r758b728],
9	,	,	O	,	_	0	SENT_506	[p18l714t681r758b728],
10	Daly	NNP	PERSON	Daly	nn	11	SENT_506	[p18l776t678r891b732],
11	ME	NNP	O	ME	appos	5	SENT_506	[p18l908t681r1002b728],
12	,	,	O	,	_	0	SENT_506	[p18l908t681r1002b728],
13	Storey	NNP	O	Storey	nn	14	SENT_506	[p18l1021t680r1184b732],
14	RF	NNP	O	RF	appos	5	SENT_506	[p18l1202t681r1274b722],
15	.	.	O	.	_	0	SENT_506	[p18l1202t681r1274b722],

1	Inhibition	NN	O	inhibition	nsubj	16	SENT_507	[p18l1293t678r1547b722],
2	of	IN	O	of	_	0	SENT_507	[p18l1565t678r1618b722],
3	platelet	NN	O	platelet	nn	4	SENT_507	[p18l1630t678r1827b732],
4	aggregation	NN	O	aggregation	prep_of	1	SENT_507	[p18l1843t679r2148b732],
5	by	IN	O	by	_	0	SENT_507	[p18l138t744r201b798],
6	clopidogrel	NN	O	clopidogrel	prep_by	4	SENT_507	[p18l237t744r525b798],
7	is	VBZ	O	be	cop	16	SENT_507	[p18l562t745r600b788],
8	unaffected	JJ	O	unaffected	amod	16	SENT_507	[p18l637t744r910b788],
9	by	IN	O	by	_	0	SENT_507	[p18l946t744r1009b798],
10	the	DT	O	the	det	11	SENT_507	[p18l1044t744r1125b788],
11	CYP2C19	NN	O	cyp2c19	prep_by	8	SENT_507	[p18l1162t746r1392b788],
12	681	CD	NUMBER	681	num	13	SENT_507	[p18l1430t746r1518b788],
13	G	NN	O	g	npadvmod	14	SENT_507	[p18l1529t746r1648b789],
14	>	JJR	O	>	amod	11	SENT_507	[p18l1529t746r1648b789],
15	A	DT	O	a	det	16	SENT_507	[p18l1529t746r1648b789],
16	polymorphism	NN	O	polymorphism	_	0	SENT_507	[p18l1683t744r2064b798],
17	in	IN	O	in	_	0	SENT_507	[p18l2100t745r2148b787],
18	patients	NNS	O	patient	prep_in	16	SENT_507	[p18l139t810r346b864],
19	with	IN	O	with	prep	18	SENT_507	[p18l363t810r482b853],
20	coronary	JJ	O	coronary	amod	21	SENT_507	[p18l498t822r728b864],
21	artery	NN	O	artery	dep	19	SENT_507	[p18l743t816r898b864],
22	disease	NN	O	disease	nn	25	SENT_507	[p18l914t810r1100b853],
23	(	NN	O	(	nn	25	SENT_507	[p18l1117t810r1332b864],
24	abstr	NN	O	abstr	nn	25	SENT_507	[p18l1117t810r1332b864],
25	)	NN	O	)	dep	21	SENT_507	[p18l1117t810r1332b864],
26	.	.	O	.	_	0	SENT_507	[p18l1117t810r1332b864],
27	]	SYM	O	]	dep	16	SENT_507	[p18l1117t810r1332b864],

1	Am	VBP	O	be	dep	3	SENT_508	[p18l1346t812r1434b853],
2	Coll	NNP	O	Coll	nn	3	SENT_508	[p18l1451t810r1547b853],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_508	[p18l1564t810r1746b853],
4	2007	CD	DATE	2007	dep	3	SENT_508	[p18l1764t812r2147b860],
5	;	:	O	;	_	0	SENT_508	[p18l1764t812r2147b860],
6	49:375	CD	NUMBER	49:375	num	7	SENT_508	[p18l1764t812r2147b860],
7	A.	NN	O	a.	dep	3	SENT_508	[p18l1764t812r2147b860],
8	[	NNP	O	[	dep	7	SENT_508	[p18l6t876r104b931],
9	59	CD	NUMBER	59	num	8	SENT_508	[p18l6t876r104b931],
10	]	CD	NUMBER	]	num	12	SENT_508	[p18l6t876r104b931],
11	Desta	NNP	O	Desta	nn	12	SENT_508	[p18l139t879r282b920],
12	Z	NN	O	z	dep	8	SENT_508	[p18l299t879r341b926],
13	,	,	O	,	_	0	SENT_508	[p18l299t879r341b926],
14	Zhao	NNP	PERSON	Zhao	nn	15	SENT_508	[p18l358t876r483b920],
15	X	NNP	PERSON	X	appos	8	SENT_508	[p18l500t879r548b926],
16	,	,	O	,	_	0	SENT_508	[p18l500t879r548b926],
17	Shin	NNP	PERSON	Shin	nn	19	SENT_508	[p18l567t876r678b920],
18	]	CD	NUMBER	]	num	19	SENT_508	[p18l690t878r763b931],
19	G	NN	O	g	appos	8	SENT_508	[p18l690t878r763b931],
20	,	,	O	,	_	0	SENT_508	[p18l690t878r763b931],
21	Flockhart	NNP	ORGANIZATION	Flockhart	nn	22	SENT_508	[p18l782t876r1023b920],
22	DA	NNP	ORGANIZATION	DA	appos	8	SENT_508	[p18l1041t878r1127b920],
23	.	.	O	.	_	0	SENT_508	[p18l1041t878r1127b920],

1	Clinical	JJ	O	clinical	amod	2	SENT_509	[p18l1147t876r1336b920],
2	signiﬁcance	NN	O	signiﬁcance	_	0	SENT_509	[p18l1355t876r1658b931],
3	of	IN	O	of	_	0	SENT_509	[p18l1677t876r1730b920],
4	the	DT	O	the	det	5	SENT_509	[p18l1741t876r1823b920],
5	cytochrome	NN	O	cytochrome	prep_of	2	SENT_509	[p18l1841t876r2147b930],

1	P450	NN	O	p450	nn	2	SENT_510	[p18l139t944r266b985],
2	2Cl9	NN	O	2cl9	_	0	SENT_510	[p18l288t944r417b985],
3	genetic	JJ	O	genetic	amod	4	SENT_510	[p18l440t942r627b996],
4	polymorphism	NN	O	polymorphism	dep	2	SENT_510	[p18l650t941r1042b996],
5	.	.	O	.	_	0	SENT_510	[p18l650t941r1042b996],

1	Clin	NNP	O	Clin	nn	2	SENT_511	[p18l1067t941r1166b985],
2	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_511	[p18l1189t941r1579b985],
3	2002	CD	DATE	2002	num	2	SENT_511	[p18l1600t944r2045b992],
4	;	:	O	;	_	0	SENT_511	[p18l1600t944r2045b992],
5	41:913	CD	NUMBER	41:913	number	6	SENT_511	[p18l1600t944r2045b992],
6	—	CD	NUMBER	—	dep	2	SENT_511	[p18l1600t944r2045b992],
7	58	CD	NUMBER	58	dep	6	SENT_511	[p18l1600t944r2045b992],
8	.	.	O	.	_	0	SENT_511	[p18l1600t944r2045b992],

1	[	RB	O	[	dep	5	SENT_512	[p18l6t1008r103b1062],
2	60	CD	NUMBER	60	num	5	SENT_512	[p18l6t1008r103b1062],
3	]	CD	NUMBER	]	num	5	SENT_512	[p18l6t1008r103b1062],
4	Xie	NNP	O	Xie	nn	5	SENT_512	[p18l136t1009r219b1052],
5	HG	NNP	O	HG	_	0	SENT_512	[p18l242t1010r333b1058],
6	,	,	O	,	_	0	SENT_512	[p18l242t1010r333b1058],
7	Kim	NNP	PERSON	Kim	nn	8	SENT_512	[p18l356t1009r459b1051],
8	RB	NN	O	rb	appos	5	SENT_512	[p18l481t1011r558b1058],
9	,	,	O	,	_	0	SENT_512	[p18l481t1011r558b1058],
10	Wood	NNP	O	Wood	nn	12	SENT_512	[p18l579t1008r734b1052],
11	A	NNP	O	A	nn	12	SENT_512	[p18l754t1010r819b1062],
12	]	NN	O	]	appos	5	SENT_512	[p18l754t1010r819b1062],
13	,	,	O	,	_	0	SENT_512	[p18l754t1010r819b1062],
14	Stein	NNP	PERSON	Stein	nn	15	SENT_512	[p18l843t1009r971b1052],
15	CM	NN	O	cm	appos	12	SENT_512	[p18l993t1010r1089b1052],
16	.	.	O	.	_	0	SENT_512	[p18l993t1010r1089b1052],

1	Molecular	JJ	MISC	molecular	amod	2	SENT_513	[p18l1113t1008r1374b1052],
2	basis	NN	O	basis	_	0	SENT_513	[p18l1393t1008r1520b1052],
3	of	IN	O	of	_	0	SENT_513	[p18l1543t1008r1596b1052],
4	ethnic	JJ	O	ethnic	amod	5	SENT_513	[p18l1613t1008r1772b1052],
5	differences	NNS	O	difference	prep_of	2	SENT_513	[p18l1795t1008r2077b1052],
6	in	IN	O	in	_	0	SENT_513	[p18l2100t1009r2148b1051],
7	drug	NN	O	drug	nn	8	SENT_513	[p18l138t1074r258b1129],
8	disposition	NN	O	disposition	prep_in	2	SENT_513	[p18l274t1074r560b1129],
9	and	CC	O	and	_	0	SENT_513	[p18l577t1074r670b1118],
10	response	NN	O	response	prep_in	2	SENT_513	[p18l688t1087r929b1129],
11	.	.	O	.	_	0	SENT_513	[p18l688t1087r929b1129],

1	Annu	NNP	O	Annu	nn	4	SENT_514	[p18l945t1076r1084b1118],
2	Rev	NN	O	rev	nn	4	SENT_514	[p18l1101t1077r1194b1118],
3	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_514	[p18l1210t1074r1482b1118],
4	Toxicol	NNP	O	Toxicol	_	0	SENT_514	[p18l1498t1074r1685b1118],
5	2001	CD	DATE	2001	num	4	SENT_514	[p18l1702t1076r1823b1118],
6	:41	CD	NUMBER	:41	number	7	SENT_514	[p18l1837t1076r1909b1124],
7	:81	CD	NUMBER	:81	dep	4	SENT_514	[p18l1924t1076r1995b1118],
8	5-50	CD	NUMBER	5-50	dep	7	SENT_514	[p18l2007t1076r2146b1118],
9	.	.	O	.	_	0	SENT_514	[p18l2007t1076r2146b1118],

1	[	NN	O	[	_	0	SENT_515	[p18l6t1140r104b1194],
2	61	CD	NUMBER	61	num	1	SENT_515	[p18l6t1140r104b1194],
3	]	CD	NUMBER	]	num	6	SENT_515	[p18l6t1140r104b1194],
4	Wedlund	NNP	PERSON	Wedlund	nn	6	SENT_515	[p18l137t1140r376b1183],
5	P	NN	O	p	nn	6	SENT_515	[p18l448t1143r506b1194],
6	]	NN	O	]	dep	1	SENT_515	[p18l448t1143r506b1194],
7	.	.	O	.	_	0	SENT_515	[p18l448t1143r506b1194],

1	The	DT	O	the	det	2	SENT_516	[p18l576t1140r670b1183],
2	CYP2Cl9	NN	O	cyp2cl9	_	0	SENT_516	[p18l741t1142r971b1183],
3	enzyme	NN	O	enzyme	nn	4	SENT_516	[p18l1042t1152r1244b1194],
4	polymorphism	NN	O	polymorphism	dep	2	SENT_516	[p18l1316t1140r1709b1194],
5	.	.	O	.	_	0	SENT_516	[p18l1316t1140r1709b1194],

1	Pharmacology	NN	O	pharmacology	_	0	SENT_517	[p18l1781t1140r2149b1194],

1	[	NN	O	[	nn	4	SENT_518	[p18l6t1271r104b1326],
2	62	CD	NUMBER	62	num	4	SENT_518	[p18l6t1271r104b1326],
3	]	NN	O	]	nn	4	SENT_518	[p18l6t1271r104b1326],
4	Azarpira	NN	O	azarpira	_	0	SENT_518	[p18l137t1272r357b1326],
5	N	NN	O	n	dep	4	SENT_518	[p18l381t1274r431b1322],
6	,	,	O	,	_	0	SENT_518	[p18l381t1274r431b1322],
7	Namazi	NNP	PERSON	Namazi	nn	8	SENT_518	[p18l454t1272r648b1315],
8	S	NNP	O	S	appos	5	SENT_518	[p18l672t1274r710b1322],
9	,	,	O	,	_	0	SENT_518	[p18l672t1274r710b1322],
10	Hendijani	NNP	PERSON	Hendijani	nn	11	SENT_518	[p18l735t1272r985b1326],
11	F	NN	PERSON	f	appos	5	SENT_518	[p18l1009t1274r1046b1322],
12	,	,	O	,	_	0	SENT_518	[p18l1009t1274r1046b1322],
13	Banan	NNP	LOCATION	Banan	nn	14	SENT_518	[p18l1070t1274r1228b1315],
14	M	NNP	O	M	appos	5	SENT_518	[p18l1251t1274r1313b1322],
15	,	,	O	,	_	0	SENT_518	[p18l1251t1274r1313b1322],
16	Darai	NNP	PERSON	Darai	nn	18	SENT_518	[p18l1337t1272r1472b1315],
17	M.	NNP	O	M.	nn	18	SENT_518	[p18l1496t1274r1557b1316],
18	Investigation	NNP	O	Investigation	appos	5	SENT_518	[p18l1582t1272r1918b1326],
19	of	IN	O	of	_	0	SENT_518	[p18l1942t1272r1995b1315],
20	allele	NN	O	allele	nn	23	SENT_518	[p18l2011t1272r2147b1315],
21	and	CC	O	and	_	0	SENT_518	[p18l139t1338r232b1382],
22	genotype	NN	O	genotype	nn	23	SENT_518	[p18l247t1345r486b1393],
23	frequencies	NNS	O	frequency	prep_of	18	SENT_518	[p18l501t1338r798b1393],
24	of	IN	O	of	_	0	SENT_518	[p18l814t1338r867b1382],
25	CYP2C9	NN	O	cyp2c9	prep_of	23	SENT_518	[p18l876t1340r1085b1389],
26	,	,	O	,	_	0	SENT_518	[p18l876t1340r1085b1389],
27	CYP2C1	NN	O	cyp2c1	appos	5	SENT_518	[p18l1101t1340r1291b1382],
28	9	CD	NUMBER	9	num	27	SENT_518	[p18l1302t1340r1330b1382],
29	and	CC	O	and	_	0	SENT_518	[p18l1346t1338r1440b1382],
30	VKORC1	NN	O	vkorc1	appos	5	SENT_518	[p18l1452t1340r1661b1382],
31	in	IN	O	in	_	0	SENT_518	[p18l1684t1339r1731b1381],
32	Iran	NNP	LOCATION	Iran	prep_in	4	SENT_518	[p18l1745t1341r1858b1382],
33	.	.	O	.	_	0	SENT_518	[p18l1745t1341r1858b1382],

1	Pharmacol	NNP	O	Pharmacol	nn	2	SENT_519	[p18l1875t1338r2147b1382],
2	Rep	NNP	O	Rep	_	0	SENT_519	[p18l139t1406r233b1458],
3	2010	CD	DATE	2010	num	2	SENT_519	[p18l256t1406r667b1454],
4	;	:	O	;	_	0	SENT_519	[p18l256t1406r667b1454],
5	62:740	CD	NUMBER	62:740	number	6	SENT_519	[p18l256t1406r667b1454],
6	—	CD	NUMBER	—	dep	2	SENT_519	[p18l256t1406r667b1454],
7	6	CD	NUMBER	6	dep	6	SENT_519	[p18l256t1406r667b1454],
8	.	.	O	.	_	0	SENT_519	[p18l256t1406r667b1454],

1	[	NN	O	[	nn	5	SENT_520	[p18l6t1470r104b1524],
2	63	CD	NUMBER	63	num	5	SENT_520	[p18l6t1470r104b1524],
3	]	CD	NUMBER	]	num	5	SENT_520	[p18l6t1470r104b1524],
4	Zand	NNP	ORGANIZATION	Zand	nn	5	SENT_520	[p18l138t1470r264b1514],
5	N	NNP	ORGANIZATION	N	_	0	SENT_520	[p18l300t1473r351b1520],
6	,	,	O	,	_	0	SENT_520	[p18l300t1473r351b1520],
7	Tajik	NNP	ORGANIZATION	Tajik	nn	8	SENT_520	[p18l384t1470r511b1524],
8	N	NNP	ORGANIZATION	N	appos	5	SENT_520	[p18l545t1473r595b1520],
9	,	,	O	,	_	0	SENT_520	[p18l545t1473r595b1520],
10	Moghaddam	NNP	PERSON	Moghaddam	nn	11	SENT_520	[p18l631t1470r956b1524],
11	AS	NNP	O	AS	appos	5	SENT_520	[p18l989t1472r1067b1520],
12	,	,	O	,	_	0	SENT_520	[p18l989t1472r1067b1520],
13	Milanian	NNP	O	Milanian	appos	5	SENT_520	[p18l1103t1470r1331b1514],
14	1	CD	NUMBER	1	num	13	SENT_520	[p18l1366t1473r1392b1514],
15	.	.	O	.	_	0	SENT_520	[p18l1366t1473r1392b1514],

1	Genetic	JJ	O	genetic	amod	2	SENT_521	[p18l1429t1471r1625b1514],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_521	[p18l1660t1470r2064b1524],
3	of	IN	O	of	_	0	SENT_521	[p18l2101t1470r2154b1514],
4	cytochrome	NN	O	cytochrome	nn	6	SENT_521	[p18l139t1536r445b1590],
5	P450	NN	O	p450	nn	6	SENT_521	[p18l474t1538r601b1580],
6	enzymes	NNS	O	enzyme	prep_of	2	SENT_521	[p18l629t1549r855b1590],
7	2C9	NN	O	2c9	dep	2	SENT_521	[p18l885t1538r981b1580],
8	and	CC	O	and	_	0	SENT_521	[p18l1010t1536r1104b1580],
9	2C19	NN	O	2c19	dep	2	SENT_521	[p18l1132t1538r1261b1580],
10	in	IN	O	in	_	0	SENT_521	[p18l1291t1537r1339b1579],
11	a	DT	O	a	det	14	SENT_521	[p18l1366t1549r1392b1580],
12	healthy	JJ	O	healthy	amod	14	SENT_521	[p18l1422t1536r1616b1590],
13	Iranian	JJ	MISC	iranian	amod	14	SENT_521	[p18l1643t1537r1825b1580],
14	population	NN	O	population	prep_in	7	SENT_521	[p18l1854t1536r2147b1590],
15	.	.	O	.	_	0	SENT_521	[p18l1854t1536r2147b1590],

1	Clin	NNP	O	Clin	nn	4	SENT_522	[p18l139t1602r238b1645],
2	Exp	NNP	O	Exp	nn	4	SENT_522	[p18l261t1604r353b1656],
3	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_522	[p18l377t1602r649b1645],
4	Physiol	NNP	O	Physiol	_	0	SENT_522	[p18l673t1602r857b1656],
5	2007	CD	DATE	2007	num	4	SENT_522	[p18l880t1604r1291b1652],
6	;	:	O	;	_	0	SENT_522	[p18l880t1604r1291b1652],
7	34:102	CD	NUMBER	34:102	number	8	SENT_522	[p18l880t1604r1291b1652],
8	—	CD	NUMBER	—	dep	4	SENT_522	[p18l880t1604r1291b1652],
9	5	CD	NUMBER	5	dep	8	SENT_522	[p18l880t1604r1291b1652],
10	.	.	O	.	_	0	SENT_522	[p18l880t1604r1291b1652],

